"id","mcq_json","rubric","question","option_a","option_b","option_c","option_d","correct_option"
"OIC-005-01-A","{""question"": ""What is required for a user to receive compensation for the harmful consequences of a medical act?"", ""option_a"": ""Only that the act caused the damage"", ""option_b"": ""Only that the act gave rise to liability"", ""option_c"": ""That the act caused the damage, that it gave rise to liability, and that there was a causal link between the act and the damage"", ""option_d"": ""That the user suffered physical or mental injury as a result of the act"", ""correct_option"": ""C""}","Definition","What is required for a user to receive compensation for the harmful consequences of a medical act?","Only that the act caused the damage","Only that the act gave rise to liability","That the act caused the damage, that it gave rise to liability, and that there was a causal link between the act and the damage","That the user suffered physical or mental injury as a result of the act","c"
"OIC-005-02-A","{""question"": ""What is the primary purpose of criminal liability in the context of medical practice?"", ""option_a"": ""To provide financial compensation to patients who have suffered harm"", ""option_b"": ""To punish individuals whose behaviour is reprehensible in society"", ""option_c"": ""To promote a culture of transparency and accountability within healthcare institutions"", ""option_d"": ""To establish a framework for resolving civil disputes between patients and healthcare providers"", ""correct_option"": ""B""}","Definition","What is the primary purpose of criminal liability in the context of medical practice?","To provide financial compensation to patients who have suffered harm","To punish individuals whose behaviour is reprehensible in society","To promote a culture of transparency and accountability within healthcare institutions","To establish a framework for resolving civil disputes between patients and healthcare providers","b"
"OIC-005-03-A","{""question"": ""Who bears civil liability for damage caused to a patient by a doctor employed by a private establishment?"", ""option_a"": ""The doctor, regardless of their actions"", ""option_b"": ""The employer of the doctor, if the doctor acted within the scope of their mission"", ""option_c"": ""The patient, for not seeking a second opinion"", ""option_d"": ""The court, for not properly assessing the situation"", ""correct_option"": ""B""}","Definition","Who bears civil liability for damage caused to a patient by a doctor employed by a private establishment?","The doctor, regardless of their actions","The employer of the doctor, if the doctor acted within the scope of their mission","The patient, for not seeking a second opinion","The court, for not properly assessing the situation","b"
"OIC-005-04-A","{""question"": ""In the context of administrative liability, what type of fault refers to misconduct committed by a public official in the performance of their duties, using official resources and without personal interest?"", ""option_a"": ""Fault in the organisation and operation of the department"", ""option_b"": ""Official misconduct"", ""option_c"": ""Personal misconduct or misconduct detached from the service"", ""option_d"": ""Therapeutic hazard"", ""correct_option"": ""B""}","Definition","In the context of administrative liability, what type of fault refers to misconduct committed by a public official in the performance of their duties, using official resources and without personal interest?","Fault in the organisation and operation of the department","Official misconduct","Personal misconduct or misconduct detached from the service","Therapeutic hazard","b"
"OIC-005-05-A","{""question"": ""What is the primary body responsible for disciplinary liability in the medical profession?"", ""option_a"": ""The Penal Code"", ""option_b"": ""The Ordre des M\u00e9decins"", ""option_c"": ""The Conseil d'Etat"", ""option_d"": ""The Public Health Code"", ""correct_option"": ""B""}","Definition","What is the primary body responsible for disciplinary liability in the medical profession?","The Penal Code","The Ordre des Médecins","The Conseil d'Etat","The Public Health Code","b"
"OIC-005-06-A","{""question"": ""What is the term used to describe liability for damage related to care that occurs without any breach of professional or scientific rules or error?"", ""option_a"": ""Fault-based liability"", ""option_b"": ""No-fault liability"", ""option_c"": ""Administrative liability"", ""option_d"": ""Disciplinary liability"", ""correct_option"": ""B""}","Definition","What is the term used to describe liability for damage related to care that occurs without any breach of professional or scientific rules or error?","Fault-based liability","No-fault liability","Administrative liability","Disciplinary liability","b"
"OIC-005-07-A","{""question"": ""According to Article L.1142-1 of the French Public Health Code, what is the condition for health professionals and establishments to be liable for the harmful consequences of preventive, preventive or therapeutic acts?"", ""option_a"": ""If the act was performed without the patient's consent"", ""option_b"": ""If the act resulted in harm to the patient"", ""option_c"": ""If they are at fault"", ""option_d"": ""If the act was not in line with the latest medical research"", ""correct_option"": ""C""}","Definition","According to Article L.1142-1 of the French Public Health Code, what is the condition for health professionals and establishments to be liable for the harmful consequences of preventive, preventive or therapeutic acts?","If the act was performed without the patient's consent","If the act resulted in harm to the patient","If they are at fault","If the act was not in line with the latest medical research","c"
"OIC-005-08-A","{""question"": ""What type of error occurs when a necessary action has not been taken in a medical context?"", ""option_a"": ""Error of commission"", ""option_b"": ""Error of execution"", ""option_c"": ""Error of omission"", ""option_d"": ""Violation or non-compliance"", ""correct_option"": ""C""}","Definition","What type of error occurs when a necessary action has not been taken in a medical context?","Error of commission","Error of execution","Error of omission","Violation or non-compliance","c"
"OIC-005-09-A","{""question"": ""What is the primary distinction between a medical accident and an iatrogenic condition?"", ""option_a"": ""A medical accident is caused by an error, while an iatrogenic condition is not."", ""option_b"": ""A medical accident occurs in a public healthcare setting, while an iatrogenic condition occurs in a private setting."", ""option_c"": ""A medical accident results from abnormal damage, while an iatrogenic condition is a expected outcome of treatment."", ""option_d"": ""A medical accident implies fault, while an iatrogenic condition is an unintended consequence of correct treatment."", ""correct_option"": ""D""}","Definition","What is the primary distinction between a medical accident and an iatrogenic condition?","A medical accident is caused by an error, while an iatrogenic condition is not.","A medical accident occurs in a public healthcare setting, while an iatrogenic condition occurs in a private setting.","A medical accident results from abnormal damage, while an iatrogenic condition is a expected outcome of treatment.","A medical accident implies fault, while an iatrogenic condition is an unintended consequence of correct treatment.","d"
"OIC-005-10-A","{""question"": ""What is the primary characteristic that defines a nosocomial infection?"", ""option_a"": ""An infection that is present upon admission to a healthcare establishment"", ""option_b"": ""An infection that is contracted during a stay in a healthcare establishment"", ""option_c"": ""An infection that is only contracted through surgical procedures"", ""option_d"": ""An infection that is always incubating upon admission to a hospital"", ""correct_option"": ""B""}","Definition","What is the primary characteristic that defines a nosocomial infection?","An infection that is present upon admission to a healthcare establishment","An infection that is contracted during a stay in a healthcare establishment","An infection that is only contracted through surgical procedures","An infection that is always incubating upon admission to a hospital","b"
"OIC-005-11-A","{""question"": ""What is the primary characteristic that distinguishes a therapeutic hazard from a medical error?"", ""option_a"": ""The severity of the outcome"", ""option_b"": ""The intent of the healthcare provider"", ""option_c"": ""The inevitability of the event despite compliant and error-free care"", ""option_d"": ""The presence of a nosocomial infection"", ""correct_option"": ""C""}","Definition","What is the primary characteristic that distinguishes a therapeutic hazard from a medical error?","The severity of the outcome","The intent of the healthcare provider","The inevitability of the event despite compliant and error-free care","The presence of a nosocomial infection","c"
"OIC-005-12-B","{""question"": ""What are the main factors that can lead to litigation following a medical accident?"", ""option_a"": ""Only factors related to the patient, such as their state of health and communication difficulties"", ""option_b"": ""Factors related to the patient, tasks, team, working environment, organisation and management, and institutional context"", ""option_c"": ""Primarily factors related to the team, such as communication within the team and supervision of junior staff"", ""option_d"": ""Exclusively factors related to the working environment, such as physical premises and equipment"", ""correct_option"": ""B""}","Epidemiology","What are the main factors that can lead to litigation following a medical accident?","Only factors related to the patient, such as their state of health and communication difficulties","Factors related to the patient, tasks, team, working environment, organisation and management, and institutional context","Primarily factors related to the team, such as communication within the team and supervision of junior staff","Exclusively factors related to the working environment, such as physical premises and equipment","b"
"OIC-005-13-A","{""question"": ""What is a key characteristic of a 'learning organisation' in the context of error prevention and management?"", ""option_a"": ""It blames individuals for mistakes to encourage personal responsibility"", ""option_b"": ""It has systems in place for identifying, analysing, and preventing errors"", ""option_c"": ""It ignores errors to maintain a positive work environment"", ""option_d"": ""It focuses solely on punishing mistakes to deter future occurrences"", ""correct_option"": ""B""}","Definition","What is a key characteristic of a 'learning organisation' in the context of error prevention and management?","It blames individuals for mistakes to encourage personal responsibility","It has systems in place for identifying, analysing, and preventing errors","It ignores errors to maintain a positive work environment","It focuses solely on punishing mistakes to deter future occurrences","b"
"OIC-005-14-B","{""question"": ""What is the primary purpose of conducting a root cause analysis after a medical error has occurred?"", ""option_a"": ""To assign blame to the individual responsible for the error"", ""option_b"": ""To identify the underlying systemic factors that contributed to the error"", ""option_c"": ""To develop a plan for disciplining staff involved in the error"", ""option_d"": ""To create a report for regulatory or legal purposes only"", ""correct_option"": ""B""}",,"What is the primary purpose of conducting a root cause analysis after a medical error has occurred?","To assign blame to the individual responsible for the error","To identify the underlying systemic factors that contributed to the error","To develop a plan for disciplining staff involved in the error","To create a report for regulatory or legal purposes only","b"
"OIC-005-15-B","{""question"": ""What is the primary goal of a positive error culture in healthcare settings?"", ""option_a"": ""To identify and punish the person responsible for the mistake"", ""option_b"": ""To encourage the reporting of errors and implement improvement measures to prevent their recurrence"", ""option_c"": ""To analyze errors solely from a neutral external viewpoint"", ""option_d"": ""To maintain anonymity and confidentiality in error reporting without taking any further action"", ""correct_option"": ""B""}","Definition","What is the primary goal of a positive error culture in healthcare settings?","To identify and punish the person responsible for the mistake","To encourage the reporting of errors and implement improvement measures to prevent their recurrence","To analyze errors solely from a neutral external viewpoint","To maintain anonymity and confidentiality in error reporting without taking any further action","b"
"OIC-006-01-A","{""question"": ""What is the primary purpose of multi-professional teamwork in a clinical setting?"", ""option_a"": ""To reduce the number of professionals involved in patient care"", ""option_b"": ""To allow professionals to work independently without collaboration"", ""option_c"": ""To combine the efforts of professionals with different qualifications to achieve a common goal"", ""option_d"": ""To eliminate the need for communication between different healthcare professionals"", ""correct_option"": ""C""}","Definition","What is the primary purpose of multi-professional teamwork in a clinical setting?","To reduce the number of professionals involved in patient care","To allow professionals to work independently without collaboration","To combine the efforts of professionals with different qualifications to achieve a common goal","To eliminate the need for communication between different healthcare professionals","c"
"OIC-006-02-A","{""question"": ""What is an example of a method used to secure a patient's care pathway in a multi-professional team setting?"", ""option_a"": ""A single-professional protocol"", ""option_b"": ""A multi-professional protocol"", ""option_c"": ""A patient self-management plan"", ""option_d"": ""A pharmacy-only consultation meeting"", ""correct_option"": ""B""}","Definition","What is an example of a method used to secure a patient's care pathway in a multi-professional team setting?","A single-professional protocol","A multi-professional protocol","A patient self-management plan","A pharmacy-only consultation meeting","b"
"OIC-006-03-A","{""question"": ""What is the primary focus of a care pathway in clinical practice?"", ""option_a"": ""To prioritize medical treatments over patient comfort"", ""option_b"": ""To organize and coordinate the right sequence of professional skills at the right time throughout a patient's care"", ""option_c"": ""To reduce the number of healthcare professionals involved in patient care"", ""option_d"": ""To standardize all patient care plans regardless of individual needs"", ""correct_option"": ""B""}","Definition","What is the primary focus of a care pathway in clinical practice?","To prioritize medical treatments over patient comfort","To organize and coordinate the right sequence of professional skills at the right time throughout a patient's care","To reduce the number of healthcare professionals involved in patient care","To standardize all patient care plans regardless of individual needs","b"
"OIC-006-04-B","{""question"": ""What is the primary purpose of a multi-professional protocol in clinical practice?"", ""option_a"": ""To establish a hierarchy among healthcare professionals"", ""option_b"": ""To facilitate teamwork and standardize the management of illnesses"", ""option_c"": ""To restrict the use of certain medical treatments or procedures"", ""option_d"": ""To solely focus on the continuing professional development of individual professionals"", ""correct_option"": ""B""}",,"What is the primary purpose of a multi-professional protocol in clinical practice?","To establish a hierarchy among healthcare professionals","To facilitate teamwork and standardize the management of illnesses","To restrict the use of certain medical treatments or procedures","To solely focus on the continuing professional development of individual professionals","b"
"OIC-006-05-A","{""question"": ""What is the primary purpose of a Multidisciplinary Consultation Meeting (RCP) in the field of oncology?"", ""option_a"": ""To discuss the latest medical research and advancements"", ""option_b"": ""To define the diagnostic, therapeutic, and follow-up strategy for cancer patients"", ""option_c"": ""To provide emotional support to cancer patients and their families"", ""option_d"": ""To determine the cost-effectiveness of different cancer treatments"", ""correct_option"": ""B""}","Definition","What is the primary purpose of a Multidisciplinary Consultation Meeting (RCP) in the field of oncology?","To discuss the latest medical research and advancements","To define the diagnostic, therapeutic, and follow-up strategy for cancer patients","To provide emotional support to cancer patients and their families","To determine the cost-effectiveness of different cancer treatments","b"
"OIC-006-06-A","{""question"": ""What is the primary purpose of the 'patient safety in the operating theatre' checklist?"", ""option_a"": ""To evaluate the surgical skills of the operating team"", ""option_b"": ""To review the situation between professionals at key moments in the operation and ensure patient safety"", ""option_c"": ""To select the appropriate equipment for the surgical procedure"", ""option_d"": ""To determine the type of anesthesia to be used during the operation"", ""correct_option"": ""B""}","Definition","What is the primary purpose of the 'patient safety in the operating theatre' checklist?","To evaluate the surgical skills of the operating team","To review the situation between professionals at key moments in the operation and ensure patient safety","To select the appropriate equipment for the surgical procedure","To determine the type of anesthesia to be used during the operation","b"
"OIC-006-07-A","{""question"": ""What is the primary purpose of a Morbidity-Mortality Meeting (MMM) in a clinical setting?"", ""option_a"": ""To assign blame to healthcare professionals for undesirable events associated with care"", ""option_b"": ""To conduct a collective, retrospective, and systemic analysis of clinical situations to implement prevention, recovery, or mitigation actions"", ""option_c"": ""To solely focus on the technical components of care when analyzing undesirable events"", ""option_d"": ""To replace the traditional methods of quality control and risk management in healthcare"", ""correct_option"": ""B""}","Definition","What is the primary purpose of a Morbidity-Mortality Meeting (MMM) in a clinical setting?","To assign blame to healthcare professionals for undesirable events associated with care","To conduct a collective, retrospective, and systemic analysis of clinical situations to implement prevention, recovery, or mitigation actions","To solely focus on the technical components of care when analyzing undesirable events","To replace the traditional methods of quality control and risk management in healthcare","b"
"OIC-006-08-A","{""question"": ""What is the primary role of the Samu-Centre 15 in emergency medical situations?"", ""option_a"": ""To provide on-site emergency care and transport patients to hospitals"", ""option_b"": ""To manage emergency calls, determine the most appropriate response, and ensure hospital facilities are available for patients"", ""option_c"": ""To specialise in transporting children and providing paediatric emergency care"", ""option_d"": ""To deal with unscheduled admissions to hospitals and provide 24-hour emergency services"", ""correct_option"": ""B""}","Taking charge","What is the primary role of the Samu-Centre 15 in emergency medical situations?","To provide on-site emergency care and transport patients to hospitals","To manage emergency calls, determine the most appropriate response, and ensure hospital facilities are available for patients","To specialise in transporting children and providing paediatric emergency care","To deal with unscheduled admissions to hospitals and provide 24-hour emergency services","b"
"OIC-008-01-A","{""question"": ""What is the primary factor that determines whether a difference in treatment constitutes discrimination?"", ""option_a"": ""The intention of the person making the distinction"", ""option_b"": ""The presence of harm to the individual"", ""option_c"": ""The use of a prohibited criterion, such as ethnicity or gender identity"", ""option_d"": ""The existence of a legitimate reason for the distinction, such as a public health concern"", ""correct_option"": ""C""}","Definition","What is the primary factor that determines whether a difference in treatment constitutes discrimination?","The intention of the person making the distinction","The presence of harm to the individual","The use of a prohibited criterion, such as ethnicity or gender identity","The existence of a legitimate reason for the distinction, such as a public health concern","c"
"OIC-008-02-B","{""question"": ""What is a significant consequence of discrimination on individuals, according to research?"", ""option_a"": ""It leads to improved mental and physical health"", ""option_b"": ""It has no impact on socio-economic integration and health"", ""option_c"": ""It increases stress, contributing to poorer cardiovascular health and mental health issues"", ""option_d"": ""It only affects individuals' economic status, without impacting their health"", ""correct_option"": ""C""}","Definition","What is a significant consequence of discrimination on individuals, according to research?","It leads to improved mental and physical health","It has no impact on socio-economic integration and health","It increases stress, contributing to poorer cardiovascular health and mental health issues","It only affects individuals' economic status, without impacting their health","c"
"OIC-008-03-B","{""question"": ""What is a key structural factor that contributes to discrimination in the healthcare system, according to the Migration Sant\u00e9 Alsace publication?"", ""option_a"": ""Lack of patient education on healthcare options"", ""option_b"": ""Asymmetrical power relationships in care, leading to patients feeling illegitimate"", ""option_c"": ""Insufficient funding for healthcare research and development"", ""option_d"": ""Overreliance on traditional healing practices"", ""correct_option"": ""B""}","Definition","What is a key structural factor that contributes to discrimination in the healthcare system, according to the Migration Santé Alsace publication?","Lack of patient education on healthcare options","Asymmetrical power relationships in care, leading to patients feeling illegitimate","Insufficient funding for healthcare research and development","Overreliance on traditional healing practices","b"
"OIC-009-01-A","{""question"": ""What is the primary goal of ethics in the context of medical practice?"", ""option_a"": ""To prescribe or forbid certain actions based on moral principles"", ""option_b"": ""To reflect critically on the moral dimension of individual and collective actions and practices"", ""option_c"": ""To enforce legal rules and impose penalties and compensation"", ""option_d"": ""To define a framework for professional responsibility based on the Hippocratic Oath"", ""correct_option"": ""B""}","Definition","What is the primary goal of ethics in the context of medical practice?","To prescribe or forbid certain actions based on moral principles","To reflect critically on the moral dimension of individual and collective actions and practices","To enforce legal rules and impose penalties and compensation","To define a framework for professional responsibility based on the Hippocratic Oath","b"
"OIC-009-02-A","{""question"": ""What was the original vision of V.R. Potter for the field of bioethics when he coined the term in the early 1970s?"", ""option_a"": ""A sub-set of health ethics focused on medical issues"", ""option_b"": ""A global ethic for the survival of human beings and the planet, combining biological sciences and ethics"", ""option_c"": ""A field primarily concerned with the economic aspects of biomedical technologies"", ""option_d"": ""A discipline restricted to the regulation of medical experimentation and organ transplants"", ""correct_option"": ""B""}","Definition","What was the original vision of V.R. Potter for the field of bioethics when he coined the term in the early 1970s?","A sub-set of health ethics focused on medical issues","A global ethic for the survival of human beings and the planet, combining biological sciences and ethics","A field primarily concerned with the economic aspects of biomedical technologies","A discipline restricted to the regulation of medical experimentation and organ transplants","b"
"OIC-009-03-A","{""question"": ""Who is responsible for drafting the code of medical ethics?"", ""option_a"": ""The government alone"", ""option_b"": ""The Ordre National des M\u00e9decins, with input from the administration, the Conseil d'Etat, and the government"", ""option_c"": ""The Conseil d'Etat alone"", ""option_d"": ""The patients alone"", ""correct_option"": ""B""}","Definition","Who is responsible for drafting the code of medical ethics?","The government alone","The Ordre National des Médecins, with input from the administration, the Conseil d'Etat, and the government","The Conseil d'Etat alone","The patients alone","b"
"OIC-009-04-A","{""question"": ""What is the primary basis for the principle of autonomy in medical ethics, according to the text?"", ""option_a"": ""Aristotelian morality and the Hippocratic conception"", ""option_b"": ""The social contract and the philosophy of the Enlightenment"", ""option_c"": ""The principle of beneficence and non-maleficence"", ""option_d"": ""The concept of justice and collective ideals"", ""correct_option"": ""B""}","Definition","What is the primary basis for the principle of autonomy in medical ethics, according to the text?","Aristotelian morality and the Hippocratic conception","The social contract and the philosophy of the Enlightenment","The principle of beneficence and non-maleficence","The concept of justice and collective ideals","b"
"OIC-009-05-A","{""question"": ""What is the primary ethical principle underlying the concept of patient autonomy in healthcare?"", ""option_a"": ""Beneficence"", ""option_b"": ""Non-maleficence"", ""option_c"": ""Respect for autonomy"", ""option_d"": ""Justice"", ""correct_option"": ""C""}",,"What is the primary ethical principle underlying the concept of patient autonomy in healthcare?","Beneficence","Non-maleficence","Respect for autonomy","Justice","c"
"OIC-009-06-A","{""question"": ""What is the primary aim of providing information to a patient when a treatment recognized and validated by medicine is proposed to the exclusion of all other options?"", ""option_a"": ""To make a therapeutic choice between different diagnostic and/or therapeutic hypotheses"", ""option_b"": ""To explain the merits of the proposal put forward in an intelligible way, in order to obtain the patient's assent"", ""option_c"": ""To discuss all possible risks, including those of death linked to a treatment or those whose occurrence is exceptional"", ""option_d"": ""To provide information solely about the diagnosis, without discussing treatment options"", ""correct_option"": ""B""}","Care","What is the primary aim of providing information to a patient when a treatment recognized and validated by medicine is proposed to the exclusion of all other options?","To make a therapeutic choice between different diagnostic and/or therapeutic hypotheses","To explain the merits of the proposal put forward in an intelligible way, in order to obtain the patient's assent","To discuss all possible risks, including those of death linked to a treatment or those whose occurrence is exceptional","To provide information solely about the diagnosis, without discussing treatment options","b"
"OIC-009-07-A","{""question"": ""According to the principle of autonomy in medical ethics, what is the primary consideration when a patient refuses treatment?"", ""option_a"": ""The doctor's obligation to provide treatment regardless of the patient's wishes"", ""option_b"": ""The patient's right to make informed decisions about their own care"", ""option_c"": ""The need to prioritize the doctor's personal beliefs and values over the patient's autonomy"", ""option_d"": ""The requirement to involve family members or close relatives in the decision-making process"", ""correct_option"": ""B""}",,"According to the principle of autonomy in medical ethics, what is the primary consideration when a patient refuses treatment?","The doctor's obligation to provide treatment regardless of the patient's wishes","The patient's right to make informed decisions about their own care","The need to prioritize the doctor's personal beliefs and values over the patient's autonomy","The requirement to involve family members or close relatives in the decision-making process","b"
"OIC-009-08-A","{""question"": ""What is the primary role of a trusted support person in the context of healthcare?"", ""option_a"": ""To make medical decisions on behalf of the patient"", ""option_b"": ""To provide financial support to the patient"", ""option_c"": ""To assist the patient in their care, support them physically and/or psychologically, and liaise with medical teams"", ""option_d"": ""To take over the patient's responsibilities in case of incapacitation"", ""correct_option"": ""C""}","Management","What is the primary role of a trusted support person in the context of healthcare?","To make medical decisions on behalf of the patient","To provide financial support to the patient","To assist the patient in their care, support them physically and/or psychologically, and liaise with medical teams","To take over the patient's responsibilities in case of incapacitation","c"
"OIC-009-09-B","{""question"": ""What are the two main definitions of vulnerability in the human and social sciences?"", ""option_a"": ""Vulnerability as a result of illness and vulnerability as a result of economic conditions"", ""option_b"": ""Vulnerability as a constituent of human existence and vulnerability dependent on particular historical and social contexts"", ""option_c"": ""Vulnerability as a personal trait and vulnerability as a social construct"", ""option_d"": ""Vulnerability as a medical condition and vulnerability as a psychological state"", ""correct_option"": ""B""}","Definition","What are the two main definitions of vulnerability in the human and social sciences?","Vulnerability as a result of illness and vulnerability as a result of economic conditions","Vulnerability as a constituent of human existence and vulnerability dependent on particular historical and social contexts","Vulnerability as a personal trait and vulnerability as a social construct","Vulnerability as a medical condition and vulnerability as a psychological state","b"
"OIC-009-10-B","{""question"": ""What is the primary purpose of introducing legal protection measures for individuals with altered intellectual or physical faculties due to illness, disability, or accident?"", ""option_a"": ""To restrict their individual freedoms and rights"", ""option_b"": ""To protect their interests and ensure their dignity is respected"", ""option_c"": ""To appoint a representative without their consent or input"", ""option_d"": ""To prioritize the interests of the representative over the protected person"", ""correct_option"": ""B""}","Definition","What is the primary purpose of introducing legal protection measures for individuals with altered intellectual or physical faculties due to illness, disability, or accident?","To restrict their individual freedoms and rights","To protect their interests and ensure their dignity is respected","To appoint a representative without their consent or input","To prioritize the interests of the representative over the protected person","b"
"OIC-009-11-A","{""question"": ""What is the primary purpose of the safeguard of justice as a temporary protective measure?"", ""option_a"": ""To provide permanent protection for individuals with intellectual or physical disabilities"", ""option_b"": ""To deal with an emergency situation where a person of legal age is at risk of taking action contrary to their interests"", ""option_c"": ""To appoint a guardian for minors when the holders of parental authority can no longer exercise them"", ""option_d"": ""To determine the actions that a person under guardianship may or may not take on their own"", ""correct_option"": ""B""}",,"What is the primary purpose of the safeguard of justice as a temporary protective measure?","To provide permanent protection for individuals with intellectual or physical disabilities","To deal with an emergency situation where a person of legal age is at risk of taking action contrary to their interests","To appoint a guardian for minors when the holders of parental authority can no longer exercise them","To determine the actions that a person under guardianship may or may not take on their own","b"
"OIC-009-12-B","{""question"": ""Who can apply for a protective measure for an adult?"", ""option_a"": ""Only the public prosecutor"", ""option_b"": ""The adult concerned, their spouse, a relative, or a person with a close and stable relationship, as well as the public prosecutor"", ""option_c"": ""Any person, regardless of their relationship to the adult"", ""option_d"": ""Only the adult's guardian or curator"", ""correct_option"": ""B""}","Support","Who can apply for a protective measure for an adult?","Only the public prosecutor","The adult concerned, their spouse, a relative, or a person with a close and stable relationship, as well as the public prosecutor","Any person, regardless of their relationship to the adult","Only the adult's guardian or curator","b"
"OIC-009-13-A","{""question"": ""What is the primary purpose of the 1975 Veil law in France regarding voluntary interruption of pregnancy?"", ""option_a"": ""To restrict access to abortion and protect the rights of the unborn"", ""option_b"": ""To provide a medical framework for a practice that was both frequent and risky, ensuring equal and safe access to the procedure"", ""option_c"": ""To establish a national registry of women who have undergone abortion"", ""option_d"": ""To impose stricter penalties on healthcare professionals who refuse to perform abortions"", ""correct_option"": ""B""}","Management","What is the primary purpose of the 1975 Veil law in France regarding voluntary interruption of pregnancy?","To restrict access to abortion and protect the rights of the unborn","To provide a medical framework for a practice that was both frequent and risky, ensuring equal and safe access to the procedure","To establish a national registry of women who have undergone abortion","To impose stricter penalties on healthcare professionals who refuse to perform abortions","b"
"OIC-009-14-B","{""question"": ""According to the law, what are the two conditions under which voluntary termination of a pregnancy for medical reasons can take place without any time limit?"", ""option_a"": ""If the woman's health is at risk and the unborn child has a serious condition"", ""option_b"": ""If continuing the pregnancy would seriously endanger the woman's health or if there is a strong probability that the unborn child will suffer from a particularly serious condition recognised as incurable"", ""option_c"": ""If the woman is under 18 years old and the unborn child has a genetic disorder"", ""option_d"": ""If the pregnancy is a result of rape or incest and the woman's health is not at risk"", ""correct_option"": ""B""}",,"According to the law, what are the two conditions under which voluntary termination of a pregnancy for medical reasons can take place without any time limit?","If the woman's health is at risk and the unborn child has a serious condition","If continuing the pregnancy would seriously endanger the woman's health or if there is a strong probability that the unborn child will suffer from a particularly serious condition recognised as incurable","If the woman is under 18 years old and the unborn child has a genetic disorder","If the pregnancy is a result of rape or incest and the woman's health is not at risk","b"
"OIC-009-15-B","{""question"": ""What is the primary purpose of prenatal diagnosis as specified by the Bioethics Act of 1994 in France?"", ""option_a"": ""To satisfy the desire for 'perfect' children"", ""option_b"": ""To prevent or treat a particularly serious condition, in the interests of the unborn child"", ""option_c"": ""To provide a means for sex selection"", ""option_d"": ""To allow for the detection of any genetic anomaly, regardless of severity"", ""correct_option"": ""B""}",,"What is the primary purpose of prenatal diagnosis as specified by the Bioethics Act of 1994 in France?","To satisfy the desire for 'perfect' children","To prevent or treat a particularly serious condition, in the interests of the unborn child","To provide a means for sex selection","To allow for the detection of any genetic anomaly, regardless of severity","b"
"OIC-009-16-B","{""question"": ""What is the primary justification for pre-implantation diagnosis (PGD) according to the CCNE's position?"", ""option_a"": ""To select embryos for personal convenience, such as choosing the sex of the child"", ""option_b"": ""To search for immunological compatibility with a sick elder child"", ""option_c"": ""The birth of a child free from a serious genetic disorder that threatens him or her"", ""option_d"": ""To balance the sexes in a family"", ""correct_option"": ""C""}","Management","What is the primary justification for pre-implantation diagnosis (PGD) according to the CCNE's position?","To select embryos for personal convenience, such as choosing the sex of the child","To search for immunological compatibility with a sick elder child","The birth of a child free from a serious genetic disorder that threatens him or her","To balance the sexes in a family","c"
"OIC-009-17-A","{""question"": ""What is the primary ethical challenge when informing patients about their end-of-life care?"", ""option_a"": ""Providing false information to alleviate emotional distress"", ""option_b"": ""Providing honest and clear information while respecting patients' autonomy"", ""option_c"": ""Withholding information to prevent patients from becoming overwhelmed"", ""option_d"": ""Only providing information to patients who explicitly request it"", ""correct_option"": ""B""}","Definition","What is the primary ethical challenge when informing patients about their end-of-life care?","Providing false information to alleviate emotional distress","Providing honest and clear information while respecting patients' autonomy","Withholding information to prevent patients from becoming overwhelmed","Only providing information to patients who explicitly request it","b"
"OIC-009-18-A","{""question"": ""What is the primary intention behind the 'double effect' argument in the context of end-of-life care?"", ""option_a"": ""To intentionally cause death as a means to end suffering"", ""option_b"": ""To relieve suffering as the primary goal, even if it may unintentionally shorten life"", ""option_c"": ""To prioritize the protection of life over the relief of suffering"", ""option_d"": ""To refuse all medical treatment in terminal cases"", ""correct_option"": ""B""}",,"What is the primary intention behind the 'double effect' argument in the context of end-of-life care?","To intentionally cause death as a means to end suffering","To relieve suffering as the primary goal, even if it may unintentionally shorten life","To prioritize the protection of life over the relief of suffering","To refuse all medical treatment in terminal cases","b"
"OIC-009-19-B","{""question"": ""Who has the final decision regarding continuing, limiting, or stopping treatment for a patient unable to express themselves at the end of their life?"", ""option_a"": ""The patient's family and close friends"", ""option_b"": ""The medical team as a whole"", ""option_c"": ""The doctor in charge of the patient"", ""option_d"": ""An external consultant doctor"", ""correct_option"": ""C""}","Management","Who has the final decision regarding continuing, limiting, or stopping treatment for a patient unable to express themselves at the end of their life?","The patient's family and close friends","The medical team as a whole","The doctor in charge of the patient","An external consultant doctor","c"
"OIC-009-20-B","{""question"": ""According to the law of 22 April 2005 on patients' rights and the end of life, what is the primary purpose of advance directives?"", ""option_a"": ""To appoint a trusted support person for medical decision-making"", ""option_b"": ""To refuse care that appears to be useless, disproportionate, or having no effect other than the artificial maintenance of life"", ""option_c"": ""To ensure the continuation of life-sustaining treatment at all costs"", ""option_d"": ""To prioritize the opinions of family members over those of the patient"", ""correct_option"": ""B""}","Definition","According to the law of 22 April 2005 on patients' rights and the end of life, what is the primary purpose of advance directives?","To appoint a trusted support person for medical decision-making","To refuse care that appears to be useless, disproportionate, or having no effect other than the artificial maintenance of life","To ensure the continuation of life-sustaining treatment at all costs","To prioritize the opinions of family members over those of the patient","b"
"OIC-009-21-A","{""question"": ""What is the primary purpose of the Nuremberg Code in the context of research involving human subjects?"", ""option_a"": ""To establish a global standard for medical malpractice lawsuits"", ""option_b"": ""To create an international code of ethics for experimentation on human beings, respecting principles of beneficence, non-maleficence, and autonomy"", ""option_c"": ""To develop guidelines for the conduct of clinical trials in developing countries"", ""option_d"": ""To promote the protection of intellectual property rights in biomedical research"", ""correct_option"": ""B""}","Definition","What is the primary purpose of the Nuremberg Code in the context of research involving human subjects?","To establish a global standard for medical malpractice lawsuits","To create an international code of ethics for experimentation on human beings, respecting principles of beneficence, non-maleficence, and autonomy","To develop guidelines for the conduct of clinical trials in developing countries","To promote the protection of intellectual property rights in biomedical research","b"
"OIC-009-22-B","{""question"": ""What is the primary purpose of the Huriet-S\u00e9rusclat Law of 20 December 1988 in France?"", ""option_a"": ""To promote biomedical research without restrictions"", ""option_b"": ""To provide legal certainty for investigators and ensure informed consent from participants"", ""option_c"": ""To allow for the commercialization of the human body in biomedical research"", ""option_d"": ""To exclude vulnerable populations from participating in clinical trials"", ""correct_option"": ""B""}","Support","What is the primary purpose of the Huriet-Sérusclat Law of 20 December 1988 in France?","To promote biomedical research without restrictions","To provide legal certainty for investigators and ensure informed consent from participants","To allow for the commercialization of the human body in biomedical research","To exclude vulnerable populations from participating in clinical trials","b"
"OIC-009-23-A","{""question"": ""According to French law, what is the primary principle underlying organ donation to prevent trafficking in human beings and organs?"", ""option_a"": ""Presumed consent for deceased donors"", ""option_b"": ""Free and anonymous donation"", ""option_c"": ""Mandatory donation for all citizens"", ""option_d"": ""Payment for donated organs"", ""correct_option"": ""B""}",,"According to French law, what is the primary principle underlying organ donation to prevent trafficking in human beings and organs?","Presumed consent for deceased donors","Free and anonymous donation","Mandatory donation for all citizens","Payment for donated organs","b"
"OIC-009-24-B","{""question"": ""What is the primary criterion for diagnosing encephalic death in a patient?"", ""option_a"": ""Absence of consciousness and spontaneous motor activity with no response to stimulation"", ""option_b"": ""No spontaneous ventilation in hypercapnia test, and two EEGs with no detectable activity 4 hours apart"", ""option_c"": ""Presence of cardiac arrest and abolition of all brain stem reflexes"", ""option_d"": ""Irreversible circulatory arrest during intensive care"", ""correct_option"": ""B""}","Management","What is the primary criterion for diagnosing encephalic death in a patient?","Absence of consciousness and spontaneous motor activity with no response to stimulation","No spontaneous ventilation in hypercapnia test, and two EEGs with no detectable activity 4 hours apart","Presence of cardiac arrest and abolition of all brain stem reflexes","Irreversible circulatory arrest during intensive care","b"
"OIC-009-25-B","{""question"": ""What is required for someone to be considered a living organ donor in relation to the recipient, aside from being a family member or spouse?"", ""option_a"": ""They must have known the recipient for at least 5 years"", ""option_b"": ""They must be able to prove they have lived with the recipient for at least two years"", ""option_c"": ""They must be of the same age as the recipient"", ""option_d"": ""They must have the same occupation as the recipient"", ""correct_option"": ""B""}","Definition","What is required for someone to be considered a living organ donor in relation to the recipient, aside from being a family member or spouse?","They must have known the recipient for at least 5 years","They must be able to prove they have lived with the recipient for at least two years","They must be of the same age as the recipient","They must have the same occupation as the recipient","b"
"OIC-009-26-B","{""question"": ""According to the French Civil Code, what is the principle governing the disclosure of information about the donor and recipient of an element or product of the human body?"", ""option_a"": ""The donor and recipient may know each other's identities if they both agree to it."", ""option_b"": ""The donor's and recipient's doctors may have access to information enabling them to be identified, but only in cases of therapeutic necessity."", ""option_c"": ""The donor and recipient must always know each other's identities to ensure transparency."", ""option_d"": ""The donor and recipient may never know each other's identities, and their doctors are also prohibited from accessing this information."", ""correct_option"": ""B""}","Definition","According to the French Civil Code, what is the principle governing the disclosure of information about the donor and recipient of an element or product of the human body?","The donor and recipient may know each other's identities if they both agree to it.","The donor's and recipient's doctors may have access to information enabling them to be identified, but only in cases of therapeutic necessity.","The donor and recipient must always know each other's identities to ensure transparency.","The donor and recipient may never know each other's identities, and their doctors are also prohibited from accessing this information.","b"
"OIC-009-27-B","{""question"": ""Under French law, what is the primary condition for conducting genetic fingerprint identification for the purpose of establishing the identity of a deceased person?"", ""option_a"": ""The identification can be carried out without any consent or court order."", ""option_b"": ""The individual's express consent must be obtained in writing before the identification is carried out, after the individual has been duly informed of its nature and purpose."", ""option_c"": ""Genetic fingerprint identification can only be carried out on the instructions of a magistrate, but no consent from the individual or their relatives is required."", ""option_d"": ""The identification can only be carried out if the deceased person's relatives give their consent."", ""correct_option"": ""B""}","Definition","Under French law, what is the primary condition for conducting genetic fingerprint identification for the purpose of establishing the identity of a deceased person?","The identification can be carried out without any consent or court order.","The individual's express consent must be obtained in writing before the identification is carried out, after the individual has been duly informed of its nature and purpose.","Genetic fingerprint identification can only be carried out on the instructions of a magistrate, but no consent from the individual or their relatives is required.","The identification can only be carried out if the deceased person's relatives give their consent.","b"
"OIC-010-01-A","{""question"": ""According to sociologist Pierre Bourdieu, what are the primary functions of the body in relation to social position?"", ""option_a"": ""Only as a marker of social position"", ""option_b"": ""As a marker of social position, an indicator of economic status, and a sign of cultural background"", ""option_c"": ""As a marker of social position, a means of memory, and a way of learning class habits"", ""option_d"": ""Only as a means of memory and a way of learning class habits"", ""correct_option"": ""C""}","Definition","According to sociologist Pierre Bourdieu, what are the primary functions of the body in relation to social position?","Only as a marker of social position","As a marker of social position, an indicator of economic status, and a sign of cultural background","As a marker of social position, a means of memory, and a way of learning class habits","Only as a means of memory and a way of learning class habits","c"
"OIC-010-02-B","{""question"": ""What is the primary impact of pain on an individual according to the given text?"", ""option_a"": ""It only affects the physical body"", ""option_b"": ""It alters one's sense of identity and affects their whole life"", ""option_c"": ""It is solely a physiological phenomenon with no emotional or existential implications"", ""option_d"": ""It has no effect on how others perceive or interact with the individual"", ""correct_option"": ""B""}","Definition","What is the primary impact of pain on an individual according to the given text?","It only affects the physical body","It alters one's sense of identity and affects their whole life","It is solely a physiological phenomenon with no emotional or existential implications","It has no effect on how others perceive or interact with the individual","b"
"OIC-010-03-B","{""question"": ""What is the primary distinction made by the human sciences when it comes to the human body in the context of healthcare?"", ""option_a"": ""Between a healthy body and an ill body"", ""option_b"": ""Between a body-object and a body-subject"", ""option_c"": ""Between the patient's subjective experience and the carer's objective observation"", ""option_d"": ""Between the physical body and the psychological body"", ""correct_option"": ""B""}","Management","What is the primary distinction made by the human sciences when it comes to the human body in the context of healthcare?","Between a healthy body and an ill body","Between a body-object and a body-subject","Between the patient's subjective experience and the carer's objective observation","Between the physical body and the psychological body","b"
"OIC-019-01-A","{""question"": ""What is the primary goal of the compulsory social insurance approach in social protection?"", ""option_a"": ""To provide a minimum income to combat poverty and exclusion"", ""option_b"": ""To protect insured persons against loss of income due to social risks"", ""option_c"": ""To cover certain categories of expenditure for all individuals without means-testing"", ""option_d"": ""To promote individual savings and private insurance"", ""correct_option"": ""B""}","Definition","What is the primary goal of the compulsory social insurance approach in social protection?","To provide a minimum income to combat poverty and exclusion","To protect insured persons against loss of income due to social risks","To cover certain categories of expenditure for all individuals without means-testing","To promote individual savings and private insurance","b"
"OIC-019-02-A","{""question"": ""What is the primary basis of social protection in France?"", ""option_a"": ""The provision of social services at market prices"", ""option_b"": ""The payment of social benefits directly to individuals"", ""option_c"": ""The regulation of employment contracts"", ""option_d"": ""The management of healthcare facilities"", ""correct_option"": ""B""}","Definition","What is the primary basis of social protection in France?","The provision of social services at market prices","The payment of social benefits directly to individuals","The regulation of employment contracts","The management of healthcare facilities","b"
"OIC-019-03-B","{""question"": ""What percentage of France's Gross Domestic Product was accounted for by social protection in 2020?"", ""option_a"": ""25%"", ""option_b"": ""30%"", ""option_c"": ""35%"", ""option_d"": ""40%"", ""correct_option"": ""C""}","Definition","What percentage of France's Gross Domestic Product was accounted for by social protection in 2020?","25%","30%","35%","40%","c"
"OIC-019-04-B","{""question"": ""What is the primary source of funding for social protection in France?"", ""option_a"": ""Tax resources, including the CSG and CRDS"", ""option_b"": ""State public contributions, such as subsidies for solidarity spending"", ""option_c"": ""Social security contributions, including those from employees, employers, and the self-employed"", ""option_d"": ""Earmarked taxes on products, such as alcohol and tobacco"", ""correct_option"": ""C""}",,"What is the primary source of funding for social protection in France?","Tax resources, including the CSG and CRDS","State public contributions, such as subsidies for solidarity spending","Social security contributions, including those from employees, employers, and the self-employed","Earmarked taxes on products, such as alcohol and tobacco","c"
"OIC-019-05-A","{""question"": ""What is the primary role of the Caisse Nationale d'Assurance Maladie (CNAM) in the General Scheme of social security in France?"", ""option_a"": ""To manage the Old Age branch and pay basic retirement pensions"", ""option_b"": ""To collect social security contributions from employers and employees"", ""option_c"": ""To cover the risks of sickness, maternity, disability, and death, as well as accidents at work and occupational diseases"", ""option_d"": ""To support families in their day-to-day lives, childcare, access to housing, and the fight against poverty and disability"", ""correct_option"": ""C""}","Definition","What is the primary role of the Caisse Nationale d'Assurance Maladie (CNAM) in the General Scheme of social security in France?","To manage the Old Age branch and pay basic retirement pensions","To collect social security contributions from employers and employees","To cover the risks of sickness, maternity, disability, and death, as well as accidents at work and occupational diseases","To support families in their day-to-day lives, childcare, access to housing, and the fight against poverty and disability","c"
"OIC-019-06-B","{""question"": ""What is the primary purpose of the Social Security Financing Act (LFSS) in France?"", ""option_a"": ""To determine the State budget and authorize the collection of revenue"", ""option_b"": ""To control social and health spending, and! set expenditure targets based on revenue forecasts"", ""option_c"": ""To extend paternity leave and increase salaries of hospital staff"", ""option_d"": ""To create a new branch of social security for independent living"", ""correct_option"": ""B""}","Definition","What is the primary purpose of the Social Security Financing Act (LFSS) in France?","To determine the State budget and authorize the collection of revenue","To control social and health spending, and! set expenditure targets based on revenue forecasts","To extend paternity leave and increase salaries of hospital staff","To create a new branch of social security for independent living","b"
"OIC-019-07-B","{""question"": ""What is the primary purpose of the National Health Insurance Expenditure Target (ONDAM) in France?"", ""option_a"": ""To increase health insurance expenditure for outpatient and in-patient care"", ""option_b"": ""To regulate health insurance expenditure and set a forecast amount that must not be exceeded for healthcare services"", ""option_c"": ""To reduce the number of private health establishments in France"", ""option_d"": ""To allocate additional funding for medico-social establishments"", ""correct_option"": ""B""}","Definition","What is the primary purpose of the National Health Insurance Expenditure Target (ONDAM) in France?","To increase health insurance expenditure for outpatient and in-patient care","To regulate health insurance expenditure and set a forecast amount that must not be exceeded for healthcare services","To reduce the number of private health establishments in France","To allocate additional funding for medico-social establishments","b"
"OIC-019-08-A","{""question"": ""What percentage of the French population is covered by the general scheme of the Social Security system?"", ""option_a"": ""5%"", ""option_b"": ""7%"", ""option_c"": ""88%"", ""option_d"": ""95%"", ""correct_option"": ""C""}","Definition","What percentage of the French population is covered by the general scheme of the Social Security system?","5%","7%","88%","95%","c"
"OIC-019-09-A","{""question"": ""What is the main mission of the Caisse nationale d'assurance maladie (CNAM) in the general social security system?"", ""option_a"": ""To provide medical care directly to insured persons"", ""option_b"": ""To pay for the care provided to insured persons"", ""option_c"": ""To manage healthcare establishments and medical professionals"", ""option_d"": ""To develop and manufacture healthcare products"", ""correct_option"": ""B""}","Definition","What is the main mission of the Caisse nationale d'assurance maladie (CNAM) in the general social security system?","To provide medical care directly to insured persons","To pay for the care provided to insured persons","To manage healthcare establishments and medical professionals","To develop and manufacture healthcare products","b"
"OIC-019-10-A","{""question"": ""What is the primary purpose of the 'ticket mod\u00e9rateur' in the French healthcare system?"", ""option_a"": ""To provide full reimbursement for all healthcare costs"", ""option_b"": ""To regulate healthcare consumption by making patients financially responsible"", ""option_c"": ""To exempt patients from paying any out-of-pocket expenses"", ""option_d"": ""To increase the cost of healthcare services for patients"", ""correct_option"": ""B""}",,"What is the primary purpose of the 'ticket modérateur' in the French healthcare system?","To provide full reimbursement for all healthcare costs","To regulate healthcare consumption by making patients financially responsible","To exempt patients from paying any out-of-pocket expenses","To increase the cost of healthcare services for patients","b"
"OIC-019-11-A","{""question"": ""What is the primary role of the 'preferred doctor' in the coordinated care pathway?"", ""option_a"": ""To provide emergency care only"", ""option_b"": ""To manage the medical file and guide patients through the care pathway"", ""option_c"": ""To prescribe medication without prior consultation"", ""option_d"": ""To perform surgical procedures"", ""correct_option"": ""B""}","Definition","What is the primary role of the 'preferred doctor' in the coordinated care pathway?","To provide emergency care only","To manage the medical file and guide patients through the care pathway","To prescribe medication without prior consultation","To perform surgical procedures","b"
"OIC-019-12-A","{""question"": ""What is the primary condition for a patient to be exempted from co-payment for care under the ALD protocol for a disease not on the list of 30 long-term conditions?"", ""option_a"": ""The disease must be serious or incapacitating, requiring continuous care for more than 3 months"", ""option_b"": ""The disease must be serious or incapacitating, involving a prolonged treatment of a foreseeable duration of more than six months and a particularly costly therapy"", ""option_c"": ""The disease must be mild and not incapacitating, requiring intermittent care for more than 6 months"", ""option_d"": ""The disease must be acute, requiring only a single treatment session"", ""correct_option"": ""B""}",,"What is the primary condition for a patient to be exempted from co-payment for care under the ALD protocol for a disease not on the list of 30 long-term conditions?","The disease must be serious or incapacitating, requiring continuous care for more than 3 months","The disease must be serious or incapacitating, involving a prolonged treatment of a foreseeable duration of more than six months and a particularly costly therapy","The disease must be mild and not incapacitating, requiring intermittent care for more than 6 months","The disease must be acute, requiring only a single treatment session","b"
"OIC-019-13-B","{""question"": ""What type of benefit is the daily allowance provided to employees who are off work due to illness?"", ""option_a"": ""A benefit in kind, which is a reimbursement of healthcare costs"", ""option_b"": ""A cash benefit, which is a replacement income"", ""option_c"": ""A death benefit, which is paid to beneficiaries under certain conditions"", ""option_d"": ""An invalidity pension, which is calculated based on income and residual capacity to work"", ""correct_option"": ""B""}","Definition","What type of benefit is the daily allowance provided to employees who are off work due to illness?","A benefit in kind, which is a reimbursement of healthcare costs","A cash benefit, which is a replacement income","A death benefit, which is paid to beneficiaries under certain conditions","An invalidity pension, which is calculated based on income and residual capacity to work","b"
"OIC-020-01-A","{""question"": ""What is the primary purpose of health research?"", ""option_a"": ""To develop new medical treatments and technologies"", ""option_b"": ""To extend scientific understanding of human beings and develop actions likely to improve health"", ""option_c"": ""To allocate resources and define strategic orientations for research"", ""option_d"": ""To manage laboratories and organise research projects"", ""correct_option"": ""B""}","Definition","What is the primary purpose of health research?","To develop new medical treatments and technologies","To extend scientific understanding of human beings and develop actions likely to improve health","To allocate resources and define strategic orientations for research","To manage laboratories and organise research projects","b"
"OIC-020-02-A","{""question"": ""What is a key characteristic of a protocol in health research methodology?"", ""option_a"": ""It is a flexible document that can be modified at any time during the study"", ""option_b"": ""It is a document written prior to the start of a study, describing the methodology and stages in great detail, and is generally not modifiable during the course of the study"", ""option_c"": ""It is a document written after the completion of a study, summarizing the results and conclusions"", ""option_d"": ""It is a document that outlines the secondary objectives of the study, but not the primary objective"", ""correct_option"": ""B""}","Definition","What is a key characteristic of a protocol in health research methodology?","It is a flexible document that can be modified at any time during the study","It is a document written prior to the start of a study, describing the methodology and stages in great detail, and is generally not modifiable during the course of the study","It is a document written after the completion of a study, summarizing the results and conclusions","It is a document that outlines the secondary objectives of the study, but not the primary objective","b"
"OIC-020-03-A","{""question"": ""What is the primary role of the Comit\u00e9 de Protection des Personnes (CPP) in the context of health research in France?"", ""option_a"": ""To conduct the research and manage its funding"", ""option_b"": ""To issue a decision-making opinion on the scientific validity and ethical aspects of the research"", ""option_c"": ""To obtain informed consent from research participants"", ""option_d"": ""To submit research proposals to the CNIL for approval"", ""correct_option"": ""B""}","Definition","What is the primary role of the Comité de Protection des Personnes (CPP) in the context of health research in France?","To conduct the research and manage its funding","To issue a decision-making opinion on the scientific validity and ethical aspects of the research","To obtain informed consent from research participants","To submit research proposals to the CNIL for approval","b"
"OIC-020-04-B","{""question"": ""What is the primary basis for justifying the usefulness and relevance of a study in health research methodology?"", ""option_a"": ""Expert opinions and clinical experience"", ""option_b"": ""Analysis of the literature, including epidemiological data and the current state of knowledge"", ""option_c"": ""Preliminary results from pilot studies and trials"", ""option_d"": ""Feedback from patients and healthcare providers"", ""correct_option"": ""B""}","Definition","What is the primary basis for justifying the usefulness and relevance of a study in health research methodology?","Expert opinions and clinical experience","Analysis of the literature, including epidemiological data and the current state of knowledge","Preliminary results from pilot studies and trials","Feedback from patients and healthcare providers","b"
"OIC-020-05-B","{""question"": ""What is the primary purpose of formulating a research hypothesis in a study?"", ""option_a"": ""To determine the study's sample size without considering the effect size"", ""option_b"": ""To establish a hierarchy of primary and secondary research objectives"", ""option_c"": ""To verify an 'a priori' hypothesis and estimate the power of a study"", ""option_d"": ""To calculate the number of subjects required without defining the research objectives"", ""correct_option"": ""C""}","Definition","What is the primary purpose of formulating a research hypothesis in a study?","To determine the study's sample size without considering the effect size","To establish a hierarchy of primary and secondary research objectives","To verify an 'a priori' hypothesis and estimate the power of a study","To calculate the number of subjects required without defining the research objectives","c"
"OIC-020-06-B","{""question"": ""What is the primary characteristic that distinguishes experimental studies from observational studies in health research methodology?"", ""option_a"": ""The study aims to describe the distribution of health events in a population"", ""option_b"": ""The study involves an experimental intervention controlled by the experimenter"", ""option_c"": ""The study seeks to identify associations between risk factors and health phenomena"", ""option_d"": ""The study evaluates the performance of diagnostic or screening methods"", ""correct_option"": ""B""}","Definition","What is the primary characteristic that distinguishes experimental studies from observational studies in health research methodology?","The study aims to describe the distribution of health events in a population","The study involves an experimental intervention controlled by the experimenter","The study seeks to identify associations between risk factors and health phenomena","The study evaluates the performance of diagnostic or screening methods","b"
"OIC-020-07-B","{""question"": ""What is the primary goal when selecting a sample in health research methodology?"", ""option_a"": ""To include as many individuals as possible from the source population"", ""option_b"": ""To ensure that the sample is as representative as possible of the source population"", ""option_c"": ""To reduce the cost and logistics of the study"", ""option_d"": ""To increase the probability of each individual belonging to the sample"", ""correct_option"": ""B""}","Definition","What is the primary goal when selecting a sample in health research methodology?","To include as many individuals as possible from the source population","To ensure that the sample is as representative as possible of the source population","To reduce the cost and logistics of the study","To increase the probability of each individual belonging to the sample","b"
"OIC-020-08-B","{""question"": ""What is the primary purpose of specifying the nature, source, and methods of measurement and collection for all collected data in health research?"", ""option_a"": ""To ensure the data is collected only from ad hoc studies"", ""option_b"": ""To guarantee the data's accuracy and reliability, regardless of the source"", ""option_c"": ""To limit the collection of data to only existing epidemiological surveillance systems"", ""option_d"": ""To exclude medico-administrative databases as a source of data"", ""correct_option"": ""B""}",,"What is the primary purpose of specifying the nature, source, and methods of measurement and collection for all collected data in health research?","To ensure the data is collected only from ad hoc studies","To guarantee the data's accuracy and reliability, regardless of the source","To limit the collection of data to only existing epidemiological surveillance systems","To exclude medico-administrative databases as a source of data","b"
"OIC-020-09-B","{""question"": ""What is the primary purpose of identifying the primary endpoint in a study?"", ""option_a"": ""To evaluate the secondary objectives of the study"", ""option_b"": ""To assess the relevance of the data collected in relation to the study's primary objective"", ""option_c"": ""To identify the exposure factors and adjustment variables"", ""option_d"": ""To describe the characteristics of the individuals in the sample"", ""correct_option"": ""B""}","Definition","What is the primary purpose of identifying the primary endpoint in a study?","To evaluate the secondary objectives of the study","To assess the relevance of the data collected in relation to the study's primary objective","To identify the exposure factors and adjustment variables","To describe the characteristics of the individuals in the sample","b"
"OIC-020-10-B","{""question"": ""What is the primary purpose of a probability law in the context of random variables?"", ""option_a"": ""To predict the exact value of a random variable"", ""option_b"": ""To describe the probability associated with each value or interval of values of a random variable"", ""option_c"": ""To determine the frequency of outcomes without observing a large series"", ""option_d"": ""To assign a number to all possible outcomes of a random phenomenon"", ""correct_option"": ""B""}","Definition","What is the primary purpose of a probability law in the context of random variables?","To predict the exact value of a random variable","To describe the probability associated with each value or interval of values of a random variable","To determine the frequency of outcomes without observing a large series","To assign a number to all possible outcomes of a random phenomenon","b"
"OIC-020-11-B","{""question"": ""What is the definition of the mode in a set of values?"", ""option_a"": ""The average of the values"", ""option_b"": ""The most frequently found value"", ""option_c"": ""The difference between the maximum and minimum values"", ""option_d"": ""The square root of the variance"", ""correct_option"": ""B""}","Definition","What is the definition of the mode in a set of values?","The average of the values","The most frequently found value","The difference between the maximum and minimum values","The square root of the variance","b"
"OIC-020-12-B","{""question"": ""What is the primary purpose of setting an alpha risk in statistical testing?"", ""option_a"": ""To determine the power of the test"", ""option_b"": ""To establish the null and alternative hypotheses"", ""option_c"": ""To define the sample size required for the study"", ""option_d"": ""To set a threshold for the risk of making a mistake in concluding that the result is not due to chance"", ""correct_option"": ""D""}","Definition","What is the primary purpose of setting an alpha risk in statistical testing?","To determine the power of the test","To establish the null and alternative hypotheses","To define the sample size required for the study","To set a threshold for the risk of making a mistake in concluding that the result is not due to chance","d"
"OIC-020-13-B","{""question"": ""What does the Kaplan-Meier method estimate in the context of survival data?"", ""option_a"": ""The absolute risk of an event occurring at a specific time point"", ""option_b"": ""The probability of survival at each time t, accounting for censoring"", ""option_c"": ""The median survival time without considering censored data"", ""option_d"": ""The instantaneous risk of an event occurring over time, similar to the hazard ratio"", ""correct_option"": ""B""}","Definition","What does the Kaplan-Meier method estimate in the context of survival data?","The absolute risk of an event occurring at a specific time point","The probability of survival at each time t, accounting for censoring","The median survival time without considering censored data","The instantaneous risk of an event occurring over time, similar to the hazard ratio","b"
"OIC-020-14-B","{""question"": ""What is the primary purpose of adjustment in statistical analysis?"", ""option_a"": ""To increase the sample size of a study"", ""option_b"": ""To identify the exposure factors that are independently linked to the phenomenon being studied, taking into account confounding factors"", ""option_c"": ""To reduce the number of variables in a multivariate analysis"", ""option_d"": ""To calculate the crude measures of association"", ""correct_option"": ""B""}","Definition","What is the primary purpose of adjustment in statistical analysis?","To increase the sample size of a study","To identify the exposure factors that are independently linked to the phenomenon being studied, taking into account confounding factors","To reduce the number of variables in a multivariate analysis","To calculate the crude measures of association","b"
"OIC-020-15-B","{""question"": ""What is the primary reason for health data being subject to special protection under the law?"", ""option_a"": ""Because it is used exclusively for clinical research"", ""option_b"": ""Because it is considered sensitive and personal, requiring respect for individual privacy"", ""option_c"": ""Because it is only used in clinical trials"", ""option_d"": ""Because it is not relevant to public health policies"", ""correct_option"": ""B""}",,"What is the primary reason for health data being subject to special protection under the law?","Because it is used exclusively for clinical research","Because it is considered sensitive and personal, requiring respect for individual privacy","Because it is only used in clinical trials","Because it is not relevant to public health policies","b"
"OIC-020-16-A","{""question"": ""What is the term used to describe the factor of interest in an analytical study that is associated with a higher probability of the presence or occurrence of a health phenomenon?"", ""option_a"": ""Exposure factor"", ""option_b"": ""Etiological factor"", ""option_c"": ""Risk factor"", ""option_d"": ""Health determinant"", ""correct_option"": ""C""}","Definition","What is the term used to describe the factor of interest in an analytical study that is associated with a higher probability of the presence or occurrence of a health phenomenon?","Exposure factor","Etiological factor","Risk factor","Health determinant","c"
"OIC-020-17-A","{""question"": ""What is the primary purpose of defining a target population in health research methodology?"", ""option_a"": ""To identify the individuals who will be included in the study"", ""option_b"": ""To determine the sampling method for the study"", ""option_c"": ""To understand the population about which we have questions and wish to obtain information"", ""option_d"": ""To evaluate the external validity of a study"", ""correct_option"": ""C""}","Definition","What is the primary purpose of defining a target population in health research methodology?","To identify the individuals who will be included in the study","To determine the sampling method for the study","To understand the population about which we have questions and wish to obtain information","To evaluate the external validity of a study","c"
"OIC-020-18-A","{""question"": ""What is the primary advantage of a case-control study in observational research?"", ""option_a"": ""It allows for the estimation of incidence rates of a disease"", ""option_b"": ""It enables the over-representation of people carrying a rare phenomenon in the population"", ""option_c"": ""It provides a longitudinal perspective on the development of a disease"", ""option_d"": ""It is the only study design that can establish causality between an exposure and an outcome"", ""correct_option"": ""B""}","Definition","What is the primary advantage of a case-control study in observational research?","It allows for the estimation of incidence rates of a disease","It enables the over-representation of people carrying a rare phenomenon in the population","It provides a longitudinal perspective on the development of a disease","It is the only study design that can establish causality between an exposure and an outcome","b"
"OIC-020-19-B","{""question"": ""What is a key characteristic of a nested case-control study?"", ""option_a"": ""It involves selecting cases and controls from a newly established cohort."", ""option_b"": ""It involves selecting cases and controls from a cohort that has already been established."", ""option_c"": ""It requires collecting data on the entire initial cohort."", ""option_d"": ""It is used to evaluate the effect of an experimental intervention on a population."", ""correct_option"": ""B""}","Definition","What is a key characteristic of a nested case-control study?","It involves selecting cases and controls from a newly established cohort.","It involves selecting cases and controls from a cohort that has already been established.","It requires collecting data on the entire initial cohort.","It is used to evaluate the effect of an experimental intervention on a population.","b"
"OIC-020-20-A","{""question"": ""What is the best definition of Incidence rate in the context of health research methodology?"", ""option_a"": ""The proportion of the number of cases of a disease in a population at a given time"", ""option_b"": ""The probability of an event occurring in a population over a given period, expressed as a percentage"", ""option_c"": ""The number of new cases during a given period, within a population, divided by the sum of person-time"", ""option_d"": ""The total number of cases of a disease in a population, regardless of the time period"", ""correct_option"": ""C""}","Definition","What is the best definition of Incidence rate in the context of health research methodology?","The proportion of the number of cases of a disease in a population at a given time","The probability of an event occurring in a population over a given period, expressed as a percentage","The number of new cases during a given period, within a population, divided by the sum of person-time","The total number of cases of a disease in a population, regardless of the time period","c"
"OIC-020-21-B","{""question"": ""What is the primary purpose of standardisation in descriptive surveys?"", ""option_a"": ""To increase the sample size of the study population"", ""option_b"": ""To reduce the incidence rate of health problems in the population"", ""option_c"": ""To make populations comparable in terms of their characteristics, allowing for valid comparisons of frequency measurements"", ""option_d"": ""To change the age and sex structure of the study population to match the reference population"", ""correct_option"": ""C""}","Definition","What is the primary purpose of standardisation in descriptive surveys?","To increase the sample size of the study population","To reduce the incidence rate of health problems in the population","To make populations comparable in terms of their characteristics, allowing for valid comparisons of frequency measurements","To change the age and sex structure of the study population to match the reference population","c"
"OIC-020-22-A","{""question"": ""What does the Absolute Risk Reduction (ARR) measure in the context of health research methodology?"", ""option_a"": ""The ratio of the probability of being ill if exposed to the probability of being ill if not exposed"", ""option_b"": ""The difference between the probability of being ill if exposed and the probability of being ill if not exposed"", ""option_c"": ""The average number of subjects that need to be treated to avoid 1 event"", ""option_d"": ""The proportion of the variability of one variable explained by the other"", ""correct_option"": ""B""}","Definition","What does the Absolute Risk Reduction (ARR) measure in the context of health research methodology?","The ratio of the probability of being ill if exposed to the probability of being ill if not exposed","The difference between the probability of being ill if exposed and the probability of being ill if not exposed","The average number of subjects that need to be treated to avoid 1 event","The proportion of the variability of one variable explained by the other","b"
"OIC-020-23-A","{""question"": ""From which type of study design can the Relative Risk (RR) not be estimated?"", ""option_a"": ""A randomised controlled trial"", ""option_b"": ""An exposed/unexposed cohort study"", ""option_c"": ""A case-control study"", ""option_d"": ""Any study design that involves human subjects"", ""correct_option"": ""C""}","Definition","From which type of study design can the Relative Risk (RR) not be estimated?","A randomised controlled trial","An exposed/unexposed cohort study","A case-control study","Any study design that involves human subjects","c"
"OIC-020-24-A","{""question"": ""What happens to the power of a study when the variability of observations, or variance, increases?"", ""option_a"": ""The power of the study increases"", ""option_b"": ""The power of the study decreases"", ""option_c"": ""The power of the study remains unchanged"", ""option_d"": ""The power of the study becomes more variable"", ""correct_option"": ""B""}","Definition","What happens to the power of a study when the variability of observations, or variance, increases?","The power of the study increases","The power of the study decreases","The power of the study remains unchanged","The power of the study becomes more variable","b"
"OIC-020-25-A","{""question"": ""What is the primary purpose of calculating the number of subjects required for a descriptive study?"", ""option_a"": ""To guarantee sufficient power for the study"", ""option_b"": ""To determine the minimum number of subjects required to ensure the desired precision of the estimated parameter"", ""option_c"": ""To establish the alpha confidence level of the confidence interval"", ""option_d"": ""To assess the effect size of the study"", ""correct_option"": ""B""}","Definition","What is the primary purpose of calculating the number of subjects required for a descriptive study?","To guarantee sufficient power for the study","To determine the minimum number of subjects required to ensure the desired precision of the estimated parameter","To establish the alpha confidence level of the confidence interval","To assess the effect size of the study","b"
"OIC-020-26-A","{""question"": ""What is the primary difference between random error and systematic error in estimating a parameter?"", ""option_a"": ""Random error is due to chance, while systematic error is due to sampling fluctuation"", ""option_b"": ""Random error depends on sample size, while systematic error does not"", ""option_c"": ""Random error is independent of sample size, while systematic error depends on it"", ""option_d"": ""Random error leads to a loss of representativeness, while systematic error leads to a decrease in precision"", ""correct_option"": ""B""}","Definition","What is the primary difference between random error and systematic error in estimating a parameter?","Random error is due to chance, while systematic error is due to sampling fluctuation","Random error depends on sample size, while systematic error does not","Random error is independent of sample size, while systematic error depends on it","Random error leads to a loss of representativeness, while systematic error leads to a decrease in precision","b"
"OIC-020-27-B","{""question"": ""What is the primary effect of non-differential classification bias on the results of a study?"", ""option_a"": ""It overestimates the association between the exposure and the outcome"", ""option_b"": ""It underestimates the association between the exposure and the outcome"", ""option_c"": ""It has no impact on the association between the exposure and the outcome"", ""option_d"": ""It randomly fluctuates the association between the exposure and the outcome"", ""correct_option"": ""B""}","Definition","What is the primary effect of non-differential classification bias on the results of a study?","It overestimates the association between the exposure and the outcome","It underestimates the association between the exposure and the outcome","It has no impact on the association between the exposure and the outcome","It randomly fluctuates the association between the exposure and the outcome","b"
"OIC-020-28-B","{""question"": ""What is the primary purpose of performing an interaction test in the context of health research methodology?"", ""option_a"": ""To identify confounding factors that may influence the association between an exposure and a health phenomenon"", ""option_b"": ""To determine whether the effect of an exposure on a health phenomenon is modified by another factor in a statistically significant way"", ""option_c"": ""To stratify the analysis by different levels of the exposure factor"", ""option_d"": ""To introduce an interaction term into a univariate model"", ""correct_option"": ""B""}","Definition","What is the primary purpose of performing an interaction test in the context of health research methodology?","To identify confounding factors that may influence the association between an exposure and a health phenomenon","To determine whether the effect of an exposure on a health phenomenon is modified by another factor in a statistically significant way","To stratify the analysis by different levels of the exposure factor","To introduce an interaction term into a univariate model","b"
"OIC-020-29-A","{""question"": ""What is the primary purpose of setting an alpha risk threshold in a statistical test?"", ""option_a"": ""To determine the probability of observing a difference that is at least as large if in reality this difference does not exist"", ""option_b"": ""To establish the confidence interval for estimating a parameter"", ""option_c"": ""To fix the risk of concluding falsely that there is a difference, prior to conducting the test"", ""option_d"": ""To calculate the p-value from the observed data"", ""correct_option"": ""C""}","Definition","What is the primary purpose of setting an alpha risk threshold in a statistical test?","To determine the probability of observing a difference that is at least as large if in reality this difference does not exist","To establish the confidence interval for estimating a parameter","To fix the risk of concluding falsely that there is a difference, prior to conducting the test","To calculate the p-value from the observed data","c"
"OIC-020-30-A","{""question"": ""What is the primary purpose of the Bradford Hill causality criteria in health research methodology?"", ""option_a"": ""To establish a statistically significant association between an exposure and a health phenomenon"", ""option_b"": ""To discuss the plausibility of causality in observational studies and provide proof of causality in experimental studies"", ""option_c"": ""To determine the level of evidence in different types of studies, such as randomised controlled trials and cohort studies"", ""option_d"": ""To minimize selection and ranking bias in study design"", ""correct_option"": ""B""}",,"What is the primary purpose of the Bradford Hill causality criteria in health research methodology?","To establish a statistically significant association between an exposure and a health phenomenon","To discuss the plausibility of causality in observational studies and provide proof of causality in experimental studies","To determine the level of evidence in different types of studies, such as randomised controlled trials and cohort studies","To minimize selection and ranking bias in study design","b"
"OIC-020-31-B","{""question"": ""What term refers to all the environmental factors to which an individual is exposed during his or her life?"", ""option_a"": ""Phenome"", ""option_b"": ""Exposome"", ""option_c"": ""Microbiome"", ""option_d"": ""Epigenome"", ""correct_option"": ""B""}","Definition","What term refers to all the environmental factors to which an individual is exposed during his or her life?","Phenome","Exposome","Microbiome","Epigenome","b"
"OIC-020-32-B","{""question"": ""What is the primary purpose of predatory journals?"", ""option_a"": ""To provide a platform for researchers to share their findings quickly and openly"", ""option_b"": ""To evaluate and validate manuscripts for scientific integrity"", ""option_c"": ""To profit from publication fees by publishing manuscripts without evaluation or validation"", ""option_d"": ""To maintain a list of non-predatory scientific journals"", ""correct_option"": ""C""}","Definition","What is the primary purpose of predatory journals?","To provide a platform for researchers to share their findings quickly and openly","To evaluate and validate manuscripts for scientific integrity","To profit from publication fees by publishing manuscripts without evaluation or validation","To maintain a list of non-predatory scientific journals","c"
"OIC-020-33-A","{""question"": ""What is the primary factor that extrinsic properties of a test, such as positive predictive value (PPV) and negative predictive value (NPV), depend on?"", ""option_a"": ""The sensitivity and specificity of the test"", ""option_b"": ""The prevalence of the disease in the population studied"", ""option_c"": ""The positive and negative likelihood ratios of the test"", ""option_d"": ""The pre-test and post-test probabilities of the disease"", ""correct_option"": ""B""}",,"What is the primary factor that extrinsic properties of a test, such as positive predictive value (PPV) and negative predictive value (NPV), depend on?","The sensitivity and specificity of the test","The prevalence of the disease in the population studied","The positive and negative likelihood ratios of the test","The pre-test and post-test probabilities of the disease","b"
"OIC-022-01-A","{""question"": ""What is the prevalence threshold for a disease to be considered rare in the general population?"", ""option_a"": ""Less than one person in 1,000"", ""option_b"": ""Less than one person in 2,000"", ""option_c"": ""Less than one person in 5,000"", ""option_d"": ""Less than one person in 10,000"", ""correct_option"": ""B""}","Definition","What is the prevalence threshold for a disease to be considered rare in the general population?","Less than one person in 1,000","Less than one person in 2,000","Less than one person in 5,000","Less than one person in 10,000","b"
"OIC-022-02-B","{""question"": ""What is the primary goal of the National Plan for Rare Diseases 3 (PNMR3) in terms of diagnosis?"", ""option_a"": ""To ensure that all patients suffering from rare diseases have received a precise diagnosis within 5 years after their first specialist medical consultation"", ""option_b"": ""To ensure that all patients suffering from rare diseases have received a precise diagnosis one year after their first specialist medical consultation"", ""option_c"": ""To provide care and therapies to patients suffering from rare diseases without a precise diagnosis"", ""option_d"": ""To limit the number of patients suffering from rare diseases"", ""correct_option"": ""B""}",,"What is the primary goal of the National Plan for Rare Diseases 3 (PNMR3) in terms of diagnosis?","To ensure that all patients suffering from rare diseases have received a precise diagnosis within 5 years after their first specialist medical consultation","To ensure that all patients suffering from rare diseases have received a precise diagnosis one year after their first specialist medical consultation","To provide care and therapies to patients suffering from rare diseases without a precise diagnosis","To limit the number of patients suffering from rare diseases","b"
"OIC-022-03-B","{""question"": ""What is the primary cause of haemochromatosis, a genetic disease characterized by excessive intestinal absorption of iron?"", ""option_a"": ""A deficiency in the production of hepcidin, the systemic iron-regulating hormone"", ""option_b"": ""An overproduction of iron in the body due to environmental factors"", ""option_c"": ""A genetic mutation that affects the body's ability to absorb other essential nutrients"", ""option_d"": ""A viral infection that disrupts the body's iron regulation system"", ""correct_option"": ""A""}","Etiologies","What is the primary cause of haemochromatosis, a genetic disease characterized by excessive intestinal absorption of iron?","A deficiency in the production of hepcidin, the systemic iron-regulating hormone","An overproduction of iron in the body due to environmental factors","A genetic mutation that affects the body's ability to absorb other essential nutrients","A viral infection that disrupts the body's iron regulation system","a"
"OIC-022-04-B","{""question"": ""What percentage of rare diseases are genetic in origin?"", ""option_a"": ""60%"", ""option_b"": ""70%"", ""option_c"": ""80%"", ""option_d"": ""90%"", ""correct_option"": ""C""}",,"What percentage of rare diseases are genetic in origin?","60%","70%","80%","90%","c"
"OIC-022-05-A","{""question"": ""What is diagnostic wandering in the context of rare diseases?"", ""option_a"": ""A situation where the cause of a disease cannot be determined despite thorough investigation"", ""option_b"": ""The period between the appearance of the first symptoms and the date on which a precise diagnosis is made"", ""option_c"": ""A condition where a patient's symptoms do not match any known disease"", ""option_d"": ""A stage of diagnosis where all available diagnostic examinations have been exhausted"", ""correct_option"": ""B""}",,"What is diagnostic wandering in the context of rare diseases?","A situation where the cause of a disease cannot be determined despite thorough investigation","The period between the appearance of the first symptoms and the date on which a precise diagnosis is made","A condition where a patient's symptoms do not match any known disease","A stage of diagnosis where all available diagnostic examinations have been exhausted","b"
"OIC-024-01-A","{""question"": ""What is a possible cause of first trimester haemorrhage?"", ""option_a"": ""A normal intrauterine pregnancy without any complications"", ""option_b"": ""A progressive intrauterine pregnancy with a decidual haematoma"", ""option_c"": ""A pelvic infection"", ""option_d"": ""A previous history of regular menstrual cycles"", ""correct_option"": ""B""}","Positive diagnosis","What is a possible cause of first trimester haemorrhage?","A normal intrauterine pregnancy without any complications","A progressive intrauterine pregnancy with a decidual haematoma","A pelvic infection","A previous history of regular menstrual cycles","b"
"OIC-024-02-A","{""question"": ""What is the primary method of preventing a specific complication in a patient who has experienced a first-trimester miscarriage?"", ""option_a"": ""Administration of prostaglandins"", ""option_b"": ""Surgical treatment of the miscarriage"", ""option_c"": ""Psychological care and reassurance"", ""option_d"": ""Prevention of rhesus alloimmunisation"", ""correct_option"": ""D""}","Management","What is the primary method of preventing a specific complication in a patient who has experienced a first-trimester miscarriage?","Administration of prostaglandins","Surgical treatment of the miscarriage","Psychological care and reassurance","Prevention of rhesus alloimmunisation","d"
"OIC-024-03-A","{""question"": ""What is the primary criterion for considering surgical treatment in a patient with an ectopic pregnancy who does not exhibit haemodynamic instability, abdominal defence, or haemoperitoneum on ultrasound?"", ""option_a"": ""A \u03b2-hCG level greater than 1,000 IU/L"", ""option_b"": ""The presence of algism and/or a \u03b2-hCG level greater than 5,000 IU/L"", ""option_c"": ""A decrease in plasma \u03b2-hCG levels over a period of one week"", ""option_d"": ""The absence of adhesions or sequelae of HGI identified through diagnostic laparoscopy"", ""correct_option"": ""B""}","Identification of the emergency","What is the primary criterion for considering surgical treatment in a patient with an ectopic pregnancy who does not exhibit haemodynamic instability, abdominal defence, or haemoperitoneum on ultrasound?","A β-hCG level greater than 1,000 IU/L","The presence of algism and/or a β-hCG level greater than 5,000 IU/L","A decrease in plasma β-hCG levels over a period of one week","The absence of adhesions or sequelae of HGI identified through diagnostic laparoscopy","b"
"OIC-024-04-A","{""question"": ""What is the primary clinical sign that distinguishes placenta previa (PP) from retroplacental haematoma (HRP) in the second or third trimester of pregnancy?"", ""option_a"": ""Presence of uterine contractions"", ""option_b"": ""Type and color of the hemorrhage, with PP typically presenting with abundant, red, and often recurrent bleeding, and HRP presenting with slight, blackish, incoagulable hemorrhage"", ""option_c"": ""Maternal age and parity"", ""option_d"": ""Fetal presentation and position"", ""correct_option"": ""B""}","Diagnosis","What is the primary clinical sign that distinguishes placenta previa (PP) from retroplacental haematoma (HRP) in the second or third trimester of pregnancy?","Presence of uterine contractions","Type and color of the hemorrhage, with PP typically presenting with abundant, red, and often recurrent bleeding, and HRP presenting with slight, blackish, incoagulable hemorrhage","Maternal age and parity","Fetal presentation and position","b"
"OIC-024-05-A","{""question"": ""What is the definition of postpartum haemorrhage (PPH) in terms of blood loss volume within 24 hours after childbirth?"", ""option_a"": ""A haemorrhage >250 mL"", ""option_b"": ""A haemorrhage >500 mL"", ""option_c"": ""A haemorrhage >1000 mL"", ""option_d"": ""A haemorrhage >2000 mL"", ""correct_option"": ""B""}","Positive diagnosis","What is the definition of postpartum haemorrhage (PPH) in terms of blood loss volume within 24 hours after childbirth?","A haemorrhage >250 mL","A haemorrhage >500 mL","A haemorrhage >1000 mL","A haemorrhage >2000 mL","b"
"OIC-024-06-B","{""question"": ""What is the initial management step for postpartum hemorrhage (PPH) if haemorrhage occurs before expulsion of the placenta?"", ""option_a"": ""Uterine massage"", ""option_b"": ""Administration of uterotonics (oxytocin) 10 IU by slow IV infusion"", ""option_c"": ""Emergency artificial delivery"", ""option_d"": ""Suturing of any perineal tears"", ""correct_option"": ""C""}","Management","What is the initial management step for postpartum hemorrhage (PPH) if haemorrhage occurs before expulsion of the placenta?","Uterine massage","Administration of uterotonics (oxytocin) 10 IU by slow IV infusion","Emergency artificial delivery","Suturing of any perineal tears","c"
"OIC-024-07-B","{""question"": ""What is the recommended prophylactic administration of oxytocin to prevent postpartum hemorrhage (PPH) during delivery?"", ""option_a"": ""1 to 5 IU of oxytocin intravenously after placental expulsion"", ""option_b"": ""5 to 10 IU of oxytocin intravenously as soon as the child is discharged"", ""option_c"": ""10 to 15 IU of oxytocin intramuscularly 30 minutes after delivery"", ""option_d"": ""15 to 20 IU of oxytocin orally 1 hour after delivery"", ""correct_option"": ""B""}",,"What is the recommended prophylactic administration of oxytocin to prevent postpartum hemorrhage (PPH) during delivery?","1 to 5 IU of oxytocin intravenously after placental expulsion","5 to 10 IU of oxytocin intravenously as soon as the child is discharged","10 to 15 IU of oxytocin intramuscularly 30 minutes after delivery","15 to 20 IU of oxytocin orally 1 hour after delivery","b"
"OIC-024-08-A","{""question"": ""What is the definition of hypertension during pregnancy?"", ""option_a"": ""Systolic blood pressure (SBP) \u2265 150 mmHg and/or diastolic blood pressure (DBP) \u2265 100 mmHg on at least two occasions"", ""option_b"": ""Systolic blood pressure (SBP) \u2265 140 mmHg and/or diastolic blood pressure (DBP) \u2265 90 mmHg on at least two occasions"", ""option_c"": ""Systolic blood pressure (SBP) \u2265 160 mmHg and/or diastolic blood pressure (DBP) \u2265 110 mmHg on at least one occasion"", ""option_d"": ""Systolic blood pressure (SBP) \u2265 120 mmHg and/or diastolic blood pressure (DBP) \u2265 80 mmHg on at least two occasions"", ""correct_option"": ""B""}","Definition","What is the definition of hypertension during pregnancy?","Systolic blood pressure (SBP) ≥ 150 mmHg and/or diastolic blood pressure (DBP) ≥ 100 mmHg on at least two occasions","Systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg on at least two occasions","Systolic blood pressure (SBP) ≥ 160 mmHg and/or diastolic blood pressure (DBP) ≥ 110 mmHg on at least one occasion","Systolic blood pressure (SBP) ≥ 120 mmHg and/or diastolic blood pressure (DBP) ≥ 80 mmHg on at least two occasions","b"
"OIC-024-09-B","{""question"": ""What percentage of pregnancies are affected by high blood pressure?"", ""option_a"": ""1-5%"", ""option_b"": ""5-10%"", ""option_c"": ""15-20%"", ""option_d"": ""20-25%"", ""correct_option"": ""B""}","Epidemiology","What percentage of pregnancies are affected by high blood pressure?","1-5%","5-10%","15-20%","20-25%","b"
"OIC-024-10-B","{""question"": ""What is the primary test to look for in a pregnant woman with gestational hypertension to rule out pre-eclampsia?"", ""option_a"": ""Umbilical artery Doppler analysis"", ""option_b"": ""Fetal biometrics with estimation of fetal weight"", ""option_c"": ""Proteinuria on a sample or 24-hour urine collection"", ""option_d"": ""Assessment of fetal growth through comparison to previous ultrasound scans"", ""correct_option"": ""C""}","Additional examinations","What is the primary test to look for in a pregnant woman with gestational hypertension to rule out pre-eclampsia?","Umbilical artery Doppler analysis","Fetal biometrics with estimation of fetal weight","Proteinuria on a sample or 24-hour urine collection","Assessment of fetal growth through comparison to previous ultrasound scans","c"
"OIC-024-11-A","{""question"": ""What is a potential life-threatening maternal complication of pre-eclampsia?"", ""option_a"": ""Intrauterine growth restriction"", ""option_b"": ""Eclampsia"", ""option_c"": ""Premature birth"", ""option_d"": ""Proteinuria"", ""correct_option"": ""B""}",,"What is a potential life-threatening maternal complication of pre-eclampsia?","Intrauterine growth restriction","Eclampsia","Premature birth","Proteinuria","b"
"OIC-024-12-A","{""question"": ""What is considered a severity criterion for proteinuria in pregnancy complications?"", ""option_a"": ""Proteinuria > 1g/24h"", ""option_b"": ""Proteinuria > 3g/24h"", ""option_c"": ""Proteinuria < 1g/24h"", ""option_d"": ""Proteinuria = 2g/24h"", ""correct_option"": ""B""}",,"What is considered a severity criterion for proteinuria in pregnancy complications?","Proteinuria > 1g/24h","Proteinuria > 3g/24h","Proteinuria < 1g/24h","Proteinuria = 2g/24h","b"
"OIC-024-13-B","{""question"": ""What is the primary goal of prescribing antihypertensive treatment in pregnant women with severe hypertension?"", ""option_a"": ""To lower blood pressure as much as possible to prevent any potential complications"", ""option_b"": ""To avoid hypertensive spikes and limit maternal complications"", ""option_c"": ""To reduce salt intake and promote diuretic use"", ""option_d"": ""To solely rely on rest measures and avoid antihypertensive medication"", ""correct_option"": ""B""}","Management","What is the primary goal of prescribing antihypertensive treatment in pregnant women with severe hypertension?","To lower blood pressure as much as possible to prevent any potential complications","To avoid hypertensive spikes and limit maternal complications","To reduce salt intake and promote diuretic use","To solely rely on rest measures and avoid antihypertensive medication","b"
"OIC-024-14-B","{""question"": ""What is a recommended approach for monitoring a pregnant woman with hypertension (HTAg) during the pregnancy?"", ""option_a"": ""Weekly consultation with a healthcare professional and quarterly biological check-up"", ""option_b"": ""Self-monitoring of blood pressure, consultation every 10 days or so, regular biological check-up, and monthly ultrasound scan"", ""option_c"": ""Only regular biological check-up and ultrasound scan at 9 months"", ""option_d"": ""No enhanced monitoring required unless severe symptoms appear"", ""correct_option"": ""B""}",,"What is a recommended approach for monitoring a pregnant woman with hypertension (HTAg) during the pregnancy?","Weekly consultation with a healthcare professional and quarterly biological check-up","Self-monitoring of blood pressure, consultation every 10 days or so, regular biological check-up, and monthly ultrasound scan","Only regular biological check-up and ultrasound scan at 9 months","No enhanced monitoring required unless severe symptoms appear","b"
"OIC-024-15-B","{""question"": ""In the postpartum period for a patient with hypertension, what type of antihypertensive medications are preferred if the patient is breast-feeding?"", ""option_a"": ""Converting enzyme inhibitors (e.g., benazepril, captopril, enalapril, quinapril)"", ""option_b"": ""Beta-blockers (e.g., labetalol, propranolol) and calcium channel blockers (e.g., nicardipine, nifedipine)"", ""option_c"": ""Alpha-blockers and diuretics"", ""option_d"": ""Angiotensin II receptor blockers (e.g., losartan, valsartan)"", ""correct_option"": ""B""}",,"In the postpartum period for a patient with hypertension, what type of antihypertensive medications are preferred if the patient is breast-feeding?","Converting enzyme inhibitors (e.g., benazepril, captopril, enalapril, quinapril)","Beta-blockers (e.g., labetalol, propranolol) and calcium channel blockers (e.g., nicardipine, nifedipine)","Alpha-blockers and diuretics","Angiotensin II receptor blockers (e.g., losartan, valsartan)","b"
"OIC-024-16-A","{""question"": ""What is the recommended preventive treatment for a patient with a history of severe IUGR or early and/or severe pre-eclampsia with induced preterm birth?"", ""option_a"": ""Low-dose aspirin: 75 to 160 mg/d in the morning after 20 weeks' gestation"", ""option_b"": ""Low-dose aspirin: 75 to 160 mg/d in the evening before 16 and up to 35 weeks' gestation"", ""option_c"": ""High-dose aspirin: 300 to 500 mg/d in the evening before 16 and up to 35 weeks' gestation"", ""option_d"": ""No aspirin treatment is recommended for patients with a history of pregnancy-induced hypertension"", ""correct_option"": ""B""}","Management","What is the recommended preventive treatment for a patient with a history of severe IUGR or early and/or severe pre-eclampsia with induced preterm birth?","Low-dose aspirin: 75 to 160 mg/d in the morning after 20 weeks' gestation","Low-dose aspirin: 75 to 160 mg/d in the evening before 16 and up to 35 weeks' gestation","High-dose aspirin: 300 to 500 mg/d in the evening before 16 and up to 35 weeks' gestation","No aspirin treatment is recommended for patients with a history of pregnancy-induced hypertension","b"
"OIC-024-17-B","{""question"": ""What is a potential long-term complication for a patient with a history of gestational hypertension?"", ""option_a"": ""Increased risk of infectious diseases"", ""option_b"": ""Risk of chronic hypertension and cardiovascular and renal pathologies"", ""option_c"": ""Decreased risk of future pregnancies"", ""option_d"": ""Guaranteed resolution of hypertension after pregnancy"", ""correct_option"": ""B""}","Positive diagnosis","What is a potential long-term complication for a patient with a history of gestational hypertension?","Increased risk of infectious diseases","Risk of chronic hypertension and cardiovascular and renal pathologies","Decreased risk of future pregnancies","Guaranteed resolution of hypertension after pregnancy","b"
"OIC-024-18-A","{""question"": ""At what gestational age is a birth considered a late miscarriage rather than a preterm birth?"", ""option_a"": ""Before 22 weeks' gestation"", ""option_b"": ""Between 22 weeks and 36 weeks + 6 days of gestation"", ""option_c"": ""After 37 weeks of gestation"", ""option_d"": ""Between 25 weeks and 36 weeks of gestation"", ""correct_option"": ""A""}","Epidemiology","At what gestational age is a birth considered a late miscarriage rather than a preterm birth?","Before 22 weeks' gestation","Between 22 weeks and 36 weeks + 6 days of gestation","After 37 weeks of gestation","Between 25 weeks and 36 weeks of gestation","a"
"OIC-024-19-A","{""question"": ""What is a potential maternal risk factor for the threat of premature birth?"", ""option_a"": ""Advanced maternal age, specifically over 40 years old"", ""option_b"": ""Maternal age between 18 and 35 years old"", ""option_c"": ""History of regular exercise during pregnancy"", ""option_d"": ""Maternal age under 18 or over 35 years old"", ""correct_option"": ""D""}","Epidemiology","What is a potential maternal risk factor for the threat of premature birth?","Advanced maternal age, specifically over 40 years old","Maternal age between 18 and 35 years old","History of regular exercise during pregnancy","Maternal age under 18 or over 35 years old","d"
"OIC-024-20-A","{""question"": ""What is the primary purpose of performing a cervical ultrasound in the assessment of a threat of premature delivery?"", ""option_a"": ""To estimate fetal weight"", ""option_b"": ""To measure the quantity of amniotic fluid"", ""option_c"": ""To measure the length of the cervix for diagnostic and prognostic purposes"", ""option_d"": ""To detect chorioamniotitis"", ""correct_option"": ""C""}",,"What is the primary purpose of performing a cervical ultrasound in the assessment of a threat of premature delivery?","To estimate fetal weight","To measure the quantity of amniotic fluid","To measure the length of the cervix for diagnostic and prognostic purposes","To detect chorioamniotitis","c"
"OIC-024-21-B","{""question"": ""What is the recommended treatment for a threatened premature birth in terms of tocolysis?"", ""option_a"": ""Tocolysis for 48 hours with oxytocin agonists"", ""option_b"": ""Tocolysis for 48 hours with calcium channel blockers (nifedipine) or oxytocin antagonists (atosiban)"", ""option_c"": ""Tocolysis for 24 hours with magnesium sulphate"", ""option_d"": ""Tocolysis for 72 hours with antipyretics and antispasmodics"", ""correct_option"": ""B""}",,"What is the recommended treatment for a threatened premature birth in terms of tocolysis?","Tocolysis for 48 hours with oxytocin agonists","Tocolysis for 48 hours with calcium channel blockers (nifedipine) or oxytocin antagonists (atosiban)","Tocolysis for 24 hours with magnesium sulphate","Tocolysis for 72 hours with antipyretics and antispasmodics","b"
"OIC-024-22-A","{""question"": ""What is the primary measure to prevent the threat of premature birth in a woman with a history of premature delivery?"", ""option_a"": ""Performing a preventive cerclage regardless of the type of history and current pregnancy"", ""option_b"": ""Morphological assessment of the uterine cavity and treatment of bacterial vaginosis"", ""option_c"": ""Eliminating risk factors such as tobacco and toxic substances"", ""option_d"": ""Stopping work and preventing alcohol-related risks"", ""correct_option"": ""C""}",,"What is the primary measure to prevent the threat of premature birth in a woman with a history of premature delivery?","Performing a preventive cerclage regardless of the type of history and current pregnancy","Morphological assessment of the uterine cavity and treatment of bacterial vaginosis","Eliminating risk factors such as tobacco and toxic substances","Stopping work and preventing alcohol-related risks","c"
"OIC-024-23-A","{""question"": ""What is the primary objective of clinical examination in a pregnant woman with fever?"", ""option_a"": ""To assess the severity of the fever"", ""option_b"": ""To look for warning signs of a specific aetiology and assess the obstetrical impact"", ""option_c"": ""To determine the presence of active fetal movements"", ""option_d"": ""To evaluate the effectiveness of ongoing treatments"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary objective of clinical examination in a pregnant woman with fever?","To assess the severity of the fever","To look for warning signs of a specific aetiology and assess the obstetrical impact","To determine the presence of active fetal movements","To evaluate the effectiveness of ongoing treatments","b"
"OIC-024-24-A","{""question"": ""What is the appropriate initial work-up for a pregnant woman presenting with fever?"", ""option_a"": ""ECBU, NFS, and obstetrical ultrasound only"", ""option_b"": ""ECBU, NFS - CRP, blood cultures, serologies, and obstetrical ultrasound"", ""option_c"": ""Rapid influenza test, streptococcal test, and urine dipstick analysis only"", ""option_d"": ""Blood cultures, serologies, and PCR for COVID-19 only"", ""correct_option"": ""B""}","Positive diagnosis","What is the appropriate initial work-up for a pregnant woman presenting with fever?","ECBU, NFS, and obstetrical ultrasound only","ECBU, NFS - CRP, blood cultures, serologies, and obstetrical ultrasound","Rapid influenza test, streptococcal test, and urine dipstick analysis only","Blood cultures, serologies, and PCR for COVID-19 only","b"
"OIC-024-25-A","{""question"": ""What is the initial approach to managing a fever during pregnancy?"", ""option_a"": ""Immediate administration of amoxicillin 6 g/d IV"", ""option_b"": ""Antipyretic treatment with paracetamol and close monitoring"", ""option_c"": ""Parenteral antibiotic therapy combining C3G and aminoglycosides"", ""option_d"": ""Tocolysis to prevent premature labor"", ""correct_option"": ""B""}","Management","What is the initial approach to managing a fever during pregnancy?","Immediate administration of amoxicillin 6 g/d IV","Antipyretic treatment with paracetamol and close monitoring","Parenteral antibiotic therapy combining C3G and aminoglycosides","Tocolysis to prevent premature labor","b"
"OIC-026-01-B","{""question"": ""What is a common risk factor for uterine rupture during pregnancy or obstetric labor?"", ""option_a"": ""Previous history of HELLP syndrome"", ""option_b"": ""Scarred uterus from a previous caesarean section or myomectomy"", ""option_c"": ""Presence of a retroplacental haematoma"", ""option_d"": ""Chorioamniotitis without rupture of membranes"", ""correct_option"": ""B""}","Positive diagnosis","What is a common risk factor for uterine rupture during pregnancy or obstetric labor?","Previous history of HELLP syndrome","Scarred uterus from a previous caesarean section or myomectomy","Presence of a retroplacental haematoma","Chorioamniotitis without rupture of membranes","b"
"OIC-026-02-A","{""question"": ""What is the definition of the threat of premature delivery in a pregnant woman?"", ""option_a"": ""Association of uterine contractions regular and painful associated with cervical changes after 37 SA"", ""option_b"": ""Association of regular, painful uterine contractions associated with cervical changes on vaginal examination before 37 weeks' gestation"", ""option_c"": ""Association of irregular, painless uterine contractions associated with cervical changes on vaginal examination before 37 weeks' gestation"", ""option_d"": ""Association of uterine contractions regular and painful without cervical changes before 37 SA"", ""correct_option"": ""B""}","Positive diagnosis","What is the definition of the threat of premature delivery in a pregnant woman?","Association of uterine contractions regular and painful associated with cervical changes after 37 SA","Association of regular, painful uterine contractions associated with cervical changes on vaginal examination before 37 weeks' gestation","Association of irregular, painless uterine contractions associated with cervical changes on vaginal examination before 37 weeks' gestation","Association of uterine contractions regular and painful without cervical changes before 37 SA","b"
"OIC-026-03-A","{""question"": ""In the context of acute abdominal pain in a pregnant woman, what is the primary focus of the initial clinical examination?"", ""option_a"": ""To detect foetal heart sounds and assess uterine contracture"", ""option_b"": ""To perform a vaginal touch and speculum examination to check for cervical changes"", ""option_c"": ""To identify life-threatening etiologies, including obstetrical context, medical and obstetrical history, and characteristics of pain"", ""option_d"": ""To take the temperature and perform abdominal palpation, including the lumbar fossa"", ""correct_option"": ""C""}","Identification of the emergency","In the context of acute abdominal pain in a pregnant woman, what is the primary focus of the initial clinical examination?","To detect foetal heart sounds and assess uterine contracture","To perform a vaginal touch and speculum examination to check for cervical changes","To identify life-threatening etiologies, including obstetrical context, medical and obstetrical history, and characteristics of pain","To take the temperature and perform abdominal palpation, including the lumbar fossa","c"
"OIC-026-04-B","{""question"": ""What is the primary goal when managing acute abdominal pain in a pregnant woman?"", ""option_a"": ""To immediately perform surgery to alleviate the pain"", ""option_b"": ""To guide the clinical examination and suggest appropriate paraclinical tests"", ""option_c"": ""To prescribe pain medication without considering the pregnancy"", ""option_d"": ""To ignore the pain and focus on the pregnancy's progression"", ""correct_option"": ""B""}","Multimedia content","What is the primary goal when managing acute abdominal pain in a pregnant woman?","To immediately perform surgery to alleviate the pain","To guide the clinical examination and suggest appropriate paraclinical tests","To prescribe pain medication without considering the pregnancy","To ignore the pain and focus on the pregnancy's progression","b"
"OIC-026-05-B","{""question"": ""What is the recommended approach for using CT scans in pregnant women?"", ""option_a"": ""CT scans should be avoided at all stages of pregnancy due to the high risk of harm to the fetus."", ""option_b"": ""An injected CT scan is possible at any stage of pregnancy without any restrictions on contrast product injections."", ""option_c"": ""An injected CT scan is possible at any stage of pregnancy, but contrast product injections should be avoided in the early months of pregnancy and when breast-feeding."", ""option_d"": ""CT scans are only recommended during the first trimester of pregnancy to minimize the risk of childhood cancer."", ""correct_option"": ""C""}","Additional examinations","What is the recommended approach for using CT scans in pregnant women?","CT scans should be avoided at all stages of pregnancy due to the high risk of harm to the fetus.","An injected CT scan is possible at any stage of pregnancy without any restrictions on contrast product injections.","An injected CT scan is possible at any stage of pregnancy, but contrast product injections should be avoided in the early months of pregnancy and when breast-feeding.","CT scans are only recommended during the first trimester of pregnancy to minimize the risk of childhood cancer.","c"
"OIC-027-01-A","{""question"": ""What is the primary cause of maternal-fetal infection (MFI) during pregnancy or delivery?"", ""option_a"": ""Contamination of the foetus by germs of environmental origin"", ""option_b"": ""Contamination of the foetus by germs of maternal origin"", ""option_c"": ""Contamination of the foetus by germs of paternal origin"", ""option_d"": ""Contamination of the foetus by germs of unknown origin"", ""correct_option"": ""B""}","Definition","What is the primary cause of maternal-fetal infection (MFI) during pregnancy or delivery?","Contamination of the foetus by germs of environmental origin","Contamination of the foetus by germs of maternal origin","Contamination of the foetus by germs of paternal origin","Contamination of the foetus by germs of unknown origin","b"
"OIC-027-02-B","{""question"": ""What is the most common cause of early bacterial neonatal infection?"", ""option_a"": ""Escherichia coli"", ""option_b"": ""Group B Streptococcus"", ""option_c"": ""Listeriosis"", ""option_d"": ""Treponema pallidum (Syphilis)"", ""correct_option"": ""B""}","Epidemiology","What is the most common cause of early bacterial neonatal infection?","Escherichia coli","Group B Streptococcus","Listeriosis","Treponema pallidum (Syphilis)","b"
"OIC-027-03-B","{""question"": ""What are the two main routes of contamination of the foetus during pregnancy?"", ""option_a"": ""Haematogenous route and direct contact with the mother's skin"", ""option_b"": ""Vaginal, ascending route and haematogenous route"", ""option_c"": ""Transplacental antenatal passage and ingestion of contaminated food"", ""option_d"": ""Intrauterine injection and airborne transmission"", ""correct_option"": ""B""}","Physiopathology","What are the two main routes of contamination of the foetus during pregnancy?","Haematogenous route and direct contact with the mother's skin","Vaginal, ascending route and haematogenous route","Transplacental antenatal passage and ingestion of contaminated food","Intrauterine injection and airborne transmission","b"
"OIC-027-04-A","{""question"": ""At what gestational age is the severity of lesions due to toxoplasmosis infection highest?"", ""option_a"": ""In the 2nd trimester"", ""option_b"": ""In the 3rd trimester"", ""option_c"": ""In the 1st trimester"", ""option_d"": ""At birth"", ""correct_option"": ""C""}","Definition","At what gestational age is the severity of lesions due to toxoplasmosis infection highest?","In the 2nd trimester","In the 3rd trimester","In the 1st trimester","At birth","c"
"OIC-027-05-A","{""question"": ""How often should serology be repeated in non-immune pregnant women for toxoplasmosis monitoring?"", ""option_a"": ""Every 3 months until delivery"", ""option_b"": ""Monthly until delivery"", ""option_c"": ""Only once at the beginning of pregnancy"", ""option_d"": ""Every 6 months until delivery"", ""correct_option"": ""B""}","Management","How often should serology be repeated in non-immune pregnant women for toxoplasmosis monitoring?","Every 3 months until delivery","Monthly until delivery","Only once at the beginning of pregnancy","Every 6 months until delivery","b"
"OIC-027-06-A","{""question"": ""What is the primary recommendation for preventing toxoplasmosis infection when handling food?"", ""option_a"": ""Avoid eating meat altogether"", ""option_b"": ""Wash hands before and after handling food"", ""option_c"": ""Only eat food from restaurants"", ""option_d"": ""Do not wash raw vegetables and salads"", ""correct_option"": ""B""}","Care","What is the primary recommendation for preventing toxoplasmosis infection when handling food?","Avoid eating meat altogether","Wash hands before and after handling food","Only eat food from restaurants","Do not wash raw vegetables and salads","b"
"OIC-027-07-A","{""question"": ""What is the risk of major fetal anomalies if maternal rubella infection occurs before 11 weeks' gestation?"", ""option_a"": ""Around 25%"", ""option_b"": ""Around 50%"", ""option_c"": ""Around 90%"", ""option_d"": ""Virtually nil"", ""correct_option"": ""C""}",,"What is the risk of major fetal anomalies if maternal rubella infection occurs before 11 weeks' gestation?","Around 25%","Around 50%","Around 90%","Virtually nil","c"
"OIC-027-08-A","{""question"": ""What is the recommended approach for a pregnant woman who has not been vaccinated against rubella and has a negative initial serology result?"", ""option_a"": ""Immediate vaccination with the live antirubella vaccine"", ""option_b"": ""Serology check at 20 weeks of gestation with a test for IgG alone"", ""option_c"": ""Biological tests in a reference laboratory, including IgM tests and measurement of the IgG avidity index"", ""option_d"": ""No further monitoring or testing is required"", ""correct_option"": ""B""}","Management","What is the recommended approach for a pregnant woman who has not been vaccinated against rubella and has a negative initial serology result?","Immediate vaccination with the live antirubella vaccine","Serology check at 20 weeks of gestation with a test for IgG alone","Biological tests in a reference laboratory, including IgM tests and measurement of the IgG avidity index","No further monitoring or testing is required","b"
"OIC-027-09-A","{""question"": ""What is the primary concern regarding maternal-fetal measles transmission at the end of pregnancy?"", ""option_a"": ""It can lead to a high risk of neonatal congenital measles due to widespread lack of vaccination."", ""option_b"": ""It results in a mild illness in the newborn with no long-term consequences."", ""option_c"": ""It may result in neonatal congenital measles, although this is exceptional given vaccination coverage."", ""option_d"": ""It has no significant impact on the newborn due to the mother's immunity from previous infections."", ""correct_option"": ""C""}","Definition","What is the primary concern regarding maternal-fetal measles transmission at the end of pregnancy?","It can lead to a high risk of neonatal congenital measles due to widespread lack of vaccination.","It results in a mild illness in the newborn with no long-term consequences.","It may result in neonatal congenital measles, although this is exceptional given vaccination coverage.","It has no significant impact on the newborn due to the mother's immunity from previous infections.","c"
"OIC-027-10-A","{""question"": ""What is the rate of hospitalisation for pneumonia among pregnant women contracting measles?"", ""option_a"": ""10%"", ""option_b"": ""20%"", ""option_c"": ""30%"", ""option_d"": ""40%"", ""correct_option"": ""C""}","Follow-up and/or prognosis","What is the rate of hospitalisation for pneumonia among pregnant women contracting measles?","10%","20%","30%","40%","c"
"OIC-027-11-A","{""question"": ""What is the recommended treatment for an HIV-negative pregnant woman who has been infected with measles within the last 6 days?"", ""option_a"": ""Administering antibiotics to prevent complications"", ""option_b"": ""IV immunoglobulins to provide protection for one month"", ""option_c"": ""Immediate vaccination with a trivalent vaccine (MMR)"", ""option_d"": ""Hospitalization in a maternity hospital for close monitoring"", ""correct_option"": ""B""}","Management","What is the recommended treatment for an HIV-negative pregnant woman who has been infected with measles within the last 6 days?","Administering antibiotics to prevent complications","IV immunoglobulins to provide protection for one month","Immediate vaccination with a trivalent vaccine (MMR)","Hospitalization in a maternity hospital for close monitoring","b"
"OIC-027-12-A","{""question"": ""What is the primary cause of congenital viral infection and a leading non-hereditary cause of sensorineural hearing loss and mental retardation in early childhood?"", ""option_a"": ""Maternal rubella infection"", ""option_b"": ""Maternal-fetal cytomegalovirus (CMV) infection"", ""option_c"": ""Maternal herpes simplex virus infection"", ""option_d"": ""Maternal varicella-zoster virus infection"", ""correct_option"": ""B""}","Definition","What is the primary cause of congenital viral infection and a leading non-hereditary cause of sensorineural hearing loss and mental retardation in early childhood?","Maternal rubella infection","Maternal-fetal cytomegalovirus (CMV) infection","Maternal herpes simplex virus infection","Maternal varicella-zoster virus infection","b"
"OIC-027-13-B","{""question"": ""What is the approximate risk of contamination with HSV during childbirth if the primary infection occurred in the month preceding labor?"", ""option_a"": ""1/1,000"", ""option_b"": ""2 to 5%"", ""option_c"": ""50%"", ""option_d"": ""1/10,000"", ""correct_option"": ""C""}",,"What is the approximate risk of contamination with HSV during childbirth if the primary infection occurred in the month preceding labor?","1/1,000","2 to 5%","50%","1/10,000","c"
"OIC-027-14-B","{""question"": ""What is the recommended management for a pregnant woman with a primary herpes simplex virus (HSV) infection within 6 weeks before the start of labor?"", ""option_a"": ""Vaginal delivery with antiviral treatment"", ""option_b"": ""Caesarean section with aciclovir treatment"", ""option_c"": ""Expectant management with close monitoring"", ""option_d"": ""Induction of labor with valaciclovir treatment"", ""correct_option"": ""B""}","Management","What is the recommended management for a pregnant woman with a primary herpes simplex virus (HSV) infection within 6 weeks before the start of labor?","Vaginal delivery with antiviral treatment","Caesarean section with aciclovir treatment","Expectant management with close monitoring","Induction of labor with valaciclovir treatment","b"
"OIC-027-15-A","{""question"": ""What is the primary factor that determines the frequency of vertical transmission of hepatitis B from mother to child?"", ""option_a"": ""Mode of delivery, with vaginal delivery being higher risk than caesarean section"", ""option_b"": ""Viral replication, as assessed by viral DNA testing"", ""option_c"": ""The presence of hepatitis B surface antigen in the mother's blood"", ""option_d"": ""The gestational age at the time of transmission"", ""correct_option"": ""B""}","Definition","What is the primary factor that determines the frequency of vertical transmission of hepatitis B from mother to child?","Mode of delivery, with vaginal delivery being higher risk than caesarean section","Viral replication, as assessed by viral DNA testing","The presence of hepatitis B surface antigen in the mother's blood","The gestational age at the time of transmission","b"
"OIC-027-16-A","{""question"": ""What is the recommended course of action for a newborn baby born to an HBs+ antigen mother?"", ""option_a"": ""Caesarean section to prevent infection transmission"", ""option_b"": ""Sero-vaccination at best before the 12th hour of life, followed by 2 further vaccination injections one month apart and a booster at one year"", ""option_c"": ""Administration of antiviral treatment, such as lamivudine, to reduce the viral load"", ""option_d"": ""Avoiding breast-feeding to prevent postnatal transmission"", ""correct_option"": ""B""}",,"What is the recommended course of action for a newborn baby born to an HBs+ antigen mother?","Caesarean section to prevent infection transmission","Sero-vaccination at best before the 12th hour of life, followed by 2 further vaccination injections one month apart and a booster at one year","Administration of antiviral treatment, such as lamivudine, to reduce the viral load","Avoiding breast-feeding to prevent postnatal transmission","b"
"OIC-027-17-A","{""question"": ""When should HIV screening be offered to pregnant women?"", ""option_a"": ""Only if the mother has a history of HIV infection"", ""option_b"": ""At the beginning of pregnancy, as part of routine prenatal care"", ""option_c"": ""After the first trimester, to minimize the risk of false positives"", ""option_d"": ""Only if the mother's partner is known to be HIV-positive"", ""correct_option"": ""B""}","Management","When should HIV screening be offered to pregnant women?","Only if the mother has a history of HIV infection","At the beginning of pregnancy, as part of routine prenatal care","After the first trimester, to minimize the risk of false positives","Only if the mother's partner is known to be HIV-positive","b"
"OIC-027-18-A","{""question"": ""For which group is varicella vaccination particularly recommended, with the stipulation that it must be! preceded by a negative pregnancy test and followed by effective contraception for 3 months after each dose?"", ""option_a"": ""All adolescents aged between 12 and 18"", ""option_b"": ""Women of childbearing age planning a pregnancy with no clinical history of chickenpox"", ""option_c"": ""Pregnant women with a history of chickenpox"", ""option_d"": ""Men of any age without a clinical history of chickenpox"", ""correct_option"": ""B""}","Management","For which group is varicella vaccination particularly recommended, with the stipulation that it must be! preceded by a negative pregnancy test and followed by effective contraception for 3 months after each dose?","All adolescents aged between 12 and 18","Women of childbearing age planning a pregnancy with no clinical history of chickenpox","Pregnant women with a history of chickenpox","Men of any age without a clinical history of chickenpox","b"
"OIC-027-19-B","{""question"": ""What is the primary mechanism by which Listeria monocytogenes infects the newborn?"", ""option_a"": ""Through direct contact with the mother's skin during delivery"", ""option_b"": ""Via the mother's bloodstream, leading to colonisation of the placenta"", ""option_c"": ""Through contaminated amniotic fluid"", ""option_d"": ""By ingestion of contaminated breast milk"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism by which Listeria monocytogenes infects the newborn?","Through direct contact with the mother's skin during delivery","Via the mother's bloodstream, leading to colonisation of the placenta","Through contaminated amniotic fluid","By ingestion of contaminated breast milk","b"
"OIC-027-20-A","{""question"": ""What type of cheese should a pregnant woman avoid to prevent maternal-fetal listeriosis?"", ""option_a"": ""Soft cheeses made from pasteurized milk"", ""option_b"": ""Soft cheeses made from raw milk"", ""option_c"": ""Hard cheeses made from raw milk"", ""option_d"": ""All types of cheese"", ""correct_option"": ""B""}","Management","What type of cheese should a pregnant woman avoid to prevent maternal-fetal listeriosis?","Soft cheeses made from pasteurized milk","Soft cheeses made from raw milk","Hard cheeses made from raw milk","All types of cheese","b"
"OIC-027-21-B","{""question"": ""In the event of suspected listeriosis in a pregnant woman, what is the primary additional test to prescribe?"", ""option_a"": ""Bacteriological examination of the placenta"", ""option_b"": ""Anatomopathological examination of the lochiae"", ""option_c"": ""Blood cultures to search for listeriosis"", ""option_d"": ""Isolation of the germ from gastric fluid"", ""correct_option"": ""C""}",,"In the event of suspected listeriosis in a pregnant woman, what is the primary additional test to prescribe?","Bacteriological examination of the placenta","Anatomopathological examination of the lochiae","Blood cultures to search for listeriosis","Isolation of the germ from gastric fluid","c"
"OIC-027-22-B","{""question"": ""What is the primary route of maternal-fetal transmission of streptococcus B during childbirth?"", ""option_a"": ""Through the placenta via the bloodstream"", ""option_b"": ""Via the vaginal, ascending route, with contamination during passage through the maternal genital tract"", ""option_c"": ""Through the amniotic fluid by direct contact with the fetus"", ""option_d"": ""By inhalation of infected particles during labor"", ""correct_option"": ""B""}",,"What is the primary route of maternal-fetal transmission of streptococcus B during childbirth?","Through the placenta via the bloodstream","Via the vaginal, ascending route, with contamination during passage through the maternal genital tract","Through the amniotic fluid by direct contact with the fetus","By inhalation of infected particles during labor","b"
"OIC-027-23-B","{""question"": ""What is the recommended treatment for bacterial vaginosis caused by Gardnerella vaginalis during pregnancy?"", ""option_a"": ""Oral metronidazole (1 g/d for 7 days or 2 g as a single dose) and topical clindamycin"", ""option_b"": ""Oral metronidazole (1 g/d for 7 days or 2 g as a single dose)"", ""option_c"": ""Topical metronidazole alone"", ""option_d"": ""No treatment is necessary unless symptoms persist"", ""correct_option"": ""B""}","Management","What is the recommended treatment for bacterial vaginosis caused by Gardnerella vaginalis during pregnancy?","Oral metronidazole (1 g/d for 7 days or 2 g as a single dose) and topical clindamycin","Oral metronidazole (1 g/d for 7 days or 2 g as a single dose)","Topical metronidazole alone","No treatment is necessary unless symptoms persist","b"
"OIC-027-24-B","{""question"": ""What is the suspected risk associated with bacterial vaginosis during pregnancy?"", ""option_a"": ""Increased risk of gestational diabetes"", ""option_b"": ""Risk of threatened premature delivery"", ""option_c"": ""Higher chance of postpartum hemorrhage"", ""option_d"": ""Increased risk of preeclampsia"", ""correct_option"": ""B""}",,"What is the suspected risk associated with bacterial vaginosis during pregnancy?","Increased risk of gestational diabetes","Risk of threatened premature delivery","Higher chance of postpartum hemorrhage","Increased risk of preeclampsia","b"
"OIC-027-25-A","{""question"": ""What is the recommended treatment for a pregnant woman with influenza, and when should it be started?"", ""option_a"": ""Oseltamivir (Tamiflu) 75 mg: 2/d for 5 days, started within 72 hours of the first signs"", ""option_b"": ""Oseltamivir (Tamiflu) 75 mg: 2/d for 5 days, started as soon as possible, and at the latest within 48 hours of the first signs"", ""option_c"": ""Amoxicillin 3 g/d for 7 days, started immediately after diagnosis"", ""option_d"": ""Paracetamol only, started within 24 hours of the first signs"", ""correct_option"": ""B""}","Management","What is the recommended treatment for a pregnant woman with influenza, and when should it be started?","Oseltamivir (Tamiflu) 75 mg: 2/d for 5 days, started within 72 hours of the first signs","Oseltamivir (Tamiflu) 75 mg: 2/d for 5 days, started as soon as possible, and at the latest within 48 hours of the first signs","Amoxicillin 3 g/d for 7 days, started immediately after diagnosis","Paracetamol only, started within 24 hours of the first signs","b"
"OIC-027-26-B","{""question"": ""What is the primary cause of foetal anaemia in cases of anti-erythrocyte alloimmunisation?"", ""option_a"": ""Foetomaternal haemorrhage leading to the passage of compatible foetal red blood cells into the maternal circulation"", ""option_b"": ""The passage of maternal antibodies across the placenta when the foetus has the corresponding erythrocyte antigen"", ""option_c"": ""Inheritance of a blood group antigen from the father that is not present in the mother"", ""option_d"": ""A spontaneous reaction to the foetal red blood cells without any prior sensitization"", ""correct_option"": ""B""}","Physiopathology","What is the primary cause of foetal anaemia in cases of anti-erythrocyte alloimmunisation?","Foetomaternal haemorrhage leading to the passage of compatible foetal red blood cells into the maternal circulation","The passage of maternal antibodies across the placenta when the foetus has the corresponding erythrocyte antigen","Inheritance of a blood group antigen from the father that is not present in the mother","A spontaneous reaction to the foetal red blood cells without any prior sensitization","b"
"OIC-027-27-A","{""question"": ""When should irregular agglutinins (antibodies) testing (RAI) be performed in pregnant women?"", ""option_a"": ""Only in RhD-negative women during the 1st trimester of pregnancy"", ""option_b"": ""In all pregnant women during the 1st trimester of pregnancy and repeated at the 6th, 8th or 9th month if necessary"", ""option_c"": ""In all pregnant women at the 6th, 8th or 9th month of pregnancy"", ""option_d"": ""Only in women who have previously received blood transfusions during the 1st trimester of pregnancy"", ""correct_option"": ""B""}","Positive diagnosis","When should irregular agglutinins (antibodies) testing (RAI) be performed in pregnant women?","Only in RhD-negative women during the 1st trimester of pregnancy","In all pregnant women during the 1st trimester of pregnancy and repeated at the 6th, 8th or 9th month if necessary","In all pregnant women at the 6th, 8th or 9th month of pregnancy","Only in women who have previously received blood transfusions during the 1st trimester of pregnancy","b"
"OIC-027-28-A","{""question"": ""What is the primary method for preventing anti-D (Rh1) alloimmunisation in RhD- patients during pregnancy?"", ""option_a"": ""Avoiding situations that may lead to foetomaternal haemorrhage"", ""option_b"": ""Injection of specific anti-D immunoglobulins, such as Rhophylac"", ""option_c"": ""Conducting regular Kleihauer tests to monitor for foetal red blood cells in maternal blood"", ""option_d"": ""Administering a standard dose of anti-D Ig at the beginning of pregnancy"", ""correct_option"": ""B""}",,"What is the primary method for preventing anti-D (Rh1) alloimmunisation in RhD- patients during pregnancy?","Avoiding situations that may lead to foetomaternal haemorrhage","Injection of specific anti-D immunoglobulins, such as Rhophylac","Conducting regular Kleihauer tests to monitor for foetal red blood cells in maternal blood","Administering a standard dose of anti-D Ig at the beginning of pregnancy","b"
"OIC-027-29-B","{""question"": ""What is the next step if a newborn is found to be RhD+ after birth, in terms of preventing antierythrocytic alloimmunisation in the mother?"", ""option_a"": ""No further action is required as the risk of alloimmunisation is low"", ""option_b"": ""A Kleihauer test is carried out on a sample of maternal blood taken immediately after delivery"", ""option_c"": ""A Kleihauer test will be carried out on a sample of maternal blood taken at least 30 minutes after delivery, followed by an offer of anti-D prophylaxis"", ""option_d"": ""The mother is immediately given anti-D prophylaxis without the need for a Kleihauer test"", ""correct_option"": ""C""}","Follow-up and/or prognosis","What is the next step if a newborn is found to be RhD+ after birth, in terms of preventing antierythrocytic alloimmunisation in the mother?","No further action is required as the risk of alloimmunisation is low","A Kleihauer test is carried out on a sample of maternal blood taken immediately after delivery","A Kleihauer test will be carried out on a sample of maternal blood taken at least 30 minutes after delivery, followed by an offer of anti-D prophylaxis","The mother is immediately given anti-D prophylaxis without the need for a Kleihauer test","c"
"OIC-027-30-A","{""question"": ""In the case of a patient taking treatment and not knowing she was pregnant, what is the first step to be taken during the consultation?"", ""option_a"": ""Immediately stopping the treatment to prevent any potential harm to the fetus"", ""option_b"": ""Recording the circumstances in which the medication was taken, including duration, quantity, and indication"", ""option_c"": ""Referring the patient to a Pluridisciplinary Centre for Prenatal Diagnosis for further evaluation"", ""option_d"": ""Contacting the regional pharmacovigilance services to report the incident"", ""correct_option"": ""B""}","Management","In the case of a patient taking treatment and not knowing she was pregnant, what is the first step to be taken during the consultation?","Immediately stopping the treatment to prevent any potential harm to the fetus","Recording the circumstances in which the medication was taken, including duration, quantity, and indication","Referring the patient to a Pluridisciplinary Centre for Prenatal Diagnosis for further evaluation","Contacting the regional pharmacovigilance services to report the incident","b"
"OIC-027-31-A","{""question"": ""Which of the following medications is a vitamin A derivative that can pose a risk during pregnancy?"", ""option_a"": ""Warfarin (Coumadin\u00ae)"", ""option_b"": ""Isotretinoin (Roaccutane\u00ae)"", ""option_c"": ""Lithium (T\u00e9ralithe\u00ae)"", ""option_d"": ""Methotrexate (Ledertrexate\u00ae)"", ""correct_option"": ""B""}","Positive diagnosis","Which of the following medications is a vitamin A derivative that can pose a risk during pregnancy?","Warfarin (Coumadin®)","Isotretinoin (Roaccutane®)","Lithium (Téralithe®)","Methotrexate (Ledertrexate®)","b"
"OIC-027-32-B","{""question"": ""What is the recommended procedure for a pregnant woman taking lithium for thymoregulation?"", ""option_a"": ""Prescription of exclusive oral contraception and provision of a follow-up booklet"", ""option_b"": ""In case of pregnancy on lithium, follow-up in CPDPN and foetal echocardiography"", ""option_c"": ""Pregnancy contraindicated within 2 years of stopping treatment"", ""option_d"": ""Replacement with LMWH for pregnancy"", ""correct_option"": ""B""}","Positive diagnosis","What is the recommended procedure for a pregnant woman taking lithium for thymoregulation?","Prescription of exclusive oral contraception and provision of a follow-up booklet","In case of pregnancy on lithium, follow-up in CPDPN and foetal echocardiography","Pregnancy contraindicated within 2 years of stopping treatment","Replacement with LMWH for pregnancy","b"
"OIC-027-33-A","{""question"": ""Which of the following vaccines is recommended for pregnant women, particularly those at risk, such as diabetics and obese women?"", ""option_a"": ""MMR (measles, mumps, rubella) vaccine"", ""option_b"": ""Influenza (flu) vaccine"", ""option_c"": ""BCG vaccine"", ""option_d"": ""Cholera vaccine"", ""correct_option"": ""B""}","Management","Which of the following vaccines is recommended for pregnant women, particularly those at risk, such as diabetics and obese women?","MMR (measles, mumps, rubella) vaccine","Influenza (flu) vaccine","BCG vaccine","Cholera vaccine","b"
"OIC-027-34-B","{""question"": ""At what stage of pregnancy does the effect of maternal smoking on the foetus seem to be more marked?"", ""option_a"": ""1st trimester"", ""option_b"": ""2nd trimester"", ""option_c"": ""3rd trimester"", ""option_d"": ""Throughout the entire pregnancy, with no specific trimester being more affected"", ""correct_option"": ""C""}","Physiopathology","At what stage of pregnancy does the effect of maternal smoking on the foetus seem to be more marked?","1st trimester","2nd trimester","3rd trimester","Throughout the entire pregnancy, with no specific trimester being more affected","c"
"OIC-027-35-A","{""question"": ""What is the effect of smoking during pregnancy on the risk of spontaneous miscarriage?"", ""option_a"": ""A dose-dependent decrease in spontaneous miscarriages"", ""option_b"": ""A dose-dependent increase in spontaneous miscarriages, with a relative risk of 1"", ""option_c"": ""A dose-dependent increase in spontaneous miscarriages, with a relative risk of 2"", ""option_d"": ""No significant effect on spontaneous miscarriages"", ""correct_option"": ""C""}","Diagnosis","What is the effect of smoking during pregnancy on the risk of spontaneous miscarriage?","A dose-dependent decrease in spontaneous miscarriages","A dose-dependent increase in spontaneous miscarriages, with a relative risk of 1","A dose-dependent increase in spontaneous miscarriages, with a relative risk of 2","No significant effect on spontaneous miscarriages","c"
"OIC-027-36-B","{""question"": ""What is often necessary to help pregnant women give up smoking?"", ""option_a"": ""Immediate cessation of all medical interventions"", ""option_b"": ""Appropriate nicotine replacement therapy"", ""option_c"": ""Increased exposure to smoking-related information"", ""option_d"": ""Mandatory addictology consultation"", ""correct_option"": ""B""}","Management","What is often necessary to help pregnant women give up smoking?","Immediate cessation of all medical interventions","Appropriate nicotine replacement therapy","Increased exposure to smoking-related information","Mandatory addictology consultation","b"
"OIC-027-37-A","{""question"": ""What is the estimated incidence of Foetal Alcohol Syndrome (FAS) in its complete form in France?"", ""option_a"": ""1 to 5/1000"", ""option_b"": ""1 to 2/1000"", ""option_c"": ""5 to 10/1000"", ""option_d"": ""10 to 20/1000"", ""correct_option"": ""B""}","Diagnosis","What is the estimated incidence of Foetal Alcohol Syndrome (FAS) in its complete form in France?","1 to 5/1000","1 to 2/1000","5 to 10/1000","10 to 20/1000","b"
"OIC-027-38-B","{""question"": ""What is the relationship between the quantity of alcohol ingested during pregnancy and the risk of foetal damage?"", ""option_a"": ""The risk of foetal damage is only associated with binge drinking"", ""option_b"": ""The risk of foetal damage is proportional to the quantity of alcohol ingested"", ""option_c"": ""There is no established relationship between the quantity of alcohol ingested and the risk of foetal damage"", ""option_d"": ""The risk of foetal damage is only associated with heavy consumption and not with occasional or moderate consumption"", ""correct_option"": ""B""}","Physiopathology","What is the relationship between the quantity of alcohol ingested during pregnancy and the risk of foetal damage?","The risk of foetal damage is only associated with binge drinking","The risk of foetal damage is proportional to the quantity of alcohol ingested","There is no established relationship between the quantity of alcohol ingested and the risk of foetal damage","The risk of foetal damage is only associated with heavy consumption and not with occasional or moderate consumption","b"
"OIC-027-39-A","{""question"": ""What is the recommended approach when questioning a pregnant woman about her alcohol consumption?"", ""option_a"": ""Using direct and confrontational questions to assess her drinking habits"", ""option_b"": ""Adopting an empathetic attitude and a non-judgemental framework, preferring indirect and/or open-ended questions"", ""option_c"": ""Focusing solely on the quantity of alcohol consumed, without considering the context or potential risks"", ""option_d"": ""Avoiding discussion of alcohol consumption altogether, to prevent causing unnecessary stress or anxiety"", ""correct_option"": ""B""}",,"What is the recommended approach when questioning a pregnant woman about her alcohol consumption?","Using direct and confrontational questions to assess her drinking habits","Adopting an empathetic attitude and a non-judgemental framework, preferring indirect and/or open-ended questions","Focusing solely on the quantity of alcohol consumed, without considering the context or potential risks","Avoiding discussion of alcohol consumption altogether, to prevent causing unnecessary stress or anxiety","b"
"OIC-027-40-B","{""question"": ""What is a common effect of cannabis use during pregnancy on the fetus?"", ""option_a"": ""Severe neonatal gastrointestinal disorders"", ""option_b"": ""Intrauterine growth retardation"", ""option_c"": ""Retroplacental haematoma"", ""option_d"": ""Cerebral haemorrhagic lesions"", ""correct_option"": ""B""}","Physiopathology","What is a common effect of cannabis use during pregnancy on the fetus?","Severe neonatal gastrointestinal disorders","Intrauterine growth retardation","Retroplacental haematoma","Cerebral haemorrhagic lesions","b"
"OIC-027-41-A","{""question"": ""During pregnancy, which of the following is an important aspect to identify in order to understand and address addictive behaviours in women?"", ""option_a"": ""Only the use of illicit substances and tobacco"", ""option_b"": ""The mother's life story, history of the parental couple, maternal lifestyle, health, and fears"", ""option_c"": ""The socio-economic status of the woman to determine the likelihood of addiction"", ""option_d"": ""The frequency of prenatal care visits to monitor substance use"", ""correct_option"": ""B""}","Diagnosis","During pregnancy, which of the following is an important aspect to identify in order to understand and address addictive behaviours in women?","Only the use of illicit substances and tobacco","The mother's life story, history of the parental couple, maternal lifestyle, health, and fears","The socio-economic status of the woman to determine the likelihood of addiction","The frequency of prenatal care visits to monitor substance use","b"
"OIC-027-42-B","{""question"": ""What is the primary goal of multidisciplinary care in a coordinated network for pregnant women with addiction?"", ""option_a"": ""To immediately stop substance consumption without medical support"", ""option_b"": ""To introduce opiate substitution treatment, reduce consumption, and support the pregnancy to minimize complications"", ""option_c"": ""To prioritize the use of anxiolytics over substitution treatments for managing addiction"", ""option_d"": ""To focus solely on the psychological aspects of addiction without medical intervention"", ""correct_option"": ""B""}","Management","What is the primary goal of multidisciplinary care in a coordinated network for pregnant women with addiction?","To immediately stop substance consumption without medical support","To introduce opiate substitution treatment, reduce consumption, and support the pregnancy to minimize complications","To prioritize the use of anxiolytics over substitution treatments for managing addiction","To focus solely on the psychological aspects of addiction without medical intervention","b"
"OIC-027-43-B","{""question"": ""What is the primary factor that influences the severity and duration of Neonatal Withdrawal Syndrome (NNDS) in children born to mothers who used opiates or opiate substitution treatments during pregnancy?"", ""option_a"": ""The dosage of opioid substitution treatment"", ""option_b"": ""The concomitant use of other products, particularly benzodiazepines"", ""option_c"": ""The mother's overall health during pregnancy"", ""option_d"": ""The duration of opiate use during pregnancy"", ""correct_option"": ""B""}","Management","What is the primary factor that influences the severity and duration of Neonatal Withdrawal Syndrome (NNDS) in children born to mothers who used opiates or opiate substitution treatments during pregnancy?","The dosage of opioid substitution treatment","The concomitant use of other products, particularly benzodiazepines","The mother's overall health during pregnancy","The duration of opiate use during pregnancy","b"
"OIC-027-44-B","{""question"": ""What is a potential long-term consequence of in utero exposure to alcohol during pregnancy?"", ""option_a"": ""Improved cognitive development"", ""option_b"": ""Malformations, psychomotor developmental abnormalities, and mental retardation"", ""option_c"": ""Enhanced social behaviour"", ""option_d"": ""Reduced risk of prematurity"", ""correct_option"": ""B""}","Diagnosis","What is a potential long-term consequence of in utero exposure to alcohol during pregnancy?","Improved cognitive development","Malformations, psychomotor developmental abnormalities, and mental retardation","Enhanced social behaviour","Reduced risk of prematurity","b"
"OIC-027-45-B","{""question"": ""At what threshold of irradiation can cell death occur in the foetus, particularly affecting neurons in the central nervous system?"", ""option_a"": ""50-100 mGy"", ""option_b"": ""100-200 mGy"", ""option_c"": ""200-500 mGy"", ""option_d"": ""500-1000 mGy"", ""correct_option"": ""B""}","Physiopathology","At what threshold of irradiation can cell death occur in the foetus, particularly affecting neurons in the central nervous system?","50-100 mGy","100-200 mGy","200-500 mGy","500-1000 mGy","b"
"OIC-027-46-A","{""question"": ""What should be done if a pregnant woman has undergone a radiodiagnostic examination where the uterus is in the radiation beam and it was a standard examination?"", ""option_a"": ""The patient should be immediately referred for further testing to assess potential harm to the fetus."", ""option_b"": ""The patient should be advised to consider termination of the pregnancy due to the high risk of radiation exposure."", ""option_c"": ""The patient can be reassured as the dose delivered to the uterus is exceptionally greater than 100 mGy, below which the risks are very low."", ""option_d"": ""The patient should undergo an ultrasound or MRI to confirm the safety of the fetus before proceeding with any further action."", ""correct_option"": ""C""}","Management","What should be done if a pregnant woman has undergone a radiodiagnostic examination where the uterus is in the radiation beam and it was a standard examination?","The patient should be immediately referred for further testing to assess potential harm to the fetus.","The patient should be advised to consider termination of the pregnancy due to the high risk of radiation exposure.","The patient can be reassured as the dose delivered to the uterus is exceptionally greater than 100 mGy, below which the risks are very low.","The patient should undergo an ultrasound or MRI to confirm the safety of the fetus before proceeding with any further action.","c"
"OIC-030-01-B","{""question"": ""What is the primary method of mother-to-child transmission of bacterial infection, such as group B streptococcus (GBS) or Escherichia coli, in the context of neonatal bacterial infection?"", ""option_a"": ""Postnatal contact with infected healthcare workers"", ""option_b"": ""Prenatal bacterial colonization of the genital tract"", ""option_c"": ""Intrapartum aspiration of infected amniotic fluid"", ""option_d"": ""Postpartum breastfeeding from an infected mother"", ""correct_option"": ""B""}","Diagnosis","What is the primary method of mother-to-child transmission of bacterial infection, such as group B streptococcus (GBS) or Escherichia coli, in the context of neonatal bacterial infection?","Postnatal contact with infected healthcare workers","Prenatal bacterial colonization of the genital tract","Intrapartum aspiration of infected amniotic fluid","Postpartum breastfeeding from an infected mother","b"
"OIC-030-02-B","{""question"": ""What is a key sign that distinguishes cyanogenic heart disease from other causes of respiratory distress in newborns?"", ""option_a"": ""Presence of polypnoea"", ""option_b"": ""Cyanosis with signs of respiratory struggle"", ""option_c"": ""Cyanosis without signs of respiratory struggle"", ""option_d"": ""Intensity of respiratory distress as measured by the Silverman score"", ""correct_option"": ""C""}","Diagnosis","What is a key sign that distinguishes cyanogenic heart disease from other causes of respiratory distress in newborns?","Presence of polypnoea","Cyanosis with signs of respiratory struggle","Cyanosis without signs of respiratory struggle","Intensity of respiratory distress as measured by the Silverman score","c"
"OIC-030-03-B","{""question"": ""What percentage of intrauterine growth retardation (IUGR) cases are due to fetal pathologies?"", ""option_a"": ""35-50%"", ""option_b"": ""10-20%"", ""option_c"": ""50-60%"", ""option_d"": ""20-30%"", ""correct_option"": ""B""}","Diagnosis","What percentage of intrauterine growth retardation (IUGR) cases are due to fetal pathologies?","35-50%","10-20%","50-60%","20-30%","b"
"OIC-030-04-B","{""question"": ""What is the primary distinction made in the classification of prematurity?"", ""option_a"": ""Between premature births occurring before 32 weeks and those occurring between 32-37 weeks"", ""option_b"": ""Between spontaneous prematurity and induced prematurity"", ""option_c"": ""Between premature births due to uterine malformations and those due to cervical incompetence"", ""option_d"": ""Between premature births resulting from multiple pregnancies and those resulting from single pregnancies"", ""correct_option"": ""B""}","Diagnosis","What is the primary distinction made in the classification of prematurity?","Between premature births occurring before 32 weeks and those occurring between 32-37 weeks","Between spontaneous prematurity and induced prematurity","Between premature births due to uterine malformations and those due to cervical incompetence","Between premature births resulting from multiple pregnancies and those resulting from single pregnancies","b"
"OIC-032-01-B","{""question"": ""What is the primary purpose of the Apgar score in assessing a newborn's adaptation to extra-uterine life?"", ""option_a"": ""To evaluate the newborn's overall health and development at birth"", ""option_b"": ""To assess the newborn's risk of developing congenital anomalies"", ""option_c"": ""To determine the newborn's ABO blood type"", ""option_d"": ""To evaluate the newborn's physical condition at 1, 5, and 10 minutes after birth"", ""correct_option"": ""D""}","Positive diagnosis","What is the primary purpose of the Apgar score in assessing a newborn's adaptation to extra-uterine life?","To evaluate the newborn's overall health and development at birth","To assess the newborn's risk of developing congenital anomalies","To determine the newborn's ABO blood type","To evaluate the newborn's physical condition at 1, 5, and 10 minutes after birth","d"
"OIC-032-02-B","{""question"": ""What is the clinical significance of the absence of primary automatisms, such as sucking or grasping reflexes, in a term newborn?"", ""option_a"": ""It is a normal variation and does not indicate any pathology"", ""option_b"": ""It may indicate a neurological issue, but only if the reflexes disappear after 4 months of age"", ""option_c"": ""It is always pathological and requires further medical evaluation"", ""option_d"": ""It is only significant if the reflexes are still absent after 6 months of age"", ""correct_option"": ""C""}","Positive diagnosis","What is the clinical significance of the absence of primary automatisms, such as sucking or grasping reflexes, in a term newborn?","It is a normal variation and does not indicate any pathology","It may indicate a neurological issue, but only if the reflexes disappear after 4 months of age","It is always pathological and requires further medical evaluation","It is only significant if the reflexes are still absent after 6 months of age","c"
"OIC-032-03-B","{""question"": ""What is the primary purpose of administering vitamin K1 to a newborn in the delivery room?"", ""option_a"": ""To prevent hypothermia"", ""option_b"": ""To prevent bleeding due to vitamin K deficiency"", ""option_c"": ""To assess the Apgar score"", ""option_d"": ""To facilitate skin-to-skin contact with the mother"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary purpose of administering vitamin K1 to a newborn in the delivery room?","To prevent hypothermia","To prevent bleeding due to vitamin K deficiency","To assess the Apgar score","To facilitate skin-to-skin contact with the mother","b"
"OIC-032-04-B","{""question"": ""What is the primary method used for screening congenital hypothyroidism in neonatal blood screening?"", ""option_a"": ""Measurement of phenylalanine dosage"", ""option_b"": ""Elevation of TSH blood level"", ""option_c"": ""Haemoglobin electrophoresis"", ""option_d"": ""Measurement of octanoyl-carnitine (C8)"", ""correct_option"": ""B""}","Management","What is the primary method used for screening congenital hypothyroidism in neonatal blood screening?","Measurement of phenylalanine dosage","Elevation of TSH blood level","Haemoglobin electrophoresis","Measurement of octanoyl-carnitine (C8)","b"
"OIC-032-05-B","{""question"": ""What is the primary method of screening for congenital dislocation of the hips in newborns?"", ""option_a"": ""Ultrasound scan of the hips"", ""option_b"": ""Pelvic X-ray"", ""option_c"": ""Clinical examination at birth and at each consultation until walking age"", ""option_d"": ""Induced acoustic emission tests"", ""correct_option"": ""C""}",,"What is the primary method of screening for congenital dislocation of the hips in newborns?","Ultrasound scan of the hips","Pelvic X-ray","Clinical examination at birth and at each consultation until walking age","Induced acoustic emission tests","c"
"OIC-032-06-A","{""question"": ""What is the recommended time frame for the initiation of breastfeeding according to the WHO?"", ""option_a"": ""Within the first 2 hours of life"", ""option_b"": ""Within the first hour of life"", ""option_c"": ""Within the first 6 hours of life"", ""option_d"": ""Within the first 24 hours of life"", ""correct_option"": ""B""}","Care","What is the recommended time frame for the initiation of breastfeeding according to the WHO?","Within the first 2 hours of life","Within the first hour of life","Within the first 6 hours of life","Within the first 24 hours of life","b"
"OIC-032-07-B","{""question"": ""What is the definition of prematurity in terms of birth and weight?"", ""option_a"": ""Birth before 38 weeks' amenorrhoea and a weight of at least 400g"", ""option_b"": ""Birth before 37 weeks' amenorrhoea and a weight of at least 500g"", ""option_c"": ""Birth before 39 weeks' amenorrhoea and a weight of at least 600g"", ""option_d"": ""Birth before 36 weeks' amenorrhoea and a weight of at least 300g"", ""correct_option"": ""B""}","Positive diagnosis","What is the definition of prematurity in terms of birth and weight?","Birth before 38 weeks' amenorrhoea and a weight of at least 400g","Birth before 37 weeks' amenorrhoea and a weight of at least 500g","Birth before 39 weeks' amenorrhoea and a weight of at least 600g","Birth before 36 weeks' amenorrhoea and a weight of at least 300g","b"
"OIC-032-08-B","{""question"": ""What is the approximate frequency of cleft lip and palate in births?"", ""option_a"": ""1/100 births"", ""option_b"": ""1/2000 births"", ""option_c"": ""1/500 births"", ""option_d"": ""1/1000 births"", ""correct_option"": ""B""}","Positive diagnosis","What is the approximate frequency of cleft lip and palate in births?","1/100 births","1/2000 births","1/500 births","1/1000 births","b"
"OIC-037-01-A","{""question"": ""What was the primary intention behind penalising abortion prior to the 1975 Veil law?"", ""option_a"": ""To protect women's health and well-being"", ""option_b"": ""To protect the country's demography"", ""option_c"": ""To promote women's rights and equality"", ""option_d"": ""To reduce the number of clandestine abortions"", ""correct_option"": ""B""}","Definition","What was the primary intention behind penalising abortion prior to the 1975 Veil law?","To protect women's health and well-being","To protect the country's demography","To promote women's rights and equality","To reduce the number of clandestine abortions","b"
"OIC-037-02-A","{""question"": ""What proportion of women who have had a termination of pregnancy were using a contraceptive method at the time of conception?"", ""option_a"": ""About one quarter"", ""option_b"": ""About half"", ""option_c"": ""About two thirds"", ""option_d"": ""Less than one tenth"", ""correct_option"": ""C""}","Etiologies","What proportion of women who have had a termination of pregnancy were using a contraceptive method at the time of conception?","About one quarter","About half","About two thirds","Less than one tenth","c"
"OIC-037-03-B","{""question"": ""What is the approximate annual number of abortions performed in France, and how has this figure changed since 2006?"", ""option_a"": ""The number of abortions has been increasing steadily since 2006, with over 300,000 performed annually"", ""option_b"": ""The number of abortions varies between 215,000 and 230,000 per year and has been stable since 2006"", ""option_c"": ""The number of abortions has been declining since 2006, with fewer than 200,000 performed annually"", ""option_d"": ""The number of abortions performed in France is unknown due to lack of data since 2006"", ""correct_option"": ""B""}","Epidemiology","What is the approximate annual number of abortions performed in France, and how has this figure changed since 2006?","The number of abortions has been increasing steadily since 2006, with over 300,000 performed annually","The number of abortions varies between 215,000 and 230,000 per year and has been stable since 2006","The number of abortions has been declining since 2006, with fewer than 200,000 performed annually","The number of abortions performed in France is unknown due to lack of data since 2006","b"
"OIC-037-04-A","{""question"": ""Which age group of women is most concerned with undergoing abortions?"", ""option_a"": ""Women aged 15-19"", ""option_b"": ""Women aged 20-24"", ""option_c"": ""Women aged 25-29"", ""option_d"": ""Women aged 30-34"", ""correct_option"": ""B""}","Epidemiology","Which age group of women is most concerned with undergoing abortions?","Women aged 15-19","Women aged 20-24","Women aged 25-29","Women aged 30-34","b"
"OIC-037-05-A","{""question"": ""Up to what gestational age is medical abortion possible in France?"", ""option_a"": ""12 weeks"", ""option_b"": ""9 weeks"", ""option_c"": ""16 weeks"", ""option_d"": ""20 weeks"", ""correct_option"": ""B""}",,"Up to what gestational age is medical abortion possible in France?","12 weeks","9 weeks","16 weeks","20 weeks","b"
"OIC-037-06-A","{""question"": ""Where can medical abortions up to 9 weeks' gestation be carried out in private practice?"", ""option_a"": ""In any private practice, regardless of the gestation period"", ""option_b"": ""Only in private practices attached to health establishments"", ""option_c"": ""In private practices of gynaecologists, general practitioners, or midwives"", ""option_d"": ""Only in family planning centres"", ""correct_option"": ""C""}",,"Where can medical abortions up to 9 weeks' gestation be carried out in private practice?","In any private practice, regardless of the gestation period","Only in private practices attached to health establishments","In private practices of gynaecologists, general practitioners, or midwives","Only in family planning centres","c"
"OIC-037-07-A","{""question"": ""What is the primary purpose of the follow-up consultation between 14 and 21 days after the abortion?"", ""option_a"": ""To confirm the patient's decision to have an abortion"", ""option_b"": ""To prescribe contraception and emergency contraception"", ""option_c"": ""To ensure that there are no complications and the patient has taken appropriate contraception"", ""option_d"": ""To decide on the technique for the abortion"", ""correct_option"": ""C""}",,"What is the primary purpose of the follow-up consultation between 14 and 21 days after the abortion?","To confirm the patient's decision to have an abortion","To prescribe contraception and emergency contraception","To ensure that there are no complications and the patient has taken appropriate contraception","To decide on the technique for the abortion","c"
"OIC-037-08-B","{""question"": ""What is the maximum legal period for performing a medical abortion?"", ""option_a"": ""Up to 12 weeks' gestation"", ""option_b"": ""Up to 16 weeks' gestation"", ""option_c"": ""Up to 9 weeks' gestation"", ""option_d"": ""Up to 6 weeks' gestation"", ""correct_option"": ""C""}",,"What is the maximum legal period for performing a medical abortion?","Up to 12 weeks' gestation","Up to 16 weeks' gestation","Up to 9 weeks' gestation","Up to 6 weeks' gestation","c"
"OIC-037-09-B","{""question"": ""What is a contraindication for the medicated technique of abortion?"", ""option_a"": ""Mild asthma controlled by treatment"", ""option_b"": ""Profound anaemia (Hb < 9-10 g/dL)"", ""option_c"": ""History of abortion"", ""option_d"": ""Previous successful use of mifepristone and misoprostol"", ""correct_option"": ""B""}","Taking charge","What is a contraindication for the medicated technique of abortion?","Mild asthma controlled by treatment","Profound anaemia (Hb < 9-10 g/dL)","History of abortion","Previous successful use of mifepristone and misoprostol","b"
"OIC-037-10-B","{""question"": ""What is the recommended first-line treatment for pain management in the context of abortion?"", ""option_a"": ""Paracetamol alone"", ""option_b"": ""Ibuprofen 400 to 600 mg"", ""option_c"": ""Phloroglucinol"", ""option_d"": ""Codeine alone"", ""correct_option"": ""B""}",,"What is the recommended first-line treatment for pain management in the context of abortion?","Paracetamol alone","Ibuprofen 400 to 600 mg","Phloroglucinol","Codeine alone","b"
"OIC-037-11-B","{""question"": ""What should be considered when choosing a contraception method after an abortion?"", ""option_a"": ""Only the efficiency and cost of the contraception method"", ""option_b"": ""The patient's wishes, side effects, contraindications, constraints on use, and failure of the previous contraception"", ""option_c"": ""The patient's age and lifestyle only"", ""option_d"": ""The cultural context and family preferences only"", ""correct_option"": ""B""}","Management","What should be considered when choosing a contraception method after an abortion?","Only the efficiency and cost of the contraception method","The patient's wishes, side effects, contraindications, constraints on use, and failure of the previous contraception","The patient's age and lifestyle only","The cultural context and family preferences only","b"
"OIC-037-12-B","{""question"": ""What is a significant risk factor for repeat abortions among young individuals?"", ""option_a"": ""Access to long-acting reversible contraceptive methods"", ""option_b"": ""Young age"", ""option_c"": ""History of voluntary termination of pregnancy in the family"", ""option_d"": ""Favourable socio-economic conditions"", ""correct_option"": ""B""}","Follow-up and/or prognosis","What is a significant risk factor for repeat abortions among young individuals?","Access to long-acting reversible contraceptive methods","Young age","History of voluntary termination of pregnancy in the family","Favourable socio-economic conditions","b"
"OIC-038-01-A","{""question"": ""What is the definition of fertility in the context of a couple?"", ""option_a"": ""The ability to conceive and give birth to a living child"", ""option_b"": ""The probability of a pregnancy occurring in the course of a month or a menstrual cycle in a couple not using contraception"", ""option_c"": ""The number of live births in a given year"", ""option_d"": ""The time taken to conceive"", ""correct_option"": ""B""}","Definition","What is the definition of fertility in the context of a couple?","The ability to conceive and give birth to a living child","The probability of a pregnancy occurring in the course of a month or a menstrual cycle in a couple not using contraception","The number of live births in a given year","The time taken to conceive","b"
"OIC-038-02-A","{""question"": ""According to the World Health Organisation (WHO), what is the definition of infertility in terms of the duration of unprotected sexual intercourse without achieving a clinical pregnancy?"", ""option_a"": ""6 months or more"", ""option_b"": ""12 months or more"", ""option_c"": ""18 months or more"", ""option_d"": ""24 months or more"", ""correct_option"": ""B""}","Definition","According to the World Health Organisation (WHO), what is the definition of infertility in terms of the duration of unprotected sexual intercourse without achieving a clinical pregnancy?","6 months or more","12 months or more","18 months or more","24 months or more","b"
"OIC-038-03-B","{""question"": ""What is the primary factor influencing fertility in women?"", ""option_a"": ""Consumption of tobacco"", ""option_b"": ""Age"", ""option_c"": ""Frequency of sexual intercourse"", ""option_d"": ""Overweight and obesity"", ""correct_option"": ""B""}","Epidemiology, prevalence","What is the primary factor influencing fertility in women?","Consumption of tobacco","Age","Frequency of sexual intercourse","Overweight and obesity","b"
"OIC-038-04-B","{""question"": ""During the first consultation for an infertile couple, what is an essential aspect to inquire about in the woman's personal history that may have an impact on fertility or future pregnancy?"", ""option_a"": ""History of travel abroad"", ""option_b"": ""History of cancer, including treatment modalities"", ""option_c"": ""History of winning awards or competitions"", ""option_d"": ""History of changing jobs frequently"", ""correct_option"": ""B""}","Positive diagnosis","During the first consultation for an infertile couple, what is an essential aspect to inquire about in the woman's personal history that may have an impact on fertility or future pregnancy?","History of travel abroad","History of cancer, including treatment modalities","History of winning awards or competitions","History of changing jobs frequently","b"
"OIC-038-05-B","{""question"": ""During the clinical examination of a man in the context of infertility, what is the primary purpose of assessing secondary sexual characteristics?"", ""option_a"": ""To evaluate the presence of varicocele"", ""option_b"": ""To assess the morphotype and potential signs of hypogonadism"", ""option_c"": ""To examine the urethral meatus for hypospadias"", ""option_d"": ""To perform a systematic rectal examination"", ""correct_option"": ""B""}","Positive diagnosis","During the clinical examination of a man in the context of infertility, what is the primary purpose of assessing secondary sexual characteristics?","To evaluate the presence of varicocele","To assess the morphotype and potential signs of hypogonadism","To examine the urethral meatus for hypospadias","To perform a systematic rectal examination","b"
"OIC-038-06-B","{""question"": ""A 30-year-old woman presents with infertility, polycystic ovary syndrome, and symptoms of acne, hirsutism, and obesity. What is the most likely clinical presentation pointing to the cause of her infertility?"", ""option_a"": ""Tubal obstruction due to previous abdomino-pelvic surgery"", ""option_b"": ""Ovulation Disorders due to polycystic ovary syndrome"", ""option_c"": ""Uterine Pathology due to previous endo-uterine procedure"", ""option_d"": ""Cervical pathology due to history of conisation"", ""correct_option"": ""B""}","Etiologies","A 30-year-old woman presents with infertility, polycystic ovary syndrome, and symptoms of acne, hirsutism, and obesity. What is the most likely clinical presentation pointing to the cause of her infertility?","Tubal obstruction due to previous abdomino-pelvic surgery","Ovulation Disorders due to polycystic ovary syndrome","Uterine Pathology due to previous endo-uterine procedure","Cervical pathology due to history of conisation","b"
"OIC-038-07-B","{""question"": ""According to WHO and various learned societies, when should an investigation of a couple presenting difficulties in procreating be carried out?"", ""option_a"": ""After 6 months of regular sexual intercourse, without contraception"", ""option_b"": ""After one year of regular sexual intercourse, without contraception"", ""option_c"": ""Immediately after the couple reports difficulties in procreating"", ""option_d"": ""Only if the woman is over 35 or has a history of known genital pathology"", ""correct_option"": ""B""}","Complementary examinations","According to WHO and various learned societies, when should an investigation of a couple presenting difficulties in procreating be carried out?","After 6 months of regular sexual intercourse, without contraception","After one year of regular sexual intercourse, without contraception","Immediately after the couple reports difficulties in procreating","Only if the woman is over 35 or has a history of known genital pathology","b"
"OIC-038-08-B","{""question"": ""What is the recommended period of abstinence before collecting a sperm sample for a spermogram?"", ""option_a"": ""Less than 2 days"", ""option_b"": ""Between 2 to 7 days"", ""option_c"": ""More than 7 days"", ""option_d"": ""No specific period of abstinence is required"", ""correct_option"": ""B""}",,"What is the recommended period of abstinence before collecting a sperm sample for a spermogram?","Less than 2 days","Between 2 to 7 days","More than 7 days","No specific period of abstinence is required","b"
"OIC-038-09-B","{""question"": ""What percentage of infertility cases are attributed to female origin?"", ""option_a"": ""20%"", ""option_b"": ""30%"", ""option_c"": ""40%"", ""option_d"": ""50%"", ""correct_option"": ""B""}","Etiologies","What percentage of infertility cases are attributed to female origin?","20%","30%","40%","50%","b"
"OIC-038-10-B","{""question"": ""What is a common genetic cause of male infertility related to testicular origin?"", ""option_a"": ""Klinefelter's syndrome"", ""option_b"": ""Hyperprolactinemia"", ""option_c"": ""Bilateral absence of the vas deferens"", ""option_d"": ""Sexological disorders, erectile dysfunction"", ""correct_option"": ""A""}","Etiologies","What is a common genetic cause of male infertility related to testicular origin?","Klinefelter's syndrome","Hyperprolactinemia","Bilateral absence of the vas deferens","Sexological disorders, erectile dysfunction","a"
"OIC-039-01-A","{""question"": ""What is the primary purpose of Medically Assisted Procreation (MAP)?"", ""option_a"": ""To prevent the transmission of genetic diseases to children"", ""option_b"": ""To remedy a couple's infertility and prevent the transmission of serious diseases"", ""option_c"": ""To preserve fertility in individuals with medical conditions"", ""option_d"": ""To conduct research on human reproduction and development"", ""correct_option"": ""B""}","Definition","What is the primary purpose of Medically Assisted Procreation (MAP)?","To prevent the transmission of genetic diseases to children","To remedy a couple's infertility and prevent the transmission of serious diseases","To preserve fertility in individuals with medical conditions","To conduct research on human reproduction and development","b"
"OIC-039-02-A","{""question"": ""What is the primary purpose of fertility preservation?"", ""option_a"": ""To immediately facilitate medically assisted procreation"", ""option_b"": ""To collect and preserve gametes or germ tissue for potential future use in medically assisted procreation or fertility restoration"", ""option_c"": ""To prevent the transmission of genetic diseases"", ""option_d"": ""To delay the onset of menopause or infertility"", ""correct_option"": ""B""}","Definition","What is the primary purpose of fertility preservation?","To immediately facilitate medically assisted procreation","To collect and preserve gametes or germ tissue for potential future use in medically assisted procreation or fertility restoration","To prevent the transmission of genetic diseases","To delay the onset of menopause or infertility","b"
"OIC-039-03-A","{""question"": ""What is the primary purpose of ovulation monitoring in Medically Assisted Procreation (MAP) techniques?"", ""option_a"": ""To identify genetic anomalies in embryonic cells"", ""option_b"": ""To check the effectiveness of ovarian stimulation and choose the optimum day for ovulation induction"", ""option_c"": ""To select mobile spermatozoa for intrauterine insemination"", ""option_d"": ""To diagnose viral risks such as HIV, hepatitis B and/or C"", ""correct_option"": ""B""}","Definition","What is the primary purpose of ovulation monitoring in Medically Assisted Procreation (MAP) techniques?","To identify genetic anomalies in embryonic cells","To check the effectiveness of ovarian stimulation and choose the optimum day for ovulation induction","To select mobile spermatozoa for intrauterine insemination","To diagnose viral risks such as HIV, hepatitis B and/or C","b"
"OIC-039-04-A","{""question"": ""What is the primary method of fertilization used for mature oocytes stored through fertility preservation techniques?"", ""option_a"": ""IVF"", ""option_b"": ""ICSI"", ""option_c"": ""GIFT"", ""option_d"": ""ZIFT"", ""correct_option"": ""B""}","Definition","What is the primary method of fertilization used for mature oocytes stored through fertility preservation techniques?","IVF","ICSI","GIFT","ZIFT","b"
"OIC-039-05-B","{""question"": ""What percentage of births in France are a result of Medical Assistance for Procreation (MAP)?"", ""option_a"": ""1.5%"", ""option_b"": ""3.7%"", ""option_c"": ""5.5%"", ""option_d"": ""7.2%"", ""correct_option"": ""B""}","Epidemiology","What percentage of births in France are a result of Medical Assistance for Procreation (MAP)?","1.5%","3.7%","5.5%","7.2%","b"
"OIC-039-06-A","{""question"": ""What is one of the main indications for recourse to Medical Assistance for Procreation (MAP)?"", ""option_a"": ""A couple's low socioeconomic status"", ""option_b"": ""The risk of transmitting a viral pathology, such as HIV"", ""option_c"": ""A woman's advanced age, but only if she is married"", ""option_d"": ""A man's lack of interest in having children"", ""correct_option"": ""B""}","Etiologies","What is one of the main indications for recourse to Medical Assistance for Procreation (MAP)?","A couple's low socioeconomic status","The risk of transmitting a viral pathology, such as HIV","A woman's advanced age, but only if she is married","A man's lack of interest in having children","b"
"OIC-039-07-A","{""question"": ""What is a common indication for Intrauterine Insemination (IUI) with frozen sperm from a third-party donor?"", ""option_a"": ""Unexplained infertility"", ""option_b"": ""Obstructive or non-obstructive azoospermia with or without failure of surgical extraction of testicular or epididymal sperm"", ""option_c"": ""Cervical infertility due to abnormalities of the cervix and/or cervical mucus"", ""option_d"": ""Mild alterations in sperm parameters"", ""correct_option"": ""B""}","Etiologies","What is a common indication for Intrauterine Insemination (IUI) with frozen sperm from a third-party donor?","Unexplained infertility","Obstructive or non-obstructive azoospermia with or without failure of surgical extraction of testicular or epididymal sperm","Cervical infertility due to abnormalities of the cervix and/or cervical mucus","Mild alterations in sperm parameters","b"
"OIC-039-08-A","{""question"": ""What is a common indication for Intracytoplasmic Sperm Injection (ICSI)?"", ""option_a"": ""Tubal infertility"", ""option_b"": ""Severe sperm abnormalities"", ""option_c"": ""Endometriosis"", ""option_d"": ""Successful IUI or simple induction of ovulation"", ""correct_option"": ""B""}","Etiologies","What is a common indication for Intracytoplasmic Sperm Injection (ICSI)?","Tubal infertility","Severe sperm abnormalities","Endometriosis","Successful IUI or simple induction of ovulation","b"
"OIC-039-09-A","{""question"": ""What is one of the main indications for gamete donation in the context of medical assistance for procreation?"", ""option_a"": ""Mild infertility due to age-related factors"", ""option_b"": ""Severe infertility or medically confirmed sterility, such as premature ovarian failure or azoospermia"", ""option_c"": ""Temporary inability to conceive due to stress or lifestyle factors"", ""option_d"": ""Preference for a child with a specific genetic trait"", ""correct_option"": ""B""}","Etiologies","What is one of the main indications for gamete donation in the context of medical assistance for procreation?","Mild infertility due to age-related factors","Severe infertility or medically confirmed sterility, such as premature ovarian failure or azoospermia","Temporary inability to conceive due to stress or lifestyle factors","Preference for a child with a specific genetic trait","b"
"OIC-039-10-A","{""question"": ""What is a main medical indication for female fertility preservation in cases of non-cancerous pathologies?"", ""option_a"": ""Gonadotoxic treatments for haematological diseases"", ""option_b"": ""Systemic diseases requiring chemotherapy"", ""option_c"": ""High-risk genetic anomalies such as Turner syndrome"", ""option_d"": ""Advanced maternal age"", ""correct_option"": ""B""}","Etiologies","What is a main medical indication for female fertility preservation in cases of non-cancerous pathologies?","Gonadotoxic treatments for haematological diseases","Systemic diseases requiring chemotherapy","High-risk genetic anomalies such as Turner syndrome","Advanced maternal age","b"
"OIC-039-11-B","{""question"": ""What is the primary purpose of the sperm survival migration test in the context of Medical Assistance for Procreation (MAP)?"", ""option_a"": ""To assess the overall health of the sperm"", ""option_b"": ""To select the most mobile spermatozoa and induce sperm capacitation for choosing the most appropriate MAP technique"", ""option_c"": ""To diagnose the causes of infertility in the couple"", ""option_d"": ""To evaluate the risk of genetic disorders in the offspring"", ""correct_option"": ""B""}","Complementary examinations","What is the primary purpose of the sperm survival migration test in the context of Medical Assistance for Procreation (MAP)?","To assess the overall health of the sperm","To select the most mobile spermatozoa and induce sperm capacitation for choosing the most appropriate MAP technique","To diagnose the causes of infertility in the couple","To evaluate the risk of genetic disorders in the offspring","b"
"OIC-039-13-B","{""question"": ""What is the main complication associated with ovarian stimulation in Medical Assistance for Procreation (MAP) techniques?"", ""option_a"": ""Adnexal torsion"", ""option_b"": ""Ovarian hyperstimulation syndrome"", ""option_c"": ""Allergic risk linked to taking medication"", ""option_d"": ""Gravid venous thromboembolism"", ""correct_option"": ""B""}",,"What is the main complication associated with ovarian stimulation in Medical Assistance for Procreation (MAP) techniques?","Adnexal torsion","Ovarian hyperstimulation syndrome","Allergic risk linked to taking medication","Gravid venous thromboembolism","b"
"OIC-045-01-A","{""question"": ""When can genetic counselling take place?"", ""option_a"": ""Only during pregnancy"", ""option_b"": ""Only after birth if a congenital disorder or malformation is found"", ""option_c"": ""At various stages, including before conception, during pregnancy, after birth, during childhood, and in adulthood"", ""option_d"": ""Only in adulthood for genetic diseases that manifest themselves in adulthood"", ""correct_option"": ""C""}","Definition","When can genetic counselling take place?","Only during pregnancy","Only after birth if a congenital disorder or malformation is found","At various stages, including before conception, during pregnancy, after birth, during childhood, and in adulthood","Only in adulthood for genetic diseases that manifest themselves in adulthood","c"
"OIC-045-02-B","{""question"": ""When informing parents that their child has been diagnosed with a genetic disease, what is the recommended approach to take?"", ""option_a"": ""Immediately list all possible complications and disabilities to prepare the parents for the worst-case scenario"", ""option_b"": ""Focus on the child's skills and set relatively short-term objectives to maintain a positive outlook"", ""option_c"": ""Predict the evolutionary trajectory of the child's disease to provide the parents with a clear understanding of what to expect"", ""option_d"": ""Encourage the parents to consider putting the child up for adoption as a viable option"", ""correct_option"": ""B""}","Definition","When informing parents that their child has been diagnosed with a genetic disease, what is the recommended approach to take?","Immediately list all possible complications and disabilities to prepare the parents for the worst-case scenario","Focus on the child's skills and set relatively short-term objectives to maintain a positive outlook","Predict the evolutionary trajectory of the child's disease to provide the parents with a clear understanding of what to expect","Encourage the parents to consider putting the child up for adoption as a viable option","b"
"OIC-045-03-A","{""question"": ""What is the primary ethical principle guiding doctors that is preserved in the trisomy 21 screening policy proposed in France?"", ""option_a"": ""Non-maleficence"", ""option_b"": ""Respect for autonomy"", ""option_c"": ""Justice"", ""option_d"": ""Caring"", ""correct_option"": ""B""}","Definition","What is the primary ethical principle guiding doctors that is preserved in the trisomy 21 screening policy proposed in France?","Non-maleficence","Respect for autonomy","Justice","Caring","b"
"OIC-045-04-B","{""question"": ""What is the primary sample source for performing a foetal karyotype between 15 weeks of amenorrhoea and the end of pregnancy?"", ""option_a"": ""Chorionic villus (CVS)"", ""option_b"": ""Amniotic fluid (PLA)"", ""option_c"": ""Foetal blood"", ""option_d"": ""Maternal blood"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary sample source for performing a foetal karyotype between 15 weeks of amenorrhoea and the end of pregnancy?","Chorionic villus (CVS)","Amniotic fluid (PLA)","Foetal blood","Maternal blood","b"
"OIC-045-05-A","{""question"": ""What is the primary method of antenatal screening for trisomy 21 in the 1st trimester?"", ""option_a"": ""Measurement of serum markers in the 2nd trimester"", ""option_b"": ""Combined test based on maternal age, nuchal translucency measurement, and serum markers in the 1st trimester"", ""option_c"": ""Foetal karyotype"", ""option_d"": ""Non-invasive prenatal screening using free foetal DNA"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method of antenatal screening for trisomy 21 in the 1st trimester?","Measurement of serum markers in the 2nd trimester","Combined test based on maternal age, nuchal translucency measurement, and serum markers in the 1st trimester","Foetal karyotype","Non-invasive prenatal screening using free foetal DNA","b"
"OIC-045-06-B","{""question"": ""At what stage of pregnancy can an abnormal neck size be used as an indicator for potential trisomy 21 diagnosis via ultrasound?"", ""option_a"": ""2nd trimester"", ""option_b"": ""1st trimester"", ""option_c"": ""3rd trimester"", ""option_d"": ""Only after birth"", ""correct_option"": ""B""}","Positive diagnosis","At what stage of pregnancy can an abnormal neck size be used as an indicator for potential trisomy 21 diagnosis via ultrasound?","2nd trimester","1st trimester","3rd trimester","Only after birth","b"
"OIC-045-07-B","{""question"": ""What is the risk of recurrence for trisomy 21 by Robertsonian translocation (14;21) if the translocation is of maternal origin?"", ""option_a"": ""1-2%"", ""option_b"": ""2-5%"", ""option_c"": ""10-15%"", ""option_d"": ""100%"", ""correct_option"": ""C""}","Management","What is the risk of recurrence for trisomy 21 by Robertsonian translocation (14;21) if the translocation is of maternal origin?","1-2%","2-5%","10-15%","100%","c"
"OIC-045-08-B","{""question"": ""What is the primary purpose of prescribing a constitutional karyotype on lymphocytes for a patient suspected of having Trisomy 21 or Down's syndrome?"", ""option_a"": ""To detect nucleotide variants and abnormalities of less than 5 megabases"", ""option_b"": ""To identify the mechanism causing Trisomy 21 for genetic counselling"", ""option_c"": ""To provide a preliminary result within 24-48 hours using Fluorescence In Situ Hybridization (FISH) study"", ""option_d"": ""To confirm the clinical suspicion of Trisomy 21 chromosomally"", ""correct_option"": ""D""}","Positive diagnosis","What is the primary purpose of prescribing a constitutional karyotype on lymphocytes for a patient suspected of having Trisomy 21 or Down's syndrome?","To detect nucleotide variants and abnormalities of less than 5 megabases","To identify the mechanism causing Trisomy 21 for genetic counselling","To provide a preliminary result within 24-48 hours using Fluorescence In Situ Hybridization (FISH) study","To confirm the clinical suspicion of Trisomy 21 chromosomally","d"
"OIC-045-09-A","{""question"": ""What is the estimated percentage of children with Down's syndrome who have obstructive sleep apnoea?"", ""option_a"": ""20-30%"", ""option_b"": ""40-50%"", ""option_c"": ""Almost 50%"", ""option_d"": ""60-70%"", ""correct_option"": ""C""}",,"What is the estimated percentage of children with Down's syndrome who have obstructive sleep apnoea?","20-30%","40-50%","Almost 50%","60-70%","c"
"OIC-045-10-A","{""question"": ""What are the main clinical signs used to diagnose trisomy 21 in the neonatal period?"", ""option_a"": ""Axial hypotonia, heart murmur on auscultation, and facial dysmorphia"", ""option_b"": ""Psychomotor retardation, learning difficulties, and heart murmur on auscultation"", ""option_c"": ""Facial dysmorphia, psychomotor retardation, and immaturity"", ""option_d"": ""Learning difficulties, axial hypotonia, and immaturity"", ""correct_option"": ""A""}","Positive diagnosis","What are the main clinical signs used to diagnose trisomy 21 in the neonatal period?","Axial hypotonia, heart murmur on auscultation, and facial dysmorphia","Psychomotor retardation, learning difficulties, and heart murmur on auscultation","Facial dysmorphia, psychomotor retardation, and immaturity","Learning difficulties, axial hypotonia, and immaturity","a"
"OIC-045-11-B","{""question"": ""What is the average age range for a person with trisomy 21 to acquire walking?"", ""option_a"": ""Between 9 and 18 months"", ""option_b"": ""Between 2 and 3 years of age"", ""option_c"": ""Between 5 and 7 years of age"", ""option_d"": ""Between 1 and 2 years of age"", ""correct_option"": ""B""}","Management","What is the average age range for a person with trisomy 21 to acquire walking?","Between 9 and 18 months","Between 2 and 3 years of age","Between 5 and 7 years of age","Between 1 and 2 years of age","b"
"OIC-045-12-B","{""question"": ""What is the primary method used to diagnose cystic fibrosis antenatally when both parents are heterozygous carriers of a CFTR mutation?"", ""option_a"": ""Ultrasound monitoring for hyperechoic bowel"", ""option_b"": ""Chorionic villus sampling or amniocentesis followed by molecular biology analysis"", ""option_c"": ""Pre-implantation diagnosis only"", ""option_d"": ""Full study of the CFTR gene in the fetus without prior testing of the parents"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method used to diagnose cystic fibrosis antenatally when both parents are heterozygous carriers of a CFTR mutation?","Ultrasound monitoring for hyperechoic bowel","Chorionic villus sampling or amniocentesis followed by molecular biology analysis","Pre-implantation diagnosis only","Full study of the CFTR gene in the fetus without prior testing of the parents","b"
"OIC-045-13-A","{""question"": ""What is the primary method used for newborn screening of cystic fibrosis?"", ""option_a"": ""A blood test from the umbilical cord"", ""option_b"": ""A bloodstain from the newborn's heel on the third day of life"", ""option_c"": ""A saliva sample on the first day of life"", ""option_d"": ""A genetic analysis of parental DNA"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method used for newborn screening of cystic fibrosis?","A blood test from the umbilical cord","A bloodstain from the newborn's heel on the third day of life","A saliva sample on the first day of life","A genetic analysis of parental DNA","b"
"OIC-045-14-A","{""question"": ""What is the primary method used to confirm a diagnosis of cystic fibrosis?"", ""option_a"": ""Genetic testing for mutations associated with cystic fibrosis"", ""option_b"": ""Sweat test measuring the chlorine content in sweat"", ""option_c"": ""Blood test to evaluate pancreatic function"", ""option_d"": ""Imaging studies such as chest X-rays to assess lung condition"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method used to confirm a diagnosis of cystic fibrosis?","Genetic testing for mutations associated with cystic fibrosis","Sweat test measuring the chlorine content in sweat","Blood test to evaluate pancreatic function","Imaging studies such as chest X-rays to assess lung condition","b"
"OIC-045-15-A","{""question"": ""What is a common respiratory manifestation of cystic fibrosis in infants?"", ""option_a"": ""Pneumothorax"", ""option_b"": ""Chronic cough"", ""option_c"": ""Asthma"", ""option_d"": ""Pulmonary embolism"", ""correct_option"": ""B""}","Positive diagnosis","What is a common respiratory manifestation of cystic fibrosis in infants?","Pneumothorax","Chronic cough","Asthma","Pulmonary embolism","b"
"OIC-045-16-B","{""question"": ""What is the main approach to managing gastrointestinal disorders in patients with cystic fibrosis?"", ""option_a"": ""A low-calorie, high-fat diet with reduced digestive enzymes and fat-soluble vitamins"", ""option_b"": ""A high-calorie, low-fat diet with digestive enzymes and fat-soluble vitamins"", ""option_c"": ""A diet rich in fiber with minimal supplementation of vitamins and enzymes"", ""option_d"": ""A gluten-free diet with high doses of antibiotics"", ""correct_option"": ""B""}","Management","What is the main approach to managing gastrointestinal disorders in patients with cystic fibrosis?","A low-calorie, high-fat diet with reduced digestive enzymes and fat-soluble vitamins","A high-calorie, low-fat diet with digestive enzymes and fat-soluble vitamins","A diet rich in fiber with minimal supplementation of vitamins and enzymes","A gluten-free diet with high doses of antibiotics","b"
"OIC-045-18-A","{""question"": ""What is a common feature in boys/men with Fragile X syndrome?"", ""option_a"": ""Severe intellectual disability with normal physical characteristics"", ""option_b"": ""Moderate to severe intellectual disability with distinct facial dysmorphia"", ""option_c"": ""Mild intellectual disability with no physical abnormalities"", ""option_d"": ""Average intelligence with advanced stature and joint hyperlaxity as the only symptoms"", ""correct_option"": ""B""}","Positive diagnosis","What is a common feature in boys/men with Fragile X syndrome?","Severe intellectual disability with normal physical characteristics","Moderate to severe intellectual disability with distinct facial dysmorphia","Mild intellectual disability with no physical abnormalities","Average intelligence with advanced stature and joint hyperlaxity as the only symptoms","b"
"OIC-045-19-B","{""question"": ""What is the primary mechanism by which the FMR1 gene is affected in individuals with full mutations of Fragile X syndrome?"", ""option_a"": ""Hypermethylation of the promoter region leading to gene overexpression"", ""option_b"": ""Hypomethylation of the promoter region leading to gene repression"", ""option_c"": ""Abnormal methylation of the promoter region leading to repression of gene transcription"", ""option_d"": ""Deletion of the FMR1 gene"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary mechanism by which the FMR1 gene is affected in individuals with full mutations of Fragile X syndrome?","Hypermethylation of the promoter region leading to gene overexpression","Hypomethylation of the promoter region leading to gene repression","Abnormal methylation of the promoter region leading to repression of gene transcription","Deletion of the FMR1 gene","c"
"OIC-045-20-A","{""question"": ""What is the estimated prevalence of Fragile X syndrome in men and women?"", ""option_a"": ""1/1,000 in men and 1/2,000 in women"", ""option_b"": ""1/5,000 in men and 1/8,000 in women"", ""option_c"": ""1/10,000 in men and 1/15,000 in women"", ""option_d"": ""1/20,000 in men and 1/25,000 in women"", ""correct_option"": ""B""}",,"What is the estimated prevalence of Fragile X syndrome in men and women?","1/1,000 in men and 1/2,000 in women","1/5,000 in men and 1/8,000 in women","1/10,000 in men and 1/15,000 in women","1/20,000 in men and 1/25,000 in women","b"
"OIC-045-21-B","{""question"": ""What is the primary pathological mechanism of premutations in Fragile X syndrome?"", ""option_a"": ""Loss of function in nervous tissue"", ""option_b"": ""Toxicity due to gain of function in nervous and ovarian tissue"", ""option_c"": ""Mitochondrial dysfunction leading to energy deficits"", ""option_d"": ""Epigenetic silencing of the FMR1 gene"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary pathological mechanism of premutations in Fragile X syndrome?","Loss of function in nervous tissue","Toxicity due to gain of function in nervous and ovarian tissue","Mitochondrial dysfunction leading to energy deficits","Epigenetic silencing of the FMR1 gene","b"
"OIC-047-01-A","{""question"": ""What is the age range for an infant?"", ""option_a"": ""0-12 months"", ""option_b"": ""1-23 months"", ""option_c"": ""2 years to puberty"", ""option_d"": ""puberty and above"", ""correct_option"": ""B""}","Definition","What is the age range for an infant?","0-12 months","1-23 months","2 years to puberty","puberty and above","b"
"OIC-047-02-B","{""question"": ""According to professional recommendations, how many compulsory health examinations are scheduled for infants and children from birth to 16 years of age?"", ""option_a"": ""15 compulsory examinations"", ""option_b"": ""20 compulsory examinations"", ""option_c"": ""25 compulsory examinations"", ""option_d"": ""30 compulsory examinations"", ""correct_option"": ""B""}","Management","According to professional recommendations, how many compulsory health examinations are scheduled for infants and children from birth to 16 years of age?","15 compulsory examinations","20 compulsory examinations","25 compulsory examinations","30 compulsory examinations","b"
"OIC-047-03-A","{""question"": ""During a paediatric follow-up consultation, what is the primary purpose of investigating a child's 'fundamental needs'?"", ""option_a"": ""To assess the child's staturo-ponderal development and intellectual abilities"", ""option_b"": ""To identify potential health risks and provide guidance on prevention strategies"", ""option_c"": ""To evaluate the child's physiological and health needs, as well as their emotional and relational security"", ""option_d"": ""To diagnose specific medical conditions, such as depressive disorders or anxiety disorders"", ""correct_option"": ""C""}","Management","During a paediatric follow-up consultation, what is the primary purpose of investigating a child's 'fundamental needs'?","To assess the child's staturo-ponderal development and intellectual abilities","To identify potential health risks and provide guidance on prevention strategies","To evaluate the child's physiological and health needs, as well as their emotional and relational security","To diagnose specific medical conditions, such as depressive disorders or anxiety disorders","c"
"OIC-047-04-A","{""question"": ""At what age should children undergo systematic eye checks?"", ""option_a"": ""At birth, 1 year, and 5 years"", ""option_b"": ""At birth, 2 months, 4 months, between 9 and 24 months, 2-3 years, and 5 years"", ""option_c"": ""Only when symptoms appear"", ""option_d"": ""At 1 year, 2 years, and 6 years"", ""correct_option"": ""B""}","Definition","At what age should children undergo systematic eye checks?","At birth, 1 year, and 5 years","At birth, 2 months, 4 months, between 9 and 24 months, 2-3 years, and 5 years","Only when symptoms appear","At 1 year, 2 years, and 6 years","b"
"OIC-047-05-B","{""question"": ""What is a personal risk factor for visual disorders in children?"", ""option_a"": ""Family history of strabismus"", ""option_b"": ""In utero exposure to toxic substances, such as cocaine or alcohol"", ""option_c"": ""Normal birth weight over 2500g"", ""option_d"": ""Absence of neuromotor disorders"", ""correct_option"": ""B""}","Management","What is a personal risk factor for visual disorders in children?","Family history of strabismus","In utero exposure to toxic substances, such as cocaine or alcohol","Normal birth weight over 2500g","Absence of neuromotor disorders","b"
"OIC-047-06-B","{""question"": ""At what age should colour vision be assessed at least once in children?"", ""option_a"": ""After 2 1/2 years"", ""option_b"": ""After the age of 4"", ""option_c"": ""On entering school"", ""option_d"": ""During the 1st weeks of life"", ""correct_option"": ""C""}","Positive diagnosis","At what age should colour vision be assessed at least once in children?","After 2 1/2 years","After the age of 4","On entering school","During the 1st weeks of life","c"
"OIC-047-07-A","{""question"": ""At what age should a child with a personal or family history of risk factors be referred to an ophthalmologist for an examination, even if there are no warning signs?"", ""option_a"": ""Between 1 and 6 months"", ""option_b"": ""Between 3 and 12 months"", ""option_c"": ""Between 1 and 2 years"", ""option_d"": ""Between 2 and 5 years"", ""correct_option"": ""B""}","Management","At what age should a child with a personal or family history of risk factors be referred to an ophthalmologist for an examination, even if there are no warning signs?","Between 1 and 6 months","Between 3 and 12 months","Between 1 and 2 years","Between 2 and 5 years","b"
"OIC-047-08-B","{""question"": ""At what age does a child typically develop stereoscopic vision?"", ""option_a"": ""4 months"", ""option_b"": ""6 months"", ""option_c"": ""1 year"", ""option_d"": ""5-6 years"", ""correct_option"": ""B""}","Physiopathology","At what age does a child typically develop stereoscopic vision?","4 months","6 months","1 year","5-6 years","b"
"OIC-047-09-A","{""question"": ""At what age is strabismus considered pathological if it is constant?"", ""option_a"": ""Before 4 months"", ""option_b"": ""After 4 months"", ""option_c"": ""After 6 months"", ""option_d"": ""After 2 years"", ""correct_option"": ""B""}","Positive diagnosis","At what age is strabismus considered pathological if it is constant?","Before 4 months","After 4 months","After 6 months","After 2 years","b"
"OIC-047-10-A","{""question"": ""At what age should children be screened for hearing disorders, according to systematic screening protocols?"", ""option_a"": ""Only at birth and at the start of school"", ""option_b"": ""At maternity, 9-month, 24-month, 36-month, and nursery school"", ""option_c"": ""Only when symptoms of hearing loss are apparent"", ""option_d"": ""Annually from birth to age 6"", ""correct_option"": ""B""}","Definition","At what age should children be screened for hearing disorders, according to systematic screening protocols?","Only at birth and at the start of school","At maternity, 9-month, 24-month, 36-month, and nursery school","Only when symptoms of hearing loss are apparent","Annually from birth to age 6","b"
"OIC-047-11-B","{""question"": ""What is a personal risk factor for hearing problems in children during the neonatal period?"", ""option_a"": ""Exposure to toxic substances in utero"", ""option_b"": ""Prematurity and low birth weight"", ""option_c"": ""Rock trauma"", ""option_d"": ""Chronic otitis media in adulthood"", ""correct_option"": ""B""}","Positive diagnosis","What is a personal risk factor for hearing problems in children during the neonatal period?","Exposure to toxic substances in utero","Prematurity and low birth weight","Rock trauma","Chronic otitis media in adulthood","b"
"OIC-047-12-B","{""question"": ""What is the primary method used for hearing screening in new-born babies?"", ""option_a"": ""Calibrated sound sources and voice tests"", ""option_b"": ""Induced acoustic emissions (OEAP) or automated auditory evoked potentials"", ""option_c"": ""Headphone tonal audiometry and tympanometry"", ""option_d"": ""External examination and otoscopy alone"", ""correct_option"": ""B""}",,"What is the primary method used for hearing screening in new-born babies?","Calibrated sound sources and voice tests","Induced acoustic emissions (OEAP) or automated auditory evoked potentials","Headphone tonal audiometry and tympanometry","External examination and otoscopy alone","b"
"OIC-047-13-A","{""question"": ""When should a child be referred to an ENT specialist?"", ""option_a"": ""Only if the child has a family history of deafness"", ""option_b"": ""If the child fails a screening test or if there are parental concerns about hearing, or if the child exhibits warning signs such as absence of reaction to noises or language disorders"", ""option_c"": ""If the child has a cold or fever that lasts for more than a week"", ""option_d"": ""Only if the child is experiencing behavioural problems without any other symptoms"", ""correct_option"": ""B""}","Management","When should a child be referred to an ENT specialist?","Only if the child has a family history of deafness","If the child fails a screening test or if there are parental concerns about hearing, or if the child exhibits warning signs such as absence of reaction to noises or language disorders","If the child has a cold or fever that lasts for more than a week","Only if the child is experiencing behavioural problems without any other symptoms","b"
"OIC-047-14-A","{""question"": ""What is the definition of a mild hearing loss in a child?"", ""option_a"": ""A hearing loss of 71 to 90 decibels (dB)"", ""option_b"": ""A hearing loss of 21 to 40 decibels (dB)"", ""option_c"": ""A hearing loss of more than 90 decibels (dB)"", ""option_d"": ""A hearing loss of 41 to 70 decibels (dB)"", ""correct_option"": ""B""}","Definition","What is the definition of a mild hearing loss in a child?","A hearing loss of 71 to 90 decibels (dB)","A hearing loss of 21 to 40 decibels (dB)","A hearing loss of more than 90 decibels (dB)","A hearing loss of 41 to 70 decibels (dB)","b"
"OIC-047-15-B","{""question"": ""What type of test requires the child's cooperation and is used by an ENT specialist for diagnostic confirmation of hearing in children?"", ""option_a"": ""Auditory evoked potentials"", ""option_b"": ""Pure tone audiometry"", ""option_c"": ""OEAP"", ""option_d"": ""PEAA"", ""correct_option"": ""B""}","Additional examinations","What type of test requires the child's cooperation and is used by an ENT specialist for diagnostic confirmation of hearing in children?","Auditory evoked potentials","Pure tone audiometry","OEAP","PEAA","b"
"OIC-047-16-A","{""question"": ""What is the primary purpose of using the international dental numbering system?"", ""option_a"": ""To track the development of orthopaedic abnormalities in children"", ""option_b"": ""To standardize the identification and recording of dental procedures and treatments"", ""option_c"": ""To screen for visual and hearing impairments in adolescents"", ""option_d"": ""To monitor child mortality and morbidity rates"", ""correct_option"": ""B""}","Definition","What is the primary purpose of using the international dental numbering system?","To track the development of orthopaedic abnormalities in children","To standardize the identification and recording of dental procedures and treatments","To screen for visual and hearing impairments in adolescents","To monitor child mortality and morbidity rates","b"
"OIC-047-17-A","{""question"": ""What is dental caries primarily characterized by?"", ""option_a"": ""The growth of tooth enamel and dentine"", ""option_b"": ""The destruction of tooth enamel and dentine, with the formation of a cavity"", ""option_c"": ""The inflammation of gums and surrounding tissues"", ""option_d"": ""The discoloration of teeth due to poor oral hygiene"", ""correct_option"": ""B""}","Definition","What is dental caries primarily characterized by?","The growth of tooth enamel and dentine","The destruction of tooth enamel and dentine, with the formation of a cavity","The inflammation of gums and surrounding tissues","The discoloration of teeth due to poor oral hygiene","b"
"OIC-047-18-A","{""question"": ""What is a key principle in preventing dental caries in children?"", ""option_a"": ""Limiting sugar consumption to mealtimes only"", ""option_b"": ""Brushing teeth once a day with fluoride toothpaste from birth"", ""option_c"": ""Avoiding nibbling between meals and taking a sugary bottle to sleep, along with regular dental check-ups and good oral hygiene"", ""option_d"": ""Applying fluoride per os and sealing of grooves for all children regardless of caries risk"", ""correct_option"": ""C""}",,"What is a key principle in preventing dental caries in children?","Limiting sugar consumption to mealtimes only","Brushing teeth once a day with fluoride toothpaste from birth","Avoiding nibbling between meals and taking a sugary bottle to sleep, along with regular dental check-ups and good oral hygiene","Applying fluoride per os and sealing of grooves for all children regardless of caries risk","c"
"OIC-047-19-B","{""question"": ""At what age do children typically start getting their first permanent molars?"", ""option_a"": ""Around 2 years of age"", ""option_b"": ""Around 6 years of age"", ""option_c"": ""Around 10-11 years of age"", ""option_d"": ""Around 18 years of age"", ""correct_option"": ""B""}","Physiopathology","At what age do children typically start getting their first permanent molars?","Around 2 years of age","Around 6 years of age","Around 10-11 years of age","Around 18 years of age","b"
"OIC-047-20-B","{""question"": ""What is a dental articulation disorder characterized by?"", ""option_a"": ""Harmony between the maxillary and mandibular teeth"", ""option_b"": ""Conflict between the two dental arches, resulting in issues such as open bite or prognathia"", ""option_c"": ""Absence of orthodontic treatment before the age of 16"", ""option_d"": ""Normal alignment and positioning of the incisors"", ""correct_option"": ""B""}","Definition","What is a dental articulation disorder characterized by?","Harmony between the maxillary and mandibular teeth","Conflict between the two dental arches, resulting in issues such as open bite or prognathia","Absence of orthodontic treatment before the age of 16","Normal alignment and positioning of the incisors","b"
"OIC-047-21-A","{""question"": ""At what age should examination of the hips be performed for screening of congenital hip dislocation?"", ""option_a"": ""Only at birth"", ""option_b"": ""At each follow-up visit from maternity until walking age"", ""option_c"": ""Only when the child starts showing signs of hip problems"", ""option_d"": ""After the child has learned to walk"", ""correct_option"": ""B""}","Positive diagnosis","At what age should examination of the hips be performed for screening of congenital hip dislocation?","Only at birth","At each follow-up visit from maternity until walking age","Only when the child starts showing signs of hip problems","After the child has learned to walk","b"
"OIC-047-22-A","{""question"": ""What is the primary purpose of the Barlow manoeuvre in infants?"", ""option_a"": ""To assess the range of abduction in the hip joint"", ""option_b"": ""To evaluate the symmetry of skin folds"", ""option_c"": ""To detect hip instability and dislocation"", ""option_d"": ""To measure the length of the thigh"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary purpose of the Barlow manoeuvre in infants?","To assess the range of abduction in the hip joint","To evaluate the symmetry of skin folds","To detect hip instability and dislocation","To measure the length of the thigh","c"
"OIC-047-23-B","{""question"": ""What are the clinical forms of congenital hip dislocation?"", ""option_a"": ""Luxated hip and Subluxation"", ""option_b"": ""Hip Luxable and normal hip"", ""option_c"": ""Subluxation and normal hip mobility"", ""option_d"": ""Luxated hip, Hip Luxable, and Subluxation"", ""correct_option"": ""D""}","Positive diagnosis","What are the clinical forms of congenital hip dislocation?","Luxated hip and Subluxation","Hip Luxable and normal hip","Subluxation and normal hip mobility","Luxated hip, Hip Luxable, and Subluxation","d"
"OIC-047-24-B","{""question"": ""At what age should an X-ray be used instead of ultrasound for imaging in cases of suspected congenital hip dislocation?"", ""option_a"": ""Immediately at birth"", ""option_b"": ""From the 4th month (3 months completed)"", ""option_c"": ""From the 6th month"", ""option_d"": ""Only after the first year"", ""correct_option"": ""B""}",,"At what age should an X-ray be used instead of ultrasound for imaging in cases of suspected congenital hip dislocation?","Immediately at birth","From the 4th month (3 months completed)","From the 6th month","Only after the first year","b"
"OIC-047-25-B","{""question"": ""What is a potential consequence of delayed diagnosis or failure to treat dislocating hip disease in infants?"", ""option_a"": ""Improved mobility and reduced risk of degenerative damage"", ""option_b"": ""Reduced risk of chronic pain and early degenerative damage"", ""option_c"": ""Limping from the onset of walking, chronic pain, and early degenerative damage"", ""option_d"": ""Spontaneous correction of the hip dislocation without any need for treatment"", ""correct_option"": ""C""}","Follow-up and/or prognosis","What is a potential consequence of delayed diagnosis or failure to treat dislocating hip disease in infants?","Improved mobility and reduced risk of degenerative damage","Reduced risk of chronic pain and early degenerative damage","Limping from the onset of walking, chronic pain, and early degenerative damage","Spontaneous correction of the hip dislocation without any need for treatment","c"
"OIC-047-26-B","{""question"": ""What is the typical age range during which genu valgum is considered a physiological condition?"", ""option_a"": ""Up to 3 years of age"", ""option_b"": ""From 3 to 10 years of age"", ""option_c"": ""After 10 years of age until puberty"", ""option_d"": ""After puberty"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical age range during which genu valgum is considered a physiological condition?","Up to 3 years of age","From 3 to 10 years of age","After 10 years of age until puberty","After puberty","b"
"OIC-047-27-A","{""question"": ""What percentage of scoliosis cases in children are attributed to underlying diseases such as neuromuscular diseases or polymalformative syndrome?"", ""option_a"": ""80%"", ""option_b"": ""50%"", ""option_c"": ""20%"", ""option_d"": ""10%"", ""correct_option"": ""C""}","Positive diagnosis","What percentage of scoliosis cases in children are attributed to underlying diseases such as neuromuscular diseases or polymalformative syndrome?","80%","50%","20%","10%","c"
"OIC-047-28-A","{""question"": ""What is a characteristic feature of scoliosis in children during clinical examination?"", ""option_a"": ""Presence of severe back pain"", ""option_b"": ""Painless spinal deformity in all 3 planes with a visible gibbous formation"", ""option_c"": ""Temporary deformity that self-corrects with growth"", ""option_d"": ""Deformity only visible in one plane of the spine"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic feature of scoliosis in children during clinical examination?","Presence of severe back pain","Painless spinal deformity in all 3 planes with a visible gibbous formation","Temporary deformity that self-corrects with growth","Deformity only visible in one plane of the spine","b"
"OIC-047-29-B","{""question"": ""What is the primary purpose of analyzing the ossification nuclei of the iliac crests in the assessment of scoliosis in children?"", ""option_a"": ""To determine the extent of the spinal deformity"", ""option_b"": ""To assess bone maturation and determine the end of growth"", ""option_c"": ""To identify malformations of the vertebral structures"", ""option_d"": ""To evaluate the statics of the spine and pelvis"", ""correct_option"": ""B""}","Additional examinations","What is the primary purpose of analyzing the ossification nuclei of the iliac crests in the assessment of scoliosis in children?","To determine the extent of the spinal deformity","To assess bone maturation and determine the end of growth","To identify malformations of the vertebral structures","To evaluate the statics of the spine and pelvis","b"
"OIC-047-30-B","{""question"": ""What is the primary purpose of radiography of the lumbar spine in infants and children?"", ""option_a"": ""To diagnose infectious diseases"", ""option_b"": ""To screen for malformative scoliosis"", ""option_c"": ""To assess bone density"", ""option_d"": ""To evaluate spinal cord injuries"", ""correct_option"": ""B""}","Multimedia content","What is the primary purpose of radiography of the lumbar spine in infants and children?","To diagnose infectious diseases","To screen for malformative scoliosis","To assess bone density","To evaluate spinal cord injuries","b"
"OIC-047-31-B","{""question"": ""What is the most frequent cause of thoracic kyphosis in children?"", ""option_a"": ""Inversion of lordosis"", ""option_b"": ""Spinal growth dystrophy (Scheuermann's disease)"", ""option_c"": ""Vertebral fracture"", ""option_d"": ""Congenital vertebral anomaly"", ""correct_option"": ""B""}","Positive diagnosis","What is the most frequent cause of thoracic kyphosis in children?","Inversion of lordosis","Spinal growth dystrophy (Scheuermann's disease)","Vertebral fracture","Congenital vertebral anomaly","b"
"OIC-047-32-A","{""question"": ""At what age is the second compulsory medical examination certificate (certificate no. 2) typically issued for infants?"", ""option_a"": ""6 months"", ""option_b"": ""9 months"", ""option_c"": ""12 months"", ""option_d"": ""16-18 months"", ""correct_option"": ""B""}","Definition","At what age is the second compulsory medical examination certificate (certificate no. 2) typically issued for infants?","6 months","9 months","12 months","16-18 months","b"
"OIC-047-33-A","{""question"": ""What is the primary focus of school medicine?"", ""option_a"": ""Only individualised reception plans for pupils with physical health needs"", ""option_b"": ""Individual and collective prevention and health promotion for all schoolchildren"", ""option_c"": ""Compulsory health examinations for children with mental health issues"", ""option_d"": ""Screening for orthopaedic abnormalities in adolescents only"", ""correct_option"": ""B""}","Definition","What is the primary focus of school medicine?","Only individualised reception plans for pupils with physical health needs","Individual and collective prevention and health promotion for all schoolchildren","Compulsory health examinations for children with mental health issues","Screening for orthopaedic abnormalities in adolescents only","b"
"OIC-047-34-A","{""question"": ""At what age is the 'Bilan de sant\u00e9' often performed by school medicine, which includes a urinalysis in addition to other examinations?"", ""option_a"": ""3 years"", ""option_b"": ""4 years"", ""option_c"": ""6 years"", ""option_d"": ""11-13 years"", ""correct_option"": ""C""}","Definition","At what age is the 'Bilan de santé' often performed by school medicine, which includes a urinalysis in addition to other examinations?","3 years","4 years","6 years","11-13 years","c"
"OIC-047-35-A","{""question"": ""What type of information is typically included in the 'Neonatal data' section of a health record?"", ""option_a"": ""Growth curves and vaccination history"", ""option_b"": ""Prenatal monitoring, delivery, and adaptation to extra-uterine life"", ""option_c"": ""Hospitalisation records and irradiating examinations"", ""option_d"": ""Oral health and dietary advice"", ""correct_option"": ""B""}","Definition","What type of information is typically included in the 'Neonatal data' section of a health record?","Growth curves and vaccination history","Prenatal monitoring, delivery, and adaptation to extra-uterine life","Hospitalisation records and irradiating examinations","Oral health and dietary advice","b"
"OIC-047-36-B","{""question"": ""Who can perform compulsory follow-up consultations for infants and children?"", ""option_a"": ""Only paediatricians"", ""option_b"": ""The child's GP, paediatrician, or general practitioner, as well as the PMI (up to the age of 6)"", ""option_c"": ""Only the PMI (up to the age of 6)"", ""option_d"": ""Any medical specialist"", ""correct_option"": ""B""}","Support","Who can perform compulsory follow-up consultations for infants and children?","Only paediatricians","The child's GP, paediatrician, or general practitioner, as well as the PMI (up to the age of 6)","Only the PMI (up to the age of 6)","Any medical specialist","b"
"OIC-047-37-B","{""question"": ""What is the primary purpose of the three medical certificates accompanying the compulsory systematic monitoring of infants at 8, 9, and 24 months?"", ""option_a"": ""To track the infant's vaccination schedule and development milestones"", ""option_b"": ""To monitor the infant's dietary habits and sleeping patterns"", ""option_c"": ""To collect epidemiological data on health status, including vaccination coverage"", ""option_d"": ""To identify potential orthopaedic, visual, hearing, and dental abnormalities"", ""correct_option"": ""A""}","Support","What is the primary purpose of the three medical certificates accompanying the compulsory systematic monitoring of infants at 8, 9, and 24 months?","To track the infant's vaccination schedule and development milestones","To monitor the infant's dietary habits and sleeping patterns","To collect epidemiological data on health status, including vaccination coverage","To identify potential orthopaedic, visual, hearing, and dental abnormalities","a"
"OIC-047-38-B","{""question"": ""What information is typically included in the medical certificate at the 9th month of a child's compulsory systematic monitoring?"", ""option_a"": ""History, vaccinations, eye and hearing tests, psychomotor development, and congenital anomalies"", ""option_b"": ""History, vaccinations, eye and hearing tests, psychomotor development, measurements, breastfeeding, risk of lead poisoning, and current medical conditions"", ""option_c"": ""Pregnancy, delivery, condition at birth, pathologies in the first week, congenital anomalies, breastfeeding, and vaccinations"", ""option_d"": ""Dental condition, newborn hearing screening, and risk of lead poisoning"", ""correct_option"": ""B""}","Management","What information is typically included in the medical certificate at the 9th month of a child's compulsory systematic monitoring?","History, vaccinations, eye and hearing tests, psychomotor development, and congenital anomalies","History, vaccinations, eye and hearing tests, psychomotor development, measurements, breastfeeding, risk of lead poisoning, and current medical conditions","Pregnancy, delivery, condition at birth, pathologies in the first week, congenital anomalies, breastfeeding, and vaccinations","Dental condition, newborn hearing screening, and risk of lead poisoning","b"
"OIC-047-39-B","{""question"": ""What is an essential aspect to cover during the consultation with adolescents?"", ""option_a"": ""Only discussing physical and pubertal development"", ""option_b"": ""Covering all important aspects including eating habits, physical development, sexuality, leisure activities, and family relationships"", ""option_c"": ""Focusing solely on vaccination history and contraception methods"", ""option_d"": ""Ignoring sensitive topics such as suicidal thoughts and traumatic events"", ""correct_option"": ""B""}","Positive diagnosis","What is an essential aspect to cover during the consultation with adolescents?","Only discussing physical and pubertal development","Covering all important aspects including eating habits, physical development, sexuality, leisure activities, and family relationships","Focusing solely on vaccination history and contraception methods","Ignoring sensitive topics such as suicidal thoughts and traumatic events","b"
"OIC-047-40-A","{""question"": ""What is a major cause of morbidity in infants, according to the provided information?"", ""option_a"": ""Mental disorders"", ""option_b"": ""Respiratory infections"", ""option_c"": ""Decompensation of chronic illnesses"", ""option_d"": ""Learning disabilities"", ""correct_option"": ""B""}","Epidemiology","What is a major cause of morbidity in infants, according to the provided information?","Mental disorders","Respiratory infections","Decompensation of chronic illnesses","Learning disabilities","b"
"OIC-047-41-A","{""question"": ""What is the estimated percentage of children who are victims of accidents in everyday life every year?"", ""option_a"": ""5-10%"", ""option_b"": ""10-15%"", ""option_c"": ""20-25%"", ""option_d"": ""30-35%"", ""correct_option"": ""B""}","Taking charge","What is the estimated percentage of children who are victims of accidents in everyday life every year?","5-10%","10-15%","20-25%","30-35%","b"
"OIC-048-01-A","{""question"": ""What type of milk is indicated for infants with severe acute diarrhea requiring hospitalization and recurrence or persistence of diarrhea 5-7 days after reintroduction of milk?"", ""option_a"": ""Hypoallergenic milk (HA)"", ""option_b"": ""Anti-regurgitation milk (AR)"", ""option_c"": ""Lactose-free milk"", ""option_d"": ""Standard milk formula"", ""correct_option"": ""C""}","Management","What type of milk is indicated for infants with severe acute diarrhea requiring hospitalization and recurrence or persistence of diarrhea 5-7 days after reintroduction of milk?","Hypoallergenic milk (HA)","Anti-regurgitation milk (AR)","Lactose-free milk","Standard milk formula","c"
"OIC-048-02-A","{""question"": ""What is the primary nutritional purpose of dietary diversification in infants between 4 and 6 months of age?"", ""option_a"": ""To provide essential nutrients that breast milk or infant formula cannot supply"", ""option_b"": ""To introduce new food proteins, flavors, textures, and fiber for developmental purposes"", ""option_c"": ""To reduce the infant's dependence on breast milk or infant formula by half"", ""option_d"": ""To increase the caloric intake of the infant to support rapid growth"", ""correct_option"": ""B""}","Taking charge","What is the primary nutritional purpose of dietary diversification in infants between 4 and 6 months of age?","To provide essential nutrients that breast milk or infant formula cannot supply","To introduce new food proteins, flavors, textures, and fiber for developmental purposes","To reduce the infant's dependence on breast milk or infant formula by half","To increase the caloric intake of the infant to support rapid growth","b"
"OIC-048-03-A","{""question"": ""What is the recommended method for reconstituting milk formulas?"", ""option_a"": ""Add 1 measuring spoon of powder to 30 ml of boiling water"", ""option_b"": ""Add 1 measuring spoon of powder to 30 ml of low mineral content or tap water"", ""option_c"": ""Add 2 measuring spoons of powder to 30 ml of low mineral content or tap water"", ""option_d"": ""Add 1 measuring spoon of powder to 60 ml of low mineral content or tap water"", ""correct_option"": ""B""}","Management","What is the recommended method for reconstituting milk formulas?","Add 1 measuring spoon of powder to 30 ml of boiling water","Add 1 measuring spoon of powder to 30 ml of low mineral content or tap water","Add 2 measuring spoons of powder to 30 ml of low mineral content or tap water","Add 1 measuring spoon of powder to 60 ml of low mineral content or tap water","b"
"OIC-048-04-A","{""question"": ""At what age should follow-on formulas typically replace infant formulas in a fully diversified meal?"", ""option_a"": ""Around 4-6 months"", ""option_b"": ""From 8 to 10 months"", ""option_c"": ""Until the age of 10-12 months"", ""option_d"": ""After 3 years of age"", ""correct_option"": ""A""}","Taking charge","At what age should follow-on formulas typically replace infant formulas in a fully diversified meal?","Around 4-6 months","From 8 to 10 months","Until the age of 10-12 months","After 3 years of age","a"
"OIC-049-01-A","{""question"": ""What is the first sign of puberty in girls and what is the typical age range for its onset?"", ""option_a"": ""Menarche, 10-15 years"", ""option_b"": ""Breast development, 8-13 years"", ""option_c"": ""Development of pubic hair, 9-14 years"", ""option_d"": ""Development of axillary hair, 11-16 years"", ""correct_option"": ""B""}","Evaluation","What is the first sign of puberty in girls and what is the typical age range for its onset?","Menarche, 10-15 years","Breast development, 8-13 years","Development of pubic hair, 9-14 years","Development of axillary hair, 11-16 years","b"
"OIC-049-02-A","{""question"": ""What is the term that refers to the first menstrual period in females?"", ""option_a"": ""Thelarche"", ""option_b"": ""Menarche"", ""option_c"": ""Adrenarche"", ""option_d"": ""Precocious puberty"", ""correct_option"": ""B""}","Definition","What is the term that refers to the first menstrual period in females?","Thelarche","Menarche","Adrenarche","Precocious puberty","b"
"OIC-049-03-B","{""question"": ""What is the average pubertal growth peak in boys?"", ""option_a"": ""15-20 cm"", ""option_b"": ""20-25 cm"", ""option_c"": ""25-30 cm"", ""option_d"": ""30-35 cm"", ""correct_option"": ""C""}","Physiopathology","What is the average pubertal growth peak in boys?","15-20 cm","20-25 cm","25-30 cm","30-35 cm","c"
"OIC-049-04-B","{""question"": ""According to the Tanner stages, what is the characteristic of breast development in girls at stage S2?"", ""option_a"": ""Mature appearance"", ""option_b"": ""No breast development"", ""option_c"": ""Small breast bud with enlarged areola"", ""option_d"": ""Protrusion of areola and nipple over gland, submammary fold"", ""correct_option"": ""C""}","Definition","According to the Tanner stages, what is the characteristic of breast development in girls at stage S2?","Mature appearance","No breast development","Small breast bud with enlarged areola","Protrusion of areola and nipple over gland, submammary fold","c"
"OIC-049-05-B","{""question"": ""At what stage of puberty does the acceleration in the rate of statural growth begin in girls?"", ""option_a"": ""At the peak of bone growth"", ""option_b"": ""With the first signs of puberty (S2)"", ""option_c"": ""After the peak of bone growth"", ""option_d"": ""During the final stages of puberty"", ""correct_option"": ""B""}","Physiopathology","At what stage of puberty does the acceleration in the rate of statural growth begin in girls?","At the peak of bone growth","With the first signs of puberty (S2)","After the peak of bone growth","During the final stages of puberty","b"
"OIC-049-06-B","{""question"": ""What triggers the onset of puberty in both males and females?"", ""option_a"": ""The increase in sex hormones"", ""option_b"": ""The reactivation of GnRH pulsatility"", ""option_c"": ""The production of gonadal and adrenal androgens"", ""option_d"": ""The appearance of secondary sexual characteristics"", ""correct_option"": ""B""}","Physiopathology","What triggers the onset of puberty in both males and females?","The increase in sex hormones","The reactivation of GnRH pulsatility","The production of gonadal and adrenal androgens","The appearance of secondary sexual characteristics","b"
"OIC-049-07-B","{""question"": ""What are the two main factors that likely influence the onset of puberty?"", ""option_a"": ""Hormonal and nutritional factors"", ""option_b"": ""Genetic and environmental factors"", ""option_c"": ""Neuroendocrine and pathological factors"", ""option_d"": ""Ethnic and sociological factors"", ""correct_option"": ""B""}","Physiopathology","What are the two main factors that likely influence the onset of puberty?","Hormonal and nutritional factors","Genetic and environmental factors","Neuroendocrine and pathological factors","Ethnic and sociological factors","b"
"OIC-049-08-B","{""question"": ""What is the primary role of Gonadotropin Releasing Hormone (GnRH) in the onset of puberty?"", ""option_a"": ""To stimulate the production of testosterone in boys and oestrogens in girls"", ""option_b"": ""To modulate the secretion of growth hormone and accelerate statural growth"", ""option_c"": ""To reactivate its pulsatility and stimulate the anteropituitary secretion of gonadotropins FSH and LH"", ""option_d"": ""To regulate the production of leptin by adipose tissue"", ""correct_option"": ""C""}","Physiopathology","What is the primary role of Gonadotropin Releasing Hormone (GnRH) in the onset of puberty?","To stimulate the production of testosterone in boys and oestrogens in girls","To modulate the secretion of growth hormone and accelerate statural growth","To reactivate its pulsatility and stimulate the anteropituitary secretion of gonadotropins FSH and LH","To regulate the production of leptin by adipose tissue","c"
"OIC-049-09-A","{""question"": ""At what age is breast development considered precocious puberty in girls?"", ""option_a"": ""Before the age of 7"", ""option_b"": ""Before the age of 8"", ""option_c"": ""Before the age of 9"", ""option_d"": ""Before the age of 10"", ""correct_option"": ""B""}","Definition","At what age is breast development considered precocious puberty in girls?","Before the age of 7","Before the age of 8","Before the age of 9","Before the age of 10","b"
"OIC-049-10-A","{""question"": ""What is an important aspect of the clinical examination for suspected precocious puberty?"", ""option_a"": ""Checking for signs of hyperthyroidism"", ""option_b"": ""Evaluating the pubertal stage using the Tanner scale"", ""option_c"": ""Assessing the patient's dietary habits"", ""option_d"": ""Conducting a thorough eye examination for retinal damage"", ""correct_option"": ""B""}","Positive diagnosis","What is an important aspect of the clinical examination for suspected precocious puberty?","Checking for signs of hyperthyroidism","Evaluating the pubertal stage using the Tanner scale","Assessing the patient's dietary habits","Conducting a thorough eye examination for retinal damage","b"
"OIC-049-11-A","{""question"": ""What is an essential step in interpreting a growth curve for a child?"", ""option_a"": ""Calculating the child's daily calorie intake"", ""option_b"": ""Measuring the child's annual growth rate and calculating their BMI"", ""option_c"": ""Assessing the child's physical activity level"", ""option_d"": ""Evaluating the child's mental health status"", ""correct_option"": ""B""}","Positive diagnosis","What is an essential step in interpreting a growth curve for a child?","Calculating the child's daily calorie intake","Measuring the child's annual growth rate and calculating their BMI","Assessing the child's physical activity level","Evaluating the child's mental health status","b"
"OIC-049-12-B","{""question"": ""What is the primary difference in the frequency of central precocious puberty between genders in France?"", ""option_a"": ""It is approximately 10 times more frequent in boys than in girls"", ""option_b"": ""It is approximately equal in frequency between boys and girls"", ""option_c"": ""It is approximately 10 times more frequent in girls than in boys"", ""option_d"": ""There is no significant difference in frequency between boys and girls"", ""correct_option"": ""C""}","Epidemiology","What is the primary difference in the frequency of central precocious puberty between genders in France?","It is approximately 10 times more frequent in boys than in girls","It is approximately equal in frequency between boys and girls","It is approximately 10 times more frequent in girls than in boys","There is no significant difference in frequency between boys and girls","c"
"OIC-049-13-B","{""question"": ""What is a common cause of early central precocious puberty (PP) due to an intracranial process?"", ""option_a"": ""Ovarian cyst"", ""option_b"": ""Chiasma glioma"", ""option_c"": ""Hyperandrogenism without gonadotropic activation"", ""option_d"": ""McCune-Albright syndrome"", ""correct_option"": ""B""}","Etiologies","What is a common cause of early central precocious puberty (PP) due to an intracranial process?","Ovarian cyst","Chiasma glioma","Hyperandrogenism without gonadotropic activation","McCune-Albright syndrome","b"
"OIC-049-14-B","{""question"": ""What is a common cause of early central precocious puberty (PP) in children?"", ""option_a"": ""Ovarian cysts"", ""option_b"": ""Intracranial tumors, such as chiasma glioma"", ""option_c"": ""Exogenous hormonal exposure"", ""option_d"": ""Genetic mutations affecting adrenal function"", ""correct_option"": ""B""}","Etiologies","What is a common cause of early central precocious puberty (PP) in children?","Ovarian cysts","Intracranial tumors, such as chiasma glioma","Exogenous hormonal exposure","Genetic mutations affecting adrenal function","b"
"OIC-049-15-B","{""question"": ""In the case of proven precocious puberty, which of the following biological tests is used to diagnose and distinguish between central and peripheral precocious puberty?"", ""option_a"": ""Measurement of bone age"", ""option_b"": ""Assessment of inhibin B levels"", ""option_c"": ""LH-RH/GnRH test to evaluate gonadotropin response"", ""option_d"": ""Evaluation of sex steroids such as testosterone and oestradiol"", ""correct_option"": ""C""}","Etiologies","In the case of proven precocious puberty, which of the following biological tests is used to diagnose and distinguish between central and peripheral precocious puberty?","Measurement of bone age","Assessment of inhibin B levels","LH-RH/GnRH test to evaluate gonadotropin response","Evaluation of sex steroids such as testosterone and oestradiol","c"
"OIC-049-16-A","{""question"": ""At what age is delayed puberty defined in boys if there is no testicular enlargement?"", ""option_a"": ""12 years old"", ""option_b"": ""14 years old"", ""option_c"": ""15 years old"", ""option_d"": ""16 years old"", ""correct_option"": ""B""}","Positive diagnosis","At what age is delayed puberty defined in boys if there is no testicular enlargement?","12 years old","14 years old","15 years old","16 years old","b"
"OIC-049-17-A","{""question"": ""What information is crucial to obtain during the questioning of a patient with potential delayed puberty?"", ""option_a"": ""Detailed dietary habits and exercise routine"", ""option_b"": ""Pubertal ages of parents and siblings, age at menarche of mother, and parental heights"", ""option_c"": ""History of vaccinations and previous surgical procedures"", ""option_d"": ""Social relationships and academic performance"", ""correct_option"": ""B""}","Positive diagnosis","What information is crucial to obtain during the questioning of a patient with potential delayed puberty?","Detailed dietary habits and exercise routine","Pubertal ages of parents and siblings, age at menarche of mother, and parental heights","History of vaccinations and previous surgical procedures","Social relationships and academic performance","b"
"OIC-049-18-B","{""question"": ""In the biological assessment of delayed puberty, what is the primary purpose of measuring baseline FSH and LH levels?"", ""option_a"": ""To distinguish between central and peripheral hypogonadism based on high or low levels of FSH and LH"", ""option_b"": ""To assess the levels of sex steroids, such as testosterone and oestradiol"", ""option_c"": ""To evaluate the function of the thyroid gland through TSH and T4L measurements"", ""option_d"": ""To diagnose multiple anterpituitary insufficiency through the measurement of various anterpituitary hormones"", ""correct_option"": ""A""}","Etiologies","In the biological assessment of delayed puberty, what is the primary purpose of measuring baseline FSH and LH levels?","To distinguish between central and peripheral hypogonadism based on high or low levels of FSH and LH","To assess the levels of sex steroids, such as testosterone and oestradiol","To evaluate the function of the thyroid gland through TSH and T4L measurements","To diagnose multiple anterpituitary insufficiency through the measurement of various anterpituitary hormones","a"
"OIC-049-19-A","{""question"": ""What are the two main etiological frameworks of delayed puberty?"", ""option_a"": ""Hypothalamic-pituitary and thyroid origins"", ""option_b"": ""Hypothalamic-pituitary and gonadal origins"", ""option_c"": ""Gonadal and adrenal origins"", ""option_d"": ""Hypothalamic and ovarian/testicular origins"", ""correct_option"": ""B""}","Etiologies","What are the two main etiological frameworks of delayed puberty?","Hypothalamic-pituitary and thyroid origins","Hypothalamic-pituitary and gonadal origins","Gonadal and adrenal origins","Hypothalamic and ovarian/testicular origins","b"
"OIC-049-20-B","{""question"": ""What is the primary indication of pubertal precocity in a 7-year-old child?"", ""option_a"": ""Delayed growth rate"", ""option_b"": ""Accelerated growth rate and mammary development"", ""option_c"": ""Normal growth rate with no physical changes"", ""option_d"": ""Decelerated growth rate with bone age advancement"", ""correct_option"": ""B""}","Multimedia content","What is the primary indication of pubertal precocity in a 7-year-old child?","Delayed growth rate","Accelerated growth rate and mammary development","Normal growth rate with no physical changes","Decelerated growth rate with bone age advancement","b"
"OIC-049-21-B","{""question"": ""What is the typical presentation of premature thelarche in girls under 2 years of age?"", ""option_a"": ""Rapid progression of breast development with advanced pubertal changes"", ""option_b"": ""Breast development beginning in the perinatal period with minimal progression thereafter"", ""option_c"": ""Delayed onset of breast development until after 2 years of age"", ""option_d"": ""Absence of breast development in the perinatal period"", ""correct_option"": ""B""}","Multimedia content","What is the typical presentation of premature thelarche in girls under 2 years of age?","Rapid progression of breast development with advanced pubertal changes","Breast development beginning in the perinatal period with minimal progression thereafter","Delayed onset of breast development until after 2 years of age","Absence of breast development in the perinatal period","b"
"OIC-049-22-B","{""question"": ""What is adrenarche?"", ""option_a"": ""A condition where the onset of puberty is abnormally early"", ""option_b"": ""A normal process in puberty where the adrenal glands start producing more androgens, leading to changes such as acne and body hair"", ""option_c"": ""A type of pathology that affects the development of secondary sexual characteristics"", ""option_d"": ""A stage of puberty where the growth spurt occurs"", ""correct_option"": ""B""}","Multimedia content","What is adrenarche?","A condition where the onset of puberty is abnormally early","A normal process in puberty where the adrenal glands start producing more androgens, leading to changes such as acne and body hair","A type of pathology that affects the development of secondary sexual characteristics","A stage of puberty where the growth spurt occurs","b"
"OIC-049-23-B","{""question"": ""What is the primary indication of precocious puberty in girls, as evident from the photograph of a 7-year-old patient (P2S2R0) showing mammary development and accelerated growth rate?"", ""option_a"": ""Delayed onset of menstruation"", ""option_b"": ""Mammary development and accelerated growth rate at an early age"", ""option_c"": ""Loss of body hair"", ""option_d"": ""Onset of menopause at an early age"", ""correct_option"": ""B""}","Multimedia content","What is the primary indication of precocious puberty in girls, as evident from the photograph of a 7-year-old patient (P2S2R0) showing mammary development and accelerated growth rate?","Delayed onset of menstruation","Mammary development and accelerated growth rate at an early age","Loss of body hair","Onset of menopause at an early age","b"
"OIC-049-24-B","{""question"": ""What is the primary indication for a brain MRI in the context of abnormal puberty?"", ""option_a"": ""To diagnose pathological peripheral puberty in girls"", ""option_b"": ""To look for a tumour affecting the hypothalamo-hypophyseal region in central precocious puberty"", ""option_c"": ""To assess the onset of normal puberty in boys"", ""option_d"": ""To evaluate the presence of ovarian cysts in girls with precocious puberty"", ""correct_option"": ""B""}","Additional examinations","What is the primary indication for a brain MRI in the context of abnormal puberty?","To diagnose pathological peripheral puberty in girls","To look for a tumour affecting the hypothalamo-hypophyseal region in central precocious puberty","To assess the onset of normal puberty in boys","To evaluate the presence of ovarian cysts in girls with precocious puberty","b"
"OIC-049-25-A","{""question"": ""What is the primary purpose of a pelvic ultrasound in girls during the evaluation of pathological puberty?"", ""option_a"": ""To assess bone age and determine the stage of puberty"", ""option_b"": ""To rule out an ovarian tumour or cyst and measure uterine length"", ""option_c"": ""To evaluate the presence of any uterine abnormalities or infections"", ""option_d"": ""To confirm the diagnosis of precocious puberty and start treatment"", ""correct_option"": ""B""}","Additional examinations","What is the primary purpose of a pelvic ultrasound in girls during the evaluation of pathological puberty?","To assess bone age and determine the stage of puberty","To rule out an ovarian tumour or cyst and measure uterine length","To evaluate the presence of any uterine abnormalities or infections","To confirm the diagnosis of precocious puberty and start treatment","b"
"OIC-049-26-B","{""question"": ""At what age does the onset of puberty typically correspond to the appearance of the sesamoid bone in boys, as assessed through bone age on a wrist X-ray?"", ""option_a"": ""10 years"", ""option_b"": ""11 years"", ""option_c"": ""13 years"", ""option_d"": ""15 years"", ""correct_option"": ""C""}","Additional examinations","At what age does the onset of puberty typically correspond to the appearance of the sesamoid bone in boys, as assessed through bone age on a wrist X-ray?","10 years","11 years","13 years","15 years","c"
"OIC-050-01-A","{""question"": ""What is the primary risk factor for testicular cancer?"", ""option_a"": ""Family history of testicular cancer"", ""option_b"": ""Cryptorchidism"", ""option_c"": ""History of testicular trauma"", ""option_d"": ""Age over 50 years"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary risk factor for testicular cancer?","Family history of testicular cancer","Cryptorchidism","History of testicular trauma","Age over 50 years","b"
"OIC-050-02-A","{""question"": ""What is the primary concern with delayed treatment of spermatic cord torsion?"", ""option_a"": ""Increased risk of testicular cancer"", ""option_b"": ""Compromised prognosis for testicular function due to ischaemia and testicular necrosis"", ""option_c"": ""Higher likelihood of developing necrotizing fasciitis"", ""option_d"": ""Reduced effectiveness of antibiotic therapy"", ""correct_option"": ""B""}","Emergency identification","What is the primary concern with delayed treatment of spermatic cord torsion?","Increased risk of testicular cancer","Compromised prognosis for testicular function due to ischaemia and testicular necrosis","Higher likelihood of developing necrotizing fasciitis","Reduced effectiveness of antibiotic therapy","b"
"OIC-050-03-B","{""question"": ""What is the term used to describe the phenomenon where a bursa allows light to pass through when a light source is applied, as seen in the provided image?"", ""option_a"": ""Transilluminated bursa"", ""option_b"": ""Non-transilluminated bursa"", ""option_c"": ""Scrotal luminescence"", ""option_d"": ""Genito-scrotal reflection"", ""correct_option"": ""A""}","Multimedia content","What is the term used to describe the phenomenon where a bursa allows light to pass through when a light source is applied, as seen in the provided image?","Transilluminated bursa","Non-transilluminated bursa","Scrotal luminescence","Genito-scrotal reflection","a"
"OIC-050-04-A","{""question"": ""What is the typical cause of orchiepididymitis in males between puberty and the age of 35?"", ""option_a"": ""Mainly enterobacteria related to a pathology of the lower urinary apparatus"", ""option_b"": ""Sexually transmitted infections, such as Chlamydia trachomatis and gonococcus"", ""option_c"": ""Urogenital infections associated with benign prostatic hypertrophy"", ""option_d"": ""Instrumental or surgical maneuvers"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical cause of orchiepididymitis in males between puberty and the age of 35?","Mainly enterobacteria related to a pathology of the lower urinary apparatus","Sexually transmitted infections, such as Chlamydia trachomatis and gonococcus","Urogenital infections associated with benign prostatic hypertrophy","Instrumental or surgical maneuvers","b"
"OIC-050-05-B","{""question"": ""What is the primary method for diagnosing orchi-epididymitis?"", ""option_a"": ""Bacteriological test for aetiology"", ""option_b"": ""Scrotal ultrasound scan"", ""option_c"": ""The diagnosis is primarily clinical"", ""option_d"": ""Blood cultures"", ""correct_option"": ""C""}","Complementary examinations","What is the primary method for diagnosing orchi-epididymitis?","Bacteriological test for aetiology","Scrotal ultrasound scan","The diagnosis is primarily clinical","Blood cultures","c"
"OIC-050-06-A","{""question"": ""What is the recommended first-line antibiotic treatment for orchi-epididymitis in children?"", ""option_a"": ""Ceftriaxone 500 mg in 1 IM injection, followed by Doxycycline 200mg/d for 10 days"", ""option_b"": ""Cotrimoxazole"", ""option_c"": ""Ciprofloxacin or levofloxacin"", ""option_d"": ""Ofloxacin 200mg twice daily for 10 days"", ""correct_option"": ""B""}","Management","What is the recommended first-line antibiotic treatment for orchi-epididymitis in children?","Ceftriaxone 500 mg in 1 IM injection, followed by Doxycycline 200mg/d for 10 days","Cotrimoxazole","Ciprofloxacin or levofloxacin","Ofloxacin 200mg twice daily for 10 days","b"
"OIC-050-07-B","{""question"": ""What is the immediate management approach for a patient diagnosed with testicular torsion?"", ""option_a"": ""Perform a series of diagnostic imaging tests to confirm the diagnosis before surgery"", ""option_b"": ""Administer antibiotic therapy and monitor the patient's condition"", ""option_c"": ""Immediate surgical scrotal exploration to untwist the spermatic cord and perform orchidopexy if the testicle is viable"", ""option_d"": ""Apply hyperbaric oxygen therapy as the primary treatment"", ""correct_option"": ""C""}","Management","What is the immediate management approach for a patient diagnosed with testicular torsion?","Perform a series of diagnostic imaging tests to confirm the diagnosis before surgery","Administer antibiotic therapy and monitor the patient's condition","Immediate surgical scrotal exploration to untwist the spermatic cord and perform orchidopexy if the testicle is viable","Apply hyperbaric oxygen therapy as the primary treatment","c"
"OIC-050-08-A","{""question"": ""What is the primary characteristic that helps in the diagnosis of a hydrocele?"", ""option_a"": ""Painful and inflammatory bursa"", ""option_b"": ""Positive transillumination"", ""option_c"": ""Sudden tension and bluish skin"", ""option_d"": ""Variations in volume during the day and increase in symptoms when standing"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic that helps in the diagnosis of a hydrocele?","Painful and inflammatory bursa","Positive transillumination","Sudden tension and bluish skin","Variations in volume during the day and increase in symptoms when standing","b"
"OIC-050-09-B","{""question"": ""What is the primary use of scrotal ultrasound in cases of hydrocele?"", ""option_a"": ""To treat the hydrocele through percutaneous puncture"", ""option_b"": ""To confirm the diagnosis and assess the underlying testicle"", ""option_c"": ""To perform a differential diagnosis of orchitis"", ""option_d"": ""To inject medication directly into the hydrocele"", ""correct_option"": ""B""}","Additional examinations","What is the primary use of scrotal ultrasound in cases of hydrocele?","To treat the hydrocele through percutaneous puncture","To confirm the diagnosis and assess the underlying testicle","To perform a differential diagnosis of orchitis","To inject medication directly into the hydrocele","b"
"OIC-050-10-A","{""question"": ""What is the characteristic clinical examination finding in a case of cryptorchidism?"", ""option_a"": ""The testicle can be easily palpated in the scrotum"", ""option_b"": ""The testicle can be palpated on the normal migration path, such as in the inguinal canal"", ""option_c"": ""The hernial orifices are open"", ""option_d"": ""It is impossible to palpate the testicle in the bursa and the hernial orifices are closed"", ""correct_option"": ""D""}",,"What is the characteristic clinical examination finding in a case of cryptorchidism?","The testicle can be easily palpated in the scrotum","The testicle can be palpated on the normal migration path, such as in the inguinal canal","The hernial orifices are open","It is impossible to palpate the testicle in the bursa and the hernial orifices are closed","d"
"OIC-050-11-B","{""question"": ""What is the recommended approach for an unpalpated testicle in an adult?"", ""option_a"": ""Referral to a paediatric surgeon"", ""option_b"": ""Laparoscopic exploration for diagnostic and/or therapeutic purposes"", ""option_c"": ""Surveillance by imaging, such as scanner or MRI"", ""option_d"": ""Clinical examination only, as no imaging technique is effective"", ""correct_option"": ""C""}","Additional examinations","What is the recommended approach for an unpalpated testicle in an adult?","Referral to a paediatric surgeon","Laparoscopic exploration for diagnostic and/or therapeutic purposes","Surveillance by imaging, such as scanner or MRI","Clinical examination only, as no imaging technique is effective","c"
"OIC-050-12-B","{""question"": ""At what age should surgery for cryptorchidism not be considered before?"", ""option_a"": ""6 months"", ""option_b"": ""1 year"", ""option_c"": ""2 years"", ""option_d"": ""5 years"", ""correct_option"": ""B""}","Management","At what age should surgery for cryptorchidism not be considered before?","6 months","1 year","2 years","5 years","b"
"OIC-050-13-A","{""question"": ""What is the primary cause of balanoposthitis?"", ""option_a"": ""Forgetting to unhood the foreskin after urination"", ""option_b"": ""Failure to unclip and accumulation of smegma"", ""option_c"": ""Constriction of the preputial ring at the level of the balanopreputial groove"", ""option_d"": ""Poorly controlled diabetes mellitus"", ""correct_option"": ""B""}",,"What is the primary cause of balanoposthitis?","Forgetting to unhood the foreskin after urination","Failure to unclip and accumulation of smegma","Constriction of the preputial ring at the level of the balanopreputial groove","Poorly controlled diabetes mellitus","b"
"OIC-050-14-A","{""question"": ""What is the recommended initial treatment for balanoposthitis in children?"", ""option_a"": ""Prescription for oral antibiotics"", ""option_b"": ""Prescription for local antiseptic-based care in a penis bath"", ""option_c"": ""Application of dermocorticoids for several weeks"", ""option_d"": ""Emergency manual reduction"", ""correct_option"": ""B""}","Management","What is the recommended initial treatment for balanoposthitis in children?","Prescription for oral antibiotics","Prescription for local antiseptic-based care in a penis bath","Application of dermocorticoids for several weeks","Emergency manual reduction","b"
"OIC-050-15-A","{""question"": ""What is the characteristic direction of detorsion for a right testicle with spermatic cord torsion?"", ""option_a"": ""Clockwise"", ""option_b"": ""Anti-clockwise"", ""option_c"": ""Towards the midline"", ""option_d"": ""Away from the midline without a specific direction"", ""correct_option"": ""B""}","Positive diagnosis","What is the characteristic direction of detorsion for a right testicle with spermatic cord torsion?","Clockwise","Anti-clockwise","Towards the midline","Away from the midline without a specific direction","b"
"OIC-050-16-B","{""question"": ""What is the primary role of testicular ultrasound coupled with Doppler in cases of suspected spermatic cord torsion?"", ""option_a"": ""To confirm the diagnosis of cord torsion with high sensitivity and specificity"", ""option_b"": ""To delay emergency surgical management and observe the patient"", ""option_c"": ""To guide the diagnosis when there is doubt, particularly in atypical presentations or after 24 hours of scrotal pain"", ""option_d"": ""To rule out all other possible causes of scrotal pain, including orchi-epididymitis"", ""correct_option"": ""C""}","Additional examinations","What is the primary role of testicular ultrasound coupled with Doppler in cases of suspected spermatic cord torsion?","To confirm the diagnosis of cord torsion with high sensitivity and specificity","To delay emergency surgical management and observe the patient","To guide the diagnosis when there is doubt, particularly in atypical presentations or after 24 hours of scrotal pain","To rule out all other possible causes of scrotal pain, including orchi-epididymitis","c"
"OIC-051-01-A","{""question"": ""What is the primary purpose of a 48-hour voiding diary in the diagnostic approach to mictional disorders in children?"", ""option_a"": ""To assess the child's psychomotor and statural development"", ""option_b"": ""To confirm and quantify pollakiuria, and assess the severity of urinary incontinence"", ""option_c"": ""To examine the external genitalia for signs of pathology"", ""option_d"": ""To conduct a complete neurological examination"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary purpose of a 48-hour voiding diary in the diagnostic approach to mictional disorders in children?","To assess the child's psychomotor and statural development","To confirm and quantify pollakiuria, and assess the severity of urinary incontinence","To examine the external genitalia for signs of pathology","To conduct a complete neurological examination","b"
"OIC-051-02-B","{""question"": ""In the diagnostic approach to micturition disorders in children, when are investigations considered useful?"", ""option_a"": ""In all cases of micturition disorders to rule out underlying conditions"", ""option_b"": ""Only in cases of resistant mictional disorders"", ""option_c"": ""During the first consultation to establish a primary diagnosis"", ""option_d"": ""When urinary tract infections are suspected, regardless of the severity of symptoms"", ""correct_option"": ""B""}","Complementary examinations","In the diagnostic approach to micturition disorders in children, when are investigations considered useful?","In all cases of micturition disorders to rule out underlying conditions","Only in cases of resistant mictional disorders","During the first consultation to establish a primary diagnosis","When urinary tract infections are suspected, regardless of the severity of symptoms","b"
"OIC-051-03-A","{""question"": ""What is the first step in the diagnostic approach for micturition disorders in children?"", ""option_a"": ""To look for secondary micturition disorders"", ""option_b"": ""To eliminate what is not a micturition disorder"", ""option_c"": ""To diagnose primary micturition disorders immediately"", ""option_d"": ""To treat the disorder based on symptoms alone"", ""correct_option"": ""B""}","Etiologies","What is the first step in the diagnostic approach for micturition disorders in children?","To look for secondary micturition disorders","To eliminate what is not a micturition disorder","To diagnose primary micturition disorders immediately","To treat the disorder based on symptoms alone","b"
"OIC-051-04-B","{""question"": ""In children with micturition disorders, which of the following conditions is commonly associated with voiding problems?"", ""option_a"": ""Sleep disorders such as insomnia"", ""option_b"": ""Nocturnal respiratory disorders like upper airway obstruction"", ""option_c"": ""Gastrointestinal problems like constipation"", ""option_d"": ""Neurological problems like cerebral palsy"", ""correct_option"": ""B""}","Etiologies","In children with micturition disorders, which of the following conditions is commonly associated with voiding problems?","Sleep disorders such as insomnia","Nocturnal respiratory disorders like upper airway obstruction","Gastrointestinal problems like constipation","Neurological problems like cerebral palsy","b"
"OIC-051-05-B","{""question"": ""What is the primary characteristic of bladder instability or overactive bladder in children?"", ""option_a"": ""A complete loss of bladder control resulting in permanent urine leakage"", ""option_b"": ""Abnormal contractions of the detrusor during the bladder filling phase"", ""option_c"": ""An inability to urinate due to abdominal thrust during micturition"", ""option_d"": ""A normal frequency of urination with occasional nocturnal enuresis"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic of bladder instability or overactive bladder in children?","A complete loss of bladder control resulting in permanent urine leakage","Abnormal contractions of the detrusor during the bladder filling phase","An inability to urinate due to abdominal thrust during micturition","A normal frequency of urination with occasional nocturnal enuresis","b"
"OIC-051-06-A","{""question"": ""What is the primary criterion for diagnosing primary enuresis in children?"", ""option_a"": ""The child has had a period of continence during sleep of at least six months in the past"", ""option_b"": ""The child has never had a period of continence during sleep of at least six months"", ""option_c"": ""The presence of other symptoms affecting the lower urinary tract, such as urgency or dysuria"", ""option_d"": ""A family history of enuresis is present"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary criterion for diagnosing primary enuresis in children?","The child has had a period of continence during sleep of at least six months in the past","The child has never had a period of continence during sleep of at least six months","The presence of other symptoms affecting the lower urinary tract, such as urgency or dysuria","A family history of enuresis is present","b"
"OIC-056-01-A","{""question"": ""According to the International Classification of Functioning (ICF), what is disability in children defined as?"", ""option_a"": ""A permanent condition resulting from a state of health that cannot be changed"", ""option_b"": ""A situation resulting from the interaction between state of health, activities, participation, environmental and personal factors"", ""option_c"": ""A condition where a child has one or more impairments but is still able to participate fully in age-related activities"", ""option_d"": ""A diagnosis made solely based on the presence of a musculoskeletal growth anomaly or paediatric pathology"", ""correct_option"": ""B""}","Definition","According to the International Classification of Functioning (ICF), what is disability in children defined as?","A permanent condition resulting from a state of health that cannot be changed","A situation resulting from the interaction between state of health, activities, participation, environmental and personal factors","A condition where a child has one or more impairments but is still able to participate fully in age-related activities","A diagnosis made solely based on the presence of a musculoskeletal growth anomaly or paediatric pathology","b"
"OIC-056-02-A","{""question"": ""What term is used to describe the coexistence of several impairments in the same child?"", ""option_a"": ""Surhandicap"", ""option_b"": ""Multi-disability or multi-handicap"", ""option_c"": ""Multiple disability"", ""option_d"": ""Congenital disability"", ""correct_option"": ""B""}","Definition","What term is used to describe the coexistence of several impairments in the same child?","Surhandicap","Multi-disability or multi-handicap","Multiple disability","Congenital disability","b"
"OIC-056-03-A","{""question"": ""What is the primary objective of a multidisciplinary and coordinated functional assessment in a disabled child?"", ""option_a"": ""To diagnose the child's disability as quickly as possible"", ""option_b"": ""To identify the needs of the child and their family, and support their development"", ""option_c"": ""To focus solely on the child's impairment and activity limitations"", ""option_d"": ""To prioritize the assessment of environmental factors over personal factors"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary objective of a multidisciplinary and coordinated functional assessment in a disabled child?","To diagnose the child's disability as quickly as possible","To identify the needs of the child and their family, and support their development","To focus solely on the child's impairment and activity limitations","To prioritize the assessment of environmental factors over personal factors","b"
"OIC-056-04-A","{""question"": ""What is the primary aim of supporting children with disabilities and their families?"", ""option_a"": ""To provide medical treatment and therapy only"", ""option_b"": ""To encourage the development of their skills and participation in family and societal life, and promote their quality of life"", ""option_c"": ""To focus solely on educational support through schooling"", ""option_d"": ""To prioritize financial assistance over other forms of support"", ""correct_option"": ""B""}","Support","What is the primary aim of supporting children with disabilities and their families?","To provide medical treatment and therapy only","To encourage the development of their skills and participation in family and societal life, and promote their quality of life","To focus solely on educational support through schooling","To prioritize financial assistance over other forms of support","b"
"OIC-056-05-A","{""question"": ""What is the primary goal of multidisciplinary care for a disabled child?"", ""option_a"": ""To focus solely on the medical treatment of the child's disability"", ""option_b"": ""To enable the child to participate as much as possible in family life and society through a comprehensive care plan"", ""option_c"": ""To prioritize the needs of the family over those of the child"", ""option_d"": ""To delay intervention until a formal diagnosis is made"", ""correct_option"": ""B""}","Taking charge","What is the primary goal of multidisciplinary care for a disabled child?","To focus solely on the medical treatment of the child's disability","To enable the child to participate as much as possible in family life and society through a comprehensive care plan","To prioritize the needs of the family over those of the child","To delay intervention until a formal diagnosis is made","b"
"OIC-056-06-A","{""question"": ""What is the primary role of the MDPH (Maison D\u00e9partementale des Personnes en Situation de Handicap) in relation to disabled children and their families?"", ""option_a"": ""To provide direct medical care and treatment to children with disabilities"", ""option_b"": ""To welcome and inform disabled people and their families, and to facilitate the completion of a file for assessment and support"", ""option_c"": ""To provide financial benefits exclusively, such as AEEH and PCH, without any assessment or support process"", ""option_d"": ""To act solely as a referral service to care facilities without any involvement in the assessment or support planning process"", ""correct_option"": ""B""}","Definition","What is the primary role of the MDPH (Maison Départementale des Personnes en Situation de Handicap) in relation to disabled children and their families?","To provide direct medical care and treatment to children with disabilities","To welcome and inform disabled people and their families, and to facilitate the completion of a file for assessment and support","To provide financial benefits exclusively, such as AEEH and PCH, without any assessment or support process","To act solely as a referral service to care facilities without any involvement in the assessment or support planning process","b"
"OIC-056-08-B","{""question"": ""What is the primary basis for aetiological orientation in the context of disability?"", ""option_a"": ""Only the systems affected, such as central or peripheral motor impairment"", ""option_b"": ""Only the age of onset of the disorders, such as antenatal, neonatal, or post-natal"", ""option_c"": ""The systems affected, the age of onset of the disorders, and their course"", ""option_d"": ""Only genetic causes, such as malformations or chromosomal abnormalities"", ""correct_option"": ""C""}","Etiologies","What is the primary basis for aetiological orientation in the context of disability?","Only the systems affected, such as central or peripheral motor impairment","Only the age of onset of the disorders, such as antenatal, neonatal, or post-natal","The systems affected, the age of onset of the disorders, and their course","Only genetic causes, such as malformations or chromosomal abnormalities","c"
"OIC-056-09-B","{""question"": ""What is the primary goal of the Projet personnalis\u00e9 de scolarisation (PPS) for a child with a disability?"", ""option_a"": ""To determine the type of medical and social services required"", ""option_b"": ""To define the specific needs of a child with a disability during their schooling"", ""option_c"": ""To decide on the admission to medical-social establishments"", ""option_d"": ""To assess the suitability of a child for mainstream schooling"", ""correct_option"": ""B""}",,"What is the primary goal of the Projet personnalisé de scolarisation (PPS) for a child with a disability?","To determine the type of medical and social services required","To define the specific needs of a child with a disability during their schooling","To decide on the admission to medical-social establishments","To assess the suitability of a child for mainstream schooling","b"
"OIC-070-01-A","{""question"": ""What is the threshold age for considering psychiatric disorders in the context of psychiatry of the elderly?"", ""option_a"": ""55"", ""option_b"": ""60"", ""option_c"": ""65"", ""option_d"": ""70"", ""correct_option"": ""C""}","Definition","What is the threshold age for considering psychiatric disorders in the context of psychiatry of the elderly?",55,60,65,70,"c"
"OIC-070-02-B","{""question"": ""What is the approximate prevalence of anxiety disorders in elderly subjects?"", ""option_a"": ""Less than 5%"", ""option_b"": ""Around 5-8%"", ""option_c"": ""More than 10%"", ""option_d"": ""Less than 1%"", ""correct_option"": ""C""}","Epidemiology","What is the approximate prevalence of anxiety disorders in elderly subjects?","Less than 5%","Around 5-8%","More than 10%","Less than 1%","c"
"OIC-070-03-B","{""question"": ""What percentage of patients with Alzheimer's disease or other dementias exhibit psychological and behavioural symptoms of dementia (BPSD)?"", ""option_a"": ""Less than 20%"", ""option_b"": ""Around 50%"", ""option_c"": ""Over 80%"", ""option_d"": ""Nearly 100%"", ""correct_option"": ""C""}",,"What percentage of patients with Alzheimer's disease or other dementias exhibit psychological and behavioural symptoms of dementia (BPSD)?","Less than 20%","Around 50%","Over 80%","Nearly 100%","c"
"OIC-070-04-B","{""question"": ""What is the primary treatment approach for Behavioral and Psychological Symptoms of Dementia (BPSD) in elderly patients?"", ""option_a"": ""Serotonergic antidepressants as first-line treatment"", ""option_b"": ""Second-generation antipsychotics as first-line treatment"", ""option_c"": ""Comprehensive management with priority given to non-drug approaches"", ""option_d"": ""Thymoregulators as the mainstay of treatment"", ""correct_option"": ""C""}","Epidemiology","What is the primary treatment approach for Behavioral and Psychological Symptoms of Dementia (BPSD) in elderly patients?","Serotonergic antidepressants as first-line treatment","Second-generation antipsychotics as first-line treatment","Comprehensive management with priority given to non-drug approaches","Thymoregulators as the mainstay of treatment","c"
"OIC-070-05-A","{""question"": ""What is a key difference in the presentation of depression in the elderly compared to young people?"", ""option_a"": ""The diagnostic criteria for depression are entirely different in the elderly"", ""option_b"": ""Atypical depression in the elderly is characterized by psychiatric symptoms only"", ""option_c"": ""Atypical depression in the elderly has specific features, including general, non-psychiatric symptoms such as complaints of pain and gastrointestinal symptoms"", ""option_d"": ""Depression in the elderly never presents with psychotic symptoms"", ""correct_option"": ""C""}","Positive diagnosis","What is a key difference in the presentation of depression in the elderly compared to young people?","The diagnostic criteria for depression are entirely different in the elderly","Atypical depression in the elderly is characterized by psychiatric symptoms only","Atypical depression in the elderly has specific features, including general, non-psychiatric symptoms such as complaints of pain and gastrointestinal symptoms","Depression in the elderly never presents with psychotic symptoms","c"
"OIC-070-06-A","{""question"": ""What are the common psycho-behavioural symptoms in demented elderly subjects?"", ""option_a"": ""Delusions, depressive symptoms, and anxiety symptoms"", ""option_b"": ""Agitation, aggressiveness, and inversion of the nycthemeral rhythm"", ""option_c"": ""All of the above, including hallucinations, apathy, and euphoria"", ""option_d"": ""Only visual hallucinations and depressive symptoms"", ""correct_option"": ""C""}","Positive diagnosis","What are the common psycho-behavioural symptoms in demented elderly subjects?","Delusions, depressive symptoms, and anxiety symptoms","Agitation, aggressiveness, and inversion of the nycthemeral rhythm","All of the above, including hallucinations, apathy, and euphoria","Only visual hallucinations and depressive symptoms","c"
"OIC-070-07-B","{""question"": ""When diagnosing mood disorders in the elderly, what should be eliminated as potential causes?"", ""option_a"": ""Psychiatric disorders, such as anxiety and personality disorders"", ""option_b"": ""Non-psychiatric medical pathologies, such as iatrogenic, ionic, metabolic, endocrine, neurological, and cardiovascular disorders"", ""option_c"": ""Neurodegenerative pathologies with only mild symptoms"", ""option_d"": ""Psychobehavioural symptoms of dementia without any other underlying conditions"", ""correct_option"": ""B""}","Positive diagnosis","When diagnosing mood disorders in the elderly, what should be eliminated as potential causes?","Psychiatric disorders, such as anxiety and personality disorders","Non-psychiatric medical pathologies, such as iatrogenic, ionic, metabolic, endocrine, neurological, and cardiovascular disorders","Neurodegenerative pathologies with only mild symptoms","Psychobehavioural symptoms of dementia without any other underlying conditions","b"
"OIC-070-08-B","{""question"": ""What is an essential aspect of the clinical examination in elderly patients presenting with potential psychological disorders?"", ""option_a"": ""Only assessing psychiatric co-morbidities such as anxiety disorders and addictions"", ""option_b"": ""Looking for non-psychiatric co-morbidities like pain, cardiovascular pathologies, and neurological diseases, in addition to psychiatric ones"", ""option_c"": ""Focusing solely on complementary tests like CBC, blood ionogram, and ECG without a physical examination"", ""option_d"": ""Ignoring potential physical discomforts such as faecal impaction or a bladder globe"", ""correct_option"": ""B""}","Additional examinations","What is an essential aspect of the clinical examination in elderly patients presenting with potential psychological disorders?","Only assessing psychiatric co-morbidities such as anxiety disorders and addictions","Looking for non-psychiatric co-morbidities like pain, cardiovascular pathologies, and neurological diseases, in addition to psychiatric ones","Focusing solely on complementary tests like CBC, blood ionogram, and ECG without a physical examination","Ignoring potential physical discomforts such as faecal impaction or a bladder globe","b"
"OIC-070-09-A","{""question"": ""What is the recommended prescription duration for anxiolytics and hypnotics in elderly patients?"", ""option_a"": ""Up to 3 months"", ""option_b"": ""Limited to 4 weeks"", ""option_c"": ""At least 6 months"", ""option_d"": ""Until the symptoms disappear"", ""correct_option"": ""B""}","Management","What is the recommended prescription duration for anxiolytics and hypnotics in elderly patients?","Up to 3 months","Limited to 4 weeks","At least 6 months","Until the symptoms disappear","b"
"OIC-070-10-B","{""question"": ""When prescribing antidepressants to elderly patients, which of the following types of antidepressants are generally preferred due to their tolerability?"", ""option_a"": ""Tricyclics"", ""option_b"": ""SSRI and SNRI antidepressants, mirtazapine and mianserin"", ""option_c"": ""Monoamine Oxidase Inhibitors (MAOIs)"", ""option_d"": ""Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) only"", ""correct_option"": ""B""}","Management","When prescribing antidepressants to elderly patients, which of the following types of antidepressants are generally preferred due to their tolerability?","Tricyclics","SSRI and SNRI antidepressants, mirtazapine and mianserin","Monoamine Oxidase Inhibitors (MAOIs)","Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) only","b"
"OIC-073-01-A","{""question"": ""What is the primary purpose of psychotherapy?"", ""option_a"": ""To diagnose psychiatric disorders"", ""option_b"": ""To use psychological means to treat psychiatric disorders or other problems causing psychological suffering"", ""option_c"": ""To prescribe medication for psychiatric disorders"", ""option_d"": ""To provide a supportive environment for social interactions"", ""correct_option"": ""B""}","Definition","What is the primary purpose of psychotherapy?","To diagnose psychiatric disorders","To use psychological means to treat psychiatric disorders or other problems causing psychological suffering","To prescribe medication for psychiatric disorders","To provide a supportive environment for social interactions","b"
"OIC-073-02-A","{""question"": ""What is a necessary condition for a therapeutic approach to be considered psychotherapy?"", ""option_a"": ""A strong caregiver-patient relationship based on respect and empathy"", ""option_b"": ""A recognised scientific theory and clearly established indications"", ""option_c"": ""The presence of a supportive family and friends network"", ""option_d"": ""A practice that is restricted to a regulated medical framework"", ""correct_option"": ""B""}","Definition","What is a necessary condition for a therapeutic approach to be considered psychotherapy?","A strong caregiver-patient relationship based on respect and empathy","A recognised scientific theory and clearly established indications","The presence of a supportive family and friends network","A practice that is restricted to a regulated medical framework","b"
"OIC-073-03-B","{""question"": ""Who can automatically be considered a psychotherapist?"", ""option_a"": ""Non-psychiatrist medical doctors with theoretical training in psychopathology"", ""option_b"": ""Psychoanalysts with practical training in psychotherapy"", ""option_c"": ""Psychiatrists and clinical psychologists"", ""option_d"": ""Private psychologists without any additional training"", ""correct_option"": ""C""}","Definition","Who can automatically be considered a psychotherapist?","Non-psychiatrist medical doctors with theoretical training in psychopathology","Psychoanalysts with practical training in psychotherapy","Psychiatrists and clinical psychologists","Private psychologists without any additional training","c"
"OIC-073-04-A","{""question"": ""What is the primary focus of Cognitive Behavioural Therapies (CBT)?"", ""option_a"": ""Unconscious conflicts from childhood"", ""option_b"": ""Identifying and changing inappropriate learned behaviour, dysfunctional cognition, and difficulties in emotional regulation"", ""option_c"": ""Rebalancing family or couple dynamics through improved communication and interrelationships"", ""option_d"": ""Helping patients acquire skills to manage their lives with a chronic disease"", ""correct_option"": ""Option B""}","Definition","What is the primary focus of Cognitive Behavioural Therapies (CBT)?","Unconscious conflicts from childhood","Identifying and changing inappropriate learned behaviour, dysfunctional cognition, and difficulties in emotional regulation","Rebalancing family or couple dynamics through improved communication and interrelationships","Helping patients acquire skills to manage their lives with a chronic disease","option b"
"OIC-073-05-B","{""question"": ""What is a fundamental aspect that underlies all psychotherapies, regardless of their specific techniques or approaches?"", ""option_a"": ""The use of medication as a primary intervention method"", ""option_b"": ""A therapeutic framework that includes objective, duration, tools, limits, and a quality psychotherapist/patient relationship"", ""option_c"": ""The exclusion of patient involvement in the therapeutic process"", ""option_d"": ""The focus solely on behavioral learning, excluding cognitive and affective aspects"", ""correct_option"": ""B""}","Taking charge","What is a fundamental aspect that underlies all psychotherapies, regardless of their specific techniques or approaches?","The use of medication as a primary intervention method","A therapeutic framework that includes objective, duration, tools, limits, and a quality psychotherapist/patient relationship","The exclusion of patient involvement in the therapeutic process","The focus solely on behavioral learning, excluding cognitive and affective aspects","b"
"OIC-073-06-B","{""question"": ""What is the primary goal of supportive psychotherapy?"", ""option_a"": ""To accompany a patient through a stressful life situation and help them express painful emotions"", ""option_b"": ""To encourage a patient to confront their fears and anxieties directly"", ""option_c"": ""To help a patient understand and resolve unconscious conflicts"", ""option_d"": ""To teach a patient specific skills and techniques to manage their symptoms"", ""correct_option"": ""A""}","Taking charge","What is the primary goal of supportive psychotherapy?","To accompany a patient through a stressful life situation and help them express painful emotions","To encourage a patient to confront their fears and anxieties directly","To help a patient understand and resolve unconscious conflicts","To teach a patient specific skills and techniques to manage their symptoms","a"
"OIC-073-07-B","{""question"": ""What is the primary focus of the third wave of cognitive-behavioural therapies, which emerged after 2000?"", ""option_a"": ""Classical and operant conditioning to address inappropriate learned behaviour"", ""option_b"": ""Dysfunctional cognitive patterns and their impact on behaviour"", ""option_c"": ""Emotional regulation and acceptance to enable cognition and behaviour modification"", ""option_d"": ""Social skills training and self-affirmation techniques"", ""correct_option"": ""C""}","Management","What is the primary focus of the third wave of cognitive-behavioural therapies, which emerged after 2000?","Classical and operant conditioning to address inappropriate learned behaviour","Dysfunctional cognitive patterns and their impact on behaviour","Emotional regulation and acceptance to enable cognition and behaviour modification","Social skills training and self-affirmation techniques","c"
"OIC-073-08-B","{""question"": ""What is the primary aim of cognitive remediation?"", ""option_a"": ""To reduce symptoms of anxiety and depression"", ""option_b"": ""To improve functional disability linked to cognitive impairment"", ""option_c"": ""To enhance neuropsychological testing methods"", ""option_d"": ""To develop new neurology treatments"", ""correct_option"": ""B""}","Taking charge","What is the primary aim of cognitive remediation?","To reduce symptoms of anxiety and depression","To improve functional disability linked to cognitive impairment","To enhance neuropsychological testing methods","To develop new neurology treatments","b"
"OIC-073-09-B","{""question"": ""What type of psychotherapy is recommended for patients with severe or decompensated psychotic disorders?"", ""option_a"": ""Psychodynamic psychotherapy"", ""option_b"": ""Cognitive-behavioural therapy"", ""option_c"": ""Supportive psychotherapy"", ""option_d"": ""Family / systemic therapies"", ""correct_option"": ""C""}",,"What type of psychotherapy is recommended for patients with severe or decompensated psychotic disorders?","Psychodynamic psychotherapy","Cognitive-behavioural therapy","Supportive psychotherapy","Family / systemic therapies","c"
"OIC-074-01-A","{""question"": ""What is the primary effect of psychotropic drugs on the human body?"", ""option_a"": ""They modify physical activity"", ""option_b"": ""They have no effect on mental activity"", ""option_c"": ""They modify mental activity"", ""option_d"": ""They only affect the nervous system"", ""correct_option"": ""C""}","Definition","What is the primary effect of psychotropic drugs on the human body?","They modify physical activity","They have no effect on mental activity","They modify mental activity","They only affect the nervous system","c"
"OIC-074-02-B","{""question"": ""What percentage of anxiolytic users in France are women, according to the given data?"", ""option_a"": ""49%"", ""option_b"": ""59%"", ""option_c"": ""69%"", ""option_d"": ""79%"", ""correct_option"": ""C""}","Epidemiology","What percentage of anxiolytic users in France are women, according to the given data?","49%","59%","69%","79%","c"
"OIC-074-03-A","{""question"": ""What is the primary mechanism of action of antipsychotic substances?"", ""option_a"": ""Agonistic action on D2 dopamine receptors"", ""option_b"": ""Antagonistic action on D2 dopamine receptors"", ""option_c"": ""Stimulation of serotonin receptors"", ""option_d"": ""Inhibition of norepinephrine reuptake"", ""correct_option"": ""B""}","Definition","What is the primary mechanism of action of antipsychotic substances?","Agonistic action on D2 dopamine receptors","Antagonistic action on D2 dopamine receptors","Stimulation of serotonin receptors","Inhibition of norepinephrine reuptake","b"
"OIC-074-04-B","{""question"": ""What is a common indication for the use of antipsychotics in mood disorders?"", ""option_a"": ""Severe manic episode without psychotic symptoms, for all antipsychotic products"", ""option_b"": ""Severe manic episode with or without psychotic symptoms"", ""option_c"": ""Mild depressive episode without psychotic symptoms"", ""option_d"": ""Bipolar depressive episode, for all antipsychotic products"", ""correct_option"": ""B""}","Management","What is a common indication for the use of antipsychotics in mood disorders?","Severe manic episode without psychotic symptoms, for all antipsychotic products","Severe manic episode with or without psychotic symptoms","Mild depressive episode without psychotic symptoms","Bipolar depressive episode, for all antipsychotic products","b"
"OIC-074-05-B","{""question"": ""What is a key principle in the 'rules for the proper use' of antipsychotics, particularly in relation to minimizing side effects and ensuring efficacy?"", ""option_a"": ""Always combining two antipsychotics for enhanced efficacy"", ""option_b"": ""Favouring the drug with the fewest side effects and aiming for monotherapy with the minimum effective dose"", ""option_c"": ""Prioritizing first-generation antipsychotics due to their lower cost"", ""option_d"": "" Routinely using the intramuscular route for administration in all patients"", ""correct_option"": ""B""}","Management","What is a key principle in the 'rules for the proper use' of antipsychotics, particularly in relation to minimizing side effects and ensuring efficacy?","Always combining two antipsychotics for enhanced efficacy","Favouring the drug with the fewest side effects and aiming for monotherapy with the minimum effective dose","Prioritizing first-generation antipsychotics due to their lower cost"," Routinely using the intramuscular route for administration in all patients","b"
"OIC-074-06-B","{""question"": ""What is a rare and serious adverse effect associated with most antipsychotic molecules that involves vital prognosis?"", ""option_a"": ""Hyperthermia"", ""option_b"": ""Neuroleptic malignant syndrome"", ""option_c"": ""Metabolic syndrome"", ""option_d"": ""Parkinsonian syndrome"", ""correct_option"": ""B""}","Management","What is a rare and serious adverse effect associated with most antipsychotic molecules that involves vital prognosis?","Hyperthermia","Neuroleptic malignant syndrome","Metabolic syndrome","Parkinsonian syndrome","b"
"OIC-074-07-A","{""question"": ""What is the preferred route of administration for antipsychotics in emergency situations when possible?"", ""option_a"": ""Intramuscularly"", ""option_b"": ""Intravenously"", ""option_c"": ""Per os"", ""option_d"": ""Subcutaneously"", ""correct_option"": ""C""}","Emergency identification","What is the preferred route of administration for antipsychotics in emergency situations when possible?","Intramuscularly","Intravenously","Per os","Subcutaneously","c"
"OIC-074-08-A","{""question"": ""Which of the following antidepressants is classified as a serotonin and norepinephrine reuptake inhibitor (SNRI)?"", ""option_a"": ""Fluoxetine"", ""option_b"": ""Venlafaxine"", ""option_c"": ""Amitriptyline"", ""option_d"": ""Vortioxetine"", ""correct_option"": ""B""}","Definition","Which of the following antidepressants is classified as a serotonin and norepinephrine reuptake inhibitor (SNRI)?","Fluoxetine","Venlafaxine","Amitriptyline","Vortioxetine","b"
"OIC-074-09-A","{""question"": ""What is a common indication for the use of antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs)?"", ""option_a"": ""Adjustment disorder"", ""option_b"": ""Characterised depressive episode"", ""option_c"": ""Epilepsy"", ""option_d"": ""Pregnancy and breastfeeding"", ""correct_option"": ""B""}","Management","What is a common indication for the use of antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs)?","Adjustment disorder","Characterised depressive episode","Epilepsy","Pregnancy and breastfeeding","b"
"OIC-074-10-B","{""question"": ""What is the recommended initial dose of antidepressants for elderly patients?"", ""option_a"": ""The same dose as used in adults"", ""option_b"": ""Half the dose used in adults, with doses gradually increased"", ""option_c"": ""Double the dose used in adults"", ""option_d"": ""A quarter of the dose used in adults"", ""correct_option"": ""B""}","Management","What is the recommended initial dose of antidepressants for elderly patients?","The same dose as used in adults","Half the dose used in adults, with doses gradually increased","Double the dose used in adults","A quarter of the dose used in adults","b"
"OIC-074-11-A","{""question"": ""What is a potential serious adverse effect of combining several antidepressants or antidepressants with certain other medications?"", ""option_a"": ""Manic mood swings"", ""option_b"": ""Serotonin syndrome"", ""option_c"": ""Sexual disorders"", ""option_d"": ""Digestive effects"", ""correct_option"": ""B""}",,"What is a potential serious adverse effect of combining several antidepressants or antidepressants with certain other medications?","Manic mood swings","Serotonin syndrome","Sexual disorders","Digestive effects","b"
"OIC-074-12-A","{""question"": ""What is a characteristic of benzodiazepines as a class of anxiolytics?"", ""option_a"": ""They have a delayed action, typically after one week's treatment"", ""option_b"": ""They are known for having no risk of dependency"", ""option_c"": ""They are fast-acting, right from the first dose, but carry a risk of problems with use and pharmacological tolerance"", ""option_d"": ""They are primarily used for their anticonvulsant properties"", ""correct_option"": ""C""}","Definition","What is a characteristic of benzodiazepines as a class of anxiolytics?","They have a delayed action, typically after one week's treatment","They are known for having no risk of dependency","They are fast-acting, right from the first dose, but carry a risk of problems with use and pharmacological tolerance","They are primarily used for their anticonvulsant properties","c"
"OIC-074-13-A","{""question"": ""What is a key consideration when prescribing benzodiazepine anxiolytics to elderly patients?"", ""option_a"": ""Start with a high dosage to ensure efficacy"", ""option_b"": ""Maintain a low dosage and regularly reassess the need for treatment"", ""option_c"": ""Avoid regular reassessment of treatment efficacy and safety"", ""option_d"": ""Increase dosage over time to account for potential tolerance"", ""correct_option"": ""B""}","Management","What is a key consideration when prescribing benzodiazepine anxiolytics to elderly patients?","Start with a high dosage to ensure efficacy","Maintain a low dosage and regularly reassess the need for treatment","Avoid regular reassessment of treatment efficacy and safety","Increase dosage over time to account for potential tolerance","b"
"OIC-074-14-A","{""question"": ""What is the recommended approach when stopping benzodiazepine treatment, particularly in elderly subjects?"", ""option_a"": ""Stop the treatment abruptly to avoid withdrawal symptoms"", ""option_b"": ""Discontinue the treatment immediately if the patient shows no signs of improvement"", ""option_c"": ""Gradually discontinue the treatment over a period of several weeks to several months"", ""option_d"": ""Replace benzodiazepines with another psychotropic drug to manage potential withdrawal symptoms"", ""correct_option"": ""C""}","Management","What is the recommended approach when stopping benzodiazepine treatment, particularly in elderly subjects?","Stop the treatment abruptly to avoid withdrawal symptoms","Discontinue the treatment immediately if the patient shows no signs of improvement","Gradually discontinue the treatment over a period of several weeks to several months","Replace benzodiazepines with another psychotropic drug to manage potential withdrawal symptoms","c"
"OIC-074-15-A","{""question"": ""What is a potential adverse effect of benzodiazepines that is particularly concerning in elderly patients?"", ""option_a"": ""Sedation and daytime sleepiness"", ""option_b"": ""Cognitive alterations, including confusion"", ""option_c"": ""Nausea and headache"", ""option_d"": ""QT prolongation"", ""correct_option"": ""B""}","Management","What is a potential adverse effect of benzodiazepines that is particularly concerning in elderly patients?","Sedation and daytime sleepiness","Cognitive alterations, including confusion","Nausea and headache","QT prolongation","b"
"OIC-074-16-A","{""question"": ""What is the preferred route of administration for benzodiazepines in emergency situations, especially when considering their bioavailability?"", ""option_a"": ""Intramuscular (IM) due to its rapid absorption"", ""option_b"": ""Intravenous (IV) for severe cases such as alcohol withdrawal syndrome"", ""option_c"": ""Oral, as it is the most common and effective route for benzodiazepines"", ""option_d"": ""Sublingual, to avoid first-pass metabolism"", ""correct_option"": ""B""}","Management","What is the preferred route of administration for benzodiazepines in emergency situations, especially when considering their bioavailability?","Intramuscular (IM) due to its rapid absorption","Intravenous (IV) for severe cases such as alcohol withdrawal syndrome","Oral, as it is the most common and effective route for benzodiazepines","Sublingual, to avoid first-pass metabolism","b"
"OIC-074-17-A","{""question"": ""What is a key characteristic that distinguishes hypnotics from anxiolytics?"", ""option_a"": ""Their ability to induce sleep"", ""option_b"": ""Their lack of clinical sedative properties"", ""option_c"": ""Their chemical composition as antihistamines"", ""option_d"": ""Their primary use as antipsychotics"", ""correct_option"": ""A""}","Definition","What is a key characteristic that distinguishes hypnotics from anxiolytics?","Their ability to induce sleep","Their lack of clinical sedative properties","Their chemical composition as antihistamines","Their primary use as antipsychotics","a"
"OIC-074-18-A","{""question"": ""In which of the following situations is the use of zolpidem or zopiclone contraindicated?"", ""option_a"": ""In patients with acute transient insomnia"", ""option_b"": ""In children under 15 years of age"", ""option_c"": ""In patients with mild respiratory insufficiency"", ""option_d"": ""In patients with chronic insomnia who have tried other treatments"", ""correct_option"": ""B""}","Management","In which of the following situations is the use of zolpidem or zopiclone contraindicated?","In patients with acute transient insomnia","In children under 15 years of age","In patients with mild respiratory insufficiency","In patients with chronic insomnia who have tried other treatments","b"
"OIC-074-19-A","{""question"": ""What is the recommended duration for prescribing hypnotics to avoid the risk of pharmacological tolerance and use disorders?"", ""option_a"": ""Up to 3 months"", ""option_b"": ""Limited to 4 weeks"", ""option_c"": ""Up to 6 months"", ""option_d"": ""For an indefinite period, as needed"", ""correct_option"": ""B""}","Management","What is the recommended duration for prescribing hypnotics to avoid the risk of pharmacological tolerance and use disorders?","Up to 3 months","Limited to 4 weeks","Up to 6 months","For an indefinite period, as needed","b"
"OIC-074-20-A","{""question"": ""What potential adverse effects do zopiclone and zolpidem share with benzodiazepines, particularly in elderly patients?"", ""option_a"": ""Increased alertness and improved cognitive function"", ""option_b"": ""Pharmacological tolerance, use disorders, and rebound anxiety"", ""option_c"": ""Reduced risk of falls and improved sleep quality"", ""option_d"": ""Enhanced motor skills and decreased risk of dependence"", ""correct_option"": ""B""}","Management","What potential adverse effects do zopiclone and zolpidem share with benzodiazepines, particularly in elderly patients?","Increased alertness and improved cognitive function","Pharmacological tolerance, use disorders, and rebound anxiety","Reduced risk of falls and improved sleep quality","Enhanced motor skills and decreased risk of dependence","b"
"OIC-074-21-A","{""question"": ""What is the primary clinical action of thymoregulators, a class of psychotropic drugs?"", ""option_a"": ""To increase the frequency and intensity of thymic episodes"", ""option_b"": ""To reduce the frequency, duration, and intensity of thymic episodes"", ""option_c"": ""To completely eliminate thymic episodes"", ""option_d"": ""To have no effect on thymic episodes"", ""correct_option"": ""B""}","Definition","What is the primary clinical action of thymoregulators, a class of psychotropic drugs?","To increase the frequency and intensity of thymic episodes","To reduce the frequency, duration, and intensity of thymic episodes","To completely eliminate thymic episodes","To have no effect on thymic episodes","b"
"OIC-074-23-B","{""question"": ""What is a notable adverse effect of Lithium treatment?"", ""option_a"": ""Hypertension"", ""option_b"": ""Trembling"", ""option_c"": ""Hyperthyroidism"", ""option_d"": ""Tachycardia"", ""correct_option"": ""B""}","Management","What is a notable adverse effect of Lithium treatment?","Hypertension","Trembling","Hyperthyroidism","Tachycardia","b"
"OIC-074-24-A","{""question"": ""What are the primary psychostimulants used therapeutically in France?"", ""option_a"": ""Amphetamine and its derivatives"", ""option_b"": ""Methylphenidate and modafinil"", ""option_c"": ""Caffeine and nicotine"", ""option_d"": ""Cocaine and ecstasy"", ""correct_option"": ""B""}","Definition","What are the primary psychostimulants used therapeutically in France?","Amphetamine and its derivatives","Methylphenidate and modafinil","Caffeine and nicotine","Cocaine and ecstasy","b"
"OIC-074-25-B","{""question"": ""What is a main contraindication for the use of Methylphenidate in the treatment of ADHD or narcolepsy?"", ""option_a"": ""Unstable psychiatric disorders"", ""option_b"": ""Stable psychiatric disorders"", ""option_c"": ""Mild hypertension"", ""option_d"": ""Hyperactivity without attention deficit"", ""correct_option"": ""A""}","Management","What is a main contraindication for the use of Methylphenidate in the treatment of ADHD or narcolepsy?","Unstable psychiatric disorders","Stable psychiatric disorders","Mild hypertension","Hyperactivity without attention deficit","a"
"OIC-074-26-B","{""question"": ""What is a potential interaction between modafinil and other medications?"", ""option_a"": ""Modafinil enhances the effect of oral contraceptives"", ""option_b"": ""Modafinil has no significant interactions with other medications"", ""option_c"": ""Modafinil inactivates oral contraceptives"", ""option_d"": ""Modafinil increases the levels of ciclosporin in the blood"", ""correct_option"": ""C""}",,"What is a potential interaction between modafinil and other medications?","Modafinil enhances the effect of oral contraceptives","Modafinil has no significant interactions with other medications","Modafinil inactivates oral contraceptives","Modafinil increases the levels of ciclosporin in the blood","c"
"OIC-075-01-A","{""question"": ""What percentage of deaths from bronchopulmonary cancer are linked to smoking?"", ""option_a"": ""50%"", ""option_b"": ""60%"", ""option_c"": ""70%"", ""option_d"": ""80%"", ""correct_option"": ""D""}","Definition","What percentage of deaths from bronchopulmonary cancer are linked to smoking?","50%","60%","70%","80%","d"
"OIC-075-02-A","{""question"": ""What is the primary agent responsible for causing addiction in tobacco users?"", ""option_a"": ""Tar"", ""option_b"": ""Nicotine"", ""option_c"": ""Carbon monoxide"", ""option_d"": ""Tobacco itself"", ""correct_option"": ""B""}","Definition","What is the primary agent responsible for causing addiction in tobacco users?","Tar","Nicotine","Carbon monoxide","Tobacco itself","b"
"OIC-075-03-B","{""question"": ""What is the basic composition of the substance inhaled from an electronic cigarette?"", ""option_a"": ""Nicotine and water"", ""option_b"": ""Mixture of propylene glycol, nicotine, water, flavourings, and glycerol"", ""option_c"": ""Only glycerol and flavourings"", ""option_d"": ""Tobacco and nicotine"", ""correct_option"": ""B""}","Definition","What is the basic composition of the substance inhaled from an electronic cigarette?","Nicotine and water","Mixture of propylene glycol, nicotine, water, flavourings, and glycerol","Only glycerol and flavourings","Tobacco and nicotine","b"
"OIC-075-04-B","{""question"": ""What is the primary agent responsible for addiction in tobacco smoke?"", ""option_a"": ""Tars"", ""option_b"": ""Carbon monoxide"", ""option_c"": ""Nicotine"", ""option_d"": ""Free radicals"", ""correct_option"": ""C""}",,"What is the primary agent responsible for addiction in tobacco smoke?","Tars","Carbon monoxide","Nicotine","Free radicals","c"
"OIC-075-05-B","{""question"": ""What is a consequence of tobacco smoke penetration into the bloodstream?"", ""option_a"": ""It only affects the respiratory system"", ""option_b"": ""It causes inflammatory phenomena and promotes platelet aggregation"", ""option_c"": ""It has no impact on the cardiovascular system"", ""option_d"": ""It only increases the risk of venous thrombosis"", ""correct_option"": ""B""}",,"What is a consequence of tobacco smoke penetration into the bloodstream?","It only affects the respiratory system","It causes inflammatory phenomena and promotes platelet aggregation","It has no impact on the cardiovascular system","It only increases the risk of venous thrombosis","b"
"OIC-075-06-A","{""question"": ""What is the primary risk factor for tobacco-related health issues, according to the given information?"", ""option_a"": ""The age at which smoking begins"", ""option_b"": ""The duration of intoxication"", ""option_c"": ""The percentage of daily smokers"", ""option_d"": ""The dose of tobacco consumed"", ""correct_option"": ""B""}","Epidemiology","What is the primary risk factor for tobacco-related health issues, according to the given information?","The age at which smoking begins","The duration of intoxication","The percentage of daily smokers","The dose of tobacco consumed","b"
"OIC-075-07-B","{""question"": ""What was the overall trend in smoking prevalence between 2017 and 2018?"", ""option_a"": ""A significant increase in overall smoking"", ""option_b"": ""A slight decrease in overall smoking"", ""option_c"": ""No change in overall smoking"", ""option_d"": ""A significant decrease in overall smoking"", ""correct_option"": ""B""}","Epidemiology","What was the overall trend in smoking prevalence between 2017 and 2018?","A significant increase in overall smoking","A slight decrease in overall smoking","No change in overall smoking","A significant decrease in overall smoking","b"
"OIC-075-08-A","{""question"": ""According to the 2019 data, what percentage of women aged 18 to 75 reported smoking tobacco?"", ""option_a"": ""30.4%"", ""option_b"": ""26.5%"", ""option_c"": ""34.6%"", ""option_d"": ""40.8%"", ""correct_option"": ""B""}","Epidemiology","According to the 2019 data, what percentage of women aged 18 to 75 reported smoking tobacco?","30.4%","26.5%","34.6%","40.8%","b"
"OIC-075-09-A","{""question"": ""At what age does tobacco experimentation often begin among young people, potentially leading to daily consumption?"", ""option_a"": ""10 years old"", ""option_b"": ""12 years old"", ""option_c"": ""14 years old"", ""option_d"": ""16 years old"", ""correct_option"": ""C""}","Epidemiology","At what age does tobacco experimentation often begin among young people, potentially leading to daily consumption?","10 years old","12 years old","14 years old","16 years old","c"
"OIC-075-10-A","{""question"": ""What proportion of pregnant women are likely to continue smoking during pregnancy, particularly among which demographic groups?"", ""option_a"": ""About a quarter, more frequently among older and highly educated women"", ""option_b"": ""Half, more frequently among the youngest and least educated women"", ""option_c"": ""Almost all, with no significant difference across age or education levels"", ""option_d"": ""Less than a tenth, predominantly among women with higher incomes"", ""correct_option"": ""B""}","Epidemiology","What proportion of pregnant women are likely to continue smoking during pregnancy, particularly among which demographic groups?","About a quarter, more frequently among older and highly educated women","Half, more frequently among the youngest and least educated women","Almost all, with no significant difference across age or education levels","Less than a tenth, predominantly among women with higher incomes","b"
"OIC-075-11-A","{""question"": ""What was the trend in overall smoking rates from 2017 to 2018?"", ""option_a"": ""Slight increase"", ""option_b"": ""No change"", ""option_c"": ""Slight decrease"", ""option_d"": ""Significant decrease"", ""correct_option"": ""A""}","Epidemiology","What was the trend in overall smoking rates from 2017 to 2018?","Slight increase","No change","Slight decrease","Significant decrease","a"
"OIC-075-12-A","{""question"": ""What percentage of all cancer cases is attributed to tobacco?"", ""option_a"": ""10%"", ""option_b"": ""15%"", ""option_c"": ""25%"", ""option_d"": ""30%"", ""correct_option"": ""C""}","Epidemiology","What percentage of all cancer cases is attributed to tobacco?","10%","15%","25%","30%","c"
"OIC-075-13-A","{""question"": ""What is the primary avoidable cause of death in France, resulting in approximately how many deaths per year?"", ""option_a"": ""Alcohol consumption, resulting in 50,000 deaths/year"", ""option_b"": ""Smoking, resulting in 75,000 deaths/year"", ""option_c"": ""Physical inactivity, resulting in 60,000 deaths/year"", ""option_d"": ""Unhealthy diet, resulting in 80,000 deaths/year"", ""correct_option"": ""B""}","Epidemiology","What is the primary avoidable cause of death in France, resulting in approximately how many deaths per year?","Alcohol consumption, resulting in 50,000 deaths/year","Smoking, resulting in 75,000 deaths/year","Physical inactivity, resulting in 60,000 deaths/year","Unhealthy diet, resulting in 80,000 deaths/year","b"
"OIC-075-14-A","{""question"": ""What is the estimated annual number of deaths in France attributed to tobacco use?"", ""option_a"": ""50,000"", ""option_b"": ""75,000"", ""option_c"": ""100,000"", ""option_d"": ""125,000"", ""correct_option"": ""B""}","Epidemiology","What is the estimated annual number of deaths in France attributed to tobacco use?","50,000","75,000","100,000","125,000","b"
"OIC-075-15-A","{""question"": ""What is the primary effect of carbon monoxide (CO) from smoking on the cardiovascular system?"", ""option_a"": ""It reduces the risk of coronary heart disease"", ""option_b"": ""It is responsible for cardiovascular disorders"", ""option_c"": ""It lowers blood pressure and reduces the risk of hypertension"", ""option_d"": ""It has no direct impact on cardiovascular mortality"", ""correct_option"": ""B""}","Epidemiology","What is the primary effect of carbon monoxide (CO) from smoking on the cardiovascular system?","It reduces the risk of coronary heart disease","It is responsible for cardiovascular disorders","It lowers blood pressure and reduces the risk of hypertension","It has no direct impact on cardiovascular mortality","b"
"OIC-075-16-A","{""question"": ""What was the percentage decrease in the proportion of smokers in 2017 and 2018?"", ""option_a"": ""5%"", ""option_b"": ""8%"", ""option_c"": ""12%"", ""option_d"": ""15%"", ""correct_option"": ""C""}","Epidemiology","What was the percentage decrease in the proportion of smokers in 2017 and 2018?","5%","8%","12%","15%","c"
"OIC-075-17-A","{""question"": ""What is a known non-psychiatric medical complication related to passive smoking?"", ""option_a"": ""Ischaemic heart disease"", ""option_b"": ""Chronic hepatitis"", ""option_c"": ""Diabetes mellitus type 2"", ""option_d"": ""Osteoporosis"", ""correct_option"": ""A""}","Epidemiology","What is a known non-psychiatric medical complication related to passive smoking?","Ischaemic heart disease","Chronic hepatitis","Diabetes mellitus type 2","Osteoporosis","a"
"OIC-075-18-B","{""question"": ""According to the trend observed from 2000 onwards in France, what happened to the daily smoking rate among the most disadvantaged smokers?"", ""option_a"": ""It increased significantly among people with the lowest incomes and the unemployed"", ""option_b"": ""It remained stable among people with the lowest incomes but decreased among the unemployed"", ""option_c"": ""It decreased among people with the lowest incomes and the unemployed"", ""option_d"": ""It increased among the unemployed but remained stable among people with the lowest incomes"", ""correct_option"": ""C""}","Epidemiology","According to the trend observed from 2000 onwards in France, what happened to the daily smoking rate among the most disadvantaged smokers?","It increased significantly among people with the lowest incomes and the unemployed","It remained stable among people with the lowest incomes but decreased among the unemployed","It decreased among people with the lowest incomes and the unemployed","It increased among the unemployed but remained stable among people with the lowest incomes","c"
"OIC-075-19-A","{""question"": ""What is the primary goal of assessing tobacco consumption in all patients?"", ""option_a"": ""To determine the patient's risk of developing a smoking-related illness"", ""option_b"": ""To monitor the patient's progress in quitting smoking"", ""option_c"": ""To calculate the patient's Packs-Year (PA) score"", ""option_d"": ""To identify smokers and provide guidance on cessation"", ""correct_option"": ""D""}","Positive diagnosis","What is the primary goal of assessing tobacco consumption in all patients?","To determine the patient's risk of developing a smoking-related illness","To monitor the patient's progress in quitting smoking","To calculate the patient's Packs-Year (PA) score","To identify smokers and provide guidance on cessation","d"
"OIC-075-20-A","{""question"": ""According to the ICD-10 criteria, which of the following statements is true about tobacco dependence?"", ""option_a"": ""Tobacco dependence is diagnosed when a patient experiences at least one of the specified criteria."", ""option_b"": ""Tobacco dependence is diagnosed when a patient experiences at least 3 of the specified criteria, including strong desire to smoke and difficulties in controlling tobacco use."", ""option_c"": ""Tobacco dependence is diagnosed when a patient's tobacco use is harmful to their health but does not meet the criteria for dependence."", ""option_d"": ""Tobacco dependence is diagnosed when a patient experiences withdrawal syndrome as the sole criterion."", ""correct_option"": ""B""}","Positive diagnosis","According to the ICD-10 criteria, which of the following statements is true about tobacco dependence?","Tobacco dependence is diagnosed when a patient experiences at least one of the specified criteria.","Tobacco dependence is diagnosed when a patient experiences at least 3 of the specified criteria, including strong desire to smoke and difficulties in controlling tobacco use.","Tobacco dependence is diagnosed when a patient's tobacco use is harmful to their health but does not meet the criteria for dependence.","Tobacco dependence is diagnosed when a patient experiences withdrawal syndrome as the sole criterion.","b"
"OIC-075-21-A","{""question"": ""What is a common sign of smoking cessation that can lead to weight gain?"", ""option_a"": ""Depressed mood"", ""option_b"": ""Increased appetite"", ""option_c"": ""Irritability"", ""option_d"": ""Anxiety"", ""correct_option"": ""B""}","Positive diagnosis","What is a common sign of smoking cessation that can lead to weight gain?","Depressed mood","Increased appetite","Irritability","Anxiety","b"
"OIC-075-22-A","{""question"": ""What percentage of all cancers is attributed to tobacco?"", ""option_a"": ""10%"", ""option_b"": ""15%"", ""option_c"": ""25%"", ""option_d"": ""30%"", ""correct_option"": ""C""}","Positive diagnosis","What percentage of all cancers is attributed to tobacco?","10%","15%","25%","30%","c"
"OIC-075-23-B","{""question"": ""What percentage of patients with schizophrenia are smokers?"", ""option_a"": ""40%"", ""option_b"": ""56%"", ""option_c"": ""68%"", ""option_d"": ""82%"", ""correct_option"": ""D""}","Positive diagnosis","What percentage of patients with schizophrenia are smokers?","40%","56%","68%","82%","d"
"OIC-075-24-A","{""question"": ""What is the primary goal of motivational interviewing in the context of smoking cessation?"", ""option_a"": ""To prescribe medication for nicotine withdrawal"", ""option_b"": ""To arouse or reinforce the patient's motivation to change their smoking behavior"", ""option_c"": ""To provide written information about the dangers of smoking"", ""option_d"": ""To assess the patient's smoking habits and provide a diagnosis"", ""correct_option"": ""B""}","Management","What is the primary goal of motivational interviewing in the context of smoking cessation?","To prescribe medication for nicotine withdrawal","To arouse or reinforce the patient's motivation to change their smoking behavior","To provide written information about the dangers of smoking","To assess the patient's smoking habits and provide a diagnosis","b"
"OIC-075-25-A","{""question"": ""What is the primary goal of the 2018-2022 National Programme for Tobacco Control in France?"", ""option_a"": ""To increase the tax on tobacco products"", ""option_b"": ""To achieve a smoking rate of less than 5% among adults born since 2014 by 2032"", ""option_c"": ""To reduce the number of smokers by 10% each year"", ""option_d"": ""To allow smoking in public places with certain restrictions"", ""correct_option"": ""B""}","Management","What is the primary goal of the 2018-2022 National Programme for Tobacco Control in France?","To increase the tax on tobacco products","To achieve a smoking rate of less than 5% among adults born since 2014 by 2032","To reduce the number of smokers by 10% each year","To allow smoking in public places with certain restrictions","b"
"OIC-075-26-A","{""question"": ""What is the primary mechanism of action of Varenicline (Champix\u00ae) in the treatment of tobacco addiction?"", ""option_a"": ""A norepinephrine and dopamine reuptake inhibitor"", ""option_b"": ""A partial nicotinic receptor agonist"", ""option_c"": ""A nicotine replacement therapy"", ""option_d"": ""A cognitive behavioural therapy"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of Varenicline (Champix®) in the treatment of tobacco addiction?","A norepinephrine and dopamine reuptake inhibitor","A partial nicotinic receptor agonist","A nicotine replacement therapy","A cognitive behavioural therapy","b"
"OIC-075-27-A","{""question"": ""What is the primary purpose of the Tabac Info Service line (3989) in relation to smoking addiction?"", ""option_a"": ""To provide medical treatment for smoking-related illnesses"", ""option_b"": ""To offer personalised coaching and support for quitting smoking"", ""option_c"": ""To sell smoking cessation products and medications"", ""option_d"": ""To conduct research on the effects of smoking on public health"", ""correct_option"": ""B""}","Taking charge","What is the primary purpose of the Tabac Info Service line (3989) in relation to smoking addiction?","To provide medical treatment for smoking-related illnesses","To offer personalised coaching and support for quitting smoking","To sell smoking cessation products and medications","To conduct research on the effects of smoking on public health","b"
"OIC-075-28-B","{""question"": ""What is the primary mechanism of action of varenicline in the treatment of smoking addiction?"", ""option_a"": ""It acts as a full nicotine receptor agonist to reduce withdrawal symptoms"", ""option_b"": ""It acts as a partial nicotine receptor agonist to reduce cravings and relapse"", ""option_c"": ""It inhibits the reuptake of serotonin to improve mood"", ""option_d"": ""It stimulates the release of dopamine to reduce nicotine cravings"", ""correct_option"": ""B""}",,"What is the primary mechanism of action of varenicline in the treatment of smoking addiction?","It acts as a full nicotine receptor agonist to reduce withdrawal symptoms","It acts as a partial nicotine receptor agonist to reduce cravings and relapse","It inhibits the reuptake of serotonin to improve mood","It stimulates the release of dopamine to reduce nicotine cravings","b"
"OIC-075-29-B","{""question"": ""What percentage of smokers are likely to have schizophrenia?"", ""option_a"": ""40%"", ""option_b"": ""56%"", ""option_c"": ""68%"", ""option_d"": ""82%"", ""correct_option"": ""D""}","Management","What percentage of smokers are likely to have schizophrenia?","40%","56%","68%","82%","d"
"OIC-075-30-B","{""question"": ""What is the recommended approach to follow-up for smokers trying to quit?"", ""option_a"": ""Follow-up should be infrequent and only as needed"", ""option_b"": ""Follow-up should be agreed upon with the smoker, with a frequency of 6 to 12 months"", ""option_c"": ""Follow-up is not necessary after the initial quit attempt"", ""option_d"": ""Follow-up should only be done after a relapse occurs"", ""correct_option"": ""B""}","Management","What is the recommended approach to follow-up for smokers trying to quit?","Follow-up should be infrequent and only as needed","Follow-up should be agreed upon with the smoker, with a frequency of 6 to 12 months","Follow-up is not necessary after the initial quit attempt","Follow-up should only be done after a relapse occurs","b"
"OIC-075-31-B","{""question"": ""What is the mechanism of action of Varenicline in the treatment of smoking addiction?"", ""option_a"": ""Noradrenaline and dopamine reuptake inhibitor"", ""option_b"": ""Partial agonist of nicotinic acetylcholine receptors"", ""option_c"": ""Nicotine replacement"", ""option_d"": ""Serotonin reuptake inhibitor"", ""correct_option"": ""B""}","Management","What is the mechanism of action of Varenicline in the treatment of smoking addiction?","Noradrenaline and dopamine reuptake inhibitor","Partial agonist of nicotinic acetylcholine receptors","Nicotine replacement","Serotonin reuptake inhibitor","b"
"OIC-075-32-B","{""question"": ""What is the minimum action that all healthcare professionals must take to help patients stop smoking during every consultation?"", ""option_a"": ""Only advise patients to stop smoking if they have a smoking-related illness"", ""option_b"": ""Use the 5A technique: ask, assess, advise, assist, and arrange"", ""option_c"": ""Refer all patients to a tobaccology consultation"", ""option_d"": ""Provide written information about the dangers of smoking"", ""correct_option"": ""B""}","Management","What is the minimum action that all healthcare professionals must take to help patients stop smoking during every consultation?","Only advise patients to stop smoking if they have a smoking-related illness","Use the 5A technique: ask, assess, advise, assist, and arrange","Refer all patients to a tobaccology consultation","Provide written information about the dangers of smoking","b"
"OIC-076-01-A","{""question"": ""What is the ranking of alcohol as a cause of avoidable death in France, after tobacco?"", ""option_a"": ""First cause"", ""option_b"": ""Second cause"", ""option_c"": ""Third cause"", ""option_d"": ""Fourth cause"", ""correct_option"": ""B""}","Epidemiology","What is the ranking of alcohol as a cause of avoidable death in France, after tobacco?","First cause","Second cause","Third cause","Fourth cause","b"
"OIC-076-02-A","{""question"": ""What is the definition of addiction in the context of addictology?"", ""option_a"": ""A behaviour that produces pleasure without any negative consequences"", ""option_b"": ""A process by which a behaviour is employed with the repeated impossibility of controlling it and its continuation despite knowledge of its negative consequences"", ""option_c"": ""The absence of consumption of psychoactive substances"", ""option_d"": ""A behaviour that is only related to the consumption of psychoactive substances"", ""correct_option"": ""B""}","Definition","What is the definition of addiction in the context of addictology?","A behaviour that produces pleasure without any negative consequences","A process by which a behaviour is employed with the repeated impossibility of controlling it and its continuation despite knowledge of its negative consequences","The absence of consumption of psychoactive substances","A behaviour that is only related to the consumption of psychoactive substances","b"
"OIC-076-03-A","{""question"": ""According to the ICD and DSM-5, what level of alcohol use disorder does dependence (ICD) correspond to?"", ""option_a"": ""Mild alcohol use disorder"", ""option_b"": ""Moderate to severe alcohol use disorders"", ""option_c"": ""Only severe alcohol use disorder"", ""option_d"": ""Any level of alcohol use disorder"", ""correct_option"": ""B""}","Definition","According to the ICD and DSM-5, what level of alcohol use disorder does dependence (ICD) correspond to?","Mild alcohol use disorder","Moderate to severe alcohol use disorders","Only severe alcohol use disorder","Any level of alcohol use disorder","b"
"OIC-076-04-A","{""question"": ""According to the low-risk drinking guidelines proposed by Sant\u00e9 Publique France in 2017, what is the recommended maximum number of standard drinks per week for those who drink alcohol?"", ""option_a"": ""5 standard drinks a week"", ""option_b"": ""10 standard drinks a week"", ""option_c"": ""15 standard drinks a week"", ""option_d"": ""20 standard drinks a week"", ""correct_option"": ""B""}",,"According to the low-risk drinking guidelines proposed by Santé Publique France in 2017, what is the recommended maximum number of standard drinks per week for those who drink alcohol?","5 standard drinks a week","10 standard drinks a week","15 standard drinks a week","20 standard drinks a week","b"
"OIC-076-05-A","{""question"": ""According to ICD 11 criteria, what is required for a diagnosis of harmful use of alcohol?"", ""option_a"": ""At least three criteria for dependence must be met"", ""option_b"": ""Physical or psychological damage due to alcohol consumption, with no criteria for dependence"", ""option_c"": ""Tolerance to alcohol and physiological withdrawal syndrome"", ""option_d"": ""Progressive abandonment of other sources of pleasure and interest in favour of alcohol use, without any harmful consequences"", ""correct_option"": ""B""}","Positive diagnosis","According to ICD 11 criteria, what is required for a diagnosis of harmful use of alcohol?","At least three criteria for dependence must be met","Physical or psychological damage due to alcohol consumption, with no criteria for dependence","Tolerance to alcohol and physiological withdrawal syndrome","Progressive abandonment of other sources of pleasure and interest in favour of alcohol use, without any harmful consequences","b"
"OIC-076-06-A","{""question"": ""What is the definition of a standard glass of alcohol in France?"", ""option_a"": ""5 g of pure alcohol, equivalent to 5 cL of wine"", ""option_b"": ""10 g of pure alcohol, equivalent to 10 cL of wine"", ""option_c"": ""15 g of pure alcohol, equivalent to 15 cL of beer at 4\u00b0"", ""option_d"": ""20 g of pure alcohol, equivalent to 5 cL of a strong spirit such as whisky at 40\u00b0"", ""correct_option"": ""B""}","Positive diagnosis","What is the definition of a standard glass of alcohol in France?","5 g of pure alcohol, equivalent to 5 cL of wine","10 g of pure alcohol, equivalent to 10 cL of wine","15 g of pure alcohol, equivalent to 15 cL of beer at 4°","20 g of pure alcohol, equivalent to 5 cL of a strong spirit such as whisky at 40°","b"
"OIC-076-07-A","{""question"": ""What is the primary characteristic that distinguishes delirium tremens from uncomplicated withdrawal syndrome in alcohol dependence?"", ""option_a"": ""The presence of tremor and anxiety"", ""option_b"": ""The occurrence of seizures within 48 hours of stopping alcohol consumption"", ""option_c"": ""A state of confusion, agitation, and delirium with hallucinations"", ""option_d"": ""The disappearance of symptoms with alcohol or benzodiazepines"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary characteristic that distinguishes delirium tremens from uncomplicated withdrawal syndrome in alcohol dependence?","The presence of tremor and anxiety","The occurrence of seizures within 48 hours of stopping alcohol consumption","A state of confusion, agitation, and delirium with hallucinations","The disappearance of symptoms with alcohol or benzodiazepines","c"
"OIC-076-08-A","{""question"": ""What is the primary method for diagnosing acute alcohol intoxication with or without ethyl coma?"", ""option_a"": ""Clinical diagnosis based solely on symptoms such as joviality, logorrhea, and disinhibition"", ""option_b"": ""Blood alcohol level confirmed by blood test or breathalyser, combined with anamnesis and characteristic breath odour"", ""option_c"": ""Systematic neurological examination and biological work-up without considering blood alcohol level"", ""option_d"": ""Brain imaging and vital sign checks alone"", ""correct_option"": ""B""}","Identify the emergency","What is the primary method for diagnosing acute alcohol intoxication with or without ethyl coma?","Clinical diagnosis based solely on symptoms such as joviality, logorrhea, and disinhibition","Blood alcohol level confirmed by blood test or breathalyser, combined with anamnesis and characteristic breath odour","Systematic neurological examination and biological work-up without considering blood alcohol level","Brain imaging and vital sign checks alone","b"
"OIC-076-09-A","{""question"": ""What is the nature of psychiatric disorders that may be associated with alcohol misuse?"", ""option_a"": ""They are always primary, existing before the onset of alcohol misuse."", ""option_b"": ""They are always secondary, resulting from alcohol consumption."", ""option_c"": ""They can be either primary, existing before the onset of misuse, or secondary, resulting from alcohol consumption."", ""option_d"": ""They are unrelated to the onset or continuation of alcohol misuse."", ""correct_option"": ""C""}","Positive diagnosis","What is the nature of psychiatric disorders that may be associated with alcohol misuse?","They are always primary, existing before the onset of alcohol misuse.","They are always secondary, resulting from alcohol consumption.","They can be either primary, existing before the onset of misuse, or secondary, resulting from alcohol consumption.","They are unrelated to the onset or continuation of alcohol misuse.","c"
"OIC-076-10-A","{""question"": ""What is a potential social complication of alcohol misuse in the family domain?"", ""option_a"": ""Improved mental health of family members"", ""option_b"": ""Increased financial stability"", ""option_c"": ""Intra-family violence, separations, or child endangerment"", ""option_d"": ""Enhanced professional opportunities"", ""correct_option"": ""C""}","Positive diagnosis","What is a potential social complication of alcohol misuse in the family domain?","Improved mental health of family members","Increased financial stability","Intra-family violence, separations, or child endangerment","Enhanced professional opportunities","c"
"OIC-076-11-A","{""question"": ""Which of the following biological markers of alcohol consumption is slightly more sensitive than GGT and very specific?"", ""option_a"": ""Blood alcohol level"", ""option_b"": ""Mean corpuscular volume (MCV)"", ""option_c"": ""Desialylated transferrin (CDT)"", ""option_d"": ""Gamma Glutamyl Transpeptidase (GGT) itself"", ""correct_option"": ""C""}","Additional tests","Which of the following biological markers of alcohol consumption is slightly more sensitive than GGT and very specific?","Blood alcohol level","Mean corpuscular volume (MCV)","Desialylated transferrin (CDT)","Gamma Glutamyl Transpeptidase (GGT) itself","c"
"OIC-076-12-A","{""question"": ""What is a strong risk factor for cancer associated with alcohol consumption?"", ""option_a"": ""Colorectal cancer"", ""option_b"": ""Breast cancer"", ""option_c"": ""Cancer of the upper aerodigestive tract and squamous cell carcinoma of the oesophagus"", ""option_d"": ""Prostate cancer"", ""correct_option"": ""C""}",,"What is a strong risk factor for cancer associated with alcohol consumption?","Colorectal cancer","Breast cancer","Cancer of the upper aerodigestive tract and squamous cell carcinoma of the oesophagus","Prostate cancer","c"
"OIC-076-13-A","{""question"": ""What is the primary focus of primary prevention of alcohol misuse?"", ""option_a"": ""The substance itself and its effects"", ""option_b"": ""The person and their individual circumstances"", ""option_c"": ""The legal and social consequences of misuse"", ""option_d"": ""The economic impact of alcohol dependence"", ""correct_option"": ""B""}","Definition","What is the primary focus of primary prevention of alcohol misuse?","The substance itself and its effects","The person and their individual circumstances","The legal and social consequences of misuse","The economic impact of alcohol dependence","b"
"OIC-076-14-B","{""question"": ""What is the primary goal of Early Identification and Brief Intervention (EIBI) in cases of alcohol misuse?"", ""option_a"": ""To diagnose and treat alcohol dependence"", ""option_b"": ""To identify and encourage reduction of alcohol consumption in non-dependent misusers"", ""option_c"": ""To provide long-term counseling and therapy for alcohol abusers"", ""option_d"": ""To restrict access to alcohol for individuals with a history of misuse"", ""correct_option"": ""B""}","Management","What is the primary goal of Early Identification and Brief Intervention (EIBI) in cases of alcohol misuse?","To diagnose and treat alcohol dependence","To identify and encourage reduction of alcohol consumption in non-dependent misusers","To provide long-term counseling and therapy for alcohol abusers","To restrict access to alcohol for individuals with a history of misuse","b"
"OIC-076-15-A","{""question"": ""What is the primary goal of treatment for alcohol dependence, as defined by the patient?"", ""option_a"": ""To immediately stop drinking completely"", ""option_b"": ""To reduce consumption with a view to reducing harm, as defined by the patient"", ""option_c"": ""To return to low-risk drinking, regardless of the patient's preferences"", ""option_d"": ""To switch to a different addictive substance"", ""correct_option"": ""B""}","Management","What is the primary goal of treatment for alcohol dependence, as defined by the patient?","To immediately stop drinking completely","To reduce consumption with a view to reducing harm, as defined by the patient","To return to low-risk drinking, regardless of the patient's preferences","To switch to a different addictive substance","b"
"OIC-076-16-A","{""question"": ""What is the primary purpose of motivational interviewing in the context of alcohol dependence?"", ""option_a"": ""To immediately stop the patient's alcohol consumption"", ""option_b"": ""To prescribe medication for alcohol dependence"", ""option_c"": ""To help patients resolve ambivalence and mobilize their intrinsic motivation to change their behavior"", ""option_d"": ""To educate patients about the dangers of alcohol dependence"", ""correct_option"": ""C""}","Management","What is the primary purpose of motivational interviewing in the context of alcohol dependence?","To immediately stop the patient's alcohol consumption","To prescribe medication for alcohol dependence","To help patients resolve ambivalence and mobilize their intrinsic motivation to change their behavior","To educate patients about the dangers of alcohol dependence","c"
"OIC-076-17-B","{""question"": ""What is the preferred setting for alcohol withdrawal in patients without contraindications?"", ""option_a"": ""Hospital setting"", ""option_b"": ""Outpatient setting supervised by a general practitioner or specialized team"", ""option_c"": ""Emergency department"", ""option_d"": ""Rehabilitation center"", ""correct_option"": ""B""}","Management","What is the preferred setting for alcohol withdrawal in patients without contraindications?","Hospital setting","Outpatient setting supervised by a general practitioner or specialized team","Emergency department","Rehabilitation center","b"
"OIC-076-18-B","{""question"": ""What is the initial treatment approach for a patient experiencing delirium tremens due to alcohol withdrawal?"", ""option_a"": ""Immediate initiation of long-term anti-comital treatment and oral rehydration"", ""option_b"": ""Intravenous rehydration, correction of hydroelectrolytic disorders, and high-dose parenteral vitamin B1 before any infusion of serum glucose"", ""option_c"": ""Restraint and isolation in a dark room to reduce stimulation"", ""option_d"": ""Administration of low-dose benzodiazepines and delayed vitamin B1 supplementation"", ""correct_option"": ""B""}","Management","What is the initial treatment approach for a patient experiencing delirium tremens due to alcohol withdrawal?","Immediate initiation of long-term anti-comital treatment and oral rehydration","Intravenous rehydration, correction of hydroelectrolytic disorders, and high-dose parenteral vitamin B1 before any infusion of serum glucose","Restraint and isolation in a dark room to reduce stimulation","Administration of low-dose benzodiazepines and delayed vitamin B1 supplementation","b"
"OIC-076-19-B","{""question"": ""What is the main objective of self-help groups in the context of addiction treatment?"", ""option_a"": ""To provide medical treatment for addiction"", ""option_b"": ""To combat isolation through mutual support and social links"", ""option_c"": ""To offer training for intermediaries in companies"", ""option_d"": ""To provide harm reduction services for drug users"", ""correct_option"": ""B""}","Taking charge","What is the main objective of self-help groups in the context of addiction treatment?","To provide medical treatment for addiction","To combat isolation through mutual support and social links","To offer training for intermediaries in companies","To provide harm reduction services for drug users","b"
"OIC-076-20-B","{""question"": ""Which of the following medications is used to help reduce alcohol consumption?"", ""option_a"": ""Disulfiram"", ""option_b"": ""Nalmefene"", ""option_c"": ""Acamprosate"", ""option_d"": ""Naltrexone and disulfiram only"", ""correct_option"": ""B""}","Management","Which of the following medications is used to help reduce alcohol consumption?","Disulfiram","Nalmefene","Acamprosate","Naltrexone and disulfiram only","b"
"OIC-082-01-A","{""question"": ""How can you determine if a visual disorder is monocular or binocular during an examination?"", ""option_a"": ""By assessing visual acuity with optical correction only"", ""option_b"": ""By occluding one eye and then the other to see if the visual problem persists"", ""option_c"": ""By only assessing the subjective sensation of mono- or binocularity of the disorder"", ""option_d"": ""By checking the laterality of the disorder if it is binocular"", ""correct_option"": ""B""}","Positive diagnosis","How can you determine if a visual disorder is monocular or binocular during an examination?","By assessing visual acuity with optical correction only","By occluding one eye and then the other to see if the visual problem persists","By only assessing the subjective sensation of mono- or binocularity of the disorder","By checking the laterality of the disorder if it is binocular","b"
"OIC-082-02-A","{""question"": ""What is the primary concern with Amaurosis fugax, given its definition as an acute onset of total visual loss lasting a few minutes and resolving spontaneously?"", ""option_a"": ""It is a permanent condition with no risk of further complications"", ""option_b"": ""It indicates a high risk of constituted retinal artery occlusion or ischaemic stroke"", ""option_c"": ""It is exclusively related to Horton's disease"", ""option_d"": ""It has no relation to carotid atheroma or embolism cardiopathy"", ""correct_option"": ""B""}","Definition","What is the primary concern with Amaurosis fugax, given its definition as an acute onset of total visual loss lasting a few minutes and resolving spontaneously?","It is a permanent condition with no risk of further complications","It indicates a high risk of constituted retinal artery occlusion or ischaemic stroke","It is exclusively related to Horton's disease","It has no relation to carotid atheroma or embolism cardiopathy","b"
"OIC-082-03-A","{""question"": ""A patient presents with anisocoria that is more pronounced in the dark. Which of the following is most likely the pathological eye?"", ""option_a"": ""The eye with the largest pupil (mydriasis)"", ""option_b"": ""The eye with the smallest pupil (myosis)"", ""option_c"": ""Either eye, as anisocoria can be caused by various factors"", ""option_d"": ""The eye that is less responsive to light"", ""correct_option"": ""B""}","Positive diagnosis","A patient presents with anisocoria that is more pronounced in the dark. Which of the following is most likely the pathological eye?","The eye with the largest pupil (mydriasis)","The eye with the smallest pupil (myosis)","Either eye, as anisocoria can be caused by various factors","The eye that is less responsive to light","b"
"OIC-082-04-A","{""question"": ""What is the primary purpose of interpreting a direct and consensual photomotor reflex?"", ""option_a"": ""To assess the patient's visual acuity"", ""option_b"": ""To evaluate the function of the cranial nerves controlling eye movement"", ""option_c"": ""To determine the integrity of the afferent and efferent pathways of the pupillary reflex"", ""option_d"": ""To diagnose color vision deficiency"", ""correct_option"": ""C""}","Multimedia content","What is the primary purpose of interpreting a direct and consensual photomotor reflex?","To assess the patient's visual acuity","To evaluate the function of the cranial nerves controlling eye movement","To determine the integrity of the afferent and efferent pathways of the pupillary reflex","To diagnose color vision deficiency","c"
"OIC-082-05-B","{""question"": ""What is the primary purpose of fundus angiography in ophthalmology?"", ""option_a"": ""To measure visual acuity"", ""option_b"": ""To examine the anterior segment of the eye"", ""option_c"": ""To visualise pathological choroidal vessels and retinal vascularisation"", ""option_d"": ""To assess the curvature of the cornea"", ""correct_option"": ""C""}",,"What is the primary purpose of fundus angiography in ophthalmology?","To measure visual acuity","To examine the anterior segment of the eye","To visualise pathological choroidal vessels and retinal vascularisation","To assess the curvature of the cornea","c"
"OIC-082-06-A","{""question"": ""What is the primary cause of anterior ischaemic optic neuropathy (NOIA) that requires urgent treatment with systemic corticosteroids?"", ""option_a"": ""Arteriosclerosis"", ""option_b"": ""Horton's disease or gigantocellular arteritis"", ""option_c"": ""Diabetes"", ""option_d"": ""Intracranial hypertension"", ""correct_option"": ""B""}","Etiologies","What is the primary cause of anterior ischaemic optic neuropathy (NOIA) that requires urgent treatment with systemic corticosteroids?","Arteriosclerosis","Horton's disease or gigantocellular arteritis","Diabetes","Intracranial hypertension","b"
"OIC-082-07-A","{""question"": ""A patient presents with sudden visual impairment and a white, painless eye. The fundus examination reveals a clearly visible but abnormal fundus. Which of the following conditions is an emergency that requires urgent admission to a neurovascular unit?"", ""option_a"": ""Occlusion of the central retinal vein or one of its branches"", ""option_b"": ""Rhegmatogenous retinal detachment"", ""option_c"": ""Occlusion of the central retinal artery or one of its branches"", ""option_d"": ""AMD complicated by macular choroidal neovessels"", ""correct_option"": ""C""}","Emergency identification","A patient presents with sudden visual impairment and a white, painless eye. The fundus examination reveals a clearly visible but abnormal fundus. Which of the following conditions is an emergency that requires urgent admission to a neurovascular unit?","Occlusion of the central retinal vein or one of its branches","Rhegmatogenous retinal detachment","Occlusion of the central retinal artery or one of its branches","AMD complicated by macular choroidal neovessels","c"
"OIC-082-08-B","{""question"": ""What is the primary indication for requesting Optical Coherence Tomography (OCT) in ophthalmology?"", ""option_a"": ""Diagnosis of glaucoma"", ""option_b"": ""Diagnosis of retinal detachment"", ""option_c"": ""Macular anomaly at the back of the eye, such as drusen or macular hole"", ""option_d"": ""Diagnosis of cataract"", ""correct_option"": ""C""}","Additional examinations","What is the primary indication for requesting Optical Coherence Tomography (OCT) in ophthalmology?","Diagnosis of glaucoma","Diagnosis of retinal detachment","Macular anomaly at the back of the eye, such as drusen or macular hole","Diagnosis of cataract","c"
"OIC-082-09-B","{""question"": ""What is the primary aim of treating a central retinal vein occlusion (CRVO)?"", ""option_a"": ""To immediately restore visual acuity"", ""option_b"": ""To prevent or treat complications such as macular oedema and neovascularisation"", ""option_c"": ""To reverse the occlusion and restore normal blood flow"", ""option_d"": ""To reduce the risk of cerebral territory emboli"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary aim of treating a central retinal vein occlusion (CRVO)?","To immediately restore visual acuity","To prevent or treat complications such as macular oedema and neovascularisation","To reverse the occlusion and restore normal blood flow","To reduce the risk of cerebral territory emboli","b"
"OIC-082-10-B","{""question"": ""A 35-year-old patient presents with a rapidly progressive, unilateral decrease in visual acuity over a few hours, accompanied by eye pain that worsens with eye movements. What is the most likely diagnosis?"", ""option_a"": ""Anterior ischaemic optic neuropathy (AION)"", ""option_b"": ""Retrobulbar optic neuritis (NORB)"", ""option_c"": ""Toxic and metabolic optic neuropathy"", ""option_d"": ""Tumoral optic neuropathy"", ""correct_option"": ""B""}","Positive diagnosis","A 35-year-old patient presents with a rapidly progressive, unilateral decrease in visual acuity over a few hours, accompanied by eye pain that worsens with eye movements. What is the most likely diagnosis?","Anterior ischaemic optic neuropathy (AION)","Retrobulbar optic neuritis (NORB)","Toxic and metabolic optic neuropathy","Tumoral optic neuropathy","b"
"OIC-082-11-A","{""question"": ""What is a characteristic feature of an ophthalmic migraine or visual migraine aura?"", ""option_a"": ""A constant and permanent visual disturbance"", ""option_b"": ""A visual stimulus that subsides in about 15 to 20 minutes, often followed by a headache"", ""option_c"": ""A complete loss of vision in one eye"", ""option_d"": ""A sudden and severe eye pain without any visual disturbance"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic feature of an ophthalmic migraine or visual migraine aura?","A constant and permanent visual disturbance","A visual stimulus that subsides in about 15 to 20 minutes, often followed by a headache","A complete loss of vision in one eye","A sudden and severe eye pain without any visual disturbance","b"
"OIC-082-12-B","{""question"": ""A patient presents with transient visual symptoms resembling migraine aura. Which of the following is a neurological differential diagnosis that could be considered?"", ""option_a"": ""Retinal detachment"", ""option_b"": ""Transient ischaemic attacks"", ""option_c"": ""Vitreous haemorrhage"", ""option_d"": ""Posterior uveitis"", ""correct_option"": ""B""}","Positive diagnosis","A patient presents with transient visual symptoms resembling migraine aura. Which of the following is a neurological differential diagnosis that could be considered?","Retinal detachment","Transient ischaemic attacks","Vitreous haemorrhage","Posterior uveitis","b"
"OIC-082-13-B","{""question"": ""What is the characteristic appearance of the papilla in a normal eye, as opposed to one with papilledema?"", ""option_a"": ""The papilla appears blurred and its border is not clearly defined"", ""option_b"": ""The papilla appears sharp-edged, with a clearly defined border"", ""option_c"": ""The papilla appears swollen, but its border can still be drawn"", ""option_d"": ""The papilla appears sunken, with a distinct border"", ""correct_option"": ""B""}","Multimedia content","What is the characteristic appearance of the papilla in a normal eye, as opposed to one with papilledema?","The papilla appears blurred and its border is not clearly defined","The papilla appears sharp-edged, with a clearly defined border","The papilla appears swollen, but its border can still be drawn","The papilla appears sunken, with a distinct border","b"
"OIC-082-14-B","{""question"": ""What is the term for the visual field defect where a patient has blindness in the outer half of each visual field, as shown in the Goldman visual field?"", ""option_a"": ""Bitemporal hemianopia"", ""option_b"": ""Homonymous lateral hemianopia"", ""option_c"": ""Binocular diplopia"", ""option_d"": ""Monocular blindness"", ""correct_option"": ""B""}","Multimedia content","What is the term for the visual field defect where a patient has blindness in the outer half of each visual field, as shown in the Goldman visual field?","Bitemporal hemianopia","Homonymous lateral hemianopia","Binocular diplopia","Monocular blindness","b"
"OIC-082-15-A","{""question"": ""What is the typical presentation of a rhegmatogenous retinal detachment (RD) in terms of symptoms and signs?"", ""option_a"": ""Sudden severe eye pain followed by blurred vision"", ""option_b"": ""Myodesopsias followed by phosphenes, then amputation of the peripheral visual field, and eventually a drop in visual acuity"", ""option_c"": ""Gradual loss of peripheral vision without any other symptoms"", ""option_d"": ""Double vision and eye movement abnormalities"", ""correct_option"": ""B""}","Identification of the emergency","What is the typical presentation of a rhegmatogenous retinal detachment (RD) in terms of symptoms and signs?","Sudden severe eye pain followed by blurred vision","Myodesopsias followed by phosphenes, then amputation of the peripheral visual field, and eventually a drop in visual acuity","Gradual loss of peripheral vision without any other symptoms","Double vision and eye movement abnormalities","b"
"OIC-082-16-B","{""question"": ""What is the primary treatment for rhegmatogenous retinal detachment?"", ""option_a"": ""Medication to reduce inflammation"", ""option_b"": ""Surgical intervention to seal the retinal tear"", ""option_c"": ""Laser therapy to repair the damaged retina"", ""option_d"": ""Observation and monitoring of the condition"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary treatment for rhegmatogenous retinal detachment?","Medication to reduce inflammation","Surgical intervention to seal the retinal tear","Laser therapy to repair the damaged retina","Observation and monitoring of the condition","b"
"OIC-082-17-B","{""question"": ""What is a possible cause of intravitreal haemorrhage due to rupture of a retinal vessel?"", ""option_a"": ""Proliferative diabetic retinopathy"", ""option_b"": ""Retinal tear, whether or not complicated by retinal detachment"", ""option_c"": ""Ischaemic occlusions of the central retinal artery or one of its branches"", ""option_d"": ""Posterior scleritis"", ""correct_option"": ""B""}",,"What is a possible cause of intravitreal haemorrhage due to rupture of a retinal vessel?","Proliferative diabetic retinopathy","Retinal tear, whether or not complicated by retinal detachment","Ischaemic occlusions of the central retinal artery or one of its branches","Posterior scleritis","b"
"OIC-086-01-A","{""question"": ""What is the primary cause of ectropion?"", ""option_a"": ""Inflammation of the eyelid"", ""option_b"": ""Relaxation of the cutaneous tissues, retraction of the tissues or muscular relaxation"", ""option_c"": ""Blockage of the lacrimal gland"", ""option_d"": ""Infection of the cornea"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary cause of ectropion?","Inflammation of the eyelid","Relaxation of the cutaneous tissues, retraction of the tissues or muscular relaxation","Blockage of the lacrimal gland","Infection of the cornea","b"
"OIC-086-02-A","{""question"": ""What is the primary cause of senile entropion?"", ""option_a"": ""Retraction of the conjunctival tissues"", ""option_b"": ""Relaxation of the cutaneous tissues"", ""option_c"": ""Trachoma or bullous pathology"", ""option_d"": ""Rubbing of the eyelashes on the cornea"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary cause of senile entropion?","Retraction of the conjunctival tissues","Relaxation of the cutaneous tissues","Trachoma or bullous pathology","Rubbing of the eyelashes on the cornea","b"
"OIC-086-03-A","{""question"": ""What is the primary characteristic that distinguishes ptosis from dermatochalasis?"", ""option_a"": ""The presence of excess eyelid skin"", ""option_b"": ""The position of the upper eyelid in relation to the upper sclero-corneal limbus"", ""option_c"": ""The age of the patient"", ""option_d"": ""The visual axis being covered by the skin fold"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic that distinguishes ptosis from dermatochalasis?","The presence of excess eyelid skin","The position of the upper eyelid in relation to the upper sclero-corneal limbus","The age of the patient","The visual axis being covered by the skin fold","b"
"OIC-086-04-A","{""question"": ""What is the main cause of 'senile' ptosis?"", ""option_a"": ""Paralysis of the III nerve"", ""option_b"": ""Relaxation of the levator aponeurosis"", ""option_c"": ""Damage to the levator muscle of the upper eyelid due to myasthenia"", ""option_d"": ""Rupture of the levator aponeurosis due to trauma"", ""correct_option"": ""B""}","Etiologies","What is the main cause of 'senile' ptosis?","Paralysis of the III nerve","Relaxation of the levator aponeurosis","Damage to the levator muscle of the upper eyelid due to myasthenia","Rupture of the levator aponeurosis due to trauma","b"
"OIC-086-05-A","{""question"": ""What is the primary cause of a chalazion?"", ""option_a"": ""Infection of the meibomian gland"", ""option_b"": ""Occlusion of the gland orifice at the posterior part of the free edge"", ""option_c"": ""Blockage of the tear duct"", ""option_d"": ""Inflammation of the conjunctiva"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary cause of a chalazion?","Infection of the meibomian gland","Occlusion of the gland orifice at the posterior part of the free edge","Blockage of the tear duct","Inflammation of the conjunctiva","b"
"OIC-086-06-A","{""question"": ""What is the primary cause of a stye?"", ""option_a"": ""Viral infection of the cornea"", ""option_b"": ""Bacterial infection of the pilosebaceous follicle"", ""option_c"": ""Fungal infection of the eyelid margin"", ""option_d"": ""Allergic reaction to eye makeup"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary cause of a stye?","Viral infection of the cornea","Bacterial infection of the pilosebaceous follicle","Fungal infection of the eyelid margin","Allergic reaction to eye makeup","b"
"OIC-086-07-A","{""question"": ""What is the term for the lump shown in the photographs, which is caused by a blocked oil gland in the eyelid?"", ""option_a"": ""Stye"", ""option_b"": ""Chalazion"", ""option_c"": ""Keratoconus"", ""option_d"": ""Blepharitis"", ""correct_option"": ""B""}","Multimedia content","What is the term for the lump shown in the photographs, which is caused by a blocked oil gland in the eyelid?","Stye","Chalazion","Keratoconus","Blepharitis","b"
"OIC-086-08-A","{""question"": ""What is the condition depicted in the photograph of the lower eyelid?"", ""option_a"": ""A chalazion"", ""option_b"": ""A stye"", ""option_c"": ""Blepharitis"", ""option_d"": ""Ectropion"", ""correct_option"": ""B""}","Multimedia content","What is the condition depicted in the photograph of the lower eyelid?","A chalazion","A stye","Blepharitis","Ectropion","b"
"OIC-086-09-B","{""question"": ""What is a common sign of malignancy in a palpebral tumour?"", ""option_a"": ""Slow and intermittent growth"", ""option_b"": ""Rapid and continuous growth"", ""option_c"": ""Absence of tissue invasion"", ""option_d"": ""Presence of heterochromia in the surrounding skin"", ""correct_option"": ""B""}","Positive diagnosis","What is a common sign of malignancy in a palpebral tumour?","Slow and intermittent growth","Rapid and continuous growth","Absence of tissue invasion","Presence of heterochromia in the surrounding skin","b"
"OIC-086-10-B","{""question"": ""What is the first-line treatment for a chalazion?"", ""option_a"": ""Incision and removal of the meibomian gland under local anaesthetic"", ""option_b"": ""Application of a local corticosteroid ointment combined with eyelid care"", ""option_c"": ""Prescription of antiseptic eye drops for 8 days"", ""option_d"": ""Massage of the eyelids with the finger from the free edge towards the orbital rim"", ""correct_option"": ""B""}","Management","What is the first-line treatment for a chalazion?","Incision and removal of the meibomian gland under local anaesthetic","Application of a local corticosteroid ointment combined with eyelid care","Prescription of antiseptic eye drops for 8 days","Massage of the eyelids with the finger from the free edge towards the orbital rim","b"
"OIC-086-11-A","{""question"": ""What is the typical treatment duration for a stye using antibiotic eye drops or ointment?"", ""option_a"": ""5 days"", ""option_b"": ""8 days"", ""option_c"": ""10 days"", ""option_d"": ""Until symptoms completely resolve"", ""correct_option"": ""B""}","Management","What is the typical treatment duration for a stye using antibiotic eye drops or ointment?","5 days","8 days","10 days","Until symptoms completely resolve","b"
"OIC-086-12-A","{""question"": ""A patient presents with acute ptosis, diplopia, and strabismus. What should be considered as a possible cause of these symptoms?"", ""option_a"": ""Claude Bernard-Horner syndrome"", ""option_b"": ""Intracranial retrocarotid aneurysm compressing the III nerve"", ""option_c"": ""Pancoast-Tobias syndrome"", ""option_d"": ""Wallenberg syndrome"", ""correct_option"": ""B""}","Identification of the emergency","A patient presents with acute ptosis, diplopia, and strabismus. What should be considered as a possible cause of these symptoms?","Claude Bernard-Horner syndrome","Intracranial retrocarotid aneurysm compressing the III nerve","Pancoast-Tobias syndrome","Wallenberg syndrome","b"
"OIC-086-13-B","{""question"": ""What is the typical treatment approach for isolated lacrimation in infants with suspected lacrimal imperforation?"", ""option_a"": ""Immediate catheterization without anaesthetic"", ""option_b"": ""Saline lavage with antiseptics during lacrimation episodes"", ""option_c"": ""Surgical intervention to perforate the lacrimal ducts"", ""option_d"": ""Antibiotic therapy to prevent infection"", ""correct_option"": ""B""}","Epidemiology","What is the typical treatment approach for isolated lacrimation in infants with suspected lacrimal imperforation?","Immediate catheterization without anaesthetic","Saline lavage with antiseptics during lacrimation episodes","Surgical intervention to perforate the lacrimal ducts","Antibiotic therapy to prevent infection","b"
"OIC-094-01-A","{""question"": ""What is the term used to describe pain felt in the posterior region of the cervical spine?"", ""option_a"": ""Lumbago"", ""option_b"": ""Cervicalgia"", ""option_c"": ""Back pain"", ""option_d"": ""Rachialgia"", ""correct_option"": ""B""}","Definition","What is the term used to describe pain felt in the posterior region of the cervical spine?","Lumbago","Cervicalgia","Back pain","Rachialgia","b"
"OIC-094-02-B","{""question"": ""What percentage of the general population is affected by common low back pain?"", ""option_a"": ""5 to 10%"", ""option_b"": ""1/4 to 1/3"", ""option_c"": ""2 to 11%"", ""option_d"": ""60 to 90%"", ""correct_option"": ""B""}","Epidemiology","What percentage of the general population is affected by common low back pain?","5 to 10%","1/4 to 1/3","2 to 11%","60 to 90%","b"
"OIC-094-03-A","{""question"": ""What is the primary goal of characterizing the pain when assessing a patient with rachialgia?"", ""option_a"": ""To identify the underlying inflammatory disease"", ""option_b"": ""To determine the effectiveness of previous treatments"", ""option_c"": ""To understand the patient's pain pattern, including its location, irradiations, and aggravating factors"", ""option_d"": ""To look for signs of vertebro-basilar insufficiency"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary goal of characterizing the pain when assessing a patient with rachialgia?","To identify the underlying inflammatory disease","To determine the effectiveness of previous treatments","To understand the patient's pain pattern, including its location, irradiations, and aggravating factors","To look for signs of vertebro-basilar insufficiency","c"
"OIC-094-04-B","{""question"": ""A 40-year-old patient presents with low back pain that worsens with exertion and trauma, and is exacerbated by hyperextension. What is the most likely origin of this patient's spinal pain?"", ""option_a"": ""Interapophyseal origin"", ""option_b"": ""Disc origin"", ""option_c"": ""Muscular origin"", ""option_d"": ""Vertebral origin"", ""correct_option"": ""B""}","Physiopathology","A 40-year-old patient presents with low back pain that worsens with exertion and trauma, and is exacerbated by hyperextension. What is the most likely origin of this patient's spinal pain?","Interapophyseal origin","Disc origin","Muscular origin","Vertebral origin","b"
"OIC-094-05-B","{""question"": ""What is a known risk factor specifically associated with low back pain?"", ""option_a"": ""Sedentary lifestyle"", ""option_b"": ""Smoking"", ""option_c"": ""Obesity"", ""option_d"": ""Spinal static disorders due to family history"", ""correct_option"": ""C""}","Epidemiology","What is a known risk factor specifically associated with low back pain?","Sedentary lifestyle","Smoking","Obesity","Spinal static disorders due to family history","c"
"OIC-094-06-A","{""question"": ""When should an MRI of the lumbar spine be requested for a patient with lombalgia?"", ""option_a"": ""Immediately after the onset of symptoms"", ""option_b"": ""After the 7th week if there is no improvement, or immediately if red flags are present"", ""option_c"": ""Only if the patient has a history of trauma"", ""option_d"": ""After 3 months of conservative treatment"", ""correct_option"": ""B""}",,"When should an MRI of the lumbar spine be requested for a patient with lombalgia?","Immediately after the onset of symptoms","After the 7th week if there is no improvement, or immediately if red flags are present","Only if the patient has a history of trauma","After 3 months of conservative treatment","b"
"OIC-094-07-A","{""question"": ""A patient presents with progressively worsening back pain, present at rest and particularly at night. What is the most appropriate next step?"", ""option_a"": ""Order a spinal X-ray to check for structural deformity"", ""option_b"": ""Refer the patient for physical therapy to address mechanical pain"", ""option_c"": ""Search for inflammatory disease, neoplasia, or infection with an inflammatory workup and imaging"", ""option_d"": ""Prescribe pain medication and schedule a follow-up appointment in 6 weeks"", ""correct_option"": ""C""}","Identification of the emergency","A patient presents with progressively worsening back pain, present at rest and particularly at night. What is the most appropriate next step?","Order a spinal X-ray to check for structural deformity","Refer the patient for physical therapy to address mechanical pain","Search for inflammatory disease, neoplasia, or infection with an inflammatory workup and imaging","Prescribe pain medication and schedule a follow-up appointment in 6 weeks","c"
"OIC-094-08-B","{""question"": ""What is a 'yellow flag' in the context of chronic spinal pain development?"", ""option_a"": ""A company policy that prevents gradual reintegration into employment"", ""option_b"": ""Emotional problems, such as anxiety or depression"", ""option_c"": ""A financial incentive for taking time off work due to back pain"", ""option_d"": ""A lack of contact with the workplace after an injury"", ""correct_option"": ""B""}","Follow-up and/or prognosis","What is a 'yellow flag' in the context of chronic spinal pain development?","A company policy that prevents gradual reintegration into employment","Emotional problems, such as anxiety or depression","A financial incentive for taking time off work due to back pain","A lack of contact with the workplace after an injury","b"
"OIC-094-09-A","{""question"": ""What is a common cause of secondary spinal pain due to an infectious etiology?"", ""option_a"": ""Osteoporotic vertebral fracture"", ""option_b"": ""Spondylodiscitis"", ""option_c"": ""Ankylosing spondylitis"", ""option_d"": ""Traumatic dislocation"", ""correct_option"": ""B""}","Etiologies","What is a common cause of secondary spinal pain due to an infectious etiology?","Osteoporotic vertebral fracture","Spondylodiscitis","Ankylosing spondylitis","Traumatic dislocation","b"
"OIC-094-10-B","{""question"": ""What is a possible cause of secondary spinal pain?"", ""option_a"": ""Intrarachid or posterior fossa tumour"", ""option_b"": ""Normal bone density"", ""option_c"": ""Chondrocalcinosis or apatite rheumatism"", ""option_d"": ""Lack of physical exercise"", ""correct_option"": ""A""}","Etiologies","What is a possible cause of secondary spinal pain?","Intrarachid or posterior fossa tumour","Normal bone density","Chondrocalcinosis or apatite rheumatism","Lack of physical exercise","a"
"OIC-094-11-B","{""question"": ""What are the aetiologies of complex spinal pain considered to be in relation to chronic low back pain?"", ""option_a"": ""Only consequences of chronic low back pain"", ""option_b"": ""Both causes and consequences of chronic low back pain"", ""option_c"": ""Only social and psychological factors"", ""option_d"": ""Only physical factors such as deconditioning and sedentary lifestyle"", ""correct_option"": ""B""}",,"What are the aetiologies of complex spinal pain considered to be in relation to chronic low back pain?","Only consequences of chronic low back pain","Both causes and consequences of chronic low back pain","Only social and psychological factors","Only physical factors such as deconditioning and sedentary lifestyle","b"
"OIC-094-12-A","{""question"": ""What is the primary approach for managing acute spinal pain, according to the main principles of management?"", ""option_a"": ""Orderly bed rest and prolonged work stoppage"", ""option_b"": ""Reassurance, therapeutic education, and remaining physically active"", ""option_c"": ""Prescribing level 3 analgesics and muscle relaxants"", ""option_d"": ""Immobilization using a mechanical restraint and spinal tractions"", ""correct_option"": ""B""}","Management","What is the primary approach for managing acute spinal pain, according to the main principles of management?","Orderly bed rest and prolonged work stoppage","Reassurance, therapeutic education, and remaining physically active","Prescribing level 3 analgesics and muscle relaxants","Immobilization using a mechanical restraint and spinal tractions","b"
"OIC-094-13-B","{""question"": ""For a patient suffering from acute spinal pain, what is the recommended approach to physical activity?"", ""option_a"": ""Orderly bed rest to allow the spine to heal"", ""option_b"": ""Prolonged work stoppage to avoid exacerbating the pain"", ""option_c"": ""Remain physically active, adapting activities to the intensity of the pain"", ""option_d"": ""Complete cessation of all physical activities for at least a month"", ""correct_option"": ""C""}","Management","For a patient suffering from acute spinal pain, what is the recommended approach to physical activity?","Orderly bed rest to allow the spine to heal","Prolonged work stoppage to avoid exacerbating the pain","Remain physically active, adapting activities to the intensity of the pain","Complete cessation of all physical activities for at least a month","c"
"OIC-094-14-A","{""question"": ""What is a possible extra-spinal cause of low back pain of abdominal-pelvic origin?"", ""option_a"": ""Degenerative disc disease"", ""option_b"": ""Abdominal aortic aneurysm"", ""option_c"": ""Osteoporosis"", ""option_d"": ""Scoliosis"", ""correct_option"": ""B""}","Positive diagnosis","What is a possible extra-spinal cause of low back pain of abdominal-pelvic origin?","Degenerative disc disease","Abdominal aortic aneurysm","Osteoporosis","Scoliosis","b"
"OIC-094-15-B","{""question"": ""What is a key aspect of the diagnostic approach to sacralgia?"", ""option_a"": ""Relief of pain with mobilisation of the lumbar spine"", ""option_b"": ""Pain localised around the sacrum, reproduced by palpation/mobilisation of the sacrum or sacroiliac joints"", ""option_c"": ""Immediate referral for surgical consultation"", ""option_d"": ""Diagnostic imaging without considering clinical signs and symptoms"", ""correct_option"": ""B""}","Positive diagnosis","What is a key aspect of the diagnostic approach to sacralgia?","Relief of pain with mobilisation of the lumbar spine","Pain localised around the sacrum, reproduced by palpation/mobilisation of the sacrum or sacroiliac joints","Immediate referral for surgical consultation","Diagnostic imaging without considering clinical signs and symptoms","b"
"OIC-094-16-B","{""question"": ""What is a key characteristic of coccygodynia that distinguishes it from other types of pain?"", ""option_a"": ""Pain radiating to the lower back and legs"", ""option_b"": ""Pain localised to the coccygeal area, without significant radiation"", ""option_c"": ""Pain exacerbated by standing and walking"", ""option_d"": ""Pain relieved by sitting and bending"", ""correct_option"": ""B""}","Positive diagnosis","What is a key characteristic of coccygodynia that distinguishes it from other types of pain?","Pain radiating to the lower back and legs","Pain localised to the coccygeal area, without significant radiation","Pain exacerbated by standing and walking","Pain relieved by sitting and bending","b"
"OIC-099-01-B","{""question"": ""What percentage of adults worldwide have had at least one headache in the previous twelve months?"", ""option_a"": ""25-50%"", ""option_b"": ""50-75%"", ""option_c"": ""75-90%"", ""option_d"": ""90-100%"", ""correct_option"": ""B""}","Epidemiology","What percentage of adults worldwide have had at least one headache in the previous twelve months?","25-50%","50-75%","75-90%","90-100%","b"
"OIC-099-02-B","{""question"": ""What is the primary mechanism underlying migraine headache?"", ""option_a"": ""Activation of the hypothalamus leading to pervasive cortical depression"", ""option_b"": ""Activation of the trigemino-vascular system with a major role for CGRP and perivascular inflammation"", ""option_c"": ""Disruption of cerebral homeostasis due to environmental factors such as changes in meals or sleep"", ""option_d"": ""Polygenic hereditary factors inducing cerebral hyperexcitability"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism underlying migraine headache?","Activation of the hypothalamus leading to pervasive cortical depression","Activation of the trigemino-vascular system with a major role for CGRP and perivascular inflammation","Disruption of cerebral homeostasis due to environmental factors such as changes in meals or sleep","Polygenic hereditary factors inducing cerebral hyperexcitability","b"
"OIC-099-03-A","{""question"": ""What is the primary basis for diagnosing a primary headache in the absence of biological or radiological markers?"", ""option_a"": ""Imaging studies such as MRI or CT scans"", ""option_b"": ""Laboratory tests to identify specific biomarkers"", ""option_c"": ""Clinical examination and questioning using the diagnostic criteria of the ICHD"", ""option_d"": ""Patient's medical history and physical examination alone"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary basis for diagnosing a primary headache in the absence of biological or radiological markers?","Imaging studies such as MRI or CT scans","Laboratory tests to identify specific biomarkers","Clinical examination and questioning using the diagnostic criteria of the ICHD","Patient's medical history and physical examination alone","c"
"OIC-099-04-A","{""question"": ""What is the primary characteristic that distinguishes migraine with aura from migraine without aura?"", ""option_a"": ""The presence of nausea and vomiting"", ""option_b"": ""The presence of transient neurological symptoms, such as visual or sensory disorders, preceding the headache"", ""option_c"": ""The duration of the headache, with migraines with aura lasting longer than those without"", ""option_d"": ""The intensity of the headache, with migraines with aura being more severe"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic that distinguishes migraine with aura from migraine without aura?","The presence of nausea and vomiting","The presence of transient neurological symptoms, such as visual or sensory disorders, preceding the headache","The duration of the headache, with migraines with aura lasting longer than those without","The intensity of the headache, with migraines with aura being more severe","b"
"OIC-099-05-A","{""question"": ""What is the primary characteristic that distinguishes episodic Algie Vasculaire de la Face (AVF) from chronic AVF?"", ""option_a"": ""The presence of nausea and vomiting"", ""option_b"": ""The duration of the pain, with episodic being less than 3 hours and chronic being more than 3 hours"", ""option_c"": ""The frequency and pattern of attacks, with episodic AVF occurring in periods and chronic AVF recurring over the long term with no remission of more than three months"", ""option_d"": ""The intensity of the pain, with episodic AVF being very intense and chronic AVF being less severe"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary characteristic that distinguishes episodic Algie Vasculaire de la Face (AVF) from chronic AVF?","The presence of nausea and vomiting","The duration of the pain, with episodic being less than 3 hours and chronic being more than 3 hours","The frequency and pattern of attacks, with episodic AVF occurring in periods and chronic AVF recurring over the long term with no remission of more than three months","The intensity of the pain, with episodic AVF being very intense and chronic AVF being less severe","c"
"OIC-099-06-A","{""question"": ""What is the primary characteristic of pain in essential trigeminal neuralgia?"", ""option_a"": ""A continuous burning type of pain"", ""option_b"": ""A very intense, searing, lightning-like or electric discharge of very short duration"", ""option_c"": ""A dull ache that persists for hours"", ""option_d"": ""A sharp stabbing pain that occurs only at night"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic of pain in essential trigeminal neuralgia?","A continuous burning type of pain","A very intense, searing, lightning-like or electric discharge of very short duration","A dull ache that persists for hours","A sharp stabbing pain that occurs only at night","b"
"OIC-099-07-A","{""question"": ""In a patient with chronic daily headaches, how many days per month of headache of a migrainous nature are required for a diagnosis of chronic migraine to take precedence over tension headache?"", ""option_a"": ""10 days per month"", ""option_b"": ""12 days per month"", ""option_c"": ""8 days per month"", ""option_d"": ""15 days per month"", ""correct_option"": ""C""}","Positive diagnosis","In a patient with chronic daily headaches, how many days per month of headache of a migrainous nature are required for a diagnosis of chronic migraine to take precedence over tension headache?","10 days per month","12 days per month","8 days per month","15 days per month","c"
"OIC-099-08-A","{""question"": ""What is a key characteristic of idiopathic facial pain?"", ""option_a"": ""It is typically associated with a local cause, such as a tumor or infection"", ""option_b"": ""It is a chronic pain condition without local causes, often linked to anxiety and/or depression"", ""option_c"": ""It is usually a symptom of a vascular condition, such as giant cell arteritis"", ""option_d"": ""It is primarily a neurological condition, caused by damage to the trigeminal nerve"", ""correct_option"": ""B""}","Positive diagnosis","What is a key characteristic of idiopathic facial pain?","It is typically associated with a local cause, such as a tumor or infection","It is a chronic pain condition without local causes, often linked to anxiety and/or depression","It is usually a symptom of a vascular condition, such as giant cell arteritis","It is primarily a neurological condition, caused by damage to the trigeminal nerve","b"
"OIC-099-09-A","{""question"": ""A patient presents with sharp, radiating, and homolateral pain in the mouth, which is provoked and then becomes spontaneous. What is the most likely cause of this pain?"", ""option_a"": ""Dentin caries"", ""option_b"": ""Acute pulpitis"", ""option_c"": ""Periodontitis"", ""option_d"": ""Traumatic ulceration"", ""correct_option"": ""B""}","Positive diagnosis","A patient presents with sharp, radiating, and homolateral pain in the mouth, which is provoked and then becomes spontaneous. What is the most likely cause of this pain?","Dentin caries","Acute pulpitis","Periodontitis","Traumatic ulceration","b"
"OIC-099-10-A","{""question"": ""What is a characteristic of otalgia?"", ""option_a"": ""It is a type of headache that occurs exclusively in the forehead"", ""option_b"": ""It can be directly linked to a pathology of the outer or middle ear"", ""option_c"": ""It is a symptom that only appears in the absence of any ear pathology"", ""option_d"": ""It is a condition that can only be treated through surgical intervention"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic of otalgia?","It is a type of headache that occurs exclusively in the forehead","It can be directly linked to a pathology of the outer or middle ear","It is a symptom that only appears in the absence of any ear pathology","It is a condition that can only be treated through surgical intervention","b"
"OIC-099-11-B","{""question"": ""What is the first-line investigation for a patient presenting with facial pain suspected to be of dental origin?"", ""option_a"": ""CT scan of the face and sinuses"", ""option_b"": ""Full ENT examination including otoscopy and fibroscopy"", ""option_c"": ""Dental panoramic radiograph"", ""option_d"": ""Biopsy of the buccal mucosa"", ""correct_option"": ""C""}","Complementary examinations","What is the first-line investigation for a patient presenting with facial pain suspected to be of dental origin?","CT scan of the face and sinuses","Full ENT examination including otoscopy and fibroscopy","Dental panoramic radiograph","Biopsy of the buccal mucosa","c"
"OIC-099-12-A","{""question"": ""What is a key factor that can contribute to the progression from episodic to chronic migraine?"", ""option_a"": ""Low household income"", ""option_b"": ""High frequency of headaches"", ""option_c"": ""Female gender"", ""option_d"": ""Age over 60"", ""correct_option"": ""B""}","Etiologies","What is a key factor that can contribute to the progression from episodic to chronic migraine?","Low household income","High frequency of headaches","Female gender","Age over 60","b"
"OIC-099-13-A","{""question"": ""What is the primary factor that contributes to the development of medication-abuse headache (MAC) in patients with pre-existing primary headache?"", ""option_a"": ""Overuse of triptans for more than 3 months"", ""option_b"": ""Overuse of crisis treatments for more than 3 months, particularly with opiates and combined analgesics"", ""option_c"": ""Underuse of prophylaxis for primary headache"", ""option_d"": ""Incorrect diagnosis of migraine and tension headache in general practice"", ""correct_option"": ""B""}","Etiologies","What is the primary factor that contributes to the development of medication-abuse headache (MAC) in patients with pre-existing primary headache?","Overuse of triptans for more than 3 months","Overuse of crisis treatments for more than 3 months, particularly with opiates and combined analgesics","Underuse of prophylaxis for primary headache","Incorrect diagnosis of migraine and tension headache in general practice","b"
"OIC-099-14-A","{""question"": ""What is the primary goal of background treatment for episodic migraine?"", ""option_a"": ""To eliminate migraine attacks completely"", ""option_b"": ""To reduce the number of headache days per month by 50%"", ""option_c"": ""To manage rebound headache and residual seizures"", ""option_d"": ""To shorten the duration of auras"", ""correct_option"": ""B""}","Management","What is the primary goal of background treatment for episodic migraine?","To eliminate migraine attacks completely","To reduce the number of headache days per month by 50%","To manage rebound headache and residual seizures","To shorten the duration of auras","b"
"OIC-099-15-B","{""question"": ""What is the recommended first-line treatment for episodic migraine in terms of background treatment?"", ""option_a"": ""Topiramate"", ""option_b"": ""Propranolol or metoprolol"", ""option_c"": ""Amitriptyline"", ""option_d"": ""Candesartan"", ""correct_option"": ""B""}","Management","What is the recommended first-line treatment for episodic migraine in terms of background treatment?","Topiramate","Propranolol or metoprolol","Amitriptyline","Candesartan","b"
"OIC-099-16-A","{""question"": ""What should be done before prescribing oral contraception to a patient with migraine?"", ""option_a"": ""Prescribe oestroprogestogenic oral contraceptives regardless of the type of migraine"", ""option_b"": ""Systematically look for a migraine and determine whether it is without aura or with aura, then look for all arterial risk factors"", ""option_c"": ""Only consider the patient's age and family history of stroke or myocardial infarction"", ""option_d"": ""Always prescribe pure progestogens to avoid any vascular risk"", ""correct_option"": ""B""}",,"What should be done before prescribing oral contraception to a patient with migraine?","Prescribe oestroprogestogenic oral contraceptives regardless of the type of migraine","Systematically look for a migraine and determine whether it is without aura or with aura, then look for all arterial risk factors","Only consider the patient's age and family history of stroke or myocardial infarction","Always prescribe pure progestogens to avoid any vascular risk","b"
"OIC-099-17-B","{""question"": ""What is the primary purpose of the video interview on the CEN website regarding migraine, facial vascular pain, and trigeminal neuralgia?"", ""option_a"": ""To demonstrate surgical procedures for treating these conditions"", ""option_b"": ""To provide patient testimonials and personal experiences with these conditions"", ""option_c"": ""To educate viewers on how to diagnose migraine, facial vascular pain, and trigeminal neuralgia"", ""option_d"": ""To promote new medications for the treatment of migraine, facial vascular pain, and trigeminal neuralgia"", ""correct_option"": ""C""}","Multimedia content","What is the primary purpose of the video interview on the CEN website regarding migraine, facial vascular pain, and trigeminal neuralgia?","To demonstrate surgical procedures for treating these conditions","To provide patient testimonials and personal experiences with these conditions","To educate viewers on how to diagnose migraine, facial vascular pain, and trigeminal neuralgia","To promote new medications for the treatment of migraine, facial vascular pain, and trigeminal neuralgia","c"
"OIC-100-01-A","{""question"": ""What is the primary objective when diagnosing a headache?"", ""option_a"": ""To determine the exact location of the pain"", ""option_b"": ""To distinguish between a primary headache, a benign secondary headache, and a headache secondary to a serious condition"", ""option_c"": ""To identify the underlying cause of the headache without considering the type of headache"", ""option_d"": ""To prescribe painkillers immediately to relieve the patient's symptoms"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary objective when diagnosing a headache?","To determine the exact location of the pain","To distinguish between a primary headache, a benign secondary headache, and a headache secondary to a serious condition","To identify the underlying cause of the headache without considering the type of headache","To prescribe painkillers immediately to relieve the patient's symptoms","b"
"OIC-100-02-A","{""question"": ""A patient presents with a sudden, severe headache that reaches maximum intensity in less than a minute. What is the most likely diagnosis?"", ""option_a"": ""Intracranial hypertension syndrome"", ""option_b"": ""Infectious meningitis"", ""option_c"": ""Subarachnoid hemorrhage (SAH)"", ""option_d"": ""Migraine"", ""correct_option"": ""C""}","Identification of the emergency","A patient presents with a sudden, severe headache that reaches maximum intensity in less than a minute. What is the most likely diagnosis?","Intracranial hypertension syndrome","Infectious meningitis","Subarachnoid hemorrhage (SAH)","Migraine","c"
"OIC-100-03-A","{""question"": ""What is the typical characteristic of a headache caused by Subarachnoid haemorrhage (SAH) or meningeal haemorrhage?"", ""option_a"": ""A gradual increase in intensity over several hours"", ""option_b"": ""A severe, explosive, and thunderclap-like headache that reaches its maximum intensity in less than one minute"", ""option_c"": ""A mild and intermittent headache that resolves on its own"", ""option_d"": ""A headache that is only present during physical activity or exertion"", ""correct_option"": ""B""}","Etiologies","What is the typical characteristic of a headache caused by Subarachnoid haemorrhage (SAH) or meningeal haemorrhage?","A gradual increase in intensity over several hours","A severe, explosive, and thunderclap-like headache that reaches its maximum intensity in less than one minute","A mild and intermittent headache that resolves on its own","A headache that is only present during physical activity or exertion","b"
"OIC-100-04-B","{""question"": ""What is the primary characteristic that distinguishes chronic migraine from chronic tension headache in the context of chronic daily headache?"", ""option_a"": ""Duration of headache"", ""option_b"": ""Presence of aura"", ""option_c"": ""Intensity of pain"", ""option_d"": ""Presence of migraine characteristics for at least 8 days a month"", ""correct_option"": ""D""}",,"What is the primary characteristic that distinguishes chronic migraine from chronic tension headache in the context of chronic daily headache?","Duration of headache","Presence of aura","Intensity of pain","Presence of migraine characteristics for at least 8 days a month","d"
"OIC-100-05-A","{""question"": ""What is a characteristic feature of headache caused by infectious meningitis and meningoencephalitis?"", ""option_a"": ""It is typically a mild and intermittent headache"", ""option_b"": ""It is a helmet-shaped, diffuse, intense headache that is resistant to analgesics and accompanied by nausea, vomiting, and photophobia"", ""option_c"": ""It is a sharp and stabbing headache that is limited to one side of the head"", ""option_d"": ""It is a headache that is only present in the morning and resolves on its own by the evening"", ""correct_option"": ""B""}","Etiologies","What is a characteristic feature of headache caused by infectious meningitis and meningoencephalitis?","It is typically a mild and intermittent headache","It is a helmet-shaped, diffuse, intense headache that is resistant to analgesics and accompanied by nausea, vomiting, and photophobia","It is a sharp and stabbing headache that is limited to one side of the head","It is a headache that is only present in the morning and resolves on its own by the evening","b"
"OIC-100-06-A","{""question"": ""What is the primary indication for performing a lumbar puncture in a patient with a suspected acute headache?"", ""option_a"": ""To diagnose a migraine headache"", ""option_b"": ""To investigate suspected infectious meningitis, especially when accompanied by fever"", ""option_c"": ""To treat a headache caused by a brain tumor"", ""option_d"": ""To monitor the patient's blood pressure"", ""correct_option"": ""B""}","Identification of the emergency","What is the primary indication for performing a lumbar puncture in a patient with a suspected acute headache?","To diagnose a migraine headache","To investigate suspected infectious meningitis, especially when accompanied by fever","To treat a headache caused by a brain tumor","To monitor the patient's blood pressure","b"
"OIC-100-07-A","{""question"": ""What is the recommended initial approach for treating a suspected secondary headache in the emergency department?"", ""option_a"": ""Administering NSAIDs"", ""option_b"": ""Lying the patient down, head at 30\u00b0, in a calm and dark environment, and prescribing analgesics such as paracetamol"", ""option_c"": ""Using sedatives to alleviate pain"", ""option_d"": ""Immediately switching to level 2 analgesics"", ""correct_option"": ""B""}","Management","What is the recommended initial approach for treating a suspected secondary headache in the emergency department?","Administering NSAIDs","Lying the patient down, head at 30°, in a calm and dark environment, and prescribing analgesics such as paracetamol","Using sedatives to alleviate pain","Immediately switching to level 2 analgesics","b"
"OIC-100-08-A","{""question"": ""What is the recommended initial imaging investigation for a patient presenting with a sudden headache?"", ""option_a"": ""Cerebral MRI scan"", ""option_b"": ""Cerebral CT scan without injection"", ""option_c"": ""Cerebral arteriography via the femoral route"", ""option_d"": ""Lumbar puncture (LP)"", ""correct_option"": ""B""}","Additional examinations","What is the recommended initial imaging investigation for a patient presenting with a sudden headache?","Cerebral MRI scan","Cerebral CT scan without injection","Cerebral arteriography via the femoral route","Lumbar puncture (LP)","b"
"OIC-100-09-A","{""question"": ""What is the primary approach to managing primary headaches outside of an emergency context?"", ""option_a"": ""Seizure treatments are prescribed to relieve each seizure, and must be as general as possible for each type of primary headache."", ""option_b"": ""Primary headaches are managed independently without consultation."", ""option_c"": ""Primary headaches are managed in consultation, with treatments sometimes supplemented by background treatment to reduce the number of attacks."", ""option_d"": ""Background treatment is always prescribed first, followed by seizure treatments as needed."", ""correct_option"": ""C""}","Management","What is the primary approach to managing primary headaches outside of an emergency context?","Seizure treatments are prescribed to relieve each seizure, and must be as general as possible for each type of primary headache.","Primary headaches are managed independently without consultation.","Primary headaches are managed in consultation, with treatments sometimes supplemented by background treatment to reduce the number of attacks.","Background treatment is always prescribed first, followed by seizure treatments as needed.","c"
"OIC-101-01-B","{""question"": ""What is the main motor function of the facial nerve?"", ""option_a"": ""Innervation of the muscles of the pharynx and soft palate"", ""option_b"": ""Innervation of all the skin muscles of the face and neck, as well as the stapedial muscle of the middle ear"", ""option_c"": ""Innervation of the masticatory muscles"", ""option_d"": ""Innervation of the muscles of the tongue"", ""correct_option"": ""B""}","Pathophysiological elements","What is the main motor function of the facial nerve?","Innervation of the muscles of the pharynx and soft palate","Innervation of all the skin muscles of the face and neck, as well as the stapedial muscle of the middle ear","Innervation of the masticatory muscles","Innervation of the muscles of the tongue","b"
"OIC-101-02-A","{""question"": ""What is the primary characteristic that distinguishes central facial paralysis from peripheral facial paralysis in terms of motor impairment?"", ""option_a"": ""Equivalent damage to the upper and lower facial regions"", ""option_b"": ""Predominantly affects the lower facial region with significant asymmetry in voluntary movements"", ""option_c"": ""Involves automatic-voluntary dissociation with more marked asymmetry in automatic movements"", ""option_d"": ""Characterized by the absence of any motor deficit in the homolateral hemisphere"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic that distinguishes central facial paralysis from peripheral facial paralysis in terms of motor impairment?","Equivalent damage to the upper and lower facial regions","Predominantly affects the lower facial region with significant asymmetry in voluntary movements","Involves automatic-voluntary dissociation with more marked asymmetry in automatic movements","Characterized by the absence of any motor deficit in the homolateral hemisphere","b"
"OIC-101-03-A","{""question"": ""What is the recommended resource for viewing photography or video of peripheral facial paralysis (PFP)?"", ""option_a"": ""American Academy of Neurology website"", ""option_b"": ""CEN website (www.cen-neurologie.fr)"", ""option_c"": ""National Institute of Neurological Disorders and Stroke website"", ""option_d"": ""World Health Organization website"", ""correct_option"": ""B""}","Multimedia content","What is the recommended resource for viewing photography or video of peripheral facial paralysis (PFP)?","American Academy of Neurology website","CEN website (www.cen-neurologie.fr)","National Institute of Neurological Disorders and Stroke website","World Health Organization website","b"
"OIC-101-04-A","{""question"": ""What is the recommended resource for accessing videos related to central facial paralysis?"", ""option_a"": ""American Academy of Neurology website"", ""option_b"": ""CEN website at www.cen-neurologie.fr"", ""option_c"": ""National Institute of Neurological Disorders and Stroke website"", ""option_d"": ""World Health Organization website"", ""correct_option"": ""B""}","Multimedia content","What is the recommended resource for accessing videos related to central facial paralysis?","American Academy of Neurology website","CEN website at www.cen-neurologie.fr","National Institute of Neurological Disorders and Stroke website","World Health Organization website","b"
"OIC-101-05-A","{""question"": ""What is the most common cause of facial paralysis?"", ""option_a"": ""Head trauma"", ""option_b"": ""Diabetes"", ""option_c"": ""Facial paralysis a frigore"", ""option_d"": ""Infections such as Lyme meningo-radiculitis"", ""correct_option"": ""C""}","Etiologies","What is the most common cause of facial paralysis?","Head trauma","Diabetes","Facial paralysis a frigore","Infections such as Lyme meningo-radiculitis","c"
"OIC-101-06-A","{""question"": ""What is a characteristic mode of onset for facial palsy with frigidity?"", ""option_a"": ""Gradually progressing over several days"", ""option_b"": ""Immediately maximal or progressing over a few hours after exposure to cold"", ""option_c"": ""Only occurring at night after a period of rest"", ""option_d"": ""Always preceded by a severe headache"", ""correct_option"": ""B""}","Etiologies","What is a characteristic mode of onset for facial palsy with frigidity?","Gradually progressing over several days","Immediately maximal or progressing over a few hours after exposure to cold","Only occurring at night after a period of rest","Always preceded by a severe headache","b"
"OIC-101-07-A","{""question"": ""What is the recommended dosage and duration of oral corticosteroids for treating facial paralysis with frigidity?"", ""option_a"": ""0.5 mg/kg/d for 14 days"", ""option_b"": ""1 mg/kg/d for 7 to 10 days"", ""option_c"": ""2 mg/kg/d for 5 days"", ""option_d"": ""1.5 mg/kg/d for 3 weeks"", ""correct_option"": ""B""}",,"What is the recommended dosage and duration of oral corticosteroids for treating facial paralysis with frigidity?","0.5 mg/kg/d for 14 days","1 mg/kg/d for 7 to 10 days","2 mg/kg/d for 5 days","1.5 mg/kg/d for 3 weeks","b"
"OIC-101-08-B","{""question"": ""What is a possible sequela of facial paralysis a frigore with an unfavourable trend?"", ""option_a"": ""Complete recovery of facial function within 1 month"", ""option_b"": ""Residual synkinetic movements"", ""option_c"": ""Immediate and permanent resolution of paralysis"", ""option_d"": ""Spontaneous improvement without any treatment"", ""correct_option"": ""B""}",,"What is a possible sequela of facial paralysis a frigore with an unfavourable trend?","Complete recovery of facial function within 1 month","Residual synkinetic movements","Immediate and permanent resolution of paralysis","Spontaneous improvement without any treatment","b"
"OIC-101-09-B","{""question"": ""What is the best way to observe post-paralytic facial hemispasm in a patient with facial paralysis?"", ""option_a"": ""Through a detailed medical history"", ""option_b"": ""By viewing a photograph or video of the patient"", ""option_c"": ""Using an MRI or CT scan"", ""option_d"": ""Via an electromyogram (EMG) test"", ""correct_option"": ""B""}","Multimedia content","What is the best way to observe post-paralytic facial hemispasm in a patient with facial paralysis?","Through a detailed medical history","By viewing a photograph or video of the patient","Using an MRI or CT scan","Via an electromyogram (EMG) test","b"
"OIC-101-10-A","{""question"": ""What is the imaging examination of choice for central facial paralysis?"", ""option_a"": ""Cerebral scan"", ""option_b"": ""MRI without and with injection of gadolinium"", ""option_c"": ""Cervical CT/MRI with injection"", ""option_d"": ""Brain MRI with injection of contrast only in cases of trauma"", ""correct_option"": ""B""}","Additional examinations","What is the imaging examination of choice for central facial paralysis?","Cerebral scan","MRI without and with injection of gadolinium","Cervical CT/MRI with injection","Brain MRI with injection of contrast only in cases of trauma","b"
"OIC-101-11-A","{""question"": ""What is a key characteristic of unilateral Peripheral Facial Palsy (PFP) that can be observed in clinical iconography?"", ""option_a"": ""Bilateral facial asymmetry with mobility of all facial territories"", ""option_b"": ""Unilateral facial asymmetry with immobility of the superior and inferior facial territories"", ""option_c"": ""Absence of facial asymmetry with normal mimicry and mobility"", ""option_d"": ""Unilateral facial asymmetry limited to the superior facial territory only"", ""correct_option"": ""B""}","Multimedia content","What is a key characteristic of unilateral Peripheral Facial Palsy (PFP) that can be observed in clinical iconography?","Bilateral facial asymmetry with mobility of all facial territories","Unilateral facial asymmetry with immobility of the superior and inferior facial territories","Absence of facial asymmetry with normal mimicry and mobility","Unilateral facial asymmetry limited to the superior facial territory only","b"
"OIC-101-12-A","{""question"": ""What is a typical clinical presentation of Ramsay Hunt syndrome type 2?"", ""option_a"": ""A unilateral facial paralysis with vesicular eruption on the concha"", ""option_b"": ""A bilateral facial paralysis with vesicular eruption on the trunk"", ""option_c"": ""A unilateral facial paralysis without any vesicular eruption"", ""option_d"": ""A bilateral facial paralysis with vesicular eruption on the limbs"", ""correct_option"": ""A""}","Multimedia content","What is a typical clinical presentation of Ramsay Hunt syndrome type 2?","A unilateral facial paralysis with vesicular eruption on the concha","A bilateral facial paralysis with vesicular eruption on the trunk","A unilateral facial paralysis without any vesicular eruption","A bilateral facial paralysis with vesicular eruption on the limbs","a"
"OIC-101-13-B","{""question"": ""What is a potential complication of a parotid tumour as shown in clinical iconography?"", ""option_a"": ""Peripheral facial palsy (PFP)"", ""option_b"": ""Cerebral hemorrhage"", ""option_c"": ""Meningitis"", ""option_d"": ""Encephalitis"", ""correct_option"": ""A""}","Multimedia content","What is a potential complication of a parotid tumour as shown in clinical iconography?","Peripheral facial palsy (PFP)","Cerebral hemorrhage","Meningitis","Encephalitis","a"
"OIC-101-14-B","{""question"": ""What type of innervation does the facial nerve provide to the face?"", ""option_a"": ""Only motor innervation"", ""option_b"": ""Only sensitive innervation"", ""option_c"": ""Motor, sensitive, and secretory innervation"", ""option_d"": ""Only secretory innervation"", ""correct_option"": ""C""}","Multimedia content","What type of innervation does the facial nerve provide to the face?","Only motor innervation","Only sensitive innervation","Motor, sensitive, and secretory innervation","Only secretory innervation","c"
"OIC-102-01-B","{""question"": ""What is the primary function of the medial longitudinal fasciculus (FLM) in relation to the oculomotor nerves?"", ""option_a"": ""To connect the nuclei of the III, IV, and VI cranial nerves for coordinated eye movement"", ""option_b"": ""To facilitate the transmission of sensory information from the eyes to the brain"", ""option_c"": ""To connect the nucleus of the abducens nerve (VI) to the contralateral nucleus of the oculomotor nerve (III) for conjugated eye movements"", ""option_d"": ""To regulate the intra-cavernous course of the cranial nerves and the superior orbital fissure"", ""correct_option"": ""C""}","Physiopathology","What is the primary function of the medial longitudinal fasciculus (FLM) in relation to the oculomotor nerves?","To connect the nuclei of the III, IV, and VI cranial nerves for coordinated eye movement","To facilitate the transmission of sensory information from the eyes to the brain","To connect the nucleus of the abducens nerve (VI) to the contralateral nucleus of the oculomotor nerve (III) for conjugated eye movements","To regulate the intra-cavernous course of the cranial nerves and the superior orbital fissure","c"
"OIC-102-02-A","{""question"": ""What happens to monocular diplopia when the healthy eye is occluded?"", ""option_a"": ""It disappears"", ""option_b"": ""It persists"", ""option_c"": ""It becomes binocular diplopia"", ""option_d"": ""It is unaffected"", ""correct_option"": ""B""}","Positive diagnosis","What happens to monocular diplopia when the healthy eye is occluded?","It disappears","It persists","It becomes binocular diplopia","It is unaffected","b"
"OIC-102-03-B","{""question"": ""What is the primary purpose of the cover-test in ophthalmological clinical tests?"", ""option_a"": ""To examine the six oculomotor muscles of each eye separately"", ""option_b"": ""To observe the corneal reflections of a light source directed onto the eyes"", ""option_c"": ""To identify oculomotor imbalance by analyzing the shift between two points of light"", ""option_d"": ""To determine the presence of paralytic strabismus by observing restitution movement"", ""correct_option"": ""D""}","Positive diagnosis","What is the primary purpose of the cover-test in ophthalmological clinical tests?","To examine the six oculomotor muscles of each eye separately","To observe the corneal reflections of a light source directed onto the eyes","To identify oculomotor imbalance by analyzing the shift between two points of light","To determine the presence of paralytic strabismus by observing restitution movement","d"
"OIC-102-04-B","{""question"": ""What term designates eye movements of the two eyes in opposite directions?"", ""option_a"": ""Ductions"", ""option_b"": ""Versions"", ""option_c"": ""Vergences"", ""option_d"": ""Ocular motility"", ""correct_option"": ""C""}",,"What term designates eye movements of the two eyes in opposite directions?","Ductions","Versions","Vergences","Ocular motility","c"
"OIC-102-05-B","{""question"": ""What is the term for an inward deviation of the eye?"", ""option_a"": ""Exotropia"", ""option_b"": ""Esotropia"", ""option_c"": ""Hypertropia"", ""option_d"": ""Hypotropia"", ""correct_option"": ""B""}",,"What is the term for an inward deviation of the eye?","Exotropia","Esotropia","Hypertropia","Hypotropia","b"
"OIC-102-06-A","{""question"": ""In a patient with total paralysis of the III cranial nerve, what is the characteristic compensatory head position?"", ""option_a"": ""Tilted to the healthy side, chin lowered"", ""option_b"": ""Turned towards the side of the oculomotor paralysis"", ""option_c"": ""Tilted to the pathological side, chin raised"", ""option_d"": ""No specific compensatory head position is adopted"", ""correct_option"": ""B""}","Multimedia content","In a patient with total paralysis of the III cranial nerve, what is the characteristic compensatory head position?","Tilted to the healthy side, chin lowered","Turned towards the side of the oculomotor paralysis","Tilted to the pathological side, chin raised","No specific compensatory head position is adopted","b"
"OIC-102-07-A","{""question"": ""What is the primary effect of paralysis of the right VI cranial nerve on eye movement?"", ""option_a"": ""Abduction of the left eye is impaired"", ""option_b"": ""Adduction of the right eye is impaired"", ""option_c"": ""Abduction of the right eye is impaired"", ""option_d"": ""Adduction of the left eye is impaired"", ""correct_option"": ""C""}","Multimedia content","What is the primary effect of paralysis of the right VI cranial nerve on eye movement?","Abduction of the left eye is impaired","Adduction of the right eye is impaired","Abduction of the right eye is impaired","Adduction of the left eye is impaired","c"
"OIC-102-08-A","{""question"": ""What is the condition depicted in the photograph/video of extrinsic/intrinsic III paralysis?"", ""option_a"": ""A condition affecting the first cranial nerve"", ""option_b"": ""A condition affecting the third cranial nerve"", ""option_c"": ""A condition affecting the sixth cranial nerve"", ""option_d"": ""A condition affecting the twelfth cranial nerve"", ""correct_option"": ""B""}","Multimedia content","What is the condition depicted in the photograph/video of extrinsic/intrinsic III paralysis?","A condition affecting the first cranial nerve","A condition affecting the third cranial nerve","A condition affecting the sixth cranial nerve","A condition affecting the twelfth cranial nerve","b"
"OIC-102-09-B","{""question"": ""What is the primary reason why VI paralysis has a low localising value in the context of intracranial hypertonia?"", ""option_a"": ""The VI nerve is more resistant to compression than other oculomotor nerves"", ""option_b"": ""The VI nerve is compressed in the cerebellopontine angle due to increased intracranial pressure"", ""option_c"": ""The VI nerve is less commonly affected by lesions in the brainstem"", ""option_d"": ""The VI nerve has a more complex path through the brain, making localization more difficult"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary reason why VI paralysis has a low localising value in the context of intracranial hypertonia?","The VI nerve is more resistant to compression than other oculomotor nerves","The VI nerve is compressed in the cerebellopontine angle due to increased intracranial pressure","The VI nerve is less commonly affected by lesions in the brainstem","The VI nerve has a more complex path through the brain, making localization more difficult","b"
"OIC-102-10-A","{""question"": ""What is a characteristic clinical feature of myasthenia gravis that may prompt its diagnosis in a patient with diplopia?"", ""option_a"": ""Constant and bilateral ptosis"", ""option_b"": ""Progressive and variable ptosis, worsening with fatigue"", ""option_c"": ""Sudden onset of permanent paralysis"", ""option_d"": ""Absence of any noticeable muscular weakness"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic clinical feature of myasthenia gravis that may prompt its diagnosis in a patient with diplopia?","Constant and bilateral ptosis","Progressive and variable ptosis, worsening with fatigue","Sudden onset of permanent paralysis","Absence of any noticeable muscular weakness","b"
"OIC-102-11-A","{""question"": ""What is the primary reason to suspect an intracranial aneurysm in a patient with III paralysis?"", ""option_a"": ""Presence of vascular risk factors"", ""option_b"": ""Absence of headaches"", ""option_c"": ""Partial oculomotor damage with pupillary signs of intrinsic III damage"", ""option_d"": ""Old age"", ""correct_option"": ""C""}","Identification of the emergency","What is the primary reason to suspect an intracranial aneurysm in a patient with III paralysis?","Presence of vascular risk factors","Absence of headaches","Partial oculomotor damage with pupillary signs of intrinsic III damage","Old age","c"
"OIC-102-12-B","{""question"": ""What is the primary indication for cerebral imaging in a patient with recent acute diplopia?"", ""option_a"": ""All cases of recent acute diplopia"", ""option_b"": ""Cases where an intracranial aneurysm is suspected"", ""option_c"": ""Cases of monocular diplopia"", ""option_d"": ""Cases where stroke is suspected"", ""correct_option"": ""D""}","Complementary examinations","What is the primary indication for cerebral imaging in a patient with recent acute diplopia?","All cases of recent acute diplopia","Cases where an intracranial aneurysm is suspected","Cases of monocular diplopia","Cases where stroke is suspected","d"
"OIC-102-13-B","{""question"": ""A patient is experiencing monocular diplopia. Which of the following conditions is a possible cause of this symptom?"", ""option_a"": ""Binocular refractive error"", ""option_b"": ""Corneal scarring following keratitis"", ""option_c"": ""Extraocular muscle imbalance"", ""option_d"": ""Retinal detachment"", ""correct_option"": ""B""}","Positive diagnosis","A patient is experiencing monocular diplopia. Which of the following conditions is a possible cause of this symptom?","Binocular refractive error","Corneal scarring following keratitis","Extraocular muscle imbalance","Retinal detachment","b"
"OIC-102-14-B","{""question"": ""What is the most common cause of painful diplopia?"", ""option_a"": ""Intracranial aneurysm"", ""option_b"": ""Diabetes"", ""option_c"": ""Multiple sclerosis"", ""option_d"": ""Myasthenia"", ""correct_option"": ""B""}","Etiologies","What is the most common cause of painful diplopia?","Intracranial aneurysm","Diabetes","Multiple sclerosis","Myasthenia","b"
"OIC-107-01-A","{""question"": ""What is characterized by involuntary, prolonged muscle contractions responsible for abnormal posture and/or repetitive movements, aggravated by movements in the vicinity of the affected area and stereotyped?"", ""option_a"": ""Tremor"", ""option_b"": ""Chorea"", ""option_c"": ""Dystonia"", ""option_d"": ""Myoclonus"", ""correct_option"": ""C""}","Positive diagnosis","What is characterized by involuntary, prolonged muscle contractions responsible for abnormal posture and/or repetitive movements, aggravated by movements in the vicinity of the affected area and stereotyped?","Tremor","Chorea","Dystonia","Myoclonus","c"
"OIC-107-02-A","{""question"": ""What is the primary characteristic that distinguishes resting tremor from action tremor in terms of when the tremor is present?"", ""option_a"": ""Resting tremor is present during muscle contraction, while action tremor is present at rest"", ""option_b"": ""Resting tremor is present at rest and disappears during muscle contraction, while action tremor is present during voluntary movement"", ""option_c"": ""Resting tremor and action tremor are both present during muscle contraction but differ in frequency"", ""option_d"": ""Resting tremor is bilateral and symmetrical, while action tremor is unilateral and asymmetric"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic that distinguishes resting tremor from action tremor in terms of when the tremor is present?","Resting tremor is present during muscle contraction, while action tremor is present at rest","Resting tremor is present at rest and disappears during muscle contraction, while action tremor is present during voluntary movement","Resting tremor and action tremor are both present during muscle contraction but differ in frequency","Resting tremor is bilateral and symmetrical, while action tremor is unilateral and asymmetric","b"
"OIC-107-03-A","{""question"": ""Which of the following types of drugs is most often associated with iatrogenic parkinsonian syndrome characterized by tremor?"", ""option_a"": ""Antidepressants"", ""option_b"": ""Antipsychotics (neuroleptics)"", ""option_c"": ""Antiepileptics"", ""option_d"": ""Calcium channel blockers"", ""correct_option"": ""B""}","Etiologies","Which of the following types of drugs is most often associated with iatrogenic parkinsonian syndrome characterized by tremor?","Antidepressants","Antipsychotics (neuroleptics)","Antiepileptics","Calcium channel blockers","b"
"OIC-107-04-A","{""question"": ""What is the primary method for recognizing main abnormal movements in neurology?"", ""option_a"": ""Through written descriptions alone"", ""option_b"": ""By observing typical video cases"", ""option_c"": ""Via patient self-reporting"", ""option_d"": ""Using MRI scans"", ""correct_option"": ""B""}","Multimedia content","What is the primary method for recognizing main abnormal movements in neurology?","Through written descriptions alone","By observing typical video cases","Via patient self-reporting","Using MRI scans","b"
"OIC-107-05-B","{""question"": ""What is the primary abnormal movement associated with Huntington's disease?"", ""option_a"": ""Dystonic abnormal movements"", ""option_b"": ""Chorea"", ""option_c"": ""Parkinsonian syndrome"", ""option_d"": ""Aphasic movements"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary abnormal movement associated with Huntington's disease?","Dystonic abnormal movements","Chorea","Parkinsonian syndrome","Aphasic movements","b"
"OIC-107-06-A","{""question"": ""What is the primary basis for the positive diagnosis of tics and Tourette's syndrome?"", ""option_a"": ""Laboratory tests and genetic analysis"", ""option_b"": ""Clinical findings and patient history"", ""option_c"": ""Neuroimaging techniques such as MRI or CT scans"", ""option_d"": ""Psychological assessments and behavioral observations"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary basis for the positive diagnosis of tics and Tourette's syndrome?","Laboratory tests and genetic analysis","Clinical findings and patient history","Neuroimaging techniques such as MRI or CT scans","Psychological assessments and behavioral observations","b"
"OIC-107-07-B","{""question"": ""What type of dyskinesias are typically induced by antipsychotics?"", ""option_a"": ""Only peak-dose dyskinesias"", ""option_b"": ""Acute dyskinesias, late dyskinesias, and akathisia"", ""option_c"": ""Only biphasic dyskinesias"", ""option_d"": ""None of the above, dyskinesias are not related to antipsychotics"", ""correct_option"": ""B""}","Positive diagnosis","What type of dyskinesias are typically induced by antipsychotics?","Only peak-dose dyskinesias","Acute dyskinesias, late dyskinesias, and akathisia","Only biphasic dyskinesias","None of the above, dyskinesias are not related to antipsychotics","b"
"OIC-108-01-B","{""question"": ""What is the primary cognitive function that is impaired in mental confusion, leading to a global disorganisation of coherent thought?"", ""option_a"": ""Memory"", ""option_b"": ""Attention"", ""option_c"": ""Language"", ""option_d"": ""Executive function"", ""correct_option"": ""B""}","Pathophysiological elements","What is the primary cognitive function that is impaired in mental confusion, leading to a global disorganisation of coherent thought?","Memory","Attention","Language","Executive function","b"
"OIC-108-02-A","{""question"": ""What is the primary characteristic that distinguishes dementia from confusion?"", ""option_a"": ""The presence of hallucinations and delusions"", ""option_b"": ""A lasting and acquired deterioration in cognitive and/or behavioural functions"", ""option_c"": ""The complete loss of autonomy in daily life"", ""option_d"": ""The reversal of the nycthemeral rhythm"", ""correct_option"": ""B""}",,"What is the primary characteristic that distinguishes dementia from confusion?","The presence of hallucinations and delusions","A lasting and acquired deterioration in cognitive and/or behavioural functions","The complete loss of autonomy in daily life","The reversal of the nycthemeral rhythm","b"
"OIC-108-03-A","{""question"": ""What is a common neurological cause of mental confusion?"", ""option_a"": ""Chronic obstructive pulmonary disease"", ""option_b"": ""Meningitis and meningoencephalitis"", ""option_c"": ""Hypertension"", ""option_d"": ""Diabetes mellitus"", ""correct_option"": ""B""}","Etiologies","What is a common neurological cause of mental confusion?","Chronic obstructive pulmonary disease","Meningitis and meningoencephalitis","Hypertension","Diabetes mellitus","b"
"OIC-108-04-A","{""question"": ""What are the main non-neurological causes of mental confusion?"", ""option_a"": ""Only neurological disorders such as Alzheimer's and Parkinson's disease"", ""option_b"": ""Toxic, metabolic, and infectious causes"", ""option_c"": ""Genetic and environmental factors only"", ""option_d"": ""Surgical and traumatic causes exclusively"", ""correct_option"": ""B""}",,"What are the main non-neurological causes of mental confusion?","Only neurological disorders such as Alzheimer's and Parkinson's disease","Toxic, metabolic, and infectious causes","Genetic and environmental factors only","Surgical and traumatic causes exclusively","b"
"OIC-108-05-A","{""question"": ""What is the primary indication for a cerebral scan without injection in a patient with mental confusion?"", ""option_a"": ""Fever with no apparent cause"", ""option_b"": ""Presence of focal signs, anticoagulant treatment, or recent head injury"", ""option_c"": ""Suspicion of encephalitis without prior CT or MRI"", ""option_d"": ""Routine examination for all patients with confusion"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary indication for a cerebral scan without injection in a patient with mental confusion?","Fever with no apparent cause","Presence of focal signs, anticoagulant treatment, or recent head injury","Suspicion of encephalitis without prior CT or MRI","Routine examination for all patients with confusion","b"
"OIC-108-06-A","{""question"": ""What is the primary approach to managing a patient with mental confusion?"", ""option_a"": ""Immediately administering sedative psychotropic drugs to calm the patient"", ""option_b"": ""Assessing the short-term impact and treating any vital problems, followed by searching for the cause of confusion"", ""option_c"": ""Withdrawing all medications and implementing physical restraint to prevent agitation"", ""option_d"": ""Focusing solely on treating the underlying cause of confusion without addressing immediate vital problems"", ""correct_option"": ""B""}","Management","What is the primary approach to managing a patient with mental confusion?","Immediately administering sedative psychotropic drugs to calm the patient","Assessing the short-term impact and treating any vital problems, followed by searching for the cause of confusion","Withdrawing all medications and implementing physical restraint to prevent agitation","Focusing solely on treating the underlying cause of confusion without addressing immediate vital problems","b"
"OIC-108-07-B","{""question"": ""What is the main characteristic of Alzheimer's disease (AD) in terms of protein accumulation?"", ""option_a"": ""Accumulation of \u03b1-amyloid peptide in intracellular deposits"", ""option_b"": ""Accumulation of \u03b2-amyloid peptide (A\u03b2-42) in extracellular deposits"", ""option_c"": ""Abnormal accumulation of normally phosphorylated TAU protein"", ""option_d"": ""Loss of neurons without any protein accumulation"", ""correct_option"": ""B""}","Pathophysiological elements","What is the main characteristic of Alzheimer's disease (AD) in terms of protein accumulation?","Accumulation of α-amyloid peptide in intracellular deposits","Accumulation of β-amyloid peptide (Aβ-42) in extracellular deposits","Abnormal accumulation of normally phosphorylated TAU protein","Loss of neurons without any protein accumulation","b"
"OIC-108-08-A","{""question"": ""What is the primary cognitive function affected during the prodromal phase of Alzheimer's disease?"", ""option_a"": ""Executive functions"", ""option_b"": ""Episodic memory"", ""option_c"": ""Language processing"", ""option_d"": ""Spatial awareness"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary cognitive function affected during the prodromal phase of Alzheimer's disease?","Executive functions","Episodic memory","Language processing","Spatial awareness","b"
"OIC-108-09-A","{""question"": ""What is the most characteristic memory impairment in Alzheimer's disease?"", ""option_a"": ""Encoding difficulties due to attention deficits"", ""option_b"": ""Episodic memory consolidation disorder"", ""option_c"": ""Retrieval disorder caused by executive function impairments"", ""option_d"": ""Semantic memory loss due to language processing issues"", ""correct_option"": ""B""}",,"What is the most characteristic memory impairment in Alzheimer's disease?","Encoding difficulties due to attention deficits","Episodic memory consolidation disorder","Retrieval disorder caused by executive function impairments","Semantic memory loss due to language processing issues","b"
"OIC-108-10-A","{""question"": ""What is a key differential diagnosis to consider in a patient presenting with symptoms of Alzheimer's disease?"", ""option_a"": ""Hypertension"", ""option_b"": ""Hypothyroidism"", ""option_c"": ""Chronic kidney disease"", ""option_d"": ""Diabetes mellitus"", ""correct_option"": ""B""}",,"What is a key differential diagnosis to consider in a patient presenting with symptoms of Alzheimer's disease?","Hypertension","Hypothyroidism","Chronic kidney disease","Diabetes mellitus","b"
"OIC-108-11-A","{""question"": ""What is the primary aim of non-drug treatment of Alzheimer's disease?"", ""option_a"": ""To cure the disease"", ""option_b"": ""To stabilise or compensate for the neurocognitive disorder, avoid social withdrawal, and support families"", ""option_c"": ""To focus solely on financial and medico-legal assistance for patients and their carers"", ""option_d"": ""To prioritize institutionalisation for all patients"", ""correct_option"": ""B""}","Management","What is the primary aim of non-drug treatment of Alzheimer's disease?","To cure the disease","To stabilise or compensate for the neurocognitive disorder, avoid social withdrawal, and support families","To focus solely on financial and medico-legal assistance for patients and their carers","To prioritize institutionalisation for all patients","b"
"OIC-108-12-B","{""question"": ""Which of the following cognitive functions is necessary for all major intellectual functions and depends on cortical alertness and arousal systems?"", ""option_a"": ""Perceptual integration functions"", ""option_b"": ""Memory"", ""option_c"": ""Executive functions"", ""option_d"": ""Attention"", ""correct_option"": ""D""}",,"Which of the following cognitive functions is necessary for all major intellectual functions and depends on cortical alertness and arousal systems?","Perceptual integration functions","Memory","Executive functions","Attention","d"
"OIC-108-13-B","{""question"": ""What is the preferred imaging modality for diagnosing a neurocognitive disorder, such as Alzheimer's disease, when there are no contraindications?"", ""option_a"": ""CT scan"", ""option_b"": ""Cerebral MRI"", ""option_c"": ""PET scan"", ""option_d"": ""Lumbar puncture"", ""correct_option"": ""B""}",,"What is the preferred imaging modality for diagnosing a neurocognitive disorder, such as Alzheimer's disease, when there are no contraindications?","CT scan","Cerebral MRI","PET scan","Lumbar puncture","b"
"OIC-108-14-B","{""question"": ""What is a characteristic appearance of a chronic subdural haematoma on medical imaging?"", ""option_a"": ""A crescent-moon shape, typically unilateral"", ""option_b"": ""A round shape, usually hyperdense"", ""option_c"": ""A crescent-moon appearance, often bilateral"", ""option_d"": ""A linear shape, always hypodense"", ""correct_option"": ""C""}","Additional examinations","What is a characteristic appearance of a chronic subdural haematoma on medical imaging?","A crescent-moon shape, typically unilateral","A round shape, usually hyperdense","A crescent-moon appearance, often bilateral","A linear shape, always hypodense","c"
"OIC-108-15-A","{""question"": ""What is the primary finding in the provided CT scan image of a chronic subdural haematoma?"", ""option_a"": ""A peri-cerebral collection in the left hemispheric convexity with a homogeneous hyper-dense appearance"", ""option_b"": ""A peri-cerebral collection in the left hemispheric convexity with a mostly hypo-dense appearance and a 'crescent moon' shape"", ""option_c"": ""A peri-cerebral collection in the right hemispheric convexity with a mixed density appearance"", ""option_d"": ""A peri-cerebral collection in the left hemispheric convexity with a completely hyper-dense appearance"", ""correct_option"": ""B""}","Multimedia content","What is the primary finding in the provided CT scan image of a chronic subdural haematoma?","A peri-cerebral collection in the left hemispheric convexity with a homogeneous hyper-dense appearance","A peri-cerebral collection in the left hemispheric convexity with a mostly hypo-dense appearance and a 'crescent moon' shape","A peri-cerebral collection in the right hemispheric convexity with a mixed density appearance","A peri-cerebral collection in the left hemispheric convexity with a completely hyper-dense appearance","b"
"OIC-108-16-B","{""question"": ""What is a characteristic feature of chronic adult hydrocephalus visible on medical imaging?"", ""option_a"": ""Presence of mass effect due to an obstacle in CSF flow"", ""option_b"": ""Tetraventricular dilatation with absence of mass effect"", ""option_c"": ""Normal ventricular size with prominent sulci"", ""option_d"": ""Unilateral ventricular dilatation due to a brain tumor"", ""correct_option"": ""B""}",,"What is a characteristic feature of chronic adult hydrocephalus visible on medical imaging?","Presence of mass effect due to an obstacle in CSF flow","Tetraventricular dilatation with absence of mass effect","Normal ventricular size with prominent sulci","Unilateral ventricular dilatation due to a brain tumor","b"
"OIC-108-17-B","{""question"": ""What is the primary indication for Dopamine transporter scintigraphy in neurocognitive disorders?"", ""option_a"": ""To diagnose Alzheimer's disease"", ""option_b"": ""To distinguish between diffuse Lewy body disease and Alzheimer's disease"", ""option_c"": ""To identify hypoperfusion in frontotemporal lobar degeneration"", ""option_d"": ""To detect hypometabolism in the medial temporal cortical regions"", ""correct_option"": ""B""}",,"What is the primary indication for Dopamine transporter scintigraphy in neurocognitive disorders?","To diagnose Alzheimer's disease","To distinguish between diffuse Lewy body disease and Alzheimer's disease","To identify hypoperfusion in frontotemporal lobar degeneration","To detect hypometabolism in the medial temporal cortical regions","b"
"OIC-109-01-A","{""question"": ""When assessing a patient with a gait disorder, what is an important aspect to consider in the patient's history?"", ""option_a"": ""Only the patient's current symptoms and medical history"", ""option_b"": ""The patient's family medical history and genetic predispositions"", ""option_c"": ""The patient's full list of medications, as well as their cognitive abilities and daily activities"", ""option_d"": ""The patient's dietary habits and sleep patterns"", ""correct_option"": ""C""}","Positive diagnosis","When assessing a patient with a gait disorder, what is an important aspect to consider in the patient's history?","Only the patient's current symptoms and medical history","The patient's family medical history and genetic predispositions","The patient's full list of medications, as well as their cognitive abilities and daily activities","The patient's dietary habits and sleep patterns","c"
"OIC-109-02-A","{""question"": ""During a gait and balance examination, what is the recommended condition for the patient's footwear and lower limbs?"", ""option_a"": ""The patient should wear shoes and have their lower limbs fully covered"", ""option_b"": ""The patient should wear shoes but have their lower limbs exposed"", ""option_c"": ""The examination should be carried out without shoes and with bare lower limbs"", ""option_d"": ""The patient's footwear and lower limb condition does not matter during the examination"", ""correct_option"": ""C""}",,"During a gait and balance examination, what is the recommended condition for the patient's footwear and lower limbs?","The patient should wear shoes and have their lower limbs fully covered","The patient should wear shoes but have their lower limbs exposed","The examination should be carried out without shoes and with bare lower limbs","The patient's footwear and lower limb condition does not matter during the examination","c"
"OIC-109-03-B","{""question"": ""Which of the following is a scale used for analyzing balance?"", ""option_a"": ""6-minute walk test"", ""option_b"": ""Functional ambulation classification (FAC)"", ""option_c"": ""Berg equilibrium scale"", ""option_d"": ""Frontal and sagittal posture"", ""correct_option"": ""C""}","Positive diagnosis","Which of the following is a scale used for analyzing balance?","6-minute walk test","Functional ambulation classification (FAC)","Berg equilibrium scale","Frontal and sagittal posture","c"
"OIC-109-04-A","{""question"": ""A patient presents with a gait disorder characterized by a 'mowing' gait, with the homolateral upper limb fixed in adduction. What is the most likely origin of this gait disorder?"", ""option_a"": ""Peripheral origin, with motor disorders affecting the extremities"", ""option_b"": ""Central origin, resulting from sequelae of a cerebrovascular accident"", ""option_c"": ""Ataxic origin, due to cerebellar ataxia"", ""option_d"": ""Painful origin, caused by a pain avoidance mechanism"", ""correct_option"": ""B""}","Positive diagnosis","A patient presents with a gait disorder characterized by a 'mowing' gait, with the homolateral upper limb fixed in adduction. What is the most likely origin of this gait disorder?","Peripheral origin, with motor disorders affecting the extremities","Central origin, resulting from sequelae of a cerebrovascular accident","Ataxic origin, due to cerebellar ataxia","Painful origin, caused by a pain avoidance mechanism","b"
"OIC-109-05-A","{""question"": ""What are the clinical and video evidence used to diagnose lameness?"", ""option_a"": ""Dodging, hopping, and Trendelenburg"", ""option_b"": ""Saluting, eschewing, and Trendelenburg"", ""option_c"": ""Dodging, saluting, and Trendelenburg"", ""option_d"": ""Hopping, skipping, and jumping"", ""correct_option"": ""C""}","Positive diagnosis","What are the clinical and video evidence used to diagnose lameness?","Dodging, hopping, and Trendelenburg","Saluting, eschewing, and Trendelenburg","Dodging, saluting, and Trendelenburg","Hopping, skipping, and jumping","c"
"OIC-109-06-A","{""question"": ""What is the primary characteristic of abasia-astasia in patients?"", ""option_a"": ""A complete loss of balance and coordination"", ""option_b"": ""A panic fear of walking, leading to clinging behavior for support"", ""option_c"": ""A temporary paralysis of the legs, causing an inability to walk"", ""option_d"": ""A lack of strength in the muscles, resulting in an unsteady gait"", ""correct_option"": ""B""}","Definition","What is the primary characteristic of abasia-astasia in patients?","A complete loss of balance and coordination","A panic fear of walking, leading to clinging behavior for support","A temporary paralysis of the legs, causing an inability to walk","A lack of strength in the muscles, resulting in an unsteady gait","b"
"OIC-109-07-B","{""question"": ""What is the primary distinction between the two forms of astasia-abasia?"", ""option_a"": ""The presence or absence of depressive symptoms"", ""option_b"": ""The level of severity of the walking disorder"", ""option_c"": ""The psychogenic versus non-psychogenic nature of the condition"", ""option_d"": ""The age of onset of the walking disorder"", ""correct_option"": ""C""}","Etiologies","What is the primary distinction between the two forms of astasia-abasia?","The presence or absence of depressive symptoms","The level of severity of the walking disorder","The psychogenic versus non-psychogenic nature of the condition","The age of onset of the walking disorder","c"
"OIC-109-08-B","{""question"": ""What is the primary cause of a waddling gait?"", ""option_a"": ""A sensory deficit in the upper limbs"", ""option_b"": ""A motor deficit in the muscles of the roots of the lower limbs and the pelvic girdle"", ""option_c"": ""\u011bsthetic approaches in the nervous system"", ""option_d"": ""A neurological disorder affecting the brain's motor control centers"", ""correct_option"": ""B""}","Etiologies","What is the primary cause of a waddling gait?","A sensory deficit in the upper limbs","A motor deficit in the muscles of the roots of the lower limbs and the pelvic girdle","ěsthetic approaches in the nervous system","A neurological disorder affecting the brain's motor control centers","b"
"OIC-109-09-A","{""question"": ""What is a characteristic of the motor component of post-fall syndrome in a patient?"", ""option_a"": ""The patient is able to move into antepulsion while seated in an armchair"", ""option_b"": ""The patient's gait is normal with no widening of the support polygon"", ""option_c"": ""The patient tends to retropelate while seated in an armchair and has a heeling gait while standing"", ""option_d"": ""The patient has a normal posture with no bending of the knees while standing"", ""correct_option"": ""C""}","Etiologies","What is a characteristic of the motor component of post-fall syndrome in a patient?","The patient is able to move into antepulsion while seated in an armchair","The patient's gait is normal with no widening of the support polygon","The patient tends to retropelate while seated in an armchair and has a heeling gait while standing","The patient has a normal posture with no bending of the knees while standing","c"
"OIC-109-10-B","{""question"": ""What is a characteristic feature of a gait disorder of conversive (psychogenic) origin?"", ""option_a"": ""A gradual onset with consistent symptoms"", ""option_b"": ""A 'bouncing' or robotic-looking gait"", ""option_c"": ""A consistent response to physical therapy"", ""option_d"": ""A constant worsening of symptoms over time"", ""correct_option"": ""B""}","Etiologies","What is a characteristic feature of a gait disorder of conversive (psychogenic) origin?","A gradual onset with consistent symptoms","A 'bouncing' or robotic-looking gait","A consistent response to physical therapy","A constant worsening of symptoms over time","b"
"OIC-109-11-B","{""question"": ""What is the primary focus of the multimedia content available on the CEN website?"", ""option_a"": ""Diagnosis and treatment of neurological disorders"", ""option_b"": ""Gait and balance disorders in patients"", ""option_c"": ""Introduction to neurology for medical students"", ""option_d"": ""Advanced neurosurgical techniques and procedures"", ""correct_option"": ""B""}","Multimedia content","What is the primary focus of the multimedia content available on the CEN website?","Diagnosis and treatment of neurological disorders","Gait and balance disorders in patients","Introduction to neurology for medical students","Advanced neurosurgical techniques and procedures","b"
"OIC-109-12-A","{""question"": ""In the diagnosis of gait and balance disorders, what is the primary indication for a cerebral MRI with diffusion sequence in acute symptoms?"", ""option_a"": ""To rule out chronic adult hydrocephalus"", ""option_b"": ""To confirm a diagnosis of Parkinson's disease"", ""option_c"": ""To rule out an acute ischaemic stroke"", ""option_d"": ""To assess the progression of a subdural haematoma"", ""correct_option"": ""C""}","Complementary examinations","In the diagnosis of gait and balance disorders, what is the primary indication for a cerebral MRI with diffusion sequence in acute symptoms?","To rule out chronic adult hydrocephalus","To confirm a diagnosis of Parkinson's disease","To rule out an acute ischaemic stroke","To assess the progression of a subdural haematoma","c"
"OIC-109-13-A","{""question"": ""What is a common complementary examination used to investigate rhythm disorders in patients with gait and balance disorders?"", ""option_a"": ""Biological work-up"", ""option_b"": ""ECG"", ""option_c"": ""Blood gas analysis"", ""option_d"": ""Injection-free brain scan"", ""correct_option"": ""B""}","Complementary examinations","What is a common complementary examination used to investigate rhythm disorders in patients with gait and balance disorders?","Biological work-up","ECG","Blood gas analysis","Injection-free brain scan","b"
"OIC-112-01-A","{""question"": ""What is the characteristic location of immunoglobulin deposition in autoimmune bullous dermatosis?"", ""option_a"": ""Within the epidermis"", ""option_b"": ""At the dermo-epidermal junction or on the surface of keratinocytes"", ""option_c"": ""In the dermis, away from the dermo-epidermal junction"", ""option_d"": ""On the basement membrane but not on keratinocytes"", ""correct_option"": ""B""}","Definition","What is the characteristic location of immunoglobulin deposition in autoimmune bullous dermatosis?","Within the epidermis","At the dermo-epidermal junction or on the surface of keratinocytes","In the dermis, away from the dermo-epidermal junction","On the basement membrane but not on keratinocytes","b"
"OIC-112-02-A","{""question"": ""What is required to confirm the diagnosis of autoimmune bullous dermatosis?"", ""option_a"": ""A single skin biopsy for standard histological analysis"", ""option_b"": ""Two skin biopsies, one for standard histological analysis and the other for direct immunofluorescence examination"", ""option_c"": ""A positive Nikolsky's sign and the presence of mucosal erosions"", ""option_d"": ""A negative direct immunofluorescence test and the presence of bullae"", ""correct_option"": ""B""}","Positive diagnosis","What is required to confirm the diagnosis of autoimmune bullous dermatosis?","A single skin biopsy for standard histological analysis","Two skin biopsies, one for standard histological analysis and the other for direct immunofluorescence examination","A positive Nikolsky's sign and the presence of mucosal erosions","A negative direct immunofluorescence test and the presence of bullae","b"
"OIC-112-03-B","{""question"": ""What is the primary characteristic that distinguishes pemphigoid from pemphigus in terms of bullae formation?"", ""option_a"": ""The presence of tense bullae in pemphigus and flaccid bullae in pemphigoid"", ""option_b"": ""The location of the bullae, with pemphigoid having subepidermal bullae and pemphigus having intraepidermal bullae"", ""option_c"": ""The age of onset, with pemphigoid affecting younger individuals and pemphigus affecting older individuals"", ""option_d"": ""The presence of mucosal lesions, with pemphigoid always involving mucous membranes and pemphigus sparing them"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic that distinguishes pemphigoid from pemphigus in terms of bullae formation?","The presence of tense bullae in pemphigus and flaccid bullae in pemphigoid","The location of the bullae, with pemphigoid having subepidermal bullae and pemphigus having intraepidermal bullae","The age of onset, with pemphigoid affecting younger individuals and pemphigus affecting older individuals","The presence of mucosal lesions, with pemphigoid always involving mucous membranes and pemphigus sparing them","b"
"OIC-112-04-A","{""question"": ""What is the primary purpose of a skin or mucous membrane biopsy with direct immunofluorescence examination in the context of bullous dermatosis?"", ""option_a"": ""To distinguish between different types of infectious causes of bullous lesions"", ""option_b"": ""To confirm the diagnosis of autoimmune bullous disease or suggest a non-autoimmune cause"", ""option_c"": ""To assess the severity of bullous dermatosis and determine the prognosis"", ""option_d"": ""To identify the specific autoantibody responsible for the autoimmune bullous disease"", ""correct_option"": ""B""}","Additional examinations","What is the primary purpose of a skin or mucous membrane biopsy with direct immunofluorescence examination in the context of bullous dermatosis?","To distinguish between different types of infectious causes of bullous lesions","To confirm the diagnosis of autoimmune bullous disease or suggest a non-autoimmune cause","To assess the severity of bullous dermatosis and determine the prognosis","To identify the specific autoantibody responsible for the autoimmune bullous disease","b"
"OIC-112-05-B","{""question"": ""What is the term for the appearance of bullous lesions on the skin after contact with certain plants and exposure to sunlight?"", ""option_a"": ""Erythema multiforme bullosa"", ""option_b"": ""Phytophotodermatosis"", ""option_c"": ""Toxidermia bullosa"", ""option_d"": ""Vasculitis"", ""correct_option"": ""B""}","Etiologies","What is the term for the appearance of bullous lesions on the skin after contact with certain plants and exposure to sunlight?","Erythema multiforme bullosa","Phytophotodermatosis","Toxidermia bullosa","Vasculitis","b"
"OIC-112-06-A","{""question"": ""What is the primary characteristic of a bullous lesion?"", ""option_a"": ""A flat, pigmented area on the skin"", ""option_b"": ""A raised, fluid-filled blister on the skin or mucous membranes"", ""option_c"": ""A thickened, scaly patch on the skin"", ""option_d"": ""A small, pus-filled bump on the skin"", ""correct_option"": ""B""}","Multimedia content","What is the primary characteristic of a bullous lesion?","A flat, pigmented area on the skin","A raised, fluid-filled blister on the skin or mucous membranes","A thickened, scaly patch on the skin","A small, pus-filled bump on the skin","b"
"OIC-112-07-B","{""question"": ""What is the characteristic appearance of bullous pemphigoid on the skin?"", ""option_a"": ""Flaccid blisters with clear content and linear crusts on normal skin"", ""option_b"": ""Tensive bubbles with clear or haemorrhagic content, and round crusts on urticarial skin"", ""option_c"": ""Pustular lesions with thick crusts on erythematous skin"", ""option_d"": ""Flat patches with scale and no blistering on atrophic skin"", ""correct_option"": ""B""}","Multimedia content","What is the characteristic appearance of bullous pemphigoid on the skin?","Flaccid blisters with clear content and linear crusts on normal skin","Tensive bubbles with clear or haemorrhagic content, and round crusts on urticarial skin","Pustular lesions with thick crusts on erythematous skin","Flat patches with scale and no blistering on atrophic skin","b"
"OIC-112-08-B","{""question"": ""What is a characteristic feature of the mucocutaneous lesions in pemphigus vulgaris?"", ""option_a"": ""Tender or flaccid bubbles with smooth edges"", ""option_b"": ""Firm bubbles with jagged edges"", ""option_c"": ""Tender or flaccid bubbles with multiple erosions and jagged edges"", ""option_d"": ""Painful nodules without any erosions"", ""correct_option"": ""C""}","Multimedia content","What is a characteristic feature of the mucocutaneous lesions in pemphigus vulgaris?","Tender or flaccid bubbles with smooth edges","Firm bubbles with jagged edges","Tender or flaccid bubbles with multiple erosions and jagged edges","Painful nodules without any erosions","c"
"OIC-121-01-A","{""question"": ""What is the primary distinction between psychiatric disability and intellectual disability?"", ""option_a"": ""Psychiatric disability is present from birth, while intellectual disability is progressive"", ""option_b"": ""Psychiatric disability is linked to a psychiatric disorder, while intellectual disability is linked to an intellectual impairment"", ""option_c"": ""Psychiatric disability requires medical care, while intellectual disability does not"", ""option_d"": ""Psychiatric disability is characterized by restrictions on participation, while intellectual disability is characterized by activity limitations"", ""correct_option"": ""B""}","Definition","What is the primary distinction between psychiatric disability and intellectual disability?","Psychiatric disability is present from birth, while intellectual disability is progressive","Psychiatric disability is linked to a psychiatric disorder, while intellectual disability is linked to an intellectual impairment","Psychiatric disability requires medical care, while intellectual disability does not","Psychiatric disability is characterized by restrictions on participation, while intellectual disability is characterized by activity limitations","b"
"OIC-121-02-B","{""question"": ""What is the primary aim of mental health care in the context of psychosocial rehabilitation?"", ""option_a"": ""To eliminate the symptoms of psychological disability"", ""option_b"": ""To help people recover and develop skills to cope with disability"", ""option_c"": ""To focus solely on therapeutic education for patients"", ""option_d"": ""To prioritize housing and social life over other aspects of care"", ""correct_option"": ""B""}",,"What is the primary aim of mental health care in the context of psychosocial rehabilitation?","To eliminate the symptoms of psychological disability","To help people recover and develop skills to cope with disability","To focus solely on therapeutic education for patients","To prioritize housing and social life over other aspects of care","b"
"OIC-121-03-B","{""question"": ""What is the primary goal of cognitive remediation in psychotherapeutic care?"", ""option_a"": ""To provide information on psychological disorders and their treatment"", ""option_b"": ""To restore impaired cognitive functions and develop compensatory strategies"", ""option_c"": ""To manage interpersonal relationships through social skills training"", ""option_d"": ""To limit the impact of cognitive biases through cognitive-behavioural therapies"", ""correct_option"": ""B""}","Management","What is the primary goal of cognitive remediation in psychotherapeutic care?","To provide information on psychological disorders and their treatment","To restore impaired cognitive functions and develop compensatory strategies","To manage interpersonal relationships through social skills training","To limit the impact of cognitive biases through cognitive-behavioural therapies","b"
"OIC-121-04-B","{""question"": ""What type of employment may be offered to individuals who are unable to work in an ordinary environment as part of psychosocial rehabilitation?"", ""option_a"": ""Ordinary employment with additional support"", ""option_b"": ""Sheltered employment through establishments and services d'aide par le travail, or adapted companies"", ""option_c"": ""Voluntary work in mutual aid groups"", ""option_d"": ""Remote work arrangements"", ""correct_option"": ""B""}","Taking charge","What type of employment may be offered to individuals who are unable to work in an ordinary environment as part of psychosocial rehabilitation?","Ordinary employment with additional support","Sheltered employment through establishments and services d'aide par le travail, or adapted companies","Voluntary work in mutual aid groups","Remote work arrangements","b"
"OIC-121-05-B","{""question"": ""What is the primary difference between curatorship and guardianship in terms of assisting a person with a psychological disability?"", ""option_a"": ""Curatorship is for temporary protection, while guardianship is for long-term protection"", ""option_b"": ""Curatorship represents the person in their civil life acts, while guardianship assists them"", ""option_c"": ""Curatorship assists the person in their civil life acts, while guardianship represents them"", ""option_d"": ""Curatorship is for people with physical disabilities, while guardianship is for people with psychological disabilities"", ""correct_option"": ""C""}",,"What is the primary difference between curatorship and guardianship in terms of assisting a person with a psychological disability?","Curatorship is for temporary protection, while guardianship is for long-term protection","Curatorship represents the person in their civil life acts, while guardianship assists them","Curatorship assists the person in their civil life acts, while guardianship represents them","Curatorship is for people with physical disabilities, while guardianship is for people with psychological disabilities","c"
"OIC-124-01-A","{""question"": ""What is the primary criterion for defining menopause according to the WHO 1996 definition?"", ""option_a"": ""A permanent cessation of menstruation resulting from a loss of ovarian follicular activity"", ""option_b"": ""A period of consecutive amenorrhoea of 6 months with no obvious physiological or pathological cause in a woman over the age of 40"", ""option_c"": ""The presence of hot flushes, vaginal dryness, and night sweats in a woman over the age of 45"", ""option_d"": ""An increase in FSH and plasma estradiol levels"", ""correct_option"": ""A""}","Definition","What is the primary criterion for defining menopause according to the WHO 1996 definition?","A permanent cessation of menstruation resulting from a loss of ovarian follicular activity","A period of consecutive amenorrhoea of 6 months with no obvious physiological or pathological cause in a woman over the age of 40","The presence of hot flushes, vaginal dryness, and night sweats in a woman over the age of 45","An increase in FSH and plasma estradiol levels","a"
"OIC-124-02-B","{""question"": ""What percentage of women in the European population are expected to reach menopause before the age of 45?"", ""option_a"": ""5-10%"", ""option_b"": ""10-15%"", ""option_c"": ""20-25%"", ""option_d"": ""30-35%"", ""correct_option"": ""B""}","Epidemiology","What percentage of women in the European population are expected to reach menopause before the age of 45?","5-10%","10-15%","20-25%","30-35%","b"
"OIC-124-03-B","{""question"": ""What is the age criterion for defining premature ovarian failure (POI)?"", ""option_a"": ""Before the age of 30"", ""option_b"": ""Before the age of 40"", ""option_c"": ""Before the age of 45"", ""option_d"": ""Before the age of 50"", ""correct_option"": ""B""}",,"What is the age criterion for defining premature ovarian failure (POI)?","Before the age of 30","Before the age of 40","Before the age of 45","Before the age of 50","b"
"OIC-124-05-A","{""question"": ""What is the primary cause of climacteric symptoms?"", ""option_a"": ""Testosterone deficiency"", ""option_b"": ""Oestrogen deficiency"", ""option_c"": ""Progesterone deficiency"", ""option_d"": ""Thyroid hormone deficiency"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary cause of climacteric symptoms?","Testosterone deficiency","Oestrogen deficiency","Progesterone deficiency","Thyroid hormone deficiency","b"
"OIC-124-06-B","{""question"": ""What is a characteristic that distinguishes atypical hot flushes from typical hot flushes?"", ""option_a"": ""They occur mainly during the day"", ""option_b"": ""They are not affected by emotions or high temperatures"", ""option_c"": ""They do not subside with the use of suitable menopausal hormone treatment"", ""option_d"": ""They always have premonitory signs"", ""correct_option"": ""C""}","Positive diagnosis","What is a characteristic that distinguishes atypical hot flushes from typical hot flushes?","They occur mainly during the day","They are not affected by emotions or high temperatures","They do not subside with the use of suitable menopausal hormone treatment","They always have premonitory signs","c"
"OIC-124-07-A","{""question"": ""What is a common symptom directly attributable to estrogen deficiency in menopausal women?"", ""option_a"": ""Irritability"", ""option_b"": ""Vulvovaginal dryness"", ""option_c"": ""Weight loss"", ""option_d"": ""Increased libido"", ""correct_option"": ""B""}","Positive diagnosis","What is a common symptom directly attributable to estrogen deficiency in menopausal women?","Irritability","Vulvovaginal dryness","Weight loss","Increased libido","b"
"OIC-124-08-B","{""question"": ""What is the primary method used for measuring bone capital in women at risk of postmenopausal osteoporosis?"", ""option_a"": ""Osteodensitometry using dual-photon absorptiometry"", ""option_b"": ""Measurement of bone remodelling markers"", ""option_c"": ""Assessment of cardiovascular risk factors"", ""option_d"": ""Evaluation of genitourinary menopause syndrome symptoms"", ""correct_option"": ""A""}",,"What is the primary method used for measuring bone capital in women at risk of postmenopausal osteoporosis?","Osteodensitometry using dual-photon absorptiometry","Measurement of bone remodelling markers","Assessment of cardiovascular risk factors","Evaluation of genitourinary menopause syndrome symptoms","a"
"OIC-124-09-B","{""question"": ""What is the primary reason for combining oestrogens with a progestogen in non-hysterectomised women undergoing menopausal hormone therapy?"", ""option_a"": ""To reduce the risk of venous thromboembolism and stroke"", ""option_b"": ""To prevent the long-term tissue consequences of estrogen deficiency, such as osteoporosis"", ""option_c"": ""To alleviate functional symptoms of climacteric symptoms, such as hot flushes and mood disorders"", ""option_d"": ""To prevent the risk of endometrial cancer induced by oestrogen treatments alone"", ""correct_option"": ""D""}",,"What is the primary reason for combining oestrogens with a progestogen in non-hysterectomised women undergoing menopausal hormone therapy?","To reduce the risk of venous thromboembolism and stroke","To prevent the long-term tissue consequences of estrogen deficiency, such as osteoporosis","To alleviate functional symptoms of climacteric symptoms, such as hot flushes and mood disorders","To prevent the risk of endometrial cancer induced by oestrogen treatments alone","d"
"OIC-124-10-B","{""question"": ""Before prescribing Hormone Replacement Therapy (HRT), which of the following tests is recommended to be performed, in addition to a mammogram, to assess the patient's condition?"", ""option_a"": ""Utero-ovarian ultrasound"", ""option_b"": ""Lipid profile analysis, including total cholesterol, triglycerides, and fasting glucose"", ""option_c"": ""Bone densitometry for all post-menopausal women"", ""option_d"": ""Routine complete blood count (CBC)"", ""correct_option"": ""B""}",,"Before prescribing Hormone Replacement Therapy (HRT), which of the following tests is recommended to be performed, in addition to a mammogram, to assess the patient's condition?","Utero-ovarian ultrasound","Lipid profile analysis, including total cholesterol, triglycerides, and fasting glucose","Bone densitometry for all post-menopausal women","Routine complete blood count (CBC)","b"
"OIC-124-11-B","{""question"": ""In which of the following situations is the non-oral route of administration preferred for Hormone Replacement Therapy (HRT)?"", ""option_a"": ""For women with a history of breast cancer"", ""option_b"": ""For women with hypertriglyceridaemia or hypertension, or those with venous thrombo-embolic risk factors"", ""option_c"": ""For women with a history of osteoporosis"", ""option_d"": ""For women with a history of migraine"", ""correct_option"": ""B""}",,"In which of the following situations is the non-oral route of administration preferred for Hormone Replacement Therapy (HRT)?","For women with a history of breast cancer","For women with hypertriglyceridaemia or hypertension, or those with venous thrombo-embolic risk factors","For women with a history of osteoporosis","For women with a history of migraine","b"
"OIC-124-12-B","{""question"": ""In the context of Hormone Replacement Therapy (HRT) for natural menopause, what is the primary condition under which the risk of myocardial infarction (MI) increases?"", ""option_a"": ""When HRT is started within 10 years of the menopause"", ""option_b"": ""When HRT is started more than 10 years after the menopause"", ""option_c"": ""Regardless of the timing of HRT initiation in relation to menopause"", ""option_d"": ""Only if the patient has a history of breast cancer"", ""correct_option"": ""B""}","Management","In the context of Hormone Replacement Therapy (HRT) for natural menopause, what is the primary condition under which the risk of myocardial infarction (MI) increases?","When HRT is started within 10 years of the menopause","When HRT is started more than 10 years after the menopause","Regardless of the timing of HRT initiation in relation to menopause","Only if the patient has a history of breast cancer","b"
"OIC-124-13-B","{""question"": ""What is a key dietary recommendation for menopausal women to mitigate the risk of osteoporosis?"", ""option_a"": ""Increasing carbohydrate and fat energy intake"", ""option_b"": ""Adequate calcium and vitamin D intake, with supplementation if necessary"", ""option_c"": ""Reducing energy expenditure through decreased physical activity"", ""option_d"": ""Avoiding regular physical activity to minimize bone stress"", ""correct_option"": ""B""}","Management","What is a key dietary recommendation for menopausal women to mitigate the risk of osteoporosis?","Increasing carbohydrate and fat energy intake","Adequate calcium and vitamin D intake, with supplementation if necessary","Reducing energy expenditure through decreased physical activity","Avoiding regular physical activity to minimize bone stress","b"
"OIC-124-14-A","{""question"": ""What is the appropriate initial step in investigating abnormal uterine bleeding in a postmenopausal woman?"", ""option_a"": ""Perform a pelvic ultrasound to measure the thickness of the endometrium"", ""option_b"": ""Conduct a clinical examination to rule out a vaginal or cervical cause"", ""option_c"": ""Carry out an endometrial biopsy using the Cornier pipelle"", ""option_d"": ""Prescribe hormone replacement therapy to regulate bleeding"", ""correct_option"": ""B""}","Positive diagnosis","What is the appropriate initial step in investigating abnormal uterine bleeding in a postmenopausal woman?","Perform a pelvic ultrasound to measure the thickness of the endometrium","Conduct a clinical examination to rule out a vaginal or cervical cause","Carry out an endometrial biopsy using the Cornier pipelle","Prescribe hormone replacement therapy to regulate bleeding","b"
"OIC-124-15-A","{""question"": ""What is the preferred term to describe the condition of age-related testosterone deficiency?"", ""option_a"": ""Andropause"", ""option_b"": ""Age-related androgen deficiency"", ""option_c"": ""Age-related testosterone deficiency syndrome"", ""option_d"": ""Hypotestosteronemia syndrome"", ""correct_option"": ""C""}","Definition","What is the preferred term to describe the condition of age-related testosterone deficiency?","Andropause","Age-related androgen deficiency","Age-related testosterone deficiency syndrome","Hypotestosteronemia syndrome","c"
"OIC-124-16-B","{""question"": ""What happens to testosterone secretion by the Leydig cells during the ageing process?"", ""option_a"": ""It increases due to an enhancement in steroidogenesis"", ""option_b"": ""It remains unchanged, but androgen receptors are reduced"", ""option_c"": ""It decreases as a result of a reduction in steroidogenesis and GnRH secretion"", ""option_d"": ""It fluctuates, but the overall effect is neutral on the symptoms associated with testosterone secretion"", ""correct_option"": ""C""}",,"What happens to testosterone secretion by the Leydig cells during the ageing process?","It increases due to an enhancement in steroidogenesis","It remains unchanged, but androgen receptors are reduced","It decreases as a result of a reduction in steroidogenesis and GnRH secretion","It fluctuates, but the overall effect is neutral on the symptoms associated with testosterone secretion","c"
"OIC-124-17-A","{""question"": ""What is the primary biochemical indicator used to diagnose andropause, specifically in terms of total testosterone levels?"", ""option_a"": ""Total testosterone < 1.5 ng/ml (4 nmol/l)"", ""option_b"": ""Total testosterone < 2.3 ng/ml (8 nmol/l) OR total testosterone between 2.3 and 3.5 ng/ml (8-12 nmol/l) AND bioavailable testosterone < 0.7 ng/ml"", ""option_c"": ""Total testosterone > 3.5 ng/ml (12 nmol/l) AND bioavailable testosterone > 0.7 ng/ml"", ""option_d"": ""Total testosterone between 1.5 and 2.3 ng/ml (4-8 nmol/l)"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary biochemical indicator used to diagnose andropause, specifically in terms of total testosterone levels?","Total testosterone < 1.5 ng/ml (4 nmol/l)","Total testosterone < 2.3 ng/ml (8 nmol/l) OR total testosterone between 2.3 and 3.5 ng/ml (8-12 nmol/l) AND bioavailable testosterone < 0.7 ng/ml","Total testosterone > 3.5 ng/ml (12 nmol/l) AND bioavailable testosterone > 0.7 ng/ml","Total testosterone between 1.5 and 2.3 ng/ml (4-8 nmol/l)","b"
"OIC-124-18-B","{""question"": ""What is a potential differential diagnosis that must be ruled out when considering a diagnosis of age-related androgen deficiency?"", ""option_a"": ""Hypothyroidism"", ""option_b"": ""Natural ageing"", ""option_c"": ""Prolactin adenoma"", ""option_d"": ""Metabolic syndrome"", ""correct_option"": ""A""}",,"What is a potential differential diagnosis that must be ruled out when considering a diagnosis of age-related androgen deficiency?","Hypothyroidism","Natural ageing","Prolactin adenoma","Metabolic syndrome","a"
"OIC-124-19-B","{""question"": ""What is a common short-term symptom of untreated age-related androgen deficiency?"", ""option_a"": ""Osteoporosis"", ""option_b"": ""Erectile dysfunction, reduced libido, and mood disorders"", ""option_c"": ""Sarcopenia and metabolic syndrome"", ""option_d"": ""Cardiovascular risk and thromboembolic risk"", ""correct_option"": ""B""}","Physiopathology","What is a common short-term symptom of untreated age-related androgen deficiency?","Osteoporosis","Erectile dysfunction, reduced libido, and mood disorders","Sarcopenia and metabolic syndrome","Cardiovascular risk and thromboembolic risk","b"
"OIC-127-01-A","{""question"": ""At what age does benign prostatic hyperplasia (BPH) typically start to develop?"", ""option_a"": ""At birth"", ""option_b"": ""From the age of 30 onwards"", ""option_c"": ""After the age of 60"", ""option_d"": ""During puberty"", ""correct_option"": ""B""}",,"At what age does benign prostatic hyperplasia (BPH) typically start to develop?","At birth","From the age of 30 onwards","After the age of 60","During puberty","b"
"OIC-127-02-A","{""question"": ""What is the primary basis for making a positive diagnosis of Benign Prostatic Hypertrophy (BPH)?"", ""option_a"": ""Presence of haematuria and risk factors for urethral stricture"", ""option_b"": ""Clinical context, questioning, absence of other causes, and result of digital rectal examination (DRE)"", ""option_c"": ""History of diabetes mellitus, sleep apnoea, and heart failure"", ""option_d"": ""Presence of lower urinary tract symptoms (LUTS) alone"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary basis for making a positive diagnosis of Benign Prostatic Hypertrophy (BPH)?","Presence of haematuria and risk factors for urethral stricture","Clinical context, questioning, absence of other causes, and result of digital rectal examination (DRE)","History of diabetes mellitus, sleep apnoea, and heart failure","Presence of lower urinary tract symptoms (LUTS) alone","b"
"OIC-127-03-A","{""question"": ""What is the initial treatment for acute renal failure linked to the subvesical obstruction of Benign Prostatic Hypertrophy (BPH)?"", ""option_a"": ""Alpha-blocker treatment and immediate surgical management"", ""option_b"": ""Emergency urinary diversion with monitoring of the obstruction removal syndrome, followed by surgical management of the BPH"", ""option_c"": ""Probabilistic antibiotic treatment and hospitalisation"", ""option_d"": ""Uro CT scan and bladder fibroscopy to rule out other causes"", ""correct_option"": ""B""}","Identifying the emergency","What is the initial treatment for acute renal failure linked to the subvesical obstruction of Benign Prostatic Hypertrophy (BPH)?","Alpha-blocker treatment and immediate surgical management","Emergency urinary diversion with monitoring of the obstruction removal syndrome, followed by surgical management of the BPH","Probabilistic antibiotic treatment and hospitalisation","Uro CT scan and bladder fibroscopy to rule out other causes","b"
"OIC-127-04-B","{""question"": ""What is the primary method for confirming a diagnosis of obstructive renal failure complicating Benign Prostatic Hypertrophy (BPH)?"", ""option_a"": ""Dynamic urological assessment"", ""option_b"": ""Reno-vesico-prostatic ultrasound showing bilateral dilatation of the pyelo-caliceal cavities"", ""option_c"": ""Blood test for creatinine levels alone"", ""option_d"": ""Clinical signs of renal failure such as oedema and hypertension"", ""correct_option"": ""B""}",,"What is the primary method for confirming a diagnosis of obstructive renal failure complicating Benign Prostatic Hypertrophy (BPH)?","Dynamic urological assessment","Reno-vesico-prostatic ultrasound showing bilateral dilatation of the pyelo-caliceal cavities","Blood test for creatinine levels alone","Clinical signs of renal failure such as oedema and hypertension","b"
"OIC-127-05-A","{""question"": ""What is the primary purpose of performing a digital rectal examination (DRE) in the diagnosis of Benign Prostatic Hyperplasia (BPH)?"", ""option_a"": ""To assess the patient's sexual function and libido"", ""option_b"": ""To evaluate the symptoms of lower urinary tract and identify storage symptoms"", ""option_c"": ""To look for cancer, pain (prostatitis), and assess the volume of the prostate"", ""option_d"": ""To diagnose urinary incontinence and voiding disorders in adults and the elderly"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary purpose of performing a digital rectal examination (DRE) in the diagnosis of Benign Prostatic Hyperplasia (BPH)?","To assess the patient's sexual function and libido","To evaluate the symptoms of lower urinary tract and identify storage symptoms","To look for cancer, pain (prostatitis), and assess the volume of the prostate","To diagnose urinary incontinence and voiding disorders in adults and the elderly","c"
"OIC-127-06-B","{""question"": ""What is the primary purpose of flowmetry in the assessment of Benign Prostatic Hyperplasia (BPH)?"", ""option_a"": ""To detect haematuria and urinary tract infections"", ""option_b"": ""To identify urinary disorders and incontinence in adults and the elderly"", ""option_c"": ""To measure post-micturition residue"", ""option_d"": ""To assess the need for surgical intervention"", ""correct_option"": ""B""}","Additional tests","What is the primary purpose of flowmetry in the assessment of Benign Prostatic Hyperplasia (BPH)?","To detect haematuria and urinary tract infections","To identify urinary disorders and incontinence in adults and the elderly","To measure post-micturition residue","To assess the need for surgical intervention","b"
"OIC-127-07-B","{""question"": ""What is the primary purpose of measuring creatinine levels in patients with Benign Prostatic Hypertrophy (BPH)?"", ""option_a"": ""To diagnose BPH"", ""option_b"": ""To detect prostate cancer"", ""option_c"": ""To assess renal function and detect potential renal failure"", ""option_d"": ""To evaluate the effectiveness of treatment for BPH"", ""correct_option"": ""C""}",,"What is the primary purpose of measuring creatinine levels in patients with Benign Prostatic Hypertrophy (BPH)?","To diagnose BPH","To detect prostate cancer","To assess renal function and detect potential renal failure","To evaluate the effectiveness of treatment for BPH","c"
"OIC-127-08-B","{""question"": ""What is the primary goal of abstention-surveillance in the management of Benign Prostatic Hypertrophy (BPH)?"", ""option_a"": ""To reduce prostate volume using 5\u03b1-reductase inhibitors"", ""option_b"": ""To improve urinary flow by relaxing the smooth muscles of the prostate and bladder neck using alpha-receptor blockers"", ""option_c"": ""To monitor patients with minimal or moderate symptoms and no impairment of quality of life, providing clear explanations and hygienic dietary advice"", ""option_d"": ""To remove subvesical obstruction through surgical treatment"", ""correct_option"": ""C""}","Management","What is the primary goal of abstention-surveillance in the management of Benign Prostatic Hypertrophy (BPH)?","To reduce prostate volume using 5α-reductase inhibitors","To improve urinary flow by relaxing the smooth muscles of the prostate and bladder neck using alpha-receptor blockers","To monitor patients with minimal or moderate symptoms and no impairment of quality of life, providing clear explanations and hygienic dietary advice","To remove subvesical obstruction through surgical treatment","c"
"OIC-127-09-A","{""question"": ""According to the Association Fran\u00e7aise d'Urologie, which of the following situations justifies a specialist opinion for a patient with benign prostatic hypertrophy?"", ""option_a"": ""Patient with mild symptoms and effective medical treatment"", ""option_b"": ""Patient under 50 years with isolated nocturia"", ""option_c"": ""Patient with normal PSA levels and no urinary incontinence"", ""option_d"": ""Patient with increased PSA levels and severe obstruction"", ""correct_option"": ""D""}",,"According to the Association Française d'Urologie, which of the following situations justifies a specialist opinion for a patient with benign prostatic hypertrophy?","Patient with mild symptoms and effective medical treatment","Patient under 50 years with isolated nocturia","Patient with normal PSA levels and no urinary incontinence","Patient with increased PSA levels and severe obstruction","d"
"OIC-132-01-A","{""question"": ""According to the DSM-5 definition, what is the key distinction between minor and major neuro-cognitive disorders?"", ""option_a"": ""The presence or absence of cognitive decline in one or more domains of cognition"", ""option_b"": ""The level of cognitive decline, with minor being moderate and major being significant"", ""option_c"": ""The impact of cognitive deficits on the patient's functional independence and autonomy in daily life"", ""option_d"": ""The presence or absence of another mental disorder that could explain the cognitive deficits"", ""correct_option"": ""C""}","Definition","According to the DSM-5 definition, what is the key distinction between minor and major neuro-cognitive disorders?","The presence or absence of cognitive decline in one or more domains of cognition","The level of cognitive decline, with minor being moderate and major being significant","The impact of cognitive deficits on the patient's functional independence and autonomy in daily life","The presence or absence of another mental disorder that could explain the cognitive deficits","c"
"OIC-132-02-A","{""question"": ""What are the cerebral histopathological lesions of Alzheimer's disease characterised by?"", ""option_a"": ""Only amyloid plaques and neurofibrillary degeneration"", ""option_b"": ""Amyloid plaques, neurofibrillary degeneration, activation of neuroinflammation, and neuronal loss"", ""option_c"": ""Primarily neuroinflammation and neuronal loss, with occasional amyloid plaques"", ""option_d"": ""Exclusively intracellular lesions composed of hyperphosphorylated tau protein"", ""correct_option"": ""B""}","Positive diagnosis","What are the cerebral histopathological lesions of Alzheimer's disease characterised by?","Only amyloid plaques and neurofibrillary degeneration","Amyloid plaques, neurofibrillary degeneration, activation of neuroinflammation, and neuronal loss","Primarily neuroinflammation and neuronal loss, with occasional amyloid plaques","Exclusively intracellular lesions composed of hyperphosphorylated tau protein","b"
"OIC-132-03-A","{""question"": ""What is a characteristic clinical presentation of vascular encephalopathy?"", ""option_a"": ""A gradual decline in cognitive function similar to Alzheimer's disease"", ""option_b"": ""The sudden onset of cognitive impairment, or a 'stair-step' progression"", ""option_c"": ""A loss of motor function without any cognitive impairment"", ""option_d"": ""A complete recovery of cognitive function after the initial onset"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic clinical presentation of vascular encephalopathy?","A gradual decline in cognitive function similar to Alzheimer's disease","The sudden onset of cognitive impairment, or a 'stair-step' progression","A loss of motor function without any cognitive impairment","A complete recovery of cognitive function after the initial onset","b"
"OIC-132-04-B","{""question"": ""Which of the following is a key clinical feature that supports the diagnosis of Lewy body disease?"", ""option_a"": ""Late-onset visual hallucinations"", ""option_b"": ""Early visual hallucinations"", ""option_c"": ""Complete loss of motor function"", ""option_d"": ""Absence of cognitive decline"", ""correct_option"": ""B""}","Positive diagnosis","Which of the following is a key clinical feature that supports the diagnosis of Lewy body disease?","Late-onset visual hallucinations","Early visual hallucinations","Complete loss of motor function","Absence of cognitive decline","b"
"OIC-132-05-A","{""question"": ""Which of the following conditions is a potentially reversible cause of neuro-cognitive disorders?"", ""option_a"": ""Alzheimer's disease"", ""option_b"": ""Vitamin B12 deficiency"", ""option_c"": ""Parkinson's disease"", ""option_d"": ""Amyotrophic lateral sclerosis"", ""correct_option"": ""B""}","Positive diagnosis","Which of the following conditions is a potentially reversible cause of neuro-cognitive disorders?","Alzheimer's disease","Vitamin B12 deficiency","Parkinson's disease","Amyotrophic lateral sclerosis","b"
"OIC-132-06-A","{""question"": ""According to the DSM 5, which of the following is a recognized etiology of major or mild neurocognitive disorders?"", ""option_a"": ""Chronic obstructive pulmonary disease"", ""option_b"": ""Lewy body disease"", ""option_c"": ""Type 2 diabetes mellitus"", ""option_d"": ""Hypertensive heart disease"", ""correct_option"": ""B""}","Etiologies","According to the DSM 5, which of the following is a recognized etiology of major or mild neurocognitive disorders?","Chronic obstructive pulmonary disease","Lewy body disease","Type 2 diabetes mellitus","Hypertensive heart disease","b"
"OIC-132-07-A","{""question"": ""Which of the following tools is used to assess executive functions in patients with neurocognitive disorders?"", ""option_a"": ""Mini Mental State Evaluation"", ""option_b"": ""Dubois 5-word test"", ""option_c"": ""BREF"", ""option_d"": ""Clock"", ""correct_option"": ""C""}",,"Which of the following tools is used to assess executive functions in patients with neurocognitive disorders?","Mini Mental State Evaluation","Dubois 5-word test","BREF","Clock","c"
"OIC-132-08-A","{""question"": ""What is the primary purpose of biological tests in the context of neurocognitive disorders?"", ""option_a"": ""To diagnose the underlying cause of cognitive disorders"", ""option_b"": ""To look for factors that could aggravate cognitive disorders and guide treatment based on associated comorbidities"", ""option_c"": ""To assess the severity of cognitive decline in elderly patients"", ""option_d"": ""To monitor the progression of neurocognitive disorders over time"", ""correct_option"": ""B""}",,"What is the primary purpose of biological tests in the context of neurocognitive disorders?","To diagnose the underlying cause of cognitive disorders","To look for factors that could aggravate cognitive disorders and guide treatment based on associated comorbidities","To assess the severity of cognitive decline in elderly patients","To monitor the progression of neurocognitive disorders over time","b"
"OIC-132-09-A","{""question"": ""What is the primary goal of the 'Initial management, aetiological investigation' phase in managing a patient with a neuro-cognitive disorder?"", ""option_a"": ""To introduce drug treatments in accordance with the MA"", ""option_b"": ""To conduct a thorough interview, clinical examination, neuropsychological assessment, biological and imaging tests"", ""option_c"": ""To manage other comorbidities such as anxiety-depression syndrome"", ""option_d"": ""To provide aids after assessing the impact of cognitive impairment on functional independence"", ""correct_option"": ""B""}","Management","What is the primary goal of the 'Initial management, aetiological investigation' phase in managing a patient with a neuro-cognitive disorder?","To introduce drug treatments in accordance with the MA","To conduct a thorough interview, clinical examination, neuropsychological assessment, biological and imaging tests","To manage other comorbidities such as anxiety-depression syndrome","To provide aids after assessing the impact of cognitive impairment on functional independence","b"
"OIC-132-10-A","{""question"": ""What is the primary goal of adapting aids to a patient with a neurocognitive disorder?"", ""option_a"": ""To restrict the patient's independence and autonomy"", ""option_b"": ""To provide medical treatment and manage symptoms"", ""option_c"": ""To adapt the patient's environment to their functional independence, ensuring safety and support"", ""option_d"": ""To focus solely on the patient's physical health and neglect their psychological well-being"", ""correct_option"": ""C""}","Management","What is the primary goal of adapting aids to a patient with a neurocognitive disorder?","To restrict the patient's independence and autonomy","To provide medical treatment and manage symptoms","To adapt the patient's environment to their functional independence, ensuring safety and support","To focus solely on the patient's physical health and neglect their psychological well-being","c"
"OIC-132-11-B","{""question"": ""What is the primary purpose of using the Neuro-Psychiatric Inventory in patients with dementia?"", ""option_a"": ""To diagnose the underlying cause of dementia"", ""option_b"": ""To assess the frequency and impact of behavioural symptoms"", ""option_c"": ""To develop a treatment plan for cognitive decline"", ""option_d"": ""To evaluate the effectiveness of medication"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary purpose of using the Neuro-Psychiatric Inventory in patients with dementia?","To diagnose the underlying cause of dementia","To assess the frequency and impact of behavioural symptoms","To develop a treatment plan for cognitive decline","To evaluate the effectiveness of medication","b"
"OIC-132-12-B","{""question"": ""In the management of agitation or aggression in the context of a neuro-cognitive disorder, what is the first step in addressing the patient's behavioral problems?"", ""option_a"": ""Give priority to non-medicinal approaches such as calm and soothing words"", ""option_b"": ""Assess the patient's self- and hetero-aggressiveness and the dangerousness of the environment"", ""option_c"": ""Rule out confusional syndrome and look for a factor triggering or aggravating the behavioral problems"", ""option_d"": ""Administer medication such as benzodiazepines or atypical antipsychotics"", ""correct_option"": ""C""}","Management","In the management of agitation or aggression in the context of a neuro-cognitive disorder, what is the first step in addressing the patient's behavioral problems?","Give priority to non-medicinal approaches such as calm and soothing words","Assess the patient's self- and hetero-aggressiveness and the dangerousness of the environment","Rule out confusional syndrome and look for a factor triggering or aggravating the behavioral problems","Administer medication such as benzodiazepines or atypical antipsychotics","c"
"OIC-132-13-B","{""question"": ""What are the brain lesions of Alzheimer's disease characterised by?"", ""option_a"": ""Only amyloid plaques and neurofibrillary degeneration"", ""option_b"": ""Amyloid plaques, neurofibrillary degeneration, activation of neuroinflammation, and neuronal loss"", ""option_c"": ""Primarily neuroinflammation and microhaemorrhages"", ""option_d"": ""Exclusively intracellular lesions composed of hyperphosphorylated tau protein"", ""correct_option"": ""B""}","Physiopathology","What are the brain lesions of Alzheimer's disease characterised by?","Only amyloid plaques and neurofibrillary degeneration","Amyloid plaques, neurofibrillary degeneration, activation of neuroinflammation, and neuronal loss","Primarily neuroinflammation and microhaemorrhages","Exclusively intracellular lesions composed of hyperphosphorylated tau protein","b"
"OIC-132-14-B","{""question"": ""What is a common initial clinical presentation of frontotemporal lobar degeneration (FTD)?"", ""option_a"": ""Memory loss and cognitive decline"", ""option_b"": ""Behavioural disorders, including disinhibition, apathy, and impulsivity"", ""option_c"": ""Motor symptoms, such as tremors and muscle weakness"", ""option_d"": ""Sensory symptoms, such as numbness and tingling"", ""correct_option"": ""B""}","Positive diagnosis","What is a common initial clinical presentation of frontotemporal lobar degeneration (FTD)?","Memory loss and cognitive decline","Behavioural disorders, including disinhibition, apathy, and impulsivity","Motor symptoms, such as tremors and muscle weakness","Sensory symptoms, such as numbness and tingling","b"
"OIC-132-15-B","{""question"": ""What is the primary purpose of performing cerebral imaging, such as MRI, in patients with recently discovered neurocognitive disorders?"", ""option_a"": ""To confirm the diagnosis of Alzheimer's disease"", ""option_b"": ""To rule out curable causes of cognitive impairment and obtain morphological elements for aetiology"", ""option_c"": ""To assess the severity of cognitive decline"", ""option_d"": ""To monitor the progression of neurocognitive disorders over time"", ""correct_option"": ""B""}",,"What is the primary purpose of performing cerebral imaging, such as MRI, in patients with recently discovered neurocognitive disorders?","To confirm the diagnosis of Alzheimer's disease","To rule out curable causes of cognitive impairment and obtain morphological elements for aetiology","To assess the severity of cognitive decline","To monitor the progression of neurocognitive disorders over time","b"
"OIC-132-16-B","{""question"": ""What does a CT scan typically reveal in a case of chronic Hydrocephalus or other cognitive disorders in the elderly?"", ""option_a"": ""A significant reduction in ventricular size"", ""option_b"": ""An enlargement of the ventricles due to excess cerebrospinal fluid"", ""option_c"": ""A decrease in cerebral blood flow without structural changes"", ""option_d"": ""No noticeable changes in brain structure or fluid dynamics"", ""correct_option"": ""B""}","Multimedia content","What does a CT scan typically reveal in a case of chronic Hydrocephalus or other cognitive disorders in the elderly?","A significant reduction in ventricular size","An enlargement of the ventricles due to excess cerebrospinal fluid","A decrease in cerebral blood flow without structural changes","No noticeable changes in brain structure or fluid dynamics","b"
"OIC-133-01-A","{""question"": ""What is the primary characteristic that distinguishes autonomy from dependence in an individual?"", ""option_a"": ""The ability to perform daily tasks without assistance"", ""option_b"": ""The capacity for judgement and self-governance"", ""option_c"": ""The need for constant medical supervision"", ""option_d"": ""The reliance on technology for daily activities"", ""correct_option"": ""B""}","Definition","What is the primary characteristic that distinguishes autonomy from dependence in an individual?","The ability to perform daily tasks without assistance","The capacity for judgement and self-governance","The need for constant medical supervision","The reliance on technology for daily activities","b"
"OIC-133-02-B","{""question"": ""What does the 'Toilette' variable in the GIR score comprise of?"", ""option_a"": ""Dressing and undressing"", ""option_b"": ""Personal hygiene, divided into top and lower toilet"", ""option_c"": ""Urinary and faecal elimination"", ""option_d"": ""Moving around inside and outside the home"", ""correct_option"": ""B""}","Definition","What does the 'Toilette' variable in the GIR score comprise of?","Dressing and undressing","Personal hygiene, divided into top and lower toilet","Urinary and faecal elimination","Moving around inside and outside the home","b"
"OIC-133-03-A","{""question"": ""According to Wood's functional analysis of diseases, what is 'disability' expressed in terms of?"", ""option_a"": ""Organ or system anomaly"", ""option_b"": ""Function or performance"", ""option_c"": ""Socio-economic difficulties"", ""option_d"": ""Life events such as widowhood or moving"", ""correct_option"": ""B""}","Definition","According to Wood's functional analysis of diseases, what is 'disability' expressed in terms of?","Organ or system anomaly","Function or performance","Socio-economic difficulties","Life events such as widowhood or moving","b"
"OIC-133-04-A","{""question"": ""What does the Katz scale measure in the context of assessing dependency in elderly people?"", ""option_a"": ""Instrumental activities of daily living, such as using a telephone or managing a personal budget"", ""option_b"": ""Basic acts of daily living, including body care, dressing, and eating"", ""option_c"": ""Cognitive functions, such as arithmetic and executive strategies"", ""option_d"": ""The ability to live alone at home without any assistance"", ""correct_option"": ""B""}","Positive diagnosis","What does the Katz scale measure in the context of assessing dependency in elderly people?","Instrumental activities of daily living, such as using a telephone or managing a personal budget","Basic acts of daily living, including body care, dressing, and eating","Cognitive functions, such as arithmetic and executive strategies","The ability to live alone at home without any assistance","b"
"OIC-133-05-B","{""question"": ""What is a common risk factor that can contribute to the development of iatrogenic dependence in elderly patients, particularly when cared for at home?"", ""option_a"": ""Chronic disease management"", ""option_b"": ""Undernutrition"", ""option_c"": ""Social isolation"", ""option_d"": ""Lack of access to healthcare services"", ""correct_option"": ""B""}","Physiopathology","What is a common risk factor that can contribute to the development of iatrogenic dependence in elderly patients, particularly when cared for at home?","Chronic disease management","Undernutrition","Social isolation","Lack of access to healthcare services","b"
"OIC-133-06-B","{""question"": ""What is the main consequence of dependency for the carer?"", ""option_a"": ""Risk of abuse"", ""option_b"": ""The exhaustion of the carer"", ""option_c"": ""Physical reduction in capacity"", ""option_d"": ""Social isolation"", ""correct_option"": ""B""}","Positive diagnosis","What is the main consequence of dependency for the carer?","Risk of abuse","The exhaustion of the carer","Physical reduction in capacity","Social isolation","b"
"OIC-133-07-A","{""question"": ""What type of financial aid is available for individuals with a GIR score of 1 to 4?"", ""option_a"": ""Financial aid paid by pension funds and/or mutual insurance companies"", ""option_b"": ""Allocation personne \u00e2g\u00e9e (APA) for home help, meal delivery, and certain home improvements"", ""option_c"": ""Full coverage of accommodation costs in Etablissements d'H\u00e9bergements pour personnes \u00e2g\u00e9es d\u00e9pendantes (EHPAD)"", ""option_d"": ""Direct financial assistance from the Conseils d\u00e9partementaux for medical expenses"", ""correct_option"": ""B""}",,"What type of financial aid is available for individuals with a GIR score of 1 to 4?","Financial aid paid by pension funds and/or mutual insurance companies","Allocation personne âgée (APA) for home help, meal delivery, and certain home improvements","Full coverage of accommodation costs in Etablissements d'Hébergements pour personnes âgées dépendantes (EHPAD)","Direct financial assistance from the Conseils départementaux for medical expenses","b"
"OIC-133-08-A","{""question"": ""What is the primary purpose of the 'Sauvegarde de justice' measure in the context of social care for dependent elderly people in France?"", ""option_a"": ""To provide long-term legal protection through guardianship or curatorship"", ""option_b"": ""To allow a relative to represent a person who is unable to express their wishes"", ""option_c"": ""To enable an adult to be represented for certain acts without the need for more restrictive measures like guardianship or curatorship"", ""option_d"": ""To require a doctor to report serious acts to the Public Prosecutor without the victim's consent"", ""correct_option"": ""C""}","Taking charge","What is the primary purpose of the 'Sauvegarde de justice' measure in the context of social care for dependent elderly people in France?","To provide long-term legal protection through guardianship or curatorship","To allow a relative to represent a person who is unable to express their wishes","To enable an adult to be represented for certain acts without the need for more restrictive measures like guardianship or curatorship","To require a doctor to report serious acts to the Public Prosecutor without the victim's consent","c"
"OIC-133-09-B","{""question"": ""What type of facility provides non-medical collective accommodation for elderly people with a good level of physical independence?"", ""option_a"": ""Residential establishments for dependent elderly people (EHPAD)"", ""option_b"": ""Establishments providing accommodation for the elderly (EHPA)"", ""option_c"": ""\u00c9tablissements de soins de longue dur\u00e9e (ou Unit\u00e9 de soins longue dur\u00e9e)"", ""option_d"": ""Accueillant familiaux"", ""correct_option"": ""B""}","Care","What type of facility provides non-medical collective accommodation for elderly people with a good level of physical independence?","Residential establishments for dependent elderly people (EHPAD)","Establishments providing accommodation for the elderly (EHPA)","Établissements de soins de longue durée (ou Unité de soins longue durée)","Accueillant familiaux","b"
"OIC-134-01-A","{""question"": ""According to the International Association for the Study of Pain, what is pain defined as?"", ""option_a"": ""A purely biological response to tissue damage"", ""option_b"": ""A sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage"", ""option_c"": ""The activation of sensory neurons in response to injury"", ""option_d"": ""A solely psychological phenomenon unrelated to physical tissue damage"", ""correct_option"": ""B""}","Definition","According to the International Association for the Study of Pain, what is pain defined as?","A purely biological response to tissue damage","A sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage","The activation of sensory neurons in response to injury","A solely psychological phenomenon unrelated to physical tissue damage","b"
"OIC-134-02-B","{""question"": ""What is the primary role of nociceptors in the body?"", ""option_a"": ""To transmit signals for emotional responses"", ""option_b"": ""To detect potentially dangerous stimuli and protect the body's integrity"", ""option_c"": ""To regulate the body's metabolic processes"", ""option_d"": ""To facilitate voluntary movement"", ""correct_option"": ""B""}","Physiopathology","What is the primary role of nociceptors in the body?","To transmit signals for emotional responses","To detect potentially dangerous stimuli and protect the body's integrity","To regulate the body's metabolic processes","To facilitate voluntary movement","b"
"OIC-134-03-A","{""question"": ""What is the primary purpose of using a validated self-assessment scale, such as the Visual Analogue Scale (VAS) or the Numerical Scale (EN), when assessing a patient's pain?"", ""option_a"": ""To diagnose the underlying cause of the patient's pain"", ""option_b"": ""To evaluate the patient's response to analgesic treatment"", ""option_c"": ""To assess the intensity of the patient's pain and determine the appropriate level of treatment"", ""option_d"": ""To identify potential psychological factors contributing to the patient's pain"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary purpose of using a validated self-assessment scale, such as the Visual Analogue Scale (VAS) or the Numerical Scale (EN), when assessing a patient's pain?","To diagnose the underlying cause of the patient's pain","To evaluate the patient's response to analgesic treatment","To assess the intensity of the patient's pain and determine the appropriate level of treatment","To identify potential psychological factors contributing to the patient's pain","c"
"OIC-134-04-A","{""question"": ""What is the primary purpose of using validated self-assessment scales, such as EVA, EN, or EVS, in the diagnosis and assessment of pain intensity in adults?"", ""option_a"": ""To determine the underlying cause of the pain"", ""option_b"": ""To assess the patient's overall quality of life"", ""option_c"": ""To evaluate the efficacy of analgesic treatment"", ""option_d"": ""To obtain a quantitative measurement of the patient's pain intensity"", ""correct_option"": ""D""}","Positive diagnosis","What is the primary purpose of using validated self-assessment scales, such as EVA, EN, or EVS, in the diagnosis and assessment of pain intensity in adults?","To determine the underlying cause of the pain","To assess the patient's overall quality of life","To evaluate the efficacy of analgesic treatment","To obtain a quantitative measurement of the patient's pain intensity","d"
"OIC-134-05-B","{""question"": ""What percentage of patients admitted to emergency departments have moderate to severe pain?"", ""option_a"": ""More than 40%"", ""option_b"": ""More than 60%"", ""option_c"": ""Less than 30%"", ""option_d"": ""Around 50%"", ""correct_option"": ""B""}",,"What percentage of patients admitted to emergency departments have moderate to severe pain?","More than 40%","More than 60%","Less than 30%","Around 50%","b"
"OIC-134-06-A","{""question"": ""What is the primary purpose of using a validated self-assessment scale, such as EVA, EN, or EVS, in assessing pain intensity in adults?"", ""option_a"": ""To diagnose the underlying cause of the pain"", ""option_b"": ""To evaluate the efficacy of analgesic treatment"", ""option_c"": ""To assess the intensity of pain and initiate appropriate treatment"", ""option_d"": ""To identify the location of the pain"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary purpose of using a validated self-assessment scale, such as EVA, EN, or EVS, in assessing pain intensity in adults?","To diagnose the underlying cause of the pain","To evaluate the efficacy of analgesic treatment","To assess the intensity of pain and initiate appropriate treatment","To identify the location of the pain","c"
"OIC-134-07-A","{""question"": ""What is the primary characteristic that distinguishes nociceptive pain from neuropathic pain in terms of symptomatology?"", ""option_a"": ""Nociceptive pain is always chronic"", ""option_b"": ""Nociceptive pain has a specific symptomatology"", ""option_c"": ""Nociceptive pain is generally located opposite the lesion"", ""option_d"": ""Nociceptive pain is not associated with inflammatory signs"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary characteristic that distinguishes nociceptive pain from neuropathic pain in terms of symptomatology?","Nociceptive pain is always chronic","Nociceptive pain has a specific symptomatology","Nociceptive pain is generally located opposite the lesion","Nociceptive pain is not associated with inflammatory signs","c"
"OIC-134-08-A","{""question"": ""What is the primary distinction between neuropathic pain and nociceptive pain?"", ""option_a"": ""Neuropathic pain is caused by injury or disease of the somatosensory system, while nociceptive pain is caused by excess nociception linked to abnormal activation of nociceptors"", ""option_b"": ""Neuropathic pain is caused by excess nociception linked to abnormal activation of nociceptors, while nociceptive pain is caused by injury or disease of the somatosensory system"", ""option_c"": ""Neuropathic pain is caused by central nervous system damage, while nociceptive pain is caused by peripheral nervous system damage"", ""option_d"": ""Neuropathic pain is caused by peripheral nervous system damage, while nociceptive pain is caused by central nervous system damage"", ""correct_option"": ""A""}","Positive diagnosis","What is the primary distinction between neuropathic pain and nociceptive pain?","Neuropathic pain is caused by injury or disease of the somatosensory system, while nociceptive pain is caused by excess nociception linked to abnormal activation of nociceptors","Neuropathic pain is caused by excess nociception linked to abnormal activation of nociceptors, while nociceptive pain is caused by injury or disease of the somatosensory system","Neuropathic pain is caused by central nervous system damage, while nociceptive pain is caused by peripheral nervous system damage","Neuropathic pain is caused by peripheral nervous system damage, while nociceptive pain is caused by central nervous system damage","a"
"OIC-134-09-A","{""question"": ""What percentage of patients with advanced cancer appear to be under-treated for pain, according to the Inca survey carried out for the second cancer plan in 2010?"", ""option_a"": ""42%"", ""option_b"": ""52%"", ""option_c"": ""62%"", ""option_d"": ""72%"", ""correct_option"": ""C""}","Positive diagnosis","What percentage of patients with advanced cancer appear to be under-treated for pain, according to the Inca survey carried out for the second cancer plan in 2010?","42%","52%","62%","72%","c"
"OIC-134-10-A","{""question"": ""What is the primary approach to pain management in elderly patients, according to the 4 pillars of pain management?"", ""option_a"": ""Treatment based solely on the patient's age"", ""option_b"": ""Rep\u00e9rage, Eappraisal, Traitement, and Re-Eappraisal of pain"", ""option_c"": ""Fighting against pain without considering the patient's state of health"", ""option_d"": ""Using only non-pharmacological techniques to manage pain"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary approach to pain management in elderly patients, according to the 4 pillars of pain management?","Treatment based solely on the patient's age","Repérage, Eappraisal, Traitement, and Re-Eappraisal of pain","Fighting against pain without considering the patient's state of health","Using only non-pharmacological techniques to manage pain","b"
"OIC-134-11-A","{""question"": ""What is the primary pathophysiological mechanism underlying nociplastic pain syndromes, such as fibromyalgia and irritable bowel syndrome?"", ""option_a"": ""An alteration in nociception due to a tissue lesion activating the nociceptors"", ""option_b"": ""A disease or lesion affecting the somato-sensory system"", ""option_c"": ""An alteration in 'pain control and modulation systems', with a reduction in inhibitory mechanisms and/or an increase in facilitatory mechanisms"", ""option_d"": ""An inflammatory response causing damage to the nervous system"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary pathophysiological mechanism underlying nociplastic pain syndromes, such as fibromyalgia and irritable bowel syndrome?","An alteration in nociception due to a tissue lesion activating the nociceptors","A disease or lesion affecting the somato-sensory system","An alteration in 'pain control and modulation systems', with a reduction in inhibitory mechanisms and/or an increase in facilitatory mechanisms","An inflammatory response causing damage to the nervous system","c"
"OIC-136-01-B","{""question"": ""What percentage of anaesthetic procedures in France are targeted to be performed on an outpatient basis in the long term?"", ""option_a"": ""40%"", ""option_b"": ""50%"", ""option_c"": ""60%"", ""option_d"": ""70%"", ""correct_option"": ""D""}",,"What percentage of anaesthetic procedures in France are targeted to be performed on an outpatient basis in the long term?","40%","50%","60%","70%","d"
"OIC-136-02-A","{""question"": ""What is the current estimated mortality rate directly attributable to anaesthesia in France?"", ""option_a"": ""1 death for every 10,000 anaesthesias"", ""option_b"": ""1 death for every 50,000 anaesthesias"", ""option_c"": ""1 death for every 200,000 anaesthesias"", ""option_d"": ""1 death for every 500,000 anaesthesias"", ""correct_option"": ""C""}","Epidemiology","What is the current estimated mortality rate directly attributable to anaesthesia in France?","1 death for every 10,000 anaesthesias","1 death for every 50,000 anaesthesias","1 death for every 200,000 anaesthesias","1 death for every 500,000 anaesthesias","c"
"OIC-136-03-A","{""question"": ""What is the minimum time required before a scheduled operation for a pre-anaesthetic consultation to be carried out?"", ""option_a"": ""At least 1 day"", ""option_b"": ""At least 2 days"", ""option_c"": ""At least 1 week"", ""option_d"": ""At least 1 month"", ""correct_option"": ""B""}","Management","What is the minimum time required before a scheduled operation for a pre-anaesthetic consultation to be carried out?","At least 1 day","At least 2 days","At least 1 week","At least 1 month","b"
"OIC-136-04-A","{""question"": ""What should be done with anticoagulant treatments in the perioperative period due to the risk of hemorrhage?"", ""option_a"": ""Continue the treatment as usual"", ""option_b"": ""Stop the treatment"", ""option_c"": ""Reduce the dosage of the treatment"", ""option_d"": ""Increase the dosage of the treatment"", ""correct_option"": ""B""}",,"What should be done with anticoagulant treatments in the perioperative period due to the risk of hemorrhage?","Continue the treatment as usual","Stop the treatment","Reduce the dosage of the treatment","Increase the dosage of the treatment","b"
"OIC-136-05-A","{""question"": ""What is the primary characteristic that distinguishes local anaesthesia from other types of anaesthesia?"", ""option_a"": ""It involves a reversible loss of consciousness"", ""option_b"": ""It is used for chronic pain management"", ""option_c"": ""It can be performed by any doctor, regardless of their specialty"", ""option_d"": ""It requires a curare for its administration"", ""correct_option"": ""C""}","Definition","What is the primary characteristic that distinguishes local anaesthesia from other types of anaesthesia?","It involves a reversible loss of consciousness","It is used for chronic pain management","It can be performed by any doctor, regardless of their specialty","It requires a curare for its administration","c"
"OIC-136-06-A","{""question"": ""What is the primary purpose of understanding the mechanism of action of curares in the context of general anaesthesia?"", ""option_a"": ""To determine the appropriate dosage for a specific patient"", ""option_b"": ""To understand how curares interact with other anaesthetic agents"", ""option_c"": ""To inform the preoperative explanation and collection of consent for an invasive diagnostic or therapeutic procedure"", ""option_d"": ""To appreciate the principles, indications, and main complications of general anaesthesia"", ""correct_option"": ""D""}","Management","What is the primary purpose of understanding the mechanism of action of curares in the context of general anaesthesia?","To determine the appropriate dosage for a specific patient","To understand how curares interact with other anaesthetic agents","To inform the preoperative explanation and collection of consent for an invasive diagnostic or therapeutic procedure","To appreciate the principles, indications, and main complications of general anaesthesia","d"
"OIC-136-07-A","{""question"": ""What is the primary purpose of understanding the anatomical bases of locoregional anaesthesia?"", ""option_a"": ""To identify the most suitable type of general anaesthesia for a patient"", ""option_b"": ""To minimize the risk of complications and ensure effective pain management during invasive procedures"", ""option_c"": ""To determine the optimal dosage of anaesthetic agents for a specific surgical procedure"", ""option_d"": ""To decide whether a preoperative explanation and collection of consent are necessary"", ""correct_option"": ""B""}","Management","What is the primary purpose of understanding the anatomical bases of locoregional anaesthesia?","To identify the most suitable type of general anaesthesia for a patient","To minimize the risk of complications and ensure effective pain management during invasive procedures","To determine the optimal dosage of anaesthetic agents for a specific surgical procedure","To decide whether a preoperative explanation and collection of consent are necessary","b"
"OIC-136-08-B","{""question"": ""What is the primary mechanism of action of local anaesthetics during locoregional anaesthesia?"", ""option_a"": ""Blocking voltage-dependent calcium channels"", ""option_b"": ""Blocking voltage-dependent sodium channels"", ""option_c"": ""Blocking voltage-dependent potassium channels"", ""option_d"": ""Enhancing voltage-dependent sodium channels"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of local anaesthetics during locoregional anaesthesia?","Blocking voltage-dependent calcium channels","Blocking voltage-dependent sodium channels","Blocking voltage-dependent potassium channels","Enhancing voltage-dependent sodium channels","b"
"OIC-136-09-B","{""question"": ""Which of the following is NOT one of the main local anaesthetics used?"", ""option_a"": ""Lidocaine"", ""option_b"": ""Mepivacaine"", ""option_c"": ""Bupivacaine"", ""option_d"": ""Ketamine"", ""correct_option"": ""D""}","Management","Which of the following is NOT one of the main local anaesthetics used?","Lidocaine","Mepivacaine","Bupivacaine","Ketamine","d"
"OIC-136-10-B","{""question"": ""What type of nerve fibers primarily transmit the visceral pain impulse during the first phase of labour?"", ""option_a"": ""A\u03b4 fibres"", ""option_b"": ""Non-myelinated C fibres"", ""option_c"": ""Myelinated A\u03b2 fibres"", ""option_d"": ""Pudendal nerves"", ""correct_option"": ""B""}","Physiopathology","What type of nerve fibers primarily transmit the visceral pain impulse during the first phase of labour?","Aδ fibres","Non-myelinated C fibres","Myelinated Aβ fibres","Pudendal nerves","b"
"OIC-136-11-A","{""question"": ""What is the technique of choice for obstetric analgesia/anaesthesia?"", ""option_a"": ""General anaesthesia"", ""option_b"": ""Peri-medullary anaesthesia"", ""option_c"": ""Local infiltration anaesthesia"", ""option_d"": ""Epidural anaesthesia"", ""correct_option"": ""B""}","Management","What is the technique of choice for obstetric analgesia/anaesthesia?","General anaesthesia","Peri-medullary anaesthesia","Local infiltration anaesthesia","Epidural anaesthesia","b"
"OIC-136-12-B","{""question"": ""What is the primary goal of early rehabilitation after surgery (RAC) in the context of ambulatory surgery?"", ""option_a"": ""To minimize the use of anaesthesia during surgical procedures"", ""option_b"": ""To promote early recovery of the patient's abilities after surgery"", ""option_c"": ""To reduce the number of overnight accommodations in healthcare facilities"", ""option_d"": ""To increase the complexity of surgical procedures performed on an outpatient basis"", ""correct_option"": ""B""}","Management","What is the primary goal of early rehabilitation after surgery (RAC) in the context of ambulatory surgery?","To minimize the use of anaesthesia during surgical procedures","To promote early recovery of the patient's abilities after surgery","To reduce the number of overnight accommodations in healthcare facilities","To increase the complexity of surgical procedures performed on an outpatient basis","b"
"OIC-142-01-B","{""question"": ""What is the primary consideration when deciding to limit or stop treatment for a newborn with a serious neurological lesion or extreme prematurity?"", ""option_a"": ""The child's potential for future suffering"", ""option_b"": ""The parents' wishes, informed of the severity of the prognosis"", ""option_c"": ""The cost of continued treatment"", ""option_d"": ""The likelihood of a full recovery"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary consideration when deciding to limit or stop treatment for a newborn with a serious neurological lesion or extreme prematurity?","The child's potential for future suffering","The parents' wishes, informed of the severity of the prognosis","The cost of continued treatment","The likelihood of a full recovery","b"
"OIC-142-02-B","{""question"": ""What is a key aspect of perinatal bereavement that healthcare providers should acknowledge?"", ""option_a"": ""The loss of a baby can be minimized if it occurs early in pregnancy"", ""option_b"": ""The experience of perinatal death is always traumatic and unique to each individual"", ""option_c"": ""Perinatal bereavement only applies to stillbirths and not to miscarriages or abortions"", ""option_d"": ""Family and friends can fully understand the situation without needing additional support or education"", ""correct_option"": ""B""}","Positive diagnosis","What is a key aspect of perinatal bereavement that healthcare providers should acknowledge?","The loss of a baby can be minimized if it occurs early in pregnancy","The experience of perinatal death is always traumatic and unique to each individual","Perinatal bereavement only applies to stillbirths and not to miscarriages or abortions","Family and friends can fully understand the situation without needing additional support or education","b"
"OIC-145-01-A","{""question"": ""What characterizes a communicable infectious disease?"", ""option_a"": ""It is caused by a non-infectious agent and can only be transmitted from person to person"", ""option_b"": ""It is caused by an infectious agent and can be transmitted between individuals or from a common source"", ""option_c"": ""It is not caused by an infectious agent but can be transmitted between individuals"", ""option_d"": ""It is caused by an infectious agent but cannot be transmitted between individuals or from a common source"", ""correct_option"": ""B""}","Definition","What characterizes a communicable infectious disease?","It is caused by a non-infectious agent and can only be transmitted from person to person","It is caused by an infectious agent and can be transmitted between individuals or from a common source","It is not caused by an infectious agent but can be transmitted between individuals","It is caused by an infectious agent but cannot be transmitted between individuals or from a common source","b"
"OIC-145-02-B","{""question"": ""What is the primary aim of communicable infectious disease surveillance?"", ""option_a"": ""To solely collect clinical data relating to infectious diseases"", ""option_b"": ""To describe a disease and study its risk factors, with a view to implementing and evaluating prevention and control measures"", ""option_c"": ""To only monitor the spread of diseases at an international level"", ""option_d"": ""To just analyze microbiological data from laboratory networks"", ""correct_option"": ""B""}",,"What is the primary aim of communicable infectious disease surveillance?","To solely collect clinical data relating to infectious diseases","To describe a disease and study its risk factors, with a view to implementing and evaluating prevention and control measures","To only monitor the spread of diseases at an international level","To just analyze microbiological data from laboratory networks","b"
"OIC-145-03-B","{""question"": ""Which organization is primarily responsible for the surveillance of communicable infectious diseases in France?"", ""option_a"": ""Regional Health Agencies (ARS)"", ""option_b"": ""National Reference Centres (CNR)"", ""option_c"": ""Sant\u00e9 Publique France"", ""option_d"": ""National surveillance networks"", ""correct_option"": ""C""}","Definition","Which organization is primarily responsible for the surveillance of communicable infectious diseases in France?","Regional Health Agencies (ARS)","National Reference Centres (CNR)","Santé Publique France","National surveillance networks","c"
"OIC-145-04-B","{""question"": ""What is the definition of the 'Attack rate' in the context of epidemiology?"", ""option_a"": ""The ratio between the number of new cases of a disease in a population, during a given period, and the total population monitored during the period"", ""option_b"": ""The ratio between the number of deaths in a given period and the total population"", ""option_c"": ""The ratio between the number of new cases of infection during a given period and the total number of uninfected contacts at the start of the period"", ""option_d"": ""The expected average number of new cases of a communicable disease directly generated by a contagious person in a population where all individuals are susceptible to infection"", ""correct_option"": ""C""}","Definition","What is the definition of the 'Attack rate' in the context of epidemiology?","The ratio between the number of new cases of a disease in a population, during a given period, and the total population monitored during the period","The ratio between the number of deaths in a given period and the total population","The ratio between the number of new cases of infection during a given period and the total number of uninfected contacts at the start of the period","The expected average number of new cases of a communicable disease directly generated by a contagious person in a population where all individuals are susceptible to infection","c"
"OIC-145-05-B","{""question"": ""What is the definition of sensitivity in the context of diagnostic tests?"", ""option_a"": ""Proportion of subjects classified as not ill out of all subjects not affected by the disease"", ""option_b"": ""Proportion of subjects classified as ill out of all subjects actually suffering from the disease"", ""option_c"": ""Proportion of sick subjects among those classified as sick"", ""option_d"": ""Proportion of non-diseased subjects among those classified as non-diseased"", ""correct_option"": ""B""}","Definition","What is the definition of sensitivity in the context of diagnostic tests?","Proportion of subjects classified as not ill out of all subjects not affected by the disease","Proportion of subjects classified as ill out of all subjects actually suffering from the disease","Proportion of sick subjects among those classified as sick","Proportion of non-diseased subjects among those classified as non-diseased","b"
"OIC-145-06-B","{""question"": ""What are the four main missions of Sant\u00e9 Publique France in the field of infectious diseases?"", ""option_a"": ""Data collection, health research, patient care, and medical education"", ""option_b"": ""Ongoing monitoring and observation, health watch and vigilance, health warning, and contributing to the management of health crisis situations"", ""option_c"": ""Vaccination programs, disease treatment, health policy development, and international collaboration"", ""option_d"": ""Environmental health monitoring, occupational health surveillance, chronic disease management, and trauma care"", ""correct_option"": ""B""}","Definition","What are the four main missions of Santé Publique France in the field of infectious diseases?","Data collection, health research, patient care, and medical education","Ongoing monitoring and observation, health watch and vigilance, health warning, and contributing to the management of health crisis situations","Vaccination programs, disease treatment, health policy development, and international collaboration","Environmental health monitoring, occupational health surveillance, chronic disease management, and trauma care","b"
"OIC-145-07-B","{""question"": ""What is the term used to describe an infection where the reservoir is the microbiota, including all commensal microorganisms hosted in the skin, mucous membranes, and digestive tract?"", ""option_a"": ""Exogenous infection"", ""option_b"": ""Endogenous infection"", ""option_c"": ""Zoonotic infection"", ""option_d"": ""Environmental infection"", ""correct_option"": ""B""}","Physiopathology","What is the term used to describe an infection where the reservoir is the microbiota, including all commensal microorganisms hosted in the skin, mucous membranes, and digestive tract?","Exogenous infection","Endogenous infection","Zoonotic infection","Environmental infection","b"
"OIC-145-08-A","{""question"": ""What is the primary mechanism by which oral-tracheal-bronchial secretions, also known as Pfl\u00fcgge droplets, are transmitted?"", ""option_a"": ""Through direct contact with contaminated food or water"", ""option_b"": ""By inhalation of airborne particles over long distances"", ""option_c"": ""By deposition on mucous membranes after being emitted through speaking, coughing, or sneezing"", ""option_d"": ""Through vertical transmission from mother to child"", ""correct_option"": ""C""}","Physiopathology","What is the primary mechanism by which oral-tracheal-bronchial secretions, also known as Pflügge droplets, are transmitted?","Through direct contact with contaminated food or water","By inhalation of airborne particles over long distances","By deposition on mucous membranes after being emitted through speaking, coughing, or sneezing","Through vertical transmission from mother to child","c"
"OIC-145-09-B","{""question"": ""What is the primary mode of transmission for tuberculosis?"", ""option_a"": ""Direct contact with an infected person's saliva"", ""option_b"": ""Through contaminated food or water"", ""option_c"": ""Airborne transmission"", ""option_d"": ""Vector-borne transmission via an insect"", ""correct_option"": ""C""}","Epidemiology","What is the primary mode of transmission for tuberculosis?","Direct contact with an infected person's saliva","Through contaminated food or water","Airborne transmission","Vector-borne transmission via an insect","c"
"OIC-145-10-A","{""question"": ""What is the primary purpose of the first stage of compulsory reporting of notifiable diseases in France?"", ""option_a"": ""Epidemiological monitoring"", ""option_b"": ""Implementation of urgent prevention or control measures around cases"", ""option_c"": ""Updating the list of notifiable diseases"", ""option_d"": ""Informing the patient or the patient's family about the report"", ""correct_option"": ""B""}","Epidemiology","What is the primary purpose of the first stage of compulsory reporting of notifiable diseases in France?","Epidemiological monitoring","Implementation of urgent prevention or control measures around cases","Updating the list of notifiable diseases","Informing the patient or the patient's family about the report","b"
"OIC-145-11-B","{""question"": ""What is the primary role of National Centres of Reference (NCR) in France?"", ""option_a"": ""To develop and implement public health policies"", ""option_b"": ""To provide expertise in microbiology and pathology of infectious agents, and contribute to epidemiological surveillance"", ""option_c"": ""To conduct clinical trials for new vaccines and treatments"", ""option_d"": ""To manage and coordinate healthcare services at the national level"", ""correct_option"": ""B""}","Definition","What is the primary role of National Centres of Reference (NCR) in France?","To develop and implement public health policies","To provide expertise in microbiology and pathology of infectious agents, and contribute to epidemiological surveillance","To conduct clinical trials for new vaccines and treatments","To manage and coordinate healthcare services at the national level","b"
"OIC-145-12-A","{""question"": ""What is the primary goal of standard precautions in healthcare settings?"", ""option_a"": ""To eradicate infectious diseases from the community"", ""option_b"": ""To reduce the risk of cross-transmission of infectious agents between carers, patients, and the environment"", ""option_c"": ""To develop new medications for infectious diseases"", ""option_d"": ""To increase the use of personal protective equipment in non-medical settings"", ""correct_option"": ""B""}",,"What is the primary goal of standard precautions in healthcare settings?","To eradicate infectious diseases from the community","To reduce the risk of cross-transmission of infectious agents between carers, patients, and the environment","To develop new medications for infectious diseases","To increase the use of personal protective equipment in non-medical settings","b"
"OIC-145-13-A","{""question"": ""What is the primary purpose of eviction measures in the context of transmissible infectious diseases?"", ""option_a"": ""To permanently exclude individuals with infectious diseases from social interactions"", ""option_b"": ""To temporarily exclude individuals with infectious diseases from certain settings, such as schools or childcare groups, to prevent disease transmission"", ""option_c"": ""To provide additional medical treatment to individuals with infectious diseases"", ""option_d"": ""To lift isolation measures for individuals with infectious diseases"", ""correct_option"": ""B""}","Epidemiology","What is the primary purpose of eviction measures in the context of transmissible infectious diseases?","To permanently exclude individuals with infectious diseases from social interactions","To temporarily exclude individuals with infectious diseases from certain settings, such as schools or childcare groups, to prevent disease transmission","To provide additional medical treatment to individuals with infectious diseases","To lift isolation measures for individuals with infectious diseases","b"
"OIC-145-14-B","{""question"": ""What is the primary purpose of the Sentinelles network in France?"", ""option_a"": ""To provide medical care to patients with infectious diseases"", ""option_b"": ""To monitor and research communicable infectious diseases in primary care"", ""option_c"": ""To develop vaccines for infectious diseases"", ""option_d"": ""To train general practitioners and paediatricians in infectious disease management"", ""correct_option"": ""B""}","Definition","What is the primary purpose of the Sentinelles network in France?","To provide medical care to patients with infectious diseases","To monitor and research communicable infectious diseases in primary care","To develop vaccines for infectious diseases","To train general practitioners and paediatricians in infectious disease management","b"
"OIC-153-01-A","{""question"": ""What is the primary material used to make mechanical valve prostheses?"", ""option_a"": ""Bovine pericardium"", ""option_b"": ""Titanium and carbon"", ""option_c"": ""Dacron or Teflon"", ""option_d"": ""Porcine xenografts"", ""correct_option"": ""B""}",,"What is the primary material used to make mechanical valve prostheses?","Bovine pericardium","Titanium and carbon","Dacron or Teflon","Porcine xenografts","b"
"OIC-153-02-A","{""question"": ""What is the main cause of thrombo-embolic complications in patients with mechanical valve prostheses?"", ""option_a"": ""Poorly balanced INR"", ""option_b"": ""Prosthesis disinsertion"", ""option_c"": ""Degeneration of bioprostheses"", ""option_d"": ""Infectious endocarditis"", ""correct_option"": ""A""}","Definition","What is the main cause of thrombo-embolic complications in patients with mechanical valve prostheses?","Poorly balanced INR","Prosthesis disinsertion","Degeneration of bioprostheses","Infectious endocarditis","a"
"OIC-153-03-A","{""question"": ""How often should clinical monitoring by the GP be carried out for wearers of prosthetic valves?"", ""option_a"": ""Every 6 months"", ""option_b"": ""Every 3 months"", ""option_c"": ""Every year"", ""option_d"": ""Only when symptoms appear"", ""correct_option"": ""B""}",,"How often should clinical monitoring by the GP be carried out for wearers of prosthetic valves?","Every 6 months","Every 3 months","Every year","Only when symptoms appear","b"
"OIC-153-04-A","{""question"": ""What is the primary factor that increases the risk of infective endocarditis in patients with prosthetic heart valves?"", ""option_a"": ""The type of material used for the prosthetic valve"", ""option_b"": ""The presence of a prosthetic valve itself"", ""option_c"": ""The patient's age at the time of implantation"", ""option_d"": ""The patient's overall health condition before surgery"", ""correct_option"": ""B""}","Identification of the emergency","What is the primary factor that increases the risk of infective endocarditis in patients with prosthetic heart valves?","The type of material used for the prosthetic valve","The presence of a prosthetic valve itself","The patient's age at the time of implantation","The patient's overall health condition before surgery","b"
"OIC-153-05-A","{""question"": ""What is the recommended INR target for a patient with a low-risk mechanical prosthesis and no risk factors?"", ""option_a"": ""2.0"", ""option_b"": ""2.5"", ""option_c"": ""3.0"", ""option_d"": ""3.5"", ""correct_option"": ""B""}",,"What is the recommended INR target for a patient with a low-risk mechanical prosthesis and no risk factors?",2,2.5,3,3.5,"b"
"OIC-153-06-B","{""question"": ""What is the primary diagnostic tool used to identify a paraprosthetic leak in a patient with a suspected prosthetic valve deinsertion?"", ""option_a"": ""Blood cultures"", ""option_b"": ""Physical examination with auscultation of regurgitant murmurs"", ""option_c"": ""Colour Doppler echocardiography, specifically TTE or TEE"", ""option_d"": ""Laboratory tests for haemolysis, such as LDH and haptoglobin levels"", ""correct_option"": ""C""}",,"What is the primary diagnostic tool used to identify a paraprosthetic leak in a patient with a suspected prosthetic valve deinsertion?","Blood cultures","Physical examination with auscultation of regurgitant murmurs","Colour Doppler echocardiography, specifically TTE or TEE","Laboratory tests for haemolysis, such as LDH and haptoglobin levels","c"
"OIC-156-01-A","{""question"": ""What is the primary characteristic that distinguishes acute osteomyelitis from chronic osteitis in the context of osteoarticular infections?"", ""option_a"": ""The presence of prosthetic material"", ""option_b"": ""The anatomical location of the infection"", ""option_c"": ""The mode of onset and progression time, with acute osteomyelitis being an acute haematogenous form of osteitis"", ""option_d"": ""The type of infectious agent, with acute osteomyelitis being caused by viruses and chronic osteitis by bacteria"", ""correct_option"": ""C""}","Definition","What is the primary characteristic that distinguishes acute osteomyelitis from chronic osteitis in the context of osteoarticular infections?","The presence of prosthetic material","The anatomical location of the infection","The mode of onset and progression time, with acute osteomyelitis being an acute haematogenous form of osteitis","The type of infectious agent, with acute osteomyelitis being caused by viruses and chronic osteitis by bacteria","c"
"OIC-156-02-B","{""question"": ""What is the overall prevalence of osteoarticular infections (OAIs) in France, including both community-acquired and healthcare-associated infections?"", ""option_a"": ""50 / 100,000 inhabitants / year"", ""option_b"": ""70 / 100,000 inhabitants / year"", ""option_c"": ""100 / 100,000 inhabitants / year"", ""option_d"": ""150 / 100,000 inhabitants / year"", ""correct_option"": ""B""}","Epidemiology","What is the overall prevalence of osteoarticular infections (OAIs) in France, including both community-acquired and healthcare-associated infections?","50 / 100,000 inhabitants / year","70 / 100,000 inhabitants / year","100 / 100,000 inhabitants / year","150 / 100,000 inhabitants / year","b"
"OIC-156-03-B","{""question"": ""What is the most frequent mechanism of onset for osteoarticular infections (OAIs), particularly in children?"", ""option_a"": ""Direct contamination during surgery or trauma"", ""option_b"": ""Extension of a local infection to the osteoarticular system"", ""option_c"": ""Haematogenic spread, where bacteria enter the bone or joints through the bloodstream"", ""option_d"": ""Inoculation through a bite or puncture wound"", ""correct_option"": ""C""}","Physiopathology","What is the most frequent mechanism of onset for osteoarticular infections (OAIs), particularly in children?","Direct contamination during surgery or trauma","Extension of a local infection to the osteoarticular system","Haematogenic spread, where bacteria enter the bone or joints through the bloodstream","Inoculation through a bite or puncture wound","c"
"OIC-156-04-B","{""question"": ""What is the most common infectious agent responsible for osteoarticular infections in children over the age of 4?"", ""option_a"": ""Kingella kingae"", ""option_b"": ""Staphylococcus aureus"", ""option_c"": ""Group A streptococcus"", ""option_d"": ""Escherichia coli"", ""correct_option"": ""B""}","Etiologies","What is the most common infectious agent responsible for osteoarticular infections in children over the age of 4?","Kingella kingae","Staphylococcus aureus","Group A streptococcus","Escherichia coli","b"
"OIC-156-05-A","{""question"": ""What is a common local sign of acute osteoarticular infections (OAIs) in children and adults?"", ""option_a"": ""Chronic pain"", ""option_b"": ""Fistulisation"", ""option_c"": ""Pain, partial or total functional impotence, and redness"", ""option_d"": ""Fever usually absent"", ""correct_option"": ""C""}",,"What is a common local sign of acute osteoarticular infections (OAIs) in children and adults?","Chronic pain","Fistulisation","Pain, partial or total functional impotence, and redness","Fever usually absent","c"
"OIC-156-06-B","{""question"": ""What is the primary advantage of using MRI in the diagnosis of osteoarticular infections?"", ""option_a"": ""Easy access and low cost"", ""option_b"": ""Ability to assess bone and joint injuries"", ""option_c"": ""Early signs of infection and best test for diagnosing inflammatory osteoarticular disease"", ""option_d"": ""Systematic use in emergencies for both children and adults"", ""correct_option"": ""C""}","Additional examinations","What is the primary advantage of using MRI in the diagnosis of osteoarticular infections?","Easy access and low cost","Ability to assess bone and joint injuries","Early signs of infection and best test for diagnosing inflammatory osteoarticular disease","Systematic use in emergencies for both children and adults","c"
"OIC-156-07-A","{""question"": ""In children, how is joint puncture typically carried out?"", ""option_a"": ""In a clinic setting without anesthesia"", ""option_b"": ""In the operating theatre under general anaesthetic by a surgeon"", ""option_c"": ""Using local anesthesia in an emergency room"", ""option_d"": ""With ultrasound guidance in an outpatient setting"", ""correct_option"": ""B""}","Complementary examinations","In children, how is joint puncture typically carried out?","In a clinic setting without anesthesia","In the operating theatre under general anaesthetic by a surgeon","Using local anesthesia in an emergency room","With ultrasound guidance in an outpatient setting","b"
"OIC-156-08-B","{""question"": ""In the management of infections in bones and joints, what is the primary purpose of initial analgesic immobilisation?"", ""option_a"": ""To promote bone consolidation and stabilisation as quickly as possible"", ""option_b"": ""To prevent venous thrombo-embolic disease"", ""option_c"": ""To allow for surgical intervention, if necessary"", ""option_d"": ""To keep the affected area immobilised for as short a period as possible to avoid stiffening"", ""correct_option"": ""D""}","Management","In the management of infections in bones and joints, what is the primary purpose of initial analgesic immobilisation?","To promote bone consolidation and stabilisation as quickly as possible","To prevent venous thrombo-embolic disease","To allow for surgical intervention, if necessary","To keep the affected area immobilised for as short a period as possible to avoid stiffening","d"
"OIC-156-09-A","{""question"": ""What is the primary goal of urgent hospital management in cases of septic arthritis?"", ""option_a"": ""To administer antibiotics orally"", ""option_b"": ""To limit the risk of complications and prevent long-term damage"", ""option_c"": ""To delay surgical intervention until the infection is under control"", ""option_d"": ""To focus solely on pain management"", ""correct_option"": ""B""}","Identifying the emergency","What is the primary goal of urgent hospital management in cases of septic arthritis?","To administer antibiotics orally","To limit the risk of complications and prevent long-term damage","To delay surgical intervention until the infection is under control","To focus solely on pain management","b"
"OIC-156-10-A","{""question"": ""What is the most common location for acute septic arthritis?"", ""option_a"": ""Monoarticular, with the elbow being the most affected joint"", ""option_b"": ""Monoarticular, with the knee and hip being the most affected joints"", ""option_c"": ""Polyarticular, with the hands and feet being the most affected"", ""option_d"": ""Polyarticular, with the shoulders and ankles being the most affected"", ""correct_option"": ""B""}","Positive diagnosis","What is the most common location for acute septic arthritis?","Monoarticular, with the elbow being the most affected joint","Monoarticular, with the knee and hip being the most affected joints","Polyarticular, with the hands and feet being the most affected","Polyarticular, with the shoulders and ankles being the most affected","b"
"OIC-156-11-B","{""question"": ""What is a potential complication of acute septic arthritis?"", ""option_a"": ""Contiguous osteitis"", ""option_b"": ""Osteoporosis"", ""option_c"": ""Joint destruction with functional sequelae"", ""option_d"": ""Tendon rupture"", ""correct_option"": ""C""}",,"What is a potential complication of acute septic arthritis?","Contiguous osteitis","Osteoporosis","Joint destruction with functional sequelae","Tendon rupture","c"
"OIC-156-12-B","{""question"": ""What is the recommended first-line antibiotic therapy for septic arthritis in adults caused by methicillin-sensitive S. aureus?"", ""option_a"": ""Ceftriaxone IV"", ""option_b"": ""C1G (cefazolin) or penicillin M (oxacillin, cloxacillin) IV"", ""option_c"": ""Amoxicillin-clavulanic acid IV"", ""option_d"": ""Clindamycin IV"", ""correct_option"": ""B""}","Management","What is the recommended first-line antibiotic therapy for septic arthritis in adults caused by methicillin-sensitive S. aureus?","Ceftriaxone IV","C1G (cefazolin) or penicillin M (oxacillin, cloxacillin) IV","Amoxicillin-clavulanic acid IV","Clindamycin IV","b"
"OIC-156-13-A","{""question"": ""What is the recommended approach for a patient with suspected disco-vertebral infection before undergoing diagnostic sampling?"", ""option_a"": ""Initiate probabilistic antibiotic therapy to reduce the risk of complications"", ""option_b"": ""Perform immediate surgical intervention to stabilize the spine"", ""option_c"": ""Avoid probabilistic antibiotic therapy to ensure accurate microbiological documentation"", ""option_d"": ""Discharge the patient with instructions for self-monitoring and follow-up"", ""correct_option"": ""C""}","Identifying the emergency","What is the recommended approach for a patient with suspected disco-vertebral infection before undergoing diagnostic sampling?","Initiate probabilistic antibiotic therapy to reduce the risk of complications","Perform immediate surgical intervention to stabilize the spine","Avoid probabilistic antibiotic therapy to ensure accurate microbiological documentation","Discharge the patient with instructions for self-monitoring and follow-up","c"
"OIC-156-14-A","{""question"": ""What is a common clinical presentation of spondylodiscitis that may lead to a delayed diagnosis?"", ""option_a"": ""Acute onset of severe spinal pain"", ""option_b"": ""Subacute presentation with gradual onset of symptoms"", ""option_c"": ""Sudden inability to walk or sit up due to intense pain"", ""option_d"": ""Complete loss of spinal mobility and paralysis"", ""correct_option"": ""B""}","Positive diagnosis","What is a common clinical presentation of spondylodiscitis that may lead to a delayed diagnosis?","Acute onset of severe spinal pain","Subacute presentation with gradual onset of symptoms","Sudden inability to walk or sit up due to intense pain","Complete loss of spinal mobility and paralysis","b"
"OIC-156-15-B","{""question"": ""What is a potential neurological complication of spondylodiscitis?"", ""option_a"": ""Paravertebral abscesses"", ""option_b"": ""Lesion syndrome with radicular compression"", ""option_c"": ""Infective endocarditis"", ""option_d"": ""Spinal destruction without instability"", ""correct_option"": ""B""}",,"What is a potential neurological complication of spondylodiscitis?","Paravertebral abscesses","Lesion syndrome with radicular compression","Infective endocarditis","Spinal destruction without instability","b"
"OIC-156-16-B","{""question"": ""What is the primary diagnostic imaging examination for spondylodiscitis, and what is its characteristic finding?"", ""option_a"": ""CT scan with characteristic finding of T1 hyposignal with gadolinium enhancement"", ""option_b"": ""MRI with characteristic finding of T1 hyposignal with gadolinium enhancement, and T2 hypersignal"", ""option_c"": ""Bone scintigraphy with characteristic finding of increased uptake in the affected disc"", ""option_d"": ""X-ray with characteristic finding of decreased bone density in the affected vertebrae"", ""correct_option"": ""B""}","Complementary examinations","What is the primary diagnostic imaging examination for spondylodiscitis, and what is its characteristic finding?","CT scan with characteristic finding of T1 hyposignal with gadolinium enhancement","MRI with characteristic finding of T1 hyposignal with gadolinium enhancement, and T2 hypersignal","Bone scintigraphy with characteristic finding of increased uptake in the affected disc","X-ray with characteristic finding of decreased bone density in the affected vertebrae","b"
"OIC-156-17-A","{""question"": ""What is a characteristic clinical sign of acute osteomyelitis in children?"", ""option_a"": ""Chronic pain"", ""option_b"": ""Painful metaphyseal palpation and lameness"", ""option_c"": ""Variable appearance with inflammation and dry gangrene"", ""option_d"": ""More or less productive fistula with serous to purulent discharge"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic clinical sign of acute osteomyelitis in children?","Chronic pain","Painful metaphyseal palpation and lameness","Variable appearance with inflammation and dry gangrene","More or less productive fistula with serous to purulent discharge","b"
"OIC-156-18-B","{""question"": ""What type of infection is most likely depicted in the photograph of a toe infection?"", ""option_a"": ""A skin infection"", ""option_b"": ""A bone infection"", ""option_c"": ""An infection in the bones and joints (IOA)"", ""option_d"": ""A fungal infection"", ""correct_option"": ""C""}","Multimedia content","What type of infection is most likely depicted in the photograph of a toe infection?","A skin infection","A bone infection","An infection in the bones and joints (IOA)","A fungal infection","c"
"OIC-156-19-B","{""question"": ""What is the recommended duration of antibiotic treatment for acute osteomyelitis in children?"", ""option_a"": ""6 to 12 weeks"", ""option_b"": ""3 weeks"", ""option_c"": ""4 to 6 weeks"", ""option_d"": ""2 to 4 weeks"", ""correct_option"": ""B""}","Management","What is the recommended duration of antibiotic treatment for acute osteomyelitis in children?","6 to 12 weeks","3 weeks","4 to 6 weeks","2 to 4 weeks","b"
"OIC-157-01-A","{""question"": ""What is the microbiological definition of bacteremia?"", ""option_a"": ""Presence of fungi in the blood"", ""option_b"": ""Presence of bacteria in the blood detectable in a blood culture bottle"", ""option_c"": ""Infection of the mucous membrane"", ""option_d"": ""Presence of bacteria in the urine"", ""correct_option"": ""B""}","Definition","What is the microbiological definition of bacteremia?","Presence of fungi in the blood","Presence of bacteria in the blood detectable in a blood culture bottle","Infection of the mucous membrane","Presence of bacteria in the urine","b"
"OIC-157-02-B","{""question"": ""What is the approximate incidence of bacteremia in hospitalized patients?"", ""option_a"": ""0.1%"", ""option_b"": ""1%"", ""option_c"": ""5%"", ""option_d"": ""10%"", ""correct_option"": ""B""}",,"What is the approximate incidence of bacteremia in hospitalized patients?","0.1%","1%","5%","10%","b"
"OIC-157-03-A","{""question"": ""In a case of suspected fungemia with persistent fever, what should be systematically sought during the examination?"", ""option_a"": ""Only retinal localization through fundus examination"", ""option_b"": ""Retinal localization through fundus examination and endocarditis through transoesophageal echocardiography"", ""option_c"": ""Hepatosplenic candidiasis using abdominal imaging combined with biological markers, without checking for other sites"", ""option_d"": ""Only catheter-related infections through catheter examination and removal if necessary"", ""correct_option"": ""B""}","Positive diagnosis","In a case of suspected fungemia with persistent fever, what should be systematically sought during the examination?","Only retinal localization through fundus examination","Retinal localization through fundus examination and endocarditis through transoesophageal echocardiography","Hepatosplenic candidiasis using abdominal imaging combined with biological markers, without checking for other sites","Only catheter-related infections through catheter examination and removal if necessary","b"
"OIC-157-04-A","{""question"": ""What is the most common route of entry for Escherichia coli causing bacteremia?"", ""option_a"": ""Skin"", ""option_b"": ""Urinary tract, digestive tract, biliary tract, or vascular catheter"", ""option_c"": ""Oral cavity"", ""option_d"": ""Lung, meninges, ENT"", ""correct_option"": ""B""}","Etiologies","What is the most common route of entry for Escherichia coli causing bacteremia?","Skin","Urinary tract, digestive tract, biliary tract, or vascular catheter","Oral cavity","Lung, meninges, ENT","b"
"OIC-157-05-B","{""question"": ""What is the most common cause of fungemia, accounting for approximately 90% of cases?"", ""option_a"": ""Aspergillosis"", ""option_b"": ""Cryptococcosis"", ""option_c"": ""Candidemia"", ""option_d"": ""Malasseziosis"", ""correct_option"": ""C""}","Etiologies","What is the most common cause of fungemia, accounting for approximately 90% of cases?","Aspergillosis","Cryptococcosis","Candidemia","Malasseziosis","c"
"OIC-157-06-B","{""question"": ""What percentage of catheter-related infections are caused by staphylococci?"", ""option_a"": ""10 to 20%"", ""option_b"": ""30 to 40%"", ""option_c"": ""50 to 60%"", ""option_d"": ""70 to 80%"", ""correct_option"": ""C""}","Etiologies","What percentage of catheter-related infections are caused by staphylococci?","10 to 20%","30 to 40%","50 to 60%","70 to 80%","c"
"OIC-157-07-A","{""question"": ""What is a characteristic of Staphylococcus aureus bacteremia that makes it a serious infection?"", ""option_a"": ""It rarely leads to septic metastases"", ""option_b"": ""It is often associated with a low risk of septic shock"", ""option_c"": ""It frequently results in septic metastases and is associated with endocarditis"", ""option_d"": ""It typically has a single, easily identifiable route of entry"", ""correct_option"": ""C""}","Etiologies","What is a characteristic of Staphylococcus aureus bacteremia that makes it a serious infection?","It rarely leads to septic metastases","It is often associated with a low risk of septic shock","It frequently results in septic metastases and is associated with endocarditis","It typically has a single, easily identifiable route of entry","c"
"OIC-157-08-A","{""question"": ""In which of the following situations can antibiotic therapy be started before taking microbiological samples?"", ""option_a"": ""In all cases of suspected bacteremia or fungemia"", ""option_b"": ""In patients presenting with septic shock or bacterial meningitis, regardless of the delay"", ""option_c"": ""In patients presenting with septic shock or bacterial meningitis, if microbiological sampling would delay antibiotic therapy by more than one hour"", ""option_d"": ""In cases of purpura fulminans, but only if the patient is stable"", ""correct_option"": ""C""}",,"In which of the following situations can antibiotic therapy be started before taking microbiological samples?","In all cases of suspected bacteremia or fungemia","In patients presenting with septic shock or bacterial meningitis, regardless of the delay","In patients presenting with septic shock or bacterial meningitis, if microbiological sampling would delay antibiotic therapy by more than one hour","In cases of purpura fulminans, but only if the patient is stable","c"
"OIC-157-09-A","{""question"": ""When should blood cultures be taken in a patient suspected of having bacteremia or fungemia?"", ""option_a"": ""Only when the patient has a fever peak or is shivering"", ""option_b"": ""Before any antibiotic therapy, except in cases of purpura fulminans, and at the time of a fever peak"", ""option_c"": ""Before any antibiotic therapy, except in cases of purpura fulminans, but not necessarily at the time of a fever peak"", ""option_d"": ""After antibiotic therapy has been initiated, to assess its effectiveness"", ""correct_option"": ""C""}",,"When should blood cultures be taken in a patient suspected of having bacteremia or fungemia?","Only when the patient has a fever peak or is shivering","Before any antibiotic therapy, except in cases of purpura fulminans, and at the time of a fever peak","Before any antibiotic therapy, except in cases of purpura fulminans, but not necessarily at the time of a fever peak","After antibiotic therapy has been initiated, to assess its effectiveness","c"
"OIC-157-10-B","{""question"": ""What is the recommended additional test for a patient with bacteremia caused by Streptococcus pneumoniae?"", ""option_a"": ""Systematic echocardiography"", ""option_b"": ""Chest X-ray +/- lumbar puncture (if meningeal syndrome or normal chest imaging)"", ""option_c"": ""Abdominal imaging"", ""option_d"": ""Fundus examination"", ""correct_option"": ""B""}","Complementary examinations","What is the recommended additional test for a patient with bacteremia caused by Streptococcus pneumoniae?","Systematic echocardiography","Chest X-ray +/- lumbar puncture (if meningeal syndrome or normal chest imaging)","Abdominal imaging","Fundus examination","b"
"OIC-157-11-A","{""question"": ""What is the significance of a procalcitonin level of less than 0.25 ng/ml in the context of bacteremia or fungemia?"", ""option_a"": ""It confirms the presence of bacteremia or fungemia"", ""option_b"": ""It indicates a high risk of sepsis"", ""option_c"": ""It makes bacteremia or fungemia unlikely"", ""option_d"": ""It has no relevance to the diagnosis of bacteremia or fungemia"", ""correct_option"": ""C""}","Additional tests","What is the significance of a procalcitonin level of less than 0.25 ng/ml in the context of bacteremia or fungemia?","It confirms the presence of bacteremia or fungemia","It indicates a high risk of sepsis","It makes bacteremia or fungemia unlikely","It has no relevance to the diagnosis of bacteremia or fungemia","c"
"OIC-157-12-A","{""question"": ""What is the primary consideration for choosing an antimicrobial agent in the treatment of bacteremia/fungemia?"", ""option_a"": ""The patient's medical history and underlying health conditions"", ""option_b"": ""The severity of the patient's symptoms and clinical presentation"", ""option_c"": ""The suspected clinical route of entry of the infection"", ""option_d"": ""The patient's age and weight"", ""correct_option"": ""C""}",,"What is the primary consideration for choosing an antimicrobial agent in the treatment of bacteremia/fungemia?","The patient's medical history and underlying health conditions","The severity of the patient's symptoms and clinical presentation","The suspected clinical route of entry of the infection","The patient's age and weight","c"
"OIC-157-13-A","{""question"": ""What is the recommended 1st-line antimicrobial for Meticillin-resistant Staphylococcus aureus (MRSA)?"", ""option_a"": ""Penicillin M or cefazolin (1st generation cephalosporin)"", ""option_b"": ""Vancomycin (glycopeptide)"", ""option_c"": ""Amoxicillin or 3rd generation cephalosporin (cefotaxime, ceftriaxone)"", ""option_d"": ""Fluconazole or Echinocandin"", ""correct_option"": ""B""}",,"What is the recommended 1st-line antimicrobial for Meticillin-resistant Staphylococcus aureus (MRSA)?","Penicillin M or cefazolin (1st generation cephalosporin)","Vancomycin (glycopeptide)","Amoxicillin or 3rd generation cephalosporin (cefotaxime, ceftriaxone)","Fluconazole or Echinocandin","b"
"OIC-157-14-A","{""question"": ""What is the primary goal of 'front door treatment' in the context of bacteremia or fungemia?"", ""option_a"": ""To immediately remove all foreign materials from the patient"", ""option_b"": ""To reduce the risk of relapse through medical and/or surgical treatment"", ""option_c"": ""To solely focus on treating secondary locations of infection"", ""option_d"": ""To delay treatment until the source of the infection is fully understood"", ""correct_option"": ""B""}",,"What is the primary goal of 'front door treatment' in the context of bacteremia or fungemia?","To immediately remove all foreign materials from the patient","To reduce the risk of relapse through medical and/or surgical treatment","To solely focus on treating secondary locations of infection","To delay treatment until the source of the infection is fully understood","b"
"OIC-157-15-B","{""question"": ""In which of the following situations is surgical or radio-interventional control of the infectious source considered essential?"", ""option_a"": ""Chronic osteomyelitis without sepsis"", ""option_b"": ""Arthritis with sepsis/septic shock or persistent bacteremia"", ""option_c"": ""Uncomplicated urinary tract infections"", ""option_d"": ""Cellulitis without abscess formation"", ""correct_option"": ""B""}","Management","In which of the following situations is surgical or radio-interventional control of the infectious source considered essential?","Chronic osteomyelitis without sepsis","Arthritis with sepsis/septic shock or persistent bacteremia","Uncomplicated urinary tract infections","Cellulitis without abscess formation","b"
"OIC-157-16-B","{""question"": ""What is the recommended duration of treatment for uncomplicated Staphylococcus aureus bacteremia without endocarditis or secondary septic localization, and with early sterilization of blood cultures?"", ""option_a"": ""4 to 6 weeks"", ""option_b"": ""7 to 10 days"", ""option_c"": ""14 days"", ""option_d"": ""21 days"", ""correct_option"": ""C""}","Management","What is the recommended duration of treatment for uncomplicated Staphylococcus aureus bacteremia without endocarditis or secondary septic localization, and with early sterilization of blood cultures?","4 to 6 weeks","7 to 10 days","14 days","21 days","c"
"OIC-157-17-B","{""question"": ""What is a key factor to consider when assessing the risk of a resistant infectious agent in a patient with a healthcare-associated infection?"", ""option_a"": ""The patient's age and underlying medical conditions"", ""option_b"": ""The length of hospital stay and prior antibiotic therapy"", ""option_c"": ""The patient's dietary habits and lifestyle choices"", ""option_d"": ""The patient's socioeconomic status and education level"", ""correct_option"": ""B""}","Management","What is a key factor to consider when assessing the risk of a resistant infectious agent in a patient with a healthcare-associated infection?","The patient's age and underlying medical conditions","The length of hospital stay and prior antibiotic therapy","The patient's dietary habits and lifestyle choices","The patient's socioeconomic status and education level","b"
"OIC-157-18-B","{""question"": ""What is the primary reason for following up on blood cultures under systematic treatment in cases of bacteraemia or fungaemia?"", ""option_a"": ""To monitor the patient's temperature"", ""option_b"": ""To check for the development of antibiotic resistance"", ""option_c"": ""In specific cases such as Staphylococcus aureus bacteremia, candidemia, endocarditis, or clinically unfavourable evolution"", ""option_d"": ""To determine the duration of antibiotic therapy"", ""correct_option"": ""C""}",,"What is the primary reason for following up on blood cultures under systematic treatment in cases of bacteraemia or fungaemia?","To monitor the patient's temperature","To check for the development of antibiotic resistance","In specific cases such as Staphylococcus aureus bacteremia, candidemia, endocarditis, or clinically unfavourable evolution","To determine the duration of antibiotic therapy","c"
"OIC-161-01-A","{""question"": ""What is the definition of recurrent cystitis?"", ""option_a"": ""Cystitis occurring with a frequency of \u2265 2 episodes/year"", ""option_b"": ""Cystitis occurring with a frequency of \u2265 4 episodes/year"", ""option_c"": ""Cystitis occurring with a frequency of \u2265 6 episodes/year"", ""option_d"": ""Cystitis occurring with a frequency of \u2265 1 episode/month"", ""correct_option"": ""B""}","Definition","What is the definition of recurrent cystitis?","Cystitis occurring with a frequency of ≥ 2 episodes/year","Cystitis occurring with a frequency of ≥ 4 episodes/year","Cystitis occurring with a frequency of ≥ 6 episodes/year","Cystitis occurring with a frequency of ≥ 1 episode/month","b"
"OIC-161-02-A","{""question"": ""What is the most common bacterium isolated during community urinary tract infections?"", ""option_a"": ""Staphylococcus saprophyticus"", ""option_b"": ""Escherichia coli"", ""option_c"": ""Klebsiella"", ""option_d"": ""Proteus mirabilis"", ""correct_option"": ""B""}","Etiologies","What is the most common bacterium isolated during community urinary tract infections?","Staphylococcus saprophyticus","Escherichia coli","Klebsiella","Proteus mirabilis","b"
"OIC-161-03-A","{""question"": ""What is the recommended first-line investigation for uncomplicated cystitis?"", ""option_a"": ""Urinalysis and ECBU with systematic antibiotic susceptibility testing"", ""option_b"": ""BU, taking into account the pitfalls listed"", ""option_c"": ""Imaging, such as non-injected AP CT scan or ultrasound scan of the kidneys and bladder"", ""option_d"": ""Complete blood count, PCR, and blood cultures"", ""correct_option"": ""B""}","Complementary examinations","What is the recommended first-line investigation for uncomplicated cystitis?","Urinalysis and ECBU with systematic antibiotic susceptibility testing","BU, taking into account the pitfalls listed","Imaging, such as non-injected AP CT scan or ultrasound scan of the kidneys and bladder","Complete blood count, PCR, and blood cultures","b"
"OIC-161-04-B","{""question"": ""What is the recommended imaging test for a patient with severe acute pyelonephritis?"", ""option_a"": ""Ultrasonography of the urinary tract with measurement of post-micturition residue"", ""option_b"": ""Urgent uro-CT scan or, failing that, urinary tract ultrasound scan"", ""option_c"": ""MRI"", ""option_d"": ""Retrograde cystography"", ""correct_option"": ""B""}","Complementary examinations","What is the recommended imaging test for a patient with severe acute pyelonephritis?","Ultrasonography of the urinary tract with measurement of post-micturition residue","Urgent uro-CT scan or, failing that, urinary tract ultrasound scan","MRI","Retrograde cystography","b"
"OIC-161-05-A","{""question"": ""What is the primary purpose of performing a urine dipstick test in patients with suspected community-acquired urinary tract infections?"", ""option_a"": ""To formally confirm or rule out a UTI diagnosis"", ""option_b"": ""To identify the presence of leukocyturia, haematuria, or nitrites, which may indicate a UTI in the right clinical context"", ""option_c"": ""To determine the appropriate antibiotic treatment for the infection"", ""option_d"": ""To assess the patient's dietary intake of nitrates"", ""correct_option"": ""B""}","Complementary examinations","What is the primary purpose of performing a urine dipstick test in patients with suspected community-acquired urinary tract infections?","To formally confirm or rule out a UTI diagnosis","To identify the presence of leukocyturia, haematuria, or nitrites, which may indicate a UTI in the right clinical context","To determine the appropriate antibiotic treatment for the infection","To assess the patient's dietary intake of nitrates","b"
"OIC-161-06-A","{""question"": ""What is the threshold for significant bacteriuria in women, except for E. coli and S. saprophyticus?"", ""option_a"": ""10^2 CFU/mL"", ""option_b"": ""10^3 CFU/mL"", ""option_c"": ""10^4 CFU/mL"", ""option_d"": ""10^5 CFU/mL"", ""correct_option"": ""C""}","Additional tests","What is the threshold for significant bacteriuria in women, except for E. coli and S. saprophyticus?","10^2 CFU/mL","10^3 CFU/mL","10^4 CFU/mL","10^5 CFU/mL","c"
"OIC-161-07-A","{""question"": ""What is urinary colonisation, also known as asymptomatic bacteriuria?"", ""option_a"": ""The presence of bacteria in the urine accompanied by symptoms such as pain or fever"", ""option_b"": ""A rare condition that only affects young, healthy individuals"", ""option_c"": ""The presence of bacteria in the urine in the absence of any symptoms"", ""option_d"": ""A condition that requires immediate treatment with antibiotics in all cases"", ""correct_option"": ""C""}","Definition","What is urinary colonisation, also known as asymptomatic bacteriuria?","The presence of bacteria in the urine accompanied by symptoms such as pain or fever","A rare condition that only affects young, healthy individuals","The presence of bacteria in the urine in the absence of any symptoms","A condition that requires immediate treatment with antibiotics in all cases","c"
"OIC-161-08-A","{""question"": ""What is the primary symptom that distinguishes acute cystitis from other bladder disorders?"", ""option_a"": ""Dysuria"", ""option_b"": ""Urinary burning"", ""option_c"": ""Haematuria"", ""option_d"": ""Pyelonephritis"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary symptom that distinguishes acute cystitis from other bladder disorders?","Dysuria","Urinary burning","Haematuria","Pyelonephritis","b"
"OIC-161-09-A","{""question"": ""What is the primary clinical presentation of acute pyelonephritis?"", ""option_a"": ""Bilateral febrile lumbar pain with lower urinary tract symptoms"", ""option_b"": ""Unilateral febrile lumbar pain in the absence of lower urinary tract symptoms"", ""option_c"": ""Radiation of pain suggestive of urinary tract obstruction without fever"", ""option_d"": ""Nausea or vomiting without any associated lumbar pain or fever"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary clinical presentation of acute pyelonephritis?","Bilateral febrile lumbar pain with lower urinary tract symptoms","Unilateral febrile lumbar pain in the absence of lower urinary tract symptoms","Radiation of pain suggestive of urinary tract obstruction without fever","Nausea or vomiting without any associated lumbar pain or fever","b"
"OIC-161-10-A","{""question"": ""What is the recommended first-line antibiotic treatment for simple acute cystitis?"", ""option_a"": ""Fluoroquinolones"", ""option_b"": ""Bosfomycin-Trometamol single dose"", ""option_c"": ""A combination of antibiotics to ensure broad coverage"", ""option_d"": ""ECBU to guide choice of treatment"", ""correct_option"": ""B""}","Management","What is the recommended first-line antibiotic treatment for simple acute cystitis?","Fluoroquinolones","Bosfomycin-Trometamol single dose","A combination of antibiotics to ensure broad coverage","ECBU to guide choice of treatment","b"
"OIC-161-11-A","{""question"": ""What is the recommended first-line antibiotic treatment for simple acute pyelonephritis (ANP), unless the patient has taken antibiotics in this class within the last 3 months?"", ""option_a"": ""IV C3G for 7 days"", ""option_b"": ""Fluoroquinolones for 7 days"", ""option_c"": ""Oral antibiotics for 14 days"", ""option_d"": ""IV C3G for 14 days"", ""correct_option"": ""B""}",,"What is the recommended first-line antibiotic treatment for simple acute pyelonephritis (ANP), unless the patient has taken antibiotics in this class within the last 3 months?","IV C3G for 7 days","Fluoroquinolones for 7 days","Oral antibiotics for 14 days","IV C3G for 14 days","b"
"OIC-161-12-B","{""question"": ""What is the recommended initial antibiotic treatment for a patient with severe acute pyelonephritis (ANP) and risk factors for ESBL?"", ""option_a"": ""C3G IV + high dose amikacin"", ""option_b"": ""Carbapenem + amikacin"", ""option_c"": ""Ciprofloxacin or levofloxacin"", ""option_d"": ""Aminoglycosides or aztreonam"", ""correct_option"": ""B""}","Management","What is the recommended initial antibiotic treatment for a patient with severe acute pyelonephritis (ANP) and risk factors for ESBL?","C3G IV + high dose amikacin","Carbapenem + amikacin","Ciprofloxacin or levofloxacin","Aminoglycosides or aztreonam","b"
"OIC-161-13-A","{""question"": ""What is a fundamental clinical element for the positive diagnosis of male urinary tract infection (MUTI)?"", ""option_a"": ""The presence of hematuria"", ""option_b"": ""The occurrence of an acute symptomatology"", ""option_c"": ""The presence of a urinary catheter"", ""option_d"": ""The history of a recent urological surgery"", ""correct_option"": ""B""}","Positive diagnosis","What is a fundamental clinical element for the positive diagnosis of male urinary tract infection (MUTI)?","The presence of hematuria","The occurrence of an acute symptomatology","The presence of a urinary catheter","The history of a recent urological surgery","b"
"OIC-161-14-A","{""question"": ""What is the recommended duration of treatment for male urinary tract infections when using fluoroquinolones, IV C3G, or cotrimoxazole?"", ""option_a"": ""7 days"", ""option_b"": ""10 days"", ""option_c"": ""14 days"", ""option_d"": ""28 days"", ""correct_option"": ""C""}","Management","What is the recommended duration of treatment for male urinary tract infections when using fluoroquinolones, IV C3G, or cotrimoxazole?","7 days","10 days","14 days","28 days","c"
"OIC-161-15-A","{""question"": ""What is the recommended first-line antibiotic treatment for urinary colonization in pregnant women?"", ""option_a"": ""Bosfomycin-Trometamol in 1 dose"", ""option_b"": ""Pivmecillinam for 7 days"", ""option_c"": ""Amoxicillin for 7 days"", ""option_d"": ""Ceftriaxone for 3 days"", ""correct_option"": ""C""}","Management","What is the recommended first-line antibiotic treatment for urinary colonization in pregnant women?","Bosfomycin-Trometamol in 1 dose","Pivmecillinam for 7 days","Amoxicillin for 7 days","Ceftriaxone for 3 days","c"
"OIC-161-16-A","{""question"": ""In the diagnosis of urinary tract infections in the elderly, what should be considered when attributing atypical symptoms to a positive ECBU result?"", ""option_a"": ""Atypical symptoms can always be attributed to a UTI if the ECBU is positive"", ""option_b"": ""Atypical symptoms should be attributed to conditions other than UTI, even if the ECBU is positive, due to common comorbidities"", ""option_c"": ""A positive ECBU result is always indicative of a UTI, regardless of symptoms"", ""option_d"": ""Urinary tract colonization is rare in geriatric populations, so a positive ECBU is likely indicative of a UTI"", ""correct_option"": ""B""}",,"In the diagnosis of urinary tract infections in the elderly, what should be considered when attributing atypical symptoms to a positive ECBU result?","Atypical symptoms can always be attributed to a UTI if the ECBU is positive","Atypical symptoms should be attributed to conditions other than UTI, even if the ECBU is positive, due to common comorbidities","A positive ECBU result is always indicative of a UTI, regardless of symptoms","Urinary tract colonization is rare in geriatric populations, so a positive ECBU is likely indicative of a UTI","b"
"OIC-161-17-A","{""question"": ""What is a key symptom that should prompt the diagnosis of acute pyelonephritis in newborns or young infants under 3 months of age?"", ""option_a"": ""Fever lasting 24 hours or more"", ""option_b"": ""Febrile urinary tract signs"", ""option_c"": ""Feeding difficulties, poor weight gain, jaundice, vomiting, etc."", ""option_d"": ""Suprapubic pain"", ""correct_option"": ""C""}","Positive diagnosis","What is a key symptom that should prompt the diagnosis of acute pyelonephritis in newborns or young infants under 3 months of age?","Fever lasting 24 hours or more","Febrile urinary tract signs","Feeding difficulties, poor weight gain, jaundice, vomiting, etc.","Suprapubic pain","c"
"OIC-161-18-A","{""question"": ""What is the primary purpose of using a urine dipstick test in children over 1 month old?"", ""option_a"": ""To confirm the diagnosis of a urinary tract infection"", ""option_b"": ""To screen for urinary tract infections and identify the presence of leucocyturia and nitrites"", ""option_c"": ""To determine the need for renal ultrasound or other imaging examinations"", ""option_d"": ""To guide the choice of empirical antibiotic therapy"", ""correct_option"": ""B""}","Additional examinations","What is the primary purpose of using a urine dipstick test in children over 1 month old?","To confirm the diagnosis of a urinary tract infection","To screen for urinary tract infections and identify the presence of leucocyturia and nitrites","To determine the need for renal ultrasound or other imaging examinations","To guide the choice of empirical antibiotic therapy","b"
"OIC-161-19-A","{""question"": ""What is the recommended initial antibiotic treatment for acute pyelonephritis in a child over 3 months old without risk factors or signs of severity?"", ""option_a"": ""IV ceftriaxone or cefotaxime followed by oral cefixime"", ""option_b"": ""Oral cefixime, to be adapted to the antibiogram"", ""option_c"": ""IV amikacin followed by oral cotrimoxazole"", ""option_d"": ""Oral amoxicillin/clavulanic acid for 10 to 14 days"", ""correct_option"": ""B""}","Management","What is the recommended initial antibiotic treatment for acute pyelonephritis in a child over 3 months old without risk factors or signs of severity?","IV ceftriaxone or cefotaxime followed by oral cefixime","Oral cefixime, to be adapted to the antibiogram","IV amikacin followed by oral cotrimoxazole","Oral amoxicillin/clavulanic acid for 10 to 14 days","b"
"OIC-161-20-B","{""question"": ""What is the primary purpose of proving the infectious nature of the infection in a patient labelled as having 'recurrent cystitis'?"", ""option_a"": ""To differentiate between the management of young patients and post-menopausal patients"", ""option_b"": ""To establish the link between symptoms and bacteriuria"", ""option_c"": ""To rule out other conditions such as idiopathic overactive bladder"", ""option_d"": ""To determine the need for flowmetry and ultrasound of the urinary tract"", ""correct_option"": ""B""}","Complementary examinations","What is the primary purpose of proving the infectious nature of the infection in a patient labelled as having 'recurrent cystitis'?","To differentiate between the management of young patients and post-menopausal patients","To establish the link between symptoms and bacteriuria","To rule out other conditions such as idiopathic overactive bladder","To determine the need for flowmetry and ultrasound of the urinary tract","b"
"OIC-161-21-B","{""question"": ""What is the only hygienic and dietary measure that has been formally proven to be effective in preventing recurrent cystitis?"", ""option_a"": ""Wearing cotton underwear"", ""option_b"": ""Increasing oral hydration"", ""option_c"": ""Regularisation of transit"", ""option_d"": ""Post-coital micturition"", ""correct_option"": ""B""}","Management","What is the only hygienic and dietary measure that has been formally proven to be effective in preventing recurrent cystitis?","Wearing cotton underwear","Increasing oral hydration","Regularisation of transit","Post-coital micturition","b"
"OIC-161-22-B","{""question"": ""What is a significant factor that contributes to the development of urinary tract infections in young boys?"", ""option_a"": ""Maturity of the bladder"", ""option_b"": ""Presence of the prepuce"", ""option_c"": ""Frequency of urination"", ""option_d"": ""Hygiene practices"", ""correct_option"": ""B""}","Epidemiology","What is a significant factor that contributes to the development of urinary tract infections in young boys?","Maturity of the bladder","Presence of the prepuce","Frequency of urination","Hygiene practices","b"
"OIC-162-01-A","{""question"": ""What is the typical presentation of gonococcal disease in men?"", ""option_a"": ""Asymptomatic, with rare cases of urethritis and anorectitis"", ""option_b"": ""Often symptomatic, with urethritis, anorectitis, and oropharyngitis"", ""option_c"": ""Usually characterized by syphilitic roseola and depilation of the eyebrows"", ""option_d"": ""Typically presents with condylomata and intraepithelial neoplasia"", ""correct_option"": ""B""}","Etiologies","What is the typical presentation of gonococcal disease in men?","Asymptomatic, with rare cases of urethritis and anorectitis","Often symptomatic, with urethritis, anorectitis, and oropharyngitis","Usually characterized by syphilitic roseola and depilation of the eyebrows","Typically presents with condylomata and intraepithelial neoplasia","b"
"OIC-162-02-B","{""question"": ""Which of the following sexually transmitted infections (STIs) is the most frequent and has an increasing incidence in developed countries, particularly among 16-25 year olds?"", ""option_a"": ""Gonococcal disease"", ""option_b"": ""Chlamydia"", ""option_c"": ""HPV infection"", ""option_d"": ""Syphilis"", ""correct_option"": ""C""}","Epidemiology","Which of the following sexually transmitted infections (STIs) is the most frequent and has an increasing incidence in developed countries, particularly among 16-25 year olds?","Gonococcal disease","Chlamydia","HPV infection","Syphilis","c"
"OIC-162-03-A","{""question"": ""What is a primary method for preventing the transmission of sexually transmitted infections (STIs) during sexual relations?"", ""option_a"": ""Getting tested for HIV regularly"", ""option_b"": ""Using condoms"", ""option_c"": ""Undergoing hepatitis B vaccination alone"", ""option_d"": ""Taking PrEP (Pre-Exposure Prophylaxis) type treatment against HIV without using condoms"", ""correct_option"": ""B""}",,"What is a primary method for preventing the transmission of sexually transmitted infections (STIs) during sexual relations?","Getting tested for HIV regularly","Using condoms","Undergoing hepatitis B vaccination alone","Taking PrEP (Pre-Exposure Prophylaxis) type treatment against HIV without using condoms","b"
"OIC-162-04-A","{""question"": ""When caring for a partner or partners with a sexually transmitted infection, what is a key step in the management process?"", ""option_a"": ""Only treating the partner with the most severe symptoms"", ""option_b"": ""Identifying the infected or contaminating partner(s) and proposing screening, diagnosis, and/or probabilistic treatment"", ""option_c"": ""Focusing solely on HIV serology and ignoring other potential infections"", ""option_d"": ""Delaying treatment until all test results are available"", ""correct_option"": ""B""}",,"When caring for a partner or partners with a sexually transmitted infection, what is a key step in the management process?","Only treating the partner with the most severe symptoms","Identifying the infected or contaminating partner(s) and proposing screening, diagnosis, and/or probabilistic treatment","Focusing solely on HIV serology and ignoring other potential infections","Delaying treatment until all test results are available","b"
"OIC-162-05-A","{""question"": ""What is a characteristic feature of a syphilitic chancre?"", ""option_a"": ""Painful superficial ulcers with polycyclic outlines"", ""option_b"": ""Mildly painful granulomatous lesions"", ""option_c"": ""Single ulcer with clean, indurated background, variable location"", ""option_d"": ""Multiple painful lesions with inflammatory adenopathies"", ""correct_option"": ""C""}","Etiologies","What is a characteristic feature of a syphilitic chancre?","Painful superficial ulcers with polycyclic outlines","Mildly painful granulomatous lesions","Single ulcer with clean, indurated background, variable location","Multiple painful lesions with inflammatory adenopathies","c"
"OIC-162-06-A","{""question"": ""What is the primary characteristic of the lesions in a genital herpes infection?"", ""option_a"": ""Painful postvesicular millimetric lesions with an inflammatory border"", ""option_b"": ""Painless postvesicular centimetric lesions without an inflammatory border"", ""option_c"": ""Itchy postvesicular micrometric lesions with a non-inflammatory border"", ""option_d"": ""Swollen antovesicular decimetric lesions with a highly inflammatory border"", ""correct_option"": ""A""}","Multimedia content","What is the primary characteristic of the lesions in a genital herpes infection?","Painful postvesicular millimetric lesions with an inflammatory border","Painless postvesicular centimetric lesions without an inflammatory border","Itchy postvesicular micrometric lesions with a non-inflammatory border","Swollen antovesicular decimetric lesions with a highly inflammatory border","a"
"OIC-162-07-A","{""question"": ""What is the characteristic presentation of a syphilitic chancre in primary syphilis?"", ""option_a"": ""A painful, shallow ulcer with a dirty base"", ""option_b"": ""A single, painless, and indurated ulcer"", ""option_c"": ""Multiple, itchy, and inflamed lesions"", ""option_d"": ""A fungal infection causing redness and swelling"", ""correct_option"": ""B""}","Multimedia content","What is the characteristic presentation of a syphilitic chancre in primary syphilis?","A painful, shallow ulcer with a dirty base","A single, painless, and indurated ulcer","Multiple, itchy, and inflamed lesions","A fungal infection causing redness and swelling","b"
"OIC-162-08-A","{""question"": ""What is a common symptom of male urethritis?"", ""option_a"": ""Prostatitis"", ""option_b"": ""Urethral discharge"", ""option_c"": ""Orchiepididymitis"", ""option_d"": ""Balanite alone"", ""correct_option"": ""B""}","Positive diagnosis","What is a common symptom of male urethritis?","Prostatitis","Urethral discharge","Orchiepididymitis","Balanite alone","b"
"OIC-162-09-B","{""question"": ""What is the most common cause of urethritis in men with a venereal origin, characterized by acute anterior urethritis and purulent urethral discharge in approximately 90% of cases?"", ""option_a"": ""Chlamydia"", ""option_b"": ""Gonorrhoea"", ""option_c"": ""Trichomoniasis"", ""option_d"": ""Human papillomavirus (HPV)"", ""correct_option"": ""B""}","Etiologies","What is the most common cause of urethritis in men with a venereal origin, characterized by acute anterior urethritis and purulent urethral discharge in approximately 90% of cases?","Chlamydia","Gonorrhoea","Trichomoniasis","Human papillomavirus (HPV)","b"
"OIC-162-10-A","{""question"": ""What is a common symptom of vulvovaginitis?"", ""option_a"": ""Pelvic heaviness"", ""option_b"": ""Pruritus"", ""option_c"": ""Signs of associated urethritis"", ""option_d"": ""Cervix +/- inflammatory and discharge from the cervical os"", ""correct_option"": ""B""}","Positive diagnosis","What is a common symptom of vulvovaginitis?","Pelvic heaviness","Pruritus","Signs of associated urethritis","Cervix +/- inflammatory and discharge from the cervical os","b"
"OIC-162-11-B","{""question"": ""What is a common clinical sign of endometritis in women?"", ""option_a"": ""Mild pelvic pain and minimal discharge"", ""option_b"": ""Severe pelvic pain on vaginal touch, high fever, and increased discharge from the cervical os"", ""option_c"": ""Absence of fever and minimal leucorrhoea"", ""option_d"": ""Asymptomatic presentation with no notable symptoms"", ""correct_option"": ""B""}","Positive diagnosis","What is a common clinical sign of endometritis in women?","Mild pelvic pain and minimal discharge","Severe pelvic pain on vaginal touch, high fever, and increased discharge from the cervical os","Absence of fever and minimal leucorrhoea","Asymptomatic presentation with no notable symptoms","b"
"OIC-162-12-A","{""question"": ""What is a common clinical presentation of gonococcal infection in women?"", ""option_a"": ""Intense pruritus and greenish, foamy leucorrhoea"", ""option_b"": ""Purulent leucorrhoea and pelvic heaviness"", ""option_c"": ""White, caseous leucorrhoea and vulvitis"", ""option_d"": ""Grey discharge with little smell"", ""correct_option"": ""B""}","Etiologies","What is a common clinical presentation of gonococcal infection in women?","Intense pruritus and greenish, foamy leucorrhoea","Purulent leucorrhoea and pelvic heaviness","White, caseous leucorrhoea and vulvitis","Grey discharge with little smell","b"
"OIC-162-13-B","{""question"": ""What is the venereal origin of upper genital infections in women?"", ""option_a"": ""Streptococcus and Staphylococcus"", ""option_b"": ""Gonococcus, Chlamydia, and Trichomoniasis"", ""option_c"": ""Mycoplasma genitalium only"", ""option_d"": ""Enterococci and Enterobacteria"", ""correct_option"": ""B""}","Etiologies","What is the venereal origin of upper genital infections in women?","Streptococcus and Staphylococcus","Gonococcus, Chlamydia, and Trichomoniasis","Mycoplasma genitalium only","Enterococci and Enterobacteria","b"
"OIC-162-14-B","{""question"": ""What is a common extra-genital manifestation of gonococcal infection?"", ""option_a"": ""Syphilitic roseola"", ""option_b"": ""Gonococcal septicaemia"", ""option_c"": ""Oculourethro-synovial syndrome"", ""option_d"": ""Pharyngitis due to chlamydia"", ""correct_option"": ""B""}","Positive diagnosis","What is a common extra-genital manifestation of gonococcal infection?","Syphilitic roseola","Gonococcal septicaemia","Oculourethro-synovial syndrome","Pharyngitis due to chlamydia","b"
"OIC-162-15-A","{""question"": ""What type of test is typically used to diagnose gonococcus and chlamydia in patients with suspected STIs?"", ""option_a"": ""Serologies such as HIV, HBV, and treponemal tests"", ""option_b"": ""PCR on 1st urine stream, urethral discharge, vaginal, pharyngeal, and anal self-sampling"", ""option_c"": ""Culture for mycoplasma and other upper respiratory tract infections"", ""option_d"": ""Direct examination and standard culture of samples taken with a speculum"", ""correct_option"": ""B""}","Additional examinations","What type of test is typically used to diagnose gonococcus and chlamydia in patients with suspected STIs?","Serologies such as HIV, HBV, and treponemal tests","PCR on 1st urine stream, urethral discharge, vaginal, pharyngeal, and anal self-sampling","Culture for mycoplasma and other upper respiratory tract infections","Direct examination and standard culture of samples taken with a speculum","b"
"OIC-162-16-B","{""question"": ""What is a recommended general measure for managing all STIs?"", ""option_a"": ""Systematic use of antibiotics for all partners"", ""option_b"": ""Identify the infected or contaminating partner(s) and offer screening, diagnosis and/or probabilistic treatment from the outset"", ""option_c"": ""Immediate vaccination against all STIs for all individuals"", ""option_d"": ""Isolation of the infected individual from all social contacts"", ""correct_option"": ""B""}",,"What is a recommended general measure for managing all STIs?","Systematic use of antibiotics for all partners","Identify the infected or contaminating partner(s) and offer screening, diagnosis and/or probabilistic treatment from the outset","Immediate vaccination against all STIs for all individuals","Isolation of the infected individual from all social contacts","b"
"OIC-162-18-A","{""question"": ""What is the recommended dose of ceftriaxone for the probabilistic treatment of gonococcal infection in cases of urethritis or cervicitis?"", ""option_a"": ""500 mg IM or IV"", ""option_b"": ""1000 mg IM or IV"", ""option_c"": ""2000 mg PO for 7 days"", ""option_d"": ""250 mg IM or IV for 3 days"", ""correct_option"": ""B""}",,"What is the recommended dose of ceftriaxone for the probabilistic treatment of gonococcal infection in cases of urethritis or cervicitis?","500 mg IM or IV","1000 mg IM or IV","2000 mg PO for 7 days","250 mg IM or IV for 3 days","b"
"OIC-162-19-A","{""question"": ""What is the recommended approach for diagnosing condyloma in women?"", ""option_a"": ""Urethroscopy alone"", ""option_b"": ""FCV or HPV-HR test +/- colposcopy-biopsy"", ""option_c"": ""Full proctological examination"", ""option_d"": ""Clinical diagnosis only, without any additional tests"", ""correct_option"": ""B""}",,"What is the recommended approach for diagnosing condyloma in women?","Urethroscopy alone","FCV or HPV-HR test +/- colposcopy-biopsy","Full proctological examination","Clinical diagnosis only, without any additional tests","b"
"OIC-162-20-A","{""question"": ""What is the recommended treatment for gonococcal infection in patients who are allergic to \u03b2-lactams?"", ""option_a"": ""Ceftriaxone single dose IM or IV 1000 mg"", ""option_b"": ""Doxycycline per os 200mg for 7 days"", ""option_c"": ""Single dose of azithromycin or gentamicin or ciprofloxacin"", ""option_d"": ""Benzathine penicillin G DU IM 2.4 million units"", ""correct_option"": ""C""}",,"What is the recommended treatment for gonococcal infection in patients who are allergic to β-lactams?","Ceftriaxone single dose IM or IV 1000 mg","Doxycycline per os 200mg for 7 days","Single dose of azithromycin or gentamicin or ciprofloxacin","Benzathine penicillin G DU IM 2.4 million units","c"
"OIC-162-21-B","{""question"": ""What is the recommended probabilistic treatment for uncomplicated upper genital infections in women, according to the 2018 CNGOF-SPILF recommendations?"", ""option_a"": ""Ceftriaxone 1g IV/IM single dose + Azithromycin 1g po single dose"", ""option_b"": ""Ceftriaxone 1g IV/IM single dose + Doxycycline 100mg/12h po 10 days + Metronidazole 500mg/12h po 10 days"", ""option_c"": ""Doxycycline 100mg/12h po 14 days + Metronidazole 500mg/12h po 10 days"", ""option_d"": ""Ceftriaxone 1g IV/IM single dose + Doxycycline 100mg/12h po 14 days"", ""correct_option"": ""B""}",,"What is the recommended probabilistic treatment for uncomplicated upper genital infections in women, according to the 2018 CNGOF-SPILF recommendations?","Ceftriaxone 1g IV/IM single dose + Azithromycin 1g po single dose","Ceftriaxone 1g IV/IM single dose + Doxycycline 100mg/12h po 10 days + Metronidazole 500mg/12h po 10 days","Doxycycline 100mg/12h po 14 days + Metronidazole 500mg/12h po 10 days","Ceftriaxone 1g IV/IM single dose + Doxycycline 100mg/12h po 14 days","b"
"OIC-162-22-A","{""question"": ""What is a key method for preventing the transmission of sexually transmitted infections (STIs) during sexual relations?"", ""option_a"": ""Avoiding vaccination against hepatitis B"", ""option_b"": ""Using condoms consistently and correctly"", ""option_c"": ""Only undergoing HIV serology testing"", ""option_d"": ""Not discussing sexual practices with partners"", ""correct_option"": ""B""}",,"What is a key method for preventing the transmission of sexually transmitted infections (STIs) during sexual relations?","Avoiding vaccination against hepatitis B","Using condoms consistently and correctly","Only undergoing HIV serology testing","Not discussing sexual practices with partners","b"
"OIC-162-23-A","{""question"": ""What is a characteristic of a syphilitic chancre in primary syphilis?"", ""option_a"": ""Multiple, painful, and bleeding ulcers"", ""option_b"": ""Single, clean, indurated ulcer with a genital background"", ""option_c"": ""Itchy, crusty, and inflamed rash"", ""option_d"": ""Painless, non-indurated, and satellite ulcers"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic of a syphilitic chancre in primary syphilis?","Multiple, painful, and bleeding ulcers","Single, clean, indurated ulcer with a genital background","Itchy, crusty, and inflamed rash","Painless, non-indurated, and satellite ulcers","b"
"OIC-162-24-B","{""question"": ""What characterizes late latent syphilis?"", ""option_a"": ""Presence of clinical signs such as gummy syphilis or bone syphilis"", ""option_b"": ""Absence of clinical signs and a positive serology test with a presumed contact date of more than one year"", ""option_c"": ""Discovery of a negative serology test with a presumed contact date of less than one year"", ""option_d"": ""Presence of cardiovascular syphilis symptoms such as aortitis or coronary stenosis"", ""correct_option"": ""B""}","Positive diagnosis","What characterizes late latent syphilis?","Presence of clinical signs such as gummy syphilis or bone syphilis","Absence of clinical signs and a positive serology test with a presumed contact date of more than one year","Discovery of a negative serology test with a presumed contact date of less than one year","Presence of cardiovascular syphilis symptoms such as aortitis or coronary stenosis","b"
"OIC-162-25-B","{""question"": ""What is a characteristic feature of the palmoplantar rash in secondary syphilis?"", ""option_a"": ""Painless, itchy, and monomorphic papules on the palms and soles"", ""option_b"": ""Copper-coloured erythematous papules on the palms and soles, often accompanied by fever"", ""option_c"": ""Soft, erosive, and contagious lesions on the palms and soles"", ""option_d"": ""Pinkish macules on the palms and soles, appearing within 2 weeks of the chancroid"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic feature of the palmoplantar rash in secondary syphilis?","Painless, itchy, and monomorphic papules on the palms and soles","Copper-coloured erythematous papules on the palms and soles, often accompanied by fever","Soft, erosive, and contagious lesions on the palms and soles","Pinkish macules on the palms and soles, appearing within 2 weeks of the chancroid","b"
"OIC-162-26-B","{""question"": ""At what stage of syphilis is a rash on the palms of the hands typically observed?"", ""option_a"": ""Primary syphilis"", ""option_b"": ""Secondary syphilis"", ""option_c"": ""Tertiary syphilis"", ""option_d"": ""Latent syphilis"", ""correct_option"": ""B""}","Multimedia content","At what stage of syphilis is a rash on the palms of the hands typically observed?","Primary syphilis","Secondary syphilis","Tertiary syphilis","Latent syphilis","b"
"OIC-162-27-A","{""question"": ""What does a positive result in both Treponemal tests (TT) and Non-treponemal tests (NTT) indicate in the context of syphilis diagnosis?"", ""option_a"": ""A false positive result"", ""option_b"": ""A very recent or cured treponematosis"", ""option_c"": ""Interpretation according to NTT kinetics, which could indicate onset of syphilis with increasing NTT levels or treated syphilis with decreasing NTT levels"", ""option_d"": ""No treponematosis or a very old tertiary syphilis"", ""correct_option"": ""C""}","Additional tests","What does a positive result in both Treponemal tests (TT) and Non-treponemal tests (NTT) indicate in the context of syphilis diagnosis?","A false positive result","A very recent or cured treponematosis","Interpretation according to NTT kinetics, which could indicate onset of syphilis with increasing NTT levels or treated syphilis with decreasing NTT levels","No treponematosis or a very old tertiary syphilis","c"
"OIC-162-28-A","{""question"": ""What is the recommended treatment for a patient with primary syphilis who has a penicillin allergy?"", ""option_a"": ""Benzathine penicillin G single dose IM 2.4 million units"", ""option_b"": ""Doxycycline for 7 days"", ""option_c"": ""Doxycycline for 14 days"", ""option_d"": ""Azithromycin for 10 days"", ""correct_option"": ""C""}",,"What is the recommended treatment for a patient with primary syphilis who has a penicillin allergy?","Benzathine penicillin G single dose IM 2.4 million units","Doxycycline for 7 days","Doxycycline for 14 days","Azithromycin for 10 days","c"
"OIC-162-29-B","{""question"": ""What is the recommended treatment for early secondary syphilis in a patient without a penicillin allergy?"", ""option_a"": ""Doxycycline for 14 days"", ""option_b"": ""Benzathine penicillin G single dose IM 2.4 million units"", ""option_c"": ""Benzathine penicillin G single dose IM 2.4 million units once a week for 3 weeks"", ""option_d"": ""Doxycycline for 28 days"", ""correct_option"": ""B""}",,"What is the recommended treatment for early secondary syphilis in a patient without a penicillin allergy?","Doxycycline for 14 days","Benzathine penicillin G single dose IM 2.4 million units","Benzathine penicillin G single dose IM 2.4 million units once a week for 3 weeks","Doxycycline for 28 days","b"
"OIC-162-30-A","{""question"": ""What is a characteristic presentation of condylomata acuminata caused by HPV?"", ""option_a"": ""Pinkish maculo-papules"", ""option_b"": ""Pre-cancerous lesions"", ""option_c"": ""Genital warts with a cauliflower-like appearance, also known as 'cocksucker's ridges'"", ""option_d"": ""Intraepithelial neoplasia with no visible lesions"", ""correct_option"": ""C""}","Positive diagnosis","What is a characteristic presentation of condylomata acuminata caused by HPV?","Pinkish maculo-papules","Pre-cancerous lesions","Genital warts with a cauliflower-like appearance, also known as 'cocksucker's ridges'","Intraepithelial neoplasia with no visible lesions","c"
"OIC-162-31-B","{""question"": ""What is the recommended age range for administering the nonavalent vaccine to men who have sex with men for the prevention of HPV-related infections?"", ""option_a"": ""Up to the age of 21"", ""option_b"": ""Up to the age of 26"", ""option_c"": ""Up to the age of 30"", ""option_d"": ""Up to the age of 35"", ""correct_option"": ""B""}",,"What is the recommended age range for administering the nonavalent vaccine to men who have sex with men for the prevention of HPV-related infections?","Up to the age of 21","Up to the age of 26","Up to the age of 30","Up to the age of 35","b"
"OIC-162-32-B","{""question"": ""What type of organism is Trichomonas vaginalis, the causative agent of Trichomoniasis?"", ""option_a"": ""A type of bacteria"", ""option_b"": ""A flagellate protozoan"", ""option_c"": ""A type of fungus"", ""option_d"": ""A type of virus"", ""correct_option"": ""B""}","Etiologies","What type of organism is Trichomonas vaginalis, the causative agent of Trichomoniasis?","A type of bacteria","A flagellate protozoan","A type of fungus","A type of virus","b"
"OIC-162-33-B","{""question"": ""What is the recommended method for diagnosing Chlamydia trachomatis infection in women?"", ""option_a"": ""Serology test"", ""option_b"": ""Vaginal self-testing using PCR"", ""option_c"": ""Gram stain of urethral discharge"", ""option_d"": ""Culture on cooked blood agar"", ""correct_option"": ""B""}",,"What is the recommended method for diagnosing Chlamydia trachomatis infection in women?","Serology test","Vaginal self-testing using PCR","Gram stain of urethral discharge","Culture on cooked blood agar","b"
"OIC-162-34-B","{""question"": ""What is the recommended treatment for an uncomplicated Neisseria gonorrheae infection in a non-pregnant patient without a \u03b2-lactam allergy?"", ""option_a"": ""Doxycycline 200mg for 7 days"", ""option_b"": ""Ceftriaxone single dose IM or IV 1000 mg"", ""option_c"": ""Azithromycin 1g single dose"", ""option_d"": ""Metronidazole PO 2g single dose"", ""correct_option"": ""B""}","Management","What is the recommended treatment for an uncomplicated Neisseria gonorrheae infection in a non-pregnant patient without a β-lactam allergy?","Doxycycline 200mg for 7 days","Ceftriaxone single dose IM or IV 1000 mg","Azithromycin 1g single dose","Metronidazole PO 2g single dose","b"
"OIC-162-35-A","{""question"": ""What are the main long-term consequences of pelvic inflammatory disease (PID) caused by sexually transmitted infections (STIs) like gonococcal and chlamydial infections in women?"", ""option_a"": ""Cervical cancer, ovarian cysts, and endometriosis"", ""option_b"": ""Pelvic inflammatory disease, tubal infertility, and ectopic pregnancy"", ""option_c"": ""Uterine fibroids, vaginal yeast infections, and bacterial vaginosis"", ""option_d"": ""Hysterectomy, oophorectomy, and salpingectomy"", ""correct_option"": ""B""}",,"What are the main long-term consequences of pelvic inflammatory disease (PID) caused by sexually transmitted infections (STIs) like gonococcal and chlamydial infections in women?","Cervical cancer, ovarian cysts, and endometriosis","Pelvic inflammatory disease, tubal infertility, and ectopic pregnancy","Uterine fibroids, vaginal yeast infections, and bacterial vaginosis","Hysterectomy, oophorectomy, and salpingectomy","b"
"OIC-162-36-B","{""question"": ""What is a notable consideration when diagnosing an STI in a child?"", ""option_a"": ""The child is likely to have contracted the STI from a family member"", ""option_b"": ""The child's symptoms will be similar to those of an adult with the same STI"", ""option_c"": ""The diagnosis may raise suspicions of sexual abuse, requiring cautious questioning and examination"", ""option_d"": ""The child will not be able to contract an STI due to their age"", ""correct_option"": ""C""}","Positive diagnosis","What is a notable consideration when diagnosing an STI in a child?","The child is likely to have contracted the STI from a family member","The child's symptoms will be similar to those of an adult with the same STI","The diagnosis may raise suspicions of sexual abuse, requiring cautious questioning and examination","The child will not be able to contract an STI due to their age","c"
"OIC-162-37-B","{""question"": ""What is the term for the genital warts caused by the human papillomavirus (HPV) as shown in the photograph of a condyloma?"", ""option_a"": ""Condylomata lata"", ""option_b"": ""Condylomata acuminata"", ""option_c"": ""Molluscum contagiosum"", ""option_d"": ""Herpes simplex"", ""correct_option"": ""B""}","Multimedia content","What is the term for the genital warts caused by the human papillomavirus (HPV) as shown in the photograph of a condyloma?","Condylomata lata","Condylomata acuminata","Molluscum contagiosum","Herpes simplex","b"
"OIC-164-01-A","{""question"": ""What is the primary basis for the classification of an exanthema?"", ""option_a"": ""The duration of the rash"", ""option_b"": ""The characterisation of the elementary lesion"", ""option_c"": ""The presence or absence of fever"", ""option_d"": ""The age of the child"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary basis for the classification of an exanthema?","The duration of the rash","The characterisation of the elementary lesion","The presence or absence of fever","The age of the child","b"
"OIC-164-02-A","{""question"": ""What is a characteristic feature of purpura fulminans, an immediate vital emergency in children with febrile rash?"", ""option_a"": ""A localized, painful erythema accompanied by general signs which may lead to sepsis"", ""option_b"": ""An extensive and/or necrotic purpura with haemodynamic failure"", ""option_c"": ""A severe drug hypersensitivity reaction with eosinophilia and systemic symptoms"", ""option_d"": ""A toxin syndrome linked to a toxin from Staphylococcus aureus or Group A Streptococcus"", ""correct_option"": ""B""}","Identification of the emergency","What is a characteristic feature of purpura fulminans, an immediate vital emergency in children with febrile rash?","A localized, painful erythema accompanied by general signs which may lead to sepsis","An extensive and/or necrotic purpura with haemodynamic failure","A severe drug hypersensitivity reaction with eosinophilia and systemic symptoms","A toxin syndrome linked to a toxin from Staphylococcus aureus or Group A Streptococcus","b"
"OIC-164-03-A","{""question"": ""What is the first step in diagnosing a febrile rash in children?"", ""option_a"": ""Characterise the rash"", ""option_b"": ""Search for associated anamnestic elements"", ""option_c"": ""Search for associated clinical features"", ""option_d"": ""Look for an emergency"", ""correct_option"": ""D""}","Positive diagnosis","What is the first step in diagnosing a febrile rash in children?","Characterise the rash","Search for associated anamnestic elements","Search for associated clinical features","Look for an emergency","d"
"OIC-164-04-A","{""question"": ""What is the primary mode of transmission for the measles virus?"", ""option_a"": ""Through contaminated food and water"", ""option_b"": ""Through human-to-human transmission by air (aerosol)"", ""option_c"": ""Through vectors such as mosquitoes or ticks"", ""option_d"": ""Through contact with infected animals"", ""correct_option"": ""B""}","Etiologies","What is the primary mode of transmission for the measles virus?","Through contaminated food and water","Through human-to-human transmission by air (aerosol)","Through vectors such as mosquitoes or ticks","Through contact with infected animals","b"
"OIC-164-05-A","{""question"": ""What is the primary mode of human-to-human transmission of the rubella virus?"", ""option_a"": ""Through direct contact with infected skin lesions"", ""option_b"": ""Via the respiratory route"", ""option_c"": ""Through contaminated food and water"", ""option_d"": ""By vectors such as mosquitoes or ticks"", ""correct_option"": ""B""}","Etiologies","What is the primary mode of human-to-human transmission of the rubella virus?","Through direct contact with infected skin lesions","Via the respiratory route","Through contaminated food and water","By vectors such as mosquitoes or ticks","b"
"OIC-164-06-A","{""question"": ""What is the primary mode of human-to-human transmission for Parvovirus B19, the cause of megalerythema epidemic?"", ""option_a"": ""Vector-borne transmission, such as through mosquito bites"", ""option_b"": ""Respiratory route, through saliva and droplets"", ""option_c"": ""Contaminated food and water"", ""option_d"": ""Direct skin-to-skin contact"", ""correct_option"": ""B""}","Etiologies","What is the primary mode of human-to-human transmission for Parvovirus B19, the cause of megalerythema epidemic?","Vector-borne transmission, such as through mosquito bites","Respiratory route, through saliva and droplets","Contaminated food and water","Direct skin-to-skin contact","b"
"OIC-164-07-A","{""question"": ""What is the typical duration of the eruptive phase of roseola, characterized by a maculopapular exanthema, in primary infection?"", ""option_a"": ""1 to 3 days"", ""option_b"": ""24 hours"", ""option_c"": ""5 to 15 days"", ""option_d"": ""6 to 12 days"", ""correct_option"": ""B""}","Etiologies","What is the typical duration of the eruptive phase of roseola, characterized by a maculopapular exanthema, in primary infection?","1 to 3 days","24 hours","5 to 15 days","6 to 12 days","b"
"OIC-164-09-A","{""question"": ""What is the primary mode of transmission for scarlet fever?"", ""option_a"": ""Human-to-human transmission via the gastrointestinal route"", ""option_b"": ""Human-to-human transmission via the respiratory route"", ""option_c"": ""Transmission through contaminated food and water"", ""option_d"": ""Transmission through insect vectors"", ""correct_option"": ""B""}","Etiologies","What is the primary mode of transmission for scarlet fever?","Human-to-human transmission via the gastrointestinal route","Human-to-human transmission via the respiratory route","Transmission through contaminated food and water","Transmission through insect vectors","b"
"OIC-164-10-A","{""question"": ""What is the primary method for diagnosing coronary artery dilatation in Kawasaki disease?"", ""option_a"": ""Blood tests for inflammatory markers"", ""option_b"": ""Transthoracic cardiac ultrasound by an experienced cardiologist"", ""option_c"": ""Physical examination of the extremities and oropharynx"", ""option_d"": ""Liver function tests for cytolysis and bilirubin levels"", ""correct_option"": ""B""}","Etiologies","What is the primary method for diagnosing coronary artery dilatation in Kawasaki disease?","Blood tests for inflammatory markers","Transthoracic cardiac ultrasound by an experienced cardiologist","Physical examination of the extremities and oropharynx","Liver function tests for cytolysis and bilirubin levels","b"
"OIC-164-11-A","{""question"": ""What is the primary mode of human-to-human contagiousness for chickenpox?"", ""option_a"": ""Airborne transmission only"", ""option_b"": ""Contact with vesicles only"", ""option_c"": ""Airborne or contact with vesicles"", ""option_d"": ""Vector-borne transmission"", ""correct_option"": ""C""}","Etiologies","What is the primary mode of human-to-human contagiousness for chickenpox?","Airborne transmission only","Contact with vesicles only","Airborne or contact with vesicles","Vector-borne transmission","c"
"OIC-176-01-A","{""question"": ""What is the quantitative definition of diarrhoea in adults?"", ""option_a"": ""A frequency of unformed stools > 2 times per 24 hours and/or a quantity of stools > 200g/24 hours"", ""option_b"": ""A frequency of unformed stools > 3 times per 24 hours and/or a quantity of stools > 250g/24 hours"", ""option_c"": ""A frequency of unformed stools > 4 times per 24 hours and/or a quantity of stools > 300g/24 hours"", ""option_d"": ""A frequency of unformed stools > 1 time per 24 hours and/or a quantity of stools > 100g/24 hours"", ""correct_option"": ""B""}","Definition","What is the quantitative definition of diarrhoea in adults?","A frequency of unformed stools > 2 times per 24 hours and/or a quantity of stools > 200g/24 hours","A frequency of unformed stools > 3 times per 24 hours and/or a quantity of stools > 250g/24 hours","A frequency of unformed stools > 4 times per 24 hours and/or a quantity of stools > 300g/24 hours","A frequency of unformed stools > 1 time per 24 hours and/or a quantity of stools > 100g/24 hours","b"
"OIC-176-02-A","{""question"": ""What is the most frequent cause of diarrhoea in children?"", ""option_a"": ""Infectious causes of bacterial origin"", ""option_b"": ""Infectious causes of viral origin"", ""option_c"": ""Non-infectious causes, such as allergy or side effects of medication"", ""option_d"": ""Inflammatory causes, such as chronic inflammatory bowel disease"", ""correct_option"": ""B""}",,"What is the most frequent cause of diarrhoea in children?","Infectious causes of bacterial origin","Infectious causes of viral origin","Non-infectious causes, such as allergy or side effects of medication","Inflammatory causes, such as chronic inflammatory bowel disease","b"
"OIC-176-03-A","{""question"": ""What is a key complication of Shigella spp or enterohaemorrhagic Escherichia coli (EHEC) infections that can lead to acute renal failure?"", ""option_a"": ""Sepsis and septic shock"", ""option_b"": ""Haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopenic purpura"", ""option_c"": ""Post-diarrhoea pseudo-occlusive picture"", ""option_d"": ""Febrile diarrhoea on returning from a trip"", ""correct_option"": ""B""}","Identifying emergencies","What is a key complication of Shigella spp or enterohaemorrhagic Escherichia coli (EHEC) infections that can lead to acute renal failure?","Sepsis and septic shock","Haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopenic purpura","Post-diarrhoea pseudo-occlusive picture","Febrile diarrhoea on returning from a trip","b"
"OIC-176-04-A","{""question"": ""A patient presents with watery diarrhea after returning from a tropical area. Which of the following pathogens is most likely responsible?"", ""option_a"": ""Salmonella enterica non Typhi"", ""option_b"": ""Norovirus"", ""option_c"": ""ETEC, EAEC, EPEC, EIEC, EHEC"", ""option_d"": ""Yersinia"", ""correct_option"": ""C""}","Positive diagnosis","A patient presents with watery diarrhea after returning from a tropical area. Which of the following pathogens is most likely responsible?","Salmonella enterica non Typhi","Norovirus","ETEC, EAEC, EPEC, EIEC, EHEC","Yersinia","c"
"OIC-176-05-A","{""question"": ""At what age is Clostridium difficile diarrhoea considered to be almost non-existent in children?"", ""option_a"": ""Under 1 year"", ""option_b"": ""Under 4 years"", ""option_c"": ""Under 6 years"", ""option_d"": ""Under 10 years"", ""correct_option"": ""B""}","Positive diagnosis","At what age is Clostridium difficile diarrhoea considered to be almost non-existent in children?","Under 1 year","Under 4 years","Under 6 years","Under 10 years","b"
"OIC-176-06-B","{""question"": ""Which of the following parasites is most frequently associated with diarrhoea in both children and adults, particularly in post-travel cases?"", ""option_a"": ""Cryptosporidium spp"", ""option_b"": ""Giardia intestinalis"", ""option_c"": ""Cystoisospora belli"", ""option_d"": ""Microsporidia"", ""correct_option"": ""B""}","Etiologies","Which of the following parasites is most frequently associated with diarrhoea in both children and adults, particularly in post-travel cases?","Cryptosporidium spp","Giardia intestinalis","Cystoisospora belli","Microsporidia","b"
"OIC-176-07-A","{""question"": ""In which of the following situations is a parasitological examination of stools most likely to be prescribed?"", ""option_a"": ""In cases of acute febrile diarrhoea, particularly in immunocompetent patients"", ""option_b"": ""After a stay in an endemic area, in immunocompromised patients, or in cases of persistent diarrhoea"", ""option_c"": ""In adults with diarrhoea following hospitalisation and/or post-antibiotic treatment"", ""option_d"": ""In children under the age of 4 with diarrhoea"", ""correct_option"": ""B""}","Complementary examinations","In which of the following situations is a parasitological examination of stools most likely to be prescribed?","In cases of acute febrile diarrhoea, particularly in immunocompetent patients","After a stay in an endemic area, in immunocompromised patients, or in cases of persistent diarrhoea","In adults with diarrhoea following hospitalisation and/or post-antibiotic treatment","In children under the age of 4 with diarrhoea","b"
"OIC-176-08-B","{""question"": ""In which of the following scenarios is testing for cryptosporidiosis specifically indicated?"", ""option_a"": ""In cases of bloody stools after a trip to an endemic area"", ""option_b"": ""In immunocompromised patients or children with persistent digestive problems"", ""option_c"": ""In adults with frothy stools after a stay in a non-endemic area"", ""option_d"": ""In all patients with diarrhoea, regardless of travel history or immune status"", ""correct_option"": ""B""}","Additional tests","In which of the following scenarios is testing for cryptosporidiosis specifically indicated?","In cases of bloody stools after a trip to an endemic area","In immunocompromised patients or children with persistent digestive problems","In adults with frothy stools after a stay in a non-endemic area","In all patients with diarrhoea, regardless of travel history or immune status","b"
"OIC-176-09-A","{""question"": ""What test is commonly used to assess the impact of infectious diarrhoea on the health of adults and children in situations of dehydration?"", ""option_a"": ""Blood gas with lactates"", ""option_b"": ""Blood ionogram"", ""option_c"": ""Assessment of organ dysfunction"", ""option_d"": ""CBC and creatininaemia only"", ""correct_option"": ""B""}",,"What test is commonly used to assess the impact of infectious diarrhoea on the health of adults and children in situations of dehydration?","Blood gas with lactates","Blood ionogram","Assessment of organ dysfunction","CBC and creatininaemia only","b"
"OIC-176-10-B","{""question"": ""In adults, what is a primary indication for rectosigmoidoscopy or colonoscopy in the context of infectious diarrhoea?"", ""option_a"": ""Acute diarrhoea with a identified cause"", ""option_b"": ""Persistent diarrhoea with no identified cause despite thorough work-up"", ""option_c"": ""Mild diarrhoea that resolves within a few days"", ""option_d"": ""Diarrhoea caused by a known viral infection"", ""correct_option"": ""B""}","Additional examinations","In adults, what is a primary indication for rectosigmoidoscopy or colonoscopy in the context of infectious diarrhoea?","Acute diarrhoea with a identified cause","Persistent diarrhoea with no identified cause despite thorough work-up","Mild diarrhoea that resolves within a few days","Diarrhoea caused by a known viral infection","b"
"OIC-176-11-A","{""question"": ""What is the primary approach for rehydrating a child with acute diarrhoea, provided the child has a weight loss of less than 10% of body weight and no signs of hypovolaemia?"", ""option_a"": ""Intravenous rehydration with an isotonic polyionic glucose solution"", ""option_b"": ""Oral rehydration with an oral rehydration solution (ORS), with fractions if vomiting occurs"", ""option_c"": ""Symptomatic treatment with antisecretory agents such as racecadotril"", ""option_d"": ""Immediate cessation of feeding to prevent further dehydration"", ""correct_option"": ""B""}","Management","What is the primary approach for rehydrating a child with acute diarrhoea, provided the child has a weight loss of less than 10% of body weight and no signs of hypovolaemia?","Intravenous rehydration with an isotonic polyionic glucose solution","Oral rehydration with an oral rehydration solution (ORS), with fractions if vomiting occurs","Symptomatic treatment with antisecretory agents such as racecadotril","Immediate cessation of feeding to prevent further dehydration","b"
"OIC-176-12-A","{""question"": ""What is the primary goal in the symptomatic management of diarrhoea in adults?"", ""option_a"": ""Immediately stop the diarrhoea using medication"", ""option_b"": ""Correct or prevent dehydration, giving preference to the oral route whenever possible"", ""option_c"": ""Reduce the intensity of diarrhoea as the first step"", ""option_d"": ""Use intravenous fluids as the primary method of rehydration"", ""correct_option"": ""B""}","Management","What is the primary goal in the symptomatic management of diarrhoea in adults?","Immediately stop the diarrhoea using medication","Correct or prevent dehydration, giving preference to the oral route whenever possible","Reduce the intensity of diarrhoea as the first step","Use intravenous fluids as the primary method of rehydration","b"
"OIC-176-13-A","{""question"": ""In adults, what is the usual duration of antibiotic therapy for Yersinia spp?"", ""option_a"": ""1-3 days"", ""option_b"": ""5-7 days"", ""option_c"": ""7 days"", ""option_d"": ""10-14 days"", ""correct_option"": ""C""}",,"In adults, what is the usual duration of antibiotic therapy for Yersinia spp?","1-3 days","5-7 days","7 days","10-14 days","c"
"OIC-176-14-A","{""question"": ""What is the primary method of preventing infectious diarrhoea in all circumstances?"", ""option_a"": ""Drinking treated or mineral water"", ""option_b"": ""Eating food that is cooked and hot"", ""option_c"": ""Good hand hygiene before meals and after using the toilet"", ""option_d"": ""Eviction from the community"", ""correct_option"": ""C""}",,"What is the primary method of preventing infectious diarrhoea in all circumstances?","Drinking treated or mineral water","Eating food that is cooked and hot","Good hand hygiene before meals and after using the toilet","Eviction from the community","c"
"OIC-176-15-A","{""question"": ""What is a collective foodborne outbreak?"", ""option_a"": ""A single case of food poisoning affecting one individual"", ""option_b"": ""An incident where two or more people experience foodborne illness from the same food source"", ""option_c"": ""A type of foodborne illness caused by a specific bacterium"", ""option_d"": ""A general term for all types of foodborne illnesses"", ""correct_option"": ""B""}","Definition","What is a collective foodborne outbreak?","A single case of food poisoning affecting one individual","An incident where two or more people experience foodborne illness from the same food source","A type of foodborne illness caused by a specific bacterium","A general term for all types of foodborne illnesses","b"
"OIC-176-16-A","{""question"": ""What is a critical situation that requires emergency treatment in cases of infectious diarrhoea?"", ""option_a"": ""Mild dehydration"", ""option_b"": ""Dehydration and Hemolytic Uremic Syndrome (HUS)"", ""option_c"": ""Food poisoning from contaminated water"", ""option_d"": ""Common cold symptoms"", ""correct_option"": ""B""}","Identification of emergencies","What is a critical situation that requires emergency treatment in cases of infectious diarrhoea?","Mild dehydration","Dehydration and Hemolytic Uremic Syndrome (HUS)","Food poisoning from contaminated water","Common cold symptoms","b"
"OIC-176-17-A","{""question"": ""What is the primary goal of prescribing oral and intravenous rehydration in patients with infectious diarrhoea?"", ""option_a"": ""To eliminate the causative pathogen"", ""option_b"": ""To reduce the frequency and severity of diarrhoeal episodes"", ""option_c"": ""To restore fluid and electrolyte balance in the body"", ""option_d"": ""To suppress the immune system's response to the infection"", ""correct_option"": ""C""}",,"What is the primary goal of prescribing oral and intravenous rehydration in patients with infectious diarrhoea?","To eliminate the causative pathogen","To reduce the frequency and severity of diarrhoeal episodes","To restore fluid and electrolyte balance in the body","To suppress the immune system's response to the infection","c"
"OIC-179-01-B","{""question"": ""What is the primary mode of transmission for Giardiasis?"", ""option_a"": ""Ingestion of contaminated water or food with oocysts from cat feces"", ""option_b"": ""Faeco-oral route or during sexual relations between men"", ""option_c"": ""Invasion of tissues by vegetative forms of Entamoeba histolytica histolytica"", ""option_d"": ""Manuported transmission of cysts"", ""correct_option"": ""B""}","Etiologies","What is the primary mode of transmission for Giardiasis?","Ingestion of contaminated water or food with oocysts from cat feces","Faeco-oral route or during sexual relations between men","Invasion of tissues by vegetative forms of Entamoeba histolytica histolytica","Manuported transmission of cysts","b"
"OIC-179-02-B","{""question"": ""What is the primary mode of transmission for Taeniasis in humans?"", ""option_a"": ""Ingestion of undercooked or uncooked meat from intermediate hosts"", ""option_b"": ""Contaminated drinking water"", ""option_c"": ""Direct contact with an infected person"", ""option_d"": ""Inhalation of airborne parasites"", ""correct_option"": ""A""}","Etiologies","What is the primary mode of transmission for Taeniasis in humans?","Ingestion of undercooked or uncooked meat from intermediate hosts","Contaminated drinking water","Direct contact with an infected person","Inhalation of airborne parasites","a"
"OIC-179-03-A","{""question"": ""What is a potential health risk associated with the consumption of water polluted with pesticides?"", ""option_a"": ""Gastrointestinal disorders"", ""option_b"": ""Neurological damage"", ""option_c"": ""Endocrine disruption"", ""option_d"": ""Dental fluorosis"", ""correct_option"": ""C""}","Definition","What is a potential health risk associated with the consumption of water polluted with pesticides?","Gastrointestinal disorders","Neurological damage","Endocrine disruption","Dental fluorosis","c"
"OIC-179-04-B","{""question"": ""What is the primary health risk associated with thermal pollution of water resources?"", ""option_a"": ""Chemical contamination from industrial waste"", ""option_b"": ""Microbiological proliferation, including the growth of free amoebae, legionella, and algae"", ""option_c"": ""Radioactive pollution from nuclear accidents"", ""option_d"": ""Organic pollution from agricultural runoff"", ""correct_option"": ""B""}","Definition","What is the primary health risk associated with thermal pollution of water resources?","Chemical contamination from industrial waste","Microbiological proliferation, including the growth of free amoebae, legionella, and algae","Radioactive pollution from nuclear accidents","Organic pollution from agricultural runoff","b"
"OIC-179-05-A","{""question"": ""What is the primary approach to preventing water-related health risks?"", ""option_a"": ""Focusing solely on water filtration and treatment"", ""option_b"": ""Implementing a comprehensive system from source to distribution"", ""option_c"": ""Regularly testing water quality only at the point of consumption"", ""option_d"": ""Controlling pollution-generating activities without considering other factors"", ""correct_option"": ""B""}","Definition","What is the primary approach to preventing water-related health risks?","Focusing solely on water filtration and treatment","Implementing a comprehensive system from source to distribution","Regularly testing water quality only at the point of consumption","Controlling pollution-generating activities without considering other factors","b"
"OIC-179-06-A","{""question"": ""What is a potential health risk associated with the consumption of poorly preserved fish?"", ""option_a"": ""Skin rash due to allergy"", ""option_b"": ""Histamine syndrome"", ""option_c"": ""Neurological damage due to heavy metals"", ""option_d"": ""Liver disease due to viruses"", ""correct_option"": ""B""}","Definition","What is a potential health risk associated with the consumption of poorly preserved fish?","Skin rash due to allergy","Histamine syndrome","Neurological damage due to heavy metals","Liver disease due to viruses","b"
"OIC-179-07-A","{""question"": ""What is the minimum number of cases required to define a foodborne outbreak?"", ""option_a"": ""1 case with severe symptoms"", ""option_b"": ""At least 2 cases of a similar symptomatology"", ""option_c"": ""5 cases with digestive symptoms"", ""option_d"": ""10 cases with neurological symptoms"", ""correct_option"": ""B""}","Definition","What is the minimum number of cases required to define a foodborne outbreak?","1 case with severe symptoms","At least 2 cases of a similar symptomatology","5 cases with digestive symptoms","10 cases with neurological symptoms","b"
"OIC-179-08-A","{""question"": ""What is the typical incubation period for food poisoning caused by Salmonella enterica non-Typhi serotypes?"", ""option_a"": ""2-4 hours"", ""option_b"": ""8-24 hours"", ""option_c"": ""12-24 hours"", ""option_d"": ""24-48 hours"", ""correct_option"": ""C""}","Etiologies","What is the typical incubation period for food poisoning caused by Salmonella enterica non-Typhi serotypes?","2-4 hours","8-24 hours","12-24 hours","24-48 hours","c"
"OIC-179-09-A","{""question"": ""What is the primary condition for suspecting a Collective Foodborne Toxicity Incident (CFTI)?"", ""option_a"": ""A single case of gastrointestinal disorder in a collective environment"", ""option_b"": ""Clustered cases of gastrointestinal or neurological disorders"", ""option_c"": ""Respected hygiene measures in a collective setting"", ""option_d"": ""Notification of the disease to the ARS without investigation"", ""correct_option"": ""B""}",,"What is the primary condition for suspecting a Collective Foodborne Toxicity Incident (CFTI)?","A single case of gastrointestinal disorder in a collective environment","Clustered cases of gastrointestinal or neurological disorders","Respected hygiene measures in a collective setting","Notification of the disease to the ARS without investigation","b"
"OIC-179-10-B","{""question"": ""What type of study is carried out in an epidemiological survey for communities with less than 30 exposed people during a CFTI investigation?"", ""option_a"": ""Case-control study"", ""option_b"": ""Cohort study"", ""option_c"": ""Cross-sectional study"", ""option_d"": ""Randomized controlled trial"", ""correct_option"": ""B""}","Definition","What type of study is carried out in an epidemiological survey for communities with less than 30 exposed people during a CFTI investigation?","Case-control study","Cohort study","Cross-sectional study","Randomized controlled trial","b"
"OIC-179-11-A","{""question"": ""What is a key aspect of preventing foodborne infections outside the context of a TIAC?"", ""option_a"": ""Implementing strict temperature controls during food storage"", ""option_b"": ""Applying scrupulous hygiene rules throughout the food preparation chain"", ""option_c"": ""Conducting regular customer surveys to monitor food quality"", ""option_d"": ""Reducing the variety of food items on the menu to minimize risk"", ""correct_option"": ""B""}",,"What is a key aspect of preventing foodborne infections outside the context of a TIAC?","Implementing strict temperature controls during food storage","Applying scrupulous hygiene rules throughout the food preparation chain","Conducting regular customer surveys to monitor food quality","Reducing the variety of food items on the menu to minimize risk","b"
"OIC-183-01-B","{""question"": ""What is a key characteristic of the organisation of occupational health and prevention services (STPS) in terms of their composition?"", ""option_a"": ""They are composed of only occupational physicians"", ""option_b"": ""They are composed of multidisciplinary teams including nurses, occupational risk specialists, and led by an occupational physician"", ""option_c"": ""They are composed of only engineers and psychologists"", ""option_d"": ""They do not include any medical professionals"", ""correct_option"": ""B""}",,"What is a key characteristic of the organisation of occupational health and prevention services (STPS) in terms of their composition?","They are composed of only occupational physicians","They are composed of multidisciplinary teams including nurses, occupational risk specialists, and led by an occupational physician","They are composed of only engineers and psychologists","They do not include any medical professionals","b"
"OIC-183-02-B","{""question"": ""What is one of the primary actions carried out by the occupational health physician or the multidisciplinary team in the workplace?"", ""option_a"": ""Conducting regular employee performance reviews"", ""option_b"": ""Assessing occupational risks through analyses or measurements"", ""option_c"": ""Developing company policies unrelated to health and safety"", ""option_d"": ""Managing employee conflicts and grievances"", ""correct_option"": ""B""}",,"What is one of the primary actions carried out by the occupational health physician or the multidisciplinary team in the workplace?","Conducting regular employee performance reviews","Assessing occupational risks through analyses or measurements","Developing company policies unrelated to health and safety","Managing employee conflicts and grievances","b"
"OIC-183-03-B","{""question"": ""What are the primary tools of an occupational health physician?"", ""option_a"": ""Only employee health monitoring"", ""option_b"": ""Only actions in the field, such as workstation studies and adaptation"", ""option_c"": ""Both employee health monitoring and actions in the field, in partnership with occupational health nurses and the multidisciplinary team"", ""option_d"": ""Neither employee health monitoring nor actions in the field, but rather solely focusing on policy development"", ""correct_option"": ""C""}","Definition","What are the primary tools of an occupational health physician?","Only employee health monitoring","Only actions in the field, such as workstation studies and adaptation","Both employee health monitoring and actions in the field, in partnership with occupational health nurses and the multidisciplinary team","Neither employee health monitoring nor actions in the field, but rather solely focusing on policy development","c"
"OIC-183-04-A","{""question"": ""What is the primary purpose of a pre-reinstatement visit in the context of occupational medicine?"", ""option_a"": ""To declare an employee unfit for work after a prolonged absence"", ""option_b"": ""To adapt working conditions for an employee returning to work after a prolonged absence"", ""option_c"": ""To conduct a medical examination for fitness every 4 years"", ""option_d"": ""To provide a mandatory medical aptitude examination prior to assignment to a workstation"", ""correct_option"": ""B""}","Definition","What is the primary purpose of a pre-reinstatement visit in the context of occupational medicine?","To declare an employee unfit for work after a prolonged absence","To adapt working conditions for an employee returning to work after a prolonged absence","To conduct a medical examination for fitness every 4 years","To provide a mandatory medical aptitude examination prior to assignment to a workstation","b"
"OIC-183-05-B","{""question"": ""What is the primary purpose of the occupational health medical file?"", ""option_a"": ""To record occupational risks and provide recommendations for reducing exposure"", ""option_b"": ""To determine an employee's fitness or unfitness for work"", ""option_c"": ""To trace the employee's state of health and occupational exposure, subject to medical confidentiality"", ""option_d"": ""To transmit the occupational physician's opinion to the employer"", ""correct_option"": ""C""}","Definition","What is the primary purpose of the occupational health medical file?","To record occupational risks and provide recommendations for reducing exposure","To determine an employee's fitness or unfitness for work","To trace the employee's state of health and occupational exposure, subject to medical confidentiality","To transmit the occupational physician's opinion to the employer","c"
"OIC-183-06-A","{""question"": ""What is the primary goal of primary prevention in occupational medicine?"", ""option_a"": ""To detect and treat work-related illnesses as early as possible"", ""option_b"": ""To keep people with work-related illnesses in work"", ""option_c"": ""To prevent the appearance of deleterious effects in employees exposed to occupational risks"", ""option_d"": ""To provide medical treatment for work-related illnesses"", ""correct_option"": ""C""}","Definition","What is the primary goal of primary prevention in occupational medicine?","To detect and treat work-related illnesses as early as possible","To keep people with work-related illnesses in work","To prevent the appearance of deleterious effects in employees exposed to occupational risks","To provide medical treatment for work-related illnesses","c"
"OIC-183-07-B","{""question"": ""Who is responsible for the hierarchisation des risques professionnels in companies?"", ""option_a"": ""The multidisciplinary occupational health team"", ""option_b"": ""The occupational physician"", ""option_c"": ""The employer"", ""option_d"": ""The employees"", ""correct_option"": ""C""}","Definition","Who is responsible for the hierarchisation des risques professionnels in companies?","The multidisciplinary occupational health team","The occupational physician","The employer","The employees","c"
"OIC-183-08-A","{""question"": ""According to the risk management approach, what is the first step to take when dealing with hazards in the workplace?"", ""option_a"": ""Limit employee exposure by wearing personal protective equipment"", ""option_b"": ""Limit emissions at source using collective protective equipment"", ""option_c"": ""Eliminate hazards by removing or redesigning them"", ""option_d"": ""Evaluate the effectiveness of preventive measures through monitoring and assessment"", ""correct_option"": ""C""}","Definition","According to the risk management approach, what is the first step to take when dealing with hazards in the workplace?","Limit employee exposure by wearing personal protective equipment","Limit emissions at source using collective protective equipment","Eliminate hazards by removing or redesigning them","Evaluate the effectiveness of preventive measures through monitoring and assessment","c"
"OIC-186-01-B","{""question"": ""What is the primary mechanism by which Type 1 hypersensitivity reactions are mediated?"", ""option_a"": ""Activation of complement or immune cells by IgG or IgM antibodies"", ""option_b"": ""Binding of IgE antibodies to receptors on the surface of mast cells and basophilic cells"", ""option_c"": ""Recognition of allergens by allergen-specific memory T lymphocytes"", ""option_d"": ""Formation of circulating soluble antigen/antibody complexes"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism by which Type 1 hypersensitivity reactions are mediated?","Activation of complement or immune cells by IgG or IgM antibodies","Binding of IgE antibodies to receptors on the surface of mast cells and basophilic cells","Recognition of allergens by allergen-specific memory T lymphocytes","Formation of circulating soluble antigen/antibody complexes","b"
"OIC-186-02-B","{""question"": ""What percentage of the general population is estimated to suffer from systemic reactions to hymenoptera venom, potentially causing severe anaphylaxis?"", ""option_a"": ""0.03 to 0.45%"", ""option_b"": ""0.3 to 7.5%"", ""option_c"": ""10 to 40%"", ""option_d"": ""50 to 70%"", ""correct_option"": ""B""}","Epidemiology","What percentage of the general population is estimated to suffer from systemic reactions to hymenoptera venom, potentially causing severe anaphylaxis?","0.03 to 0.45%","0.3 to 7.5%","10 to 40%","50 to 70%","b"
"OIC-186-03-B","{""question"": ""What is the most common allergen responsible for food allergies in children?"", ""option_a"": ""Peanuts"", ""option_b"": ""Eggs"", ""option_c"": ""Cow's milk and eggs"", ""option_d"": ""Fish"", ""correct_option"": ""C""}","Epidemiology","What is the most common allergen responsible for food allergies in children?","Peanuts","Eggs","Cow's milk and eggs","Fish","c"
"OIC-186-04-B","{""question"": ""What is the approximate prevalence of drug hypersensitivity in the general population, and what is the proportion of non-allergic cases?"", ""option_a"": ""Approximately 1% of the general population, with about 50% of cases being non-allergic"", ""option_b"": ""Approximately 7% of the general population, with more than 90% of cases being non-allergic"", ""option_c"": ""Approximately 10% of the general population, with about 20% of cases being non-allergic"", ""option_d"": ""Approximately 5% of the general population, with about 80% of cases being non-allergic"", ""correct_option"": ""B""}","Epidemiology","What is the approximate prevalence of drug hypersensitivity in the general population, and what is the proportion of non-allergic cases?","Approximately 1% of the general population, with about 50% of cases being non-allergic","Approximately 7% of the general population, with more than 90% of cases being non-allergic","Approximately 10% of the general population, with about 20% of cases being non-allergic","Approximately 5% of the general population, with about 80% of cases being non-allergic","b"
"OIC-186-05-B","{""question"": ""What type of hypersensitivity reaction is mediated by Hymenoptera venom allergies?"", ""option_a"": ""Type 2 hypersensitivity"", ""option_b"": ""Type 3 hypersensitivity"", ""option_c"": ""Type 1 hypersensitivity"", ""option_d"": ""Type 4 hypersensitivity"", ""correct_option"": ""C""}","Physiopathology","What type of hypersensitivity reaction is mediated by Hymenoptera venom allergies?","Type 2 hypersensitivity","Type 3 hypersensitivity","Type 1 hypersensitivity","Type 4 hypersensitivity","c"
"OIC-186-06-A","{""question"": ""What is the primary basis for diagnosing respiratory allergies?"", ""option_a"": ""Demonstration of a strong association between exposure to an allergen and the onset of symptoms"", ""option_b"": ""Presence of asthma and/or rhinitis symptoms alone"", ""option_c"": ""Identification of indoor allergens such as dust mites and cockroaches"", ""option_d"": ""Evidence of seasonal variations in symptom severity"", ""correct_option"": ""A""}","Positive diagnosis","What is the primary basis for diagnosing respiratory allergies?","Demonstration of a strong association between exposure to an allergen and the onset of symptoms","Presence of asthma and/or rhinitis symptoms alone","Identification of indoor allergens such as dust mites and cockroaches","Evidence of seasonal variations in symptom severity","a"
"OIC-186-07-A","{""question"": ""What is the most common allergen responsible for IgE-mediated food allergy in children under the age of 15?"", ""option_a"": ""Peanuts, especially after the age of 3"", ""option_b"": ""Eggs"", ""option_c"": ""Nuts, shellfish, and soya"", ""option_d"": ""Fruits, such as apples and bananas"", ""correct_option"": ""B""}","Positive diagnosis","What is the most common allergen responsible for IgE-mediated food allergy in children under the age of 15?","Peanuts, especially after the age of 3","Eggs","Nuts, shellfish, and soya","Fruits, such as apples and bananas","b"
"OIC-186-08-B","{""question"": ""What is the primary method to confirm the diagnosis of a peanut or nut allergy when other tests are inconclusive?"", ""option_a"": ""Skin tests with standardized extracts"", ""option_b"": ""Multi-allergen test"", ""option_c"": ""Provocation test"", ""option_d"": ""Food category survey"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary method to confirm the diagnosis of a peanut or nut allergy when other tests are inconclusive?","Skin tests with standardized extracts","Multi-allergen test","Provocation test","Food category survey","c"
"OIC-186-09-B","{""question"": ""What is the primary mechanism underlying cross-allergies between respiratory and food allergens?"", ""option_a"": ""The presence of identical allergens in both respiratory and food sources"", ""option_b"": ""The recognition of similar or highly homologous allergens by a patient's specific IgE antibodies"", ""option_c"": ""The direct transfer of allergens from respiratory sources to food sources"", ""option_d"": ""The overproduction of IgE antibodies in response to multiple allergenic sources"", ""correct_option"": ""B""}",,"What is the primary mechanism underlying cross-allergies between respiratory and food allergens?","The presence of identical allergens in both respiratory and food sources","The recognition of similar or highly homologous allergens by a patient's specific IgE antibodies","The direct transfer of allergens from respiratory sources to food sources","The overproduction of IgE antibodies in response to multiple allergenic sources","b"
"OIC-186-10-B","{""question"": ""What is the primary basis for diagnosing a reaction following a hymenoptera sting?"", ""option_a"": ""Only skin tests, such as intradermal tests, are used for diagnosis"", ""option_b"": ""Biological tests, like venom-specific IgE assay, are the sole diagnostic method"", ""option_c"": ""A combination of history, skin tests, and biological tests are used for diagnosis"", ""option_d"": ""Identification of the insect by visual inspection of the stinger alone is sufficient for diagnosis"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary basis for diagnosing a reaction following a hymenoptera sting?","Only skin tests, such as intradermal tests, are used for diagnosis","Biological tests, like venom-specific IgE assay, are the sole diagnostic method","A combination of history, skin tests, and biological tests are used for diagnosis","Identification of the insect by visual inspection of the stinger alone is sufficient for diagnosis","c"
"OIC-186-11-A","{""question"": ""What is the primary factor contributing to the decline in microbial biodiversity, according to the hygienist theory, which is linked to an increase in allergic and auto-immune diseases?"", ""option_a"": ""Increased exposure to atmospheric pollution"", ""option_b"": ""Decline in infectious contacts due to improved hygiene practices"", ""option_c"": ""Changes in eating habits and introduction of new food allergens"", ""option_d"": ""Occupational exposure to allergens such as latex and isocyanates"", ""correct_option"": ""B""}","Etiologies","What is the primary factor contributing to the decline in microbial biodiversity, according to the hygienist theory, which is linked to an increase in allergic and auto-immune diseases?","Increased exposure to atmospheric pollution","Decline in infectious contacts due to improved hygiene practices","Changes in eating habits and introduction of new food allergens","Occupational exposure to allergens such as latex and isocyanates","b"
"OIC-186-12-B","{""question"": ""What is the primary purpose of a multi-allergen IgE screening test in patients suspected of having a respiratory or food allergy?"", ""option_a"": ""To confirm the presence of an allergy and initiate treatment"", ""option_b"": ""To detect IgE antibodies specific to a panel of commonly encountered allergens"", ""option_c"": ""To identify the exact allergen causing the allergic reaction"", ""option_d"": ""To monitor the progression of an existing allergy"", ""correct_option"": ""B""}",,"What is the primary purpose of a multi-allergen IgE screening test in patients suspected of having a respiratory or food allergy?","To confirm the presence of an allergy and initiate treatment","To detect IgE antibodies specific to a panel of commonly encountered allergens","To identify the exact allergen causing the allergic reaction","To monitor the progression of an existing allergy","b"
"OIC-186-13-B","{""question"": ""What is the primary purpose of a prick test in allergology?"", ""option_a"": ""To investigate delayed reactions and diagnose type IV hypersensitivity"", ""option_b"": ""To explore immediate allergic reactions and diagnose type I hypersensitivity"", ""option_c"": ""To examine the presence of IgG antibodies in the skin"", ""option_d"": ""To assess the severity of anaphylactic reactions"", ""correct_option"": ""B""}","Management","What is the primary purpose of a prick test in allergology?","To investigate delayed reactions and diagnose type IV hypersensitivity","To explore immediate allergic reactions and diagnose type I hypersensitivity","To examine the presence of IgG antibodies in the skin","To assess the severity of anaphylactic reactions","b"
"OIC-186-14-A","{""question"": ""What is the primary purpose of the 'projet d'accueil individualis\u00e9' (PAI) in the context of food allergy management in children?"", ""option_a"": ""To provide a detailed list of high-risk foods for the child to avoid"", ""option_b"": ""To establish a treatment protocol in the event of an accidental allergic reaction at school or during extra-curricular activities, while also waiving doctor-patient confidentiality"", ""option_c"": ""To educate the child on how to self-administer auto-injectable adrenaline"", ""option_d"": ""To assess the child's symptoms and determine the need for an emergency kit"", ""correct_option"": ""B""}",,"What is the primary purpose of the 'projet d'accueil individualisé' (PAI) in the context of food allergy management in children?","To provide a detailed list of high-risk foods for the child to avoid","To establish a treatment protocol in the event of an accidental allergic reaction at school or during extra-curricular activities, while also waiving doctor-patient confidentiality","To educate the child on how to self-administer auto-injectable adrenaline","To assess the child's symptoms and determine the need for an emergency kit","b"
"OIC-186-15-A","{""question"": ""What is the primary method for diagnosing allergic conjunctivitis?"", ""option_a"": ""Conjunctival provocation testing with the suspected allergen"", ""option_b"": ""Clinical signs and the presence of sensitisation"", ""option_c"": ""Symptom assessment alone, such as tearing and redness"", ""option_d"": ""Genetic testing for allergic predisposition"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method for diagnosing allergic conjunctivitis?","Conjunctival provocation testing with the suspected allergen","Clinical signs and the presence of sensitisation","Symptom assessment alone, such as tearing and redness","Genetic testing for allergic predisposition","b"
"OIC-186-16-A","{""question"": ""What is a common local treatment approach for allergic conjunctivitis, in addition to systemic treatment with 2nd generation anti-H1 medication and eviction of the allergen?"", ""option_a"": ""Application of warm compresses and oral administration of H1 antihistamines"", ""option_b"": ""Frequent eye washing, application of cold wet compresses, and use of H1 antihistamines or mast cell degranulation inhibitors in eye drops"", ""option_c"": ""Surgical removal of the affected conjunctiva"", ""option_d"": ""Prolonged use of antibiotic eye drops"", ""correct_option"": ""B""}","Management","What is a common local treatment approach for allergic conjunctivitis, in addition to systemic treatment with 2nd generation anti-H1 medication and eviction of the allergen?","Application of warm compresses and oral administration of H1 antihistamines","Frequent eye washing, application of cold wet compresses, and use of H1 antihistamines or mast cell degranulation inhibitors in eye drops","Surgical removal of the affected conjunctiva","Prolonged use of antibiotic eye drops","b"
"OIC-186-17-A","{""question"": ""What is the most common food allergen in children between birth and 5.5 years of age, according to the ELFE cohort data?"", ""option_a"": ""Peanut"", ""option_b"": ""Milk"", ""option_c"": ""Egg"", ""option_d"": ""Gluten"", ""correct_option"": ""B""}","Epidemiology","What is the most common food allergen in children between birth and 5.5 years of age, according to the ELFE cohort data?","Peanut","Milk","Egg","Gluten","b"
"OIC-186-18-A","{""question"": ""What is the estimated percentage of children who develop asthma if both parents are asthmatic?"", ""option_a"": ""10%"", ""option_b"": ""25%"", ""option_c"": ""More than 50%"", ""option_d"": ""Less than 5%"", ""correct_option"": ""C""}","Epidemiology","What is the estimated percentage of children who develop asthma if both parents are asthmatic?","10%","25%","More than 50%","Less than 5%","c"
"OIC-186-19-A","{""question"": ""For a child over 1 year old, which test is prescribed to detect food allergies as part of a multi-allergen IgE screening?"", ""option_a"": ""fx5 test"", ""option_b"": ""Trophatop\u00ae child"", ""option_c"": ""Respiratory allergy test"", ""option_d"": ""Total IgE test"", ""correct_option"": ""B""}",,"For a child over 1 year old, which test is prescribed to detect food allergies as part of a multi-allergen IgE screening?","fx5 test","Trophatop® child","Respiratory allergy test","Total IgE test","b"
"OIC-187-01-A","{""question"": ""What is the typical duration that distinguishes chronic urticaria from acute urticaria?"", ""option_a"": ""More than 2 weeks"", ""option_b"": ""More than 6 weeks"", ""option_c"": ""Less than 1 week"", ""option_d"": ""Exactly 4 weeks"", ""correct_option"": ""B""}","Definition","What is the typical duration that distinguishes chronic urticaria from acute urticaria?","More than 2 weeks","More than 6 weeks","Less than 1 week","Exactly 4 weeks","b"
"OIC-187-02-B","{""question"": ""What is the primary mechanism by which mast cells release mediators, such as histamine, leading to urticaria?"", ""option_a"": ""Immunological mechanism via IgM-type autoantibodies"", ""option_b"": ""Non-immunological mechanism via direct activation of mast cells"", ""option_c"": ""Immunological mechanism via IgE or IgG-type autoantibodies"", ""option_d"": ""Pharmacological action of certain drugs, such as antibiotics"", ""correct_option"": ""C""}","Pathophysiological elements","What is the primary mechanism by which mast cells release mediators, such as histamine, leading to urticaria?","Immunological mechanism via IgM-type autoantibodies","Non-immunological mechanism via direct activation of mast cells","Immunological mechanism via IgE or IgG-type autoantibodies","Pharmacological action of certain drugs, such as antibiotics","c"
"OIC-187-03-A","{""question"": ""What percentage of cases involve superficial urticaria isolated from deep urticaria?"", ""option_a"": ""10%"", ""option_b"": ""40%"", ""option_c"": ""50%"", ""option_d"": ""60%"", ""correct_option"": ""C""}","Positive diagnosis","What percentage of cases involve superficial urticaria isolated from deep urticaria?","10%","40%","50%","60%","c"
"OIC-187-04-A","{""question"": ""What is the primary characteristic of the skin lesions shown in the photography of urticaria?"", ""option_a"": ""Erythematous plaques"", ""option_b"": ""Edematous papules"", ""option_c"": ""Vesicular rashes"", ""option_d"": ""Pustular lesions"", ""correct_option"": ""B""}","Multimedia content","What is the primary characteristic of the skin lesions shown in the photography of urticaria?","Erythematous plaques","Edematous papules","Vesicular rashes","Pustular lesions","b"
"OIC-187-05-A","{""question"": ""What is a characteristic that distinguishes anaphylaxis from chronic urticaria?"", ""option_a"": ""Presence of respiratory signs such as dysphonia and dyspnoea"", ""option_b"": ""Association with an allergy or immediate hypersensitivity"", ""option_c"": ""Chronic duration of the condition"", ""option_d"": ""Absence of digestive signs such as nausea and vomiting"", ""correct_option"": ""C""}","Identifying the emergency","What is a characteristic that distinguishes anaphylaxis from chronic urticaria?","Presence of respiratory signs such as dysphonia and dyspnoea","Association with an allergy or immediate hypersensitivity","Chronic duration of the condition","Absence of digestive signs such as nausea and vomiting","c"
"OIC-187-06-A","{""question"": ""What is the primary mechanism behind most cases of drug-induced urticaria?"", ""option_a"": ""Immunological mechanism via IgE antibodies"", ""option_b"": ""Non-immunological mast cell activation"", ""option_c"": ""Delayed hypersensitivity reaction"", ""option_d"": ""Autoimmune response"", ""correct_option"": ""B""}","Etiologies","What is the primary mechanism behind most cases of drug-induced urticaria?","Immunological mechanism via IgE antibodies","Non-immunological mast cell activation","Delayed hypersensitivity reaction","Autoimmune response","b"
"OIC-187-07-A","{""question"": ""What is the recommended initial dosage of 2nd generation anti-H1 antihistamines for the symptomatic treatment of acute urticaria?"", ""option_a"": ""1 to 2 tablets/day"", ""option_b"": ""2 to 4 tablets/day"", ""option_c"": ""4 tablets/day"", ""option_d"": ""1 tablet every other day"", ""correct_option"": ""A""}","Management","What is the recommended initial dosage of 2nd generation anti-H1 antihistamines for the symptomatic treatment of acute urticaria?","1 to 2 tablets/day","2 to 4 tablets/day","4 tablets/day","1 tablet every other day","a"
"OIC-187-08-B","{""question"": ""What type of genes are involved in the development of atopic dermatitis, in addition to epidermal barrier genes?"", ""option_a"": ""Genes regulating only the innate immune system"", ""option_b"": ""Genes regulating the adaptive and innate immune system"", ""option_c"": ""Genes regulating only the adaptive immune system"", ""option_d"": ""Genes regulating the nervous system"", ""correct_option"": ""B""}",,"What type of genes are involved in the development of atopic dermatitis, in addition to epidermal barrier genes?","Genes regulating only the innate immune system","Genes regulating the adaptive and innate immune system","Genes regulating only the adaptive immune system","Genes regulating the nervous system","b"
"OIC-187-09-A","{""question"": ""At what age does atopic dermatitis most often begin, and what percentage of children progress to an adult form?"", ""option_a"": ""It begins in the first 6 months of life, and 10 to 15% of children progress to an adult form"", ""option_b"": ""It begins in the first 12 months of life, and 3 to 5% of children progress to an adult form"", ""option_c"": ""It begins in the first 2 years of life, and 20 to 25% of children progress to an adult form"", ""option_d"": ""It begins in the first 5 years of life, and 1 to 2% of children progress to an adult form"", ""correct_option"": ""B""}","Positive diagnosis","At what age does atopic dermatitis most often begin, and what percentage of children progress to an adult form?","It begins in the first 6 months of life, and 10 to 15% of children progress to an adult form","It begins in the first 12 months of life, and 3 to 5% of children progress to an adult form","It begins in the first 2 years of life, and 20 to 25% of children progress to an adult form","It begins in the first 5 years of life, and 1 to 2% of children progress to an adult form","b"
"OIC-187-10-A","{""question"": ""What is the condition depicted in the photo of the infant?"", ""option_a"": ""Urticaria"", ""option_b"": ""Atopic dermatitis"", ""option_c"": ""Contact dermatitis"", ""option_d"": ""Irritant contact dermatitis"", ""correct_option"": ""B""}","Multimedia content","What is the condition depicted in the photo of the infant?","Urticaria","Atopic dermatitis","Contact dermatitis","Irritant contact dermatitis","b"
"OIC-187-11-B","{""question"": ""What is a clinical sign that is NOT indicative of superinfection in atopic dermatitis?"", ""option_a"": ""Presence of purulent discharge"", ""option_b"": ""Vesiculo-bullous lesions"", ""option_c"": ""Light yellow oozing from acute lesions"", ""option_d"": ""Melicoid crusts"", ""correct_option"": ""C""}",,"What is a clinical sign that is NOT indicative of superinfection in atopic dermatitis?","Presence of purulent discharge","Vesiculo-bullous lesions","Light yellow oozing from acute lesions","Melicoid crusts","c"
"OIC-187-12-A","{""question"": ""What are the primary factors to consider when choosing a dermocorticoid for the treatment of atopic dermatitis?"", ""option_a"": ""Age, location of lesions, and patient's medical history"", ""option_b"": ""Age, location of lesions, extent to be treated, and oozing nature of lesions"", ""option_c"": ""Location of lesions, extent to be treated, and patient's preferences"", ""option_d"": ""Extent to be treated, oozing nature of lesions, and patient's socioeconomic status"", ""correct_option"": ""B""}","Management","What are the primary factors to consider when choosing a dermocorticoid for the treatment of atopic dermatitis?","Age, location of lesions, and patient's medical history","Age, location of lesions, extent to be treated, and oozing nature of lesions","Location of lesions, extent to be treated, and patient's preferences","Extent to be treated, oozing nature of lesions, and patient's socioeconomic status","b"
"OIC-187-13-B","{""question"": ""What type of hypersensitivity reaction is allergic contact dermatitis classified as in the Gel and Coombs classification?"", ""option_a"": ""Type I immediate hypersensitivity"", ""option_b"": ""Type II antibody-dependent hypersensitivity"", ""option_c"": ""Type III immune complex-mediated hypersensitivity"", ""option_d"": ""Type IV delayed hypersensitivity"", ""correct_option"": ""D""}","Physiopathology","What type of hypersensitivity reaction is allergic contact dermatitis classified as in the Gel and Coombs classification?","Type I immediate hypersensitivity","Type II antibody-dependent hypersensitivity","Type III immune complex-mediated hypersensitivity","Type IV delayed hypersensitivity","d"
"OIC-187-14-A","{""question"": ""What is the typical sequence of phases in the evolution of acute eczema?"", ""option_a"": ""Vesicular, scabbing, erythematous, pruritus"", ""option_b"": ""Erythematous, vesicular, oozing, scabbing"", ""option_c"": ""Pruritus, scabbing, erythematous, vesicular"", ""option_d"": ""Oozing, pruritus, scabbing, erythematous"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical sequence of phases in the evolution of acute eczema?","Vesicular, scabbing, erythematous, pruritus","Erythematous, vesicular, oozing, scabbing","Pruritus, scabbing, erythematous, vesicular","Oozing, pruritus, scabbing, erythematous","b"
"OIC-187-15-A","{""question"": ""What are the characteristic elementary lesions of acute eczema?"", ""option_a"": ""Only oedema and poorly limited erythema"", ""option_b"": ""Oedema, poorly limited erythema, and vesicles"", ""option_c"": ""Vesicles and well-defined erythema"", ""option_d"": ""Only pruritic papules"", ""correct_option"": ""B""}","Multimedia content","What are the characteristic elementary lesions of acute eczema?","Only oedema and poorly limited erythema","Oedema, poorly limited erythema, and vesicles","Vesicles and well-defined erythema","Only pruritic papules","b"
"OIC-187-16-A","{""question"": ""What are the four main sources of allergens that should be investigated when diagnosing contact eczema?"", ""option_a"": ""Food, clothing, cosmetics, and medicines"", ""option_b"": ""Clothing products, cosmetics, medicines for cutaneous application, and occupational allergens"", ""option_c"": ""Animals, plants, metals, and plastics"", ""option_d"": ""Household products, personal care products, food additives, and environmental pollutants"", ""correct_option"": ""B""}","Etiologies","What are the four main sources of allergens that should be investigated when diagnosing contact eczema?","Food, clothing, cosmetics, and medicines","Clothing products, cosmetics, medicines for cutaneous application, and occupational allergens","Animals, plants, metals, and plastics","Household products, personal care products, food additives, and environmental pollutants","b"
"OIC-187-17-B","{""question"": ""What is the primary indicator of a positive patch test result?"", ""option_a"": ""Simple erythema that disappears within a few hours"", ""option_b"": ""Contact eczema characterized by erythema and vesicles"", ""option_c"": ""Absence of any skin reaction"", ""option_d"": ""Irritation that persists for several weeks"", ""correct_option"": ""B""}","Additional tests","What is the primary indicator of a positive patch test result?","Simple erythema that disappears within a few hours","Contact eczema characterized by erythema and vesicles","Absence of any skin reaction","Irritation that persists for several weeks","b"
"OIC-187-18-A","{""question"": ""What is the primary principle of treating contact eczema?"", ""option_a"": ""Applying dermatocorticoid cream or ointment twice daily"", ""option_b"": ""Avoiding contact with the allergen"", ""option_c"": ""Using moisturising cream as the first line of treatment"", ""option_d"": ""Applying cream or ointment without considering the site of the eczema"", ""correct_option"": ""B""}","Management","What is the primary principle of treating contact eczema?","Applying dermatocorticoid cream or ointment twice daily","Avoiding contact with the allergen","Using moisturising cream as the first line of treatment","Applying cream or ointment without considering the site of the eczema","b"
"OIC-188-01-A","{""question"": ""What is the primary characteristic of asthma?"", ""option_a"": ""A chronic inflammatory disease of the upper airways"", ""option_b"": ""A chronic inflammatory disease leading to changes in the structure of the lower airways with variable respiratory symptoms and reversible airway obstruction"", ""option_c"": ""An acute infectious disease of the lower airways"", ""option_d"": ""A non-inflammatory disease of the lower airways with constant respiratory symptoms"", ""correct_option"": ""B""}","Definition","What is the primary characteristic of asthma?","A chronic inflammatory disease of the upper airways","A chronic inflammatory disease leading to changes in the structure of the lower airways with variable respiratory symptoms and reversible airway obstruction","An acute infectious disease of the lower airways","A non-inflammatory disease of the lower airways with constant respiratory symptoms","b"
"OIC-188-02-B","{""question"": ""What is the estimated risk of a child developing asthma if both parents have asthma?"", ""option_a"": ""10%"", ""option_b"": ""25%"", ""option_c"": ""More than 50%"", ""option_d"": ""Less than 5%"", ""correct_option"": ""C""}","Epidemiology","What is the estimated risk of a child developing asthma if both parents have asthma?","10%","25%","More than 50%","Less than 5%","c"
"OIC-188-03-B","{""question"": ""What is the primary mechanism of airway inflammation in Th2 asthma?"", ""option_a"": ""Involvement of Th1 lymphocytes and neutrophils"", ""option_b"": ""Involvement of Th2 lymphocytes and eosinophils"", ""option_c"": ""Involvement of Th17 lymphocytes and basophils"", ""option_d"": ""Involvement of mast cells and macrophages"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism of airway inflammation in Th2 asthma?","Involvement of Th1 lymphocytes and neutrophils","Involvement of Th2 lymphocytes and eosinophils","Involvement of Th17 lymphocytes and basophils","Involvement of mast cells and macrophages","b"
"OIC-188-04-A","{""question"": ""What does the acronym PAREO stand for in the context of allergic rhinitis symptoms?"", ""option_a"": ""Pruritus, Anosmia, Rhinorrhoea, Eczema, Ocular symptoms"", ""option_b"": ""Pruritus, Anosmia, Rhinorrhoea, Epistaxis, Ocular symptoms"", ""option_c"": ""Pruritus, Anosmia, Rhinorrhoea, Sneezing, Ocular symptoms"", ""option_d"": ""Pruritus, Asthma, Rhinorrhoea, Sneezing, Ocular symptoms"", ""correct_option"": ""C""}","Positive diagnosis","What does the acronym PAREO stand for in the context of allergic rhinitis symptoms?","Pruritus, Anosmia, Rhinorrhoea, Eczema, Ocular symptoms","Pruritus, Anosmia, Rhinorrhoea, Epistaxis, Ocular symptoms","Pruritus, Anosmia, Rhinorrhoea, Sneezing, Ocular symptoms","Pruritus, Asthma, Rhinorrhoea, Sneezing, Ocular symptoms","c"
"OIC-188-05-A","{""question"": ""What is required to diagnose asthma in children and adults?"", ""option_a"": ""Characteristic symptoms alone"", ""option_b"": ""Demonstration of reversible airway obstruction alone"", ""option_c"": ""Characteristic symptoms AND demonstration of reversible airway obstruction"", ""option_d"": ""Presence of allergens and respiratory discomfort"", ""correct_option"": ""C""}","Positive diagnosis","What is required to diagnose asthma in children and adults?","Characteristic symptoms alone","Demonstration of reversible airway obstruction alone","Characteristic symptoms AND demonstration of reversible airway obstruction","Presence of allergens and respiratory discomfort","c"
"OIC-188-06-B","{""question"": ""What is the primary basis for diagnosing occupational asthma?"", ""option_a"": ""Presence of allergic rhinitis"", ""option_b"": ""Evidence of occupational exposure to a sensitising agent and a link between asthma and occupational exposure"", ""option_c"": ""Non-specific bronchial hyperresponsiveness test results alone"", ""option_d"": ""History of asthma in the patient's family"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary basis for diagnosing occupational asthma?","Presence of allergic rhinitis","Evidence of occupational exposure to a sensitising agent and a link between asthma and occupational exposure","Non-specific bronchial hyperresponsiveness test results alone","History of asthma in the patient's family","b"
"OIC-188-07-B","{""question"": ""Which of the following occupations is at risk of occupational asthma due to exposure to isocyanates?"", ""option_a"": ""Baker"", ""option_b"": ""Healthcare professional"", ""option_c"": ""Hairdresser"", ""option_d"": ""Painter"", ""correct_option"": ""D""}","Etiologies","Which of the following occupations is at risk of occupational asthma due to exposure to isocyanates?","Baker","Healthcare professional","Hairdresser","Painter","d"
"OIC-188-08-A","{""question"": ""What is one of the indicators that asthma is controlled?"", ""option_a"": ""Asthma symptoms are present daily"", ""option_b"": ""Exacerbations require more than 2 courses of systemic corticosteroid therapy in the previous year"", ""option_c"": ""FEV1/FVC ratio is greater than 0.7 and FEV1 is \u2265 80%"", ""option_d"": ""Bronchial obstruction is present with FEV1/FVC < 0.6"", ""correct_option"": ""C""}","Positive diagnosis","What is one of the indicators that asthma is controlled?","Asthma symptoms are present daily","Exacerbations require more than 2 courses of systemic corticosteroid therapy in the previous year","FEV1/FVC ratio is greater than 0.7 and FEV1 is ≥ 80%","Bronchial obstruction is present with FEV1/FVC < 0.6","c"
"OIC-188-09-A","{""question"": ""What is a key characteristic of an asthma exacerbation in children and adults?"", ""option_a"": ""A sudden onset of symptoms that resolve within 24 hours"", ""option_b"": ""A progressive increase in symptoms lasting at least two days, requiring a change in treatment"", ""option_c"": ""Mild symptoms that are easily controlled with occasional use of rapid-acting bronchodilators"", ""option_d"": ""Symptoms that worsen only at night and improve during the day"", ""correct_option"": ""B""}","Positive diagnosis","What is a key characteristic of an asthma exacerbation in children and adults?","A sudden onset of symptoms that resolve within 24 hours","A progressive increase in symptoms lasting at least two days, requiring a change in treatment","Mild symptoms that are easily controlled with occasional use of rapid-acting bronchodilators","Symptoms that worsen only at night and improve during the day","b"
"OIC-188-10-A","{""question"": ""What is a sign of struggle in a patient experiencing an asthma exacerbation?"", ""option_a"": ""Able to speak in long sentences without interruption"", ""option_b"": ""Prefers lying down to sitting"", ""option_c"": ""Speaks in short sentences or interrupted by inspiration"", ""option_d"": ""Has a normal respiratory rate and oxygen saturation"", ""correct_option"": ""C""}","Emergency identification","What is a sign of struggle in a patient experiencing an asthma exacerbation?","Able to speak in long sentences without interruption","Prefers lying down to sitting","Speaks in short sentences or interrupted by inspiration","Has a normal respiratory rate and oxygen saturation","c"
"OIC-188-11-B","{""question"": ""What are the radiological signs of thoracic distension on a chest X-ray?"", ""option_a"": ""Hyperclarity of the lung fields with flattening of the diaphragmatic cupolas and horizontalization of the ribs"", ""option_b"": ""Increased opacity of the lungs with elevation of the diaphragm"", ""option_c"": ""Cardiomegaly with pulmonary edema"", ""option_d"": ""Pleural effusion with atelectasis"", ""correct_option"": ""A""}","Multimedia content","What are the radiological signs of thoracic distension on a chest X-ray?","Hyperclarity of the lung fields with flattening of the diaphragmatic cupolas and horizontalization of the ribs","Increased opacity of the lungs with elevation of the diaphragm","Cardiomegaly with pulmonary edema","Pleural effusion with atelectasis","a"
"OIC-188-12-B","{""question"": ""What is the criterion for diagnosing an obstructive ventilatory disorder in functional respiratory examinations (EFR)?"", ""option_a"": ""FEV1/CV \u2265 0.7"", ""option_b"": ""FEV1/CV < 0.7"", ""option_c"": ""FEV1/CV = 0.7"", ""option_d"": ""FEV1/CV > 0.8"", ""correct_option"": ""B""}",,"What is the criterion for diagnosing an obstructive ventilatory disorder in functional respiratory examinations (EFR)?","FEV1/CV ≥ 0.7","FEV1/CV < 0.7","FEV1/CV = 0.7","FEV1/CV > 0.8","b"
"OIC-188-13-B","{""question"": ""When is the specific IgE assay typically indicated?"", ""option_a"": ""When a patient is diagnosed with a common cold"", ""option_b"": ""When chronic rhinitis of suspected allergic origin is diagnosed"", ""option_c"": ""When a patient has a family history of allergy but no current symptoms"", ""option_d"": ""When a patient is diagnosed with pneumonia"", ""correct_option"": ""B""}","Additional tests","When is the specific IgE assay typically indicated?","When a patient is diagnosed with a common cold","When chronic rhinitis of suspected allergic origin is diagnosed","When a patient has a family history of allergy but no current symptoms","When a patient is diagnosed with pneumonia","b"
"OIC-188-14-A","{""question"": ""What is a common cause of occupational asthma in workers?"", ""option_a"": ""Inhalation of dust in construction workers"", ""option_b"": ""Exposure to pollen in agricultural workers"", ""option_c"": ""Inhalation of flour dust in bakers"", ""option_d"": ""Exposure to sunlight in office workers"", ""correct_option"": ""C""}","Etiologies","What is a common cause of occupational asthma in workers?","Inhalation of dust in construction workers","Exposure to pollen in agricultural workers","Inhalation of flour dust in bakers","Exposure to sunlight in office workers","c"
"OIC-188-15-B","{""question"": ""What is a significant risk factor for asthma-related death?"", ""option_a"": ""Exposure to a bronchial irritant such as tobacco"", ""option_b"": ""History of severe exacerbation requiring a stay in intensive care or requiring intubation and mechanical ventilation"", ""option_c"": ""Mild intermittent asthma"", ""option_d"": ""Rhinitis"", ""correct_option"": ""B""}","Etiologies","What is a significant risk factor for asthma-related death?","Exposure to a bronchial irritant such as tobacco","History of severe exacerbation requiring a stay in intensive care or requiring intubation and mechanical ventilation","Mild intermittent asthma","Rhinitis","b"
"OIC-188-16-A","{""question"": ""What is the primary role of anti-histamines in the treatment of allergic rhinitis?"", ""option_a"": ""To reduce inflammation in the nasal passages"", ""option_b"": ""To alleviate symptoms such as itching, sneezing, and runny nose"", ""option_c"": ""To strengthen the immune system against allergens"", ""option_d"": ""To promote nasal cleansing with saline solution"", ""correct_option"": ""B""}","Management","What is the primary role of anti-histamines in the treatment of allergic rhinitis?","To reduce inflammation in the nasal passages","To alleviate symptoms such as itching, sneezing, and runny nose","To strengthen the immune system against allergens","To promote nasal cleansing with saline solution","b"
"OIC-188-17-A","{""question"": ""What is the primary background treatment prescribed for all persistent asthma?"", ""option_a"": ""Short-acting B2-mimetic bronchodilators (SADB)"", ""option_b"": ""Inhaled corticosteroids (ICS)"", ""option_c"": ""Long-acting B2-mimetic bronchodilators (LABD) alone"", ""option_d"": ""Anti-leukotriene (montelukast) alone"", ""correct_option"": ""B""}","Management","What is the primary background treatment prescribed for all persistent asthma?","Short-acting B2-mimetic bronchodilators (SADB)","Inhaled corticosteroids (ICS)","Long-acting B2-mimetic bronchodilators (LABD) alone","Anti-leukotriene (montelukast) alone","b"
"OIC-188-18-B","{""question"": ""What is an important factor to consider when choosing an inhaled treatment device for a patient with asthma?"", ""option_a"": ""The patient's age"", ""option_b"": ""The patient's co-ordination skills and inspiratory capacities"", ""option_c"": ""The cost of the device"", ""option_d"": ""The brand of the device"", ""correct_option"": ""B""}","Management","What is an important factor to consider when choosing an inhaled treatment device for a patient with asthma?","The patient's age","The patient's co-ordination skills and inspiratory capacities","The cost of the device","The brand of the device","b"
"OIC-188-19-A","{""question"": ""What is an important aspect of monitoring first-line disease-modifying asthma treatment?"", ""option_a"": ""Only assessing the patient's lung function"", ""option_b"": ""Assessing compliance with treatment, systematic assessment of the grip technique, and looking for side effects"", ""option_c"": ""Focusing solely on the reduction of asthma symptoms"", ""option_d"": ""Discontinuing treatment if the patient shows no immediate improvement"", ""correct_option"": ""B""}",,"What is an important aspect of monitoring first-line disease-modifying asthma treatment?","Only assessing the patient's lung function","Assessing compliance with treatment, systematic assessment of the grip technique, and looking for side effects","Focusing solely on the reduction of asthma symptoms","Discontinuing treatment if the patient shows no immediate improvement","b"
"OIC-188-20-A","{""question"": ""What is the primary treatment approach for acute asthma exacerbations in children and adults?"", ""option_a"": ""Systemic corticosteroid therapy alone"", ""option_b"": ""Combination of inhaled bronchodilators, systemic corticosteroid therapy, and oxygen therapy as needed"", ""option_c"": ""Nebulised anticholinergic therapy as the first line of treatment"", ""option_d"": ""Ventilatory assistance without prior use of bronchodilators or corticosteroids"", ""correct_option"": ""B""}","Management","What is the primary treatment approach for acute asthma exacerbations in children and adults?","Systemic corticosteroid therapy alone","Combination of inhaled bronchodilators, systemic corticosteroid therapy, and oxygen therapy as needed","Nebulised anticholinergic therapy as the first line of treatment","Ventilatory assistance without prior use of bronchodilators or corticosteroids","b"
"OIC-188-21-B","{""question"": ""What is the primary goal of therapeutic asthma education?"", ""option_a"": ""To immediately resolve asthma symptoms"", ""option_b"": ""To enable patients to understand their disease and treatment, improving compliance and control of asthma"", ""option_c"": ""To solely focus on the technical use of inhalation devices"", ""option_d"": ""To completely avoid environmental factors that trigger asthma"", ""correct_option"": ""B""}","Management","What is the primary goal of therapeutic asthma education?","To immediately resolve asthma symptoms","To enable patients to understand their disease and treatment, improving compliance and control of asthma","To solely focus on the technical use of inhalation devices","To completely avoid environmental factors that trigger asthma","b"
"OIC-188-22-A","{""question"": ""What is the most effective way to reduce dust mite allergens in a bedroom?"", ""option_a"": ""Using a dehumidifier to reduce indoor relative humidity to below 30%"", ""option_b"": ""Vacuum cleaning with a High Efficiency Particulate Air Filter and washing sheets regularly at a high temperature"", ""option_c"": ""Keeping the room temperature above 25\u00b0C and using an air purifier"", ""option_d"": ""Removing all carpets and rugs from the bedroom and using a hardwood floor"", ""correct_option"": ""B""}","Management","What is the most effective way to reduce dust mite allergens in a bedroom?","Using a dehumidifier to reduce indoor relative humidity to below 30%","Vacuum cleaning with a High Efficiency Particulate Air Filter and washing sheets regularly at a high temperature","Keeping the room temperature above 25°C and using an air purifier","Removing all carpets and rugs from the bedroom and using a hardwood floor","b"
"OIC-188-23-B","{""question"": ""What is a potential complication of poorly controlled asthma?"", ""option_a"": ""Increased participation in physical activities"", ""option_b"": ""Improved lung function"", ""option_c"": ""Absenteeism from school or work"", ""option_d"": ""A decrease in sedentary lifestyle"", ""correct_option"": ""C""}",,"What is a potential complication of poorly controlled asthma?","Increased participation in physical activities","Improved lung function","Absenteeism from school or work","A decrease in sedentary lifestyle","c"
"OIC-190-01-A","{""question"": ""What is the primary criterion for the duration of 'classic' prolonged fever?"", ""option_a"": ""At least 1 week"", ""option_b"": ""At least 2 weeks"", ""option_c"": ""At least 3 weeks"", ""option_d"": ""At least 4 weeks"", ""correct_option"": ""C""}",,"What is the primary criterion for the duration of 'classic' prolonged fever?","At least 1 week","At least 2 weeks","At least 3 weeks","At least 4 weeks","c"
"OIC-190-02-A","{""question"": ""What are the three main categories of causes of prolonged fever?"", ""option_a"": ""Infectious, Genetic, and Environmental"", ""option_b"": ""Infectious, Neoplastic, and Non-infectious inflammatory"", ""option_c"": ""Infectious, Neoplastic, and Autoimmune"", ""option_d"": ""Infectious, Inflammatory, and Traumatic"", ""correct_option"": ""B""}","Etiologies","What are the three main categories of causes of prolonged fever?","Infectious, Genetic, and Environmental","Infectious, Neoplastic, and Non-infectious inflammatory","Infectious, Neoplastic, and Autoimmune","Infectious, Inflammatory, and Traumatic","b"
"OIC-190-03-A","{""question"": ""What is an essential step in the etiological investigation of prolonged fever?"", ""option_a"": ""Laboratory tests only"", ""option_b"": ""Imaging studies only"", ""option_c"": ""Clinical examination"", ""option_d"": ""Gynaecological examination in all patients"", ""correct_option"": ""C""}","Etiologies","What is an essential step in the etiological investigation of prolonged fever?","Laboratory tests only","Imaging studies only","Clinical examination","Gynaecological examination in all patients","c"
"OIC-190-04-A","{""question"": ""What is a common viral infection responsible for prolonged fever in both adults and children?"", ""option_a"": ""Rickettsiosis"", ""option_b"": ""Epstein Barr virus (EBV)"", ""option_c"": ""Whipple's disease"", ""option_d"": ""Coxiellosis"", ""correct_option"": ""B""}","Etiologies","What is a common viral infection responsible for prolonged fever in both adults and children?","Rickettsiosis","Epstein Barr virus (EBV)","Whipple's disease","Coxiellosis","b"
"OIC-190-05-A","{""question"": ""What are the main non-infectious causes of prolonged fever in adults?"", ""option_a"": ""Only malignant diseases and inflammatory or autoimmune diseases"", ""option_b"": ""Malignant diseases, systemic diseases, drugs, and rare causes such as hyperthyroidism and venous thrombo-embolic disease"", ""option_c"": ""Inflammatory or autoimmune diseases and medicines, but not malignant diseases"", ""option_d"": ""Only drugs and various rare causes, excluding malignant and inflammatory diseases"", ""correct_option"": ""B""}","Etiologies","What are the main non-infectious causes of prolonged fever in adults?","Only malignant diseases and inflammatory or autoimmune diseases","Malignant diseases, systemic diseases, drugs, and rare causes such as hyperthyroidism and venous thrombo-embolic disease","Inflammatory or autoimmune diseases and medicines, but not malignant diseases","Only drugs and various rare causes, excluding malignant and inflammatory diseases","b"
"OIC-190-06-B","{""question"": ""In cases of prolonged fever, what is the most common first-line imaging examination that replaces the minimum requirement of full-face chest X-ray and abdomino-pelvic ultrasound?"", ""option_a"": ""Thoraco-abdomino-pelvic computed tomography (CT) without injection"", ""option_b"": ""Thoraco-abdomino-pelvic computed tomography (CT) with injection"", ""option_c"": ""Trans-thoracic echocardiography"", ""option_d"": ""Cerebral magnetic resonance imaging (MRI)"", ""correct_option"": ""B""}","Additional examinations","In cases of prolonged fever, what is the most common first-line imaging examination that replaces the minimum requirement of full-face chest X-ray and abdomino-pelvic ultrasound?","Thoraco-abdomino-pelvic computed tomography (CT) without injection","Thoraco-abdomino-pelvic computed tomography (CT) with injection","Trans-thoracic echocardiography","Cerebral magnetic resonance imaging (MRI)","b"
"OIC-190-07-B","{""question"": ""What is the primary purpose of conducting a temporal artery biopsy in the context of prolonged fever?"", ""option_a"": ""To diagnose infectious diseases such as EBV or CMV"", ""option_b"": ""To assess the level of inflammation in the body"", ""option_c"": ""To diagnose giant cell arteritis, particularly in patients over 50 years old"", ""option_d"": ""To evaluate the effectiveness of antibiotic treatment"", ""correct_option"": ""C""}","Complementary examinations","What is the primary purpose of conducting a temporal artery biopsy in the context of prolonged fever?","To diagnose infectious diseases such as EBV or CMV","To assess the level of inflammation in the body","To diagnose giant cell arteritis, particularly in patients over 50 years old","To evaluate the effectiveness of antibiotic treatment","c"
"OIC-191-01-A","{""question"": ""What is the definition of febrile neutropenia in terms of neutrophil count?"", ""option_a"": ""Neutrophil Polynuclei (PNN) < 1500/mm3"", ""option_b"": ""Neutrophil Polynuclei (PNN) < 0.5G/L"", ""option_c"": ""Neutrophil Polynuclei (PNN) < 1.0G/L"", ""option_d"": ""Neutrophil Polynuclei (PNN) < 2.0G/L"", ""correct_option"": ""B""}","Definition","What is the definition of febrile neutropenia in terms of neutrophil count?","Neutrophil Polynuclei (PNN) < 1500/mm3","Neutrophil Polynuclei (PNN) < 0.5G/L","Neutrophil Polynuclei (PNN) < 1.0G/L","Neutrophil Polynuclei (PNN) < 2.0G/L","b"
"OIC-191-02-B","{""question"": ""Which of the following is a risk factor for invasive candidemia?"", ""option_a"": ""HIV infection with CD4>500/mm^3"", ""option_b"": ""Prior colonization"", ""option_c"": ""Mild disease severity"", ""option_d"": ""Short length of stay in intensive care"", ""correct_option"": ""B""}","Epidemiology","Which of the following is a risk factor for invasive candidemia?","HIV infection with CD4>500/mm^3","Prior colonization","Mild disease severity","Short length of stay in intensive care","b"
"OIC-191-03-A","{""question"": ""What is the primary purpose of including constants such as blood pressure, heart rate, and temperature in the clinical examination of an immunocompromised patient with fever?"", ""option_a"": ""To quickly identify the source of the fever"", ""option_b"": ""To detect signs of severity and monitor the patient's condition"", ""option_c"": ""To determine the appropriate antibiotic treatment"", ""option_d"": ""To assess the patient's nutritional status"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary purpose of including constants such as blood pressure, heart rate, and temperature in the clinical examination of an immunocompromised patient with fever?","To quickly identify the source of the fever","To detect signs of severity and monitor the patient's condition","To determine the appropriate antibiotic treatment","To assess the patient's nutritional status","b"
"OIC-191-04-B","{""question"": ""In a patient with neutropenia of less than 7 days, which of the following pathogens is most likely responsible for infection?"", ""option_a"": ""Pseudomonas aeruginosa"", ""option_b"": ""Enterobacteriaceae"", ""option_c"": ""Aspergillus"", ""option_d"": ""Invasive candidiasis"", ""correct_option"": ""B""}","Physiopathology","In a patient with neutropenia of less than 7 days, which of the following pathogens is most likely responsible for infection?","Pseudomonas aeruginosa","Enterobacteriaceae","Aspergillus","Invasive candidiasis","b"
"OIC-191-05-A","{""question"": ""What are the three main routes of entry for infections in neutropenic patients?"", ""option_a"": ""Respiratory, Circulatory, and Nervous systems"", ""option_b"": ""Respiratory, Digestive tract, and Skin"", ""option_c"": ""Muscular, Skeletal, and Integumentary systems"", ""option_d"": ""Endocrine, Lymphatic, and Urinary systems"", ""correct_option"": ""B""}",,"What are the three main routes of entry for infections in neutropenic patients?","Respiratory, Circulatory, and Nervous systems","Respiratory, Digestive tract, and Skin","Muscular, Skeletal, and Integumentary systems","Endocrine, Lymphatic, and Urinary systems","b"
"OIC-191-06-A","{""question"": ""What is the appropriate approach to antibiotic therapy in a patient with febrile neutropenia?"", ""option_a"": ""Narrow-spectrum antibiotic therapy should be started only after microbiological samples have been analyzed"", ""option_b"": ""Broad and adapted antibiotic therapy should be started as early as possible, after taking appropriate microbiological samples"", ""option_c"": ""Antibiotic therapy should be delayed until the patient's neutropenia has resolved"", ""option_d"": ""Antibiotic therapy is not necessary unless a specific infectious agent has been identified"", ""correct_option"": ""B""}","Identification of urgency","What is the appropriate approach to antibiotic therapy in a patient with febrile neutropenia?","Narrow-spectrum antibiotic therapy should be started only after microbiological samples have been analyzed","Broad and adapted antibiotic therapy should be started as early as possible, after taking appropriate microbiological samples","Antibiotic therapy should be delayed until the patient's neutropenia has resolved","Antibiotic therapy is not necessary unless a specific infectious agent has been identified","b"
"OIC-191-07-B","{""question"": ""A patient with cellular immunity deficiency is most likely to be infected with which of the following pathogens?"", ""option_a"": ""Streptococcus pneumoniae"", ""option_b"": ""Cytomegalovirus (CMV)"", ""option_c"": ""Neisseria meningitidis"", ""option_d"": ""Pseudomonas aeruginosa"", ""correct_option"": ""B""}","Etiologies","A patient with cellular immunity deficiency is most likely to be infected with which of the following pathogens?","Streptococcus pneumoniae","Cytomegalovirus (CMV)","Neisseria meningitidis","Pseudomonas aeruginosa","b"
"OIC-191-08-B","{""question"": ""In a febrile neutropenic patient, what is the next step if fever persists after 48 hours of probabilistic antibiotic therapy?"", ""option_a"": ""Discontinue antibiotic therapy and monitor the patient's condition"", ""option_b"": ""Perform a thoracic-abdominal-pelvic CT scan to look for a deep-seated infection and test for aspergillosis antigenemia and B-D glucans if neutropenia \u2265 7 days"", ""option_c"": ""Start antifungal therapy without further testing"", ""option_d"": ""Repeat peripheral aero-anaerobic blood cultures and central blood cultures"", ""correct_option"": ""B""}","Complementary examinations","In a febrile neutropenic patient, what is the next step if fever persists after 48 hours of probabilistic antibiotic therapy?","Discontinue antibiotic therapy and monitor the patient's condition","Perform a thoracic-abdominal-pelvic CT scan to look for a deep-seated infection and test for aspergillosis antigenemia and B-D glucans if neutropenia ≥ 7 days","Start antifungal therapy without further testing","Repeat peripheral aero-anaerobic blood cultures and central blood cultures","b"
"OIC-191-09-B","{""question"": ""What is the recommended antibiotic therapy for a patient with febrile neutropenia who meets the criteria for oral antibiotic therapy?"", ""option_a"": ""Piperacillin/tazobactam + vancomycin"", ""option_b"": ""Amoxicillin/clavulanic acid + ciprofloxacin"", ""option_c"": ""Cefepime + an aminoglycoside"", ""option_d"": ""Vancomycin + ciprofloxacin"", ""correct_option"": ""B""}","Management","What is the recommended antibiotic therapy for a patient with febrile neutropenia who meets the criteria for oral antibiotic therapy?","Piperacillin/tazobactam + vancomycin","Amoxicillin/clavulanic acid + ciprofloxacin","Cefepime + an aminoglycoside","Vancomycin + ciprofloxacin","b"
"OIC-191-10-B","{""question"": ""What is the recommended antibiotic prophylaxis for asplenic patients after splenectomy?"", ""option_a"": ""Amoxicillin for 5 years after splenectomy"", ""option_b"": ""Penicillin V for 2 years after splenectomy"", ""option_c"": ""Ceftriaxone for 1 year after splenectomy"", ""option_d"": ""No antibiotic prophylaxis is necessary after splenectomy"", ""correct_option"": ""B""}","Management","What is the recommended antibiotic prophylaxis for asplenic patients after splenectomy?","Amoxicillin for 5 years after splenectomy","Penicillin V for 2 years after splenectomy","Ceftriaxone for 1 year after splenectomy","No antibiotic prophylaxis is necessary after splenectomy","b"
"OIC-191-11-B","{""question"": ""What is the primary concern with administering live vaccines to immunocompromised patients?"", ""option_a"": ""Reduced immunogenicity of the vaccine"", ""option_b"": ""Increased risk of complications associated with certain infections"", ""option_c"": ""Risk of developing vaccine disease after administration"", ""option_d"": ""Need for additional injections due to insufficient response"", ""correct_option"": ""C""}",,"What is the primary concern with administering live vaccines to immunocompromised patients?","Reduced immunogenicity of the vaccine","Increased risk of complications associated with certain infections","Risk of developing vaccine disease after administration","Need for additional injections due to insufficient response","c"
"OIC-197-01-A","{""question"": ""What is the term used to describe chronic inflammatory rheumatic diseases that share common clinical manifestations and a common genetic background, including conditions such as ankylosing spondylitis and psoriatic arthritis?"", ""option_a"": ""Rheumatoid arthritis"", ""option_b"": ""Osteoarthritis"", ""option_c"": ""Spondyloarthritis"", ""option_d"": ""Fibromyalgia"", ""correct_option"": ""C""}","Definition","What is the term used to describe chronic inflammatory rheumatic diseases that share common clinical manifestations and a common genetic background, including conditions such as ankylosing spondylitis and psoriatic arthritis?","Rheumatoid arthritis","Osteoarthritis","Spondyloarthritis","Fibromyalgia","c"
"OIC-197-02-B","{""question"": ""At what age do symptoms of spondyloarthritis generally begin?"", ""option_a"": ""After the age of 50"", ""option_b"": ""Before the age of 45"", ""option_c"": ""Exactly at the age of 45"", ""option_d"": ""After the age of 60"", ""correct_option"": ""B""}","Epidemiology","At what age do symptoms of spondyloarthritis generally begin?","After the age of 50","Before the age of 45","Exactly at the age of 45","After the age of 60","b"
"OIC-197-03-B","{""question"": ""What is the approximate prevalence of HLA-B27 among Caucasian populations?"", ""option_a"": ""Over 90%"", ""option_b"": ""6 to 8%"", ""option_c"": ""20 to 30%"", ""option_d"": ""50 to 60%"", ""correct_option"": ""B""}","Physiopathology","What is the approximate prevalence of HLA-B27 among Caucasian populations?","Over 90%","6 to 8%","20 to 30%","50 to 60%","b"
"OIC-197-04-B","{""question"": ""What is the primary lesion that characterizes spondyloarthritis, distinguishing it from rheumatoid arthritis?"", ""option_a"": ""Synovitis"", ""option_b"": ""Enthesitis"", ""option_c"": ""Osteitis"", ""option_d"": ""Myositis"", ""correct_option"": ""B""}","Physiopathology","What is the primary lesion that characterizes spondyloarthritis, distinguishing it from rheumatoid arthritis?","Synovitis","Enthesitis","Osteitis","Myositis","b"
"OIC-197-05-A","{""question"": ""What is a common manifestation of peripheral enthesopathic disease in spondyloarthritis?"", ""option_a"": ""Oligoarthritis of the upper limbs"", ""option_b"": ""Inflammatory pygalgia"", ""option_c"": ""Talalgia, which is inflammatory in nature"", ""option_d"": ""Coxofemoral involvement"", ""correct_option"": ""C""}","Positive diagnosis","What is a common manifestation of peripheral enthesopathic disease in spondyloarthritis?","Oligoarthritis of the upper limbs","Inflammatory pygalgia","Talalgia, which is inflammatory in nature","Coxofemoral involvement","c"
"OIC-197-06-B","{""question"": ""Which of the following is an extra-articular sign associated with spondyloarthritis?"", ""option_a"": ""Osteoarthritis"", ""option_b"": ""Acute anterior uveitis"", ""option_c"": ""Hypertension"", ""option_d"": ""Chronic obstructive pulmonary disease"", ""correct_option"": ""B""}","Positive diagnosis","Which of the following is an extra-articular sign associated with spondyloarthritis?","Osteoarthritis","Acute anterior uveitis","Hypertension","Chronic obstructive pulmonary disease","b"
"OIC-197-07-B","{""question"": ""According to the ASAS 2009 classification criteria, what is the primary characteristic for axial spondyloarthritis?"", ""option_a"": ""Spinal pain lasting more than 1 month and starting before the age of 50"", ""option_b"": ""Spinal pain lasting more than 3 months and starting before the age of 45"", ""option_c"": ""Peripheral joint pain lasting more than 6 months and starting before the age of 40"", ""option_d"": ""Spinal pain lasting more than 6 months and starting before the age of 30"", ""correct_option"": ""B""}",,"According to the ASAS 2009 classification criteria, what is the primary characteristic for axial spondyloarthritis?","Spinal pain lasting more than 1 month and starting before the age of 50","Spinal pain lasting more than 3 months and starting before the age of 45","Peripheral joint pain lasting more than 6 months and starting before the age of 40","Spinal pain lasting more than 6 months and starting before the age of 30","b"
"OIC-197-08-B","{""question"": ""What is the characteristic that distinguishes ankylosing spondylitis from other forms of spondyloarthritis?"", ""option_a"": ""Association with psoriatic skin lesions"", ""option_b"": ""Occurrence after a genital or digestive infection"", ""option_c"": ""Damage to the axial skeleton leading to potential ankylosis"", ""option_d"": ""Presence of chronic inflammatory enterocolopathies"", ""correct_option"": ""C""}","Positive diagnosis","What is the characteristic that distinguishes ankylosing spondylitis from other forms of spondyloarthritis?","Association with psoriatic skin lesions","Occurrence after a genital or digestive infection","Damage to the axial skeleton leading to potential ankylosis","Presence of chronic inflammatory enterocolopathies","c"
"OIC-197-09-A","{""question"": ""What is dactylitis, as shown in the photography of a spondylitis?"", ""option_a"": ""A type of arthritis that affects the spine"", ""option_b"": ""Inflammation of an entire toe, characteristic of spondyloarthritis"", ""option_c"": ""A skin condition causing rashes on the feet"", ""option_d"": ""A fungal infection affecting the nails"", ""correct_option"": ""B""}","Multimedia content","What is dactylitis, as shown in the photography of a spondylitis?","A type of arthritis that affects the spine","Inflammation of an entire toe, characteristic of spondyloarthritis","A skin condition causing rashes on the feet","A fungal infection affecting the nails","b"
"OIC-197-10-A","{""question"": ""What are syndesmophytes characterized as in radiography of the spine?"", ""option_a"": ""Thick, horizontal bony structures within a single vertebra"", ""option_b"": ""Thin, vertical bony structures between two vertebrae"", ""option_c"": ""Irregular, diagonal bony growths on the surface of vertebrae"", ""option_d"": ""Large, circular bony lesions replacing vertebral bodies"", ""correct_option"": ""B""}","Multimedia content","What are syndesmophytes characterized as in radiography of the spine?","Thick, horizontal bony structures within a single vertebra","Thin, vertical bony structures between two vertebrae","Irregular, diagonal bony growths on the surface of vertebrae","Large, circular bony lesions replacing vertebral bodies","b"
"OIC-197-11-B","{""question"": ""What is a key characteristic of coxitis visible on a pelvic X-ray?"", ""option_a"": ""Overall widening of the joint space with osteophytosis"", ""option_b"": ""Overall narrowing of the joint space without osteophytosis"", ""option_c"": ""Presence of osteophytosis with normal joint space"", ""option_d"": ""Absence of sacroiliitis"", ""correct_option"": ""B""}","Multimedia content","What is a key characteristic of coxitis visible on a pelvic X-ray?","Overall widening of the joint space with osteophytosis","Overall narrowing of the joint space without osteophytosis","Presence of osteophytosis with normal joint space","Absence of sacroiliitis","b"
"OIC-197-12-A","{""question"": ""What is the primary difference between a syndesmophyte and an osteophyte in the context of spondyloarthritis?"", ""option_a"": ""A syndesmophyte is coarse, while an osteophyte is fine"", ""option_b"": ""A syndesmophyte is specific to spondyloarthritis, while an osteophyte is not"", ""option_c"": ""A syndesmophyte forms quickly, while an osteophyte forms slowly"", ""option_d"": ""A syndesmophyte is fine and vertically directed, while an osteophyte is coarse"", ""correct_option"": ""D""}","Complementary examinations","What is the primary difference between a syndesmophyte and an osteophyte in the context of spondyloarthritis?","A syndesmophyte is coarse, while an osteophyte is fine","A syndesmophyte is specific to spondyloarthritis, while an osteophyte is not","A syndesmophyte forms quickly, while an osteophyte forms slowly","A syndesmophyte is fine and vertically directed, while an osteophyte is coarse","d"
"OIC-197-13-A","{""question"": ""What is the primary goal of physiotherapy in the management of spondyloarthritis?"", ""option_a"": ""To reduce pain and inflammation through the use of NSAIDs"", ""option_b"": ""To reduce the risk of axial and peripheral ankylosis and maintain exercise capacity and function"", ""option_c"": ""To promote smoking cessation and regular physical activity"", ""option_d"": ""To provide emotional support and counseling to patients"", ""correct_option"": ""B""}","Management","What is the primary goal of physiotherapy in the management of spondyloarthritis?","To reduce pain and inflammation through the use of NSAIDs","To reduce the risk of axial and peripheral ankylosis and maintain exercise capacity and function","To promote smoking cessation and regular physical activity","To provide emotional support and counseling to patients","b"
"OIC-197-14-B","{""question"": ""What is a factor that indicates a poor prognosis in patients with ankylosing spondylitis?"", ""option_a"": ""Late onset of the disease (after the age of 30)"", ""option_b"": ""Early onset of the disease (before the age of sixteen)"", ""option_c"": ""Mild inflammatory syndrome"", ""option_d"": ""Good response to NSAIDs"", ""correct_option"": ""B""}",,"What is a factor that indicates a poor prognosis in patients with ankylosing spondylitis?","Late onset of the disease (after the age of 30)","Early onset of the disease (before the age of sixteen)","Mild inflammatory syndrome","Good response to NSAIDs","b"
"OIC-198-01-A","{""question"": ""Which of the following microcrystals is responsible for gout?"", ""option_a"": ""Calcium pyrophosphate"", ""option_b"": ""Calcium phosphate (apatite)"", ""option_c"": ""Sodium urate"", ""option_d"": ""Uric acid"", ""correct_option"": ""C""}","Definition","Which of the following microcrystals is responsible for gout?","Calcium pyrophosphate","Calcium phosphate (apatite)","Sodium urate","Uric acid","c"
"OIC-198-02-A","{""question"": ""What is the threshold value for hyperuricemia?"", ""option_a"": ""280 \u00b5mol/l or 45 mg/l"", ""option_b"": ""360 \u00b5mol/l or 60 mg/l"", ""option_c"": ""400 \u00b5mol/l or 65 mg/l"", ""option_d"": ""420 \u00b5mol/l or 70 mg/l"", ""correct_option"": ""B""}","Definition","What is the threshold value for hyperuricemia?","280 µmol/l or 45 mg/l","360 µmol/l or 60 mg/l","400 µmol/l or 65 mg/l","420 µmol/l or 70 mg/l","b"
"OIC-198-03-B","{""question"": ""What is the primary mechanism leading to hyperuricaemia?"", ""option_a"": ""Excess production of uric acid"", ""option_b"": ""Renal and/or intestinal elimination defect"", ""option_c"": ""Acute inflammatory reaction"", ""option_d"": ""Formation of sodium urate crystals"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism leading to hyperuricaemia?","Excess production of uric acid","Renal and/or intestinal elimination defect","Acute inflammatory reaction","Formation of sodium urate crystals","b"
"OIC-198-04-B","{""question"": ""What is a characteristic radiographic finding in microcrystalline arthropathies of the wrist?"", ""option_a"": ""Calcification of the triangular ligament of the carpus"", ""option_b"": ""Erosion of the distal radius"", ""option_c"": ""Osteophytes on the metacarpal bones"", ""option_d"": ""Subluxation of the carpometacarpal joint"", ""correct_option"": ""A""}","Multimedia content","What is a characteristic radiographic finding in microcrystalline arthropathies of the wrist?","Calcification of the triangular ligament of the carpus","Erosion of the distal radius","Osteophytes on the metacarpal bones","Subluxation of the carpometacarpal joint","a"
"OIC-198-05-B","{""question"": ""What is a characteristic finding in radiography of the knee for microcrystalline arthropathies?"", ""option_a"": ""Meniscal tears"", ""option_b"": ""Meniscal calcification, cartilage calcification"", ""option_c"": ""Ligament sprains"", ""option_d"": ""Bone fractures"", ""correct_option"": ""B""}","Multimedia content","What is a characteristic finding in radiography of the knee for microcrystalline arthropathies?","Meniscal tears","Meniscal calcification, cartilage calcification","Ligament sprains","Bone fractures","b"
"OIC-198-06-B","{""question"": ""What is a key feature that can be observed in radiography of the pelvis in cases of microcrystalline arthropathies?"", ""option_a"": ""Calcifications of the hip joint"", ""option_b"": ""Calcifications of the pubic symphysis and femoral cartilages"", ""option_c"": ""Fractures of the femoral neck"", ""option_d"": ""Osteoporosis of the pelvic bones"", ""correct_option"": ""B""}","Multimedia content","What is a key feature that can be observed in radiography of the pelvis in cases of microcrystalline arthropathies?","Calcifications of the hip joint","Calcifications of the pubic symphysis and femoral cartilages","Fractures of the femoral neck","Osteoporosis of the pelvic bones","b"
"OIC-198-07-B","{""question"": ""What is the prevalence of gout in adults in France?"", ""option_a"": ""0.5%"", ""option_b"": ""0.9%"", ""option_c"": ""1.2%"", ""option_d"": ""1.5%"", ""correct_option"": ""B""}","Epidemiology","What is the prevalence of gout in adults in France?","0.5%","0.9%","1.2%","1.5%","b"
"OIC-198-08-A","{""question"": ""What is a characteristic feature of the onset of pain in typical articular or periarticular microcrystalline attacks?"", ""option_a"": ""Gradual onset over several days"", ""option_b"": ""Abrupt onset with intense pain"", ""option_c"": ""Onset of pain only during physical activity"", ""option_d"": ""Pain that worsens gradually over weeks"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic feature of the onset of pain in typical articular or periarticular microcrystalline attacks?","Gradual onset over several days","Abrupt onset with intense pain","Onset of pain only during physical activity","Pain that worsens gradually over weeks","b"
"OIC-198-09-B","{""question"": ""What is a common triggering factor for a gout attack?"", ""option_a"": ""A low-protein diet"", ""option_b"": ""Trauma"", ""option_c"": ""Regular exercise"", ""option_d"": ""Adequate hydration"", ""correct_option"": ""B""}","Epidemiology","What is a common triggering factor for a gout attack?","A low-protein diet","Trauma","Regular exercise","Adequate hydration","b"
"OIC-198-10-A","{""question"": ""What is the most important diagnostic test for gout, which is considered pathognomonic?"", ""option_a"": ""Uricemia measurement"", ""option_b"": ""Detection of UMS microcrystals in the joint fluid or in a clinical tophus"", ""option_c"": ""Joint radiography"", ""option_d"": ""Joint ultrasound with colour Doppler"", ""correct_option"": ""B""}","Positive diagnosis","What is the most important diagnostic test for gout, which is considered pathognomonic?","Uricemia measurement","Detection of UMS microcrystals in the joint fluid or in a clinical tophus","Joint radiography","Joint ultrasound with colour Doppler","b"
"OIC-198-11-A","{""question"": ""What is the primary reason to perform a joint fluid puncture in a patient presenting with acute inflammation caused by crystals?"", ""option_a"": ""To confirm the diagnosis of gout"", ""option_b"": ""To rule out septic arthritis"", ""option_c"": ""To reduce the inflammation caused by the crystals"", ""option_d"": ""To administer medication directly into the joint"", ""correct_option"": ""B""}","Identification of the emergency","What is the primary reason to perform a joint fluid puncture in a patient presenting with acute inflammation caused by crystals?","To confirm the diagnosis of gout","To rule out septic arthritis","To reduce the inflammation caused by the crystals","To administer medication directly into the joint","b"
"OIC-198-12-B","{""question"": ""What can occur in gout sufferers after several years, apart from gouty attacks?"", ""option_a"": ""Only oligoarthritis in the lower limbs"", ""option_b"": ""Oligoarthritis or polyarthritis, potentially affecting upper limbs, spine, hip, and shoulder"", ""option_c"": ""Exclusive involvement of the spine, hip, and shoulder without upper limb involvement"", ""option_d"": ""Gouty attacks become less frequent and less severe"", ""correct_option"": ""B""}","Positive diagnosis","What can occur in gout sufferers after several years, apart from gouty attacks?","Only oligoarthritis in the lower limbs","Oligoarthritis or polyarthritis, potentially affecting upper limbs, spine, hip, and shoulder","Exclusive involvement of the spine, hip, and shoulder without upper limb involvement","Gouty attacks become less frequent and less severe","b"
"OIC-198-13-B","{""question"": ""What is a characteristic of the synovial fluid in microcrystalline arthropathies?"", ""option_a"": ""The presence of inflammatory joint fluid with cellularity less than 1,000 nucleated cells/mm^3"", ""option_b"": ""The presence of inflammatory joint fluid with cellularity greater than 2,000 nucleated cells/mm^3, predominantly neutrophils"", ""option_c"": ""The consistent presence of microcrystals in all cases"", ""option_d"": ""Positive results from routine bacteriological tests"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic of the synovial fluid in microcrystalline arthropathies?","The presence of inflammatory joint fluid with cellularity less than 1,000 nucleated cells/mm^3","The presence of inflammatory joint fluid with cellularity greater than 2,000 nucleated cells/mm^3, predominantly neutrophils","The consistent presence of microcrystals in all cases","Positive results from routine bacteriological tests","b"
"OIC-198-14-A","{""question"": ""Where is a clinically detectable tophus typically found?"", ""option_a"": ""On the elbow or knee joint"", ""option_b"": ""On the helix, finger pad, toe, or foot"", ""option_c"": ""On the spine or spinal cord"", ""option_d"": ""On the hip or shoulder joint"", ""correct_option"": ""B""}","Multimedia content","Where is a clinically detectable tophus typically found?","On the elbow or knee joint","On the helix, finger pad, toe, or foot","On the spine or spinal cord","On the hip or shoulder joint","b"
"OIC-198-15-A","{""question"": ""What are the two essential biological tests for the diagnosis of gout?"", ""option_a"": ""Uricemia and serum creatinine with estimated glomerular filtration rate (eGFR)"", ""option_b"": ""Blood count and serum creatinine with estimated glomerular filtration rate (eGFR)"", ""option_c"": ""Uricemia and blood count"", ""option_d"": ""Serum creatinine with estimated glomerular filtration rate (eGFR) and liver function tests"", ""correct_option"": ""A""}",,"What are the two essential biological tests for the diagnosis of gout?","Uricemia and serum creatinine with estimated glomerular filtration rate (eGFR)","Blood count and serum creatinine with estimated glomerular filtration rate (eGFR)","Uricemia and blood count","Serum creatinine with estimated glomerular filtration rate (eGFR) and liver function tests","a"
"OIC-198-16-B","{""question"": ""What is the relationship between uric acid levels and mortality in the context of gout?"", ""option_a"": ""High uric acid levels are associated with increased mortality, while low uric acid levels have no mortality risk"", ""option_b"": ""Both high and low uric acid levels are associated with increased mortality, forming a U-shaped curve"", ""option_c"": ""Low uric acid levels are associated with increased mortality, while high uric acid levels have no mortality risk"", ""option_d"": ""There is no relationship between uric acid levels and mortality in gout patients"", ""correct_option"": ""B""}",,"What is the relationship between uric acid levels and mortality in the context of gout?","High uric acid levels are associated with increased mortality, while low uric acid levels have no mortality risk","Both high and low uric acid levels are associated with increased mortality, forming a U-shaped curve","Low uric acid levels are associated with increased mortality, while high uric acid levels have no mortality risk","There is no relationship between uric acid levels and mortality in gout patients","b"
"OIC-198-17-B","{""question"": ""Which of the following demographic groups is most commonly associated with apatitic calcification?"", ""option_a"": ""Mature men with a history of cardiovascular disease"", ""option_b"": ""Elderly subjects with kidney failure"", ""option_c"": ""Younger women"", ""option_d"": ""Overweight or obese men with diabetes mellitus"", ""correct_option"": ""C""}",,"Which of the following demographic groups is most commonly associated with apatitic calcification?","Mature men with a history of cardiovascular disease","Elderly subjects with kidney failure","Younger women","Overweight or obese men with diabetes mellitus","c"
"OIC-198-18-A","{""question"": ""What is the primary goal of hypouricemic treatment in the management of gout?"", ""option_a"": ""To immediately relieve the symptoms of a gout attack"", ""option_b"": ""To permanently relieve the symptoms of gout"", ""option_c"": ""To reduce the frequency of gout attacks"", ""option_d"": ""To treat co-morbidities associated with gout"", ""correct_option"": ""B""}","Management","What is the primary goal of hypouricemic treatment in the management of gout?","To immediately relieve the symptoms of a gout attack","To permanently relieve the symptoms of gout","To reduce the frequency of gout attacks","To treat co-morbidities associated with gout","b"
"OIC-198-19-A","{""question"": ""What is the primary goal of hypouricemic treatment in gout patients?"", ""option_a"": ""To immediately stop gout attacks"", ""option_b"": ""To lower uricemia to a target value, allowing for the dissolution of urate crystals"", ""option_c"": ""To reduce the consumption of alcoholic beverages only"", ""option_d"": ""To promote the consumption of sugary soft drinks"", ""correct_option"": ""B""}",,"What is the primary goal of hypouricemic treatment in gout patients?","To immediately stop gout attacks","To lower uricemia to a target value, allowing for the dissolution of urate crystals","To reduce the consumption of alcoholic beverages only","To promote the consumption of sugary soft drinks","b"
"OIC-198-21-B","{""question"": ""What are the two main conditions associated with PPCa deposits?"", ""option_a"": ""Haemochromatosis and primary hyperparathyroidism"", ""option_b"": ""Gout and pseudogout"", ""option_c"": ""Osteoarthritis and rheumatoid arthritis"", ""option_d"": ""Haemochromatosis and osteoporosis"", ""correct_option"": ""A""}","Etiologies","What are the two main conditions associated with PPCa deposits?","Haemochromatosis and primary hyperparathyroidism","Gout and pseudogout","Osteoarthritis and rheumatoid arthritis","Haemochromatosis and osteoporosis","a"
"OIC-198-22-A","{""question"": ""What is the recommended approach for treating an acute attack of calcium pyrophosphate crystals in older patients?"", ""option_a"": ""Same treatment as for gouty attacks without any dosage adjustments"", ""option_b"": ""Same treatment as for gouty attacks, with dosage adapted to the patient's age and co-morbidities"", ""option_c"": ""Intra-articular infiltration of a cortisone derivative as the first line of treatment, regardless of the presence of infection"", ""option_d"": ""Avoiding the use of NSAIDs and colchicine altogether due to the risk of interactions"", ""correct_option"": ""B""}",,"What is the recommended approach for treating an acute attack of calcium pyrophosphate crystals in older patients?","Same treatment as for gouty attacks without any dosage adjustments","Same treatment as for gouty attacks, with dosage adapted to the patient's age and co-morbidities","Intra-articular infiltration of a cortisone derivative as the first line of treatment, regardless of the presence of infection","Avoiding the use of NSAIDs and colchicine altogether due to the risk of interactions","b"
"OIC-198-23-B","{""question"": ""What is the recommended initial treatment approach for an acute attack of hydroxyapatite crystals?"", ""option_a"": ""Immediate local cortisone injections"", ""option_b"": ""Rest, icing, NSAIDs, and oral corticosteroids"", ""option_c"": ""Surgery to remove the affected area"", ""option_d"": ""Prolonged use of oral corticosteroids without NSAIDs"", ""correct_option"": ""B""}",,"What is the recommended initial treatment approach for an acute attack of hydroxyapatite crystals?","Immediate local cortisone injections","Rest, icing, NSAIDs, and oral corticosteroids","Surgery to remove the affected area","Prolonged use of oral corticosteroids without NSAIDs","b"
"OIC-201-01-A","{""question"": ""What are the three categories of organ donors?"", ""option_a"": ""Donors in a state of brain death, donors who have died after circulatory arrest, and cadaveric donors"", ""option_b"": ""Donors in a state of brain death, living donors, and donors who have died from infectious diseases"", ""option_c"": ""Donors in a state of brain death, donors who have died after circulatory arrest (DCAD), and living donors"", ""option_d"": ""Donors who have died after circulatory arrest, living donors, and donors who have died from traumatic injuries"", ""correct_option"": ""C""}","Definition","What are the three categories of organ donors?","Donors in a state of brain death, donors who have died after circulatory arrest, and cadaveric donors","Donors in a state of brain death, living donors, and donors who have died from infectious diseases","Donors in a state of brain death, donors who have died after circulatory arrest (DCAD), and living donors","Donors who have died after circulatory arrest, living donors, and donors who have died from traumatic injuries","c"
"OIC-201-02-A","{""question"": ""What type of transplant involves the use of haematopoietic stem cells?"", ""option_a"": ""Organ transplant"", ""option_b"": ""Tissue transplant"", ""option_c"": ""Cell transplant"", ""option_d"": ""Bone marrow transplant only"", ""correct_option"": ""C""}","Definition","What type of transplant involves the use of haematopoietic stem cells?","Organ transplant","Tissue transplant","Cell transplant","Bone marrow transplant only","c"
"OIC-201-03-B","{""question"": ""What is taken into account for organ transplants in terms of blood group compatibility?"", ""option_a"": ""Only the rhesus blood group system"", ""option_b"": ""Both the ABO and rhesus blood group systems"", ""option_c"": ""The ABO blood group system, with ABO-incompatible transplants possible in certain circumstances"", ""option_d"": ""Neither the ABO nor the rhesus blood group systems"", ""correct_option"": ""C""}","Physiopathology","What is taken into account for organ transplants in terms of blood group compatibility?","Only the rhesus blood group system","Both the ABO and rhesus blood group systems","The ABO blood group system, with ABO-incompatible transplants possible in certain circumstances","Neither the ABO nor the rhesus blood group systems","c"
"OIC-201-04-B","{""question"": ""What is the primary role of the Agence de la Biom\u00e9decine in the context of organ transplantation in France?"", ""option_a"": ""To perform organ transplants and monitor patient survival"", ""option_b"": ""To manage the national list of patients awaiting transplantation and coordinate organ harvesting"", ""option_c"": ""To promote organ donation and conduct transplantation research only"", ""option_d"": ""To evaluate the medical activities of transplantation teams and manage the National Refusal Register only"", ""correct_option"": ""B""}","Epidemiology","What is the primary role of the Agence de la Biomédecine in the context of organ transplantation in France?","To perform organ transplants and monitor patient survival","To manage the national list of patients awaiting transplantation and coordinate organ harvesting","To promote organ donation and conduct transplantation research only","To evaluate the medical activities of transplantation teams and manage the National Refusal Register only","b"
"OIC-201-05-A","{""question"": ""What are the three main ethical principles governing organ donation as per the French Bioethics Act?"", ""option_a"": ""Presumed consent, free donation, and anonymity between donor and recipient"", ""option_b"": ""Mandatory consent, paid donation, and disclosure of donor information"", ""option_c"": ""Informed consent, forced donation, and confidentiality of recipient information"", ""option_d"": ""Express consent, altruistic donation, and transparency between donor and recipient families"", ""correct_option"": ""A""}","Definition","What are the three main ethical principles governing organ donation as per the French Bioethics Act?","Presumed consent, free donation, and anonymity between donor and recipient","Mandatory consent, paid donation, and disclosure of donor information","Informed consent, forced donation, and confidentiality of recipient information","Express consent, altruistic donation, and transparency between donor and recipient families","a"
"OIC-201-06-A","{""question"": ""What is encephalic death characterized by?"", ""option_a"": ""Reversible destruction of the brain stem"", ""option_b"": ""Definitive and irreversible destruction of the brain, with disappearance of all brain stem reflexes and absence of spontaneous breathing"", ""option_c"": ""Temporary loss of brain function with potential for recovery"", ""option_d"": ""Selective destruction of higher brain functions while preserving brain stem reflexes"", ""correct_option"": ""B""}","Definition","What is encephalic death characterized by?","Reversible destruction of the brain stem","Definitive and irreversible destruction of the brain, with disappearance of all brain stem reflexes and absence of spontaneous breathing","Temporary loss of brain function with potential for recovery","Selective destruction of higher brain functions while preserving brain stem reflexes","b"
"OIC-201-07-B","{""question"": ""What is one of the clinical criteria required for the diagnosis of brain death?"", ""option_a"": ""Partial absence of consciousness and spontaneous motor activity"", ""option_b"": ""Total absence of consciousness and spontaneous motor activity"", ""option_c"": ""Presence of some brainstem reflexes"", ""option_d"": ""Presence of spontaneous ventilation"", ""correct_option"": ""B""}","Positive diagnosis","What is one of the clinical criteria required for the diagnosis of brain death?","Partial absence of consciousness and spontaneous motor activity","Total absence of consciousness and spontaneous motor activity","Presence of some brainstem reflexes","Presence of spontaneous ventilation","b"
"OIC-201-08-B","{""question"": ""What is the primary mechanism of action of calcineurin inhibitors, such as ciclosporin and tacrolimus, in immunosuppressive treatment?"", ""option_a"": ""Inhibition of cell proliferation"", ""option_b"": ""Depletion of circulating T lymphocytes"", ""option_c"": ""Inhibitors of T-receptor engagement signal 1"", ""option_d"": ""Purine base inhibition"", ""correct_option"": ""C""}","Management","What is the primary mechanism of action of calcineurin inhibitors, such as ciclosporin and tacrolimus, in immunosuppressive treatment?","Inhibition of cell proliferation","Depletion of circulating T lymphocytes","Inhibitors of T-receptor engagement signal 1","Purine base inhibition","c"
"OIC-201-09-B","{""question"": ""What is the primary method to verify the total absence of spontaneous ventilation in a patient being diagnosed with encephalic death?"", ""option_a"": ""A hypercapnia test"", ""option_b"": ""A cerebral angiography showing cessation of encephalic circulation"", ""option_c"": ""An electroencephalogram showing no brain activity"", ""option_d"": ""A chest X-ray to confirm lung function"", ""correct_option"": ""A""}","Positive diagnosis","What is the primary method to verify the total absence of spontaneous ventilation in a patient being diagnosed with encephalic death?","A hypercapnia test","A cerebral angiography showing cessation of encephalic circulation","An electroencephalogram showing no brain activity","A chest X-ray to confirm lung function","a"
"OIC-201-10-A","{""question"": ""What is the principle governing the removal of organs from donors in a state of encephalic death in France, as per the 1994 bioethics laws?"", ""option_a"": ""Informed consent"", ""option_b"": ""Presumed consent"", ""option_c"": ""Express consent"", ""option_d"": ""Implied refusal"", ""correct_option"": ""B""}","Definition","What is the principle governing the removal of organs from donors in a state of encephalic death in France, as per the 1994 bioethics laws?","Informed consent","Presumed consent","Express consent","Implied refusal","b"
"OIC-201-11-A","{""question"": ""What is one of the primary advantages of living donor kidney transplants for the recipient?"", ""option_a"": ""It increases the recipient's waiting time for a transplant"", ""option_b"": ""It reduces the long-term survival of the transplanted organ"", ""option_c"": ""It reduces the recipient's waiting time and offers better long-term survival of the transplanted organ"", ""option_d"": ""It makes the transplant process more complex and risky for the recipient"", ""correct_option"": ""C""}","Management","What is one of the primary advantages of living donor kidney transplants for the recipient?","It increases the recipient's waiting time for a transplant","It reduces the long-term survival of the transplanted organ","It reduces the recipient's waiting time and offers better long-term survival of the transplanted organ","It makes the transplant process more complex and risky for the recipient","c"
"OIC-207-01-A","{""question"": ""What should a well-circumscribed round opacity in the lung suggest until proven otherwise?"", ""option_a"": ""Benign pulmonary nodule"", ""option_b"": ""Infectious pneumonia"", ""option_c"": ""Lung cancer"", ""option_d"": ""Pleural plaque"", ""correct_option"": ""C""}","Positive diagnosis","What should a well-circumscribed round opacity in the lung suggest until proven otherwise?","Benign pulmonary nodule","Infectious pneumonia","Lung cancer","Pleural plaque","c"
"OIC-207-02-B","{""question"": ""What is the definition of a costal flap in the context of rib fractures?"", ""option_a"": ""A single fracture site involving at least two successive ribs"", ""option_b"": ""Two fracture sites involving at least three successive ribs"", ""option_c"": ""A displaced rib fracture with associated pneumothorax or haemothorax"", ""option_d"": ""A non-displaced rib fracture with no associated complications"", ""correct_option"": ""B""}","Positive diagnosis","What is the definition of a costal flap in the context of rib fractures?","A single fracture site involving at least two successive ribs","Two fracture sites involving at least three successive ribs","A displaced rib fracture with associated pneumothorax or haemothorax","A non-displaced rib fracture with no associated complications","b"
"OIC-207-03-A","{""question"": ""What is the characteristic appearance of a liquid pleural effusion on a front upright chest X-ray?"", ""option_a"": ""Homogeneous, sloping, systematic, retractile opacity"", ""option_b"": ""Homogeneous, sloping, non-systematic, non-retractile opacity, limited by a concave line above and medially"", ""option_c"": ""Heterogeneous, non-sloping, systematic, retractile opacity"", ""option_d"": ""Heterogeneous, sloping, non-systematic, retractile opacity"", ""correct_option"": ""B""}","Positive diagnosis","What is the characteristic appearance of a liquid pleural effusion on a front upright chest X-ray?","Homogeneous, sloping, systematic, retractile opacity","Homogeneous, sloping, non-systematic, non-retractile opacity, limited by a concave line above and medially","Heterogeneous, non-sloping, systematic, retractile opacity","Heterogeneous, sloping, non-systematic, retractile opacity","b"
"OIC-207-04-A","{""question"": ""What is the most sensitive examination for diagnosing a pneumothorax?"", ""option_a"": ""Chest X-ray in the upright position"", ""option_b"": ""Pleural ultrasound"", ""option_c"": ""Chest CT scan"", ""option_d"": ""MRI"", ""correct_option"": ""C""}","Positive diagnosis","What is the most sensitive examination for diagnosing a pneumothorax?","Chest X-ray in the upright position","Pleural ultrasound","Chest CT scan","MRI","c"
"OIC-207-05-B","{""question"": ""What is the classic definition of alveolar syndrome in imaging based on?"", ""option_a"": ""One criterion: pulmonary opacity"", ""option_b"": ""Two criteria: pulmonary opacity and containing images of aerated bronchi"", ""option_c"": ""Three criteria: pulmonary opacity, containing images of aerated bronchi, and pleural effusion"", ""option_d"": ""Four criteria: pulmonary opacity, containing images of aerated bronchi, pleural effusion, and pneumonic lung cancer"", ""correct_option"": ""B""}","Positive diagnosis","What is the classic definition of alveolar syndrome in imaging based on?","One criterion: pulmonary opacity","Two criteria: pulmonary opacity and containing images of aerated bronchi","Three criteria: pulmonary opacity, containing images of aerated bronchi, and pleural effusion","Four criteria: pulmonary opacity, containing images of aerated bronchi, pleural effusion, and pneumonic lung cancer","b"
"OIC-207-06-B","{""question"": ""What is the primary purpose of a thoracic CT scan in the diagnosis of interstitial lung disease?"", ""option_a"": ""To confirm a diagnosis based on chest X-ray findings"", ""option_b"": ""To characterise elementary lesions and assess their distribution, integrating it into the clinical-biological context"", ""option_c"": ""To identify the presence of lung cancer"", ""option_d"": ""To monitor the progression of fibrosis over time"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary purpose of a thoracic CT scan in the diagnosis of interstitial lung disease?","To confirm a diagnosis based on chest X-ray findings","To characterise elementary lesions and assess their distribution, integrating it into the clinical-biological context","To identify the presence of lung cancer","To monitor the progression of fibrosis over time","b"
"OIC-207-07-B","{""question"": ""What is the characteristic appearance of a mediastinal abnormality on a chest X-ray?"", ""option_a"": ""A clear external boundary concave towards the lung"", ""option_b"": ""A clear external boundary convex towards the lung"", ""option_c"": ""Internal limit visible and distinguishable from mediastinal elements"", ""option_d"": ""Hydric in tone unlike the rest of the mediastinum"", ""correct_option"": ""B""}","Positive diagnosis","What is the characteristic appearance of a mediastinal abnormality on a chest X-ray?","A clear external boundary concave towards the lung","A clear external boundary convex towards the lung","Internal limit visible and distinguishable from mediastinal elements","Hydric in tone unlike the rest of the mediastinum","b"
"OIC-207-08-B","{""question"": ""What is the most common cause of atelectasis?"", ""option_a"": ""Passive collapse due to pleural effusion"", ""option_b"": ""Bronchial origin, secondary to endo-luminal, mural or extrinsic obstruction of a bronchus"", ""option_c"": ""Coiling secondary to pleural thickening"", ""option_d"": ""Compensatory hyperinflation of adjacent territories"", ""correct_option"": ""B""}","Positive diagnosis","What is the most common cause of atelectasis?","Passive collapse due to pleural effusion","Bronchial origin, secondary to endo-luminal, mural or extrinsic obstruction of a bronchus","Coiling secondary to pleural thickening","Compensatory hyperinflation of adjacent territories","b"
"OIC-207-09-A","{""question"": ""What is the preferred initial imaging modality for a patient with suspected pulmonary embolism?"", ""option_a"": ""Chest X-ray"", ""option_b"": ""CT scan with injection"", ""option_c"": ""ECG"", ""option_d"": ""Profile radiography"", ""correct_option"": ""B""}",,"What is the preferred initial imaging modality for a patient with suspected pulmonary embolism?","Chest X-ray","CT scan with injection","ECG","Profile radiography","b"
"OIC-207-10-B","{""question"": ""What is the typical appearance of a normal thymus on a frontal chest radiograph in an infant?"", ""option_a"": ""A symmetric and well-defined mass in the posterior inferior mediastinum"", ""option_b"": ""A bilateral and asymmetric opacity of the anterior superior mediastinum, inseparable from the cardiac mass"", ""option_c"": ""A unilateral and homogeneous mass in the middle mediastinum, compressing adjacent structures"", ""option_d"": ""A well-defined and spherical mass in the posterior superior mediastinum, separate from the cardiac silhouette"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical appearance of a normal thymus on a frontal chest radiograph in an infant?","A symmetric and well-defined mass in the posterior inferior mediastinum","A bilateral and asymmetric opacity of the anterior superior mediastinum, inseparable from the cardiac mass","A unilateral and homogeneous mass in the middle mediastinum, compressing adjacent structures","A well-defined and spherical mass in the posterior superior mediastinum, separate from the cardiac silhouette","b"
"OIC-207-11-B","{""question"": ""What is the preferred imaging modality for diagnosing mediastinal lesions in infants due to radiation exposure concerns?"", ""option_a"": ""CT scan"", ""option_b"": ""MRI"", ""option_c"": ""Ultrasound"", ""option_d"": ""X-ray"", ""correct_option"": ""B""}","Positive diagnosis","What is the preferred imaging modality for diagnosing mediastinal lesions in infants due to radiation exposure concerns?","CT scan","MRI","Ultrasound","X-ray","b"
"OIC-207-12-B","{""question"": ""What is the most common type of tumor found in the posterior mediastinum in children?"", ""option_a"": ""Thymic tumors"", ""option_b"": ""Germ cell tumors"", ""option_c"": ""Neurogenic tumors"", ""option_d"": ""Vascular tumors"", ""correct_option"": ""C""}","Etiologies","What is the most common type of tumor found in the posterior mediastinum in children?","Thymic tumors","Germ cell tumors","Neurogenic tumors","Vascular tumors","c"
"OIC-208-01-A","{""question"": ""What is the threshold for chronic respiratory failure in terms of PaO2 measured in room air at rest and in a stable state?"", ""option_a"": ""Less than 60 mmHg"", ""option_b"": ""70 mmHg"", ""option_c"": ""80 mmHg"", ""option_d"": ""90 mmHg"", ""correct_option"": ""B""}","Positive diagnosis","What is the threshold for chronic respiratory failure in terms of PaO2 measured in room air at rest and in a stable state?","Less than 60 mmHg","70 mmHg","80 mmHg","90 mmHg","b"
"OIC-208-02-A","{""question"": ""A patient presents with exertional dyspnoea and a dry cough. What type of chronic kidney disease (CKD) should be suspected based on these symptoms?"", ""option_a"": ""Obstructive CKD due to chronic sputum production"", ""option_b"": ""Restrictive CKD related to an abnormality of the ventilatory pump"", ""option_c"": ""Infiltrative lung disease with tele-inspiratory crackles"", ""option_d"": ""Obstructive CKD with associated emphysema"", ""correct_option"": ""B""}","Positive diagnosis","A patient presents with exertional dyspnoea and a dry cough. What type of chronic kidney disease (CKD) should be suspected based on these symptoms?","Obstructive CKD due to chronic sputum production","Restrictive CKD related to an abnormality of the ventilatory pump","Infiltrative lung disease with tele-inspiratory crackles","Obstructive CKD with associated emphysema","b"
"OIC-208-03-A","{""question"": ""What is the definition of pulmonary hypertension (PH) in adults?"", ""option_a"": ""Mean pulmonary arterial pressure >15 mmHg and resistance >2 UW measured during right heart catheterisation"", ""option_b"": ""Mean pulmonary arterial pressure >20 mmHg and resistance >3 UW measured during right heart catheterisation"", ""option_c"": ""Systolic blood pressure >40 mmHg measured by cardiac ultrasound"", ""option_d"": ""Diastolic blood pressure >25 mmHg measured by cardiac ultrasound"", ""correct_option"": ""B""}",,"What is the definition of pulmonary hypertension (PH) in adults?","Mean pulmonary arterial pressure >15 mmHg and resistance >2 UW measured during right heart catheterisation","Mean pulmonary arterial pressure >20 mmHg and resistance >3 UW measured during right heart catheterisation","Systolic blood pressure >40 mmHg measured by cardiac ultrasound","Diastolic blood pressure >25 mmHg measured by cardiac ultrasound","b"
"OIC-208-04-B","{""question"": ""What is a common sign that may suggest the diagnosis of Pulmonary Hypertension (PH) related to right heart failure?"", ""option_a"": ""Exertional dyspnoea"", ""option_b"": ""Holosystolic murmur of tricuspid insufficiency"", ""option_c"": ""Jugular turgidity and hepato-jugular reflux"", ""option_d"": ""Diastolic murmur of mitral stenosis"", ""correct_option"": ""C""}","Positive diagnosis","What is a common sign that may suggest the diagnosis of Pulmonary Hypertension (PH) related to right heart failure?","Exertional dyspnoea","Holosystolic murmur of tricuspid insufficiency","Jugular turgidity and hepato-jugular reflux","Diastolic murmur of mitral stenosis","c"
"OIC-208-05-A","{""question"": ""What is the primary functional investigation used to diagnose obstructive chronic kidney disease (CKD)?"", ""option_a"": ""Plethysmography with CPT<80% of predicted values"", ""option_b"": ""Spirometry with flow-volume curve showing FEV1/CV<0.7"", ""option_c"": ""Blood gases to assess the alveolar-arterial difference"", ""option_d"": ""Impaired diffusion test (TLCO<0.7) to check for diffuse infiltrative lung disease"", ""correct_option"": ""B""}",,"What is the primary functional investigation used to diagnose obstructive chronic kidney disease (CKD)?","Plethysmography with CPT<80% of predicted values","Spirometry with flow-volume curve showing FEV1/CV<0.7","Blood gases to assess the alveolar-arterial difference","Impaired diffusion test (TLCO<0.7) to check for diffuse infiltrative lung disease","b"
"OIC-208-06-B","{""question"": ""What is the primary method used to differentiate between obstructive and restrictive chronic kidney disease (CKD) through functional explorations?"", ""option_a"": ""Forced Expiratory Volume (FEV1) and Forced Vital Capacity (FVC) ratio"", ""option_b"": ""Blood urea nitrogen (BUN) and creatinine levels"", ""option_c"": ""Glomerular filtration rate (GFR) measurement"", ""option_d"": ""Complete Blood Count (CBC) analysis"", ""correct_option"": ""A""}",,"What is the primary method used to differentiate between obstructive and restrictive chronic kidney disease (CKD) through functional explorations?","Forced Expiratory Volume (FEV1) and Forced Vital Capacity (FVC) ratio","Blood urea nitrogen (BUN) and creatinine levels","Glomerular filtration rate (GFR) measurement","Complete Blood Count (CBC) analysis","a"
"OIC-208-07-A","{""question"": ""What is a sign of severe decompensation in a patient with Chronic Kidney Disease (CKD) that should be systematically sought?"", ""option_a"": ""Mild hypoxaemia (PaO2>80mmHg)"", ""option_b"": ""Compensated respiratory acidosis (pH=7.4 with PaCO2=40mmHg)"", ""option_c"": ""Severe hypoxaemia (PaO2<60mmHg)"", ""option_d"": ""Mild respiratory alkalosis (pH=7.5 with PaCO2=30mmHg)"", ""correct_option"": ""C""}","Identifying the emergency","What is a sign of severe decompensation in a patient with Chronic Kidney Disease (CKD) that should be systematically sought?","Mild hypoxaemia (PaO2>80mmHg)","Compensated respiratory acidosis (pH=7.4 with PaCO2=40mmHg)","Severe hypoxaemia (PaO2<60mmHg)","Mild respiratory alkalosis (pH=7.5 with PaCO2=30mmHg)","c"
"OIC-208-08-A","{""question"": ""What is a potential consequence of chronic hypoxaemia in patients with chronic respiratory failure?"", ""option_a"": ""Acute pulmonary embolism"", ""option_b"": ""Polycythemia"", ""option_c"": ""Pulmonary fibrosis"", ""option_d"": ""Cardiac arrhythmia"", ""correct_option"": ""B""}",,"What is a potential consequence of chronic hypoxaemia in patients with chronic respiratory failure?","Acute pulmonary embolism","Polycythemia","Pulmonary fibrosis","Cardiac arrhythmia","b"
"OIC-208-09-B","{""question"": ""What is the primary pathophysiological mechanism underlying Chronic Kidney Disease (CKD) in cases of neuromuscular diseases?"", ""option_a"": ""Impaired ventilation/perfusion ratio due to diseases of the pulmonary exchanger"", ""option_b"": ""Diseases of the ventilatory pump, specifically related to neuromuscular dysfunction"", ""option_c"": ""Impairment of alveolar-capillary diffusion in the context of diffuse infiltrative lung disease"", ""option_d"": ""Impairment of ventilatory control due to rare brain stem disorders"", ""correct_option"": ""B""}","Physiopathology, Etiologies","What is the primary pathophysiological mechanism underlying Chronic Kidney Disease (CKD) in cases of neuromuscular diseases?","Impaired ventilation/perfusion ratio due to diseases of the pulmonary exchanger","Diseases of the ventilatory pump, specifically related to neuromuscular dysfunction","Impairment of alveolar-capillary diffusion in the context of diffuse infiltrative lung disease","Impairment of ventilatory control due to rare brain stem disorders","b"
"OIC-208-10-B","{""question"": ""In Chronic Obstructive Pulmonary Disease (COPD), what is the primary mechanism responsible for hypoxaemia in the initial stages?"", ""option_a"": ""Alveolar hypoventilation"", ""option_b"": ""Diseases of the pulmonary exchanger"", ""option_c"": ""Diseases of the ventilatory pump"", ""option_d"": ""Hypercapnia"", ""correct_option"": ""B""}","Physiopathology, Etiologies","In Chronic Obstructive Pulmonary Disease (COPD), what is the primary mechanism responsible for hypoxaemia in the initial stages?","Alveolar hypoventilation","Diseases of the pulmonary exchanger","Diseases of the ventilatory pump","Hypercapnia","b"
"OIC-208-11-B","{""question"": ""What is the primary aim of long-term oxygen therapy (LTO) in patients with chronic respiratory failure?"", ""option_a"": ""To provide symptomatic relief for dyspnoea"", ""option_b"": ""To correct the consequences of chronic hypoxaemia and reduce mortality"", ""option_c"": ""To increase oxygen flow rates during physical activity"", ""option_d"": ""To manage right ventricular adequacy in patients with obstructive CKD"", ""correct_option"": ""B""}",,"What is the primary aim of long-term oxygen therapy (LTO) in patients with chronic respiratory failure?","To provide symptomatic relief for dyspnoea","To correct the consequences of chronic hypoxaemia and reduce mortality","To increase oxygen flow rates during physical activity","To manage right ventricular adequacy in patients with obstructive CKD","b"
"OIC-208-12-B","{""question"": ""What is the primary criterion for a patient with Chronic Kidney Disease (CKD) to be exempt from co-payment under ALD 14?"", ""option_a"": ""Severe CKD with PaO2 < 50mmHg"", ""option_b"": ""Severe CKD with PaO2 < 60mmHg"", ""option_c"": ""Mild CKD with PaO2 < 70mmHg"", ""option_d"": ""End-stage CKD requiring dialysis"", ""correct_option"": ""B""}","Prise en charge","What is the primary criterion for a patient with Chronic Kidney Disease (CKD) to be exempt from co-payment under ALD 14?","Severe CKD with PaO2 < 50mmHg","Severe CKD with PaO2 < 60mmHg","Mild CKD with PaO2 < 70mmHg","End-stage CKD requiring dialysis","b"
"OIC-208-13-B","{""question"": ""What is the appropriate saturation target for oxygen therapy in hypercapnic patients?"", ""option_a"": ""94%<Saturation<96%"", ""option_b"": ""88%<Saturation<92%"", ""option_c"": ""90%<Saturation<94%"", ""option_d"": ""98%<Saturation<100%"", ""correct_option"": ""B""}","Management","What is the appropriate saturation target for oxygen therapy in hypercapnic patients?","94%<Saturation<96%","88%<Saturation<92%","90%<Saturation<94%","98%<Saturation<100%","b"
"OIC-208-14-B","{""question"": ""What is the primary basis for etiological diagnosis and monitoring of chronic respiratory failure?"", ""option_a"": ""Imaging examinations such as chest X-rays and thoracic CT scans"", ""option_b"": ""Functional respiratory investigations"", ""option_c"": ""Blood tests and physical examinations"", ""option_d"": ""Patient history and symptoms"", ""correct_option"": ""B""}","Additional examinations","What is the primary basis for etiological diagnosis and monitoring of chronic respiratory failure?","Imaging examinations such as chest X-rays and thoracic CT scans","Functional respiratory investigations","Blood tests and physical examinations","Patient history and symptoms","b"
"OIC-215-01-A","{""question"": ""What is a characteristic feature of purpura that distinguishes it from other skin lesions?"", ""option_a"": ""They are red or purplish skin lesions that disappear with vitropression"", ""option_b"": ""They are associated with the extravasation of blood into the epidermis"", ""option_c"": ""They do not disappear with vitropression and are associated with extravasation of blood into the dermis"", ""option_d"": ""They are always in the form of linear streaks and are not variable in appearance"", ""correct_option"": ""C""}",,"What is a characteristic feature of purpura that distinguishes it from other skin lesions?","They are red or purplish skin lesions that disappear with vitropression","They are associated with the extravasation of blood into the epidermis","They do not disappear with vitropression and are associated with extravasation of blood into the dermis","They are always in the form of linear streaks and are not variable in appearance","c"
"OIC-215-02-A","{""question"": ""What is the primary mechanism underlying thrombocytopenic purpura?"", ""option_a"": ""Inflammation of the vascular wall"", ""option_b"": ""Fragility of the capillary vascular wall"", ""option_c"": ""Primary haemostasis disorder, especially thrombocytopenia"", ""option_d"": ""Vascular wall pathology due to vasculitis"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary mechanism underlying thrombocytopenic purpura?","Inflammation of the vascular wall","Fragility of the capillary vascular wall","Primary haemostasis disorder, especially thrombocytopenia","Vascular wall pathology due to vasculitis","c"
"OIC-215-03-A","{""question"": ""What is the primary treatment approach for purpura fulminans, a severe and life-threatening condition characterized by rapid extension of vascular purpura associated with sepsis or septic shock?"", ""option_a"": ""Immediate lumbar puncture to identify the underlying infection"", ""option_b"": ""Urgent intramuscular or intravenous injection of antibiotics, preferably 3rd generation cephalosporin, followed by supportive care"", ""option_c"": ""Administration of platelet transfusions to correct profound thrombocytopenia"", ""option_d"": ""Use of anticoagulant therapy to prevent further clotting"", ""correct_option"": ""B""}","Identifying the emergency","What is the primary treatment approach for purpura fulminans, a severe and life-threatening condition characterized by rapid extension of vascular purpura associated with sepsis or septic shock?","Immediate lumbar puncture to identify the underlying infection","Urgent intramuscular or intravenous injection of antibiotics, preferably 3rd generation cephalosporin, followed by supportive care","Administration of platelet transfusions to correct profound thrombocytopenia","Use of anticoagulant therapy to prevent further clotting","b"
"OIC-215-04-A","{""question"": ""What is a key clinical feature that should prompt suspicion of purpura fulminans?"", ""option_a"": ""Isolated petechiae without other symptoms"", ""option_b"": ""Necrotic and/or ecchymotic and/or extensive purpura along with signs of haemodynamic failure"", ""option_c"": ""Mild hypothermia with no other significant findings"", ""option_d"": ""Absence of neurological signs such as obnubilation or coma"", ""correct_option"": ""B""}","Identification of the emergency","What is a key clinical feature that should prompt suspicion of purpura fulminans?","Isolated petechiae without other symptoms","Necrotic and/or ecchymotic and/or extensive purpura along with signs of haemodynamic failure","Mild hypothermia with no other significant findings","Absence of neurological signs such as obnubilation or coma","b"
"OIC-215-05-A","{""question"": ""A patient presents with vascular purpura and fever. Which of the following clinical findings would most strongly suggest vasculitis as the underlying cause?"", ""option_a"": ""Heart murmur"", ""option_b"": ""Signs of malnutrition"", ""option_c"": ""Peripheral neuropathy"", ""option_d"": ""Hepatomegaly"", ""correct_option"": ""C""}","Positive diagnosis","A patient presents with vascular purpura and fever. Which of the following clinical findings would most strongly suggest vasculitis as the underlying cause?","Heart murmur","Signs of malnutrition","Peripheral neuropathy","Hepatomegaly","c"
"OIC-215-06-A","{""question"": ""In a case of suspected thrombocytopenic purpura, which of the following laboratory tests is NOT typically necessary to check for thrombocytopenia?"", ""option_a"": ""Blood count on a citrate tube"", ""option_b"": ""Prothrombin time (PT)"", ""option_c"": ""Activated partial thromboplastin time (APTT)"", ""option_d"": ""Blood smear"", ""correct_option"": ""A""}",,"In a case of suspected thrombocytopenic purpura, which of the following laboratory tests is NOT typically necessary to check for thrombocytopenia?","Blood count on a citrate tube","Prothrombin time (PT)","Activated partial thromboplastin time (APTT)","Blood smear","a"
"OIC-215-07-B","{""question"": ""In non-emergency cases of vascular purpura, which of the following tests is typically prescribed to aid in diagnosis?"", ""option_a"": ""Complete Blood Count (CBC) and blood smear"", ""option_b"": ""Anti-neutrophil cytoplasmic antibodies (ANCA) and Cryoglobulinemia tests"", ""option_c"": ""Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) tests"", ""option_d"": ""Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) tests"", ""correct_option"": ""B""}","Positive diagnosis","In non-emergency cases of vascular purpura, which of the following tests is typically prescribed to aid in diagnosis?","Complete Blood Count (CBC) and blood smear","Anti-neutrophil cytoplasmic antibodies (ANCA) and Cryoglobulinemia tests","Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) tests","Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) tests","b"
"OIC-215-08-A","{""question"": ""What is a common cause of small-calibre vasculitides that can lead to purpura?"", ""option_a"": ""Periarteritis nodosa"", ""option_b"": ""ANCA-associated vasculitides"", ""option_c"": ""Large-vessel vasculitis"", ""option_d"": ""Capillary fragility due to vitamin C deficiency"", ""correct_option"": ""B""}","Etiologies","What is a common cause of small-calibre vasculitides that can lead to purpura?","Periarteritis nodosa","ANCA-associated vasculitides","Large-vessel vasculitis","Capillary fragility due to vitamin C deficiency","b"
"OIC-215-09-A","{""question"": ""In the management of purpura, when may platelet transfusion be indicated?"", ""option_a"": ""In all cases of purpura, regardless of the underlying cause"", ""option_b"": ""In the setting of central thrombocytopenia with haemorrhage and/or profound thrombocytopenia"", ""option_c"": ""Only in emergency situations, such as severe bleeding"", ""option_d"": ""Never, as it can worsen the condition"", ""correct_option"": ""B""}",,"In the management of purpura, when may platelet transfusion be indicated?","In all cases of purpura, regardless of the underlying cause","In the setting of central thrombocytopenia with haemorrhage and/or profound thrombocytopenia","Only in emergency situations, such as severe bleeding","Never, as it can worsen the condition","b"
"OIC-217-01-A","{""question"": ""What is the definition of mononucleosis syndrome in terms of blood count?"", ""option_a"": ""Presence of more than 20% of mononucleated elements among leukocytes due to a hyperlymphocytosis"", ""option_b"": ""Presence of more than 50% of mononucleated elements among leukocytes due to a hyperlymphocytosis and \u2265 10% activated lymphocytes on the blood smear"", ""option_c"": ""Presence of more than 30% of polymorphonuclear cells among leukocytes due to a hypermonocytosis"", ""option_d"": ""Presence of less than 50% of mononucleated elements among leukocytes due to a hypolymphocytosis"", ""correct_option"": ""B""}","Definition","What is the definition of mononucleosis syndrome in terms of blood count?","Presence of more than 20% of mononucleated elements among leukocytes due to a hyperlymphocytosis","Presence of more than 50% of mononucleated elements among leukocytes due to a hyperlymphocytosis and ≥ 10% activated lymphocytes on the blood smear","Presence of more than 30% of polymorphonuclear cells among leukocytes due to a hypermonocytosis","Presence of less than 50% of mononucleated elements among leukocytes due to a hypolymphocytosis","b"
"OIC-217-02-B","{""question"": ""What is typically observed in the blood smear of a patient with mononucleosis syndrome?"", ""option_a"": ""Presence of blast cells and normal lymphocytes"", ""option_b"": ""Activated mononuclear cells with large size and hyperbasophilic cytoplasm, absence of blast cells, and normal other haematopoietic lineages"", ""option_c"": ""Atypical mononuclear cells with small size and hypobasophilic cytoplasm, presence of blast cells, and abnormal other haematopoietic lineages"", ""option_d"": ""Normal mononuclear cells, absence of atypical cells, and presence of blast cells"", ""correct_option"": ""B""}","Positive diagnosis","What is typically observed in the blood smear of a patient with mononucleosis syndrome?","Presence of blast cells and normal lymphocytes","Activated mononuclear cells with large size and hyperbasophilic cytoplasm, absence of blast cells, and normal other haematopoietic lineages","Atypical mononuclear cells with small size and hypobasophilic cytoplasm, presence of blast cells, and abnormal other haematopoietic lineages","Normal mononuclear cells, absence of atypical cells, and presence of blast cells","b"
"OIC-217-03-B","{""question"": ""What is characteristic of the lymphocytes observed in the blood smear of a patient with mononucleosis syndrome?"", ""option_a"": ""They are hypo-basophilic, indicating a decrease in their metabolic activity"", ""option_b"": ""They are hyperbasophilic, indicating an increase in their metabolic activity"", ""option_c"": ""They have a normal basophilic level, similar to those found in a healthy individual"", ""option_d"": ""They are basophilic only in certain stages of the disease"", ""correct_option"": ""B""}","Multimedia content","What is characteristic of the lymphocytes observed in the blood smear of a patient with mononucleosis syndrome?","They are hypo-basophilic, indicating a decrease in their metabolic activity","They are hyperbasophilic, indicating an increase in their metabolic activity","They have a normal basophilic level, similar to those found in a healthy individual","They are basophilic only in certain stages of the disease","b"
"OIC-217-04-A","{""question"": ""What is a key element to consider when questioning a patient with suspected mononucleosis syndrome regarding their medical history?"", ""option_a"": ""Recent travel history to tropical regions"", ""option_b"": ""Introduction of new medication or medication taken in the previous weeks"", ""option_c"": ""History of frequent exercise or sports activities"", ""option_d"": ""Family history of genetic disorders"", ""correct_option"": ""B""}","Positive diagnosis","What is a key element to consider when questioning a patient with suspected mononucleosis syndrome regarding their medical history?","Recent travel history to tropical regions","Introduction of new medication or medication taken in the previous weeks","History of frequent exercise or sports activities","Family history of genetic disorders","b"
"OIC-217-05-A","{""question"": ""What is the most common infectious cause of mononucleosis syndrome?"", ""option_a"": ""Cytomegalovirus (CMV)"", ""option_b"": ""Epstein Barr virus (EBV)"", ""option_c"": ""Human Immunodeficiency Virus (HIV)"", ""option_d"": ""Toxoplasmosis"", ""correct_option"": ""B""}","Etiologies","What is the most common infectious cause of mononucleosis syndrome?","Cytomegalovirus (CMV)","Epstein Barr virus (EBV)","Human Immunodeficiency Virus (HIV)","Toxoplasmosis","b"
"OIC-217-06-B","{""question"": ""A patient presents with symptoms of mononucleosis syndrome, including a skin rash, polyadenopathies, and hyperthermia. Which of the following is a potential non-infectious etiology of these symptoms?"", ""option_a"": ""Viral infection"", ""option_b"": ""Allergic drug reaction, such as DRESS syndrome"", ""option_c"": ""Bacterial infection"", ""option_d"": ""Nutritional deficiency"", ""correct_option"": ""B""}","Etiologies","A patient presents with symptoms of mononucleosis syndrome, including a skin rash, polyadenopathies, and hyperthermia. Which of the following is a potential non-infectious etiology of these symptoms?","Viral infection","Allergic drug reaction, such as DRESS syndrome","Bacterial infection","Nutritional deficiency","b"
"OIC-223-01-A","{""question"": ""What is the primary factor used to assess the 10-year risk of coronary ischaemia or stroke using the SCORE2 and SCORE2-OP equations?"", ""option_a"": ""Serum HDL cholesterol concentration"", ""option_b"": ""Serum non-HDL cholesterol concentration"", ""option_c"": ""Diastolic blood pressure"", ""option_d"": ""Family history of cardiovascular disease"", ""correct_option"": ""B""}","Definition","What is the primary factor used to assess the 10-year risk of coronary ischaemia or stroke using the SCORE2 and SCORE2-OP equations?","Serum HDL cholesterol concentration","Serum non-HDL cholesterol concentration","Diastolic blood pressure","Family history of cardiovascular disease","b"
"OIC-223-02-A","{""question"": ""What are the three main types of dyslipidemia?"", ""option_a"": ""Pure hypercholesterolaemia, pure hypertriglyceridaemia, and primary hyperlipidaemia"", ""option_b"": ""Pure hypercholesterolaemia, pure hypertriglyceridaemia, and mixed hyperlipidaemia"", ""option_c"": ""Primary hyperlipidaemia, secondary hyperlipidaemia, and dyslipidaemia associated with type 2 diabetes"", ""option_d"": ""Mixed hyperlipidaemia, primary hyperlipidaemia, and secondary hyperlipidaemia"", ""correct_option"": ""B""}","Definition","What are the three main types of dyslipidemia?","Pure hypercholesterolaemia, pure hypertriglyceridaemia, and primary hyperlipidaemia","Pure hypercholesterolaemia, pure hypertriglyceridaemia, and mixed hyperlipidaemia","Primary hyperlipidaemia, secondary hyperlipidaemia, and dyslipidaemia associated with type 2 diabetes","Mixed hyperlipidaemia, primary hyperlipidaemia, and secondary hyperlipidaemia","b"
"OIC-223-03-B","{""question"": ""What is the relationship between LDL-cholesterol and the development of atherosclerotic plaque?"", ""option_a"": ""LDL-cholesterol has no direct role in the formation of atherosclerotic plaque"", ""option_b"": ""LDL-cholesterol is indirectly involved in the development of atherosclerotic plaque through its effects on blood pressure"", ""option_c"": ""LDL-cholesterol is directly involved in the development of atherosclerotic plaque through its accumulation in macrophages, with oxidation and inflammation contributing to the process"", ""option_d"": ""LDL-cholesterol levels are not a significant predictor of cardiovascular risk and do not contribute to the formation of atherosclerotic plaque"", ""correct_option"": ""C""}","Physiopathology","What is the relationship between LDL-cholesterol and the development of atherosclerotic plaque?","LDL-cholesterol has no direct role in the formation of atherosclerotic plaque","LDL-cholesterol is indirectly involved in the development of atherosclerotic plaque through its effects on blood pressure","LDL-cholesterol is directly involved in the development of atherosclerotic plaque through its accumulation in macrophages, with oxidation and inflammation contributing to the process","LDL-cholesterol levels are not a significant predictor of cardiovascular risk and do not contribute to the formation of atherosclerotic plaque","c"
"OIC-223-04-A","{""question"": ""At what age is screening for dyslipidaemia recommended for men without any cardiovascular risk factors?"", ""option_a"": ""From the age of 30"", ""option_b"": ""From the age of 40"", ""option_c"": ""From the age of 50"", ""option_d"": ""From the age of 60"", ""correct_option"": ""B""}","Testing","At what age is screening for dyslipidaemia recommended for men without any cardiovascular risk factors?","From the age of 30","From the age of 40","From the age of 50","From the age of 60","b"
"OIC-223-05-A","{""question"": ""What is the primary method for diagnosing dyslipidemias?"", ""option_a"": ""A physical examination and medical history"", ""option_b"": ""A Lipid Abnormality Investigation (LAI) on serum after 12 hours' fasting"", ""option_c"": ""Genetic testing for lipid metabolism disorders"", ""option_d"": ""Imaging tests such as ultrasound or MRI"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method for diagnosing dyslipidemias?","A physical examination and medical history","A Lipid Abnormality Investigation (LAI) on serum after 12 hours' fasting","Genetic testing for lipid metabolism disorders","Imaging tests such as ultrasound or MRI","b"
"OIC-223-06-A","{""question"": ""What is a common clinical manifestation of hypercholesterolaemia, especially in severe forms like familial hypercholesterolaemia?"", ""option_a"": ""Eruptive xanthomatosis"", ""option_b"": ""Xanthelasma"", ""option_c"": ""Retinal lipaemia"", ""option_d"": ""Corneal opacification"", ""correct_option"": ""B""}","Multimedia content","What is a common clinical manifestation of hypercholesterolaemia, especially in severe forms like familial hypercholesterolaemia?","Eruptive xanthomatosis","Xanthelasma","Retinal lipaemia","Corneal opacification","b"
"OIC-223-07-A","{""question"": ""What is a common cause of secondary hyperlipidemia related to kidney function?"", ""option_a"": ""Hypothyroidism"", ""option_b"": ""Nephrotic syndrome"", ""option_c"": ""Cholestasis due to liver damage"", ""option_d"": ""Medication side effects from antihypertensive drugs"", ""correct_option"": ""B""}","Etiologies","What is a common cause of secondary hyperlipidemia related to kidney function?","Hypothyroidism","Nephrotic syndrome","Cholestasis due to liver damage","Medication side effects from antihypertensive drugs","b"
"OIC-223-08-B","{""question"": ""In the search for secondary dyslipidaemia, which of the following biological tests is least relevant to order initially?"", ""option_a"": ""TSH"", ""option_b"": ""Creatinine"", ""option_c"": ""Fasting glucose"", ""option_d"": ""Uric acid"", ""correct_option"": ""D""}","Additional tests","In the search for secondary dyslipidaemia, which of the following biological tests is least relevant to order initially?","TSH","Creatinine","Fasting glucose","Uric acid","d"
"OIC-223-09-A","{""question"": ""What is the recommended LDL-cholesterol target for patients aged \u2265 40 years without diabetes, familial hypercholesterolaemia, renal insufficiency, or known cardiovascular disease who have a high cardiovascular risk?"", ""option_a"": ""LDL-cholesterol target < 2.6 mmol/L"", ""option_b"": ""LDL-cholesterol target < 1.8 mmol/L"", ""option_c"": ""LDL-cholesterol target < 1.4 mmol/L"", ""option_d"": ""LDL-cholesterol target < 3.5 mmol/L"", ""correct_option"": ""B""}","Management","What is the recommended LDL-cholesterol target for patients aged ≥ 40 years without diabetes, familial hypercholesterolaemia, renal insufficiency, or known cardiovascular disease who have a high cardiovascular risk?","LDL-cholesterol target < 2.6 mmol/L","LDL-cholesterol target < 1.8 mmol/L","LDL-cholesterol target < 1.4 mmol/L","LDL-cholesterol target < 3.5 mmol/L","b"
"OIC-225-01-A","{""question"": ""What is the definition of Obliterative Arterial Disease of the Lower Limbs (AOMI)?"", ""option_a"": ""The presence of atherosclerotic lesions in the arteries perfusing the upper limbs"", ""option_b"": ""The presence of atherosclerotic lesions in the aorta and underlying arteries perfusing the lower limbs"", ""option_c"": ""The presence of atherosclerotic lesions in the arteries perfusing the visceral organs"", ""option_d"": ""The presence of atherosclerotic lesions in the arteries perfusing the brain"", ""correct_option"": ""B""}","Definition","What is the definition of Obliterative Arterial Disease of the Lower Limbs (AOMI)?","The presence of atherosclerotic lesions in the arteries perfusing the upper limbs","The presence of atherosclerotic lesions in the aorta and underlying arteries perfusing the lower limbs","The presence of atherosclerotic lesions in the arteries perfusing the visceral organs","The presence of atherosclerotic lesions in the arteries perfusing the brain","b"
"OIC-225-02-B","{""question"": ""What is a major factor that influences the prognosis of AOMI, in addition to local expression of the disease?"", ""option_a"": ""Cerebrovascular complications and cardiac complications such as angina and myocardial infarction"", ""option_b"": ""Only cardiac complications like angina and myocardial infarction"", ""option_c"": ""Only cerebrovascular complications"", ""option_d"": ""Neither cardiac nor cerebrovascular complications"", ""correct_option"": ""A""}","Physiopathology","What is a major factor that influences the prognosis of AOMI, in addition to local expression of the disease?","Cerebrovascular complications and cardiac complications such as angina and myocardial infarction","Only cardiac complications like angina and myocardial infarction","Only cerebrovascular complications","Neither cardiac nor cerebrovascular complications","a"
"OIC-225-03-A","{""question"": ""What is the primary method for diagnosing AOMI in patients with diabetes or chronic renal failure, due to the inaccuracy of systolic ankle pressure index (SAPI) and ankle pressure?"", ""option_a"": ""Measurement of systolic ankle pressure index (SAPI)"", ""option_b"": ""Measurement of toe pressure (digital pressure)"", ""option_c"": ""Clinical evaluation of symptoms only"", ""option_d"": ""Functional classification of Leriche and Fontaine"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method for diagnosing AOMI in patients with diabetes or chronic renal failure, due to the inaccuracy of systolic ankle pressure index (SAPI) and ankle pressure?","Measurement of systolic ankle pressure index (SAPI)","Measurement of toe pressure (digital pressure)","Clinical evaluation of symptoms only","Functional classification of Leriche and Fontaine","b"
"OIC-225-04-A","{""question"": ""What is the reference examination for determining the location of arterial lesions and their haemodynamic impact in the diagnosis of Arteriopathy of the aorta, visceral arteries and lower limbs?"", ""option_a"": ""Angioscanner of the aorta and arteries of the lower limbs"", ""option_b"": ""Doppler ultrasound of the aorta and arteries of the lower limbs"", ""option_c"": ""Angio-MRI of the aorta and arteries of the lower limbs"", ""option_d"": ""Arteriography of the lower limbs"", ""correct_option"": ""B""}","Complementary examinations","What is the reference examination for determining the location of arterial lesions and their haemodynamic impact in the diagnosis of Arteriopathy of the aorta, visceral arteries and lower limbs?","Angioscanner of the aorta and arteries of the lower limbs","Doppler ultrasound of the aorta and arteries of the lower limbs","Angio-MRI of the aorta and arteries of the lower limbs","Arteriography of the lower limbs","b"
"OIC-225-05-A","{""question"": ""What is the primary goal of medical management in patients with Arteriopathy of the aorta, visceral arteries, and lower limbs, particularly in those with symptomatic AOMI?"", ""option_a"": ""To immediately perform surgical revascularisation"", ""option_b"": ""To slow the progression of atheromatous disease by correcting risk factors and instituting systematic drug treatment"", ""option_c"": ""To solely focus on walking training and supervised rehabilitation"", ""option_d"": ""To prioritize amputation in cases of symptoms at rest"", ""correct_option"": ""B""}",,"What is the primary goal of medical management in patients with Arteriopathy of the aorta, visceral arteries, and lower limbs, particularly in those with symptomatic AOMI?","To immediately perform surgical revascularisation","To slow the progression of atheromatous disease by correcting risk factors and instituting systematic drug treatment","To solely focus on walking training and supervised rehabilitation","To prioritize amputation in cases of symptoms at rest","b"
"OIC-225-06-A","{""question"": ""What is the primary factor that determines the patient's vital prognosis in the context of arteriopathy of the aorta, visceral arteries, and lower limbs?"", ""option_a"": ""The presence of acute limb ischaemia"", ""option_b"": ""The severity of chronic occlusive vascular lesions"", ""option_c"": ""Coronary, cerebrovascular, and mesenteric complications"", ""option_d"": ""The timing of medical treatment for trophic disorders"", ""correct_option"": ""C""}",,"What is the primary factor that determines the patient's vital prognosis in the context of arteriopathy of the aorta, visceral arteries, and lower limbs?","The presence of acute limb ischaemia","The severity of chronic occlusive vascular lesions","Coronary, cerebrovascular, and mesenteric complications","The timing of medical treatment for trophic disorders","c"
"OIC-225-07-A","{""question"": ""What is the primary criterion for determining the severity of acute ischaemia?"", ""option_a"": ""Intensity of pain"", ""option_b"": ""Presence of peripheral pulses"", ""option_c"": ""Paralysis"", ""option_d"": ""Limb colour abnormalities"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary criterion for determining the severity of acute ischaemia?","Intensity of pain","Presence of peripheral pulses","Paralysis","Limb colour abnormalities","c"
"OIC-225-08-B","{""question"": ""What is the primary distinction between embolism and thrombosis in the context of acute ischaemia?"", ""option_a"": ""The presence or absence of cardiac arrhythmia"", ""option_b"": ""The severity of sensory-motor ischaemia and the onset of symptoms"", ""option_c"": ""The location of the obstruction in the arterial territory"", ""option_d"": ""The age of the patient and the history of arterial disease"", ""correct_option"": ""B""}","Etiologies","What is the primary distinction between embolism and thrombosis in the context of acute ischaemia?","The presence or absence of cardiac arrhythmia","The severity of sensory-motor ischaemia and the onset of symptoms","The location of the obstruction in the arterial territory","The age of the patient and the history of arterial disease","b"
"OIC-225-09-A","{""question"": ""What is the primary goal of anticoagulant treatment with heparin in the therapeutic strategy for acute ischaemia?"", ""option_a"": ""To promote revascularisation of the ischaemic territory"", ""option_b"": ""To prevent the thrombus from spreading and embolic recurrence"", ""option_c"": ""To manage low cardiac output and rhythm disorders"", ""option_d"": ""To correct pathological processes aggravating ischaemia"", ""correct_option"": ""B""}","Emergency identification","What is the primary goal of anticoagulant treatment with heparin in the therapeutic strategy for acute ischaemia?","To promote revascularisation of the ischaemic territory","To prevent the thrombus from spreading and embolic recurrence","To manage low cardiac output and rhythm disorders","To correct pathological processes aggravating ischaemia","b"
"OIC-225-10-A","{""question"": ""What is the definition of an arterial aneurysm?"", ""option_a"": ""A temporary dilatation of the artery with preservation of parallelism of its walls"", ""option_b"": ""A focal and permanent dilatation of the artery with a loss of parallelism of its walls, and whose diameter is greater than 1.5 times the upstream diameter"", ""option_c"": ""A permanent dilatation of the artery with preservation of parallelism of its walls, and whose diameter is less than 1.5 times the upstream diameter"", ""option_d"": ""A focal and temporary dilatation of the artery with a loss of parallelism of its walls, and whose diameter is greater than 1.5 times the upstream diameter"", ""correct_option"": ""B""}","Definition","What is the definition of an arterial aneurysm?","A temporary dilatation of the artery with preservation of parallelism of its walls","A focal and permanent dilatation of the artery with a loss of parallelism of its walls, and whose diameter is greater than 1.5 times the upstream diameter","A permanent dilatation of the artery with preservation of parallelism of its walls, and whose diameter is less than 1.5 times the upstream diameter","A focal and temporary dilatation of the artery with a loss of parallelism of its walls, and whose diameter is greater than 1.5 times the upstream diameter","b"
"OIC-225-11-B","{""question"": ""What is the most common aetiology associated with abdominal aortic aneurysms (AAAs)?"", ""option_a"": ""Inflammatory aortitis"", ""option_b"": ""Atherosclerosis"", ""option_c"": ""Hereditary connective tissue dystrophies"", ""option_d"": ""Infectious aneurysm"", ""correct_option"": ""B""}","Etiologies","What is the most common aetiology associated with abdominal aortic aneurysms (AAAs)?","Inflammatory aortitis","Atherosclerosis","Hereditary connective tissue dystrophies","Infectious aneurysm","b"
"OIC-225-12-A","{""question"": ""What is the most common presentation of an abdominal aortic aneurysm (AAA)?"", ""option_a"": ""Abdominal or lumbar pain"", ""option_b"": ""Asymptomatic, discovered incidentally on clinical examination or imaging test"", ""option_c"": ""Acute arterial occlusion of the lower limb"", ""option_d"": ""Cholesterol crystal embolisms resulting in blue toe syndrome"", ""correct_option"": ""B""}","Positive diagnosis","What is the most common presentation of an abdominal aortic aneurysm (AAA)?","Abdominal or lumbar pain","Asymptomatic, discovered incidentally on clinical examination or imaging test","Acute arterial occlusion of the lower limb","Cholesterol crystal embolisms resulting in blue toe syndrome","b"
"OIC-225-13-A","{""question"": ""What is the preferred imaging examination for screening and monitoring asymptomatic abdominal aortic aneurysms?"", ""option_a"": ""Thoracic-abdominal-pelvic CT with injection of iodinated contrast"", ""option_b"": ""Abdominal ultrasound"", ""option_c"": ""Arteriography"", ""option_d"": ""MRI"", ""correct_option"": ""B""}",,"What is the preferred imaging examination for screening and monitoring asymptomatic abdominal aortic aneurysms?","Thoracic-abdominal-pelvic CT with injection of iodinated contrast","Abdominal ultrasound","Arteriography","MRI","b"
"OIC-225-14-B","{""question"": ""What is the primary goal of surgical treatment for an abdominal aortic aneurysm (AAA)?"", ""option_a"": ""To reduce the diameter of the aneurysm"", ""option_b"": ""To prevent the aneurysm from rupturing"", ""option_c"": ""To treat associated atherosclerotic disease"", ""option_d"": ""To improve blood flow to the lower limbs"", ""correct_option"": ""B""}","Management","What is the primary goal of surgical treatment for an abdominal aortic aneurysm (AAA)?","To reduce the diameter of the aneurysm","To prevent the aneurysm from rupturing","To treat associated atherosclerotic disease","To improve blood flow to the lower limbs","b"
"OIC-225-15-A","{""question"": ""What is the recommended immediate management for a patient with acute lower limb ischaemia due to embolism from an abdominal aortic aneurysm thrombus?"", ""option_a"": ""Emergency vascular surgery to repair the aneurysm"", ""option_b"": ""Immediate embolectomy to restore blood flow to the limb"", ""option_c"": ""CT scan to assess the aneurysm and surrounding structures"", ""option_d"": ""Administration of anticoagulant therapy to prevent further embolism"", ""correct_option"": ""B""}","Emergency identification","What is the recommended immediate management for a patient with acute lower limb ischaemia due to embolism from an abdominal aortic aneurysm thrombus?","Emergency vascular surgery to repair the aneurysm","Immediate embolectomy to restore blood flow to the limb","CT scan to assess the aneurysm and surrounding structures","Administration of anticoagulant therapy to prevent further embolism","b"
"OIC-225-16-A","{""question"": ""What is the primary cause of chronic intestinal ischaemia?"", ""option_a"": ""Acute embolism"", ""option_b"": ""Atheromatous obstruction"", ""option_c"": ""Dissection of the digestive arteries"", ""option_d"": ""In situ thrombosis of the venous system"", ""correct_option"": ""B""}","Definition","What is the primary cause of chronic intestinal ischaemia?","Acute embolism","Atheromatous obstruction","Dissection of the digestive arteries","In situ thrombosis of the venous system","b"
"OIC-225-17-A","{""question"": ""What is the primary symptom of chronic intestinal ischemia, and when does it typically occur?"", ""option_a"": ""Sudden and intense cramp-like pain immediately after ingestion"", ""option_b"": ""Post-prandial abdominal pain 15 to 30 minutes after ingestion, which slowly subsides over one to two hours"", ""option_c"": ""Persistent and severe abdominal pain with peritoneal signs from the onset"", ""option_d"": ""Mild abdominal discomfort only after ingestion of high-fat meals"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary symptom of chronic intestinal ischemia, and when does it typically occur?","Sudden and intense cramp-like pain immediately after ingestion","Post-prandial abdominal pain 15 to 30 minutes after ingestion, which slowly subsides over one to two hours","Persistent and severe abdominal pain with peritoneal signs from the onset","Mild abdominal discomfort only after ingestion of high-fat meals","b"
"OIC-226-01-A","{""question"": ""What is the definition of high-risk pulmonary embolism (PE)?"", ""option_a"": ""PE associated with haemodynamic failure due to sepsis"", ""option_b"": ""PE associated with haemodynamic failure (systolic blood pressure < 90 mmHg or drop in SBP \u2265 40 mmHg for more than 15 minutes), in the absence of another cause"", ""option_c"": ""PE with a mortality rate of less than 10%"", ""option_d"": ""PE occurring in the distal veins of the lower limbs"", ""correct_option"": ""B""}",,"What is the definition of high-risk pulmonary embolism (PE)?","PE associated with haemodynamic failure due to sepsis","PE associated with haemodynamic failure (systolic blood pressure < 90 mmHg or drop in SBP ≥ 40 mmHg for more than 15 minutes), in the absence of another cause","PE with a mortality rate of less than 10%","PE occurring in the distal veins of the lower limbs","b"
"OIC-226-02-A","{""question"": ""What is considered a major transient risk factor for venous thromboembolism (VTE)?"", ""option_a"": ""Prolonged travel by plane for more than 6 hours"", ""option_b"": ""Surgery with general anaesthesia lasting more than 30 minutes in the last 3 months"", ""option_c"": ""Chronic inflammatory diseases such as Crohn's or UC"", ""option_d"": ""Age-related factors, such as increasing risk with age"", ""correct_option"": ""B""}","Etiologies","What is considered a major transient risk factor for venous thromboembolism (VTE)?","Prolonged travel by plane for more than 6 hours","Surgery with general anaesthesia lasting more than 30 minutes in the last 3 months","Chronic inflammatory diseases such as Crohn's or UC","Age-related factors, such as increasing risk with age","b"
"OIC-226-03-B","{""question"": ""According to Virchow's triad, which of the following factors contributes to the occurrence of Deep Vein Thrombosis (DVT) by promoting endothelial damage?"", ""option_a"": ""Immobilisation"", ""option_b"": ""Surgery"", ""option_c"": ""Acute medical events such as sepsis"", ""option_d"": ""Pregnancy"", ""correct_option"": ""C""}",,"According to Virchow's triad, which of the following factors contributes to the occurrence of Deep Vein Thrombosis (DVT) by promoting endothelial damage?","Immobilisation","Surgery","Acute medical events such as sepsis","Pregnancy","c"
"OIC-226-04-A","{""question"": ""What is the primary use of clinical probability scores, such as the Wells DVT score, in the diagnosis of VTE?"", ""option_a"": ""To confirm the diagnosis of DVT or PE"", ""option_b"": ""To guide the performance of additional tests, such as D-dimers and imaging"", ""option_c"": ""To determine the severity of VTE"", ""option_d"": ""To rule out differential diagnoses"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary use of clinical probability scores, such as the Wells DVT score, in the diagnosis of VTE?","To confirm the diagnosis of DVT or PE","To guide the performance of additional tests, such as D-dimers and imaging","To determine the severity of VTE","To rule out differential diagnoses","b"
"OIC-226-05-A","{""question"": ""What is the definition of a high-risk pulmonary embolism (PE) in terms of systolic blood pressure (SBP)?"", ""option_a"": ""A PE associated with haemodynamic failure defined by a systolic blood pressure (SBP) < 80 mmHg or a fall in SBP \u2265 30 mmHg for more than 15 minutes"", ""option_b"": ""A PE associated with haemodynamic failure defined by a systolic blood pressure (SBP) < 90 mmHg or a fall in SBP \u2265 40 mmHg for more than 15 minutes"", ""option_c"": ""A PE associated with haemodynamic failure defined by a systolic blood pressure (SBP) < 100 mmHg or a fall in SBP \u2265 20 mmHg for more than 15 minutes"", ""option_d"": ""A PE associated with haemodynamic failure defined by a systolic blood pressure (SBP) < 90 mmHg or a fall in SBP \u2265 30 mmHg for more than 10 minutes"", ""correct_option"": ""B""}",,"What is the definition of a high-risk pulmonary embolism (PE) in terms of systolic blood pressure (SBP)?","A PE associated with haemodynamic failure defined by a systolic blood pressure (SBP) < 80 mmHg or a fall in SBP ≥ 30 mmHg for more than 15 minutes","A PE associated with haemodynamic failure defined by a systolic blood pressure (SBP) < 90 mmHg or a fall in SBP ≥ 40 mmHg for more than 15 minutes","A PE associated with haemodynamic failure defined by a systolic blood pressure (SBP) < 100 mmHg or a fall in SBP ≥ 20 mmHg for more than 15 minutes","A PE associated with haemodynamic failure defined by a systolic blood pressure (SBP) < 90 mmHg or a fall in SBP ≥ 30 mmHg for more than 10 minutes","b"
"OIC-226-06-A","{""question"": ""What is the primary purpose of adjusting the D-dimer threshold for age in the diagnosis of pulmonary embolism (PE)?"", ""option_a"": ""To increase the sensitivity of the test for patients under 50 years old"", ""option_b"": ""To reduce the number of false negatives in patients over 50 years old"", ""option_c"": ""To improve the specificity of the test for ruling out non-severe PE in patients over 50 years old"", ""option_d"": ""To make the D-dimer test applicable for diagnosing deep vein thrombosis (DVT) as well"", ""correct_option"": ""C""}",,"What is the primary purpose of adjusting the D-dimer threshold for age in the diagnosis of pulmonary embolism (PE)?","To increase the sensitivity of the test for patients under 50 years old","To reduce the number of false negatives in patients over 50 years old","To improve the specificity of the test for ruling out non-severe PE in patients over 50 years old","To make the D-dimer test applicable for diagnosing deep vein thrombosis (DVT) as well","c"
"OIC-226-07-A","{""question"": ""What is the primary diagnostic criterion for deep vein thrombosis (DVT) using venous Doppler ultrasound?"", ""option_a"": ""The presence of a visible thrombus"", ""option_b"": ""The inability to compress the vein"", ""option_c"": ""A significant increase in blood flow velocity"", ""option_d"": ""The detection of a blood clot in the pulmonary arteries"", ""correct_option"": ""B""}",,"What is the primary diagnostic criterion for deep vein thrombosis (DVT) using venous Doppler ultrasound?","The presence of a visible thrombus","The inability to compress the vein","A significant increase in blood flow velocity","The detection of a blood clot in the pulmonary arteries","b"
"OIC-226-08-A","{""question"": ""What is the primary limitation of ventilation-perfusion scintigraphy in diagnosing pulmonary embolism (PE)?"", ""option_a"": ""It is contraindicated in cases of allergy to contrast products"", ""option_b"": ""It is not conclusive, particularly in cases of underlying respiratory pathology"", ""option_c"": ""It is only used in pregnant women due to less radiation exposure"", ""option_d"": ""It is unable to detect thrombi in the right heart chambers"", ""correct_option"": ""B""}","Additional tests","What is the primary limitation of ventilation-perfusion scintigraphy in diagnosing pulmonary embolism (PE)?","It is contraindicated in cases of allergy to contrast products","It is not conclusive, particularly in cases of underlying respiratory pathology","It is only used in pregnant women due to less radiation exposure","It is unable to detect thrombi in the right heart chambers","b"
"OIC-226-09-A","{""question"": ""What is the defining characteristic of high-risk pulmonary embolism (PE) in terms of systolic blood pressure (SBP)?"", ""option_a"": ""SBP < 90 mmHg or a fall in SBP \u2265 20 mmHg for more than 15 minutes"", ""option_b"": ""SBP < 90 mmHg or a fall in SBP \u2265 40 mmHg for more than 15 minutes in the absence of another cause"", ""option_c"": ""SBP < 80 mmHg or a fall in SBP \u2265 30 mmHg for more than 10 minutes"", ""option_d"": ""SBP < 100 mmHg or a fall in SBP \u2265 50 mmHg for more than 20 minutes"", ""correct_option"": ""B""}",,"What is the defining characteristic of high-risk pulmonary embolism (PE) in terms of systolic blood pressure (SBP)?","SBP < 90 mmHg or a fall in SBP ≥ 20 mmHg for more than 15 minutes","SBP < 90 mmHg or a fall in SBP ≥ 40 mmHg for more than 15 minutes in the absence of another cause","SBP < 80 mmHg or a fall in SBP ≥ 30 mmHg for more than 10 minutes","SBP < 100 mmHg or a fall in SBP ≥ 50 mmHg for more than 20 minutes","b"
"OIC-226-10-A","{""question"": ""What is the recommended first-line treatment for non-severe pulmonary embolism (PE) in terms of anticoagulant therapy?"", ""option_a"": ""Direct oral anticoagulants (such as Rivaroxaban, Apixaban) with an initial heparin phase"", ""option_b"": ""Low molecular weight heparin (LMWH) / fondaparinux - VKA relay"", ""option_c"": ""Unfractionated heparin (UFH) with daily monitoring of anti-Xa activity"", ""option_d"": ""Direct oral anticoagulants (such as Rivaroxaban, Apixaban) without an initial heparin phase"", ""correct_option"": ""D""}",,"What is the recommended first-line treatment for non-severe pulmonary embolism (PE) in terms of anticoagulant therapy?","Direct oral anticoagulants (such as Rivaroxaban, Apixaban) with an initial heparin phase","Low molecular weight heparin (LMWH) / fondaparinux - VKA relay","Unfractionated heparin (UFH) with daily monitoring of anti-Xa activity","Direct oral anticoagulants (such as Rivaroxaban, Apixaban) without an initial heparin phase","d"
"OIC-226-11-A","{""question"": ""In cases of Deep Vein Thrombosis (DVT) of the lower limbs, what is the primary purpose of using class 3 elastic compression?"", ""option_a"": ""To immediately dissolve the blood clot"", ""option_b"": ""To reduce oedema and pain in the acute phase, and to reduce post-thrombotic syndrome outside the acute phase"", ""option_c"": ""To increase blood flow to the affected limb without any compression"", ""option_d"": ""To completely replace anticoagulant therapy"", ""correct_option"": ""B""}",,"In cases of Deep Vein Thrombosis (DVT) of the lower limbs, what is the primary purpose of using class 3 elastic compression?","To immediately dissolve the blood clot","To reduce oedema and pain in the acute phase, and to reduce post-thrombotic syndrome outside the acute phase","To increase blood flow to the affected limb without any compression","To completely replace anticoagulant therapy","b"
"OIC-226-12-A","{""question"": ""In a patient with a history of major venous thromboembolic events (VTE), such as deep vein thrombosis (DVT) or pulmonary embolism (PE), what is the recommended approach to contraception?"", ""option_a"": ""Prescribe a combined oral contraceptive pill containing both oestrogen and progestogen"", ""option_b"": ""Recommend an intra-uterine device (IUD) or a micro-progestogen pill as an alternative contraceptive method"", ""option_c"": ""Suggest a contraceptive method containing only oestrogen for its potential benefits"", ""option_d"": ""Advise against any form of hormonal contraception and recommend barrier methods only"", ""correct_option"": ""B""}",,"In a patient with a history of major venous thromboembolic events (VTE), such as deep vein thrombosis (DVT) or pulmonary embolism (PE), what is the recommended approach to contraception?","Prescribe a combined oral contraceptive pill containing both oestrogen and progestogen","Recommend an intra-uterine device (IUD) or a micro-progestogen pill as an alternative contraceptive method","Suggest a contraceptive method containing only oestrogen for its potential benefits","Advise against any form of hormonal contraception and recommend barrier methods only","b"
"OIC-226-13-A","{""question"": ""In which of the following situations is thromboprophylaxis usually prescribed?"", ""option_a"": ""In medicine, for patients with a single risk factor for VTE"", ""option_b"": ""In surgery, for patients undergoing low-risk procedures with no risk factors for VTE"", ""option_c"": ""In medicine, for patients with multiple risk factors for VTE, and in surgery, for certain high-risk procedures or presence of multiple risk factors for VTE"", ""option_d"": ""For all patients, regardless of their risk factors for VTE"", ""correct_option"": ""C""}",,"In which of the following situations is thromboprophylaxis usually prescribed?","In medicine, for patients with a single risk factor for VTE","In surgery, for patients undergoing low-risk procedures with no risk factors for VTE","In medicine, for patients with multiple risk factors for VTE, and in surgery, for certain high-risk procedures or presence of multiple risk factors for VTE","For all patients, regardless of their risk factors for VTE","c"
"OIC-226-14-B","{""question"": ""What is the recommended minimum duration of anticoagulant treatment for proximal Deep Vein Thrombosis (DVT) or pulmonary embolism (PE)?"", ""option_a"": ""1 month"", ""option_b"": ""3 months"", ""option_c"": ""6 months"", ""option_d"": ""12 months"", ""correct_option"": ""B""}",,"What is the recommended minimum duration of anticoagulant treatment for proximal Deep Vein Thrombosis (DVT) or pulmonary embolism (PE)?","1 month","3 months","6 months","12 months","b"
"OIC-226-15-B","{""question"": ""What is the initial step in assessing the need for cancer screening in patients with deep vein thrombosis or pulmonary embolism?"", ""option_a"": ""Ordering a full-body CT scan to rule out any potential cancers"", ""option_b"": ""Conducting a thorough clinical examination and reviewing routine biological test results"", ""option_c"": ""Referring the patient to an oncologist for further evaluation"", ""option_d"": ""Performing a PSA test on all patients regardless of gender"", ""correct_option"": ""B""}","Etiologies","What is the initial step in assessing the need for cancer screening in patients with deep vein thrombosis or pulmonary embolism?","Ordering a full-body CT scan to rule out any potential cancers","Conducting a thorough clinical examination and reviewing routine biological test results","Referring the patient to an oncologist for further evaluation","Performing a PSA test on all patients regardless of gender","b"
"OIC-226-16-B","{""question"": ""What is a common long-term complication of deep vein thrombosis (DVT) that can occur despite well-managed treatment?"", ""option_a"": ""Post-embolic pulmonary hypertension (PH)"", ""option_b"": ""Post-thrombotic syndrome (PTS)"", ""option_c"": ""Right heart failure due to pulmonary embolism (PE)"", ""option_d"": ""Left heart failure due to atrial fibrillation"", ""correct_option"": ""B""}",,"What is a common long-term complication of deep vein thrombosis (DVT) that can occur despite well-managed treatment?","Post-embolic pulmonary hypertension (PH)","Post-thrombotic syndrome (PTS)","Right heart failure due to pulmonary embolism (PE)","Left heart failure due to atrial fibrillation","b"
"OIC-226-17-B","{""question"": ""Before stopping anticoagulant treatment for pulmonary embolism (PE), what complication should be detected in case of dyspnoea?"", ""option_a"": ""Post-embolic pulmonary hypertension (PH) using a chest X-ray"", ""option_b"": ""Post-embolic pulmonary hypertension (PH) using a transthoracic Doppler cardiac ultrasound"", ""option_c"": ""Deep vein thrombosis using a D-dimer test"", ""option_d"": ""Pulmonary embolism recurrence using a CT scan"", ""correct_option"": ""B""}",,"Before stopping anticoagulant treatment for pulmonary embolism (PE), what complication should be detected in case of dyspnoea?","Post-embolic pulmonary hypertension (PH) using a chest X-ray","Post-embolic pulmonary hypertension (PH) using a transthoracic Doppler cardiac ultrasound","Deep vein thrombosis using a D-dimer test","Pulmonary embolism recurrence using a CT scan","b"
"OIC-226-18-B","{""question"": ""What is the primary purpose of performing a venous Doppler ultrasound of the lower limbs in a patient with suspected superficial venous thrombosis?"", ""option_a"": ""To assess the need for anticoagulant treatment"", ""option_b"": ""To confirm the diagnosis, estimate the extent of thrombosis, and exclude associated DVT"", ""option_c"": ""To evaluate the effectiveness of elastic compression"", ""option_d"": ""To determine the optimal timing for varicose vein treatment"", ""correct_option"": ""B""}",,"What is the primary purpose of performing a venous Doppler ultrasound of the lower limbs in a patient with suspected superficial venous thrombosis?","To assess the need for anticoagulant treatment","To confirm the diagnosis, estimate the extent of thrombosis, and exclude associated DVT","To evaluate the effectiveness of elastic compression","To determine the optimal timing for varicose vein treatment","b"
"OIC-227-01-A","{""question"": ""What is the primary cause of chronic venous insufficiency (CVI)?"", ""option_a"": ""Valvular incontinence with or without associated venous obliteration"", ""option_b"": ""Permanent dilatation of superficial veins in the upper limbs"", ""option_c"": ""Stasis of venous blood in the hands due to gravitational forces"", ""option_d"": ""Atherosclerosis of the arterial system"", ""correct_option"": ""A""}","Definition","What is the primary cause of chronic venous insufficiency (CVI)?","Valvular incontinence with or without associated venous obliteration","Permanent dilatation of superficial veins in the upper limbs","Stasis of venous blood in the hands due to gravitational forces","Atherosclerosis of the arterial system","a"
"OIC-227-02-B","{""question"": ""What is the primary mechanism ensuring venous return in the lower limbs?"", ""option_a"": ""Contraction of the heart's ventricles"", ""option_b"": ""Synergy of suction and propulsion forces aided by centripetal and unidirectional venous valves"", ""option_c"": ""Orthostatic pressure due to gravity"", ""option_d"": ""Left ventricular perfusion pressure alone"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism ensuring venous return in the lower limbs?","Contraction of the heart's ventricles","Synergy of suction and propulsion forces aided by centripetal and unidirectional venous valves","Orthostatic pressure due to gravity","Left ventricular perfusion pressure alone","b"
"OIC-227-03-A","{""question"": ""What is the primary method used to assess the severity of post-thrombotic syndrome (PTS)?"", ""option_a"": ""Clinical evaluation of venous reflux"", ""option_b"": ""Villalta score based on subjective and objective clinical signs of venous insufficiency"", ""option_c"": ""Measurement of valve destruction extent"", ""option_d"": ""Residual venous obstruction assessment"", ""correct_option"": ""B""}","Definition","What is the primary method used to assess the severity of post-thrombotic syndrome (PTS)?","Clinical evaluation of venous reflux","Villalta score based on subjective and objective clinical signs of venous insufficiency","Measurement of valve destruction extent","Residual venous obstruction assessment","b"
"OIC-227-04-B","{""question"": ""What is the most common aetiology of chronic venous insufficiency (CVI)?"", ""option_a"": ""Primary deep valve insufficiency"", ""option_b"": ""Post-thrombotic syndrome (PTS)"", ""option_c"": ""Varicose disease or essential varicose veins"", ""option_d"": ""Functional venous insufficiency"", ""correct_option"": ""C""}","Etiologies","What is the most common aetiology of chronic venous insufficiency (CVI)?","Primary deep valve insufficiency","Post-thrombotic syndrome (PTS)","Varicose disease or essential varicose veins","Functional venous insufficiency","c"
"OIC-227-05-A","{""question"": ""What is a major factor that contributes to the development of chronic venous insufficiency and varicose veins?"", ""option_a"": ""Sedentary lifestyle"", ""option_b"": ""Heredity"", ""option_c"": ""Exposure to cold"", ""option_d"": ""Low body mass index"", ""correct_option"": ""B""}","Etiologies","What is a major factor that contributes to the development of chronic venous insufficiency and varicose veins?","Sedentary lifestyle","Heredity","Exposure to cold","Low body mass index","b"
"OIC-227-06-B","{""question"": ""What is the estimated overall prevalence of chronic venous insufficiency in industrialised countries?"", ""option_a"": ""Between 10% and 20%"", ""option_b"": ""Between 30% and 60%"", ""option_c"": ""Between 60% and 80%"", ""option_d"": ""Between 80% and 90%"", ""correct_option"": ""B""}","Epidemiology","What is the estimated overall prevalence of chronic venous insufficiency in industrialised countries?","Between 10% and 20%","Between 30% and 60%","Between 60% and 80%","Between 80% and 90%","b"
"OIC-227-07-A","{""question"": ""What is the primary symptom of chronic venous insufficiency (CVI) that occurs in the calves or legs?"", ""option_a"": ""Painful vein pathway or phlebalgia"", ""option_b"": ""Intermittent venous claudication"", ""option_c"": ""Pain or heaviness in the lower limbs"", ""option_d"": ""Nocturnal impatience"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary symptom of chronic venous insufficiency (CVI) that occurs in the calves or legs?","Painful vein pathway or phlebalgia","Intermittent venous claudication","Pain or heaviness in the lower limbs","Nocturnal impatience","c"
"OIC-227-08-A","{""question"": ""What is a characteristic feature of a varicose ulcer?"", ""option_a"": ""Deep, digging appearance"", ""option_b"": ""Peri-malleolar location"", ""option_c"": ""Typically small in size"", ""option_d"": ""Usually found on the hands"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic feature of a varicose ulcer?","Deep, digging appearance","Peri-malleolar location","Typically small in size","Usually found on the hands","b"
"OIC-227-09-A","{""question"": ""What is the primary position of the patient during the clinical examination for Chronic Venous Insufficiency (CVI)?"", ""option_a"": ""Sitting position"", ""option_b"": ""Lying down position"", ""option_c"": ""Standing position"", ""option_d"": ""Kneeling position"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary position of the patient during the clinical examination for Chronic Venous Insufficiency (CVI)?","Sitting position","Lying down position","Standing position","Kneeling position","c"
"OIC-227-10-B","{""question"": ""What is the primary purpose of elastic compression in the management of chronic venous insufficiency?"", ""option_a"": ""To increase venous pressure and reduce blood flow to the affected limb"", ""option_b"": ""To apply pressure to a segment of the limb and decrease venous hyperpressure"", ""option_c"": ""To promote blood flow to the affected limb through the use of heat therapy"", ""option_d"": ""To reduce the diameter of varicose veins through the use of sclerotherapy"", ""correct_option"": ""B""}","Management","What is the primary purpose of elastic compression in the management of chronic venous insufficiency?","To increase venous pressure and reduce blood flow to the affected limb","To apply pressure to a segment of the limb and decrease venous hyperpressure","To promote blood flow to the affected limb through the use of heat therapy","To reduce the diameter of varicose veins through the use of sclerotherapy","b"
"OIC-229-01-A","{""question"": ""What is the primary distinction between central and peripheral venous access?"", ""option_a"": ""The material used for the catheter"", ""option_b"": ""The location of the insertion site"", ""option_c"": ""The rate of fluid administration"", ""option_d"": ""The type of medication administered"", ""correct_option"": ""B""}","Definition","What is the primary distinction between central and peripheral venous access?","The material used for the catheter","The location of the insertion site","The rate of fluid administration","The type of medication administered","b"
"OIC-229-02-A","{""question"": ""What are the main categories of complications associated with both peripheral and central venous accesses?"", ""option_a"": ""Infectious, thrombotic, and mechanical"", ""option_b"": ""Infectious, thrombotic, mechanical, haemorrhagic, and embolic"", ""option_c"": ""Haemorrhagic, embolic, and mechanical"", ""option_d"": ""Thrombotic, haemorrhagic, and respiratory"", ""correct_option"": ""B""}","Definition","What are the main categories of complications associated with both peripheral and central venous accesses?","Infectious, thrombotic, and mechanical","Infectious, thrombotic, mechanical, haemorrhagic, and embolic","Haemorrhagic, embolic, and mechanical","Thrombotic, haemorrhagic, and respiratory","b"
"OIC-229-03-A","{""question"": ""What is the primary purpose of monitoring a peripheral venous line after insertion?"", ""option_a"": ""To assess the patient's overall cardiovascular health"", ""option_b"": ""To check for signs of infection or complications at the insertion site"", ""option_c"": ""To evaluate the effectiveness of the medication being administered"", ""option_d"": ""To determine the patient's blood type"", ""correct_option"": ""B""}",,"What is the primary purpose of monitoring a peripheral venous line after insertion?","To assess the patient's overall cardiovascular health","To check for signs of infection or complications at the insertion site","To evaluate the effectiveness of the medication being administered","To determine the patient's blood type","b"
"OIC-229-04-A","{""question"": ""What is the primary reason for removing venous ports as soon as possible?"", ""option_a"": ""To reduce the risk of mechanical complications"", ""option_b"": ""To limit the risk of iatrogenicity"", ""option_c"": ""To prevent thrombotic complications"", ""option_d"": ""To minimize the risk of hemorrhagic complications"", ""correct_option"": ""B""}",,"What is the primary reason for removing venous ports as soon as possible?","To reduce the risk of mechanical complications","To limit the risk of iatrogenicity","To prevent thrombotic complications","To minimize the risk of hemorrhagic complications","b"
"OIC-229-05-A","{""question"": ""What is the recommended position for a conscious non-ventilated patient when removing a central venous line from the superior vena cava to minimize the risk of gas embolism?"", ""option_a"": ""Sitting up with the head elevated"", ""option_b"": ""Supine position, breathing normally"", ""option_c"": ""Supine position, holding their breath or breathing out"", ""option_d"": ""Standing with the affected arm elevated"", ""correct_option"": ""C""}",,"What is the recommended position for a conscious non-ventilated patient when removing a central venous line from the superior vena cava to minimize the risk of gas embolism?","Sitting up with the head elevated","Supine position, breathing normally","Supine position, holding their breath or breathing out","Standing with the affected arm elevated","c"
"OIC-229-06-B","{""question"": ""What is the primary purpose of knowing the conditions for inserting a central venous line?"", ""option_a"": ""To reduce the risk of complications during the insertion procedure"", ""option_b"": ""To increase the flow rate of fluids and medications administered through the line"", ""option_c"": ""To determine the optimal location for peripheral venous access"", ""option_d"": ""To assess the patient's overall health status prior to surgery"", ""correct_option"": ""A""}",,"What is the primary purpose of knowing the conditions for inserting a central venous line?","To reduce the risk of complications during the insertion procedure","To increase the flow rate of fluids and medications administered through the line","To determine the optimal location for peripheral venous access","To assess the patient's overall health status prior to surgery","a"
"OIC-229-07-B","{""question"": ""What is the primary approach when signs of infection are observed in a venous line?"", ""option_a"": ""Immediately start antibiotic therapy without removing the catheter"", ""option_b"": ""Remove the equipment and culture the catheter, considering antibiotic therapy based on the symptoms"", ""option_c"": ""Leave the catheter in place and start anticoagulation therapy"", ""option_d"": ""Take blood cultures but do not remove the catheter unless absolutely necessary"", ""correct_option"": ""B""}","Management","What is the primary approach when signs of infection are observed in a venous line?","Immediately start antibiotic therapy without removing the catheter","Remove the equipment and culture the catheter, considering antibiotic therapy based on the symptoms","Leave the catheter in place and start anticoagulation therapy","Take blood cultures but do not remove the catheter unless absolutely necessary","b"
"OIC-230-01-A","{""question"": ""What is the definition of acute chest pain?"", ""option_a"": ""Pain in the region of the rib cage that occurs gradually over time"", ""option_b"": ""Pain or discomfort in the region of the rib cage occurring suddenly"", ""option_c"": ""Pain in the abdominal region below the umbilicus"", ""option_d"": ""Chronic pain in the neck and shoulder region"", ""correct_option"": ""B""}","Definition","What is the definition of acute chest pain?","Pain in the region of the rib cage that occurs gradually over time","Pain or discomfort in the region of the rib cage occurring suddenly","Pain in the abdominal region below the umbilicus","Chronic pain in the neck and shoulder region","b"
"OIC-230-02-A","{""question"": ""What are the signs of vital distress that should be looked for in a patient presenting with acute chest pain?"", ""option_a"": ""Only acute respiratory distress"", ""option_b"": ""Acute respiratory distress, haemodynamic distress, and neurological distress"", ""option_c"": ""Haemodynamic distress and neurological distress, but not acute respiratory distress"", ""option_d"": ""Only haemodynamic distress"", ""correct_option"": ""B""}","Identification of the emergency","What are the signs of vital distress that should be looked for in a patient presenting with acute chest pain?","Only acute respiratory distress","Acute respiratory distress, haemodynamic distress, and neurological distress","Haemodynamic distress and neurological distress, but not acute respiratory distress","Only haemodynamic distress","b"
"OIC-230-04-A","{""question"": ""What are the four cardiovascular emergencies that can cause chest pain?"", ""option_a"": ""Aortic dissection, acute coronary syndrome, pericarditis, and myocarditis"", ""option_b"": ""Aortic dissection, acute coronary syndrome, pulmonary embolism, and pericarditis with tamponade"", ""option_c"": ""Aortic dissection, acute coronary syndrome, cardiac arrhythmia, and pulmonary embolism"", ""option_d"": ""Aortic dissection, myocardial infarction, pericarditis, and cardiomyopathy"", ""correct_option"": ""B""}","Positive diagnosis","What are the four cardiovascular emergencies that can cause chest pain?","Aortic dissection, acute coronary syndrome, pericarditis, and myocarditis","Aortic dissection, acute coronary syndrome, pulmonary embolism, and pericarditis with tamponade","Aortic dissection, acute coronary syndrome, cardiac arrhythmia, and pulmonary embolism","Aortic dissection, myocardial infarction, pericarditis, and cardiomyopathy","b"
"OIC-230-05-A","{""question"": ""What is a characteristic physical symptom of aortic dissection?"", ""option_a"": ""Symmetric blood pressure in both arms"", ""option_b"": ""Asymmetric blood pressure (difference >20 mmHg) between arms"", ""option_c"": ""Presence of all major pulses (radial, femoral, popliteal) with normal intensity"", ""option_d"": ""Murmur of mitral stenosis"", ""correct_option"": ""B""}",,"What is a characteristic physical symptom of aortic dissection?","Symmetric blood pressure in both arms","Asymmetric blood pressure (difference >20 mmHg) between arms","Presence of all major pulses (radial, femoral, popliteal) with normal intensity","Murmur of mitral stenosis","b"
"OIC-230-06-A","{""question"": ""What is the first step in the diagnostic approach to the four cardiovascular emergencies?"", ""option_a"": ""Performing an ECG and interpreting the results"", ""option_b"": ""Conducting a clinical examination to identify specific features"", ""option_c"": ""Gathering information about the patient's medical history and characteristics of the pain through anamnesis"", ""option_d"": ""Looking for signs of shock or vital distress"", ""correct_option"": ""C""}","Positive diagnosis","What is the first step in the diagnostic approach to the four cardiovascular emergencies?","Performing an ECG and interpreting the results","Conducting a clinical examination to identify specific features","Gathering information about the patient's medical history and characteristics of the pain through anamnesis","Looking for signs of shock or vital distress","c"
"OIC-230-07-A","{""question"": ""What is the characteristic electrocardiographic abnormality for acute coronary syndrome with ST-segment elevation?"", ""option_a"": ""ST elevation \u2265 1 mm in precordial and \u2265 0.5 mm in inferior and high lateral leads"", ""option_b"": ""ST elevation \u2265 2 mm in precordial and \u2265 1 mm in inferior and high lateral leads, in at least 2 contiguous leads of the same coronary territory"", ""option_c"": ""Negative T waves in at least 2 contiguous leads of the same coronary territory"", ""option_d"": ""Diffuse ST segment elevation without mirror, without Q wave, and concave upward ST segment elevation"", ""correct_option"": ""B""}","Additional examinations","What is the characteristic electrocardiographic abnormality for acute coronary syndrome with ST-segment elevation?","ST elevation ≥ 1 mm in precordial and ≥ 0.5 mm in inferior and high lateral leads","ST elevation ≥ 2 mm in precordial and ≥ 1 mm in inferior and high lateral leads, in at least 2 contiguous leads of the same coronary territory","Negative T waves in at least 2 contiguous leads of the same coronary territory","Diffuse ST segment elevation without mirror, without Q wave, and concave upward ST segment elevation","b"
"OIC-230-08-A","{""question"": ""What is the typical finding on a chest X-ray in a patient with aortic dissection?"", ""option_a"": ""Cardiomegaly with heart in decanter"", ""option_b"": ""Widening of the mediastinum, double aortic contour"", ""option_c"": ""Pulmonary hyperclarity, ascension of a diaphragmatic cupola"", ""option_d"": ""Normal radiograph with no abnormalities"", ""correct_option"": ""B""}","Additional examinations","What is the typical finding on a chest X-ray in a patient with aortic dissection?","Cardiomegaly with heart in decanter","Widening of the mediastinum, double aortic contour","Pulmonary hyperclarity, ascension of a diaphragmatic cupola","Normal radiograph with no abnormalities","b"
"OIC-230-09-A","{""question"": ""What is the primary purpose of measuring ultrasensitive troponins in patients with suspected cardiovascular emergencies?"", ""option_a"": ""To confirm the diagnosis of acute pericarditis"", ""option_b"": ""To rule out pulmonary embolism"", ""option_c"": ""To detect elevation of cardiac enzymes in acute coronary syndrome (ACS)"", ""option_d"": ""To assess the severity of aortic dissection"", ""correct_option"": ""C""}","Additional tests","What is the primary purpose of measuring ultrasensitive troponins in patients with suspected cardiovascular emergencies?","To confirm the diagnosis of acute pericarditis","To rule out pulmonary embolism","To detect elevation of cardiac enzymes in acute coronary syndrome (ACS)","To assess the severity of aortic dissection","c"
"OIC-230-10-B","{""question"": ""What is the recommended timeframe for performing primary angioplasty in patients with ST+ acute coronary syndrome?"", ""option_a"": ""Within 24 hours of symptom onset"", ""option_b"": ""Within 120 minutes of diagnosis"", ""option_c"": ""Within 12 hours of ECG diagnosis"", ""option_d"": ""Within 48 hours of symptom onset"", ""correct_option"": ""B""}",,"What is the recommended timeframe for performing primary angioplasty in patients with ST+ acute coronary syndrome?","Within 24 hours of symptom onset","Within 120 minutes of diagnosis","Within 12 hours of ECG diagnosis","Within 48 hours of symptom onset","b"
"OIC-230-11-B","{""question"": ""What is the most appropriate initial examination for a haemodynamically unstable patient suspected of having an aortic dissection?"", ""option_a"": ""Thoracic computed tomography (CT) scan"", ""option_b"": ""Trans-oesophageal echocardiography (TEE)"", ""option_c"": ""Trans-thoracic echocardiography (TTE)"", ""option_d"": ""Magnetic resonance imaging (MRI) of the aorta"", ""correct_option"": ""C""}","Additional examinations","What is the most appropriate initial examination for a haemodynamically unstable patient suspected of having an aortic dissection?","Thoracic computed tomography (CT) scan","Trans-oesophageal echocardiography (TEE)","Trans-thoracic echocardiography (TTE)","Magnetic resonance imaging (MRI) of the aorta","c"
"OIC-230-12-B","{""question"": ""What is a common cause of functional angina in the context of exertional angina?"", ""option_a"": ""Tight mitral stenosis"", ""option_b"": ""Tight aortic stenosis"", ""option_c"": ""Hypertrophic cardiomyopathy with a normal ejection fraction"", ""option_d"": ""Chronic obstructive pulmonary disease (COPD)"", ""correct_option"": ""B""}","Etiologies","What is a common cause of functional angina in the context of exertional angina?","Tight mitral stenosis","Tight aortic stenosis","Hypertrophic cardiomyopathy with a normal ejection fraction","Chronic obstructive pulmonary disease (COPD)","b"
"OIC-230-13-A","{""question"": ""What is a common infectious cause of acute chest pain outside of cardiovascular emergencies?"", ""option_a"": ""Pleural effusion"", ""option_b"": ""Infectious pneumopathy"", ""option_c"": ""Musculoskeletal parietal pain"", ""option_d"": ""Rib fractures due to trauma"", ""correct_option"": ""B""}","Etiologies","What is a common infectious cause of acute chest pain outside of cardiovascular emergencies?","Pleural effusion","Infectious pneumopathy","Musculoskeletal parietal pain","Rib fractures due to trauma","b"
"OIC-230-14-A","{""question"": ""What is a common extra-thoracic cause of chest pain that involves the stomach?"", ""option_a"": ""Pancreatitis"", ""option_b"": ""Cholecystitis"", ""option_c"": ""Peptic ulcer"", ""option_d"": ""Pneumonia"", ""correct_option"": ""C""}","Etiologies","What is a common extra-thoracic cause of chest pain that involves the stomach?","Pancreatitis","Cholecystitis","Peptic ulcer","Pneumonia","c"
"OIC-233-01-A","{""question"": ""What is the definition of mitral insufficiency (MI)?"", ""option_a"": ""Dysfunction of the mitral valve with limited opening, resulting in an obstacle to systolic ejection from the left ventricle (LV)"", ""option_b"": ""Dysfunction of the mitral valve with systolic closure defect resulting in regurgitation of blood from the left ventricle (LV) into the left atrium (LA) during systole"", ""option_c"": ""Dysfunction of the aortic valve with closure defect in diastole resulting in regurgitation of blood from the aorta into the LV in diastole"", ""option_d"": ""Dysfunction of the mitral valve with limited opening in diastole, resulting in an obstacle to the flow of blood from the left atrium (LA) to the left ventricle (LV) at the time of cardiac filling"", ""correct_option"": ""B""}","Definition","What is the definition of mitral insufficiency (MI)?","Dysfunction of the mitral valve with limited opening, resulting in an obstacle to systolic ejection from the left ventricle (LV)","Dysfunction of the mitral valve with systolic closure defect resulting in regurgitation of blood from the left ventricle (LV) into the left atrium (LA) during systole","Dysfunction of the aortic valve with closure defect in diastole resulting in regurgitation of blood from the aorta into the LV in diastole","Dysfunction of the mitral valve with limited opening in diastole, resulting in an obstacle to the flow of blood from the left atrium (LA) to the left ventricle (LV) at the time of cardiac filling","b"
"OIC-233-02-B","{""question"": ""What is the primary mechanism of mitral insufficiency Type II according to the Carpentier classification?"", ""option_a"": ""Closure in the plane of the annulus with normal valve movement"", ""option_b"": ""Closure of the leaflets beyond the plane of the annulus due to prolapse or rupture of cordage"", ""option_c"": ""Closure of the leaflets downstream of the plane of the annulus towards the LV with restriction of movement"", ""option_d"": ""Commissural fusion and lesions of the subvalvular apparatus"", ""correct_option"": ""B""}",,"What is the primary mechanism of mitral insufficiency Type II according to the Carpentier classification?","Closure in the plane of the annulus with normal valve movement","Closure of the leaflets beyond the plane of the annulus due to prolapse or rupture of cordage","Closure of the leaflets downstream of the plane of the annulus towards the LV with restriction of movement","Commissural fusion and lesions of the subvalvular apparatus","b"
"OIC-233-03-A","{""question"": ""What is the most common cause of mitral narrowing?"", ""option_a"": ""Degenerative valve disease"", ""option_b"": ""Post-rheumatic valve disease"", ""option_c"": ""Infectious endocarditis"", ""option_d"": ""Congenital valve disease"", ""correct_option"": ""B""}","Etiologies","What is the most common cause of mitral narrowing?","Degenerative valve disease","Post-rheumatic valve disease","Infectious endocarditis","Congenital valve disease","b"
"OIC-233-04-A","{""question"": ""What is the characteristic auscultation finding in a patient with severe mitral insufficiency?"", ""option_a"": ""Raspy, meso-systolic murmur radiating to the carotid arteries"", ""option_b"": ""Soft, steam-jet murmur, holosystolic if severe, predominant at the mitral focus, radiating into the left axilla"", ""option_c"": ""Protodiastolic murmur, soft, aspirative, aortic focus radiating along the left edge of the sternum"", ""option_d"": ""Mitral focus diastolic rolling, B1 burst if valve is flexible, B2 splitting if PAH"", ""correct_option"": ""B""}",,"What is the characteristic auscultation finding in a patient with severe mitral insufficiency?","Raspy, meso-systolic murmur radiating to the carotid arteries","Soft, steam-jet murmur, holosystolic if severe, predominant at the mitral focus, radiating into the left axilla","Protodiastolic murmur, soft, aspirative, aortic focus radiating along the left edge of the sternum","Mitral focus diastolic rolling, B1 burst if valve is flexible, B2 splitting if PAH","b"
"OIC-233-05-B","{""question"": ""What is the primary limitation of electrocardiogram (ECG) and chest X-ray in the diagnosis of valvulopathy?"", ""option_a"": ""They are too sensitive and detect minor issues"", ""option_b"": ""They are not very specific and are of limited value in early diagnosis"", ""option_c"": ""They are only useful for diagnosing severe cases"", ""option_d"": ""They are invasive tests that pose a risk to patients"", ""correct_option"": ""B""}","Additional tests","What is the primary limitation of electrocardiogram (ECG) and chest X-ray in the diagnosis of valvulopathy?","They are too sensitive and detect minor issues","They are not very specific and are of limited value in early diagnosis","They are only useful for diagnosing severe cases","They are invasive tests that pose a risk to patients","b"
"OIC-233-06-A","{""question"": ""What is the primary value of echocardiography in the diagnosis of valvular heart diseases such as Mitral Insufficiency (MI), Mitral Regurgitation (MR), Aortic Insufficiency (IA), and Aortic Regurgitation (AR)?"", ""option_a"": ""To assess only the severity of the valve disease"", ""option_b"": ""To confirm the diagnosis, assess the severity, determine the aetiology, and evaluate the impact of the disease"", ""option_c"": ""To identify other cardiac conditions unrelated to valvular heart disease"", ""option_d"": ""To provide a treatment plan for the valve disease without the need for further testing"", ""correct_option"": ""B""}",,"What is the primary value of echocardiography in the diagnosis of valvular heart diseases such as Mitral Insufficiency (MI), Mitral Regurgitation (MR), Aortic Insufficiency (IA), and Aortic Regurgitation (AR)?","To assess only the severity of the valve disease","To confirm the diagnosis, assess the severity, determine the aetiology, and evaluate the impact of the disease","To identify other cardiac conditions unrelated to valvular heart disease","To provide a treatment plan for the valve disease without the need for further testing","b"
"OIC-233-07-B","{""question"": ""What is the average rate of reduction in aortic surface area per year in patients with aortic stenosis?"", ""option_a"": ""0.05 cm^2/year"", ""option_b"": ""0.1 cm^2/year"", ""option_c"": ""0.5 cm^2/year"", ""option_d"": ""1.0 cm^2/year"", ""correct_option"": ""B""}",,"What is the average rate of reduction in aortic surface area per year in patients with aortic stenosis?","0.05 cm^2/year","0.1 cm^2/year","0.5 cm^2/year","1.0 cm^2/year","b"
"OIC-233-08-B","{""question"": ""What is the preferred surgical treatment for mitral insufficiency if feasible?"", ""option_a"": ""Aortic valve replacement with mechanical or biological prosthesis"", ""option_b"": ""Mitral valve replacement by mechanical or biological prosthesis"", ""option_c"": ""Mitral plastic surgery"", ""option_d"": ""Ascending aortic replacement using the Bentall procedure"", ""correct_option"": ""C""}",,"What is the preferred surgical treatment for mitral insufficiency if feasible?","Aortic valve replacement with mechanical or biological prosthesis","Mitral valve replacement by mechanical or biological prosthesis","Mitral plastic surgery","Ascending aortic replacement using the Bentall procedure","c"
"OIC-233-09-B","{""question"": ""What is the principle of percutaneous treatment for mitral insufficiency?"", ""option_a"": ""Percutaneous aortic bioprosthesis implantation"", ""option_b"": ""Percutaneous mitral repair using Mitraclip"", ""option_c"": ""Aortic balloon valvuloplasty"", ""option_d"": ""Percutaneous commissurotomy"", ""correct_option"": ""B""}",,"What is the principle of percutaneous treatment for mitral insufficiency?","Percutaneous aortic bioprosthesis implantation","Percutaneous mitral repair using Mitraclip","Aortic balloon valvuloplasty","Percutaneous commissurotomy","b"
"OIC-233-10-B","{""question"": ""What is the primary indication for surgical treatment of severe chronic mitral insufficiency?"", ""option_a"": ""Asymptomatic patients with LVEF > 60% and no LV damage"", ""option_b"": ""Symptomatic patients with LVEF > 30% and feasible mitral plasty"", ""option_c"": ""Asymptomatic patients with LVEF > 50% and significant LVH"", ""option_d"": ""Patients with acute poorly tolerated mitral insufficiency"", ""correct_option"": ""B""}",,"What is the primary indication for surgical treatment of severe chronic mitral insufficiency?","Asymptomatic patients with LVEF > 60% and no LV damage","Symptomatic patients with LVEF > 30% and feasible mitral plasty","Asymptomatic patients with LVEF > 50% and significant LVH","Patients with acute poorly tolerated mitral insufficiency","b"
"OIC-233-11-B","{""question"": ""What is the primary indication for Mitraclip in patients with organic Mitral Insufficiency (MI)?"", ""option_a"": ""Patients with a life expectancy of < 1 year"", ""option_b"": ""Patients contraindicated for surgery or at high surgical risk"", ""option_c"": ""Patients with a left ventricular ejection fraction (LVEF) > 50%"", ""option_d"": ""Patients with minimal symptoms and no history of heart failure"", ""correct_option"": ""B""}",,"What is the primary indication for Mitraclip in patients with organic Mitral Insufficiency (MI)?","Patients with a life expectancy of < 1 year","Patients contraindicated for surgery or at high surgical risk","Patients with a left ventricular ejection fraction (LVEF) > 50%","Patients with minimal symptoms and no history of heart failure","b"
"OIC-233-12-B","{""question"": ""In the medical treatment of aortic insufficiency (AI), what is the recommended pharmacological treatment for a patient with Marfan's disease or dilatation of the ascending aorta?"", ""option_a"": ""ACE inhibitors alone"", ""option_b"": ""Beta-blockers or ARB 2 (Losartan) to slow down the dilatation of the aorta"", ""option_c"": ""Diuretics alone"", ""option_d"": ""Pharmacological treatment is not indicated in Marfan's disease"", ""correct_option"": ""B""}",,"In the medical treatment of aortic insufficiency (AI), what is the recommended pharmacological treatment for a patient with Marfan's disease or dilatation of the ascending aorta?","ACE inhibitors alone","Beta-blockers or ARB 2 (Losartan) to slow down the dilatation of the aorta","Diuretics alone","Pharmacological treatment is not indicated in Marfan's disease","b"
"OIC-234-01-B","{""question"": ""What is the average age of individuals with heart failure?"", ""option_a"": ""50-60 years"", ""option_b"": ""60-70 years"", ""option_c"": ""70-80 years"", ""option_d"": ""80-90 years"", ""correct_option"": ""C""}","Epidemiology","What is the average age of individuals with heart failure?","50-60 years","60-70 years","70-80 years","80-90 years","c"
"OIC-234-02-A","{""question"": ""What is the primary cause of diastolic heart failure or heart failure with preserved ejection fraction (LVEF \u226550%)?"", ""option_a"": ""Failure of myocardial contraction"", ""option_b"": ""Failure to fill the left ventricle (relaxation compliance)"", ""option_c"": ""Elevated level of natriuretic peptide"", ""option_d"": ""Structural and/or functional cardiac anomaly"", ""correct_option"": ""B""}","Definition","What is the primary cause of diastolic heart failure or heart failure with preserved ejection fraction (LVEF ≥50%)?","Failure of myocardial contraction","Failure to fill the left ventricle (relaxation compliance)","Elevated level of natriuretic peptide","Structural and/or functional cardiac anomaly","b"
"OIC-234-03-A","{""question"": ""What is the primary cause of cardiogenic acute pulmonary oedema (PAO)?"", ""option_a"": ""Right heart failure leading to obstructive pulmonary oedema"", ""option_b"": ""Left heart failure leading to transudative pulmonary oedema"", ""option_c"": ""Sudden onset of acute respiratory distress due to pulmonary embolism"", ""option_d"": ""Chronic increase in left ventricular filling pressure due to hypertension"", ""correct_option"": ""B""}","Definition","What is the primary cause of cardiogenic acute pulmonary oedema (PAO)?","Right heart failure leading to obstructive pulmonary oedema","Left heart failure leading to transudative pulmonary oedema","Sudden onset of acute respiratory distress due to pulmonary embolism","Chronic increase in left ventricular filling pressure due to hypertension","b"
"OIC-234-04-A","{""question"": ""What is the primary characteristic of cardiogenic shock?"", ""option_a"": ""A gradual decrease in cardiac function over time"", ""option_b"": ""The inability of the heart to generate sufficient blood flow to meet the metabolic needs of peripheral organs"", ""option_c"": ""A condition where the heart's electrical system is disrupted, leading to arrhythmias"", ""option_d"": ""A type of heart failure that only affects the right side of the heart"", ""correct_option"": ""B""}","Definition","What is the primary characteristic of cardiogenic shock?","A gradual decrease in cardiac function over time","The inability of the heart to generate sufficient blood flow to meet the metabolic needs of peripheral organs","A condition where the heart's electrical system is disrupted, leading to arrhythmias","A type of heart failure that only affects the right side of the heart","b"
"OIC-234-05-B","{""question"": ""What is the primary factor that determines the systolic ejection volume in the context of left heart failure?"", ""option_a"": ""Intrinsic cardiac properties, such as inotropy and compliance"", ""option_b"": ""Ventricular loading conditions, including preload and afterload"", ""option_c"": ""Heart rate and cardiac output"", ""option_d"": ""Both intrinsic cardiac properties and ventricular loading conditions"", ""correct_option"": ""D""}",,"What is the primary factor that determines the systolic ejection volume in the context of left heart failure?","Intrinsic cardiac properties, such as inotropy and compliance","Ventricular loading conditions, including preload and afterload","Heart rate and cardiac output","Both intrinsic cardiac properties and ventricular loading conditions","d"
"OIC-234-06-B","{""question"": ""What is the primary cause of lesional pulmonary oedema?"", ""option_a"": ""Sudden increase in pulmonary capillary wedge pressure"", ""option_b"": ""Damage to the alveolar-capillary membrane leading to increased permeability"", ""option_c"": ""Decrease in oncotic pressure"", ""option_d"": ""Chronic decrease in pulmonary capillary pressure"", ""correct_option"": ""B""}",,"What is the primary cause of lesional pulmonary oedema?","Sudden increase in pulmonary capillary wedge pressure","Damage to the alveolar-capillary membrane leading to increased permeability","Decrease in oncotic pressure","Chronic decrease in pulmonary capillary pressure","b"
"OIC-234-07-A","{""question"": ""A patient presents with acute respiratory failure and you are considering cardiogenic pulmonary artery occlusion (PAO) as a potential diagnosis. Which of the following symptoms would most strongly suggest a non-cardiogenic cause?"", ""option_a"": ""Fever"", ""option_b"": ""Coughing and expectoration"", ""option_c"": ""Hypotension"", ""option_d"": ""Tachycardia"", ""correct_option"": ""B""}","Positive diagnosis","A patient presents with acute respiratory failure and you are considering cardiogenic pulmonary artery occlusion (PAO) as a potential diagnosis. Which of the following symptoms would most strongly suggest a non-cardiogenic cause?","Fever","Coughing and expectoration","Hypotension","Tachycardia","b"
"OIC-234-08-B","{""question"": ""What is the threshold value for Left Ventricular Ejection Fraction (LVEF) to classify heart failure as having preserved LVEF?"", ""option_a"": ""LVEF \u2264 40%"", ""option_b"": ""LVEF \u2265 50%"", ""option_c"": ""LVEF \u2265 60%"", ""option_d"": ""LVEF \u2264 45%"", ""correct_option"": ""B""}",,"What is the threshold value for Left Ventricular Ejection Fraction (LVEF) to classify heart failure as having preserved LVEF?","LVEF ≤ 40%","LVEF ≥ 50%","LVEF ≥ 60%","LVEF ≤ 45%","b"
"OIC-234-09-A","{""question"": ""What is the primary symptom of heart failure that is most common on exertion but also the least specific?"", ""option_a"": ""Orthopnoea"", ""option_b"": ""Paroxysmal nocturnal dyspnoea"", ""option_c"": ""Dyspnoea"", ""option_d"": ""Jugular turgidity"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary symptom of heart failure that is most common on exertion but also the least specific?","Orthopnoea","Paroxysmal nocturnal dyspnoea","Dyspnoea","Jugular turgidity","c"
"OIC-234-10-B","{""question"": ""What is the primary purpose of prescribing a transthoracic echocardiography (TTE) in patients with congestive heart failure (CHF)?"", ""option_a"": ""To confirm the diagnosis of coronary artery disease"", ""option_b"": ""To assess the geometry and function of the left ventricle, measure LVEF value, and search for valvulopathy"", ""option_c"": ""To evaluate the severity of atrial fibrillation"", ""option_d"": ""To investigate the presence of haemochromatosis or martial deficiency"", ""correct_option"": ""B""}","Additional examinations","What is the primary purpose of prescribing a transthoracic echocardiography (TTE) in patients with congestive heart failure (CHF)?","To confirm the diagnosis of coronary artery disease","To assess the geometry and function of the left ventricle, measure LVEF value, and search for valvulopathy","To evaluate the severity of atrial fibrillation","To investigate the presence of haemochromatosis or martial deficiency","b"
"OIC-234-11-A","{""question"": ""What is the primary reason for ordering an ECG in a patient with suspected cardiogenic pulmonary artery occlusion?"", ""option_a"": ""To assess liver function"", ""option_b"": ""To evaluate the need for cardiac ultrasound"", ""option_c"": ""To identify potential cardiac arrhythmias or ischemia"", ""option_d"": ""To measure natriuretic peptide levels"", ""correct_option"": ""C""}","Additional tests","What is the primary reason for ordering an ECG in a patient with suspected cardiogenic pulmonary artery occlusion?","To assess liver function","To evaluate the need for cardiac ultrasound","To identify potential cardiac arrhythmias or ischemia","To measure natriuretic peptide levels","c"
"OIC-234-12-B","{""question"": ""In patients with acute dyspnea, what do normal values of BNP or NT-proBNP indicate?"", ""option_a"": ""A likely diagnosis of heart failure"", ""option_b"": ""An unlikely diagnosis of heart failure"", ""option_c"": ""The need for further testing with ARNI"", ""option_d"": ""The presence of renal insufficiency or atrial fibrillation"", ""correct_option"": ""B""}","Additional tests","In patients with acute dyspnea, what do normal values of BNP or NT-proBNP indicate?","A likely diagnosis of heart failure","An unlikely diagnosis of heart failure","The need for further testing with ARNI","The presence of renal insufficiency or atrial fibrillation","b"
"OIC-234-13-B","{""question"": ""What is one of the primary values of transthoracic echocardiography in the diagnosis of heart failure?"", ""option_a"": ""To solely diagnose coronary artery disease"", ""option_b"": ""To determine the aetiology and specify the mechanism of heart failure"", ""option_c"": ""To only measure filling pressures and monitor evolution"", ""option_d"": ""To exclusively assess the geometry and function of the right atrium"", ""correct_option"": ""B""}","Additional examinations","What is one of the primary values of transthoracic echocardiography in the diagnosis of heart failure?","To solely diagnose coronary artery disease","To determine the aetiology and specify the mechanism of heart failure","To only measure filling pressures and monitor evolution","To exclusively assess the geometry and function of the right atrium","b"
"OIC-234-14-A","{""question"": ""What is a characteristic radiological sign of pulmonary stasis with alveolo-interstitial syndrome?"", ""option_a"": ""Vascular redistribution from the apices to the bases"", ""option_b"": ""Vascular redistribution from the base to the apices"", ""option_c"": ""Interstitial oedema with Kerley's A lines"", ""option_d"": ""Alveolar oedema resulting in flaky opacities with clear outlines"", ""correct_option"": ""B""}","Additional examinations","What is a characteristic radiological sign of pulmonary stasis with alveolo-interstitial syndrome?","Vascular redistribution from the apices to the bases","Vascular redistribution from the base to the apices","Interstitial oedema with Kerley's A lines","Alveolar oedema resulting in flaky opacities with clear outlines","b"
"OIC-234-15-A","{""question"": ""What is the primary purpose of chest radiography in a patient with symptoms of acute lung oedema?"", ""option_a"": ""To assess the patient's cardiac function"", ""option_b"": ""To evaluate the severity of pulmonary oedema and guide haemodynamic management"", ""option_c"": ""To diagnose underlying conditions such as pneumonia or pneumothorax"", ""option_d"": ""To monitor the patient's response to diuretic therapy"", ""correct_option"": ""B""}","Multimedia content","What is the primary purpose of chest radiography in a patient with symptoms of acute lung oedema?","To assess the patient's cardiac function","To evaluate the severity of pulmonary oedema and guide haemodynamic management","To diagnose underlying conditions such as pneumonia or pneumothorax","To monitor the patient's response to diuretic therapy","b"
"OIC-234-16-A","{""question"": ""What is a common cause of heart failure with preserved ejection fraction?"", ""option_a"": ""Ischaemic heart disease"", ""option_b"": ""Hypertension"", ""option_c"": ""Valvular heart disease"", ""option_d"": ""Cardiomyopathy"", ""correct_option"": ""B""}","Etiologies","What is a common cause of heart failure with preserved ejection fraction?","Ischaemic heart disease","Hypertension","Valvular heart disease","Cardiomyopathy","b"
"OIC-234-17-A","{""question"": ""What is a characteristic sign of cardiogenic pulmonary edema (PAO) that distinguishes it from other respiratory distress causes?"", ""option_a"": ""Chronic onset of symptoms with gradual progression"", ""option_b"": ""Presence of fever and productive cough"", ""option_c"": ""Sudden onset of acute respiratory distress with superficial polypnoea and bilateral crackling rales"", ""option_d"": ""Isolated unilateral pleural effusion without other symptoms"", ""correct_option"": ""C""}","Emergency identification","What is a characteristic sign of cardiogenic pulmonary edema (PAO) that distinguishes it from other respiratory distress causes?","Chronic onset of symptoms with gradual progression","Presence of fever and productive cough","Sudden onset of acute respiratory distress with superficial polypnoea and bilateral crackling rales","Isolated unilateral pleural effusion without other symptoms","c"
"OIC-234-18-A","{""question"": ""What is the primary goal of oxygen therapy in the emergency treatment of cardiogenic pulmonary oedema?"", ""option_a"": ""To reduce the heart rate"", ""option_b"": ""To achieve a target SaO2 > 90%"", ""option_c"": ""To decrease blood pressure"", ""option_d"": ""To increase diuresis"", ""correct_option"": ""B""}","Management","What is the primary goal of oxygen therapy in the emergency treatment of cardiogenic pulmonary oedema?","To reduce the heart rate","To achieve a target SaO2 > 90%","To decrease blood pressure","To increase diuresis","b"
"OIC-234-19-A","{""question"": ""What is the primary goal of a low-salt diet in the context of adult heart failure management?"", ""option_a"": ""To completely eliminate salt from the diet"", ""option_b"": ""To limit salt intake to at least 5 to 6 g of salt a day"", ""option_c"": ""To reduce salt intake to less than 2 g a day"", ""option_d"": ""To increase salt intake to improve blood pressure"", ""correct_option"": ""B""}","Management","What is the primary goal of a low-salt diet in the context of adult heart failure management?","To completely eliminate salt from the diet","To limit salt intake to at least 5 to 6 g of salt a day","To reduce salt intake to less than 2 g a day","To increase salt intake to improve blood pressure","b"
"OIC-234-20-A","{""question"": ""What is the primary purpose of prescribing loop diuretics in the treatment of heart failure with reduced ejection fraction?"", ""option_a"": ""To reduce mortality and improve patient symptoms"", ""option_b"": ""To improve symptoms and control congestive signs, with a target of minimum effective dose"", ""option_c"": ""To reduce re-hospitalisation for heart failure and improve patients' quality of life"", ""option_d"": ""To increase cardiac output and improve exercise tolerance"", ""correct_option"": ""B""}","Management","What is the primary purpose of prescribing loop diuretics in the treatment of heart failure with reduced ejection fraction?","To reduce mortality and improve patient symptoms","To improve symptoms and control congestive signs, with a target of minimum effective dose","To reduce re-hospitalisation for heart failure and improve patients' quality of life","To increase cardiac output and improve exercise tolerance","b"
"OIC-234-21-B","{""question"": ""What is a common cause of sudden death in patients with heart failure?"", ""option_a"": ""Chronic refractory heart failure"", ""option_b"": ""Ventricular rhythm disturbances, such as ventricular tachycardia or ventricular fibrillation"", ""option_c"": ""End-stage renal failure due to cardiorenal syndrome"", ""option_d"": ""Hypotension"", ""correct_option"": ""B""}",,"What is a common cause of sudden death in patients with heart failure?","Chronic refractory heart failure","Ventricular rhythm disturbances, such as ventricular tachycardia or ventricular fibrillation","End-stage renal failure due to cardiorenal syndrome","Hypotension","b"
"OIC-234-22-A","{""question"": ""What is a key criterion for diagnosing cardiogenic shock in terms of systolic blood pressure?"", ""option_a"": ""Systolic blood pressure < 80 mmHg for at least 15 minutes"", ""option_b"": ""Systolic blood pressure < 90 mmHg for at least 30 minutes"", ""option_c"": ""Systolic blood pressure < 100 mmHg for at least 60 minutes"", ""option_d"": ""Systolic blood pressure < 70 mmHg for at least 45 minutes"", ""correct_option"": ""B""}",,"What is a key criterion for diagnosing cardiogenic shock in terms of systolic blood pressure?","Systolic blood pressure < 80 mmHg for at least 15 minutes","Systolic blood pressure < 90 mmHg for at least 30 minutes","Systolic blood pressure < 100 mmHg for at least 60 minutes","Systolic blood pressure < 70 mmHg for at least 45 minutes","b"
"OIC-234-23-B","{""question"": ""In the management of cardiogenic shock, what is the primary goal of administering dobutamine as a first-line treatment?"", ""option_a"": ""To induce peripheral vasoconstriction and increase blood pressure"", ""option_b"": ""To increase cardiac contractility and improve cardiac output"", ""option_c"": ""To reduce extracellular fluid volume and alleviate signs of overload"", ""option_d"": ""To decrease heart rate and reduce myocardial oxygen demand"", ""correct_option"": ""B""}","Management","In the management of cardiogenic shock, what is the primary goal of administering dobutamine as a first-line treatment?","To induce peripheral vasoconstriction and increase blood pressure","To increase cardiac contractility and improve cardiac output","To reduce extracellular fluid volume and alleviate signs of overload","To decrease heart rate and reduce myocardial oxygen demand","b"
"OIC-235-01-A","{""question"": ""What is acute pericarditis characterized by?"", ""option_a"": ""Chronic inflammation of the pericardium with pericardial effusion"", ""option_b"": ""Acute inflammation of the leaflets of the pericardium, with or without pericardial effusion"", ""option_c"": ""Elevated troponin levels without pericardial involvement"", ""option_d"": ""Pericardial effusion without inflammation of the pericardium"", ""correct_option"": ""B""}","Definition","What is acute pericarditis characterized by?","Chronic inflammation of the pericardium with pericardial effusion","Acute inflammation of the leaflets of the pericardium, with or without pericardial effusion","Elevated troponin levels without pericardial involvement","Pericardial effusion without inflammation of the pericardium","b"
"OIC-235-02-A","{""question"": ""What is a characteristic feature of chest pain in acute pericarditis?"", ""option_a"": ""It is relieved by trinitrate"", ""option_b"": ""It is increased in the supine position and calmed by sitting bent forward"", ""option_c"": ""It is constant and does not change with position or respiration"", ""option_d"": ""It is typically pleuritic and worsens with deep inspiration, but not with coughing"", ""correct_option"": ""B""}",,"What is a characteristic feature of chest pain in acute pericarditis?","It is relieved by trinitrate","It is increased in the supine position and calmed by sitting bent forward","It is constant and does not change with position or respiration","It is typically pleuritic and worsens with deep inspiration, but not with coughing","b"
"OIC-235-03-A","{""question"": ""What is a sign suggestive of tamponade in a patient with acute pericarditis?"", ""option_a"": ""Jugular turgidity and fever > 38\u00b0"", ""option_b"": ""Paradoxical pulse with a drop in systolic blood pressure of 10 mmHg during inspiration"", ""option_c"": ""Troponin elevation and ventricular rhythm disorders"", ""option_d"": ""Mottling and cold extremities"", ""correct_option"": ""B""}","Identify the emergency","What is a sign suggestive of tamponade in a patient with acute pericarditis?","Jugular turgidity and fever > 38°","Paradoxical pulse with a drop in systolic blood pressure of 10 mmHg during inspiration","Troponin elevation and ventricular rhythm disorders","Mottling and cold extremities","b"
"OIC-235-04-A","{""question"": ""What is the characteristic evolution of ECG signs in acute pericarditis?"", ""option_a"": ""Concave upward ST elevation, followed by negative T waves, then normalization, and finally microvoltage"", ""option_b"": ""Concave upward ST elevation, followed by flat T waves, then negative T waves, and finally normalization"", ""option_c"": ""Sinus tachycardia, followed by PQ undershift, then microvoltage, and finally electrical alternation"", ""option_d"": ""Normal ECG, followed by diffuse non-systematic abnormalities, then concave upward ST elevation, and finally negative T waves"", ""correct_option"": ""B""}",,"What is the characteristic evolution of ECG signs in acute pericarditis?","Concave upward ST elevation, followed by negative T waves, then normalization, and finally microvoltage","Concave upward ST elevation, followed by flat T waves, then negative T waves, and finally normalization","Sinus tachycardia, followed by PQ undershift, then microvoltage, and finally electrical alternation","Normal ECG, followed by diffuse non-systematic abnormalities, then concave upward ST elevation, and finally negative T waves","b"
"OIC-235-05-B","{""question"": ""What is the primary purpose of analyzing the drained fluid during pericardial drainage in cases of pericardial effusion?"", ""option_a"": ""To assess the volume of the effusion"", ""option_b"": ""To evaluate the patient's blood pressure"", ""option_c"": ""To determine the need for surgical intervention"", ""option_d"": ""To contribute to the etiological assessment of the pericardial effusion"", ""correct_option"": ""D""}","Additional examinations","What is the primary purpose of analyzing the drained fluid during pericardial drainage in cases of pericardial effusion?","To assess the volume of the effusion","To evaluate the patient's blood pressure","To determine the need for surgical intervention","To contribute to the etiological assessment of the pericardial effusion","d"
"OIC-235-06-B","{""question"": ""What is the primary purpose of using echocardiography in the investigation of acute pericarditis?"", ""option_a"": ""To assess pulmonary parenchymal abnormalities"", ""option_b"": ""To evaluate the abundance and haemodynamic impact of pericardial effusion"", ""option_c"": ""To detect mediastinal abnormalities"", ""option_d"": ""To visualize pericardial calcification"", ""correct_option"": ""B""}","Additional examinations","What is the primary purpose of using echocardiography in the investigation of acute pericarditis?","To assess pulmonary parenchymal abnormalities","To evaluate the abundance and haemodynamic impact of pericardial effusion","To detect mediastinal abnormalities","To visualize pericardial calcification","b"
"OIC-235-07-A","{""question"": ""What characteristic finding is typically observed in the electrocardiogram (ECG) of a patient with acute pericarditis?"", ""option_a"": ""A localized, convex ST elevation with the presence of Q waves"", ""option_b"": ""A diffuse, non-systematized ST elevation that is concave upwards, without Q waves or mirror image"", ""option_c"": ""A widespread PR depression with inverted T waves"", ""option_d"": ""A pattern of ST depression in leads I and II, with T wave inversion in lead III"", ""correct_option"": ""B""}","Multimedia content","What characteristic finding is typically observed in the electrocardiogram (ECG) of a patient with acute pericarditis?","A localized, convex ST elevation with the presence of Q waves","A diffuse, non-systematized ST elevation that is concave upwards, without Q waves or mirror image","A widespread PR depression with inverted T waves","A pattern of ST depression in leads I and II, with T wave inversion in lead III","b"
"OIC-235-08-A","{""question"": ""Which of the following is a factor predictive of tamponade in a patient with acute pericarditis?"", ""option_a"": ""Symptoms present for less than 24 hours"", ""option_b"": ""Symptoms present for several weeks"", ""option_c"": ""Normal troponin levels"", ""option_d"": ""Patient not on oral anticoagulants"", ""correct_option"": ""B""}",,"Which of the following is a factor predictive of tamponade in a patient with acute pericarditis?","Symptoms present for less than 24 hours","Symptoms present for several weeks","Normal troponin levels","Patient not on oral anticoagulants","b"
"OIC-235-09-A","{""question"": ""What is the most common etiology of acute pericarditis?"", ""option_a"": ""Bacterial infection"", ""option_b"": ""Viral infection"", ""option_c"": ""Fungal infection"", ""option_d"": ""Parasitic infection"", ""correct_option"": ""B""}","Etiologies","What is the most common etiology of acute pericarditis?","Bacterial infection","Viral infection","Fungal infection","Parasitic infection","b"
"OIC-235-10-B","{""question"": ""What is the typical time frame for the occurrence of Dressler syndrome, a form of late pericarditis, following a myocardial infarction?"", ""option_a"": ""Within the first 48 hours"", ""option_b"": ""Between 2-16 weeks"", ""option_c"": ""Immediately after the infarction, as a result of haemopericardial infarction"", ""option_d"": ""More than 6 months after the myocardial infarction"", ""correct_option"": ""B""}","Etiologies","What is the typical time frame for the occurrence of Dressler syndrome, a form of late pericarditis, following a myocardial infarction?","Within the first 48 hours","Between 2-16 weeks","Immediately after the infarction, as a result of haemopericardial infarction","More than 6 months after the myocardial infarction","b"
"OIC-235-11-B","{""question"": ""What is the most common cause of neoplastic pericarditis?"", ""option_a"": ""Primary pericardial cancer (mesothelioma)"", ""option_b"": ""Secondary location of lung cancer"", ""option_c"": ""Secondary location of lymphomas"", ""option_d"": ""Secondary location of all cancers, but most frequently primary lung cancer and lymphomas"", ""correct_option"": ""D""}","Etiologies","What is the most common cause of neoplastic pericarditis?","Primary pericardial cancer (mesothelioma)","Secondary location of lung cancer","Secondary location of lymphomas","Secondary location of all cancers, but most frequently primary lung cancer and lymphomas","d"
"OIC-235-12-A","{""question"": ""What is the recommended initial treatment for benign acute pericarditis?"", ""option_a"": ""Rest, analgesics, and corticosteroids"", ""option_b"": ""Rest, aspirin or ibuprofen, and colchicine"", ""option_c"": ""Rest, anti-inflammatory bi-therapy without colchicine"", ""option_d"": ""Immediate surgical intervention and pain management"", ""correct_option"": ""B""}","Management","What is the recommended initial treatment for benign acute pericarditis?","Rest, analgesics, and corticosteroids","Rest, aspirin or ibuprofen, and colchicine","Rest, anti-inflammatory bi-therapy without colchicine","Immediate surgical intervention and pain management","b"
"OIC-235-13-A","{""question"": ""What is a potential complication of acute pericarditis that can lead to right heart failure and is characterized by a 'dip plateau' and equalization of diastolic pressures on right catheterization?"", ""option_a"": ""Myocarditis"", ""option_b"": ""Tamponade"", ""option_c"": ""Pericardial constriction (chronic calcifying pericarditis)"", ""option_d"": ""Recurrent pericarditis"", ""correct_option"": ""C""}","Follow-up and/or prognosis","What is a potential complication of acute pericarditis that can lead to right heart failure and is characterized by a 'dip plateau' and equalization of diastolic pressures on right catheterization?","Myocarditis","Tamponade","Pericardial constriction (chronic calcifying pericarditis)","Recurrent pericarditis","c"
"OIC-235-14-B","{""question"": ""What are the most common causes of tamponade?"", ""option_a"": ""Purulent and viral"", ""option_b"": ""Neoplastic and traumatic"", ""option_c"": ""Tuberculosis and aortic dissection"", ""option_d"": ""Traumatic, neoplastic, and viral"", ""correct_option"": ""B""}","Etiologies","What are the most common causes of tamponade?","Purulent and viral","Neoplastic and traumatic","Tuberculosis and aortic dissection","Traumatic, neoplastic, and viral","b"
"OIC-235-15-A","{""question"": ""What is the characteristic drop in pulmonary artery systolic (PAS) pressure on inspiration in a patient with cardiac tamponade?"", ""option_a"": ""5 mmHg"", ""option_b"": ""10 mmHg"", ""option_c"": ""15 mmHg"", ""option_d"": ""20 mmHg"", ""correct_option"": ""B""}","Identification of the emergency","What is the characteristic drop in pulmonary artery systolic (PAS) pressure on inspiration in a patient with cardiac tamponade?","5 mmHg","10 mmHg","15 mmHg","20 mmHg","b"
"OIC-237-01-A","{""question"": ""What is the definition of palpitations?"", ""option_a"": ""An objective disorder corresponding to abnormal heart rhythms"", ""option_b"": ""A subjective disorder corresponding to abnormal perception of heartbeats, normal or abnormal"", ""option_c"": ""A condition where the heart beats too slowly"", ""option_d"": ""A type of heart disease characterized by chest pain"", ""correct_option"": ""B""}","Definition","What is the definition of palpitations?","An objective disorder corresponding to abnormal heart rhythms","A subjective disorder corresponding to abnormal perception of heartbeats, normal or abnormal","A condition where the heart beats too slowly","A type of heart disease characterized by chest pain","b"
"OIC-237-02-A","{""question"": ""What is the primary indicator that suggests ventricular tachycardia until proven otherwise in an electrocardiogram?"", ""option_a"": ""Any regular tachycardia with narrow QRS"", ""option_b"": ""Any regular tachycardia with wide QRS"", ""option_c"": ""Irregular tachycardia with wide QRS"", ""option_d"": ""Bradycardia with narrow QRS"", ""correct_option"": ""B""}",,"What is the primary indicator that suggests ventricular tachycardia until proven otherwise in an electrocardiogram?","Any regular tachycardia with narrow QRS","Any regular tachycardia with wide QRS","Irregular tachycardia with wide QRS","Bradycardia with narrow QRS","b"
"OIC-237-03-A","{""question"": ""What is the primary purpose of a percritical ECG recording in patients with palpitations?"", ""option_a"": ""To monitor the patient's heart activity during periods without palpitations"", ""option_b"": ""To establish an electroclinical correlation and obtain a definite diagnosis"", ""option_c"": ""To identify the triggering circumstances of palpitations"", ""option_d"": ""To perform a stress test on the patient"", ""correct_option"": ""B""}",,"What is the primary purpose of a percritical ECG recording in patients with palpitations?","To monitor the patient's heart activity during periods without palpitations","To establish an electroclinical correlation and obtain a definite diagnosis","To identify the triggering circumstances of palpitations","To perform a stress test on the patient","b"
"OIC-237-04-B","{""question"": ""What is the recommended ambulatory ECG recording approach for a patient experiencing palpitations less than once a week?"", ""option_a"": ""A Holter ECG with a recording time of 24 hours"", ""option_b"": ""A long-term ambulatory ECG for 7 to 21 days"", ""option_c"": ""An exercise stress test to check for myocardial ischaemia"", ""option_d"": ""Echocardiography to look for underlying heart disease"", ""correct_option"": ""B""}",,"What is the recommended ambulatory ECG recording approach for a patient experiencing palpitations less than once a week?","A Holter ECG with a recording time of 24 hours","A long-term ambulatory ECG for 7 to 21 days","An exercise stress test to check for myocardial ischaemia","Echocardiography to look for underlying heart disease","b"
"OIC-237-05-A","{""question"": ""What is a key characteristic that distinguishes ventricular extrasystoles from atrial extrasystoles on an ECG?"", ""option_a"": ""The presence of a P wave before the QRS complex"", ""option_b"": ""The width of the QRS complex is narrower in ventricular extrasystoles"", ""option_c"": ""The morphology of the P wave is identical to the sinus P wave"", ""option_d"": ""The premature QRS complex is wide and not preceded by a P wave"", ""correct_option"": ""D""}","Etiologies","What is a key characteristic that distinguishes ventricular extrasystoles from atrial extrasystoles on an ECG?","The presence of a P wave before the QRS complex","The width of the QRS complex is narrower in ventricular extrasystoles","The morphology of the P wave is identical to the sinus P wave","The premature QRS complex is wide and not preceded by a P wave","d"
"OIC-237-06-A","{""question"": ""What is the most common context in which sinus tachycardia occurs?"", ""option_a"": ""In isolation, as inappropriate sinus tachycardia"", ""option_b"": ""As a result of hyperthyroidism or pregnancy"", ""option_c"": ""As an adaptive response to physiological, cardiac, or extracardiac conditions"", ""option_d"": ""Exclusively in cardiac contexts, such as heart failure or pulmonary embolism"", ""correct_option"": ""C""}","Etiologies","What is the most common context in which sinus tachycardia occurs?","In isolation, as inappropriate sinus tachycardia","As a result of hyperthyroidism or pregnancy","As an adaptive response to physiological, cardiac, or extracardiac conditions","Exclusively in cardiac contexts, such as heart failure or pulmonary embolism","c"
"OIC-237-07-A","{""question"": ""What is a characteristic feature of junctional tachycardias on an ECG?"", ""option_a"": ""Wide QRS complexes with anterograde atrial activity"", ""option_b"": ""Regular tachycardia with fine QRS and retrograde atrial activity"", ""option_c"": ""Irregular tachycardia with visible P waves in all leads"", ""option_d"": ""Normal sinus rhythm with first-degree atrioventricular block"", ""correct_option"": ""B""}","Etiologies","What is a characteristic feature of junctional tachycardias on an ECG?","Wide QRS complexes with anterograde atrial activity","Regular tachycardia with fine QRS and retrograde atrial activity","Irregular tachycardia with visible P waves in all leads","Normal sinus rhythm with first-degree atrioventricular block","b"
"OIC-237-08-B","{""question"": ""What is the characteristic ECG manifestation of Wolff-Parkinson-White syndrome?"", ""option_a"": ""Prolonged PR interval and narrow QRS complex"", ""option_b"": ""Short PR interval, wide QRS complex, and presence of a delta wave"", ""option_c"": ""Normal PR interval and wide QRS complex without a delta wave"", ""option_d"": ""Prolonged PR interval, wide QRS complex, and absence of a delta wave"", ""correct_option"": ""B""}","Etiologies","What is the characteristic ECG manifestation of Wolff-Parkinson-White syndrome?","Prolonged PR interval and narrow QRS complex","Short PR interval, wide QRS complex, and presence of a delta wave","Normal PR interval and wide QRS complex without a delta wave","Prolonged PR interval, wide QRS complex, and absence of a delta wave","b"
"OIC-237-09-B","{""question"": ""What is a key characteristic of cardiac neurosis diagnosis?"", ""option_a"": ""It is typically diagnosed with an abnormal ECG reading"", ""option_b"": ""It is a diagnosis of elimination based on a strictly normal percritical ECG"", ""option_c"": ""It requires the presence of an identified cardiac pathology"", ""option_d"": ""It is usually associated with symptoms of severe physical trauma"", ""correct_option"": ""B""}","Etiologies","What is a key characteristic of cardiac neurosis diagnosis?","It is typically diagnosed with an abnormal ECG reading","It is a diagnosis of elimination based on a strictly normal percritical ECG","It requires the presence of an identified cardiac pathology","It is usually associated with symptoms of severe physical trauma","b"
"OIC-239-01-A","{""question"": ""What is the primary characteristic of Raynaud's phenomenon?"", ""option_a"": ""Vasodilatation triggered by heat or exercise"", ""option_b"": ""Paroxysmal vascular acrosyndrome with vasoconstriction, triggered by exposure to cold"", ""option_c"": ""Permanent vascular acrosyndrome with a pronounced cold, cyanotic appearance of the extremities"", ""option_d"": ""Ischaemia localized to the fingers or toes"", ""correct_option"": ""B""}","Definition","What is the primary characteristic of Raynaud's phenomenon?","Vasodilatation triggered by heat or exercise","Paroxysmal vascular acrosyndrome with vasoconstriction, triggered by exposure to cold","Permanent vascular acrosyndrome with a pronounced cold, cyanotic appearance of the extremities","Ischaemia localized to the fingers or toes","b"
"OIC-239-02-A","{""question"": ""What is the primary characteristic that distinguishes acrocyanosis from other acrosyndromes?"", ""option_a"": ""Presence of pain during episodes"", ""option_b"": ""Painless nature of the condition"", ""option_c"": ""Occurrence of hemorrhagic bullae"", ""option_d"": ""Sensitivity to aspirin"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic that distinguishes acrocyanosis from other acrosyndromes?","Presence of pain during episodes","Painless nature of the condition","Occurrence of hemorrhagic bullae","Sensitivity to aspirin","b"
"OIC-239-03-A","{""question"": ""What is a clinical feature that raises suspicion of secondary Raynaud's phenomenon?"", ""option_a"": ""Female sex and onset before the age of 30"", ""option_b"": ""Male sex and onset after the age of 40"", ""option_c"": ""Bilateral involvement of the fingers and presence of summer remission"", ""option_d"": ""Family history of Raynaud's phenomenon and absence of digital ulcers"", ""correct_option"": ""B""}","Positive diagnosis","What is a clinical feature that raises suspicion of secondary Raynaud's phenomenon?","Female sex and onset before the age of 30","Male sex and onset after the age of 40","Bilateral involvement of the fingers and presence of summer remission","Family history of Raynaud's phenomenon and absence of digital ulcers","b"
"OIC-239-04-B","{""question"": ""What is a characteristic dermatological sign of systemic scleroderma, often affecting the extremities?"", ""option_a"": ""Digital hippocratism"", ""option_b"": ""Sclerodactyly"", ""option_c"": ""Erythermalgia"", ""option_d"": ""Acrocyanosis"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic dermatological sign of systemic scleroderma, often affecting the extremities?","Digital hippocratism","Sclerodactyly","Erythermalgia","Acrocyanosis","b"
"OIC-239-05-B","{""question"": ""What is the primary purpose of performing an Allen manoeuvre?"", ""option_a"": ""To assess the function of the radial and ulnar nerves"", ""option_b"": ""To evaluate the permeability of the digital arteries and the function of the palmar arches"", ""option_c"": ""To diagnose color abnormalities of the extremities"", ""option_d"": ""To treat digital ischaemia"", ""correct_option"": ""B""}",,"What is the primary purpose of performing an Allen manoeuvre?","To assess the function of the radial and ulnar nerves","To evaluate the permeability of the digital arteries and the function of the palmar arches","To diagnose color abnormalities of the extremities","To treat digital ischaemia","b"
"OIC-239-06-A","{""question"": ""What is the term for the condition characterized by the temporary narrowing of blood vessels in response to cold or stress, resulting in discoloration of the fingers and toes?"", ""option_a"": ""Erythermalgia"", ""option_b"": ""Acrocyanosis"", ""option_c"": ""Raynaud's phenomenon"", ""option_d"": ""Digital ischaemia"", ""correct_option"": ""C""}","Multimedia content","What is the term for the condition characterized by the temporary narrowing of blood vessels in response to cold or stress, resulting in discoloration of the fingers and toes?","Erythermalgia","Acrocyanosis","Raynaud's phenomenon","Digital ischaemia","c"
"OIC-239-07-B","{""question"": ""What is the primary purpose of photography in the context of frostbite?"", ""option_a"": ""To provide a visual aid for patient education"", ""option_b"": ""To document the progression of frostbite for medical records"", ""option_c"": ""To create a multimedia presentation for academic purposes"", ""option_d"": ""To diagnose frostbite remotely through image analysis"", ""correct_option"": ""B""}","Multimedia content","What is the primary purpose of photography in the context of frostbite?","To provide a visual aid for patient education","To document the progression of frostbite for medical records","To create a multimedia presentation for academic purposes","To diagnose frostbite remotely through image analysis","b"
"OIC-239-08-B","{""question"": ""What is the primary purpose of the Allen manoeuvre?"", ""option_a"": ""To assess blood flow in the upper limbs"", ""option_b"": ""To diagnose Raynaud's phenomenon"", ""option_c"": ""To evaluate the effectiveness of treatments for acrocyanosis"", ""option_d"": ""To demonstrate the severity of frostbite"", ""correct_option"": ""A""}","Multimedia content","What is the primary purpose of the Allen manoeuvre?","To assess blood flow in the upper limbs","To diagnose Raynaud's phenomenon","To evaluate the effectiveness of treatments for acrocyanosis","To demonstrate the severity of frostbite","a"
"OIC-239-09-B","{""question"": ""What is the primary indication for testing anti-nuclear antibodies (ANA) and performing capillaroscopy in patients with Rheumatoid Arthritis (RA)?"", ""option_a"": ""To diagnose primary RA"", ""option_b"": ""To differentiate between RA and other autoimmune diseases"", ""option_c"": ""To identify secondary RA, recent onset, or worsening RA"", ""option_d"": ""To monitor the effectiveness of RA treatment"", ""correct_option"": ""C""}",,"What is the primary indication for testing anti-nuclear antibodies (ANA) and performing capillaroscopy in patients with Rheumatoid Arthritis (RA)?","To diagnose primary RA","To differentiate between RA and other autoimmune diseases","To identify secondary RA, recent onset, or worsening RA","To monitor the effectiveness of RA treatment","c"
"OIC-242-01-A","{""question"": ""What is the primary difference between hyperthyroidism and thyrotoxicosis?"", ""option_a"": ""Hyperthyroidism refers to the consequences of excess thyroid hormones, while thyrotoxicosis refers to the excess production of thyroid hormones"", ""option_b"": ""Hyperthyroidism is caused by an exogenous supply of thyroid hormones, while thyrotoxicosis is caused by hyperproduction of thyroid hormones by the thyroid gland"", ""option_c"": ""Hyperthyroidism refers to the excess production of thyroid hormones linked to hyperfunction of the thyroid gland, while thyrotoxicosis refers to the consequences of excess thyroid hormones in target tissues, whatever the cause"", ""option_d"": ""Hyperthyroidism and thyrotoxicosis are interchangeable terms that refer to the same condition"", ""correct_option"": ""C""}","Definition","What is the primary difference between hyperthyroidism and thyrotoxicosis?","Hyperthyroidism refers to the consequences of excess thyroid hormones, while thyrotoxicosis refers to the excess production of thyroid hormones","Hyperthyroidism is caused by an exogenous supply of thyroid hormones, while thyrotoxicosis is caused by hyperproduction of thyroid hormones by the thyroid gland","Hyperthyroidism refers to the excess production of thyroid hormones linked to hyperfunction of the thyroid gland, while thyrotoxicosis refers to the consequences of excess thyroid hormones in target tissues, whatever the cause","Hyperthyroidism and thyrotoxicosis are interchangeable terms that refer to the same condition","c"
"OIC-242-02-B","{""question"": ""What is the approximate sex ratio of women to men affected by hyperthyroidism?"", ""option_a"": ""1:1"", ""option_b"": ""3:1"", ""option_c"": ""7:1"", ""option_d"": ""10:1"", ""correct_option"": ""C""}","Epidemiology","What is the approximate sex ratio of women to men affected by hyperthyroidism?","1:1","3:1","7:1","10:1","c"
"OIC-242-03-A","{""question"": ""What is a common ophthalmological sign specific to Graves' disease, characterized by the protrusion of the eyeball?"", ""option_a"": ""Retraction of the upper eyelid"", ""option_b"": ""Exophthalmos"", ""option_c"": ""Conjunctival redness"", ""option_d"": ""Palpebral oedema"", ""correct_option"": ""B""}","Positive diagnosis","What is a common ophthalmological sign specific to Graves' disease, characterized by the protrusion of the eyeball?","Retraction of the upper eyelid","Exophthalmos","Conjunctival redness","Palpebral oedema","b"
"OIC-242-04-A","{""question"": ""What is a common trigger for an acute thyrotoxic crisis?"", ""option_a"": ""A sudden increase in thyroid hormone medication"", ""option_b"": ""Thyroidectomy without prior medical preparation"", ""option_c"": ""A decrease in iodine intake"", ""option_d"": ""A routine check-up with normal thyroid function test results"", ""correct_option"": ""B""}","Identification of the emergency","What is a common trigger for an acute thyrotoxic crisis?","A sudden increase in thyroid hormone medication","Thyroidectomy without prior medical preparation","A decrease in iodine intake","A routine check-up with normal thyroid function test results","b"
"OIC-242-05-B","{""question"": ""What is a possible complication of Basedowian ophthalmopathy?"", ""option_a"": ""Compressive optic neuropathy"", ""option_b"": ""Hypertension due to thyroid hormone imbalance"", ""option_c"": ""Glaucoma caused by increased intraocular pressure"", ""option_d"": ""Retinal detachment from excessive eye movement"", ""correct_option"": ""A""}","Positive diagnosis","What is a possible complication of Basedowian ophthalmopathy?","Compressive optic neuropathy","Hypertension due to thyroid hormone imbalance","Glaucoma caused by increased intraocular pressure","Retinal detachment from excessive eye movement","a"
"OIC-242-06-A","{""question"": ""What is the next step if the TSH level is low in a patient suspected of having hyperthyroidism?"", ""option_a"": ""Determination of T3L to assess the severity of thyrotoxicosis"", ""option_b"": ""Second-line T4L assay to assess the severity of thyrotoxicosis"", ""option_c"": ""Repeat the TSH test to confirm the results"", ""option_d"": ""Immediately start treatment for hyperthyroidism"", ""correct_option"": ""B""}","Positive diagnosis","What is the next step if the TSH level is low in a patient suspected of having hyperthyroidism?","Determination of T3L to assess the severity of thyrotoxicosis","Second-line T4L assay to assess the severity of thyrotoxicosis","Repeat the TSH test to confirm the results","Immediately start treatment for hyperthyroidism","b"
"OIC-242-07-B","{""question"": ""What is a specific biological sign used to confirm the diagnosis of Graves' disease?"", ""option_a"": ""Elevated liver enzymes"", ""option_b"": ""Lower cholesterol and triglyceride levels"", ""option_c"": ""Presence of TSH receptor antibodies"", ""option_d"": ""Leukoneutropenia with relative lymphocytosis"", ""correct_option"": ""C""}","Positive diagnosis","What is a specific biological sign used to confirm the diagnosis of Graves' disease?","Elevated liver enzymes","Lower cholesterol and triglyceride levels","Presence of TSH receptor antibodies","Leukoneutropenia with relative lymphocytosis","c"
"OIC-242-08-B","{""question"": ""What is the primary purpose of thyroid scintigraphy and ultrasonography in the context of hyperthyroidism?"", ""option_a"": ""To assess the severity of hyperthyroidism symptoms"", ""option_b"": ""To determine the etiological diagnosis of hyperthyroidism"", ""option_c"": ""To evaluate the effectiveness of treatment for hyperthyroidism"", ""option_d"": ""To screen for hyperthyroidism in the general population"", ""correct_option"": ""B""}",,"What is the primary purpose of thyroid scintigraphy and ultrasonography in the context of hyperthyroidism?","To assess the severity of hyperthyroidism symptoms","To determine the etiological diagnosis of hyperthyroidism","To evaluate the effectiveness of treatment for hyperthyroidism","To screen for hyperthyroidism in the general population","b"
"OIC-242-09-A","{""question"": ""What is the leading cause of hyperthyroidism in young women?"", ""option_a"": ""Toxic multinodular goitre"", ""option_b"": ""Toxic adenoma"", ""option_c"": ""Graves' disease"", ""option_d"": ""Hypothyroidism"", ""correct_option"": ""C""}","Etiologies","What is the leading cause of hyperthyroidism in young women?","Toxic multinodular goitre","Toxic adenoma","Graves' disease","Hypothyroidism","c"
"OIC-242-11-A","{""question"": ""What is the characteristic scintigraphy finding for a toxic multinodular goitre?"", ""option_a"": ""A single hyperfixing area with extinction of healthy thyroid parenchyma"", ""option_b"": ""Alternating hot and cold fixation areas known as a checkerboard pattern"", ""option_c"": ""Complete extinction of thyroid parenchyma without any hyperfixing areas"", ""option_d"": ""Uniformly decreased fixation throughout the thyroid gland"", ""correct_option"": ""B""}","Positive diagnosis","What is the characteristic scintigraphy finding for a toxic multinodular goitre?","A single hyperfixing area with extinction of healthy thyroid parenchyma","Alternating hot and cold fixation areas known as a checkerboard pattern","Complete extinction of thyroid parenchyma without any hyperfixing areas","Uniformly decreased fixation throughout the thyroid gland","b"
"OIC-242-12-B","{""question"": ""What is the primary mechanism by which amiodarone induces hyperthyroidism in patients?"", ""option_a"": ""By stimulating the production of TSH receptor antibodies"", ""option_b"": ""Through two different mechanisms: excess synthesis in pre-existing nodular thyroid pathology and thyroiditis with release of preformed thyroid hormones"", ""option_c"": ""By inhibiting the production of thyroid hormones, leading to a compensatory increase in TSH"", ""option_d"": ""By directly damaging the thyroid gland, leading to a release of stored thyroid hormones"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary mechanism by which amiodarone induces hyperthyroidism in patients?","By stimulating the production of TSH receptor antibodies","Through two different mechanisms: excess synthesis in pre-existing nodular thyroid pathology and thyroiditis with release of preformed thyroid hormones","By inhibiting the production of thyroid hormones, leading to a compensatory increase in TSH","By directly damaging the thyroid gland, leading to a release of stored thyroid hormones","b"
"OIC-242-13-B","{""question"": ""What is the primary factor that influences the choice of treatment for hyperthyroidism?"", ""option_a"": ""The patient's age and desire for pregnancy"", ""option_b"": ""The presence of heart disease or other chronic conditions"", ""option_c"": ""The cause of the hyperthyroidism and the context"", ""option_d"": ""The severity of symptoms such as tachycardia and tremors"", ""correct_option"": ""C""}","Management","What is the primary factor that influences the choice of treatment for hyperthyroidism?","The patient's age and desire for pregnancy","The presence of heart disease or other chronic conditions","The cause of the hyperthyroidism and the context","The severity of symptoms such as tachycardia and tremors","c"
"OIC-245-01-A","{""question"": ""What is the primary cause of primary or peripheral adrenal insufficiency, also known as Addison's disease?"", ""option_a"": ""Deficient production of pituitary ACTH"", ""option_b"": ""Adrenal cortisol deficiency associated with aldosterone and adrenal androgen deficiency"", ""option_c"": ""Involvement of only one adrenal gland"", ""option_d"": ""Acute hormone deficiency"", ""correct_option"": ""B""}","Definition","What is the primary cause of primary or peripheral adrenal insufficiency, also known as Addison's disease?","Deficient production of pituitary ACTH","Adrenal cortisol deficiency associated with aldosterone and adrenal androgen deficiency","Involvement of only one adrenal gland","Acute hormone deficiency","b"
"OIC-245-02-A","{""question"": ""What is a key difference in the semiological characteristics of primary and secondary adrenal insufficiency regarding skin and mucous membranes?"", ""option_a"": ""Hyperpigmentation is more common in secondary adrenal insufficiency"", ""option_b"": ""Pallor is a characteristic of primary adrenal insufficiency"", ""option_c"": ""Hyperpigmentation is characteristic of primary adrenal insufficiency, while pallor is seen in secondary adrenal insufficiency"", ""option_d"": ""Both primary and secondary adrenal insufficiency present with similar skin and mucous membrane characteristics"", ""correct_option"": ""C""}","Positive diagnosis","What is a key difference in the semiological characteristics of primary and secondary adrenal insufficiency regarding skin and mucous membranes?","Hyperpigmentation is more common in secondary adrenal insufficiency","Pallor is a characteristic of primary adrenal insufficiency","Hyperpigmentation is characteristic of primary adrenal insufficiency, while pallor is seen in secondary adrenal insufficiency","Both primary and secondary adrenal insufficiency present with similar skin and mucous membrane characteristics","c"
"OIC-245-03-A","{""question"": ""What are the three 'A's that are always present in primary adrenal insufficiency?"", ""option_a"": ""Asthenia, Anxiety, and Arthritis"", ""option_b"": ""Asthenia, Weight loss, and Anorexia"", ""option_c"": ""Apathy, Anemia, and Angina"", ""option_d"": ""Arrhythmia, Aphasia, and Ataxia"", ""correct_option"": ""B""}","Positive diagnosis","What are the three 'A's that are always present in primary adrenal insufficiency?","Asthenia, Anxiety, and Arthritis","Asthenia, Weight loss, and Anorexia","Apathy, Anemia, and Angina","Arrhythmia, Aphasia, and Ataxia","b"
"OIC-245-04-A","{""question"": ""What is a notable difference in clinical signs between primary adrenal insufficiency and secondary adrenal insufficiency?"", ""option_a"": ""Presence of melanoderma in secondary adrenal insufficiency"", ""option_b"": ""Absence of asthenia in secondary adrenal insufficiency"", ""option_c"": ""Presence of pallor instead of melanoderma in secondary adrenal insufficiency"", ""option_d"": ""Similarity in general signs between primary and secondary adrenal insufficiency"", ""correct_option"": ""C""}","Positive diagnosis","What is a notable difference in clinical signs between primary adrenal insufficiency and secondary adrenal insufficiency?","Presence of melanoderma in secondary adrenal insufficiency","Absence of asthenia in secondary adrenal insufficiency","Presence of pallor instead of melanoderma in secondary adrenal insufficiency","Similarity in general signs between primary and secondary adrenal insufficiency","c"
"OIC-245-05-A","{""question"": ""What is the next step when cortisol levels are between 50 ng/ml and 180 ng/ml in an 8-hour cortisol test?"", ""option_a"": ""Diagnose adrenal insufficiency"", ""option_b"": ""Eliminate adrenal insufficiency"", ""option_c"": ""Perform a stimulation test, such as the synACTHene test"", ""option_d"": ""Repeat the 8-hour cortisol test"", ""correct_option"": ""C""}",,"What is the next step when cortisol levels are between 50 ng/ml and 180 ng/ml in an 8-hour cortisol test?","Diagnose adrenal insufficiency","Eliminate adrenal insufficiency","Perform a stimulation test, such as the synACTHene test","Repeat the 8-hour cortisol test","c"
"OIC-245-06-B","{""question"": ""In the context of diagnosing adrenal insufficiency, what does a high ACTH level typically indicate?"", ""option_a"": ""Corticotropic insufficiency"", ""option_b"": ""Primary adrenal insufficiency"", ""option_c"": ""Normal adrenal function"", ""option_d"": ""Adrenal insufficiency of unknown etiology"", ""correct_option"": ""B""}",,"In the context of diagnosing adrenal insufficiency, what does a high ACTH level typically indicate?","Corticotropic insufficiency","Primary adrenal insufficiency","Normal adrenal function","Adrenal insufficiency of unknown etiology","b"
"OIC-245-07-A","{""question"": ""What is the interpretation of a peak cortisol level of 180 ng/ml (500 nmol/l) or higher during the synacthen test?"", ""option_a"": ""Adrenal insufficiency is confirmed, regardless of the underlying cause"", ""option_b"": ""Adrenal insufficiency is ruled out, except in cases of recent or partial adrenocortical insufficiency"", ""option_c"": ""The test is inconclusive and additional testing is required"", ""option_d"": ""The adrenal cortex is atrophied and unable to respond to exogenous ACTH"", ""correct_option"": ""B""}","Additional tests","What is the interpretation of a peak cortisol level of 180 ng/ml (500 nmol/l) or higher during the synacthen test?","Adrenal insufficiency is confirmed, regardless of the underlying cause","Adrenal insufficiency is ruled out, except in cases of recent or partial adrenocortical insufficiency","The test is inconclusive and additional testing is required","The adrenal cortex is atrophied and unable to respond to exogenous ACTH","b"
"OIC-245-08-B","{""question"": ""What is the most common cause of primary adrenal insufficiency in adults?"", ""option_a"": ""Bilateral adrenal tuberculosis"", ""option_b"": ""Autoimmune cortical shrinkage"", ""option_c"": ""Bilateral adrenal metastases"", ""option_d"": ""Vascular causes such as adrenal necrosis"", ""correct_option"": ""B""}","Etiologies","What is the most common cause of primary adrenal insufficiency in adults?","Bilateral adrenal tuberculosis","Autoimmune cortical shrinkage","Bilateral adrenal metastases","Vascular causes such as adrenal necrosis","b"
"OIC-245-09-A","{""question"": ""What is the most frequent cause of adrenal insufficiency?"", ""option_a"": ""Tumours of the hypothalamic-pituitary region"", ""option_b"": ""Interruption of prolonged corticosteroid therapy"", ""option_c"": ""Pituitary adenoma"", ""option_d"": ""Inhaled corticosteroid therapy"", ""correct_option"": ""B""}","Etiologies","What is the most frequent cause of adrenal insufficiency?","Tumours of the hypothalamic-pituitary region","Interruption of prolonged corticosteroid therapy","Pituitary adenoma","Inhaled corticosteroid therapy","b"
"OIC-245-10-B","{""question"": ""What is a rare cause of corticotropic insufficiency in the post-partum period?"", ""option_a"": ""Autoimmune disease affecting the pituitary"", ""option_b"": ""Sudden necrosis during hypovolaemic shock, also known as Sheehan's syndrome"", ""option_c"": ""Pituitary surgery complications"", ""option_d"": ""Granulomatosis due to sarcoidosis"", ""correct_option"": ""B""}","Etiologies","What is a rare cause of corticotropic insufficiency in the post-partum period?","Autoimmune disease affecting the pituitary","Sudden necrosis during hypovolaemic shock, also known as Sheehan's syndrome","Pituitary surgery complications","Granulomatosis due to sarcoidosis","b"
"OIC-245-11-B","{""question"": ""What is the biological half-life of Prednisolone?"", ""option_a"": ""8 - 12 hours"", ""option_b"": ""18 - 36 hours"", ""option_c"": ""36 - 54 hours"", ""option_d"": ""12 - 18 hours"", ""correct_option"": ""B""}","Management","What is the biological half-life of Prednisolone?","8 - 12 hours","18 - 36 hours","36 - 54 hours","12 - 18 hours","b"
"OIC-245-12-A","{""question"": ""What is the initial dose of hydrocortisone administered to a patient suspected of having acute adrenal insufficiency at home or in the hospital?"", ""option_a"": ""50 mg IV or IM"", ""option_b"": ""100 mg IV or IM or, failing that, SC"", ""option_c"": ""200 mg IV or IM"", ""option_d"": ""50 mg SC"", ""correct_option"": ""B""}",,"What is the initial dose of hydrocortisone administered to a patient suspected of having acute adrenal insufficiency at home or in the hospital?","50 mg IV or IM","100 mg IV or IM or, failing that, SC","200 mg IV or IM","50 mg SC","b"
"OIC-245-13-B","{""question"": ""What type of diet is recommended for patients with chronic adrenal insufficiency as part of their replacement treatment?"", ""option_a"": ""High-sodium diet"", ""option_b"": ""Low-sodium diet"", ""option_c"": ""Normosodium diet"", ""option_d"": ""Keto diet"", ""correct_option"": ""C""}","Management","What type of diet is recommended for patients with chronic adrenal insufficiency as part of their replacement treatment?","High-sodium diet","Low-sodium diet","Normosodium diet","Keto diet","c"
"OIC-245-14-B","{""question"": ""What is the primary method for monitoring the treatment of adrenal insufficiency?"", ""option_a"": ""Regular measurement of cortisol and ACTH levels"", ""option_b"": ""Clinical monitoring, including assessment of fatigue, weight, and blood pressure"", ""option_c"": ""Periodic renin assays and blood ionograms"", ""option_d"": ""Routine bone density scans and cardiovascular assessments"", ""correct_option"": ""B""}",,"What is the primary method for monitoring the treatment of adrenal insufficiency?","Regular measurement of cortisol and ACTH levels","Clinical monitoring, including assessment of fatigue, weight, and blood pressure","Periodic renin assays and blood ionograms","Routine bone density scans and cardiovascular assessments","b"
"OIC-245-15-A","{""question"": ""What is the appropriate approach when suspecting acute adrenal insufficiency?"", ""option_a"": ""Wait for diagnostic certainty before starting treatment"", ""option_b"": ""Start treatment as soon as the diagnosis is suspected, without delaying for diagnostic tests"", ""option_c"": ""Measure hormone levels immediately, and only start treatment if the results confirm the diagnosis"", ""option_d"": ""Delay treatment until the patient's condition stabilizes"", ""correct_option"": ""B""}","Identification of the emergency","What is the appropriate approach when suspecting acute adrenal insufficiency?","Wait for diagnostic certainty before starting treatment","Start treatment as soon as the diagnosis is suspected, without delaying for diagnostic tests","Measure hormone levels immediately, and only start treatment if the results confirm the diagnosis","Delay treatment until the patient's condition stabilizes","b"
"OIC-245-16-A","{""question"": ""What is a common biological sign of adrenal insufficiency in adults and children?"", ""option_a"": ""Hypernatremia and hypokalaemia"", ""option_b"": ""Hyponatremia and hyperkalaemia"", ""option_c"": ""Metabolic alkalosis and anaemia"", ""option_d"": ""Hypoglycaemia and hyperglycaemia"", ""correct_option"": ""B""}","Positive diagnosis","What is a common biological sign of adrenal insufficiency in adults and children?","Hypernatremia and hypokalaemia","Hyponatremia and hyperkalaemia","Metabolic alkalosis and anaemia","Hypoglycaemia and hyperglycaemia","b"
"OIC-245-17-B","{""question"": ""What is the appropriate initial step when the diagnosis of adrenal insufficiency is unknown?"", ""option_a"": ""Wait for the results of blood cortisol and ACTH tests before starting treatment"", ""option_b"": ""Start treatment immediately, without waiting for the results of blood cortisol and ACTH tests"", ""option_c"": ""Only measure blood cortisol levels and start treatment based on those results"", ""option_d"": ""Only measure ACTH levels and start treatment based on those results"", ""correct_option"": ""B""}","Positive diagnosis","What is the appropriate initial step when the diagnosis of adrenal insufficiency is unknown?","Wait for the results of blood cortisol and ACTH tests before starting treatment","Start treatment immediately, without waiting for the results of blood cortisol and ACTH tests","Only measure blood cortisol levels and start treatment based on those results","Only measure ACTH levels and start treatment based on those results","b"
"OIC-245-18-B","{""question"": ""What is a common cause of decompensation in treated adrenal insufficiency?"", ""option_a"": ""A well-managed hydrocortisone treatment regimen"", ""option_b"": ""Any intercurrent pathology, such as infection or major physical effort"", ""option_c"": ""A decrease in the patient's psychological stress levels"", ""option_d"": ""The patient's adherence to a regular exercise routine"", ""correct_option"": ""B""}","Etiologies","What is a common cause of decompensation in treated adrenal insufficiency?","A well-managed hydrocortisone treatment regimen","Any intercurrent pathology, such as infection or major physical effort","A decrease in the patient's psychological stress levels","The patient's adherence to a regular exercise routine","b"
"OIC-245-19-B","{""question"": ""Acute adrenal insufficiency in adulthood can be a sign of which of the following diseases or conditions?"", ""option_a"": ""Hypothyroidism"", ""option_b"": ""Addison's disease"", ""option_c"": ""Hyperparathyroidism"", ""option_d"": ""Pheochromocytoma"", ""correct_option"": ""B""}","Positive diagnosis","Acute adrenal insufficiency in adulthood can be a sign of which of the following diseases or conditions?","Hypothyroidism","Addison's disease","Hyperparathyroidism","Pheochromocytoma","b"
"OIC-245-20-B","{""question"": ""What should be done with fludrocortisone doses in patients with primary adrenal insufficiency during a stressful situation?"", ""option_a"": ""Increase the dose to prevent acute adrenal insufficiency"", ""option_b"": ""Decrease the dose to avoid excessive mineralocorticoid activity"", ""option_c"": ""Keep the dose the same as the usual maintenance dose"", ""option_d"": ""Stop the dose temporarily until the stressful situation resolves"", ""correct_option"": ""C""}","Management","What should be done with fludrocortisone doses in patients with primary adrenal insufficiency during a stressful situation?","Increase the dose to prevent acute adrenal insufficiency","Decrease the dose to avoid excessive mineralocorticoid activity","Keep the dose the same as the usual maintenance dose","Stop the dose temporarily until the stressful situation resolves","c"
"OIC-245-21-B","{""question"": ""What is the recommended adjustment to hydrocortisone dosage for adults experiencing stress due to acute adrenal insufficiency?"", ""option_a"": ""Reduce the dose by half to prevent over-suppression of the adrenal gland"", ""option_b"": ""Increase the dose to a minimum of 60 mg per 24 hours, taken in three or four doses including one at night"", ""option_c"": ""Maintain the regular dose without any adjustments, as stress does not significantly impact hydrocortisone requirements"", ""option_d"": ""Double the dose only at night to account for increased cortisol needs during stress"", ""correct_option"": ""B""}",,"What is the recommended adjustment to hydrocortisone dosage for adults experiencing stress due to acute adrenal insufficiency?","Reduce the dose by half to prevent over-suppression of the adrenal gland","Increase the dose to a minimum of 60 mg per 24 hours, taken in three or four doses including one at night","Maintain the regular dose without any adjustments, as stress does not significantly impact hydrocortisone requirements","Double the dose only at night to account for increased cortisol needs during stress","b"
"OIC-245-22-B","{""question"": ""What is the primary consequence of adrenal insufficiency due to 21 hydroxylase block in children?"", ""option_a"": ""Accumulation of very long-chain fatty acids in the cells"", ""option_b"": ""Deficit in cortisol and aldosterone, leading to adrenal insufficiency, salt loss, and dehydration, as well as hyperandrogenism"", ""option_c"": ""Mutation of a gene encoding a transporter of very long-chain fatty acids in the peroxisome"", ""option_d"": ""Elevation of androgens without any effect on cortisol and aldosterone levels"", ""correct_option"": ""B""}","Physiopathology","What is the primary consequence of adrenal insufficiency due to 21 hydroxylase block in children?","Accumulation of very long-chain fatty acids in the cells","Deficit in cortisol and aldosterone, leading to adrenal insufficiency, salt loss, and dehydration, as well as hyperandrogenism","Mutation of a gene encoding a transporter of very long-chain fatty acids in the peroxisome","Elevation of androgens without any effect on cortisol and aldosterone levels","b"
"OIC-245-23-A","{""question"": ""What is a common clinical manifestation of primary adrenal insufficiency in little girls?"", ""option_a"": ""Normal external genitalia"", ""option_b"": ""Abnormality of the external genitalia, ranging from clitoral hypertrophy to a male appearance without testicles"", ""option_c"": ""Arterial hypotension without any genital abnormalities"", ""option_d"": ""Persistent cholestatic jaundice as the sole symptom"", ""correct_option"": ""B""}","Positive diagnosis","What is a common clinical manifestation of primary adrenal insufficiency in little girls?","Normal external genitalia","Abnormality of the external genitalia, ranging from clitoral hypertrophy to a male appearance without testicles","Arterial hypotension without any genital abnormalities","Persistent cholestatic jaundice as the sole symptom","b"
"OIC-245-24-B","{""question"": ""What is the primary purpose of measuring 17 OH progesterone in newborns in the context of adrenal insufficiency?"", ""option_a"": ""To diagnose adrenoleukodystrophy"", ""option_b"": ""To determine the level of long-chain fatty acids"", ""option_c"": ""To identify 21 hydroxylase block, a common cause of congenital adrenal hyperplasia"", ""option_d"": ""To assess the function of the adrenal glands in general"", ""correct_option"": ""C""}",,"What is the primary purpose of measuring 17 OH progesterone in newborns in the context of adrenal insufficiency?","To diagnose adrenoleukodystrophy","To determine the level of long-chain fatty acids","To identify 21 hydroxylase block, a common cause of congenital adrenal hyperplasia","To assess the function of the adrenal glands in general","c"
"OIC-245-25-B","{""question"": ""What is the most common cause of adrenal insufficiency in children?"", ""option_a"": ""Adrenoleukodystrophy, an X-linked recessive disease"", ""option_b"": ""21-hydroxylase deficiency, an autosomal recessive disease"", ""option_c"": ""Autoimmune disorders"", ""option_d"": ""Infections such as tuberculosis"", ""correct_option"": ""B""}","Etiologies","What is the most common cause of adrenal insufficiency in children?","Adrenoleukodystrophy, an X-linked recessive disease","21-hydroxylase deficiency, an autosomal recessive disease","Autoimmune disorders","Infections such as tuberculosis","b"
"OIC-247-01-A","{""question"": ""What is the basis for the definition of diabetes?"", ""option_a"": ""The risk of short-term complications such as hypoglycaemia"", ""option_b"": ""The risk of long-term retinopathy"", ""option_c"": ""The level of insulin resistance in the body"", ""option_d"": ""The presence of symptoms such as polyuria and polydipsia"", ""correct_option"": ""B""}","Definition","What is the basis for the definition of diabetes?","The risk of short-term complications such as hypoglycaemia","The risk of long-term retinopathy","The level of insulin resistance in the body","The presence of symptoms such as polyuria and polydipsia","b"
"OIC-247-02-A","{""question"": ""What is the primary cause of death in individuals with Type 1 diabetes?"", ""option_a"": ""Cardiovascular disease"", ""option_b"": ""Kidney failure"", ""option_c"": ""Obesity-related complications"", ""option_d"": ""Hypoglycemic coma"", ""correct_option"": ""B""}","Definition","What is the primary cause of death in individuals with Type 1 diabetes?","Cardiovascular disease","Kidney failure","Obesity-related complications","Hypoglycemic coma","b"
"OIC-247-04-A","{""question"": ""What is the primary method of screening for type 2 diabetes mellitus (T2DM) in asymptomatic patients?"", ""option_a"": ""Oral glucose tolerance test"", ""option_b"": ""Fasting venous glycaemia"", ""option_c"": ""Random blood glucose measurement"", ""option_d"": ""Urine glucose test"", ""correct_option"": ""B""}",,"What is the primary method of screening for type 2 diabetes mellitus (T2DM) in asymptomatic patients?","Oral glucose tolerance test","Fasting venous glycaemia","Random blood glucose measurement","Urine glucose test","b"
"OIC-247-05-B","{""question"": ""What is the primary distinction between pregestational diabetes and gestational diabetes?"", ""option_a"": ""The type of glucose test used for diagnosis"", ""option_b"": ""The presence of diabetes prior to pregnancy"", ""option_c"": ""The severity of glucose intolerance"", ""option_d"": ""The age of onset of diabetes"", ""correct_option"": ""B""}","Definition","What is the primary distinction between pregestational diabetes and gestational diabetes?","The type of glucose test used for diagnosis","The presence of diabetes prior to pregnancy","The severity of glucose intolerance","The age of onset of diabetes","b"
"OIC-247-06-A","{""question"": ""What is a known risk factor for the onset of microangiopathic disorders in individuals with diabetes?"", ""option_a"": ""Hypoglycaemia"", ""option_b"": ""Hyperglycaemia: level and duration of exposure"", ""option_c"": ""Regular physical activity"", ""option_d"": ""Balanced diet"", ""correct_option"": ""B""}",,"What is a known risk factor for the onset of microangiopathic disorders in individuals with diabetes?","Hypoglycaemia","Hyperglycaemia: level and duration of exposure","Regular physical activity","Balanced diet","b"
"OIC-247-07-A","{""question"": ""What is one of the key risk factors for the onset of macroangiopathic disorders in patients with type 2 diabetes mellitus (T2DM), in addition to age and sex?"", ""option_a"": ""Family history of diabetes"", ""option_b"": ""Glycaemic control (HbA1c)"", ""option_c"": ""Obesity"", ""option_d"": ""Physical inactivity"", ""correct_option"": ""B""}",,"What is one of the key risk factors for the onset of macroangiopathic disorders in patients with type 2 diabetes mellitus (T2DM), in addition to age and sex?","Family history of diabetes","Glycaemic control (HbA1c)","Obesity","Physical inactivity","b"
"OIC-247-08-B","{""question"": ""What is the primary cause of the lack of insulin secretion in Type 1 Diabetes Mellitus (T1DM)?"", ""option_a"": ""Genetic predisposition alone"", ""option_b"": ""Autoimmune destruction of pancreatic beta cells"", ""option_c"": ""Environmental factors such as diet and lifestyle"", ""option_d"": ""Viral infections affecting the pancreas"", ""correct_option"": ""B""}",,"What is the primary cause of the lack of insulin secretion in Type 1 Diabetes Mellitus (T1DM)?","Genetic predisposition alone","Autoimmune destruction of pancreatic beta cells","Environmental factors such as diet and lifestyle","Viral infections affecting the pancreas","b"
"OIC-247-09-B","{""question"": ""What are the two major pathophysiological mechanisms of Type 2 Diabetes Mellitus (T2DM)?"", ""option_a"": ""Insulin resistance and hyperglycaemia"", ""option_b"": ""Insulin secretion abnormalities and glucotoxicity"", ""option_c"": ""Insulin resistance and insulin secretion abnormalities"", ""option_d"": ""Lipotoxicity and chronic low-grade inflammation"", ""correct_option"": ""C""}",,"What are the two major pathophysiological mechanisms of Type 2 Diabetes Mellitus (T2DM)?","Insulin resistance and hyperglycaemia","Insulin secretion abnormalities and glucotoxicity","Insulin resistance and insulin secretion abnormalities","Lipotoxicity and chronic low-grade inflammation","c"
"OIC-247-10-B","{""question"": ""What is the primary factor that differentiates grade 1 from grade 2 in the grading of diabetic foot?"", ""option_a"": ""History of ulceration"", ""option_b"": ""Association of neuropathy with arteriopathy or foot/toe deformities"", ""option_c"": ""Presence of social insecurity"", ""option_d"": ""Absence of sensory neuropathy and arteriopathy"", ""correct_option"": ""B""}",,"What is the primary factor that differentiates grade 1 from grade 2 in the grading of diabetic foot?","History of ulceration","Association of neuropathy with arteriopathy or foot/toe deformities","Presence of social insecurity","Absence of sensory neuropathy and arteriopathy","b"
"OIC-247-11-B","{""question"": ""What is the recommended monitoring rhythm for moderate Non-proliferative Diabetic Retinopathy (RDNP)?"", ""option_a"": ""1-2 years depending on BP, HbA1c"", ""option_b"": ""Annual"", ""option_c"": ""3-4 months"", ""option_d"": ""3 months"", ""correct_option"": ""B""}","Positive diagnosis","What is the recommended monitoring rhythm for moderate Non-proliferative Diabetic Retinopathy (RDNP)?","1-2 years depending on BP, HbA1c","Annual","3-4 months","3 months","b"
"OIC-247-12-B","{""question"": ""What is the primary characteristic of Stage 3 diabetic nephropathy, also known as nephropathy incipiens?"", ""option_a"": ""Normal albuminuria and high glomerular filtration rate"", ""option_b"": ""Microalbuminuria with normal or slightly increased blood pressure"", ""option_c"": ""Proteinuria with high blood pressure and reduced glomerular filtration rate"", ""option_d"": ""Massive proteinuria with low glomerular filtration rate and high blood pressure"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic of Stage 3 diabetic nephropathy, also known as nephropathy incipiens?","Normal albuminuria and high glomerular filtration rate","Microalbuminuria with normal or slightly increased blood pressure","Proteinuria with high blood pressure and reduced glomerular filtration rate","Massive proteinuria with low glomerular filtration rate and high blood pressure","b"
"OIC-247-13-B","{""question"": ""What is the primary diagnostic criterion for cardiac autonomic neuropathy (NAC) in diabetic patients?"", ""option_a"": ""Abnormal monofilament test"", ""option_b"": ""QT prolongation, variation in heart rate (M. Vasalva, tilt test), stress test"", ""option_c"": ""EMG (nerve root involvement T1 to T12)"", ""option_d"": ""FOGD (food bolus, bezoar), gastric emptying scan"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary diagnostic criterion for cardiac autonomic neuropathy (NAC) in diabetic patients?","Abnormal monofilament test","QT prolongation, variation in heart rate (M. Vasalva, tilt test), stress test","EMG (nerve root involvement T1 to T12)","FOGD (food bolus, bezoar), gastric emptying scan","b"
"OIC-247-14-B","{""question"": ""What is the recommended approach for assessing arteriopathy of the lower limbs in patients with diabetes?"", ""option_a"": ""Systematic annual Doppler ultrasound of the arteries of the lower limbs"", ""option_b"": ""Doppler ultrasound of the arteries of the lower limbs only if a patent clinical abnormality is observed"", ""option_c"": ""Measurement of the systolic pressure index (SPI) and auscultation of arterial paths, but no Doppler ultrasound"", ""option_d"": ""Stress test and myocardial scintigraphy to assess arteriopathy of the lower limbs"", ""correct_option"": ""B""}",,"What is the recommended approach for assessing arteriopathy of the lower limbs in patients with diabetes?","Systematic annual Doppler ultrasound of the arteries of the lower limbs","Doppler ultrasound of the arteries of the lower limbs only if a patent clinical abnormality is observed","Measurement of the systolic pressure index (SPI) and auscultation of arterial paths, but no Doppler ultrasound","Stress test and myocardial scintigraphy to assess arteriopathy of the lower limbs","b"
"OIC-247-15-A","{""question"": ""What is considered a significant level of coronary risk, similar to that observed after a myocardial infarction, in terms of 10-year event risk percentage?"", ""option_a"": ""Less than 10%"", ""option_b"": ""Between 10% and 20%"", ""option_c"": ""More than 20%"", ""option_d"": ""More than 40%"", ""correct_option"": ""C""}",,"What is considered a significant level of coronary risk, similar to that observed after a myocardial infarction, in terms of 10-year event risk percentage?","Less than 10%","Between 10% and 20%","More than 20%","More than 40%","c"
"OIC-247-16-A","{""question"": ""What is the primary distinguishing factor between hyperosmolar coma and diabetic ketoacidosis in terms of blood glucose levels?"", ""option_a"": ""Blood glucose levels are always lower in diabetic ketoacidosis"", ""option_b"": ""Blood glucose levels are often higher in hyperosmolar coma, typically > 30 mmol/l"", ""option_c"": ""Blood glucose levels are the same in both conditions"", ""option_d"": ""Blood glucose levels are irrelevant in distinguishing between the two conditions"", ""correct_option"": ""B""}","Identification of the emergency","What is the primary distinguishing factor between hyperosmolar coma and diabetic ketoacidosis in terms of blood glucose levels?","Blood glucose levels are always lower in diabetic ketoacidosis","Blood glucose levels are often higher in hyperosmolar coma, typically > 30 mmol/l","Blood glucose levels are the same in both conditions","Blood glucose levels are irrelevant in distinguishing between the two conditions","b"
"OIC-247-17-A","{""question"": ""A diabetic patient presents with acute abdominal pain, nausea, and vomiting. What should be considered as a potential complication?"", ""option_a"": ""Hypoglycaemia"", ""option_b"": ""Hyperglycaemia"", ""option_c"": ""Ketosis"", ""option_d"": ""Dehydration alone"", ""correct_option"": ""C""}","Identifying the emergency","A diabetic patient presents with acute abdominal pain, nausea, and vomiting. What should be considered as a potential complication?","Hypoglycaemia","Hyperglycaemia","Ketosis","Dehydration alone","c"
"OIC-247-18-A","{""question"": ""What is the most appropriate initial treatment for a child with severe hypoglycaemia who is unconscious?"", ""option_a"": ""Oral resugaring with 1 sugar cube or 1/2 glass of fruit juice/soda"", ""option_b"": ""Injection of glucagon IM or SC, followed by oral resugaring"", ""option_c"": ""Administration of rapid-acting IV insulin"", ""option_d"": ""Fluid and electrolyte rehydration and vascular filling"", ""correct_option"": ""B""}","Identifying emergencies","What is the most appropriate initial treatment for a child with severe hypoglycaemia who is unconscious?","Oral resugaring with 1 sugar cube or 1/2 glass of fruit juice/soda","Injection of glucagon IM or SC, followed by oral resugaring","Administration of rapid-acting IV insulin","Fluid and electrolyte rehydration and vascular filling","b"
"OIC-247-19-A","{""question"": ""In the event of suspected hyperglycaemic imbalance, which of the following tests is performed to calculate the severity of the condition when ketonemia is positive?"", ""option_a"": ""Osmolarity calculation: (Na+) \u00d7 2 + Gly in mmol/l"", ""option_b"": ""Anion gap calculation: (Na+ + K+) - (Cl- + HCO3-)"", ""option_c"": ""Venous pH and blood ionogram"", ""option_d"": ""ECG and clinical search for infectious outbreaks"", ""correct_option"": ""B""}","Additional tests","In the event of suspected hyperglycaemic imbalance, which of the following tests is performed to calculate the severity of the condition when ketonemia is positive?","Osmolarity calculation: (Na+) × 2 + Gly in mmol/l","Anion gap calculation: (Na+ + K+) - (Cl- + HCO3-)","Venous pH and blood ionogram","ECG and clinical search for infectious outbreaks","b"
"OIC-247-20-A","{""question"": ""What is the primary goal of intensified insulin therapy in the treatment of type 1 diabetes mellitus?"", ""option_a"": ""To completely eliminate the risk of hypoglycaemia"", ""option_b"": ""To reduce glycated haemoglobin and delay the onset of micro- and macroangiopathic complications"", ""option_c"": ""To increase the frequency of insulin injections"", ""option_d"": ""To solely rely on rapid-acting insulin for blood glucose control"", ""correct_option"": ""B""}",,"What is the primary goal of intensified insulin therapy in the treatment of type 1 diabetes mellitus?","To completely eliminate the risk of hypoglycaemia","To reduce glycated haemoglobin and delay the onset of micro- and macroangiopathic complications","To increase the frequency of insulin injections","To solely rely on rapid-acting insulin for blood glucose control","b"
"OIC-247-21-A","{""question"": ""What is one of the primary aims of Self-Monitoring of Blood Glucose (SMBG) in patients with Type 1 Diabetes Mellitus (T1DM)?"", ""option_a"": ""To achieve a target HbA1c level"", ""option_b"": ""To adapt insulin doses and monitor diabetes"", ""option_c"": ""To detect the presence of ketone bodies in the urine"", ""option_d"": ""To manage only emergency situations of hypoglycaemia"", ""correct_option"": ""B""}",,"What is one of the primary aims of Self-Monitoring of Blood Glucose (SMBG) in patients with Type 1 Diabetes Mellitus (T1DM)?","To achieve a target HbA1c level","To adapt insulin doses and monitor diabetes","To detect the presence of ketone bodies in the urine","To manage only emergency situations of hypoglycaemia","b"
"OIC-247-22-B","{""question"": ""What is the primary goal of dietary management in type 1 diabetes?"", ""option_a"": ""To restrict carbohydrate intake as much as possible"", ""option_b"": ""To avoid excessive fluctuations in blood sugar levels"", ""option_c"": ""To increase protein intake to compensate for insulin deficiency"", ""option_d"": ""To reduce physical activity to minimize blood sugar spikes"", ""correct_option"": ""B""}",,"What is the primary goal of dietary management in type 1 diabetes?","To restrict carbohydrate intake as much as possible","To avoid excessive fluctuations in blood sugar levels","To increase protein intake to compensate for insulin deficiency","To reduce physical activity to minimize blood sugar spikes","b"
"OIC-247-23-A","{""question"": ""What is the primary consideration for determining lipid control targets in the multifactorial management of T2DM?"", ""option_a"": ""The patient's motivation and adherence to dietary rules"", ""option_b"": ""The patient's life expectancy and existence of co-morbidities"", ""option_c"": ""The cardiovascular risk, including primary prevention, presence of family history of cardiovascular disease, and secondary prevention"", ""option_d"": ""The patient's blood sugar levels and HbA1c values"", ""correct_option"": ""C""}",,"What is the primary consideration for determining lipid control targets in the multifactorial management of T2DM?","The patient's motivation and adherence to dietary rules","The patient's life expectancy and existence of co-morbidities","The cardiovascular risk, including primary prevention, presence of family history of cardiovascular disease, and secondary prevention","The patient's blood sugar levels and HbA1c values","c"
"OIC-247-24-A","{""question"": ""What is the primary mechanism of action for biguanides, a class of oral antidiabetic treatments?"", ""option_a"": ""Triggering insulin secretion"", ""option_b"": ""Reducing hepatic glucose production, particularly hepatic gluconeogenesis"", ""option_c"": ""Inhibiting glucose reabsorption by the proximal convoluted tubule"", ""option_d"": ""Slowing down the digestion of complex carbohydrates"", ""correct_option"": ""B""}",,"What is the primary mechanism of action for biguanides, a class of oral antidiabetic treatments?","Triggering insulin secretion","Reducing hepatic glucose production, particularly hepatic gluconeogenesis","Inhibiting glucose reabsorption by the proximal convoluted tubule","Slowing down the digestion of complex carbohydrates","b"
"OIC-247-25-A","{""question"": ""What is the recommended treatment for an unconscious patient experiencing hypoglycemia who is currently taking hypoglycemic sulfamide?"", ""option_a"": ""IM or SC injection of glucagon"", ""option_b"": ""Nasal glucagon"", ""option_c"": ""Direct intravenous injection of one or two ampoules of 30% glucose solution"", ""option_d"": ""Oral ingestion of sugar or sweets"", ""correct_option"": ""C""}","Management","What is the recommended treatment for an unconscious patient experiencing hypoglycemia who is currently taking hypoglycemic sulfamide?","IM or SC injection of glucagon","Nasal glucagon","Direct intravenous injection of one or two ampoules of 30% glucose solution","Oral ingestion of sugar or sweets","c"
"OIC-247-26-B","{""question"": ""What is the primary goal of blood pressure control in the prevention of nephroprotection in diabetics at the microalbuminuria stage?"", ""option_a"": ""Blood pressure control: < 120/80 mm Hg"", ""option_b"": ""Blood pressure control: < 140/85 mm Hg"", ""option_c"": ""Blood pressure control: < 130/80 mm Hg"", ""option_d"": ""Blood pressure control: < 150/90 mm Hg"", ""correct_option"": ""B""}","Management","What is the primary goal of blood pressure control in the prevention of nephroprotection in diabetics at the microalbuminuria stage?","Blood pressure control: < 120/80 mm Hg","Blood pressure control: < 140/85 mm Hg","Blood pressure control: < 130/80 mm Hg","Blood pressure control: < 150/90 mm Hg","b"
"OIC-247-27-B","{""question"": ""What is the primary goal of glycaemic control in the treatment of diabetic retinopathy?"", ""option_a"": ""Achieving an HbA1c level of < 8%"", ""option_b"": ""Achieving an HbA1c level of < 7%"", ""option_c"": ""Maintaining a constant blood glucose level throughout the day"", ""option_d"": ""Delaying the onset of insulin therapy for as long as possible"", ""correct_option"": ""B""}","Management","What is the primary goal of glycaemic control in the treatment of diabetic retinopathy?","Achieving an HbA1c level of < 8%","Achieving an HbA1c level of < 7%","Maintaining a constant blood glucose level throughout the day","Delaying the onset of insulin therapy for as long as possible","b"
"OIC-247-28-B","{""question"": ""What is the primary goal of local care by an IDE in diabetic foot management?"", ""option_a"": ""To administer probabilistic antibiotic therapy"", ""option_b"": ""To remove hyperkeratosis and fibrin and apply special dressings adapted to the stage of the wound"", ""option_c"": ""To perform surgical management of serious wounds or suspected osteitis"", ""option_d"": ""To provide education for the prevention of other lesions"", ""correct_option"": ""B""}","Management","What is the primary goal of local care by an IDE in diabetic foot management?","To administer probabilistic antibiotic therapy","To remove hyperkeratosis and fibrin and apply special dressings adapted to the stage of the wound","To perform surgical management of serious wounds or suspected osteitis","To provide education for the prevention of other lesions","b"
"OIC-247-29-B","{""question"": ""What is the appropriate action when a patient with ketoacidosis has a blood glucose level < 2.5 g/l and positive ketonemia?"", ""option_a"": ""Stop insulin infusion and administer 10% glucose"", ""option_b"": ""Maintain insulin flow rate and add 10% glucose"", ""option_c"": ""Increase insulin flow rate and stop glucose administration"", ""option_d"": ""Decrease insulin flow rate and administer 10% glucose"", ""correct_option"": ""B""}","Management","What is the appropriate action when a patient with ketoacidosis has a blood glucose level < 2.5 g/l and positive ketonemia?","Stop insulin infusion and administer 10% glucose","Maintain insulin flow rate and add 10% glucose","Increase insulin flow rate and stop glucose administration","Decrease insulin flow rate and administer 10% glucose","b"
"OIC-247-30-B","{""question"": ""What is the primary goal of insulin therapy in the treatment of hyperosmolar coma?"", ""option_a"": ""To achieve blood sugar levels < 1.5 g/l as quickly as possible"", ""option_b"": ""To achieve blood sugar levels > 2.5 g/l"", ""option_c"": ""To administer a maximum of 10 IU/h of insulin"", ""option_d"": ""To lower blood pressure and heart rate"", ""correct_option"": ""B""}","Management","What is the primary goal of insulin therapy in the treatment of hyperosmolar coma?","To achieve blood sugar levels < 1.5 g/l as quickly as possible","To achieve blood sugar levels > 2.5 g/l","To administer a maximum of 10 IU/h of insulin","To lower blood pressure and heart rate","b"
"OIC-247-31-B","{""question"": ""What is the primary objective of multidisciplinary monitoring in diabetic patients?"", ""option_a"": ""To solely manage cardiovascular risk factors"", ""option_b"": ""To prevent, screen, treat complications, and achieve optimal control of CV risk factors"", ""option_c"": ""To only provide dietary care plans and insulin therapy"", ""option_d"": ""To exclusively coordinate care within centres specialising in the management of foot injuries"", ""correct_option"": ""B""}",,"What is the primary objective of multidisciplinary monitoring in diabetic patients?","To solely manage cardiovascular risk factors","To prevent, screen, treat complications, and achieve optimal control of CV risk factors","To only provide dietary care plans and insulin therapy","To exclusively coordinate care within centres specialising in the management of foot injuries","b"
"OIC-254-01-B","{""question"": ""What happens to pregnant women's energy requirements during the three trimesters of pregnancy?"", ""option_a"": ""They decrease by 70, 260, and 500 kcal/d in the 1st, 2nd, and 3rd trimesters, respectively"", ""option_b"": ""They remain the same throughout the pregnancy"", ""option_c"": ""They increase by 70, 260, and 500 kcal/d in the 1st, 2nd, and 3rd trimesters, respectively"", ""option_d"": ""They increase by 500, 260, and 70 kcal/d in the 1st, 2nd, and 3rd trimesters, respectively"", ""correct_option"": ""C""}","Physiopathology","What happens to pregnant women's energy requirements during the three trimesters of pregnancy?","They decrease by 70, 260, and 500 kcal/d in the 1st, 2nd, and 3rd trimesters, respectively","They remain the same throughout the pregnancy","They increase by 70, 260, and 500 kcal/d in the 1st, 2nd, and 3rd trimesters, respectively","They increase by 500, 260, and 70 kcal/d in the 1st, 2nd, and 3rd trimesters, respectively","c"
"OIC-254-02-B","{""question"": ""For a pregnant woman with a BMI of 28 kg/m\u00b2 at conception, what is the recommended weight gain during pregnancy?"", ""option_a"": ""11.5 - 16 kg"", ""option_b"": ""7 - 11.5 kg"", ""option_c"": ""12.5 - 18 kg"", ""option_d"": ""5 - 9 kg"", ""correct_option"": ""B""}","Physiopathology","For a pregnant woman with a BMI of 28 kg/m² at conception, what is the recommended weight gain during pregnancy?","11.5 - 16 kg","7 - 11.5 kg","12.5 - 18 kg","5 - 9 kg","b"
"OIC-254-03-B","{""question"": ""What is the recommended daily dosage of folic acid supplementation for preventing spina bifida in pregnant women?"", ""option_a"": ""100 \u00b5g/d"", ""option_b"": ""400 \u00b5g/d"", ""option_c"": ""1000 \u00b5g/d"", ""option_d"": ""2000 \u00b5g/d"", ""correct_option"": ""B""}","Physiopathology","What is the recommended daily dosage of folic acid supplementation for preventing spina bifida in pregnant women?","100 µg/d","400 µg/d","1000 µg/d","2000 µg/d","b"
"OIC-254-04-A","{""question"": ""Which of the following populations is at a higher risk of nutritional deficiency and/or malformation during pregnancy?"", ""option_a"": ""Women from affluent backgrounds with a history of healthy eating habits"", ""option_b"": ""Teenage girls"", ""option_c"": ""Women with a normal body mass index and no history of addiction"", ""option_d"": ""Women over 40 with a history of balanced diets and regular exercise"", ""correct_option"": ""B""}","Positive diagnosis","Which of the following populations is at a higher risk of nutritional deficiency and/or malformation during pregnancy?","Women from affluent backgrounds with a history of healthy eating habits","Teenage girls","Women with a normal body mass index and no history of addiction","Women over 40 with a history of balanced diets and regular exercise","b"
"OIC-254-05-A","{""question"": ""According to the French National Authority for Health (HAS), what is the recommended daily iron supplementation for pregnant women with anaemia?"", ""option_a"": ""20 mg of iron metal per day"", ""option_b"": ""50 mg of iron metal per day"", ""option_c"": ""100 mg of iron metal per day"", ""option_d"": ""200 mg of iron metal per day"", ""correct_option"": ""B""}","Management","According to the French National Authority for Health (HAS), what is the recommended daily iron supplementation for pregnant women with anaemia?","20 mg of iron metal per day","50 mg of iron metal per day","100 mg of iron metal per day","200 mg of iron metal per day","b"
"OIC-254-06-A","{""question"": ""Which of the following cheese types should be avoided by non-immune women to reduce the risk of food-borne infection?"", ""option_a"": ""Pressed cooked cheeses like Gruy\u00e8re or Comt\u00e9"", ""option_b"": ""Soft cheeses with a bloomy rind like Camembert and Brie"", ""option_c"": ""Aged hard cheeses like Cheddar or Parmesan"", ""option_d"": ""Fresh cheeses like Ricotta or Cottage cheese"", ""correct_option"": ""B""}","Management","Which of the following cheese types should be avoided by non-immune women to reduce the risk of food-borne infection?","Pressed cooked cheeses like Gruyère or Comté","Soft cheeses with a bloomy rind like Camembert and Brie","Aged hard cheeses like Cheddar or Parmesan","Fresh cheeses like Ricotta or Cottage cheese","b"
"OIC-254-07-A","{""question"": ""What is the recommended consumption frequency for highly bioaccumulative freshwater fish such as eel, barbel, bream, carp, and catfish during pregnancy?"", ""option_a"": ""Once a week"", ""option_b"": ""Once every two months"", ""option_c"": ""Once a month"", ""option_d"": ""Twice a month"", ""correct_option"": ""B""}","Taking charge","What is the recommended consumption frequency for highly bioaccumulative freshwater fish such as eel, barbel, bream, carp, and catfish during pregnancy?","Once a week","Once every two months","Once a month","Twice a month","b"
"OIC-256-01-A","{""question"": ""What is the primary purpose of a medical certificate in the context of sports participation?"", ""option_a"": ""To provide proof of age for underage athletes"", ""option_b"": ""To confirm the athlete's identity and membership in a sports federation"", ""option_c"": ""To state that there are no contraindications to practising the sport, in competition where applicable"", ""option_d"": ""To grant permission for athletes to participate in high-risk sports without proper training"", ""correct_option"": ""C""}","Support","What is the primary purpose of a medical certificate in the context of sports participation?","To provide proof of age for underage athletes","To confirm the athlete's identity and membership in a sports federation","To state that there are no contraindications to practising the sport, in competition where applicable","To grant permission for athletes to participate in high-risk sports without proper training","c"
"OIC-256-02-B","{""question"": ""What is required for a child or adolescent to be exempt from physical and sports education in the school environment?"", ""option_a"": ""A parental note explaining the reason for exemption"", ""option_b"": ""A medical certificate from a licensed physician"", ""option_c"": ""A self-assessment of their physical abilities"", ""option_d"": ""A recommendation from a physical education teacher"", ""correct_option"": ""B""}",,"What is required for a child or adolescent to be exempt from physical and sports education in the school environment?","A parental note explaining the reason for exemption","A medical certificate from a licensed physician","A self-assessment of their physical abilities","A recommendation from a physical education teacher","b"
"OIC-256-03-B","{""question"": ""According to the French Society of Cardiology, how often should an ECG be performed for individuals between the ages of 20 and 35 as part of a medical examination for sports participation?"", ""option_a"": ""Every 1 to 2 years"", ""option_b"": ""Every 3 years"", ""option_c"": ""Every 5 years"", ""option_d"": ""Only at the first licence from the age of 12"", ""correct_option"": ""C""}","Support","According to the French Society of Cardiology, how often should an ECG be performed for individuals between the ages of 20 and 35 as part of a medical examination for sports participation?","Every 1 to 2 years","Every 3 years","Every 5 years","Only at the first licence from the age of 12","c"
"OIC-256-04-B","{""question"": ""What is a key particularity to consider when conducting a medical examination for a child to ensure they have no contraindications to practising sport?"", ""option_a"": ""The child's favorite sport and position played"", ""option_b"": ""The overall amount of physical activity the child does each week, including all types of activity"", ""option_c"": ""The child's ability to perform a specific number of push-ups or sit-ups"", ""option_d"": ""The distance the child lives from the sports facility"", ""correct_option"": ""B""}","Support","What is a key particularity to consider when conducting a medical examination for a child to ensure they have no contraindications to practising sport?","The child's favorite sport and position played","The overall amount of physical activity the child does each week, including all types of activity","The child's ability to perform a specific number of push-ups or sit-ups","The distance the child lives from the sports facility","b"
"OIC-256-05-A","{""question"": ""What is the most common origin of sudden death during exercise?"", ""option_a"": ""Respiratory origin"", ""option_b"": ""Cardiovascular origin"", ""option_c"": ""Neurological origin"", ""option_d"": ""Musculoskeletal origin"", ""correct_option"": ""B""}","Definition","What is the most common origin of sudden death during exercise?","Respiratory origin","Cardiovascular origin","Neurological origin","Musculoskeletal origin","b"
"OIC-256-06-A","{""question"": ""What is the primary risk associated with practicing sport at any age?"", ""option_a"": ""Mainly muscular"", ""option_b"": ""Mainly cardiovascular"", ""option_c"": ""Mainly neurological"", ""option_d"": ""Mainly respiratory"", ""correct_option"": ""B""}","Definition","What is the primary risk associated with practicing sport at any age?","Mainly muscular","Mainly cardiovascular","Mainly neurological","Mainly respiratory","b"
"OIC-256-07-B","{""question"": ""What is the primary cause of osteochondrosis, a common pathology in children who engage in intensive sports?"", ""option_a"": ""Macrotraumatic risks, such as fractures or wounds"", ""option_b"": ""Disturbances in ossification and mechanical factors generated by sporting movements"", ""option_c"": ""Inadequate nutrition and hydration"", ""option_d"": ""Insufficient warm-up and stretching exercises"", ""correct_option"": ""B""}","Etiologies","What is the primary cause of osteochondrosis, a common pathology in children who engage in intensive sports?","Macrotraumatic risks, such as fractures or wounds","Disturbances in ossification and mechanical factors generated by sporting movements","Inadequate nutrition and hydration","Insufficient warm-up and stretching exercises","b"
"OIC-256-08-B","{""question"": ""What is the primary nutritional adaptation required for most adult athletes engaging in regular sporting activity?"", ""option_a"": ""A significant increase in protein intake to support muscle growth"", ""option_b"": ""An increase in energy intake to cover total energy expenditure"", ""option_c"": ""A reduction in carbohydrate intake to promote fat metabolism"", ""option_d"": ""A decrease in lipid intake to minimize weight gain"", ""correct_option"": ""option_b""}","Management","What is the primary nutritional adaptation required for most adult athletes engaging in regular sporting activity?","A significant increase in protein intake to support muscle growth","An increase in energy intake to cover total energy expenditure","A reduction in carbohydrate intake to promote fat metabolism","A decrease in lipid intake to minimize weight gain","option_b"
"OIC-256-09-B","{""question"": ""What is the recommended daily intake of dairy products for child athletes to ensure adequate calcium and vitamin D intake?"", ""option_a"": ""2 dairy products a day"", ""option_b"": ""3 dairy products a day"", ""option_c"": ""4 dairy products a day"", ""option_d"": ""5 dairy products a day"", ""correct_option"": ""C""}",,"What is the recommended daily intake of dairy products for child athletes to ensure adequate calcium and vitamin D intake?","2 dairy products a day","3 dairy products a day","4 dairy products a day","5 dairy products a day","c"
"OIC-256-10-B","{""question"": ""What is the recommended daily protein intake for an individual engaged in endurance sports?"", ""option_a"": ""0.83 g/kg/day"", ""option_b"": ""1.2-1.4 g/kg/day"", ""option_c"": ""1.3-1.5 g/kg/day"", ""option_d"": ""Up to 3.5 g/kg/day"", ""correct_option"": ""B""}",,"What is the recommended daily protein intake for an individual engaged in endurance sports?","0.83 g/kg/day","1.2-1.4 g/kg/day","1.3-1.5 g/kg/day","Up to 3.5 g/kg/day","b"
"OIC-256-11-A","{""question"": ""What is the most common cause of sudden deaths during exercise?"", ""option_a"": ""Respiratory problems"", ""option_b"": ""Cardiovascular origin"", ""option_c"": ""Neurological disorders"", ""option_d"": ""Musculoskeletal injuries"", ""correct_option"": ""B""}","Management","What is the most common cause of sudden deaths during exercise?","Respiratory problems","Cardiovascular origin","Neurological disorders","Musculoskeletal injuries","b"
"OIC-257-01-A","{""question"": ""What is oedema defined as?"", ""option_a"": ""The visible or palpable accumulation of fluid in the vascular tissue"", ""option_b"": ""The visible or palpable accumulation of fluid in the interstitial tissue"", ""option_c"": ""The invisible accumulation of fluid in the interstitial tissue"", ""option_d"": ""The accumulation of fluid in the intracellular tissue"", ""correct_option"": ""B""}","Definition","What is oedema defined as?","The visible or palpable accumulation of fluid in the vascular tissue","The visible or palpable accumulation of fluid in the interstitial tissue","The invisible accumulation of fluid in the interstitial tissue","The accumulation of fluid in the intracellular tissue","b"
"OIC-257-02-B","{""question"": ""What is a possible cause of locally caused oedema?"", ""option_a"": ""An increase in arterial pressure"", ""option_b"": ""A lymphatic obstacle"", ""option_c"": ""A decrease in capillary permeability"", ""option_d"": ""An increase in venous pressure"", ""correct_option"": ""B""}","Physiopathology","What is a possible cause of locally caused oedema?","An increase in arterial pressure","A lymphatic obstacle","A decrease in capillary permeability","An increase in venous pressure","b"
"OIC-257-03-B","{""question"": ""What is the primary cause of hypovolaemia in nephrotic syndrome according to the filling deficit theory?"", ""option_a"": ""Increase in capillary hydrostatic pressure"", ""option_b"": ""Decrease in plasma oncotic pressure"", ""option_c"": ""Increase in capillary permeability"", ""option_d"": ""Primary excess of distal sodium reabsorption"", ""correct_option"": ""B""}","Physiopathology","What is the primary cause of hypovolaemia in nephrotic syndrome according to the filling deficit theory?","Increase in capillary hydrostatic pressure","Decrease in plasma oncotic pressure","Increase in capillary permeability","Primary excess of distal sodium reabsorption","b"
"OIC-257-04-A","{""question"": ""What is the term used to describe the appearance of oedema due to fluid retention, as shown in photographs?"", ""option_a"": ""Bucket sign"", ""option_b"": ""Oedema scale"", ""option_c"": ""Fluid retention index"", ""option_d"": ""Lower limb swelling indicator"", ""correct_option"": ""A""}","Multimedia content","What is the term used to describe the appearance of oedema due to fluid retention, as shown in photographs?","Bucket sign","Oedema scale","Fluid retention index","Lower limb swelling indicator","a"
"OIC-257-05-A","{""question"": ""What is a characteristic clinical sign that distinguishes generalised oedema from localised oedema?"", ""option_a"": ""Unilateral or asymmetrical distribution"", ""option_b"": ""Inflammatory appearance"", ""option_c"": ""Bilateral and symmetrical distribution"", ""option_d"": ""Painful and hard texture"", ""correct_option"": ""C""}","Positive diagnosis","What is a characteristic clinical sign that distinguishes generalised oedema from localised oedema?","Unilateral or asymmetrical distribution","Inflammatory appearance","Bilateral and symmetrical distribution","Painful and hard texture","c"
"OIC-257-06-A","{""question"": ""What is a characteristic of serous effusions in the context of oedema?"", ""option_a"": ""They are exudates with a protein concentration greater than 20 g/Litre"", ""option_b"": ""They are transudates with a protein concentration less than 20 g/Litre"", ""option_c"": ""They have a variable protein concentration depending on the underlying cause"", ""option_d"": ""They are always associated with hemodilution and hypoprotidemia"", ""correct_option"": ""B""}","Additional tests","What is a characteristic of serous effusions in the context of oedema?","They are exudates with a protein concentration greater than 20 g/Litre","They are transudates with a protein concentration less than 20 g/Litre","They have a variable protein concentration depending on the underlying cause","They are always associated with hemodilution and hypoprotidemia","b"
"OIC-257-07-A","{""question"": ""What is a common cause of generalised oedema related to the liver?"", ""option_a"": ""Hepatic cirrhosis"", ""option_b"": ""Acute renal failure"", ""option_c"": ""Global heart failure"", ""option_d"": ""Thrombophlebitis"", ""correct_option"": ""A""}","Etiologies","What is a common cause of generalised oedema related to the liver?","Hepatic cirrhosis","Acute renal failure","Global heart failure","Thrombophlebitis","a"
"OIC-257-08-A","{""question"": ""What type of diuretics have the most powerful natriuretic effect in the treatment of generalized oedema?"", ""option_a"": ""Thiazides"", ""option_b"": ""Distal-acting diuretics"", ""option_c"": ""Henle loop diuretics"", ""option_d"": ""Aldosterone antagonists"", ""correct_option"": ""C""}",,"What type of diuretics have the most powerful natriuretic effect in the treatment of generalized oedema?","Thiazides","Distal-acting diuretics","Henle loop diuretics","Aldosterone antagonists","c"
"OIC-260-01-A","{""question"": ""What is the definition of haematuria?"", ""option_a"": ""The normal presence of red blood cells in the urine"", ""option_b"": ""The abnormal presence of white blood cells in the urine"", ""option_c"": ""The abnormal presence of red blood cells in the urine"", ""option_d"": ""The presence of red blood cells in the urine only during micturition"", ""correct_option"": ""C""}","Definition","What is the definition of haematuria?","The normal presence of red blood cells in the urine","The abnormal presence of white blood cells in the urine","The abnormal presence of red blood cells in the urine","The presence of red blood cells in the urine only during micturition","c"
"OIC-260-02-B","{""question"": ""What is the primary mechanism of haematuria in nephrological etiologies?"", ""option_a"": ""Lesion of the renal parenchyma or urinary tree with effraction of blood vessels"", ""option_b"": ""Passage of red blood cells through an altered glomerular basement membrane"", ""option_c"": ""Activation of fibrinolytic tubular urokinase without glomerular damage"", ""option_d"": ""Remodelling of the glomerular structure without altered glomerular basement membrane"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism of haematuria in nephrological etiologies?","Lesion of the renal parenchyma or urinary tree with effraction of blood vessels","Passage of red blood cells through an altered glomerular basement membrane","Activation of fibrinolytic tubular urokinase without glomerular damage","Remodelling of the glomerular structure without altered glomerular basement membrane","b"
"OIC-260-03-A","{""question"": ""What is the diagnostic value of microscopic haematuria compared to macroscopic haematuria?"", ""option_a"": ""Microscopic haematuria has a lower diagnostic value than macroscopic haematuria"", ""option_b"": ""Microscopic haematuria has the same diagnostic value as macroscopic haematuria"", ""option_c"": ""Microscopic haematuria is only used to confirm macroscopic haematuria"", ""option_d"": ""The diagnostic value of microscopic haematuria is directly correlated with the amount of bleeding"", ""correct_option"": ""B""}","Positive diagnosis","What is the diagnostic value of microscopic haematuria compared to macroscopic haematuria?","Microscopic haematuria has a lower diagnostic value than macroscopic haematuria","Microscopic haematuria has the same diagnostic value as macroscopic haematuria","Microscopic haematuria is only used to confirm macroscopic haematuria","The diagnostic value of microscopic haematuria is directly correlated with the amount of bleeding","b"
"OIC-260-04-B","{""question"": ""What is the localising value of initial haematuria during micturition in a patient with macroscopic haematuria of urological origin?"", ""option_a"": ""Bladder origin"", ""option_b"": ""Urethro-prostatic or bladder neck origin"", ""option_c"": ""Renal origin"", ""option_d"": ""Nephrological origin with associated proteinuria"", ""correct_option"": ""B""}","Positive diagnosis","What is the localising value of initial haematuria during micturition in a patient with macroscopic haematuria of urological origin?","Bladder origin","Urethro-prostatic or bladder neck origin","Renal origin","Nephrological origin with associated proteinuria","b"
"OIC-260-05-B","{""question"": ""What is the primary imaging modality used in the initial assessment of haematuria?"", ""option_a"": ""Uro-scanner"", ""option_b"": ""Renal-vesical ultrasound"", ""option_c"": ""Uro-MRI"", ""option_d"": ""Intravenous pyelography"", ""correct_option"": ""B""}","Complementary examinations","What is the primary imaging modality used in the initial assessment of haematuria?","Uro-scanner","Renal-vesical ultrasound","Uro-MRI","Intravenous pyelography","b"
"OIC-260-06-B","{""question"": ""What is a typical example of a frequent cause of haematuria that can be identified through imaging?"", ""option_a"": ""Infection of the urinary tract"", ""option_b"": ""Locally advanced renal tumour, such as clear cell renal cell carcinoma"", ""option_c"": ""Kidney stone"", ""option_d"": ""Bladder cyst"", ""correct_option"": ""B""}","Multimedia content","What is a typical example of a frequent cause of haematuria that can be identified through imaging?","Infection of the urinary tract","Locally advanced renal tumour, such as clear cell renal cell carcinoma","Kidney stone","Bladder cyst","b"
"OIC-260-07-A","{""question"": ""What is the term used to describe the presence of blood in the urine that can be seen with the naked eye?"", ""option_a"": ""Microscopic haematuria"", ""option_b"": ""Macroscopic haematuria"", ""option_c"": ""Gross haemoglobinuria"", ""option_d"": ""Visible proteinuria"", ""correct_option"": ""B""}","Multimedia content","What is the term used to describe the presence of blood in the urine that can be seen with the naked eye?","Microscopic haematuria","Macroscopic haematuria","Gross haemoglobinuria","Visible proteinuria","b"
"OIC-260-08-A","{""question"": ""What does the presence of three crosses (+++) on a urine dipstick typically indicate?"", ""option_a"": ""Normal urine composition"", ""option_b"": ""Presence of an infection"", ""option_c"": ""Haematuria, or blood in the urine"", ""option_d"": ""Proteinuria, or excess protein in the urine"", ""correct_option"": ""C""}","Multimedia content","What does the presence of three crosses (+++) on a urine dipstick typically indicate?","Normal urine composition","Presence of an infection","Haematuria, or blood in the urine","Proteinuria, or excess protein in the urine","c"
"OIC-260-09-A","{""question"": ""What is the most likely nephrological cause of haematuria in a young man with a history of recurrent macroscopic haematuria 48 hours after an episode of ENT infection?"", ""option_a"": ""Alport syndrome"", ""option_b"": ""Acute interstitial nephropathy"", ""option_c"": ""Primary IgA nephropathy"", ""option_d"": ""Autosomal dominant polycystic kidney disease (ADPKD)"", ""correct_option"": ""C""}","Etiologies","What is the most likely nephrological cause of haematuria in a young man with a history of recurrent macroscopic haematuria 48 hours after an episode of ENT infection?","Alport syndrome","Acute interstitial nephropathy","Primary IgA nephropathy","Autosomal dominant polycystic kidney disease (ADPKD)","c"
"OIC-260-10-A","{""question"": ""What is the main etiology to be ruled out in adults with haematuria due to its severity?"", ""option_a"": ""Urinary tract infections"", ""option_b"": ""Urinary lithiasis"", ""option_c"": ""Urothelial tumours of the bladder and upper excretory tract"", ""option_d"": ""Benign prostatic hypertrophy"", ""correct_option"": ""C""}","Etiologies","What is the main etiology to be ruled out in adults with haematuria due to its severity?","Urinary tract infections","Urinary lithiasis","Urothelial tumours of the bladder and upper excretory tract","Benign prostatic hypertrophy","c"
"OIC-260-11-A","{""question"": ""What is the primary goal of a diagnostic tree for haematuria?"", ""option_a"": ""To determine the underlying cause of haematuria"", ""option_b"": ""To decide on the treatment for haematuria without considering the cause"", ""option_c"": ""To identify the most common symptoms associated with haematuria"", ""option_d"": ""To rule out other conditions that may mimic haematuria"", ""correct_option"": ""A""}","Positive diagnosis","What is the primary goal of a diagnostic tree for haematuria?","To determine the underlying cause of haematuria","To decide on the treatment for haematuria without considering the cause","To identify the most common symptoms associated with haematuria","To rule out other conditions that may mimic haematuria","a"
"OIC-260-12-A","{""question"": ""What is a potential complication of significant haemorrhage in macroscopic haematuria?"", ""option_a"": ""Chronic anaemia due to persistent haematuria"", ""option_b"": ""Bladder or ureteral clotting leading to acute urine retention or renal colic"", ""option_c"": ""Sepsis due to bacterial infection of the urinary tract"", ""option_d"": ""Hypertension due to increased blood pressure from haematuria"", ""correct_option"": ""B""}","Identification of the emergency","What is a potential complication of significant haemorrhage in macroscopic haematuria?","Chronic anaemia due to persistent haematuria","Bladder or ureteral clotting leading to acute urine retention or renal colic","Sepsis due to bacterial infection of the urinary tract","Hypertension due to increased blood pressure from haematuria","b"
"OIC-260-13-B","{""question"": ""What is the recommended approach for managing urine retention due to bladder clotting in cases of clotting macroscopic haematuria?"", ""option_a"": ""Placement of a suprapubic catheter to allow for continuous bladder drainage"", ""option_b"": ""Placement of a double-stream bladder catheter with manual decapping and continuous irrigation"", ""option_c"": ""Immediate endoscopic surgical decalcification in the operating theatre"", ""option_d"": ""Insertion of a ureteral stent to relieve obstruction"", ""correct_option"": ""B""}","Management","What is the recommended approach for managing urine retention due to bladder clotting in cases of clotting macroscopic haematuria?","Placement of a suprapubic catheter to allow for continuous bladder drainage","Placement of a double-stream bladder catheter with manual decapping and continuous irrigation","Immediate endoscopic surgical decalcification in the operating theatre","Insertion of a ureteral stent to relieve obstruction","b"
"OIC-261-01-A","{""question"": ""What is a key characteristic of proteinuria in glomerular nephropathy?"", ""option_a"": ""Composed of less than 30% albumin"", ""option_b"": ""Detected only by assay in g/g creatinine"", ""option_c"": ""Composed of at least 60% albumin"", ""option_d"": ""Always associated with macroscopic haematuria"", ""correct_option"": ""C""}","Positive diagnosis","What is a key characteristic of proteinuria in glomerular nephropathy?","Composed of less than 30% albumin","Detected only by assay in g/g creatinine","Composed of at least 60% albumin","Always associated with macroscopic haematuria","c"
"OIC-261-02-A","{""question"": ""What is a characteristic sign of the Nephrotic syndrome?"", ""option_a"": ""Sudden onset of edema and anasarca"", ""option_b"": ""Proteinuria \u2265 3 g/24 h and albumin levels < 30 g/L"", ""option_c"": ""Recurrent macroscopic haematuria and microscopic haematuria between episodes"", ""option_d"": ""Rapidly progressive renal failure and oliguria"", ""correct_option"": ""B""}","Definition","What is a characteristic sign of the Nephrotic syndrome?","Sudden onset of edema and anasarca","Proteinuria ≥ 3 g/24 h and albumin levels < 30 g/L","Recurrent macroscopic haematuria and microscopic haematuria between episodes","Rapidly progressive renal failure and oliguria","b"
"OIC-261-03-B","{""question"": ""What is the leading cause of nephrotic syndrome in adults, excluding diabetic nephropathy?"", ""option_a"": ""Nephrotic syndrome with minimal glomerular lesions (SNLGM)"", ""option_b"": ""Extra-membranous glomerulopathy"", ""option_c"": ""IgA nephropathy"", ""option_d"": ""Lupus nephropathy"", ""correct_option"": ""B""}","Epidemiology","What is the leading cause of nephrotic syndrome in adults, excluding diabetic nephropathy?","Nephrotic syndrome with minimal glomerular lesions (SNLGM)","Extra-membranous glomerulopathy","IgA nephropathy","Lupus nephropathy","b"
"OIC-261-04-A","{""question"": ""What is a common cause of glomerular diseases that can lead to glomerulonephritis (GN)?"", ""option_a"": ""Hypertension"", ""option_b"": ""Diabetes"", ""option_c"": ""Hyperlipidemia"", ""option_d"": ""Asthma"", ""correct_option"": ""B""}","Etiologies","What is a common cause of glomerular diseases that can lead to glomerulonephritis (GN)?","Hypertension","Diabetes","Hyperlipidemia","Asthma","b"
"OIC-261-05-B","{""question"": ""What is a contraindication for renal puncture biopsy (RPB) that is considered temporary?"", ""option_a"": ""Single kidney"", ""option_b"": ""Poorly controlled hypertension"", ""option_c"": ""Acute pyelonephritis"", ""option_d"": ""Hereditary cluster disease already documented in the family"", ""correct_option"": ""C""}","Additional examinations","What is a contraindication for renal puncture biopsy (RPB) that is considered temporary?","Single kidney","Poorly controlled hypertension","Acute pyelonephritis","Hereditary cluster disease already documented in the family","c"
"OIC-261-06-B","{""question"": ""What is the primary method used to study cell proliferation in the glomerulus, such as mesangial proliferation and endocapillary proliferation?"", ""option_a"": ""Electron microscopy"", ""option_b"": ""Light microscopy using PAS, trichrome, and silver staining"", ""option_c"": ""Immunofluorescence examination using antibodies directed against IgG, IgA, and IgM"", ""option_d"": ""Urinalysis"", ""correct_option"": ""B""}","Definition","What is the primary method used to study cell proliferation in the glomerulus, such as mesangial proliferation and endocapillary proliferation?","Electron microscopy","Light microscopy using PAS, trichrome, and silver staining","Immunofluorescence examination using antibodies directed against IgG, IgA, and IgM","Urinalysis","b"
"OIC-261-07-B","{""question"": ""What is the main histological feature of Minimal glomerular lesions?"", ""option_a"": ""Presence of IgG and C3 deposits on the lateral side of the glomerular basement membrane"", ""option_b"": ""Mesangial proliferation and IgA deposits"", ""option_c"": ""Absence of abnormalities with no proliferation and no deposits"", ""option_d"": ""Extracapillary proliferation with linear IgG deposits along the glomerular basement membrane"", ""correct_option"": ""C""}","Definition","What is the main histological feature of Minimal glomerular lesions?","Presence of IgG and C3 deposits on the lateral side of the glomerular basement membrane","Mesangial proliferation and IgA deposits","Absence of abnormalities with no proliferation and no deposits","Extracapillary proliferation with linear IgG deposits along the glomerular basement membrane","c"
"OIC-261-08-A","{""question"": ""What is a characteristic finding on electron microscopy in patients with minimal glomerular nephrotic syndrome (MGNS)?"", ""option_a"": ""Presence of immune complex deposits"", ""option_b"": ""Fusion of the feet of the podocytes"", ""option_c"": ""Thickening of the glomerular basement membrane"", ""option_d"": ""Inflammation of the glomeruli"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic finding on electron microscopy in patients with minimal glomerular nephrotic syndrome (MGNS)?","Presence of immune complex deposits","Fusion of the feet of the podocytes","Thickening of the glomerular basement membrane","Inflammation of the glomeruli","b"
"OIC-261-09-B","{""question"": ""What is the primary treatment approach for idiopathic SNLGM?"", ""option_a"": ""Symptomatic treatment of nephrotic syndrome alone"", ""option_b"": ""Prolonged high-dose oral corticosteroid therapy with adjuvant treatments"", ""option_c"": ""Immediate kidney transplantation"", ""option_d"": ""Low-dose oral corticosteroid therapy without adjuvant treatments"", ""correct_option"": ""B""}","Management","What is the primary treatment approach for idiopathic SNLGM?","Symptomatic treatment of nephrotic syndrome alone","Prolonged high-dose oral corticosteroid therapy with adjuvant treatments","Immediate kidney transplantation","Low-dose oral corticosteroid therapy without adjuvant treatments","b"
"OIC-261-10-B","{""question"": ""What is the typical outcome for patients with corticosteroid-sensitive nephrotic syndrome (NS) after discontinuation of treatment?"", ""option_a"": ""Relapse occurs in nearly all cases, necessitating lifelong corticosteroid therapy"", ""option_b"": ""Relapse after discontinuation of treatment in 50% of cases, necessitating resumption of corticosteroid therapy"", ""option_c"": ""Disappearance of proteinuria is permanent, with no risk of relapse"", ""option_d"": ""Progression to end-stage chronic renal failure within 1 year"", ""correct_option"": ""B""}",,"What is the typical outcome for patients with corticosteroid-sensitive nephrotic syndrome (NS) after discontinuation of treatment?","Relapse occurs in nearly all cases, necessitating lifelong corticosteroid therapy","Relapse after discontinuation of treatment in 50% of cases, necessitating resumption of corticosteroid therapy","Disappearance of proteinuria is permanent, with no risk of relapse","Progression to end-stage chronic renal failure within 1 year","b"
"OIC-261-11-B","{""question"": ""What is the most common presentation of extra-membranous glomerulopathy (GEM) in over 85% of cases?"", ""option_a"": ""Nephritic syndrome"", ""option_b"": ""Nephrotic syndrome which is often impure"", ""option_c"": ""Acute kidney injury"", ""option_d"": ""Chronic kidney disease"", ""correct_option"": ""B""}","Positive diagnosis","What is the most common presentation of extra-membranous glomerulopathy (GEM) in over 85% of cases?","Nephritic syndrome","Nephrotic syndrome which is often impure","Acute kidney injury","Chronic kidney disease","b"
"OIC-261-12-B","{""question"": ""What is a suggestive clinical element for IgA nephropathy?"", ""option_a"": ""Haematuria occurring immediately after an infectious episode"", ""option_b"": ""Haematuria occurring 48 hours after an infectious episode"", ""option_c"": ""Proteinuria alone without any history of infection"", ""option_d"": ""Chronic glomerulonephritis syndrome without any history of haematuria"", ""correct_option"": ""B""}","Positive diagnosis","What is a suggestive clinical element for IgA nephropathy?","Haematuria occurring immediately after an infectious episode","Haematuria occurring 48 hours after an infectious episode","Proteinuria alone without any history of infection","Chronic glomerulonephritis syndrome without any history of haematuria","b"
"OIC-261-13-B","{""question"": ""What is a significant poor prognostic factor in primary IgA nephropathy?"", ""option_a"": ""Female sex"", ""option_b"": ""Mild hypertension"", ""option_c"": ""Significance of proteinuria"", ""option_d"": ""Absence of renal failure at diagnosis"", ""correct_option"": ""C""}","Monitoring and/or prognosis","What is a significant poor prognostic factor in primary IgA nephropathy?","Female sex","Mild hypertension","Significance of proteinuria","Absence of renal failure at diagnosis","c"
"OIC-261-14-A","{""question"": ""What is the primary method for determining the type of Rapidly Progressive Glomerulonephritis (RPGN) and guiding the aetiological diagnosis?"", ""option_a"": ""Clinical presentation and patient history"", ""option_b"": ""Renal biopsy showing extra-capillary proliferative glomerulonephritis with extra-capillary crescents"", ""option_c"": ""Laboratory tests including anti-GBM, ANCA, and complement levels"", ""option_d"": ""Imaging studies such as chest scans and BAL"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method for determining the type of Rapidly Progressive Glomerulonephritis (RPGN) and guiding the aetiological diagnosis?","Clinical presentation and patient history","Renal biopsy showing extra-capillary proliferative glomerulonephritis with extra-capillary crescents","Laboratory tests including anti-GBM, ANCA, and complement levels","Imaging studies such as chest scans and BAL","b"
"OIC-261-15-A","{""question"": ""What is a significant risk associated with GNRP syndrome?"", ""option_a"": ""Temporary kidney dysfunction"", ""option_b"": ""Permanent kidney failure (stage 5 chronic kidney disease)"", ""option_c"": ""Mild respiratory issues"", ""option_d"": ""Reversible digestive problems"", ""correct_option"": ""B""}","Emergency identification","What is a significant risk associated with GNRP syndrome?","Temporary kidney dysfunction","Permanent kidney failure (stage 5 chronic kidney disease)","Mild respiratory issues","Reversible digestive problems","b"
"OIC-261-16-B","{""question"": ""What is the typical time frame for the development of acute nephritic syndrome after an episode of ENT or skin infection in acute post-infectious glomerulonephritis?"", ""option_a"": ""Immediately after the infection"", ""option_b"": ""Within 10-15 days of the infection"", ""option_c"": ""Several months after the infection"", ""option_d"": ""Only after antibiotic treatment has begun"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical time frame for the development of acute nephritic syndrome after an episode of ENT or skin infection in acute post-infectious glomerulonephritis?","Immediately after the infection","Within 10-15 days of the infection","Several months after the infection","Only after antibiotic treatment has begun","b"
"OIC-261-17-B","{""question"": ""What is the primary finding in immunofluorescence studies of renal biopsy specimens from patients with acute post-infectious glomerulonephritis?"", ""option_a"": ""Deposits of IgA in the mesangium"", ""option_b"": ""Deposits of C3 in the mesangium and in the wall of the glomerular capillaries"", ""option_c"": ""Deposits of C4 in the glomerular capillaries"", ""option_d"": ""Absence of immunoglobulin deposits"", ""correct_option"": ""B""}","Additional tests","What is the primary finding in immunofluorescence studies of renal biopsy specimens from patients with acute post-infectious glomerulonephritis?","Deposits of IgA in the mesangium","Deposits of C3 in the mesangium and in the wall of the glomerular capillaries","Deposits of C4 in the glomerular capillaries","Absence of immunoglobulin deposits","b"
"OIC-261-18-B","{""question"": ""What is the primary treatment approach for primary GEM with persistent nephrotic syndrome after 6 months of evolution and/or with renal failure?"", ""option_a"": ""Symptomatic and anti-proteinuric treatment only"", ""option_b"": ""Treatment with an immunosuppressant"", ""option_c"": ""Plasma exchange"", ""option_d"": ""Corticosteroids only"", ""correct_option"": ""B""}","Management","What is the primary treatment approach for primary GEM with persistent nephrotic syndrome after 6 months of evolution and/or with renal failure?","Symptomatic and anti-proteinuric treatment only","Treatment with an immunosuppressant","Plasma exchange","Corticosteroids only","b"
"OIC-263-01-A","{""question"": ""What is the primary characteristic that distinguishes vascular nephropathies from other kidney diseases?"", ""option_a"": ""Damage to the renal parenchyma"", ""option_b"": ""Damage to the renal vessels"", ""option_c"": ""Infection of the urinary tract"", ""option_d"": ""Obstruction of the ureters"", ""correct_option"": ""B""}","Definition","What is the primary characteristic that distinguishes vascular nephropathies from other kidney diseases?","Damage to the renal parenchyma","Damage to the renal vessels","Infection of the urinary tract","Obstruction of the ureters","b"
"OIC-263-02-A","{""question"": ""What is the biological definition of thrombotic microangiopathy syndrome?"", ""option_a"": ""Haemolytic anaemia, consumption thrombocytopenia, and associated organ dysfunctions without schizocytes"", ""option_b"": ""Haemolytic anaemia, mechanical type with schizocytes, consumption thrombocytopenia, and associated with one or more organ dysfunctions"", ""option_c"": ""Only consumption thrombocytopenia and associated organ dysfunctions"", ""option_d"": ""Haemolytic anaemia and consumption thrombocytopenia without associated organ dysfunctions"", ""correct_option"": ""B""}","Definition","What is the biological definition of thrombotic microangiopathy syndrome?","Haemolytic anaemia, consumption thrombocytopenia, and associated organ dysfunctions without schizocytes","Haemolytic anaemia, mechanical type with schizocytes, consumption thrombocytopenia, and associated with one or more organ dysfunctions","Only consumption thrombocytopenia and associated organ dysfunctions","Haemolytic anaemia and consumption thrombocytopenia without associated organ dysfunctions","b"
"OIC-263-03-B","{""question"": ""What is a common cause of atypical Hemolytic Uremic Syndrome (HUS)?"", ""option_a"": ""Infection with E.Coli O157:H7"", ""option_b"": ""Mutation of genes coding for complement proteins"", ""option_c"": ""Use of anti-VEGF medications"", ""option_d"": ""Malignant hypertension"", ""correct_option"": ""B""}","Etiologies","What is a common cause of atypical Hemolytic Uremic Syndrome (HUS)?","Infection with E.Coli O157:H7","Mutation of genes coding for complement proteins","Use of anti-VEGF medications","Malignant hypertension","b"
"OIC-263-04-B","{""question"": ""What is a common cause of typical Haemolytic Uraemic Syndrome (HUS) in children?"", ""option_a"": ""A viral infection"", ""option_b"": ""Bloody diarrhoea caused by Shigatoxin-secreting enterobacteria"", ""option_c"": ""A genetic disorder"", ""option_d"": ""A chronic kidney disease"", ""correct_option"": ""B""}","Definition","What is a common cause of typical Haemolytic Uraemic Syndrome (HUS) in children?","A viral infection","Bloody diarrhoea caused by Shigatoxin-secreting enterobacteria","A genetic disorder","A chronic kidney disease","b"
"OIC-263-05-B","{""question"": ""What is the typical presentation of Hemolytic Uremic Syndrome (HUS) in children?"", ""option_a"": ""Acute renal failure, haemolytic anaemia, and thrombocytopenia following a viral infection"", ""option_b"": ""Combination of acute renal failure, haemolytic anaemia, and thrombocytopenia following food contamination causing bloody diarrhoea"", ""option_c"": ""Atypical HUS with recurrent episodes after renal transplantation"", ""option_d"": ""Nephrotic syndrome with hypercoagulability and thrombosis"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical presentation of Hemolytic Uremic Syndrome (HUS) in children?","Acute renal failure, haemolytic anaemia, and thrombocytopenia following a viral infection","Combination of acute renal failure, haemolytic anaemia, and thrombocytopenia following food contamination causing bloody diarrhoea","Atypical HUS with recurrent episodes after renal transplantation","Nephrotic syndrome with hypercoagulability and thrombosis","b"
"OIC-263-06-A","{""question"": ""What is the most common type of renal artery stenosis, accounting for 90% of cases?"", ""option_a"": ""Fibrodysplastic stenosis"", ""option_b"": ""Atheromatous stenosis"", ""option_c"": ""Mixed stenosis"", ""option_d"": ""Idiopathic stenosis"", ""correct_option"": ""B""}","Positive diagnosis","What is the most common type of renal artery stenosis, accounting for 90% of cases?","Fibrodysplastic stenosis","Atheromatous stenosis","Mixed stenosis","Idiopathic stenosis","b"
"OIC-263-07-B","{""question"": ""What are the two main causes of renal artery stenosis?"", ""option_a"": ""Atheromatous and diabetic nephropathy"", ""option_b"": ""Fibrodysplastic and hypertensive nephrosclerosis"", ""option_c"": ""Atheromatous and fibrodysplastic"", ""option_d"": ""Chronic pyelonephritis and glomerulonephritis"", ""correct_option"": ""C""}","Positive diagnosis","What are the two main causes of renal artery stenosis?","Atheromatous and diabetic nephropathy","Fibrodysplastic and hypertensive nephrosclerosis","Atheromatous and fibrodysplastic","Chronic pyelonephritis and glomerulonephritis","c"
"OIC-263-08-B","{""question"": ""What is the primary advantage of using Angio-MRI for diagnosing renal artery stenosis?"", ""option_a"": ""Direct visualisation of the renal arteries with no risk of iodine injection"", ""option_b"": ""Widespread availability and low cost compared to other imaging techniques"", ""option_c"": ""Ability to measure resistance indexes and predict response to treatment"", ""option_d"": ""High sensitivity for detecting kidney size asymmetry"", ""correct_option"": ""A""}","Positive diagnosis","What is the primary advantage of using Angio-MRI for diagnosing renal artery stenosis?","Direct visualisation of the renal arteries with no risk of iodine injection","Widespread availability and low cost compared to other imaging techniques","Ability to measure resistance indexes and predict response to treatment","High sensitivity for detecting kidney size asymmetry","a"
"OIC-263-09-A","{""question"": ""What is the primary cause of benign nephroangiosclerosis?"", ""option_a"": ""Acute occlusion of a renal artery or its branches"", ""option_b"": ""Rupture of an atheromatous plaque leading to cholesterol crystal embolism"", ""option_c"": ""Long-standing, inadequately controlled hypertension"", ""option_d"": ""Arterial embolism due to atrial fibrillation"", ""correct_option"": ""C""}","Definition","What is the primary cause of benign nephroangiosclerosis?","Acute occlusion of a renal artery or its branches","Rupture of an atheromatous plaque leading to cholesterol crystal embolism","Long-standing, inadequately controlled hypertension","Arterial embolism due to atrial fibrillation","c"
"OIC-263-10-B","{""question"": ""What is the primary method to confirm the diagnosis of renal infarction?"", ""option_a"": ""Blood tests, including elevation of LDH and variable elevation of creatinine"", ""option_b"": ""Spiral CT scan, MRI angiography, or arteriography"", ""option_c"": ""Urinalysis, including the presence of haematuria or leucocyturia"", ""option_d"": ""Physical examination, including the assessment of back pain and abdominal pain"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary method to confirm the diagnosis of renal infarction?","Blood tests, including elevation of LDH and variable elevation of creatinine","Spiral CT scan, MRI angiography, or arteriography","Urinalysis, including the presence of haematuria or leucocyturia","Physical examination, including the assessment of back pain and abdominal pain","b"
"OIC-265-01-A","{""question"": ""What is the primary location where the majority of urinary stones form?"", ""option_a"": ""Bladder"", ""option_b"": ""Kidneys"", ""option_c"": ""Ureter"", ""option_d"": ""Urethra"", ""correct_option"": ""B""}","Definition","What is the primary location where the majority of urinary stones form?","Bladder","Kidneys","Ureter","Urethra","b"
"OIC-265-02-B","{""question"": ""What is the estimated sex ratio of urinary lithiasis?"", ""option_a"": ""1 man to 1 woman"", ""option_b"": ""2 men to 1 woman"", ""option_c"": ""1 man to 2 women"", ""option_d"": ""3 men to 1 woman"", ""correct_option"": ""B""}","Epidemiology","What is the estimated sex ratio of urinary lithiasis?","1 man to 1 woman","2 men to 1 woman","1 man to 2 women","3 men to 1 woman","b"
"OIC-265-03-B","{""question"": ""What is the most common type of urinary stone, according to prevalence?"", ""option_a"": ""Calcium phosphate"", ""option_b"": ""Calcium oxalate"", ""option_c"": ""Ammonium magnesium phosphate"", ""option_d"": ""Uric acid"", ""correct_option"": ""B""}","Epidemiology","What is the most common type of urinary stone, according to prevalence?","Calcium phosphate","Calcium oxalate","Ammonium magnesium phosphate","Uric acid","b"
"OIC-265-04-B","{""question"": ""What is a common genetic disease associated with urinary lithiasis?"", ""option_a"": ""Cystinuria"", ""option_b"": ""Hypercalciuria"", ""option_c"": ""Pseudomonas infection"", ""option_d"": ""Pyeloureteral junction syndrome"", ""correct_option"": ""A""}","Physiopathology","What is a common genetic disease associated with urinary lithiasis?","Cystinuria","Hypercalciuria","Pseudomonas infection","Pyeloureteral junction syndrome","a"
"OIC-265-05-A","{""question"": ""What is the primary characteristic of renal colic?"", ""option_a"": ""A gradual increase in pain due to infection in the upper urinary tract"", ""option_b"": ""Sudden pain due to tension in the upper excretory tract caused by an obstruction"", ""option_c"": ""Chronic pain in the lower back unrelated to the urinary tract"", ""option_d"": ""A mild ache in the abdominal region caused by digestive issues"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary characteristic of renal colic?","A gradual increase in pain due to infection in the upper urinary tract","Sudden pain due to tension in the upper excretory tract caused by an obstruction","Chronic pain in the lower back unrelated to the urinary tract","A mild ache in the abdominal region caused by digestive issues","b"
"OIC-265-06-A","{""question"": ""What is a factor that can contribute to the onset of renal colic?"", ""option_a"": ""Hypothermia"", ""option_b"": ""Dehydration"", ""option_c"": ""Sedentary lifestyle"", ""option_d"": ""Adequate hydration"", ""correct_option"": ""B""}","Positive diagnosis","What is a factor that can contribute to the onset of renal colic?","Hypothermia","Dehydration","Sedentary lifestyle","Adequate hydration","b"
"OIC-265-07-A","{""question"": ""What characterizes simple renal colic?"", ""option_a"": ""Presence of fever and chills with biological renal failure"", ""option_b"": ""Absence of pain and radiation with nausea"", ""option_c"": ""Occurrence without fever or chills, no biological renal failure, and subsidence with NSAIDs"", ""option_d"": ""Necessity for surgical intervention due to oligo-anuria"", ""correct_option"": ""C""}","Positive diagnosis","What characterizes simple renal colic?","Presence of fever and chills with biological renal failure","Absence of pain and radiation with nausea","Occurrence without fever or chills, no biological renal failure, and subsidence with NSAIDs","Necessity for surgical intervention due to oligo-anuria","c"
"OIC-265-08-A","{""question"": ""What is the recommended initial imaging approach for a pregnant woman with nephritic colic in the 1st trimester?"", ""option_a"": ""Low-dose CT (<4 mSv)"", ""option_b"": ""Ultrasound or non-injected 1.5T MRI"", ""option_c"": ""Contrast-enhanced CT scan"", ""option_d"": ""Intravenous urography (IVU)"", ""correct_option"": ""B""}","Positive diagnosis","What is the recommended initial imaging approach for a pregnant woman with nephritic colic in the 1st trimester?","Low-dose CT (<4 mSv)","Ultrasound or non-injected 1.5T MRI","Contrast-enhanced CT scan","Intravenous urography (IVU)","b"
"OIC-265-09-B","{""question"": ""What are the symptoms associated with a urinary calculus, excluding renal colic?"", ""option_a"": ""Only haematuria and urinary infections"", ""option_b"": ""Haematuria, urinary infections, and renal insufficiency"", ""option_c"": ""Renal insufficiency alone, as other symptoms are rare"", ""option_d"": ""None, urinary calculi always present with renal colic"", ""correct_option"": ""B""}","Positive diagnosis","What are the symptoms associated with a urinary calculus, excluding renal colic?","Only haematuria and urinary infections","Haematuria, urinary infections, and renal insufficiency","Renal insufficiency alone, as other symptoms are rare","None, urinary calculi always present with renal colic","b"
"OIC-265-10-B","{""question"": ""Which of the following types of kidney stones are not visible on a CT scan?"", ""option_a"": ""Uric acid stones"", ""option_b"": ""Calcium oxalate stones"", ""option_c"": ""Cystine stones"", ""option_d"": ""Drug stones"", ""correct_option"": ""D""}","Complementary examinations","Which of the following types of kidney stones are not visible on a CT scan?","Uric acid stones","Calcium oxalate stones","Cystine stones","Drug stones","d"
"OIC-265-11-A","{""question"": ""What is the primary purpose of biological tests carried out in the emergency department for renal colic?"", ""option_a"": ""To confirm the diagnosis of renal colic"", ""option_b"": ""To identify severe or complicated forms of renal colic"", ""option_c"": ""To determine the size and location of kidney stones"", ""option_d"": ""To assess the patient's overall kidney function"", ""correct_option"": ""B""}","Additional tests","What is the primary purpose of biological tests carried out in the emergency department for renal colic?","To confirm the diagnosis of renal colic","To identify severe or complicated forms of renal colic","To determine the size and location of kidney stones","To assess the patient's overall kidney function","b"
"OIC-265-12-B","{""question"": ""What is included in the first-line metabolic work-up for the aetiological diagnosis of urinary lithiasis as recommended by the Lithiasis Committee?"", ""option_a"": ""Only morphological and infrared analysis of the stone or fragments"", ""option_b"": ""Morphological and infrared analysis of the stone or fragments, and a metabolic assessment including urine and blood analysis"", ""option_c"": ""A metabolic assessment on fresh morning urine sample and 24-hour urine analysis, but not blood analysis"", ""option_d"": ""Blood analysis only, including creatinine, calcium, fasting blood sugar, and uricemia"", ""correct_option"": ""B""}","Additional tests","What is included in the first-line metabolic work-up for the aetiological diagnosis of urinary lithiasis as recommended by the Lithiasis Committee?","Only morphological and infrared analysis of the stone or fragments","Morphological and infrared analysis of the stone or fragments, and a metabolic assessment including urine and blood analysis","A metabolic assessment on fresh morning urine sample and 24-hour urine analysis, but not blood analysis","Blood analysis only, including creatinine, calcium, fasting blood sugar, and uricemia","b"
"OIC-265-13-B","{""question"": ""What are the main metabolic abnormalities associated with calcium lithiasis?"", ""option_a"": ""Hyperparathyroidism"", ""option_b"": ""Hyperoxaluria and renal tubular acidosis"", ""option_c"": ""Idiopathic hypercalciuria and primary hypercalcaemia"", ""option_d"": ""Granulomatosis and nephrocalcinosis"", ""correct_option"": ""A""}","Etiologies","What are the main metabolic abnormalities associated with calcium lithiasis?","Hyperparathyroidism","Hyperoxaluria and renal tubular acidosis","Idiopathic hypercalciuria and primary hypercalcaemia","Granulomatosis and nephrocalcinosis","a"
"OIC-265-14-A","{""question"": ""What is the primary indication for medical expulsive therapy (MET) in the management of urinary lithiasis?"", ""option_a"": ""Fever and signs of infection"", ""option_b"": ""High probability of spontaneous elimination, pain relieved by standard analgesics, and no signs of infection or renal failure"", ""option_c"": ""Acute renal failure or chronic obstruction"", ""option_d"": ""Stone size greater than 15mm"", ""correct_option"": ""B""}","Management","What is the primary indication for medical expulsive therapy (MET) in the management of urinary lithiasis?","Fever and signs of infection","High probability of spontaneous elimination, pain relieved by standard analgesics, and no signs of infection or renal failure","Acute renal failure or chronic obstruction","Stone size greater than 15mm","b"
"OIC-267-01-A","{""question"": ""In which of the following situations is it necessary to perform venous gasometry?"", ""option_a"": ""Shock"", ""option_b"": ""Suspected ketoacidosis"", ""option_c"": ""Acute respiratory failure"", ""option_d"": ""Severe acute renal failure with no suspicion of ketoacidosis"", ""correct_option"": ""B""}","Positive diagnosis","In which of the following situations is it necessary to perform venous gasometry?","Shock","Suspected ketoacidosis","Acute respiratory failure","Severe acute renal failure with no suspicion of ketoacidosis","b"
"OIC-267-02-B","{""question"": ""What is the primary mechanism by which the lung contributes to acid-base balance?"", ""option_a"": ""By regulating the concentration of bicarbonate ions in the blood"", ""option_b"": ""By excreting carbon dioxide through the respiratory tract, thereby modifying the pCO2 of arterial blood"", ""option_c"": ""By directly buffering fixed acids resulting from protein metabolism"", ""option_d"": ""By reabsorbing bicarbonates filtered by the glomerulus"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism by which the lung contributes to acid-base balance?","By regulating the concentration of bicarbonate ions in the blood","By excreting carbon dioxide through the respiratory tract, thereby modifying the pCO2 of arterial blood","By directly buffering fixed acids resulting from protein metabolism","By reabsorbing bicarbonates filtered by the glomerulus","b"
"OIC-267-03-A","{""question"": ""What is the primary characteristic that distinguishes metabolic acidosis from respiratory acidosis in terms of blood gas analysis?"", ""option_a"": ""A low pH level"", ""option_b"": ""A primary abnormality in HCO3- levels"", ""option_c"": ""A primary abnormality in PCO2 levels"", ""option_d"": ""The presence of alkalosis"", ""correct_option"": ""B""}","Definition","What is the primary characteristic that distinguishes metabolic acidosis from respiratory acidosis in terms of blood gas analysis?","A low pH level","A primary abnormality in HCO3- levels","A primary abnormality in PCO2 levels","The presence of alkalosis","b"
"OIC-267-04-A","{""question"": ""At what pH level or bicarbonaemia concentration does a metabolic acidosis condition become life-threatening?"", ""option_a"": ""pH < 7.20 or bicarbonaemia < 10 mmol/L"", ""option_b"": ""pH < 7.10 or bicarbonaemia < 8 mmol/L"", ""option_c"": ""pH < 7.00 or bicarbonaemia < 6 mmol/L"", ""option_d"": ""pH < 7.30 or bicarbonaemia < 12 mmol/L"", ""correct_option"": ""B""}","Identification of the emergency","At what pH level or bicarbonaemia concentration does a metabolic acidosis condition become life-threatening?","pH < 7.20 or bicarbonaemia < 10 mmol/L","pH < 7.10 or bicarbonaemia < 8 mmol/L","pH < 7.00 or bicarbonaemia < 6 mmol/L","pH < 7.30 or bicarbonaemia < 12 mmol/L","b"
"OIC-267-05-A","{""question"": ""A patient presents with metabolic acidosis and an increased plasma anion gap. Which of the following conditions is most likely to cause this presentation?"", ""option_a"": ""Diarrhoea"", ""option_b"": ""Lactic acidosis due to tissue hypoxia"", ""option_c"": ""Renal tubular acidosis"", ""option_d"": ""Severe renal failure with accumulation of organic acids"", ""correct_option"": ""B""}","Diagnostic approach","A patient presents with metabolic acidosis and an increased plasma anion gap. Which of the following conditions is most likely to cause this presentation?","Diarrhoea","Lactic acidosis due to tissue hypoxia","Renal tubular acidosis","Severe renal failure with accumulation of organic acids","b"
"OIC-267-06-B","{""question"": ""A patient presents with hyperchloremic metabolic acidosis and a urinary anion gap (UAG) greater than 0. What does this indicate about the origin of the acidosis?"", ""option_a"": ""Extrarenal origin of the acidosis due to digestive loss of bicarbonate"", ""option_b"": ""Renal tubular origin of the acidosis"", ""option_c"": ""Toxic cause of the acidosis due to accumulation of an exogenous acid"", ""option_d"": ""Normal renal response to metabolic acidosis"", ""correct_option"": ""B""}","Diagnostic approach","A patient presents with hyperchloremic metabolic acidosis and a urinary anion gap (UAG) greater than 0. What does this indicate about the origin of the acidosis?","Extrarenal origin of the acidosis due to digestive loss of bicarbonate","Renal tubular origin of the acidosis","Toxic cause of the acidosis due to accumulation of an exogenous acid","Normal renal response to metabolic acidosis","b"
"OIC-267-07-A","{""question"": ""What is a common cause of respiratory acidosis due to ventilatory control dysfunction of the respiratory centers?"", ""option_a"": ""Severe COPD"", ""option_b"": ""Hypothyroidism"", ""option_c"": ""Bilateral carotid endarterectomy"", ""option_d"": ""Cyphoscoliosis"", ""correct_option"": ""B""}","Etiologies","What is a common cause of respiratory acidosis due to ventilatory control dysfunction of the respiratory centers?","Severe COPD","Hypothyroidism","Bilateral carotid endarterectomy","Cyphoscoliosis","b"
"OIC-267-08-B","{""question"": ""What is the primary goal when treating chronic metabolic acidosis in patients with chronic kidney disease?"", ""option_a"": ""To reduce plasma bicarbonate levels and prevent muscle wasting"", ""option_b"": ""To maintain plasma bicarbonate levels > 22 mmol/L and prevent complications such as bone demineralisation"", ""option_c"": ""To increase plasma bicarbonate levels to normal ranges as quickly as possible, regardless of the method"", ""option_d"": ""To only treat symptoms of metabolic acidosis, without focusing on plasma bicarbonate levels"", ""correct_option"": ""B""}","Management","What is the primary goal when treating chronic metabolic acidosis in patients with chronic kidney disease?","To reduce plasma bicarbonate levels and prevent muscle wasting","To maintain plasma bicarbonate levels > 22 mmol/L and prevent complications such as bone demineralisation","To increase plasma bicarbonate levels to normal ranges as quickly as possible, regardless of the method","To only treat symptoms of metabolic acidosis, without focusing on plasma bicarbonate levels","b"
"OIC-267-09-B","{""question"": ""What is the recommended approach for managing hyperchloremic acidosis or acidosis associated with certain intoxications?"", ""option_a"": ""Administering insulin and rehydration"", ""option_b"": ""Using IV sodium bicarbonate to rapidly raise pH > 7.20 and bicarbonaemia > 10 mmol/L"", ""option_c"": ""Avoiding alkalinisation due to the risk of fluid and sodium overload"", ""option_d"": ""Implementing extrarenal purification without considering the patient's renal function"", ""correct_option"": ""B""}","Management","What is the recommended approach for managing hyperchloremic acidosis or acidosis associated with certain intoxications?","Administering insulin and rehydration","Using IV sodium bicarbonate to rapidly raise pH > 7.20 and bicarbonaemia > 10 mmol/L","Avoiding alkalinisation due to the risk of fluid and sodium overload","Implementing extrarenal purification without considering the patient's renal function","b"
"OIC-267-10-B","{""question"": ""What is the primary effect of metabolic acidosis on potassium regulation in the body?"", ""option_a"": ""It stimulates cellular uptake of potassium"", ""option_b"": ""It blocks cellular potassium entry and increases passive leakage of potassium into the extracellular sector"", ""option_c"": ""It has no significant effect on potassium regulation"", ""option_d"": ""It increases the activity of NaK-ATPase to promote potassium entry into cells"", ""correct_option"": ""B""}","Physiopathology","What is the primary effect of metabolic acidosis on potassium regulation in the body?","It stimulates cellular uptake of potassium","It blocks cellular potassium entry and increases passive leakage of potassium into the extracellular sector","It has no significant effect on potassium regulation","It increases the activity of NaK-ATPase to promote potassium entry into cells","b"
"OIC-267-11-A","{""question"": ""What is the definition of hyperkalaemia in terms of plasma potassium concentration?"", ""option_a"": ""A plasma potassium concentration greater than 4.5 mmol/L"", ""option_b"": ""A plasma potassium concentration greater than 5.0 mmol/L"", ""option_c"": ""A plasma potassium concentration greater than 5.5 mmol/L"", ""option_d"": ""A plasma potassium concentration less than 4.0 mmol/L"", ""correct_option"": ""B""}","Definition","What is the definition of hyperkalaemia in terms of plasma potassium concentration?","A plasma potassium concentration greater than 4.5 mmol/L","A plasma potassium concentration greater than 5.0 mmol/L","A plasma potassium concentration greater than 5.5 mmol/L","A plasma potassium concentration less than 4.0 mmol/L","b"
"OIC-267-12-B","{""question"": ""What is a characteristic of neuromuscular signs in hyperkalaemia?"", ""option_a"": ""They are highly specific and only affect the upper limbs"", ""option_b"": ""They are non-specific and may include muscular weakness or flaccid paralysis starting in the upper limbs"", ""option_c"": ""They are non-specific and may include muscular weakness or flaccid paralysis starting in the lower limbs"", ""option_d"": ""They only occur in severe forms of hyperkalaemia and are always accompanied by normal ECG readings"", ""correct_option"": ""C""}","Positive diagnosis","What is a characteristic of neuromuscular signs in hyperkalaemia?","They are highly specific and only affect the upper limbs","They are non-specific and may include muscular weakness or flaccid paralysis starting in the upper limbs","They are non-specific and may include muscular weakness or flaccid paralysis starting in the lower limbs","They only occur in severe forms of hyperkalaemia and are always accompanied by normal ECG readings","c"
"OIC-267-13-A","{""question"": ""What is the first electrocardiographic change associated with hyperkalaemia?"", ""option_a"": ""Atrial conduction abnormalities with disappearance of the P wave"", ""option_b"": ""Intraventricular conduction abnormalities with widening of the QRS complexes"", ""option_c"": ""Accelerated repolarisation with an increase in the amplitude of the T waves"", ""option_d"": ""Ventricular arrhythmias such as ventricular tachycardia"", ""correct_option"": ""C""}",,"What is the first electrocardiographic change associated with hyperkalaemia?","Atrial conduction abnormalities with disappearance of the P wave","Intraventricular conduction abnormalities with widening of the QRS complexes","Accelerated repolarisation with an increase in the amplitude of the T waves","Ventricular arrhythmias such as ventricular tachycardia","c"
"OIC-267-14-A","{""question"": ""What is a common iatrogenic cause of hyperkalaemia?"", ""option_a"": ""Excessive potassium intake through diet salts or supplements"", ""option_b"": ""Use of beta-blockers"", ""option_c"": ""Use of ACE inhibitors or ARB2 in patients with underlying chronic renal failure or effective hypovolaemia"", ""option_d"": ""Metabolic acidosis with normal plasma anion gap"", ""correct_option"": ""C""}","Etiologies","What is a common iatrogenic cause of hyperkalaemia?","Excessive potassium intake through diet salts or supplements","Use of beta-blockers","Use of ACE inhibitors or ARB2 in patients with underlying chronic renal failure or effective hypovolaemia","Metabolic acidosis with normal plasma anion gap","c"
"OIC-267-15-A","{""question"": ""In the emergency treatment of severe hyperkalaemia, what is the primary purpose of administering IV calcium salts?"", ""option_a"": ""To transfer potassium to the intracellular compartment"", ""option_b"": ""To counteract the cardiac effects of hyperkalaemia by stabilizing the membrane"", ""option_c"": ""To replace potassium lost due to hyperkalaemic drugs"", ""option_d"": ""To enhance the effect of insulin-glucose regimen"", ""correct_option"": ""B""}","Management","In the emergency treatment of severe hyperkalaemia, what is the primary purpose of administering IV calcium salts?","To transfer potassium to the intracellular compartment","To counteract the cardiac effects of hyperkalaemia by stabilizing the membrane","To replace potassium lost due to hyperkalaemic drugs","To enhance the effect of insulin-glucose regimen","b"
"OIC-267-16-B","{""question"": ""What is the primary purpose of using sodium bicarbonate in the emergency treatment of severe hyperkalemia?"", ""option_a"": ""To enhance the elimination of potassium through the kidneys"", ""option_b"": ""To transfer potassium to the intracellular compartment through moderate alkalinisation"", ""option_c"": ""To counteract the effects of \u03b2-adrenergic agents such as salbutamol"", ""option_d"": ""To treat pulmonary oedema associated with organic renal failure"", ""correct_option"": ""B""}","Management","What is the primary purpose of using sodium bicarbonate in the emergency treatment of severe hyperkalemia?","To enhance the elimination of potassium through the kidneys","To transfer potassium to the intracellular compartment through moderate alkalinisation","To counteract the effects of β-adrenergic agents such as salbutamol","To treat pulmonary oedema associated with organic renal failure","b"
"OIC-267-17-A","{""question"": ""What is a suitable treatment approach for moderate chronic hyperkalaemia?"", ""option_a"": ""Administration of potassium supplements to balance electrolyte levels"", ""option_b"": ""Reduction of dietary potassium intake, adjustment of hyperkalaemic drug dosages, and administration of ion exchange resins"", ""option_c"": ""Immediate initiation of dialysis to rapidly lower potassium levels"", ""option_d"": ""Discontinuation of all medications without adjusting dietary potassium intake"", ""correct_option"": ""B""}",,"What is a suitable treatment approach for moderate chronic hyperkalaemia?","Administration of potassium supplements to balance electrolyte levels","Reduction of dietary potassium intake, adjustment of hyperkalaemic drug dosages, and administration of ion exchange resins","Immediate initiation of dialysis to rapidly lower potassium levels","Discontinuation of all medications without adjusting dietary potassium intake","b"
"OIC-267-18-A","{""question"": ""What is the definition of hypokalaemia in terms of plasma potassium concentration?"", ""option_a"": ""A plasma potassium concentration of less than 3.0 mmol/L"", ""option_b"": ""A plasma potassium concentration of less than 3.5 mmol/L"", ""option_c"": ""A plasma potassium concentration of less than 4.0 mmol/L"", ""option_d"": ""A plasma potassium concentration of less than 4.5 mmol/L"", ""correct_option"": ""B""}","Definition","What is the definition of hypokalaemia in terms of plasma potassium concentration?","A plasma potassium concentration of less than 3.0 mmol/L","A plasma potassium concentration of less than 3.5 mmol/L","A plasma potassium concentration of less than 4.0 mmol/L","A plasma potassium concentration of less than 4.5 mmol/L","b"
"OIC-267-19-A","{""question"": ""What is a common muscular clinical sign of hypokalaemia?"", ""option_a"": ""Tetany"", ""option_b"": ""Muscular weakness or even paralysis beginning in the lower limbs and progressing upwards"", ""option_c"": ""Polyuro-polydipsic syndrome"", ""option_d"": ""Metabolic acidosis"", ""correct_option"": ""B""}","Positive diagnosis","What is a common muscular clinical sign of hypokalaemia?","Tetany","Muscular weakness or even paralysis beginning in the lower limbs and progressing upwards","Polyuro-polydipsic syndrome","Metabolic acidosis","b"
"OIC-267-20-A","{""question"": ""What is a factor that favours the onset of arrhythmia in the context of hypokalaemia?"", ""option_a"": ""Hypocalcaemia"", ""option_b"": ""Underlying ischaemic heart disease"", ""option_c"": ""Left ventricular atrophy"", ""option_d"": ""Hypermagnesaemia"", ""correct_option"": ""B""}",,"What is a factor that favours the onset of arrhythmia in the context of hypokalaemia?","Hypocalcaemia","Underlying ischaemic heart disease","Left ventricular atrophy","Hypermagnesaemia","b"
"OIC-267-21-A","{""question"": ""A patient is diagnosed with hypokalemia. Which of the following conditions is most likely to cause hypokalemia without hypertension?"", ""option_a"": ""Hyperaldosteronism II due to renal artery stenosis"", ""option_b"": ""Thiazides and loop diuretics"", ""option_c"": ""Familial periodic paralysis"", ""option_d"": ""Hyperaldosteronism I due to Cushing's disease"", ""correct_option"": ""B""}","Etiologies","A patient is diagnosed with hypokalemia. Which of the following conditions is most likely to cause hypokalemia without hypertension?","Hyperaldosteronism II due to renal artery stenosis","Thiazides and loop diuretics","Familial periodic paralysis","Hyperaldosteronism I due to Cushing's disease","b"
"OIC-267-22-A","{""question"": ""What is the primary concern when correcting severe hypokalaemia with intravenous potassium supplementation?"", ""option_a"": ""Administering too high a dose of potassium too quickly"", ""option_b"": ""Failing to simultaneously correct associated hypomagnesemia"", ""option_c"": ""Giving glucose during the initial phase of correction to help stabilize the patient"", ""option_d"": ""Not monitoring the patient's heart rate and infused vein for signs of venotoxicity"", ""correct_option"": ""B""}","Management","What is the primary concern when correcting severe hypokalaemia with intravenous potassium supplementation?","Administering too high a dose of potassium too quickly","Failing to simultaneously correct associated hypomagnesemia","Giving glucose during the initial phase of correction to help stabilize the patient","Not monitoring the patient's heart rate and infused vein for signs of venotoxicity","b"
"OIC-267-23-A","{""question"": ""What is the biological definition of severe hyponatremia?"", ""option_a"": ""Sodium level below 130 mmol/L"", ""option_b"": ""Sodium level below 120 mmol/L"", ""option_c"": ""Sodium level below 110 mmol/L"", ""option_d"": ""Sodium level below 140 mmol/L"", ""correct_option"": ""B""}","Definition","What is the biological definition of severe hyponatremia?","Sodium level below 130 mmol/L","Sodium level below 120 mmol/L","Sodium level below 110 mmol/L","Sodium level below 140 mmol/L","b"
"OIC-267-24-B","{""question"": ""A patient presents with hyponatremia due to a positive water balance. Which of the following scenarios would most likely lead to this condition?"", ""option_a"": ""A low osmolar intake of 120 mOsm/day with a water intake of 1 litre"", ""option_b"": ""A standard osmolar intake of 600 mOsm/day with a water intake of more than 10 litres"", ""option_c"": ""A high ADH secretion in a hypervolaemic situation"", ""option_d"": ""A low ADH secretion in a euvolaemic situation"", ""correct_option"": ""B""}","Physiopathology","A patient presents with hyponatremia due to a positive water balance. Which of the following scenarios would most likely lead to this condition?","A low osmolar intake of 120 mOsm/day with a water intake of 1 litre","A standard osmolar intake of 600 mOsm/day with a water intake of more than 10 litres","A high ADH secretion in a hypervolaemic situation","A low ADH secretion in a euvolaemic situation","b"
"OIC-267-25-A","{""question"": ""What is a characteristic of clinical signs in severe hyponatremia?"", ""option_a"": ""They are highly specific and easily recognizable"", ""option_b"": ""They are non-specific and correlated with the severity of the hyponatremia"", ""option_c"": ""They only occur in cases of rapid onset hyponatremia"", ""option_d"": ""They are never correlated with the severity of the hyponatremia"", ""correct_option"": ""B""}","Identification of the emergency","What is a characteristic of clinical signs in severe hyponatremia?","They are highly specific and easily recognizable","They are non-specific and correlated with the severity of the hyponatremia","They only occur in cases of rapid onset hyponatremia","They are never correlated with the severity of the hyponatremia","b"
"OIC-267-26-A","{""question"": ""What is the primary criterion for diagnosing the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a patient with hyponatremia?"", ""option_a"": ""Urinary osmolality < 100 mOsm/kg"", ""option_b"": ""Clinical signs of extracellular dehydration"", ""option_c"": ""Urinary sodium > 30 mmol/L with normal sodium and water intake"", ""option_d"": ""Plasma osmolality < 275 mOsm/kg and hypothyroidism"", ""correct_option"": ""C""}","Etiologies","What is the primary criterion for diagnosing the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a patient with hyponatremia?","Urinary osmolality < 100 mOsm/kg","Clinical signs of extracellular dehydration","Urinary sodium > 30 mmol/L with normal sodium and water intake","Plasma osmolality < 275 mOsm/kg and hypothyroidism","c"
"OIC-267-27-A","{""question"": ""What is the recommended rate of correction for hyponatremia in the first 48 hours?"", ""option_a"": ""12 mmol/L/day for the first 24 hours and 10 mmol/L for the following 24 hours"", ""option_b"": ""10 mmol/L/day for the first 24 hours and 8 mmol/L for the following 24 hours"", ""option_c"": ""8 mmol/L/day for the first 24 hours and 6 mmol/L for the following 24 hours"", ""option_d"": ""15 mmol/L/day for the first 24 hours and 12 mmol/L for the following 24 hours"", ""correct_option"": ""B""}","Management","What is the recommended rate of correction for hyponatremia in the first 48 hours?","12 mmol/L/day for the first 24 hours and 10 mmol/L for the following 24 hours","10 mmol/L/day for the first 24 hours and 8 mmol/L for the following 24 hours","8 mmol/L/day for the first 24 hours and 6 mmol/L for the following 24 hours","15 mmol/L/day for the first 24 hours and 12 mmol/L for the following 24 hours","b"
"OIC-267-28-A","{""question"": ""What is the main risk associated with the rapid correction of chronic hyponatremia?"", ""option_a"": ""Development of hypernatremia"", ""option_b"": ""Central pontine myelinolysis (CPM) or osmotic demyelination"", ""option_c"": ""Severe dehydration"", ""option_d"": ""Electrolyte imbalance leading to cardiac arrhythmias"", ""correct_option"": ""B""}","Management","What is the main risk associated with the rapid correction of chronic hyponatremia?","Development of hypernatremia","Central pontine myelinolysis (CPM) or osmotic demyelination","Severe dehydration","Electrolyte imbalance leading to cardiac arrhythmias","b"
"OIC-267-29-A","{""question"": ""What is the biological diagnosis of intracellular dehydration (ICD) in the context of hypernatremia?"", ""option_a"": ""Hypernatremia associated with plasma hypo-osmolality (< 280 mOsm/Kg H2O)"", ""option_b"": ""Hypernatremia associated with plasma hyperosmolality (> 300 mOsm/Kg H2O)"", ""option_c"": ""Hyponatremia associated with plasma hyperosmolality (> 300 mOsm/Kg H2O)"", ""option_d"": ""Hypernatremia associated with normal plasma osmolality (280-300 mOsm/Kg H2O)"", ""correct_option"": ""B""}","Definition","What is the biological diagnosis of intracellular dehydration (ICD) in the context of hypernatremia?","Hypernatremia associated with plasma hypo-osmolality (< 280 mOsm/Kg H2O)","Hypernatremia associated with plasma hyperosmolality (> 300 mOsm/Kg H2O)","Hyponatremia associated with plasma hyperosmolality (> 300 mOsm/Kg H2O)","Hypernatremia associated with normal plasma osmolality (280-300 mOsm/Kg H2O)","b"
"OIC-267-30-B","{""question"": ""What is the primary mechanism by which antidiuretic hormone (ADH) enables water reabsorption in the collecting duct?"", ""option_a"": ""ADH increases the permeability of the collecting duct to sodium"", ""option_b"": ""ADH enables the expression of water channels, type 2 aquaporins, on the apical membrane"", ""option_c"": ""ADH reduces the osmolar concentration gradient between the tubular fluid and the interstitium"", ""option_d"": ""ADH decreases the secretion of aquaporins in the collecting duct"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism by which antidiuretic hormone (ADH) enables water reabsorption in the collecting duct?","ADH increases the permeability of the collecting duct to sodium","ADH enables the expression of water channels, type 2 aquaporins, on the apical membrane","ADH reduces the osmolar concentration gradient between the tubular fluid and the interstitium","ADH decreases the secretion of aquaporins in the collecting duct","b"
"OIC-267-31-A","{""question"": ""What is a common neurological symptom associated with severe hypernatremia?"", ""option_a"": ""Hypotension"", ""option_b"": ""Somnolence"", ""option_c"": ""Hypokalemia"", ""option_d"": ""Tachycardia"", ""correct_option"": ""B""}","Identification of the emergency","What is a common neurological symptom associated with severe hypernatremia?","Hypotension","Somnolence","Hypokalemia","Tachycardia","b"
"OIC-267-32-A","{""question"": ""What is a common cause of isolated intracellular dehydration associated with extracellular euvolaemia?"", ""option_a"": ""Excessive sodium intake"", ""option_b"": ""Uncompensated water loss due to diabetes insipidus"", ""option_c"": ""Global dehydration due to lack of water and NaCl intake"", ""option_d"": ""Hyperventilation-induced respiratory alkalosis"", ""correct_option"": ""B""}","Etiologies","What is a common cause of isolated intracellular dehydration associated with extracellular euvolaemia?","Excessive sodium intake","Uncompensated water loss due to diabetes insipidus","Global dehydration due to lack of water and NaCl intake","Hyperventilation-induced respiratory alkalosis","b"
"OIC-267-33-A","{""question"": ""What is the recommended initial rate of correction for acute symptomatic hypernatremia in adults?"", ""option_a"": ""0.5 mmol/L/h"", ""option_b"": ""1 mmol/L/h"", ""option_c"": ""2 mmol/L/h"", ""option_d"": ""5 mmol/L/h"", ""correct_option"": ""C""}","Management","What is the recommended initial rate of correction for acute symptomatic hypernatremia in adults?","0.5 mmol/L/h","1 mmol/L/h","2 mmol/L/h","5 mmol/L/h","c"
"OIC-267-34-A","{""question"": ""A patient has a total plasma calcium concentration of 2.15 mmol/L and an albumin level of 35 g/L. What is the most appropriate interpretation of this result?"", ""option_a"": ""The patient has true hypocalcaemia due to a decrease in ionised calcium"", ""option_b"": ""The patient has false hypocalcaemia due to a decrease in the protein-bound fraction of calcium"", ""option_c"": ""The patient's calcium level is within the normal range after correcting for albumin level"", ""option_d"": ""The patient has hypercalcaemia due to an increase in ionised calcium"", ""correct_option"": ""B""}","Definition","A patient has a total plasma calcium concentration of 2.15 mmol/L and an albumin level of 35 g/L. What is the most appropriate interpretation of this result?","The patient has true hypocalcaemia due to a decrease in ionised calcium","The patient has false hypocalcaemia due to a decrease in the protein-bound fraction of calcium","The patient's calcium level is within the normal range after correcting for albumin level","The patient has hypercalcaemia due to an increase in ionised calcium","b"
"OIC-267-35-B","{""question"": ""What is the primary mechanism by which parathyroid hormone (PTH) regulates calcium levels in the body?"", ""option_a"": ""PTH increases calcium excretion by the kidneys"", ""option_b"": ""PTH mobilises calcium from the bone mineral phase and increases tubular reabsorption of calcium"", ""option_c"": ""PTH decreases the digestive absorption of calcium and phosphorus"", ""option_d"": ""PTH inhibits bone resorption and decreases calcitriol synthesis"", ""correct_option"": ""B""}","Physiopathology","What is the primary mechanism by which parathyroid hormone (PTH) regulates calcium levels in the body?","PTH increases calcium excretion by the kidneys","PTH mobilises calcium from the bone mineral phase and increases tubular reabsorption of calcium","PTH decreases the digestive absorption of calcium and phosphorus","PTH inhibits bone resorption and decreases calcitriol synthesis","b"
"OIC-267-36-A","{""question"": ""What are the primary clinical manifestations of hypocalcaemia?"", ""option_a"": ""Gastrointestinal disorders, such as diarrhea and abdominal cramps"", ""option_b"": ""Neuromuscular disorders, including distal paraesthesias, muscle cramps, and tetany"", ""option_c"": ""Cardiovascular disorders, such as hypertension and arrhythmias"", ""option_d"": ""Dermatological disorders, such as skin rash and itching"", ""correct_option"": ""B""}","Positive diagnosis","What are the primary clinical manifestations of hypocalcaemia?","Gastrointestinal disorders, such as diarrhea and abdominal cramps","Neuromuscular disorders, including distal paraesthesias, muscle cramps, and tetany","Cardiovascular disorders, such as hypertension and arrhythmias","Dermatological disorders, such as skin rash and itching","b"
"OIC-267-37-B","{""question"": ""What is a common ECG abnormality associated with hypocalcaemia?"", ""option_a"": ""Shortening of the QT interval"", ""option_b"": ""Prolongation of the QT interval"", ""option_c"": ""Narrowing of the QRS complex"", ""option_d"": ""Flattening of the T wave"", ""correct_option"": ""B""}",,"What is a common ECG abnormality associated with hypocalcaemia?","Shortening of the QT interval","Prolongation of the QT interval","Narrowing of the QRS complex","Flattening of the T wave","b"
"OIC-267-38-A","{""question"": ""What is the primary distinction in the diagnostic approach to hypocalcaemia based on parathyroid hormone (PTH) levels?"", ""option_a"": ""Between hypocalcaemia with low phosphate and high phosphate levels"", ""option_b"": ""Between hypocalcaemia with low PTH and high PTH levels, indicating parathyroid or extraparathyroidal origin"", ""option_c"": ""Between hypocalcaemia with low vitamin D and high vitamin D levels"", ""option_d"": ""Between hypocalcaemia with low albumin and high albumin levels"", ""correct_option"": ""B""}","Complementary examinations","What is the primary distinction in the diagnostic approach to hypocalcaemia based on parathyroid hormone (PTH) levels?","Between hypocalcaemia with low phosphate and high phosphate levels","Between hypocalcaemia with low PTH and high PTH levels, indicating parathyroid or extraparathyroidal origin","Between hypocalcaemia with low vitamin D and high vitamin D levels","Between hypocalcaemia with low albumin and high albumin levels","b"
"OIC-267-39-A","{""question"": ""What is an important initial step before investigating the aetiology of hypocalcaemia?"", ""option_a"": ""Measuring the total and ionised calcium levels"", ""option_b"": ""Checking the sample has not been taken in a citrate tube and ruling out pseudo hypocalcaemia"", ""option_c"": ""Assessing the patient's vitamin D levels"", ""option_d"": ""Evaluating the patient's renal function"", ""correct_option"": ""B""}","Etiologies","What is an important initial step before investigating the aetiology of hypocalcaemia?","Measuring the total and ionised calcium levels","Checking the sample has not been taken in a citrate tube and ruling out pseudo hypocalcaemia","Assessing the patient's vitamin D levels","Evaluating the patient's renal function","b"
"OIC-267-40-A","{""question"": ""What is the recommended approach to treating hypocalcaemia in patients with chronic renal failure?"", ""option_a"": ""Administering high doses of calcium per os without vitamin D supplementation"", ""option_b"": ""Supplementing with vitamin D hydroxylated in position 1 or 1.25, along with careful calcium intake, provided there is no significant hyperphosphatemia"", ""option_c"": ""Using parenteral calcium as the first line of treatment"", ""option_d"": ""Avoiding calcium and vitamin D supplementation altogether to prevent hypercalcaemia"", ""correct_option"": ""B""}","Management","What is the recommended approach to treating hypocalcaemia in patients with chronic renal failure?","Administering high doses of calcium per os without vitamin D supplementation","Supplementing with vitamin D hydroxylated in position 1 or 1.25, along with careful calcium intake, provided there is no significant hyperphosphatemia","Using parenteral calcium as the first line of treatment","Avoiding calcium and vitamin D supplementation altogether to prevent hypercalcaemia","b"
"OIC-270-01-A","{""question"": ""What is the primary goal when evaluating a patient with acute low back pain?"", ""option_a"": ""To immediately prescribe pain medication"", ""option_b"": ""To rule out other possible causes before accepting the diagnosis of common acute low back pain"", ""option_c"": ""To perform a surgical intervention"", ""option_d"": ""To recommend bed rest for an extended period"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary goal when evaluating a patient with acute low back pain?","To immediately prescribe pain medication","To rule out other possible causes before accepting the diagnosis of common acute low back pain","To perform a surgical intervention","To recommend bed rest for an extended period","b"
"OIC-270-02-A","{""question"": ""What is a common characteristic that distinguishes secondary low back pain from common low back pain?"", ""option_a"": ""Absence of signs of severity"", ""option_b"": ""Presence of fever or trauma"", ""option_c"": ""Degenerative origin"", ""option_d"": ""Older age"", ""correct_option"": ""B""}","Etiologies","What is a common characteristic that distinguishes secondary low back pain from common low back pain?","Absence of signs of severity","Presence of fever or trauma","Degenerative origin","Older age","b"
"OIC-270-03-A","{""question"": ""What is a sign of severity in acute low back pain that may indicate a secondary cause?"", ""option_a"": ""Mild dyspnoea"", ""option_b"": ""Severe dyspnoea, respiratory distress"", ""option_c"": ""Mild motor deficit"", ""option_d"": ""Abnormal gastrointestinal examination"", ""correct_option"": ""B""}","Identifying an emergency","What is a sign of severity in acute low back pain that may indicate a secondary cause?","Mild dyspnoea","Severe dyspnoea, respiratory distress","Mild motor deficit","Abnormal gastrointestinal examination","b"
"OIC-270-04-A","{""question"": ""What is the characteristic radiation pattern of pain in renal colic?"", ""option_a"": ""Bilateral lumbar pain radiating to the lower back"", ""option_b"": ""Unilateral lumbar pain radiating to the homolateral iliac fossa or external genitalia"", ""option_c"": ""Pain radiating from the lower back to the thighs"", ""option_d"": ""Pain localized to the lumbar region without radiation"", ""correct_option"": ""B""}","Etiologies","What is the characteristic radiation pattern of pain in renal colic?","Bilateral lumbar pain radiating to the lower back","Unilateral lumbar pain radiating to the homolateral iliac fossa or external genitalia","Pain radiating from the lower back to the thighs","Pain localized to the lumbar region without radiation","b"
"OIC-270-05-A","{""question"": ""What is the primary indication for ordering imaging examinations in adults with acute low back pain?"", ""option_a"": ""All of the above"", ""option_b"": ""Only if the pain is resistant to symptomatic treatment or worsening"", ""option_c"": ""If there are signs of severity, such as fever or neurological deficit, or arguments for a secondary cause"", ""option_d"": ""Systematically at the end of the clinical examination"", ""correct_option"": ""C""}","Additional examinations","What is the primary indication for ordering imaging examinations in adults with acute low back pain?","All of the above","Only if the pain is resistant to symptomatic treatment or worsening","If there are signs of severity, such as fever or neurological deficit, or arguments for a secondary cause","Systematically at the end of the clinical examination","c"
"OIC-270-06-A","{""question"": ""In cases of acute low back pain, when is a biological work-up required?"", ""option_a"": ""Always, as a routine procedure for all patients"", ""option_b"": ""Only if a secondary cause is suspected or if there are signs of seriousness"", ""option_c"": ""If the patient has a history of disco-vertebral or arthrosic conditions"", ""option_d"": ""If the patient is over 60 years old, regardless of other factors"", ""correct_option"": ""B""}","Additional tests","In cases of acute low back pain, when is a biological work-up required?","Always, as a routine procedure for all patients","Only if a secondary cause is suspected or if there are signs of seriousness","If the patient has a history of disco-vertebral or arthrosic conditions","If the patient is over 60 years old, regardless of other factors","b"
"OIC-270-07-B","{""question"": ""What type of factors are associated with the transition to chronicity in acute low back pain, including prolonged work stoppages and professional conflict?"", ""option_a"": ""Yellow flags, which include biological factors such as age and genetics"", ""option_b"": ""Black flags, which include occupational factors such as work environment and job satisfaction"", ""option_c"": ""Red flags, which include symptoms such as fever and weight loss"", ""option_d"": ""Green flags, which include positive factors such as social support and healthy lifestyle"", ""correct_option"": ""B""}",,"What type of factors are associated with the transition to chronicity in acute low back pain, including prolonged work stoppages and professional conflict?","Yellow flags, which include biological factors such as age and genetics","Black flags, which include occupational factors such as work environment and job satisfaction","Red flags, which include symptoms such as fever and weight loss","Green flags, which include positive factors such as social support and healthy lifestyle","b"
"OIC-283-01-B","{""question"": ""What percentage of paediatric consultations in private practice is attributed to constipation?"", ""option_a"": ""1%"", ""option_b"": ""3%"", ""option_c"": ""5%"", ""option_d"": ""10%"", ""correct_option"": ""C""}","Epidemiology","What percentage of paediatric consultations in private practice is attributed to constipation?","1%","3%","5%","10%","c"
"OIC-283-02-A","{""question"": ""What is the minimum duration for constipation to be considered chronic?"", ""option_a"": ""3 months"", ""option_b"": ""6 months"", ""option_c"": ""1 year"", ""option_d"": ""2 years"", ""correct_option"": ""B""}","Definition","What is the minimum duration for constipation to be considered chronic?","3 months","6 months","1 year","2 years","b"
"OIC-283-03-B","{""question"": ""What is the primary mechanism of constipation in children under 6 months old?"", ""option_a"": ""Terminal retention due to repeated retention of stool in the rectal ampulla"", ""option_b"": ""Lack of water or fibre intake"", ""option_c"": ""Essentially reflex"", ""option_d"": ""Hypertonia of the sphincter"", ""correct_option"": ""C""}","Physiopathology","What is the primary mechanism of constipation in children under 6 months old?","Terminal retention due to repeated retention of stool in the rectal ampulla","Lack of water or fibre intake","Essentially reflex","Hypertonia of the sphincter","c"
"OIC-283-04-B","{""question"": ""What is the primary indication for a colonoscopy in a patient with constipation?"", ""option_a"": ""In all patients with chronic constipation"", ""option_b"": ""If the symptoms appear or worsen after the age of 50, or in the event of warning signs"", ""option_c"": ""As a routine examination for all patients consulting for constipation for the first time"", ""option_d"": ""Only in situations where biological tests are inconclusive"", ""correct_option"": ""B""}","Complementary examinations","What is the primary indication for a colonoscopy in a patient with constipation?","In all patients with chronic constipation","If the symptoms appear or worsen after the age of 50, or in the event of warning signs","As a routine examination for all patients consulting for constipation for the first time","Only in situations where biological tests are inconclusive","b"
"OIC-283-05-A","{""question"": ""What is the purpose of a rectal examination in a patient with constipation?"", ""option_a"": ""To assess the patient's quality of life"", ""option_b"": ""To look for signs of colorectal cancer or anal canal cancer"", ""option_c"": ""To check for the presence of abnormal matter in the rectal ampulla, assess anal sphincter tone, and look for a rectocele"", ""option_d"": ""To examine the patient's abdomen for tenderness in the left iliac fossa"", ""correct_option"": ""C""}","Positive diagnosis","What is the purpose of a rectal examination in a patient with constipation?","To assess the patient's quality of life","To look for signs of colorectal cancer or anal canal cancer","To check for the presence of abnormal matter in the rectal ampulla, assess anal sphincter tone, and look for a rectocele","To examine the patient's abdomen for tenderness in the left iliac fossa","c"
"OIC-283-06-B","{""question"": ""What is the primary distinction to be made in the diagnosis of constipation?"", ""option_a"": ""Between acute and chronic constipation"", ""option_b"": ""Between idiopathic or primary constipation and secondary constipation"", ""option_c"": ""Between constipation in children and adults"", ""option_d"": ""Between functional and anatomical disorders of the rectum"", ""correct_option"": ""B""}","Etiologies","What is the primary distinction to be made in the diagnosis of constipation?","Between acute and chronic constipation","Between idiopathic or primary constipation and secondary constipation","Between constipation in children and adults","Between functional and anatomical disorders of the rectum","b"
"OIC-283-07-A","{""question"": ""What is the recommended daily fibre intake for adults to help manage constipation?"", ""option_a"": ""Around 10g/day"", ""option_b"": ""Around 25g/day"", ""option_c"": ""Around 50g/day"", ""option_d"": ""Around 100g/day"", ""correct_option"": ""B""}","Management","What is the recommended daily fibre intake for adults to help manage constipation?","Around 10g/day","Around 25g/day","Around 50g/day","Around 100g/day","b"
"OIC-283-08-B","{""question"": ""What is a common complication of chronic constipation in children, characterized by leakage of material into underwear, more common in boys after 4 years of age?"", ""option_a"": ""Anal fissure"", ""option_b"": ""Urinary tract infections"", ""option_c"": ""Encopresis"", ""option_d"": ""Rectal prolapse"", ""correct_option"": ""C""}","Follow-up and/or prognosis","What is a common complication of chronic constipation in children, characterized by leakage of material into underwear, more common in boys after 4 years of age?","Anal fissure","Urinary tract infections","Encopresis","Rectal prolapse","c"
"OIC-283-09-B","{""question"": ""What is the primary goal of medicinal treatment in older children with chronic constipation?"", ""option_a"": ""To immediately stop the treatment once the constipation is relieved"", ""option_b"": ""To soften the stools and eliminate the vicious circle of hard stools-pain-retention for a short period"", ""option_c"": ""To soften the stools and eliminate the vicious circle of hard stools-pain-retention, to be prolonged for several months and then gradually reduced"", ""option_d"": ""To completely replace hygienic and dietary measures with medicinal treatment"", ""correct_option"": ""C""}","Management","What is the primary goal of medicinal treatment in older children with chronic constipation?","To immediately stop the treatment once the constipation is relieved","To soften the stools and eliminate the vicious circle of hard stools-pain-retention for a short period","To soften the stools and eliminate the vicious circle of hard stools-pain-retention, to be prolonged for several months and then gradually reduced","To completely replace hygienic and dietary measures with medicinal treatment","c"
"OIC-284-01-A","{""question"": ""What are the four subtypes of Irritable Bowel Syndrome (IBS), classified based on the predominant transit?"", ""option_a"": ""IBS with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), Inflammatory Bowel Disease (IBD), and IBS indeterminate (IBS-I)"", ""option_b"": ""IBS with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), IBS with alternating diarrhoea and constipation (IBS-M), and IBS indeterminate (IBS-I)"", ""option_c"": ""IBS with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), IBS with rapid transit (IBS-R), and IBS indeterminate (IBS-I)"", ""option_d"": ""IBS with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), IBS with slow transit (IBS-S), and IBS indeterminate (IBS-I)"", ""correct_option"": ""B""}","Definition","What are the four subtypes of Irritable Bowel Syndrome (IBS), classified based on the predominant transit?","IBS with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), Inflammatory Bowel Disease (IBD), and IBS indeterminate (IBS-I)","IBS with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), IBS with alternating diarrhoea and constipation (IBS-M), and IBS indeterminate (IBS-I)","IBS with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), IBS with rapid transit (IBS-R), and IBS indeterminate (IBS-I)","IBS with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), IBS with slow transit (IBS-S), and IBS indeterminate (IBS-I)","b"
"OIC-284-02-A","{""question"": ""What are the diagnostic criteria for irritable bowel syndrome according to the Rome criteria?"", ""option_a"": ""Abdominal pain >1 day/month in the last 3 months with 1 criterion"", ""option_b"": ""Abdominal pain >1 day/week in the last 3 months with at least 2 criteria"", ""option_c"": ""Abdominal pain >1 day/month in the last 6 months with at least 1 criterion"", ""option_d"": ""Abdominal pain >1 day/week in the last 6 months with at least 1 criterion"", ""correct_option"": ""B""}","Positive diagnosis","What are the diagnostic criteria for irritable bowel syndrome according to the Rome criteria?","Abdominal pain >1 day/month in the last 3 months with 1 criterion","Abdominal pain >1 day/week in the last 3 months with at least 2 criteria","Abdominal pain >1 day/month in the last 6 months with at least 1 criterion","Abdominal pain >1 day/week in the last 6 months with at least 1 criterion","b"
"OIC-284-03-B","{""question"": ""What is the estimated prevalence of irritable bowel syndrome in the general population worldwide?"", ""option_a"": ""1% of the general population"", ""option_b"": ""4% of the general population"", ""option_c"": ""10% of the general population"", ""option_d"": ""20% of the general population"", ""correct_option"": ""B""}","Prevalence","What is the estimated prevalence of irritable bowel syndrome in the general population worldwide?","1% of the general population","4% of the general population","10% of the general population","20% of the general population","b"
"OIC-284-04-A","{""question"": ""What is the typical characteristic of abdominal pain experienced by patients with Irritable Bowel Syndrome (IBS)?"", ""option_a"": ""A constant, sharp pain localized in the right iliac fossa"", ""option_b"": ""An intermittent, spasm-like pain often localized in the left iliac fossa or hypogastrium, which may be exacerbated by eating"", ""option_c"": ""A dull, aching pain that worsens at night and improves with stress or anxiety"", ""option_d"": ""A crampy pain that occurs only after defecation"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical characteristic of abdominal pain experienced by patients with Irritable Bowel Syndrome (IBS)?","A constant, sharp pain localized in the right iliac fossa","An intermittent, spasm-like pain often localized in the left iliac fossa or hypogastrium, which may be exacerbated by eating","A dull, aching pain that worsens at night and improves with stress or anxiety","A crampy pain that occurs only after defecation","b"
"OIC-284-05-A","{""question"": ""What is a clinical warning sign that should prompt a colonoscopy to rule out organic causes in a patient with functional colorectal disease?"", ""option_a"": ""Diarrhea in a patient under 40 years old with no family history of colorectal cancer"", ""option_b"": ""Blood in the stools (rectorrhagia or melena) in a patient over 50 years old"", ""option_c"": ""Mild and stable symptoms with no weight loss or nocturnal symptoms"", ""option_d"": ""Family history of irritable bowel syndrome (IBS) without any other symptoms"", ""correct_option"": ""B""}","Positive diagnosis","What is a clinical warning sign that should prompt a colonoscopy to rule out organic causes in a patient with functional colorectal disease?","Diarrhea in a patient under 40 years old with no family history of colorectal cancer","Blood in the stools (rectorrhagia or melena) in a patient over 50 years old","Mild and stable symptoms with no weight loss or nocturnal symptoms","Family history of irritable bowel syndrome (IBS) without any other symptoms","b"
"OIC-284-06-B","{""question"": ""What is the primary purpose of taking staged biopsies during a colonoscopy for a diarrhoeal subtype?"", ""option_a"": ""To confirm the presence of colorectal cancer"", ""option_b"": ""To look for microscopic colitis in all colonic segments and rule out ileal Crohn's disease"", ""option_c"": ""To identify the source of rectorrhagia or melena"", ""option_d"": ""To assess the effectiveness of the oral colonic preparation"", ""correct_option"": ""B""}","Additional examinations","What is the primary purpose of taking staged biopsies during a colonoscopy for a diarrhoeal subtype?","To confirm the presence of colorectal cancer","To look for microscopic colitis in all colonic segments and rule out ileal Crohn's disease","To identify the source of rectorrhagia or melena","To assess the effectiveness of the oral colonic preparation","b"
"OIC-284-07-B","{""question"": ""What is the primary purpose of carrying out a biological work-up in patients presenting with Irritable Bowel Syndrome (IBS)?"", ""option_a"": ""To confirm the diagnosis of IBS"", ""option_b"": ""To rule out an organic pathology"", ""option_c"": ""To determine the severity of IBS symptoms"", ""option_d"": ""To identify the underlying cause of IBS"", ""correct_option"": ""B""}",,"What is the primary purpose of carrying out a biological work-up in patients presenting with Irritable Bowel Syndrome (IBS)?","To confirm the diagnosis of IBS","To rule out an organic pathology","To determine the severity of IBS symptoms","To identify the underlying cause of IBS","b"
"OIC-284-08-A","{""question"": ""What is the primary goal of therapeutic management in functional colorectal disease?"", ""option_a"": ""To achieve a complete cure of the disease"", ""option_b"": ""To improve symptoms and enhance quality of life"", ""option_c"": ""To solely rely on medicinal treatments for management"", ""option_d"": ""To immediately refer patients for colonoscopy"", ""correct_option"": ""B""}","Therapeutic management","What is the primary goal of therapeutic management in functional colorectal disease?","To achieve a complete cure of the disease","To improve symptoms and enhance quality of life","To solely rely on medicinal treatments for management","To immediately refer patients for colonoscopy","b"
"OIC-288-01-A","{""question"": ""What are haemorrhoids composed of?"", ""option_a"": ""Dilated venous lakes, small arterioles, and a lining epithelium"", ""option_b"": ""Dilated venous lakes, small arterioles or arteriovenous shunts, supporting tissue, and a lining epithelium"", ""option_c"": ""Smooth muscle fibres, collagen tissue, and a porto-systemic anastomotic system"", ""option_d"": ""Small arterioles, supporting tissue, and a lining epithelium"", ""correct_option"": ""B""}","Definition","What are haemorrhoids composed of?","Dilated venous lakes, small arterioles, and a lining epithelium","Dilated venous lakes, small arterioles or arteriovenous shunts, supporting tissue, and a lining epithelium","Smooth muscle fibres, collagen tissue, and a porto-systemic anastomotic system","Small arterioles, supporting tissue, and a lining epithelium","b"
"OIC-288-02-B","{""question"": ""What proportion of the French adult population is estimated to have experienced at least one haemorrhoidal symptom in the past year?"", ""option_a"": ""About one fifth"", ""option_b"": ""About a third"", ""option_c"": ""About half"", ""option_d"": ""About two thirds"", ""correct_option"": ""B""}","Epidemiology","What proportion of the French adult population is estimated to have experienced at least one haemorrhoidal symptom in the past year?","About one fifth","About a third","About half","About two thirds","b"
"OIC-288-03-B","{""question"": ""What are the two main theories that lead to a normal, asymptomatic anatomical component becoming symptomatic in haemorrhoidal disease?"", ""option_a"": ""The mechanical theory and the inflammatory theory"", ""option_b"": ""The vascular theory and the neurological theory"", ""option_c"": ""The mechanical theory and the vascular theory"", ""option_d"": ""The hormonal theory and the genetic theory"", ""correct_option"": ""C""}","Physiopathology","What are the two main theories that lead to a normal, asymptomatic anatomical component becoming symptomatic in haemorrhoidal disease?","The mechanical theory and the inflammatory theory","The vascular theory and the neurological theory","The mechanical theory and the vascular theory","The hormonal theory and the genetic theory","c"
"OIC-288-04-A","{""question"": ""What is the primary difference in the epithelial lining between the internal and external haemorrhoidal plexus?"", ""option_a"": ""The internal plexus has a squamous lining, while the external plexus has an intestinal lining"", ""option_b"": ""The internal plexus has an intestinal lining, while the external plexus has a squamous lining"", ""option_c"": ""Both plexuses have the same type of epithelial lining"", ""option_d"": ""The lining of the internal plexus is not related to the type of lining in the external plexus"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary difference in the epithelial lining between the internal and external haemorrhoidal plexus?","The internal plexus has a squamous lining, while the external plexus has an intestinal lining","The internal plexus has an intestinal lining, while the external plexus has a squamous lining","Both plexuses have the same type of epithelial lining","The lining of the internal plexus is not related to the type of lining in the external plexus","b"
"OIC-288-05-A","{""question"": ""What is a characteristic feature of external haemorrhoidal thrombosis that can be identified without the need for anoscopy?"", ""option_a"": ""A soft and fluctuant swelling"", ""option_b"": ""A sensitive bluish swelling that is indurated on palpation"", ""option_c"": ""Painless bleeding in the early stages"", ""option_d"": ""A diffuse and non-tender swelling of the anal region"", ""correct_option"": ""B""}","Positive diagnosis","What is a characteristic feature of external haemorrhoidal thrombosis that can be identified without the need for anoscopy?","A soft and fluctuant swelling","A sensitive bluish swelling that is indurated on palpation","Painless bleeding in the early stages","A diffuse and non-tender swelling of the anal region","b"
"OIC-288-06-A","{""question"": ""What is the primary characteristic that distinguishes Grade I internal haemorrhoids from other grades?"", ""option_a"": ""Procidence outside the anus during pushing but spontaneous reintegration at the end of pushing"", ""option_b"": ""Permanent procidence from the outset"", ""option_c"": ""No procidence in the anoscopic lumen"", ""option_d"": ""Procidence in the lumen of the anoscopy but not outside"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary characteristic that distinguishes Grade I internal haemorrhoids from other grades?","Procidence outside the anus during pushing but spontaneous reintegration at the end of pushing","Permanent procidence from the outset","No procidence in the anoscopic lumen","Procidence in the lumen of the anoscopy but not outside","c"
"OIC-288-07-B","{""question"": ""A patient presents with intense pain that worsens with touching or support, lasting a few hours to a few days, accompanied by painful anal tumefaction. What is the most likely diagnosis?"", ""option_a"": ""Anal fissure"", ""option_b"": ""External haemorrhoidal thrombosis"", ""option_c"": ""Haemorrhoidal crisis"", ""option_d"": ""Abscess"", ""correct_option"": ""B""}","Positive diagnosis","A patient presents with intense pain that worsens with touching or support, lasting a few hours to a few days, accompanied by painful anal tumefaction. What is the most likely diagnosis?","Anal fissure","External haemorrhoidal thrombosis","Haemorrhoidal crisis","Abscess","b"
"OIC-288-08-B","{""question"": ""What is the primary consideration when differentiating external haemorrhoidal thrombosis from other anal conditions?"", ""option_a"": ""The presence of bleeding"", ""option_b"": ""The location and severity of pain"", ""option_c"": ""The patient's medical history"", ""option_d"": ""The appearance of the anal mucosa"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary consideration when differentiating external haemorrhoidal thrombosis from other anal conditions?","The presence of bleeding","The location and severity of pain","The patient's medical history","The appearance of the anal mucosa","b"
"OIC-288-09-B","{""question"": ""What should be considered when diagnosing iron deficiency anaemia in a patient with internal haemorrhoids?"", ""option_a"": ""Internal haemorrhoids are always the primary cause of iron deficiency anaemia"", ""option_b"": ""Other possible causes of iron deficiency anaemia should be ruled out before attributing it to haemorrhoids"", ""option_c"": ""Chronic bleeding from haemorrhoids is a common cause of iron deficiency anaemia"", ""option_d"": ""Iron deficiency anaemia is never related to haemorrhoidal pathology"", ""correct_option"": ""B""}","Positive diagnosis","What should be considered when diagnosing iron deficiency anaemia in a patient with internal haemorrhoids?","Internal haemorrhoids are always the primary cause of iron deficiency anaemia","Other possible causes of iron deficiency anaemia should be ruled out before attributing it to haemorrhoids","Chronic bleeding from haemorrhoids is a common cause of iron deficiency anaemia","Iron deficiency anaemia is never related to haemorrhoidal pathology","b"
"OIC-288-10-A","{""question"": ""What characterizes stage III internal hemorrhoids?"", ""option_a"": ""Internal hemorrhoids are permanently externalized and may undergo squamous metaplasia"", ""option_b"": ""Internal hemorrhoids bulge into the anoscopic lumen but do not prolapse"", ""option_c"": ""Internal hemorrhoids come out when you push, but then go back into the anal canal"", ""option_d"": ""There is a normal appearance of the haemorrhoidal mucosa with no bulging into the anoscopic lumen"", ""correct_option"": ""C""}","Multimedia content","What characterizes stage III internal hemorrhoids?","Internal hemorrhoids are permanently externalized and may undergo squamous metaplasia","Internal hemorrhoids bulge into the anoscopic lumen but do not prolapse","Internal hemorrhoids come out when you push, but then go back into the anal canal","There is a normal appearance of the haemorrhoidal mucosa with no bulging into the anoscopic lumen","c"
"OIC-288-11-A","{""question"": ""What is the condition depicted in the photograph of External haemorrhoidal thrombosis with ulceration at the top of the clot?"", ""option_a"": ""A blood clot that has formed inside the hemorrhoid"", ""option_b"": ""A blood clot that has formed outside the hemorrhoid, near the anus"", ""option_c"": ""A normal variation of hemorrhoidal tissue"", ""option_d"": ""A complication of internal hemorrhoids"", ""correct_option"": ""B""}","Multimedia content","What is the condition depicted in the photograph of External haemorrhoidal thrombosis with ulceration at the top of the clot?","A blood clot that has formed inside the hemorrhoid","A blood clot that has formed outside the hemorrhoid, near the anus","A normal variation of hemorrhoidal tissue","A complication of internal hemorrhoids","b"
"OIC-288-12-B","{""question"": ""What is a primary factor that contributes to the development of hemorrhoidal pathology?"", ""option_a"": ""Aging and genetic predisposition"", ""option_b"": ""Infectious diseases of the gastrointestinal tract"", ""option_c"": ""Chronic use of antibiotics"", ""option_d"": ""Poor posture and sedentary lifestyle"", ""correct_option"": ""A""}","Etiologies","What is a primary factor that contributes to the development of hemorrhoidal pathology?","Aging and genetic predisposition","Infectious diseases of the gastrointestinal tract","Chronic use of antibiotics","Poor posture and sedentary lifestyle","a"
"OIC-288-13-A","{""question"": ""What is the primary goal of dietary hygiene rules in the management of haemorrhoidal disease?"", ""option_a"": ""To reduce the intake of soluble fibre"", ""option_b"": ""To combat chronic constipation and regulate transit"", ""option_c"": ""To increase the use of local topicals and emollient products"", ""option_d"": ""To promote the use of surgical treatment for haemorrhoidal disease"", ""correct_option"": ""B""}","Management","What is the primary goal of dietary hygiene rules in the management of haemorrhoidal disease?","To reduce the intake of soluble fibre","To combat chronic constipation and regulate transit","To increase the use of local topicals and emollient products","To promote the use of surgical treatment for haemorrhoidal disease","b"
"OIC-288-14-A","{""question"": ""What is the primary consideration for treating haemorrhoids according to the therapeutic preamble?"", ""option_a"": ""The presence of haemorrhoids regardless of symptoms"", ""option_b"": ""The patient's request for treatment and the presence of symptoms"", ""option_c"": ""The risk of degeneration or life-threatening complications"", ""option_d"": ""The therapist's personal preference for treatment approach"", ""correct_option"": ""B""}","Management","What is the primary consideration for treating haemorrhoids according to the therapeutic preamble?","The presence of haemorrhoids regardless of symptoms","The patient's request for treatment and the presence of symptoms","The risk of degeneration or life-threatening complications","The therapist's personal preference for treatment approach","b"
"OIC-288-15-A","{""question"": ""What is the primary treatment approach for external haemorrhoidal thrombosis?"", ""option_a"": ""Immediate surgical excision"", ""option_b"": ""Conservative management with pain relief and warm baths"", ""option_c"": ""Rubber band ligation"", ""option_d"": ""Sclerotherapy"", ""correct_option"": ""B""}","Management","What is the primary treatment approach for external haemorrhoidal thrombosis?","Immediate surgical excision","Conservative management with pain relief and warm baths","Rubber band ligation","Sclerotherapy","b"
"OIC-288-16-B","{""question"": ""What is the primary consideration for indicating surgical treatment in hemorrhoidal pathology?"", ""option_a"": ""Mild symptoms that do not impact daily life"", ""option_b"": ""Failure of conservative management or severe symptoms"", ""option_c"": ""Patient preference for surgical intervention over other treatments"", ""option_d"": ""Presence of hemorrhoids regardless of symptom severity"", ""correct_option"": ""B""}","Management","What is the primary consideration for indicating surgical treatment in hemorrhoidal pathology?","Mild symptoms that do not impact daily life","Failure of conservative management or severe symptoms","Patient preference for surgical intervention over other treatments","Presence of hemorrhoids regardless of symptom severity","b"
"OIC-288-17-B","{""question"": ""What is the typical outcome of external haemorrhoidal thrombosis?"", ""option_a"": ""The condition usually leads to severe, chronic bleeding and requires immediate surgical intervention."", ""option_b"": ""The clot is slowly resorbed over several days, potentially leaving a raised scar known as a mariscus."", ""option_c"": ""External haemorrhoidal thrombosis typically results in secondary suppurative complications that can be life-threatening."", ""option_d"": ""The condition is usually accompanied by a severe inflammatory reaction that necessitates hospitalization."", ""correct_option"": ""B""}",,"What is the typical outcome of external haemorrhoidal thrombosis?","The condition usually leads to severe, chronic bleeding and requires immediate surgical intervention.","The clot is slowly resorbed over several days, potentially leaving a raised scar known as a mariscus.","External haemorrhoidal thrombosis typically results in secondary suppurative complications that can be life-threatening.","The condition is usually accompanied by a severe inflammatory reaction that necessitates hospitalization.","b"
"OIC-299-01-A","{""question"": ""What is the primary distinction between a benign and a malignant intracranial tumour?"", ""option_a"": ""Location within the brain"", ""option_b"": ""Rate of growth and prognosis"", ""option_c"": ""Presence of metastasis"", ""option_d"": ""Type of brain tissue affected"", ""correct_option"": ""B""}","Definition","What is the primary distinction between a benign and a malignant intracranial tumour?","Location within the brain","Rate of growth and prognosis","Presence of metastasis","Type of brain tissue affected","b"
"OIC-299-02-A","{""question"": ""What is the primary characteristic that distinguishes primary intracranial tumours originating in the central nervous system (CNS) from those originating in its adnexa?"", ""option_a"": ""The presence of meningioma"", ""option_b"": ""The location of the tumour, with CNS tumours being intra-axial and adnexal tumours being extra-axial"", ""option_c"": ""The type of cells from which the tumour develops, with CNS tumours originating from neurons and adnexal tumours from glial cells"", ""option_d"": ""The severity of the symptoms caused by the tumour"", ""correct_option"": ""B""}","Definition","What is the primary characteristic that distinguishes primary intracranial tumours originating in the central nervous system (CNS) from those originating in its adnexa?","The presence of meningioma","The location of the tumour, with CNS tumours being intra-axial and adnexal tumours being extra-axial","The type of cells from which the tumour develops, with CNS tumours originating from neurons and adnexal tumours from glial cells","The severity of the symptoms caused by the tumour","b"
"OIC-299-03-B","{""question"": ""What is the primary treatment approach for symptomatic meningiomas or those showing radiological progression?"", ""option_a"": ""Chemotherapy and radiotherapy"", ""option_b"": ""Surgery"", ""option_c"": ""Hormone therapy"", ""option_d"": ""Targeted therapies"", ""correct_option"": ""B""}","Definition","What is the primary treatment approach for symptomatic meningiomas or those showing radiological progression?","Chemotherapy and radiotherapy","Surgery","Hormone therapy","Targeted therapies","b"
"OIC-299-04-B","{""question"": ""What is the most common location for a medulloblastoma to occur?"", ""option_a"": ""Supraventricular region in adults"", ""option_b"": ""Vermis of the cerebellum"", ""option_c"": ""Internal auditory canal"", ""option_d"": ""Ventricular region in children"", ""correct_option"": ""B""}","Epidemiology","What is the most common location for a medulloblastoma to occur?","Supraventricular region in adults","Vermis of the cerebellum","Internal auditory canal","Ventricular region in children","b"
"OIC-299-05-A","{""question"": ""What is a common symptom of intracranial hypertension syndrome (HTIC) that is often relieved by vomiting?"", ""option_a"": ""Horizontal diplopia"", ""option_b"": ""Headache"", ""option_c"": ""Psychic slowing down"", ""option_d"": ""Focal neurological deficits"", ""correct_option"": ""B""}","Positive diagnosis","What is a common symptom of intracranial hypertension syndrome (HTIC) that is often relieved by vomiting?","Horizontal diplopia","Headache","Psychic slowing down","Focal neurological deficits","b"
"OIC-299-06-B","{""question"": ""What is the most effective imaging modality for the diagnosis and preoperative assessment of adult intracranial tumours?"", ""option_a"": ""CT scans without injection"", ""option_b"": ""CT scans with injection"", ""option_c"": ""MRI scans without and with injections"", ""option_d"": ""PET scans"", ""correct_option"": ""C""}","Additional examinations","What is the most effective imaging modality for the diagnosis and preoperative assessment of adult intracranial tumours?","CT scans without injection","CT scans with injection","MRI scans without and with injections","PET scans","c"
"OIC-299-07-A","{""question"": ""In the presence of brain metastases, what is the recommended initial step in the systematic search for primary cancer?"", ""option_a"": ""Perform a thoracic-abdominal-pelvic scan with contrast medium"", ""option_b"": ""Conduct a skin examination to check for melanoma"", ""option_c"": ""Start with mammography in women"", ""option_d"": ""Begin with fluorodeoxyglucose PET scanner"", ""correct_option"": ""A""}","Positive diagnosis","In the presence of brain metastases, what is the recommended initial step in the systematic search for primary cancer?","Perform a thoracic-abdominal-pelvic scan with contrast medium","Conduct a skin examination to check for melanoma","Start with mammography in women","Begin with fluorodeoxyglucose PET scanner","a"
"OIC-299-08-A","{""question"": ""What is a possible complication of intracranial hypertension (ICHT) in a patient with an intracerebral tumour?"", ""option_a"": ""Seizure with full recovery"", ""option_b"": ""Damage to the II and VI cranial nerves"", ""option_c"": ""Sudden improvement in cognitive function"", ""option_d"": ""Spontaneous resolution of the tumour"", ""correct_option"": ""B""}","Identification of the emergency","What is a possible complication of intracranial hypertension (ICHT) in a patient with an intracerebral tumour?","Seizure with full recovery","Damage to the II and VI cranial nerves","Sudden improvement in cognitive function","Spontaneous resolution of the tumour","b"
"OIC-299-09-B","{""question"": ""What is the primary treatment approach for peritumoral vasogenic oedema in a patient with an intracerebral tumour?"", ""option_a"": ""Resection surgery"", ""option_b"": ""Corticosteroid therapy and diuretics"", ""option_c"": ""Endoscopic ventriculocisternostomy"", ""option_d"": ""Internal or external LCS shunt"", ""correct_option"": ""B""}",,"What is the primary treatment approach for peritumoral vasogenic oedema in a patient with an intracerebral tumour?","Resection surgery","Corticosteroid therapy and diuretics","Endoscopic ventriculocisternostomy","Internal or external LCS shunt","b"
"OIC-302-01-A","{""question"": ""What type of cells do melanomas develop from?"", ""option_a"": ""Keratinocytes"", ""option_b"": ""Melanocytes"", ""option_c"": ""Fibroblasts"", ""option_d"": ""Lymphocytes"", ""correct_option"": ""B""}","Definition","What type of cells do melanomas develop from?","Keratinocytes","Melanocytes","Fibroblasts","Lymphocytes","b"
"OIC-302-02-A","{""question"": ""What is the typical presentation of a plantar wart caused by HPV1?"", ""option_a"": ""A superficial, painless wart in a keratotic plaque"", ""option_b"": ""A deep wart, painful on pressure, with a thick keratotic ring and black dots"", ""option_c"": ""A small, barely raised papule with a smooth surface, usually on the face or hands"", ""option_d"": ""An exophytic lesion with greyish keratotic projections, mainly on the dorsal surface of the hands"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical presentation of a plantar wart caused by HPV1?","A superficial, painless wart in a keratotic plaque","A deep wart, painful on pressure, with a thick keratotic ring and black dots","A small, barely raised papule with a smooth surface, usually on the face or hands","An exophytic lesion with greyish keratotic projections, mainly on the dorsal surface of the hands","b"
"OIC-302-03-B","{""question"": ""What is the main factor promoting carcinomas, including both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)?"", ""option_a"": ""Immunosuppression due to chronic diseases"", ""option_b"": ""Genetic predisposition due to family history"", ""option_c"": ""Sun exposure, including both chronic and cumulative exposure, as well as intense and intermittent exposure"", ""option_d"": ""Age and light phototype alone"", ""correct_option"": ""C""}","Epidemiology","What is the main factor promoting carcinomas, including both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)?","Immunosuppression due to chronic diseases","Genetic predisposition due to family history","Sun exposure, including both chronic and cumulative exposure, as well as intense and intermittent exposure","Age and light phototype alone","c"
"OIC-302-04-A","{""question"": ""What is the recommended safety margin for surgical excision of an intraepidermal melanoma?"", ""option_a"": ""1-2 cm"", ""option_b"": ""0.5 cm"", ""option_c"": ""2 cm"", ""option_d"": ""5-10 mm"", ""correct_option"": ""B""}","Management","What is the recommended safety margin for surgical excision of an intraepidermal melanoma?","1-2 cm","0.5 cm","2 cm","5-10 mm","b"
"OIC-302-05-A","{""question"": ""What is the most common clinical presentation of basal cell carcinoma (BCC)?"", ""option_a"": ""A rapidly growing, painful nodule with multiple ulcerations"", ""option_b"": ""A translucent pearly papule of firm consistency associated with telangiectasias"", ""option_c"": ""A red, keratotic, rough patch that bleeds after removal, typically found on non-exposed areas"", ""option_d"": ""A yellowish-white, hard, poorly limited plaque with no associated ulceration or pigmentation"", ""correct_option"": ""B""}","Positive diagnosis","What is the most common clinical presentation of basal cell carcinoma (BCC)?","A rapidly growing, painful nodule with multiple ulcerations","A translucent pearly papule of firm consistency associated with telangiectasias","A red, keratotic, rough patch that bleeds after removal, typically found on non-exposed areas","A yellowish-white, hard, poorly limited plaque with no associated ulceration or pigmentation","b"
"OIC-302-06-B","{""question"": ""What is a poor prognostic factor for squamous cell carcinomas (EC)?"", ""option_a"": ""Location on the trunk or limbs"", ""option_b"": ""A high level of histological differentiation"", ""option_c"": ""Location on the temple, ear or lip"", ""option_d"": ""Histological tumour thickness <1mm"", ""correct_option"": ""C""}",,"What is a poor prognostic factor for squamous cell carcinomas (EC)?","Location on the trunk or limbs","A high level of histological differentiation","Location on the temple, ear or lip","Histological tumour thickness <1mm","c"
"OIC-302-07-A","{""question"": ""What is the primary method of preventing squamous cell and basal cell carcinomas?"", ""option_a"": ""Early detection and treatment of existing tumors"", ""option_b"": ""Encouraging sun protection and treating precancerous lesions"", ""option_c"": ""Surgical removal of all moles and suspicious skin lesions"", ""option_d"": ""Vaccination against common skin cancer-causing viruses"", ""correct_option"": ""B""}","Management","What is the primary method of preventing squamous cell and basal cell carcinomas?","Early detection and treatment of existing tumors","Encouraging sun protection and treating precancerous lesions","Surgical removal of all moles and suspicious skin lesions","Vaccination against common skin cancer-causing viruses","b"
"OIC-302-08-A","{""question"": ""What is the primary factor that influences the number of nevi in an individual, according to their ethnic origin?"", ""option_a"": ""Caucasian individuals have fewer nevi than Asian individuals"", ""option_b"": ""Black individuals have more nevi than Caucasian individuals"", ""option_c"": ""The number of nevi is the same across all ethnic origins"", ""option_d"": ""Caucasian individuals tend to have more nevi than Asian and black individuals"", ""correct_option"": ""D""}","Definition","What is the primary factor that influences the number of nevi in an individual, according to their ethnic origin?","Caucasian individuals have fewer nevi than Asian individuals","Black individuals have more nevi than Caucasian individuals","The number of nevi is the same across all ethnic origins","Caucasian individuals tend to have more nevi than Asian and black individuals","d"
"OIC-302-09-B","{""question"": ""What is the primary differential diagnosis to consider when examining a pigmented lesion to distinguish it from a simple nevus?"", ""option_a"": ""Seborrheic keratosis"", ""option_b"": ""Basal cell carcinoma"", ""option_c"": ""Melanoma"", ""option_d"": ""Actinic lentigo"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary differential diagnosis to consider when examining a pigmented lesion to distinguish it from a simple nevus?","Seborrheic keratosis","Basal cell carcinoma","Melanoma","Actinic lentigo","c"
"OIC-302-10-B","{""question"": ""What is the typical natural history of common nevi in individuals?"", ""option_a"": ""They appear around birth and remain stable throughout life"", ""option_b"": ""They appear around 4-5 years of age, gradually increase up to age 30, and then regress after age 60"", ""option_c"": ""They appear in adulthood and increase in number with age"", ""option_d"": ""They appear in infancy and disappear by age 10"", ""correct_option"": ""B""}","Physiopathology","What is the typical natural history of common nevi in individuals?","They appear around birth and remain stable throughout life","They appear around 4-5 years of age, gradually increase up to age 30, and then regress after age 60","They appear in adulthood and increase in number with age","They appear in infancy and disappear by age 10","b"
"OIC-302-11-A","{""question"": ""What is the primary method for confirming the diagnosis of melanoma after clinical suspicion?"", ""option_a"": ""Dermoscopy"", ""option_b"": ""Biopsy"", ""option_c"": ""Anatomopathological examination after complete excision of the lesion"", ""option_d"": ""Clinical examination using the ABCDE rule"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary method for confirming the diagnosis of melanoma after clinical suspicion?","Dermoscopy","Biopsy","Anatomopathological examination after complete excision of the lesion","Clinical examination using the ABCDE rule","c"
"OIC-302-12-B","{""question"": ""What is the most common type of melanoma, accounting for 60-70% of cases?"", ""option_a"": ""Nodular melanoma"", ""option_b"": ""Superficial spreading melanoma"", ""option_c"": ""Lentiginous acral melanoma"", ""option_d"": ""Dubreuilh melanoma"", ""correct_option"": ""B""}","Follow-up and/or prognosis","What is the most common type of melanoma, accounting for 60-70% of cases?","Nodular melanoma","Superficial spreading melanoma","Lentiginous acral melanoma","Dubreuilh melanoma","b"
"OIC-302-13-A","{""question"": ""What is the primary method of preventing melanoma?"", ""option_a"": ""Early detection through regular screening"", ""option_b"": ""Reducing UV exposure through photoprotection"", ""option_c"": ""Improving prognosis through advanced treatment options"", ""option_d"": ""Increasing awareness among high-risk groups only"", ""correct_option"": ""B""}","Management","What is the primary method of preventing melanoma?","Early detection through regular screening","Reducing UV exposure through photoprotection","Improving prognosis through advanced treatment options","Increasing awareness among high-risk groups only","b"
"OIC-302-14-B","{""question"": ""What is the condition depicted in the photograph of the skin lesion?"", ""option_a"": ""Melanoma"", ""option_b"": ""Actinic keratoses"", ""option_c"": ""Squamous cell carcinoma"", ""option_d"": ""Basal cell carcinoma"", ""correct_option"": ""B""}","Multimedia content","What is the condition depicted in the photograph of the skin lesion?","Melanoma","Actinic keratoses","Squamous cell carcinoma","Basal cell carcinoma","b"
"OIC-302-15-B","{""question"": ""What is a characteristic feature of a nodular basal cell carcinoma?"", ""option_a"": ""A well-limited erythematosquamous plaque with a pearly border"", ""option_b"": ""A translucent nodule covered with telangiectasias"", ""option_c"": ""A pigmented lesion with irregular borders"", ""option_d"": ""A painful ulcerative lesion"", ""correct_option"": ""B""}","Multimedia content","What is a characteristic feature of a nodular basal cell carcinoma?","A well-limited erythematosquamous plaque with a pearly border","A translucent nodule covered with telangiectasias","A pigmented lesion with irregular borders","A painful ulcerative lesion","b"
"OIC-302-16-B","{""question"": ""What is the characteristic appearance of a squamous cell carcinoma?"", ""option_a"": ""A smooth, non-ulcerative tumor with well-defined margins"", ""option_b"": ""An irregular, ulcerative-vegetative tumor with inflammatory margins and an indurated base"", ""option_c"": ""A pigmented, nodular tumor with a flat, broad base"", ""option_d"": ""A cystic, fluid-filled tumor with a thin, translucent wall"", ""correct_option"": ""B""}","Multimedia content","What is the characteristic appearance of a squamous cell carcinoma?","A smooth, non-ulcerative tumor with well-defined margins","An irregular, ulcerative-vegetative tumor with inflammatory margins and an indurated base","A pigmented, nodular tumor with a flat, broad base","A cystic, fluid-filled tumor with a thin, translucent wall","b"
"OIC-302-17-A","{""question"": ""What characteristic is often associated with a melanoma, as visible in a photography of the skin lesion?"", ""option_a"": ""Symmetric pigmented lesion with regular margins"", ""option_b"": ""Asymmetric pigmented lesion with irregular margins"", ""option_c"": ""Homogeneously colored lesion with a consistent diameter"", ""option_d"": ""Lesion that has not changed in size or color over time"", ""correct_option"": ""B""}","Multimedia content","What characteristic is often associated with a melanoma, as visible in a photography of the skin lesion?","Symmetric pigmented lesion with regular margins","Asymmetric pigmented lesion with irregular margins","Homogeneously colored lesion with a consistent diameter","Lesion that has not changed in size or color over time","b"
"OIC-310-01-B","{""question"": ""What is the most common form of prostate cancer, accounting for 95% of cases?"", ""option_a"": ""Neuroendocrine carcinoma"", ""option_b"": ""Adenocarcinoma"", ""option_c"": ""Lymphoma"", ""option_d"": ""Sarcoma"", ""correct_option"": ""B""}","Definition","What is the most common form of prostate cancer, accounting for 95% of cases?","Neuroendocrine carcinoma","Adenocarcinoma","Lymphoma","Sarcoma","b"
"OIC-310-02-B","{""question"": ""At what age is the median diagnosis of prostate cancer in men?"", ""option_a"": ""50"", ""option_b"": ""60"", ""option_c"": ""68"", ""option_d"": ""70"", ""correct_option"": ""C""}","Epidemiology","At what age is the median diagnosis of prostate cancer in men?",50,60,68,70,"c"
"OIC-310-03-A","{""question"": ""What is a recognised risk factor for prostate cancer that is associated with an increased incidence of the disease?"", ""option_a"": ""Young age"", ""option_b"": ""Genetic factors, such as a family history of breast or ovarian cancer"", ""option_c"": ""A diet low in saturated fats"", ""option_d"": ""Metabolic syndrome"", ""correct_option"": ""D""}","Etiologies","What is a recognised risk factor for prostate cancer that is associated with an increased incidence of the disease?","Young age","Genetic factors, such as a family history of breast or ovarian cancer","A diet low in saturated fats","Metabolic syndrome","d"
"OIC-310-04-B","{""question"": ""What is the primary site of non-node metastasis for prostate cancer?"", ""option_a"": ""Lung"", ""option_b"": ""Liver"", ""option_c"": ""Bone"", ""option_d"": ""Pelvic wall"", ""correct_option"": ""C""}","Physiopathology","What is the primary site of non-node metastasis for prostate cancer?","Lung","Liver","Bone","Pelvic wall","c"
"OIC-310-05-A","{""question"": ""What is a common presentation of localized prostate cancer?"", ""option_a"": ""Urinary retention and renal failure"", ""option_b"": ""Haemospermia and sexual problems"", ""option_c"": ""Typically asymptomatic, with possible urinary symptoms due to concomitant prostate adenoma"", ""option_d"": ""Diffuse bone metastases and impaired general condition"", ""correct_option"": ""C""}","Positive diagnosis","What is a common presentation of localized prostate cancer?","Urinary retention and renal failure","Haemospermia and sexual problems","Typically asymptomatic, with possible urinary symptoms due to concomitant prostate adenoma","Diffuse bone metastases and impaired general condition","c"
"OIC-310-06-A","{""question"": ""What is the primary consideration for determining the threshold value of PSA that should prompt further investigation for prostate cancer?"", ""option_a"": ""The patient's age and overall health"", ""option_b"": ""The volume of the prostate and the patient's age"", ""option_c"": ""The presence of benign prostatic hyperplasia or prostatitis"", ""option_d"": ""The patient's family history of prostate cancer"", ""correct_option"": ""B""}","Additional tests","What is the primary consideration for determining the threshold value of PSA that should prompt further investigation for prostate cancer?","The patient's age and overall health","The volume of the prostate and the patient's age","The presence of benign prostatic hyperplasia or prostatitis","The patient's family history of prostate cancer","b"
"OIC-310-07-B","{""question"": ""According to the D'Amico classification, what are the criteria used to determine the risk group for localized or locally advanced but non-metastatic prostate cancer?"", ""option_a"": ""Digital rectal examination and PSA level"", ""option_b"": ""ISUP group and clinical stage"", ""option_c"": ""Digital rectal examination, PSA level, and ISUP group"", ""option_d"": ""Clinical stage and treatment strategy"", ""correct_option"": ""C""}","Management","According to the D'Amico classification, what are the criteria used to determine the risk group for localized or locally advanced but non-metastatic prostate cancer?","Digital rectal examination and PSA level","ISUP group and clinical stage","Digital rectal examination, PSA level, and ISUP group","Clinical stage and treatment strategy","c"
"OIC-312-02-B","{""question"": ""Which of the following is a recognized intrinsic risk factor for breast cancer?"", ""option_a"": ""High body mass index (BMI) or an increase in BMI during the menopause"", ""option_b"": ""Sedentary lifestyle (after the menopause)"", ""option_c"": ""Family history of breast or ovarian cancer, with possible knowledge of a genetic predisposition (germline mutation 'BRCA1, BRCA2')"", ""option_d"": ""Thoracic irradiation"", ""correct_option"": ""C""}",,"Which of the following is a recognized intrinsic risk factor for breast cancer?","High body mass index (BMI) or an increase in BMI during the menopause","Sedentary lifestyle (after the menopause)","Family history of breast or ovarian cancer, with possible knowledge of a genetic predisposition (germline mutation 'BRCA1, BRCA2')","Thoracic irradiation","c"
"OIC-312-03-B","{""question"": ""What is the primary mode of transmission for hereditary breast and ovarian cancer syndrome (HBOC) caused by germline mutations in the BRCA1 and BRCA2 genes?"", ""option_a"": ""Autosomal dominant"", ""option_b"": ""Autosomal recessive"", ""option_c"": ""X-linked dominant"", ""option_d"": ""X-linked recessive"", ""correct_option"": ""B""}","Physiopathology","What is the primary mode of transmission for hereditary breast and ovarian cancer syndrome (HBOC) caused by germline mutations in the BRCA1 and BRCA2 genes?","Autosomal dominant","Autosomal recessive","X-linked dominant","X-linked recessive","b"
"OIC-312-04-A","{""question"": ""How do breast cancer cells primarily spread after becoming invasive?"", ""option_a"": ""Through the bloodstream only"", ""option_b"": ""Through the lymphatic system and by contiguity"", ""option_c"": ""By direct extension to adjacent tissues only"", ""option_d"": ""Through the nervous system"", ""correct_option"": ""B""}","Physiopathology","How do breast cancer cells primarily spread after becoming invasive?","Through the bloodstream only","Through the lymphatic system and by contiguity","By direct extension to adjacent tissues only","Through the nervous system","b"
"OIC-312-05-A","{""question"": ""What is the recommended frequency for a clinical breast examination by a health professional for all women from the age of 25?"", ""option_a"": ""Every 2 years"", ""option_b"": ""Every year"", ""option_c"": ""Every 5 years"", ""option_d"": ""Only when symptoms appear"", ""correct_option"": ""B""}","Positive diagnosis","What is the recommended frequency for a clinical breast examination by a health professional for all women from the age of 25?","Every 2 years","Every year","Every 5 years","Only when symptoms appear","b"
"OIC-312-06-A","{""question"": ""During a clinical examination for breast tumours, what is the primary purpose of the inspection?"", ""option_a"": ""To look for breast pain and self-exploration of nodules"", ""option_b"": ""To examine the axillary, supra- and sub-clavicular lymph nodes"", ""option_c"": ""To identify changes in the skin of the breast or nipple, such as retraction or nipple discharge"", ""option_d"": ""To assess the patient's general condition, including asthenia and weight loss"", ""correct_option"": ""C""}","Positive diagnosis","During a clinical examination for breast tumours, what is the primary purpose of the inspection?","To look for breast pain and self-exploration of nodules","To examine the axillary, supra- and sub-clavicular lymph nodes","To identify changes in the skin of the breast or nipple, such as retraction or nipple discharge","To assess the patient's general condition, including asthenia and weight loss","c"
"OIC-312-07-B","{""question"": ""What is a common sign associated with breast skin lesions or anomalies, as shown in the photographs?"", ""option_a"": ""A symmetrical and firm breast texture"", ""option_b"": ""An orange peel appearance and inflamed breast"", ""option_c"": ""A uniform and consistent nipple discharge"", ""option_d"": ""A complete absence of any visible skin anomalies"", ""correct_option"": ""B""}","Multimedia content","What is a common sign associated with breast skin lesions or anomalies, as shown in the photographs?","A symmetrical and firm breast texture","An orange peel appearance and inflamed breast","A uniform and consistent nipple discharge","A complete absence of any visible skin anomalies","b"
"OIC-312-08-A","{""question"": ""For which of the following age groups is mammography not the examination of choice for 1st-line screening?"", ""option_a"": ""Women over 50 years of age"", ""option_b"": ""Women between 30 and 50 years of age"", ""option_c"": ""Women under 30 years of age"", ""option_d"": ""Women over 70 years of age"", ""correct_option"": ""C""}","Additional examinations","For which of the following age groups is mammography not the examination of choice for 1st-line screening?","Women over 50 years of age","Women between 30 and 50 years of age","Women under 30 years of age","Women over 70 years of age","c"
"OIC-312-09-B","{""question"": ""Which of the following lesions must be biopsied?"", ""option_a"": ""Lesions classified as Bi-rads 2"", ""option_b"": ""Lesions classified as Bi-rads 4 and 5, as well as Bi-rads 3 in BRCA mutated patients"", ""option_c"": ""Lesions classified as Bi-rads 1 and 2"", ""option_d"": ""Lesions classified as Bi-rads 3 in all patients"", ""correct_option"": ""B""}","Additional examinations","Which of the following lesions must be biopsied?","Lesions classified as Bi-rads 2","Lesions classified as Bi-rads 4 and 5, as well as Bi-rads 3 in BRCA mutated patients","Lesions classified as Bi-rads 1 and 2","Lesions classified as Bi-rads 3 in all patients","b"
"OIC-312-10-B","{""question"": ""What is the characteristic of fibrocystic mastopathy that distinguishes it from other benign breast diseases?"", ""option_a"": ""It occurs in young women under 25-30 years and presents as a firm, well-defined mass."", ""option_b"": ""It is the most common benign breast disease in women aged between 35 and 50, revealed by mastodynia associated with menstrual cycles."", ""option_c"": ""It is a type of 'in situ' carcinoma with metastatic potential."", ""option_d"": ""It is a mixed epithelial and conjunctival proliferation occurring in adolescents and young women."", ""correct_option"": ""B""}","Definition","What is the characteristic of fibrocystic mastopathy that distinguishes it from other benign breast diseases?","It occurs in young women under 25-30 years and presents as a firm, well-defined mass.","It is the most common benign breast disease in women aged between 35 and 50, revealed by mastodynia associated with menstrual cycles.","It is a type of 'in situ' carcinoma with metastatic potential.","It is a mixed epithelial and conjunctival proliferation occurring in adolescents and young women.","b"
"OIC-312-11-B","{""question"": ""What is the primary method for axillary exploration in breast cancer patients with no clinical or histological evidence of lymph node invasion and a breast lesion less than 5 cm?"", ""option_a"": ""Axillary curage (removal of all the axillary lymph nodes)"", ""option_b"": ""Analysis of the sentinel lymph node (1 to 4 lymph nodes)"", ""option_c"": ""MRI of the axillary region"", ""option_d"": ""Ultrasound of the axillary region"", ""correct_option"": ""B""}","Additional examinations","What is the primary method for axillary exploration in breast cancer patients with no clinical or histological evidence of lymph node invasion and a breast lesion less than 5 cm?","Axillary curage (removal of all the axillary lymph nodes)","Analysis of the sentinel lymph node (1 to 4 lymph nodes)","MRI of the axillary region","Ultrasound of the axillary region","b"
"OIC-312-12-A","{""question"": ""What is the primary goal of systemic treatments in the metastatic stages of breast cancer?"", ""option_a"": ""To achieve a curative outcome"", ""option_b"": ""To increase patients' survival and improve their quality of life"", ""option_c"": ""To perform breast surgery and surgery of the homolateral axillary lymph nodes"", ""option_d"": ""To administer radiotherapy to the whole breast and additional radiation in the operating bed"", ""correct_option"": ""B""}","Management","What is the primary goal of systemic treatments in the metastatic stages of breast cancer?","To achieve a curative outcome","To increase patients' survival and improve their quality of life","To perform breast surgery and surgery of the homolateral axillary lymph nodes","To administer radiotherapy to the whole breast and additional radiation in the operating bed","b"
"OIC-315-01-A","{""question"": ""What is the percentage of blasts in the bone marrow that defines acute leukemia?"", ""option_a"": ""10%"", ""option_b"": ""15%"", ""option_c"": ""20%"", ""option_d"": ""30%"", ""correct_option"": ""C""}","Definition","What is the percentage of blasts in the bone marrow that defines acute leukemia?","10%","15%","20%","30%","c"
"OIC-315-02-A","{""question"": ""What are the two main categories of acute leukaemia?"", ""option_a"": ""Acute myeloblastic leukaemia (AML) and Chronic lymphoblastic leukaemia (CLL)"", ""option_b"": ""Acute myeloblastic or myeloid leukaemia (AML) and acute lymphoblastic or lymphoid leukaemia (ALL)"", ""option_c"": ""Acute lymphoblastic leukaemia (ALL) and Chronic myeloid leukaemia (CML)"", ""option_d"": ""Acute myeloid leukaemia (AML) and Acute myelomonocytic leukaemia (AMML)"", ""correct_option"": ""B""}","Definition","What are the two main categories of acute leukaemia?","Acute myeloblastic leukaemia (AML) and Chronic lymphoblastic leukaemia (CLL)","Acute myeloblastic or myeloid leukaemia (AML) and acute lymphoblastic or lymphoid leukaemia (ALL)","Acute lymphoblastic leukaemia (ALL) and Chronic myeloid leukaemia (CML)","Acute myeloid leukaemia (AML) and Acute myelomonocytic leukaemia (AMML)","b"
"OIC-315-03-B","{""question"": ""What is a known risk factor for developing Acute Myeloid Leukaemia (AML)?"", ""option_a"": ""History of exposure to antibiotics"", ""option_b"": ""History of exposure to toxic substances, such as benzene hydrocarbons"", ""option_c"": ""Regular exercise and a healthy diet"", ""option_d"": ""Vaccination against common viruses"", ""correct_option"": ""B""}","Etiologies","What is a known risk factor for developing Acute Myeloid Leukaemia (AML)?","History of exposure to antibiotics","History of exposure to toxic substances, such as benzene hydrocarbons","Regular exercise and a healthy diet","Vaccination against common viruses","b"
"OIC-315-04-A","{""question"": ""What is a common clinical manifestation of bone marrow failure in acute leukaemia?"", ""option_a"": ""Anaemic syndrome with a slow onset"", ""option_b"": ""Haemorrhagic syndrome secondary to thrombocytopenia"", ""option_c"": ""Infectious syndrome associated with lymphocytosis"", ""option_d"": ""Gastrointestinal syndrome associated with eosinophilia"", ""correct_option"": ""B""}","Positive diagnosis","What is a common clinical manifestation of bone marrow failure in acute leukaemia?","Anaemic syndrome with a slow onset","Haemorrhagic syndrome secondary to thrombocytopenia","Infectious syndrome associated with lymphocytosis","Gastrointestinal syndrome associated with eosinophilia","b"
"OIC-315-05-A","{""question"": ""What is a potential complication of hyperleukocytosis in acute leukaemia?"", ""option_a"": ""Haemorrhagic shock"", ""option_b"": ""Leukostasis"", ""option_c"": ""Myocardial damage"", ""option_d"": ""Acute renal failure due to lysis syndrome"", ""correct_option"": ""B""}","Identification of the emergency","What is a potential complication of hyperleukocytosis in acute leukaemia?","Haemorrhagic shock","Leukostasis","Myocardial damage","Acute renal failure due to lysis syndrome","b"
"OIC-315-06-A","{""question"": ""What is a common finding in the haemogram of a patient with Acute Leukaemia?"", ""option_a"": ""Normo- or microcytic anaemia"", ""option_b"": ""Normo- or macrocytic anaemia"", ""option_c"": ""Thrombocytosis and neutrophilia"", ""option_d"": ""Absence of circulating blasts"", ""correct_option"": ""B""}",,"What is a common finding in the haemogram of a patient with Acute Leukaemia?","Normo- or microcytic anaemia","Normo- or macrocytic anaemia","Thrombocytosis and neutrophilia","Absence of circulating blasts","b"
"OIC-315-07-B","{""question"": ""What is the primary method for achieving a positive diagnosis of acute leukaemia?"", ""option_a"": ""Immunophenotyping of blood cells"", ""option_b"": ""Morphological examination of bone marrow tissue through bone marrow aspiration"", ""option_c"": ""Cytogenetic analysis of peripheral blood cells"", ""option_d"": ""Molecular analysis of urine samples"", ""correct_option"": ""B""}",,"What is the primary method for achieving a positive diagnosis of acute leukaemia?","Immunophenotyping of blood cells","Morphological examination of bone marrow tissue through bone marrow aspiration","Cytogenetic analysis of peripheral blood cells","Molecular analysis of urine samples","b"
"OIC-315-08-A","{""question"": ""What percentage of childhood cancers is accounted for by Acute Lymphoblastic Leukaemia (ALL)?"", ""option_a"": ""20-25%"", ""option_b"": ""30-35%"", ""option_c"": ""40-45%"", ""option_d"": ""50-55%"", ""correct_option"": ""B""}","Epidemiology","What percentage of childhood cancers is accounted for by Acute Lymphoblastic Leukaemia (ALL)?","20-25%","30-35%","40-45%","50-55%","b"
"OIC-315-09-A","{""question"": ""What is a common manifestation of bone marrow invasion in children suspected of having acute leukaemia?"", ""option_a"": ""Isolated lymphadenopathy"", ""option_b"": ""Blastic infiltration of the haematopoietic system with symptoms such as bone pain and hepatomegaly"", ""option_c"": ""Recurrent infections due to a compromised immune system"", ""option_d"": ""Severe allergic reactions"", ""correct_option"": ""B""}",,"What is a common manifestation of bone marrow invasion in children suspected of having acute leukaemia?","Isolated lymphadenopathy","Blastic infiltration of the haematopoietic system with symptoms such as bone pain and hepatomegaly","Recurrent infections due to a compromised immune system","Severe allergic reactions","b"
"OIC-315-10-B","{""question"": ""What is a common indication for performing a myelogram in children?"", ""option_a"": ""Isolated anaemia without any other blood line impairments"", ""option_b"": ""Impairment of 2 or 3 blood lines, such as anaemia, thrombocytopenia, and neutropenia"", ""option_c"": ""Presence of neurological symptoms only"", ""option_d"": ""Normal haemogram results with no signs of cytopenias"", ""correct_option"": ""B""}",,"What is a common indication for performing a myelogram in children?","Isolated anaemia without any other blood line impairments","Impairment of 2 or 3 blood lines, such as anaemia, thrombocytopenia, and neutropenia","Presence of neurological symptoms only","Normal haemogram results with no signs of cytopenias","b"
"OIC-325-01-A","{""question"": ""What is an adverse drug reaction (ADR)?"", ""option_a"": ""A predicted and intended response to a medicinal product"", ""option_b"": ""Any suspected noxious and unintended response to a medicinal product"", ""option_c"": ""A response to a medicinal product that only occurs with overdose or misuse"", ""option_d"": ""A response to a medicinal product that is only associated with medication errors"", ""correct_option"": ""B""}",,"What is an adverse drug reaction (ADR)?","A predicted and intended response to a medicinal product","Any suspected noxious and unintended response to a medicinal product","A response to a medicinal product that only occurs with overdose or misuse","A response to a medicinal product that is only associated with medication errors","b"
"OIC-325-02-A","{""question"": ""What are the two types of risk associated with medicines?"", ""option_a"": ""Individual and environmental issues"", ""option_b"": ""Public health and economic issues"", ""option_c"": ""Individual issues and public health issues"", ""option_d"": ""Pharmaceutical and biotechnological issues"", ""correct_option"": ""C""}",,"What are the two types of risk associated with medicines?","Individual and environmental issues","Public health and economic issues","Individual issues and public health issues","Pharmaceutical and biotechnological issues","c"
"OIC-325-03-A","{""question"": ""What is an example of inappropriate prescribing of medicines?"", ""option_a"": ""Prescribing a medication with a clear clinical indication and in accordance with the marketing authorisation"", ""option_b"": ""Prescribing a medication without considering the patient's age, weight, or co-morbidities"", ""option_c"": ""Prescribing a medication that is not approved by the relevant regulatory authorities"", ""option_d"": ""Prescribing a medication with a well-documented benefit-risk profile for the patient"", ""correct_option"": ""B""}",,"What is an example of inappropriate prescribing of medicines?","Prescribing a medication with a clear clinical indication and in accordance with the marketing authorisation","Prescribing a medication without considering the patient's age, weight, or co-morbidities","Prescribing a medication that is not approved by the relevant regulatory authorities","Prescribing a medication with a well-documented benefit-risk profile for the patient","b"
"OIC-325-04-B","{""question"": ""What does the 'Right Route' in the 5-B rule refer to in the context of preventing medication circuit malfunctions?"", ""option_a"": ""The correct answer to a patient's medical question"", ""option_b"": ""The method by which a medication is administered to a patient"", ""option_c"": ""The time of day a medication should be taken"", ""option_d"": ""The dosage instructions for a particular medication"", ""correct_option"": ""B""}","Definition","What does the 'Right Route' in the 5-B rule refer to in the context of preventing medication circuit malfunctions?","The correct answer to a patient's medical question","The method by which a medication is administered to a patient","The time of day a medication should be taken","The dosage instructions for a particular medication","b"
"OIC-325-05-B","{""question"": ""What is the primary mechanism behind the development of serotonin syndrome due to drug interactions?"", ""option_a"": ""Dopaminergic blockade leading to an increase in dopamine levels"", ""option_b"": ""Increase in the bioavailability of serotonin at the synapse due to drug interactions"", ""option_c"": ""Muscarinic receptor antagonism at the peripheral level"", ""option_d"": ""Negative chronotropic effect on the heart"", ""correct_option"": ""B""}",,"What is the primary mechanism behind the development of serotonin syndrome due to drug interactions?","Dopaminergic blockade leading to an increase in dopamine levels","Increase in the bioavailability of serotonin at the synapse due to drug interactions","Muscarinic receptor antagonism at the peripheral level","Negative chronotropic effect on the heart","b"
"OIC-325-06-B","{""question"": ""What percentage of medical and surgical admissions were due to a serious adverse event, according to the national study of adverse events related to healthcare (ENEIS)?"", ""option_a"": ""1 to 3%"", ""option_b"": ""3 to 5%"", ""option_c"": ""5 to 7%"", ""option_d"": ""7 to 10%"", ""correct_option"": ""B""}","Epidemiology","What percentage of medical and surgical admissions were due to a serious adverse event, according to the national study of adverse events related to healthcare (ENEIS)?","1 to 3%","3 to 5%","5 to 7%","7 to 10%","b"
"OIC-325-07-A","{""question"": ""What is a key characteristic of Adverse Drug Reactions (ADRs) in elderly subjects?"", ""option_a"": ""They are less frequent due to reduced medication use"", ""option_b"": ""They have a consistent and typical clinical presentation"", ""option_c"": ""They are more severe and have varied symptomatology due to co-morbidities and age-related pharmacokinetic changes"", ""option_d"": ""They are primarily associated with antibiotics and vaccines"", ""correct_option"": ""C""}",,"What is a key characteristic of Adverse Drug Reactions (ADRs) in elderly subjects?","They are less frequent due to reduced medication use","They have a consistent and typical clinical presentation","They are more severe and have varied symptomatology due to co-morbidities and age-related pharmacokinetic changes","They are primarily associated with antibiotics and vaccines","c"
"OIC-325-09-B","{""question"": ""What is the primary purpose of assessing imputability in the context of adverse drug reactions?"", ""option_a"": ""To determine the severity of the adverse reaction"", ""option_b"": ""To establish the causal link between the drug and the observed effect"", ""option_c"": ""To identify the pharmacological properties of the drug"", ""option_d"": ""To decide on the appropriate treatment for the adverse reaction"", ""correct_option"": ""B""}","Definition","What is the primary purpose of assessing imputability in the context of adverse drug reactions?","To determine the severity of the adverse reaction","To establish the causal link between the drug and the observed effect","To identify the pharmacological properties of the drug","To decide on the appropriate treatment for the adverse reaction","b"
"OIC-325-10-A","{""question"": ""Who is mandated to report adverse drug reactions, particularly serious and/or unexpected reactions?"", ""option_a"": ""Patients and approved patient associations"", ""option_b"": ""Companies or organisations exploiting medicinal products"", ""option_c"": ""Healthcare professionals"", ""option_d"": ""Only the Regional Pharmacovigilance Centre"", ""correct_option"": ""C""}","Definition","Who is mandated to report adverse drug reactions, particularly serious and/or unexpected reactions?","Patients and approved patient associations","Companies or organisations exploiting medicinal products","Healthcare professionals","Only the Regional Pharmacovigilance Centre","c"
"OIC-325-11-A","{""question"": ""What is the primary goal of addictovigilance in France?"", ""option_a"": ""To monitor and regulate the use of alcohol and tobacco"", ""option_b"": ""To assess, prevent, and manage the risk of abuse, misuse, and dependence linked to psychoactive substances"", ""option_c"": ""To provide treatment for individuals with substance use disorders"", ""option_d"": ""To conduct research solely on the medicinal use of psychoactive substances"", ""correct_option"": ""B""}","Definition","What is the primary goal of addictovigilance in France?","To monitor and regulate the use of alcohol and tobacco","To assess, prevent, and manage the risk of abuse, misuse, and dependence linked to psychoactive substances","To provide treatment for individuals with substance use disorders","To conduct research solely on the medicinal use of psychoactive substances","b"
"OIC-325-12-A","{""question"": ""Who is mandatorily required to declare cases of serious drug dependence or abuse of a substance, plant, medicine, or other product?"", ""option_a"": ""All healthcare professionals and other persons"", ""option_b"": ""Doctor, dental surgeon, midwife, pharmacist"", ""option_c"": ""Only other healthcare professionals and other persons"", ""option_d"": ""Nurses and hospital administrators"", ""correct_option"": ""B""}","Definition","Who is mandatorily required to declare cases of serious drug dependence or abuse of a substance, plant, medicine, or other product?","All healthcare professionals and other persons","Doctor, dental surgeon, midwife, pharmacist","Only other healthcare professionals and other persons","Nurses and hospital administrators","b"
"OIC-325-13-B","{""question"": ""What is the primary aim of materiovigilance?"", ""option_a"": ""To monitor the development of new medical devices"", ""option_b"": ""To ensure the safety of patients and users by monitoring medical devices after they have been placed on the market"", ""option_c"": ""To regulate the pricing of medical devices"", ""option_d"": ""To promote the use of medical devices in healthcare settings"", ""correct_option"": ""B""}","Definition","What is the primary aim of materiovigilance?","To monitor the development of new medical devices","To ensure the safety of patients and users by monitoring medical devices after they have been placed on the market","To regulate the pricing of medical devices","To promote the use of medical devices in healthcare settings","b"
"OIC-325-14-A","{""question"": ""If you are a witness to an incident involving a biomaterial and you do not work in a health establishment, how should you report the adverse reaction?"", ""option_a"": ""To the local materials vigilance correspondent"", ""option_b"": ""Directly to the ANSM using their portal for reporting adverse health events or by post"", ""option_c"": ""To the manufacturer of the biomaterial"", ""option_d"": ""To the patient's primary care physician"", ""correct_option"": ""B""}","Definition","If you are a witness to an incident involving a biomaterial and you do not work in a health establishment, how should you report the adverse reaction?","To the local materials vigilance correspondent","Directly to the ANSM using their portal for reporting adverse health events or by post","To the manufacturer of the biomaterial","To the patient's primary care physician","b"
"OIC-325-15-A","{""question"": ""According to the French National Authority for Health, what is considered a medicinal product error?"", ""option_a"": ""Any intentional act involving the medicinal product during the care process"", ""option_b"": ""Any preventable event which could cause or lead to the inappropriate use of a medicinal product or to harm to the patient"", ""option_c"": ""A planned change in the medicinal product during the care process"", ""option_d"": ""An unavoidable event involving the medicinal product during the care process"", ""correct_option"": ""B""}",,"According to the French National Authority for Health, what is considered a medicinal product error?","Any intentional act involving the medicinal product during the care process","Any preventable event which could cause or lead to the inappropriate use of a medicinal product or to harm to the patient","A planned change in the medicinal product during the care process","An unavoidable event involving the medicinal product during the care process","b"
"OIC-325-16-A","{""question"": ""What is the primary purpose of declaring a medication error?"", ""option_a"": ""To punish the healthcare professional responsible for the error"", ""option_b"": ""To implement measures that will limit the risk of the error recurring"", ""option_c"": ""To inform the patient's family about the error"", ""option_d"": ""To increase the cost of healthcare services"", ""correct_option"": ""B""}",,"What is the primary purpose of declaring a medication error?","To punish the healthcare professional responsible for the error","To implement measures that will limit the risk of the error recurring","To inform the patient's family about the error","To increase the cost of healthcare services","b"
"OIC-325-17-A","{""question"": ""At which stage of the medication circuit can errors occur due to lack of asepsis, risk of cross-contamination, and failure to comply with preparation conditions?"", ""option_a"": ""Prescription"", ""option_b"": ""Preparation"", ""option_c"": ""Transport"", ""option_d"": ""Dispensation"", ""correct_option"": ""B""}",,"At which stage of the medication circuit can errors occur due to lack of asepsis, risk of cross-contamination, and failure to comply with preparation conditions?","Prescription","Preparation","Transport","Dispensation","b"
"OIC-325-18-B","{""question"": ""What is the primary characteristic of counterfeit medicines according to the World Health Organisation (WHO) definition?"", ""option_a"": ""Infringement of patent rights"", ""option_b"": ""Deliberate and fraudulent misrepresentation of a medicine's identity or source"", ""option_c"": ""Unintentional failure to meet quality standards"", ""option_d"": ""Unregistered products for sale in a given country"", ""correct_option"": ""B""}","Definition","What is the primary characteristic of counterfeit medicines according to the World Health Organisation (WHO) definition?","Infringement of patent rights","Deliberate and fraudulent misrepresentation of a medicine's identity or source","Unintentional failure to meet quality standards","Unregistered products for sale in a given country","b"
"OIC-325-19-B","{""question"": ""What is a potential consequence of long-term use of an under-dosed counterfeit antibiotic product?"", ""option_a"": ""The development of a new disease"", ""option_b"": ""The enhancement of the immune system"", ""option_c"": ""The acquisition of drug resistance, reducing the effectiveness of therapies against the disease"", ""option_d"": ""The immediate cure of the disease"", ""correct_option"": ""C""}",,"What is a potential consequence of long-term use of an under-dosed counterfeit antibiotic product?","The development of a new disease","The enhancement of the immune system","The acquisition of drug resistance, reducing the effectiveness of therapies against the disease","The immediate cure of the disease","c"
"OIC-325-20-B","{""question"": ""What is the time limit for the ICC to give its opinion on the circumstances, causes, nature, and extent of the damage suffered by the victim after receiving a complete file?"", ""option_a"": ""3 months"", ""option_b"": ""6 months"", ""option_c"": ""12 months"", ""option_d"": ""24 months"", ""correct_option"": ""B""}","Definition","What is the time limit for the ICC to give its opinion on the circumstances, causes, nature, and extent of the damage suffered by the victim after receiving a complete file?","3 months","6 months","12 months","24 months","b"
"OIC-325-21-B","{""question"": ""What is the primary goal of the no-fault liability regime in French medical law?"", ""option_a"": ""To punish medical professionals for their faults"", ""option_b"": ""To compensate victims of medical accidents without requiring proof of fault"", ""option_c"": ""To reduce the number of medical accidents through stricter regulations"", ""option_d"": ""To provide additional funding for medical research and development"", ""correct_option"": ""B""}",,"What is the primary goal of the no-fault liability regime in French medical law?","To punish medical professionals for their faults","To compensate victims of medical accidents without requiring proof of fault","To reduce the number of medical accidents through stricter regulations","To provide additional funding for medical research and development","b"
"OIC-326-01-A","{""question"": ""Which of the following health professionals has the authority to prescribe all procedures, products, and services necessary for the practice of dentistry?"", ""option_a"": ""Physicians"", ""option_b"": ""Dental surgeons"", ""option_c"": ""Midwives"", ""option_d"": ""Pharmacists"", ""correct_option"": ""B""}",,"Which of the following health professionals has the authority to prescribe all procedures, products, and services necessary for the practice of dentistry?","Physicians","Dental surgeons","Midwives","Pharmacists","b"
"OIC-326-02-A","{""question"": ""What is the primary condition for a generic drug to be considered bioequivalent to an originator drug?"", ""option_a"": ""The generic drug must have the same excipients as the originator drug"", ""option_b"": ""The 90% confidence intervals of the geometric mean of the maximum concentrations and the area under the concentration-time curve of the generic drug must be within the range 80-125% of those of the originator drug"", ""option_c"": ""The generic drug must have the same pharmaceutical form and appearance as the originator drug"", ""option_d"": ""The generic drug must be produced by the same pharmaceutical laboratory as the originator drug"", ""correct_option"": ""B""}","Prescribing","What is the primary condition for a generic drug to be considered bioequivalent to an originator drug?","The generic drug must have the same excipients as the originator drug","The 90% confidence intervals of the geometric mean of the maximum concentrations and the area under the concentration-time curve of the generic drug must be within the range 80-125% of those of the originator drug","The generic drug must have the same pharmaceutical form and appearance as the originator drug","The generic drug must be produced by the same pharmaceutical laboratory as the originator drug","b"
"OIC-326-03-B","{""question"": ""What is the primary purpose of the Medical Service Rendered (SMR) assessment in the context of therapeutic prescribing and recommendations for correct use?"", ""option_a"": ""To evaluate the therapeutic progress of a drug compared to existing treatments"", ""option_b"": ""To determine the price of a drug based on its clinical benefit and therapeutic interest"", ""option_c"": ""To provide scientific and clinical evidence for justifying reimbursement of drugs by national solidarity"", ""option_d"": ""To assess the safety and efficacy of a drug before granting marketing authorization"", ""correct_option"": ""C""}","Definition","What is the primary purpose of the Medical Service Rendered (SMR) assessment in the context of therapeutic prescribing and recommendations for correct use?","To evaluate the therapeutic progress of a drug compared to existing treatments","To determine the price of a drug based on its clinical benefit and therapeutic interest","To provide scientific and clinical evidence for justifying reimbursement of drugs by national solidarity","To assess the safety and efficacy of a drug before granting marketing authorization","c"
"OIC-326-04-B","{""question"": ""According to article L.5125-23 of the CSP, under what circumstances can a pharmacist dispense a medicinal product other than the one prescribed?"", ""option_a"": ""With the express prior agreement of the prescriber and in the patient's best interests"", ""option_b"": ""Only in emergency situations, without needing the prescriber's agreement"", ""option_c"": ""Whenever the pharmacist deems it necessary, without needing the prescriber's agreement"", ""option_d"": ""Never, as the pharmacist must always dispense the prescribed medicinal product"", ""correct_option"": ""A""}","Definition","According to article L.5125-23 of the CSP, under what circumstances can a pharmacist dispense a medicinal product other than the one prescribed?","With the express prior agreement of the prescriber and in the patient's best interests","Only in emergency situations, without needing the prescriber's agreement","Whenever the pharmacist deems it necessary, without needing the prescriber's agreement","Never, as the pharmacist must always dispense the prescribed medicinal product","a"
"OIC-326-05-A","{""question"": ""At what level is the benefit/risk balance estimated when physicians and patients determine the most appropriate treatment for a given situation?"", ""option_a"": ""Population scale"", ""option_b"": ""Individual level"", ""option_c"": ""Both population and individual levels"", ""option_d"": ""Only during clinical trials"", ""correct_option"": ""B""}",,"At what level is the benefit/risk balance estimated when physicians and patients determine the most appropriate treatment for a given situation?","Population scale","Individual level","Both population and individual levels","Only during clinical trials","b"
"OIC-326-06-B","{""question"": ""What is the primary aim of continuing professional development (CPD) for healthcare professionals, as stated in Article L4021-1 of the CSP?"", ""option_a"": ""To reduce the workload of healthcare professionals"", ""option_b"": ""To maintain and update knowledge and skills and to improve practices"", ""option_c"": ""To increase the number of healthcare professionals in the workforce"", ""option_d"": ""To decrease the cost of healthcare services"", ""correct_option"": ""B""}","Definition","What is the primary aim of continuing professional development (CPD) for healthcare professionals, as stated in Article L4021-1 of the CSP?","To reduce the workload of healthcare professionals","To maintain and update knowledge and skills and to improve practices","To increase the number of healthcare professionals in the workforce","To decrease the cost of healthcare services","b"
"OIC-326-07-B","{""question"": ""What is the primary purpose of assessing a patient's demographic characteristics, medical history, and major drug purification functions before prescribing a drug?"", ""option_a"": ""To determine the patient's ability to pay for the medication"", ""option_b"": ""To establish a therapeutic objective and assess the benefit/risk ratio of the prescription"", ""option_c"": ""To identify potential drug interactions and contraindications"", ""option_d"": ""To evaluate the efficacy of the treatment and assess the drug's safety profile"", ""correct_option"": ""B""}","Management","What is the primary purpose of assessing a patient's demographic characteristics, medical history, and major drug purification functions before prescribing a drug?","To determine the patient's ability to pay for the medication","To establish a therapeutic objective and assess the benefit/risk ratio of the prescription","To identify potential drug interactions and contraindications","To evaluate the efficacy of the treatment and assess the drug's safety profile","b"
"OIC-328-01-A","{""question"": ""What is the primary basis for establishing an indication for non-medicinal therapies after an initial assessment?"", ""option_a"": ""Therapeutic efficacy and tolerance"", ""option_b"": ""Patient's medical history and diagnosis"", ""option_c"": ""Disabilities, activity limitations, participation restrictions, and environmental factors"", ""option_d"": ""Compliance, conditions of use, and maintenance"", ""correct_option"": ""C""}","Evaluation","What is the primary basis for establishing an indication for non-medicinal therapies after an initial assessment?","Therapeutic efficacy and tolerance","Patient's medical history and diagnosis","Disabilities, activity limitations, participation restrictions, and environmental factors","Compliance, conditions of use, and maintenance","c"
"OIC-328-02-A","{""question"": ""What is the primary characteristic that distinguishes a medical device from other health products?"", ""option_a"": ""Its ability to be used in combination with pharmacological products"", ""option_b"": ""Its principal intended action is obtained by pharmacological, immunological, or metabolic means"", ""option_c"": ""Its use for medical purposes in humans without relying on pharmacological, immunological, or metabolic means"", ""option_d"": ""Its regulation of prices and reimbursements by social organizations"", ""correct_option"": ""C""}","Definition","What is the primary characteristic that distinguishes a medical device from other health products?","Its ability to be used in combination with pharmacological products","Its principal intended action is obtained by pharmacological, immunological, or metabolic means","Its use for medical purposes in humans without relying on pharmacological, immunological, or metabolic means","Its regulation of prices and reimbursements by social organizations","c"
"OIC-328-03-B","{""question"": ""Who can prescribe the renewal of orthotics, including orthopaedic shoes, prostheses, and electric wheelchairs?"", ""option_a"": ""A specialist"", ""option_b"": ""A general practitioner"", ""option_c"": ""A physiotherapist"", ""option_d"": ""A nurse"", ""correct_option"": ""B""}","Management","Who can prescribe the renewal of orthotics, including orthopaedic shoes, prostheses, and electric wheelchairs?","A specialist","A general practitioner","A physiotherapist","A nurse","b"
"OIC-328-04-B","{""question"": ""What is a key characteristic that distinguishes 'petit appareillage' (small appliances) from 'major equipment' in terms of prescription?"", ""option_a"": ""The need for a specialist doctor for the initial prescription"", ""option_b"": ""The type of material used, such as standard or low-temperature thermoplastic"", ""option_c"": ""The requirement for a simple prescription that can be made by non-specialists"", ""option_d"": ""The level of reimbursement, with small appliances reimbursed at 100%"", ""correct_option"": ""C""}","Definition","What is a key characteristic that distinguishes 'petit appareillage' (small appliances) from 'major equipment' in terms of prescription?","The need for a specialist doctor for the initial prescription","The type of material used, such as standard or low-temperature thermoplastic","The requirement for a simple prescription that can be made by non-specialists","The level of reimbursement, with small appliances reimbursed at 100%","c"
"OIC-328-05-A","{""question"": ""What is the primary purpose of an orthosis?"", ""option_a"": ""To replace a missing limb"", ""option_b"": ""To supplement a limb or segment of limb that is deficient or the spine"", ""option_c"": ""To enhance athletic performance"", ""option_d"": ""To diagnose musculoskeletal disorders"", ""correct_option"": ""B""}","Definition","What is the primary purpose of an orthosis?","To replace a missing limb","To supplement a limb or segment of limb that is deficient or the spine","To enhance athletic performance","To diagnose musculoskeletal disorders","b"
"OIC-328-06-B","{""question"": ""What is the primary objective of an immobilisation orthosis?"", ""option_a"": ""To improve joint function"", ""option_b"": ""To stabilise a joint and improve function"", ""option_c"": ""To immobilise a joint"", ""option_d"": ""To reduce pain and inflammation"", ""correct_option"": ""C""}","Management of costs","What is the primary objective of an immobilisation orthosis?","To improve joint function","To stabilise a joint and improve function","To immobilise a joint","To reduce pain and inflammation","c"
"OIC-328-07-B","{""question"": ""What is the primary purpose of prescribing orthoses in medical treatment?"", ""option_a"": ""To replace damaged or missing body parts with prosthetic devices"", ""option_b"": ""To provide support, stability, and alignment to affected body parts, promoting healing and mobility"", ""option_c"": ""To administer medication directly to the affected area through implanted devices"", ""option_d"": ""To enhance athletic performance by providing additional support and flexibility"", ""correct_option"": ""B""}",,"What is the primary purpose of prescribing orthoses in medical treatment?","To replace damaged or missing body parts with prosthetic devices","To provide support, stability, and alignment to affected body parts, promoting healing and mobility","To administer medication directly to the affected area through implanted devices","To enhance athletic performance by providing additional support and flexibility","b"
"OIC-328-08-A","{""question"": ""What is the primary purpose of a prosthesis for a lower limb?"", ""option_a"": ""Aesthetic purposes"", ""option_b"": ""Functional purposes"", ""option_c"": ""Both functional and aesthetic purposes, with equal importance"", ""option_d"": ""To replace the entire limb, including the residual limb"", ""correct_option"": ""B""}","Definition","What is the primary purpose of a prosthesis for a lower limb?","Aesthetic purposes","Functional purposes","Both functional and aesthetic purposes, with equal importance","To replace the entire limb, including the residual limb","b"
"OIC-328-09-A","{""question"": ""What is the primary indication for custom-made orthopaedic shoes?"", ""option_a"": ""Trophic disorders or oedema"", ""option_b"": ""Neurological pathology, volumetric disorder, instability, inequality of length, or limping"", ""option_c"": ""Fall in the young population"", ""option_d"": ""Temporary protection of the toes"", ""correct_option"": ""B""}","Definition","What is the primary indication for custom-made orthopaedic shoes?","Trophic disorders or oedema","Neurological pathology, volumetric disorder, instability, inequality of length, or limping","Fall in the young population","Temporary protection of the toes","b"
"OIC-328-10-B","{""question"": ""What is the primary objective of walking aids, such as canes, for individuals with mobility issues?"", ""option_a"": ""To improve balance and reduce the risk of falls"", ""option_b"": ""To enhance muscle strength in the lower legs"", ""option_c"": ""To stabilize walking and reduce activity limitations"", ""option_d"": ""To accelerate recovery from paralysis or osteoarthritis"", ""correct_option"": ""C""}","Definition","What is the primary objective of walking aids, such as canes, for individuals with mobility issues?","To improve balance and reduce the risk of falls","To enhance muscle strength in the lower legs","To stabilize walking and reduce activity limitations","To accelerate recovery from paralysis or osteoarthritis","c"
"OIC-328-11-A","{""question"": ""What is required for prescribing an electric wheelchair?"", ""option_a"": ""A simple prescription by any doctor"", ""option_b"": ""A trial to validate the wheelchair's suitability, conducted by a PRM doctor and a physiotherapist or occupational therapist, along with a simple prescription"", ""option_c"": ""Prior agreement with the health insurance scheme, but no trial is necessary"", ""option_d"": ""Purchase only, without any prescription or trial"", ""correct_option"": ""B""}","Definition","What is required for prescribing an electric wheelchair?","A simple prescription by any doctor","A trial to validate the wheelchair's suitability, conducted by a PRM doctor and a physiotherapist or occupational therapist, along with a simple prescription","Prior agreement with the health insurance scheme, but no trial is necessary","Purchase only, without any prescription or trial","b"
"OIC-328-12-B","{""question"": ""What is the primary factor used to classify mineral waters in thermal medicine?"", ""option_a"": ""Temperature and mineral composition"", ""option_b"": ""Source location and treatment method"", ""option_c"": ""Patient's medical condition and treatment duration"", ""option_d"": ""Water's physical characteristics and therapeutic orientation"", ""correct_option"": ""A""}","Definition","What is the primary factor used to classify mineral waters in thermal medicine?","Temperature and mineral composition","Source location and treatment method","Patient's medical condition and treatment duration","Water's physical characteristics and therapeutic orientation","a"
"OIC-330-01-A","{""question"": ""What is the primary mechanism of action of nonsteroidal anti-inflammatory drugs (NSAIDs) in reducing inflammation?"", ""option_a"": ""Inhibiting the production of prostaglandins by activating cyclooxygenase (COX) enzymes"", ""option_b"": ""Reducing the production of prostanoids by inhibiting cyclooxygenase (COX) enzymes"", ""option_c"": ""Stimulating the release of anti-inflammatory cytokines"", ""option_d"": ""Blocking the action of inflammatory mediators such as histamine and bradykinin"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of nonsteroidal anti-inflammatory drugs (NSAIDs) in reducing inflammation?","Inhibiting the production of prostaglandins by activating cyclooxygenase (COX) enzymes","Reducing the production of prostanoids by inhibiting cyclooxygenase (COX) enzymes","Stimulating the release of anti-inflammatory cytokines","Blocking the action of inflammatory mediators such as histamine and bradykinin","b"
"OIC-330-02-A","{""question"": ""What is the primary mechanism of action of loop diuretics, such as furosemide?"", ""option_a"": ""Inhibition of the NCC transporter in the distal convoluted tubule"", ""option_b"": ""Inhibition of the NKCC2 co-transporter at the level of the large ascending branch of Henl\u00e9"", ""option_c"": ""Aldosterone receptor antagonism"", ""option_d"": ""Inhibition of the epithelial sodium channel (eNaC)"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of loop diuretics, such as furosemide?","Inhibition of the NCC transporter in the distal convoluted tubule","Inhibition of the NKCC2 co-transporter at the level of the large ascending branch of Henlé","Aldosterone receptor antagonism","Inhibition of the epithelial sodium channel (eNaC)","b"
"OIC-330-03-A","{""question"": ""What is the primary mechanism of action of beta-blockers?"", ""option_a"": ""They are agonists of \u03b2-adrenergic receptors"", ""option_b"": ""They are competitive antagonists of \u03b2-adrenergic receptors"", ""option_c"": ""They have a direct effect on the heart muscle to increase contractility"", ""option_d"": ""They primarily act on the vascular system to cause vasoconstriction"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of beta-blockers?","They are agonists of β-adrenergic receptors","They are competitive antagonists of β-adrenergic receptors","They have a direct effect on the heart muscle to increase contractility","They primarily act on the vascular system to cause vasoconstriction","b"
"OIC-330-04-A","{""question"": ""What is the primary mechanism of action of Angiotensin II receptor antagonists?"", ""option_a"": ""Inhibiting the conversion of angiotensin I to angiotensin II"", ""option_b"": ""Competitive inhibition of angiotensin II AT1 receptors"", ""option_c"": ""Increasing concentrations of bradykinin"", ""option_d"": ""Blocking the action of potassium-sparing diuretics"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of Angiotensin II receptor antagonists?","Inhibiting the conversion of angiotensin I to angiotensin II","Competitive inhibition of angiotensin II AT1 receptors","Increasing concentrations of bradykinin","Blocking the action of potassium-sparing diuretics","b"
"OIC-330-05-A","{""question"": ""What is the primary mechanism of action of calcium channel blockers?"", ""option_a"": ""They increase the inflow of calcium into cardiomyocytes and smooth muscle cells."", ""option_b"": ""They bind to cardiac and/or vascular membrane L-type calcium channels, reducing the inflow of calcium."", ""option_c"": ""They block the release of calcium from the sarcoplasmic reticulum."", ""option_d"": ""They enhance the activity of calcium pumps in the cell membrane."", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of calcium channel blockers?","They increase the inflow of calcium into cardiomyocytes and smooth muscle cells.","They bind to cardiac and/or vascular membrane L-type calcium channels, reducing the inflow of calcium.","They block the release of calcium from the sarcoplasmic reticulum.","They enhance the activity of calcium pumps in the cell membrane.","b"
"OIC-330-06-A","{""question"": ""What is the primary mechanism of action of Acetylsalicylic acid (ASA) as an anti-platelet agent?"", ""option_a"": ""Inhibition of the ADP-dependent platelet activation pathway (P2Y12 receptor antagonist)"", ""option_b"": ""Inhibition of platelet activation by inhibiting the synthesis of thromboxane A2"", ""option_c"": ""Stimulation of the ADP-dependent platelet activation pathway (P2Y12 receptor agonist)"", ""option_d"": ""Enhancement of platelet activation by increasing the synthesis of thromboxane A2"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of Acetylsalicylic acid (ASA) as an anti-platelet agent?","Inhibition of the ADP-dependent platelet activation pathway (P2Y12 receptor antagonist)","Inhibition of platelet activation by inhibiting the synthesis of thromboxane A2","Stimulation of the ADP-dependent platelet activation pathway (P2Y12 receptor agonist)","Enhancement of platelet activation by increasing the synthesis of thromboxane A2","b"
"OIC-330-07-A","{""question"": ""What is the primary mechanism of action for unfractionated heparin in the treatment of thrombosis?"", ""option_a"": ""Direct inhibition of thrombin"", ""option_b"": ""Reinforcement of ATIII action: inhibition of IIa = Xa"", ""option_c"": ""Inhibition of platelet aggregation"", ""option_d"": ""Stimulation of fibrinolysis"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action for unfractionated heparin in the treatment of thrombosis?","Direct inhibition of thrombin","Reinforcement of ATIII action: inhibition of IIa = Xa","Inhibition of platelet aggregation","Stimulation of fibrinolysis","b"
"OIC-330-08-A","{""question"": ""What is the primary mechanism of action for the oral anticoagulant dabigatran?"", ""option_a"": ""Inhibition of carboxylation of vitamin K-dependent factors"", ""option_b"": ""Factor Xa inhibition"", ""option_c"": ""Thrombin inhibition"", ""option_d"": ""Acetylation of platelet receptors"", ""correct_option"": ""C""}","Management","What is the primary mechanism of action for the oral anticoagulant dabigatran?","Inhibition of carboxylation of vitamin K-dependent factors","Factor Xa inhibition","Thrombin inhibition","Acetylation of platelet receptors","c"
"OIC-330-09-A","{""question"": ""What is the primary mechanism of action of benzodiazepines?"", ""option_a"": ""They block the action of acetylcholine in the brain"", ""option_b"": ""They enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor"", ""option_c"": ""They inhibit the reuptake of serotonin in the synaptic cleft"", ""option_d"": ""They stimulate the release of dopamine in the reward pathway"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of benzodiazepines?","They block the action of acetylcholine in the brain","They enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor","They inhibit the reuptake of serotonin in the synaptic cleft","They stimulate the release of dopamine in the reward pathway","b"
"OIC-330-10-A","{""question"": ""What is the primary mechanism of action of serotonin reuptake inhibitors?"", ""option_a"": ""Increasing the production of serotonin in the brain"", ""option_b"": ""Blocking the reabsorption of serotonin into the presynaptic neuron"", ""option_c"": ""Enhancing the breakdown of serotonin in the synaptic cleft"", ""option_d"": ""Reducing the release of serotonin from the presynaptic neuron"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of serotonin reuptake inhibitors?","Increasing the production of serotonin in the brain","Blocking the reabsorption of serotonin into the presynaptic neuron","Enhancing the breakdown of serotonin in the synaptic cleft","Reducing the release of serotonin from the presynaptic neuron","b"
"OIC-330-11-A","{""question"": ""What is the primary mechanism of action of most antipsychotic medications?"", ""option_a"": ""Enhancing the release of serotonin in the brain"", ""option_b"": ""Blocking the action of dopamine in the brain"", ""option_c"": ""Increasing the levels of norepinephrine in the synaptic cleft"", ""option_d"": ""Inhibiting the reuptake of acetylcholine"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of most antipsychotic medications?","Enhancing the release of serotonin in the brain","Blocking the action of dopamine in the brain","Increasing the levels of norepinephrine in the synaptic cleft","Inhibiting the reuptake of acetylcholine","b"
"OIC-330-12-A","{""question"": ""What is the primary mechanism of action of many anti-epileptic drugs, including valproic acid, phenytoin, and carbamazepine?"", ""option_a"": ""Blockade of voltage-gated potassium channels"", ""option_b"": ""Blockade of voltage-gated sodium channels"", ""option_c"": ""Enhancement of GABAergic tone through direct agonism of GABA-A receptors"", ""option_d"": ""Inhibition of glutamatergic neurotransmission through antagonism of NMDA receptors"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of many anti-epileptic drugs, including valproic acid, phenytoin, and carbamazepine?","Blockade of voltage-gated potassium channels","Blockade of voltage-gated sodium channels","Enhancement of GABAergic tone through direct agonism of GABA-A receptors","Inhibition of glutamatergic neurotransmission through antagonism of NMDA receptors","b"
"OIC-330-13-A","{""question"": ""What is the primary mechanism of action of statins in reducing cholesterol levels?"", ""option_a"": ""They prevent the reabsorption of bile acids and reduce the absorption of dietary cholesterol"", ""option_b"": ""They stimulate the activity of LDL receptors and increase the capture of LDL by hepatocytes"", ""option_c"": ""They reduce the absorption of enterocyte cholesterol by binding to NPC1L1 and SR-BI"", ""option_d"": ""They increase the expression of hepatic VLDL receptors and reduce triglyceride synthesis"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of statins in reducing cholesterol levels?","They prevent the reabsorption of bile acids and reduce the absorption of dietary cholesterol","They stimulate the activity of LDL receptors and increase the capture of LDL by hepatocytes","They reduce the absorption of enterocyte cholesterol by binding to NPC1L1 and SR-BI","They increase the expression of hepatic VLDL receptors and reduce triglyceride synthesis","b"
"OIC-330-14-A","{""question"": ""What is the primary mechanism of action of insulins in reducing blood glucose levels?"", ""option_a"": ""Increasing glucose uptake in the liver"", ""option_b"": ""Reducing peripheral uptake of glucose by skeletal muscle and adipose tissue"", ""option_c"": ""Increasing peripheral uptake of glucose by skeletal muscle and adipose tissue and reducing its release in the liver"", ""option_d"": ""Decreasing insulin secretion from the pancreas"", ""correct_option"": ""C""}","Management","What is the primary mechanism of action of insulins in reducing blood glucose levels?","Increasing glucose uptake in the liver","Reducing peripheral uptake of glucose by skeletal muscle and adipose tissue","Increasing peripheral uptake of glucose by skeletal muscle and adipose tissue and reducing its release in the liver","Decreasing insulin secretion from the pancreas","c"
"OIC-330-15-A","{""question"": ""What is the primary mechanism of action of Metformin in the treatment of type 2 diabetes?"", ""option_a"": ""Stimulation of insulin release by the pancreas"", ""option_b"": ""Inhibition of hepatic gluconeogenesis and glycogenolysis, increase in peripheral glucose uptake"", ""option_c"": ""Inhibition of the degradation of incretins by DPP-4"", ""option_d"": ""Reduction of glucose reabsorption in the renal tubule"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action of Metformin in the treatment of type 2 diabetes?","Stimulation of insulin release by the pancreas","Inhibition of hepatic gluconeogenesis and glycogenolysis, increase in peripheral glucose uptake","Inhibition of the degradation of incretins by DPP-4","Reduction of glucose reabsorption in the renal tubule","b"
"OIC-330-16-A","{""question"": ""What is the primary mechanism of action for paracetamol in terms of its analgesic effect?"", ""option_a"": ""Inhibition of COX-1 and COX-2 cyclooxygenases"", ""option_b"": ""Effect on serotonergic controls and probably on calcium channels"", ""option_c"": ""Blockage of voltage-dependent sodium channels"", ""option_d"": ""Inhibition of mono-amine re-uptake"", ""correct_option"": ""B""}","Management","What is the primary mechanism of action for paracetamol in terms of its analgesic effect?","Inhibition of COX-1 and COX-2 cyclooxygenases","Effect on serotonergic controls and probably on calcium channels","Blockage of voltage-dependent sodium channels","Inhibition of mono-amine re-uptake","b"
"OIC-330-17-A","{""question"": ""What is the primary mechanism of action for opioid analgesics?"", ""option_a"": ""They act on the endogenous pain control systems by binding to opiate receptors in the brain, spinal cord, and periphery"", ""option_b"": ""They act on the inflammatory response by reducing the production of prostaglandins"", ""option_c"": ""They act on the nervous system by blocking the transmission of pain signals"", ""option_d"": ""They act on the musculoskeletal system by relaxing muscles and reducing tension"", ""correct_option"": ""A""}","Management","What is the primary mechanism of action for opioid analgesics?","They act on the endogenous pain control systems by binding to opiate receptors in the brain, spinal cord, and periphery","They act on the inflammatory response by reducing the production of prostaglandins","They act on the nervous system by blocking the transmission of pain signals","They act on the musculoskeletal system by relaxing muscles and reducing tension","a"
"OIC-332-01-A","{""question"": ""What is the primary cause of cellular energy suffering in shock?"", ""option_a"": ""Circulatory insufficiency alone"", ""option_b"": ""Mismatch between oxygen requirements and supply"", ""option_c"": ""Organ failure"", ""option_d"": ""Arterial hypotension"", ""correct_option"": ""B""}","Definition","What is the primary cause of cellular energy suffering in shock?","Circulatory insufficiency alone","Mismatch between oxygen requirements and supply","Organ failure","Arterial hypotension","b"
"OIC-332-02-A","{""question"": ""What is the main cause of cardiogenic shock?"", ""option_a"": ""Decrease in intravascular volume"", ""option_b"": ""Heart pump failure"", ""option_c"": ""Circulatory obstruction"", ""option_d"": ""Infections leading to septic shock"", ""correct_option"": ""B""}","Etiologies","What is the main cause of cardiogenic shock?","Decrease in intravascular volume","Heart pump failure","Circulatory obstruction","Infections leading to septic shock","b"
"OIC-332-03-B","{""question"": ""In the context of shock states, what characterizes the hemodynamic profile of cardiogenic shock?"", ""option_a"": ""Increased cardiac output, decreased cardiac preload, and decreased systemic vascular resistance"", ""option_b"": ""Decreased cardiac output, increased cardiac preload, and variable systemic vascular resistance"", ""option_c"": ""Variable cardiac output, decreased cardiac preload, and decreased systemic vascular resistance"", ""option_d"": ""Decreased cardiac output, decreased cardiac preload, and increased systemic vascular resistance"", ""correct_option"": ""B""}","Physiopathology","In the context of shock states, what characterizes the hemodynamic profile of cardiogenic shock?","Increased cardiac output, decreased cardiac preload, and decreased systemic vascular resistance","Decreased cardiac output, increased cardiac preload, and variable systemic vascular resistance","Variable cardiac output, decreased cardiac preload, and decreased systemic vascular resistance","Decreased cardiac output, decreased cardiac preload, and increased systemic vascular resistance","b"
"OIC-332-04-A","{""question"": ""What is the definition of arterial hypotension in the context of shock?"", ""option_a"": ""PAS < 80 mmHg and MAP < 60 mmHg"", ""option_b"": ""PAS < 90 mmHg, MAP < 65 mmHg, or a variation of more than 30% in chronically hypertensive patients"", ""option_c"": ""PAS < 100 mmHg and MAP < 70 mmHg"", ""option_d"": ""PAS < 80 mmHg or MAP < 60 mmHg"", ""correct_option"": ""B""}","Positive diagnosis","What is the definition of arterial hypotension in the context of shock?","PAS < 80 mmHg and MAP < 60 mmHg","PAS < 90 mmHg, MAP < 65 mmHg, or a variation of more than 30% in chronically hypertensive patients","PAS < 100 mmHg and MAP < 70 mmHg","PAS < 80 mmHg or MAP < 60 mmHg","b"
"OIC-332-05-A","{""question"": ""What are the primary elements used for etiological orientation in the initial phase of evaluating a state of shock?"", ""option_a"": ""Laboratory tests and medical history"", ""option_b"": ""Clinical elements and patient interview"", ""option_c"": ""Imaging studies and physical examination"", ""option_d"": ""Family history and social background"", ""correct_option"": ""B""}","Positive diagnosis","What are the primary elements used for etiological orientation in the initial phase of evaluating a state of shock?","Laboratory tests and medical history","Clinical elements and patient interview","Imaging studies and physical examination","Family history and social background","b"
"OIC-332-06-B","{""question"": ""What is the primary purpose of using echocardiography in a patient with shock?"", ""option_a"": ""To assess the severity of hypoxaemia and acidosis"", ""option_b"": ""To characterise the haemodynamic profile and guide further management"", ""option_c"": ""To determine the liver function and diagnose liver shock"", ""option_d"": ""To identify the presence of sepsis and guide antibiotic therapy"", ""correct_option"": ""B""}","Additional tests","What is the primary purpose of using echocardiography in a patient with shock?","To assess the severity of hypoxaemia and acidosis","To characterise the haemodynamic profile and guide further management","To determine the liver function and diagnose liver shock","To identify the presence of sepsis and guide antibiotic therapy","b"
"OIC-332-07-B","{""question"": ""What is the primary goal of biological tests in the investigation strategy for haemorrhagic shock?"", ""option_a"": ""To identify the underlying cause of the haemorrhage"", ""option_b"": ""To confirm the haemorrhage, quantify the blood loss, and assess its severity"", ""option_c"": ""To determine the need for surgical intervention"", ""option_d"": ""To rule out other potential causes of shock"", ""correct_option"": ""B""}","Additional investigations","What is the primary goal of biological tests in the investigation strategy for haemorrhagic shock?","To identify the underlying cause of the haemorrhage","To confirm the haemorrhage, quantify the blood loss, and assess its severity","To determine the need for surgical intervention","To rule out other potential causes of shock","b"
"OIC-332-08-A","{""question"": ""What is the first step in managing a state of shock?"", ""option_a"": ""Start vascular filling with 500 ml of crystalloids"", ""option_b"": ""Call for help and coordinate tasks with colleagues"", ""option_c"": ""Assess and manage ventilation according to procedure B"", ""option_d"": ""Apply a tourniquet or compression to control bleeding"", ""correct_option"": ""B""}","Management","What is the first step in managing a state of shock?","Start vascular filling with 500 ml of crystalloids","Call for help and coordinate tasks with colleagues","Assess and manage ventilation according to procedure B","Apply a tourniquet or compression to control bleeding","b"
"OIC-332-09-A","{""question"": ""In the management of haemorrhagic shock, what is the recommended ratio of packed red blood cells to fresh frozen plasma?"", ""option_a"": ""1:3 to 1:4"", ""option_b"": ""1:1 to 1:2"", ""option_c"": ""2:1 to 3:1"", ""option_d"": ""4:1 to 5:1"", ""correct_option"": ""B""}","Management","In the management of haemorrhagic shock, what is the recommended ratio of packed red blood cells to fresh frozen plasma?","1:3 to 1:4","1:1 to 1:2","2:1 to 3:1","4:1 to 5:1","b"
"OIC-332-10-B","{""question"": ""What is the primary goal of managing septic shock?"", ""option_a"": ""To immediately administer antibiotics"", ""option_b"": ""To rapidly restore circulatory volume and maintain blood pressure"", ""option_c"": ""To prioritize the treatment of the underlying infection over supportive care"", ""option_d"": ""To delay fluid resuscitation until the source of infection is identified"", ""correct_option"": ""B""}","Management","What is the primary goal of managing septic shock?","To immediately administer antibiotics","To rapidly restore circulatory volume and maintain blood pressure","To prioritize the treatment of the underlying infection over supportive care","To delay fluid resuscitation until the source of infection is identified","b"
"OIC-332-11-B","{""question"": ""What is the initial approach to managing cardiogenic shock due to isolated right heart failure?"", ""option_a"": ""Aggressive fluid resuscitation to maximize left heart filling"", ""option_b"": ""Cautious fluid filling to avoid left heart deflation due to right heart/left heart interaction"", ""option_c"": ""Immediate use of inotropic drugs like dobutamine and noradrenaline"", ""option_d"": ""Administration of hypotensive drugs such as nitrates or calcium antagonists"", ""correct_option"": ""B""}",,"What is the initial approach to managing cardiogenic shock due to isolated right heart failure?","Aggressive fluid resuscitation to maximize left heart filling","Cautious fluid filling to avoid left heart deflation due to right heart/left heart interaction","Immediate use of inotropic drugs like dobutamine and noradrenaline","Administration of hypotensive drugs such as nitrates or calcium antagonists","b"
"OIC-332-12-B","{""question"": ""What is the recommended initial management for a patient in shock due to pulmonary embolism with acute right heart strain?"", ""option_a"": ""Immediate thrombolysis without anticoagulant treatment"", ""option_b"": ""Anticoagulant treatment and discussion of thrombolysis"", ""option_c"": ""Angioscanner to confirm the diagnosis before treatment"", ""option_d"": ""Pericardial drainage to relieve the strain"", ""correct_option"": ""B""}",,"What is the recommended initial management for a patient in shock due to pulmonary embolism with acute right heart strain?","Immediate thrombolysis without anticoagulant treatment","Anticoagulant treatment and discussion of thrombolysis","Angioscanner to confirm the diagnosis before treatment","Pericardial drainage to relieve the strain","b"
"OIC-332-13-A","{""question"": ""What is the recommended first-line treatment for anaphylactic shock?"", ""option_a"": ""IV corticosteroid therapy with methylprednisolone"", ""option_b"": ""Injection of adrenaline IM"", ""option_c"": ""Administration of antihistamines"", ""option_d"": ""Crystalloid volume expansion alone"", ""correct_option"": ""B""}",,"What is the recommended first-line treatment for anaphylactic shock?","IV corticosteroid therapy with methylprednisolone","Injection of adrenaline IM","Administration of antihistamines","Crystalloid volume expansion alone","b"
"OIC-336-01-A","{""question"": ""What is required for a patient to be considered conscious?"", ""option_a"": ""Only the opening of the eyes"", ""option_b"": ""Only the presence of an old-sleep rhythm"", ""option_c"": ""Interaction with the environment, such as eye tracking"", ""option_d"": ""Response to verbal, tactile, or painful stimulation"", ""correct_option"": ""C""}","Definition","What is required for a patient to be considered conscious?","Only the opening of the eyes","Only the presence of an old-sleep rhythm","Interaction with the environment, such as eye tracking","Response to verbal, tactile, or painful stimulation","c"
"OIC-336-02-B","{""question"": ""What is the primary mechanism that contributes to coma in adults and children?"", ""option_a"": ""Damage to the brainstem, which regulates vital functions"", ""option_b"": ""Disruption of the blood-brain barrier, leading to inflammation"", ""option_c"": ""Impaired function of the nerve centres responsible for awakening and consciousness"", ""option_d"": ""Overactivation of the parasympathetic nervous system, causing excessive relaxation"", ""correct_option"": ""C""}","Physiopathology","What is the primary mechanism that contributes to coma in adults and children?","Damage to the brainstem, which regulates vital functions","Disruption of the blood-brain barrier, leading to inflammation","Impaired function of the nerve centres responsible for awakening and consciousness","Overactivation of the parasympathetic nervous system, causing excessive relaxation","c"
"OIC-336-03-A","{""question"": ""What is the primary purpose of using the Glasgow Coma Scale in patients?"", ""option_a"": ""To diagnose the cause of a coma"", ""option_b"": ""To assess the depth and stage of a coma"", ""option_c"": ""To determine the need for cardiorespiratory arrest treatment"", ""option_d"": ""To evaluate the effectiveness of pain management"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary purpose of using the Glasgow Coma Scale in patients?","To diagnose the cause of a coma","To assess the depth and stage of a coma","To determine the need for cardiorespiratory arrest treatment","To evaluate the effectiveness of pain management","b"
"OIC-336-04-A","{""question"": ""What does unilateral mydriasis in a comatose patient typically indicate until proven otherwise?"", ""option_a"": ""Opioid toxidrome"", ""option_b"": ""Tricyclic antidepressant toxidrome"", ""option_c"": ""Temporal engagement"", ""option_d"": ""Severe neurological impairment due to brain stem lesion"", ""correct_option"": ""C""}","Positive diagnosis","What does unilateral mydriasis in a comatose patient typically indicate until proven otherwise?","Opioid toxidrome","Tricyclic antidepressant toxidrome","Temporal engagement","Severe neurological impairment due to brain stem lesion","c"
"OIC-336-05-A","{""question"": ""What is a key clinical sign that could indicate a non-traumatic coma in an adult or child?"", ""option_a"": ""Presence of fever"", ""option_b"": ""History of recent vaccination"", ""option_c"": ""Sudden onset of deafness"", ""option_d"": ""Meningeal syndrome"", ""correct_option"": ""A""}","Positive diagnosis","What is a key clinical sign that could indicate a non-traumatic coma in an adult or child?","Presence of fever","History of recent vaccination","Sudden onset of deafness","Meningeal syndrome","a"
"OIC-336-06-B","{""question"": ""What is one of the required clinical examinations for diagnosing brain death in the absence of confounding factors?"", ""option_a"": ""Presence of trunk reflexes"", ""option_b"": ""Absence of all brain stem reflexes"", ""option_c"": ""Presence of corneal reflex"", ""option_d"": ""Absence of spontaneous ventilation without hypercapnia test"", ""correct_option"": ""option_b""}","Positive diagnosis","What is one of the required clinical examinations for diagnosing brain death in the absence of confounding factors?","Presence of trunk reflexes","Absence of all brain stem reflexes","Presence of corneal reflex","Absence of spontaneous ventilation without hypercapnia test","option_b"
"OIC-336-07-A","{""question"": ""What is the appropriate initial treatment for a patient with hypoglycemia who is conscious?"", ""option_a"": ""Administering direct IV glucose serum"", ""option_b"": ""Providing sugar cubes or orange juice orally"", ""option_c"": ""Performing emergency resuscitation"", ""option_d"": ""Reevaluating the patient's condition without intervention"", ""correct_option"": ""B""}","Positive diagnosis","What is the appropriate initial treatment for a patient with hypoglycemia who is conscious?","Administering direct IV glucose serum","Providing sugar cubes or orange juice orally","Performing emergency resuscitation","Reevaluating the patient's condition without intervention","b"
"OIC-336-08-A","{""question"": ""What is a critical indicator of extreme emergency situations in coma patients, particularly in cases of internal temporal involvement?"", ""option_a"": ""Bilateral mydriasis with normal motor response"", ""option_b"": ""Unilateral mydriasis with decerebrate motor response on the same side"", ""option_c"": ""Generalized tonic-clonic seizures lasting less than 1 minute"", ""option_d"": ""Blood glucose levels above 10 mmol/L"", ""correct_option"": ""B""}","Emergency identification","What is a critical indicator of extreme emergency situations in coma patients, particularly in cases of internal temporal involvement?","Bilateral mydriasis with normal motor response","Unilateral mydriasis with decerebrate motor response on the same side","Generalized tonic-clonic seizures lasting less than 1 minute","Blood glucose levels above 10 mmol/L","b"
"OIC-336-09-A","{""question"": ""In the emergency management of non-traumatic coma in adults and children, what is the most appropriate initial step in prescribing complementary examinations?"", ""option_a"": ""Ordering a brain scan to rule out structural causes"", ""option_b"": ""Performing a lumbar puncture to check for meningitis or encephalitis"", ""option_c"": ""Verifying capillary glycaemia and ordering a standard biological check-up"", ""option_d"": ""Discussing blood/urine toxicology analysis without considering the anamnestic context"", ""correct_option"": ""C""}",,"In the emergency management of non-traumatic coma in adults and children, what is the most appropriate initial step in prescribing complementary examinations?","Ordering a brain scan to rule out structural causes","Performing a lumbar puncture to check for meningitis or encephalitis","Verifying capillary glycaemia and ordering a standard biological check-up","Discussing blood/urine toxicology analysis without considering the anamnestic context","c"
"OIC-336-10-B","{""question"": ""In which of the following situations is an emergency MRI preferred as the first intention in adults and children, if available?"", ""option_a"": ""Suspected intracranial hemorrhage with mass effect"", ""option_b"": ""Suspected ischaemic stroke with basilar trunk thrombosis or malignant sylvian stroke"", ""option_c"": ""Head trauma with suspected skull fracture"", ""option_d"": ""Status epilepticus with no clear cause"", ""correct_option"": ""B""}",,"In which of the following situations is an emergency MRI preferred as the first intention in adults and children, if available?","Suspected intracranial hemorrhage with mass effect","Suspected ischaemic stroke with basilar trunk thrombosis or malignant sylvian stroke","Head trauma with suspected skull fracture","Status epilepticus with no clear cause","b"
"OIC-336-11-B","{""question"": ""On a CT scan without contrast, what is the typical appearance of a spontaneous intracranial hemorrhage in the subarachnoid spaces?"", ""option_a"": ""Hypodensity in the cerebral parenchyma"", ""option_b"": ""Spontaneous hyperdensity in the ventricles"", ""option_c"": ""Spontaneous hyperdensity in the subarachnoid spaces"", ""option_d"": ""Isodensity in the cisterns of the base"", ""correct_option"": ""C""}","Multimedia content","On a CT scan without contrast, what is the typical appearance of a spontaneous intracranial hemorrhage in the subarachnoid spaces?","Hypodensity in the cerebral parenchyma","Spontaneous hyperdensity in the ventricles","Spontaneous hyperdensity in the subarachnoid spaces","Isodensity in the cisterns of the base","c"
"OIC-336-12-B","{""question"": ""What is a sign of mass effect and cerebral involvement in computed tomography?"", ""option_a"": ""Enlargement of the ventricles"", ""option_b"": ""Disappearance of the space between the temporal lobe and the brain stem"", ""option_c"": ""Lateral deviation of the brain stem"", ""option_d"": ""Increase in the space between the cerebral hemispheres"", ""correct_option"": ""B""}","Multimedia content","What is a sign of mass effect and cerebral involvement in computed tomography?","Enlargement of the ventricles","Disappearance of the space between the temporal lobe and the brain stem","Lateral deviation of the brain stem","Increase in the space between the cerebral hemispheres","b"
"OIC-336-13-A","{""question"": ""What is a common cause of non-traumatic coma in adults and children?"", ""option_a"": ""Intracerebral haematoma due to trauma"", ""option_b"": ""Metabolic disorders, such as hypercapnic encephalopathy or hepatic encephalopathy"", ""option_c"": ""Severe dehydration"", ""option_d"": ""Chronic obstructive pulmonary disease (COPD) without any acute complication"", ""correct_option"": ""B""}","Etiologies","What is a common cause of non-traumatic coma in adults and children?","Intracerebral haematoma due to trauma","Metabolic disorders, such as hypercapnic encephalopathy or hepatic encephalopathy","Severe dehydration","Chronic obstructive pulmonary disease (COPD) without any acute complication","b"
"OIC-336-14-A","{""question"": ""What is the appropriate initial treatment for a patient with hypoglycemia?"", ""option_a"": ""Administration of IV flumazenil"", ""option_b"": ""Administration of serum glucose (G30 IV)"", ""option_c"": ""Insertion of a Gu\u00e9del cannula and oxygen therapy"", ""option_d"": ""Setting up an infusion with physiological serum and monitoring with electrocardioscope"", ""correct_option"": ""B""}","Management","What is the appropriate initial treatment for a patient with hypoglycemia?","Administration of IV flumazenil","Administration of serum glucose (G30 IV)","Insertion of a Guédel cannula and oxygen therapy","Setting up an infusion with physiological serum and monitoring with electrocardioscope","b"
"OIC-336-15-B","{""question"": ""What is the recommended initial intervention for a patient with a Glasgow Coma Scale (GCS) score less than 8 and no rapidly reversible cause?"", ""option_a"": ""Immediate surgical intervention to relieve compression"", ""option_b"": ""Orotracheal intubation and initiation of mechanical ventilation"", ""option_c"": ""Administration of hypertonic saline to manage intracranial pressure"", ""option_d"": ""Mobilization to prevent decubitus complications"", ""correct_option"": ""B""}","Management","What is the recommended initial intervention for a patient with a Glasgow Coma Scale (GCS) score less than 8 and no rapidly reversible cause?","Immediate surgical intervention to relieve compression","Orotracheal intubation and initiation of mechanical ventilation","Administration of hypertonic saline to manage intracranial pressure","Mobilization to prevent decubitus complications","b"
"OIC-342-01-A","{""question"": ""What is the primary characteristic that distinguishes lipothymia from other forms of loss of consciousness, such as syncope?"", ""option_a"": ""A prolonged loss of consciousness lasting several minutes"", ""option_b"": ""An imminent sensation of syncope without actual loss of consciousness"", ""option_c"": ""A gradual regaining of consciousness typically occurring in an emergency vehicle or room"", ""option_d"": ""A loss of consciousness associated with myoclonus that begins before the loss of consciousness"", ""correct_option"": ""B""}","Definition","What is the primary characteristic that distinguishes lipothymia from other forms of loss of consciousness, such as syncope?","A prolonged loss of consciousness lasting several minutes","An imminent sensation of syncope without actual loss of consciousness","A gradual regaining of consciousness typically occurring in an emergency vehicle or room","A loss of consciousness associated with myoclonus that begins before the loss of consciousness","b"
"OIC-342-02-B","{""question"": ""What is the main pathophysiological mechanism of malaise in adults?"", ""option_a"": ""Cerebral hyperperfusion and enhanced cerebral activity"", ""option_b"": ""Cerebral hypoperfusion or dysfunction of cerebral activity"", ""option_c"": ""Cardiac hypoperfusion and respiratory dysfunction"", ""option_d"": ""Renal hypoperfusion and hepatic dysfunction"", ""correct_option"": ""B""}","Physiopathology","What is the main pathophysiological mechanism of malaise in adults?","Cerebral hyperperfusion and enhanced cerebral activity","Cerebral hypoperfusion or dysfunction of cerebral activity","Cardiac hypoperfusion and respiratory dysfunction","Renal hypoperfusion and hepatic dysfunction","b"
"OIC-342-03-A","{""question"": ""What is the main diagnostic criterion to distinguish a syncope/lipothymia from a generalised epileptic seizure?"", ""option_a"": ""The presence of prodromes"", ""option_b"": ""The duration of the loss of consciousness"", ""option_c"": ""The type of abnormal movements"", ""option_d"": ""The presence of traumatic lesions"", ""correct_option"": ""B""}","Positive diagnosis","What is the main diagnostic criterion to distinguish a syncope/lipothymia from a generalised epileptic seizure?","The presence of prodromes","The duration of the loss of consciousness","The type of abnormal movements","The presence of traumatic lesions","b"
"OIC-342-04-A","{""question"": ""What is an important factor to consider when diagnosing syncope and lipothymia?"", ""option_a"": ""The patient's medical history only"", ""option_b"": ""The presence or absence of prodromal symptoms and triggering circumstances"", ""option_c"": ""The patient's age and weight"", ""option_d"": ""The time of day the loss of consciousness occurred"", ""correct_option"": ""B""}","Positive diagnosis","What is an important factor to consider when diagnosing syncope and lipothymia?","The patient's medical history only","The presence or absence of prodromal symptoms and triggering circumstances","The patient's age and weight","The time of day the loss of consciousness occurred","b"
"OIC-342-05-A","{""question"": ""What is one of the diagnostic criteria for orthostatic arterial hypotension?"", ""option_a"": ""A fall of > 15 mmHg in systolic blood pressure within 1 minute of becoming orthostatic"", ""option_b"": ""A fall of > 20 mmHg in systolic blood pressure within 1 to 3 minutes of becoming orthostatic"", ""option_c"": ""A fall of > 10 mmHg in diastolic blood pressure within 30 seconds of becoming orthostatic"", ""option_d"": ""Systolic blood pressure \u2264 80 mmHg reproducing spontaneous symptoms within 5 minutes of transition to orthostatism"", ""correct_option"": ""B""}","Positive diagnosis","What is one of the diagnostic criteria for orthostatic arterial hypotension?","A fall of > 15 mmHg in systolic blood pressure within 1 minute of becoming orthostatic","A fall of > 20 mmHg in systolic blood pressure within 1 to 3 minutes of becoming orthostatic","A fall of > 10 mmHg in diastolic blood pressure within 30 seconds of becoming orthostatic","Systolic blood pressure ≤ 80 mmHg reproducing spontaneous symptoms within 5 minutes of transition to orthostatism","b"
"OIC-342-06-A","{""question"": ""What is the primary distinction between an epileptic event and a non-epileptic event (pseudo-seizure) in adults?"", ""option_a"": ""The presence or absence of a fever"", ""option_b"": ""The duration of the loss of consciousness"", ""option_c"": ""The underlying neurological cause, with epileptic events being caused by abnormal electrical activity in the brain"", ""option_d"": ""The level of discomfort experienced by the individual during the event"", ""correct_option"": ""C""}","Positive diagnosis","What is the primary distinction between an epileptic event and a non-epileptic event (pseudo-seizure) in adults?","The presence or absence of a fever","The duration of the loss of consciousness","The underlying neurological cause, with epileptic events being caused by abnormal electrical activity in the brain","The level of discomfort experienced by the individual during the event","c"
"OIC-342-07-A","{""question"": ""What are the main categories of causes of syncope/lipothymia?"", ""option_a"": ""Respiratory, neurological, and endocrine"", ""option_b"": ""Reflex, hypotensive, and cardiac"", ""option_c"": ""Gastrointestinal, musculoskeletal, and integumentary"", ""option_d"": ""Hematological, immunological, and oncological"", ""correct_option"": ""B""}","Etiologies","What are the main categories of causes of syncope/lipothymia?","Respiratory, neurological, and endocrine","Reflex, hypotensive, and cardiac","Gastrointestinal, musculoskeletal, and integumentary","Hematological, immunological, and oncological","b"
"OIC-342-08-A","{""question"": ""What is a potential neurological cause of malaise with partial or total loss of consciousness?"", ""option_a"": ""Focal intracerebral lesion"", ""option_b"": ""Catalepsy"", ""option_c"": ""Hypoglycaemia"", ""option_d"": ""Psychogenic pseudo syncope"", ""correct_option"": ""C""}","Etiologies","What is a potential neurological cause of malaise with partial or total loss of consciousness?","Focal intracerebral lesion","Catalepsy","Hypoglycaemia","Psychogenic pseudo syncope","c"
"OIC-342-09-A","{""question"": ""What is a common non-cardiac and non-neurological cause of malaise with partial or total loss of consciousness?"", ""option_a"": ""Panic attack"", ""option_b"": ""Hypoglycaemia"", ""option_c"": ""Catalepsy"", ""option_d"": ""Fall"", ""correct_option"": ""B""}","Etiologies","What is a common non-cardiac and non-neurological cause of malaise with partial or total loss of consciousness?","Panic attack","Hypoglycaemia","Catalepsy","Fall","b"
"OIC-342-10-A","{""question"": ""What is the recommended course of action for a patient presenting with malaise due to a cardiac cause?"", ""option_a"": ""Discharge with follow-up appointment in one week"", ""option_b"": ""Hospitalisation with continuous monitoring of cardiac rhythm"", ""option_c"": ""Observation in the emergency department for 24 hours"", ""option_d"": ""Referral to a cardiologist for outpatient evaluation"", ""correct_option"": ""B""}",,"What is the recommended course of action for a patient presenting with malaise due to a cardiac cause?","Discharge with follow-up appointment in one week","Hospitalisation with continuous monitoring of cardiac rhythm","Observation in the emergency department for 24 hours","Referral to a cardiologist for outpatient evaluation","b"
"OIC-342-11-A","{""question"": ""What is the primary purpose of an electrocardiogram (ECG) in a patient who has experienced syncope or lipothymia?"", ""option_a"": ""To assess the patient's blood pressure and heart rate"", ""option_b"": ""To evaluate the patient's cardiac structure and function"", ""option_c"": ""To identify decisive ECG abnormalities of immediate diagnostic value"", ""option_d"": ""To monitor the patient's oxygen saturation levels"", ""correct_option"": ""C""}",,"What is the primary purpose of an electrocardiogram (ECG) in a patient who has experienced syncope or lipothymia?","To assess the patient's blood pressure and heart rate","To evaluate the patient's cardiac structure and function","To identify decisive ECG abnormalities of immediate diagnostic value","To monitor the patient's oxygen saturation levels","c"
"OIC-342-12-B","{""question"": ""What is the primary indication for ordering an electroencephalogram (EEG) in an adult patient?"", ""option_a"": ""To diagnose the cause of a headache"", ""option_b"": ""To assess the severity of a traumatic brain injury"", ""option_c"": ""To evaluate malaise or loss of consciousness presumed to be of epileptic origin"", ""option_d"": ""To monitor the progression of a stroke"", ""correct_option"": ""C""}","Additional examinations","What is the primary indication for ordering an electroencephalogram (EEG) in an adult patient?","To diagnose the cause of a headache","To assess the severity of a traumatic brain injury","To evaluate malaise or loss of consciousness presumed to be of epileptic origin","To monitor the progression of a stroke","c"
"OIC-342-13-B","{""question"": ""What are the appropriate second-line tests for diagnosing syncope and lipothymia?"", ""option_a"": ""Blood ionogram, creatininemia, and chest X-ray"", ""option_b"": ""Implantable ECG monitoring, tilt test, and endocavitary electrophysiological study"", ""option_c"": ""Complete blood count, erythrocyte sedimentation rate, and C-reactive protein"", ""option_d"": ""Liver function tests, blood glucose, and electrolyte panel"", ""correct_option"": ""B""}","Additional tests","What are the appropriate second-line tests for diagnosing syncope and lipothymia?","Blood ionogram, creatininemia, and chest X-ray","Implantable ECG monitoring, tilt test, and endocavitary electrophysiological study","Complete blood count, erythrocyte sedimentation rate, and C-reactive protein","Liver function tests, blood glucose, and electrolyte panel","b"
"OIC-342-14-A","{""question"": ""What is a clinical element that justifies a cardiological opinion within 24 hours?"", ""option_a"": ""Tongue biting"", ""option_b"": ""Loss of consciousness during physical effort"", ""option_c"": ""Confusion after brief loss of consciousness"", ""option_d"": ""Persistent coma"", ""correct_option"": ""B""}","Identifying the emergency","What is a clinical element that justifies a cardiological opinion within 24 hours?","Tongue biting","Loss of consciousness during physical effort","Confusion after brief loss of consciousness","Persistent coma","b"
"OIC-342-15-A","{""question"": ""What is the primary goal when managing a patient experiencing a generalized convulsive seizure?"", ""option_a"": ""To immediately stop the seizure using medication"", ""option_b"": ""To keep the patient safe and prevent injury until the seizure ends"", ""option_c"": ""To attempt to restrain the patient to prevent movement"", ""option_d"": ""To leave the patient alone until the seizure passes"", ""correct_option"": ""B""}","Management","What is the primary goal when managing a patient experiencing a generalized convulsive seizure?","To immediately stop the seizure using medication","To keep the patient safe and prevent injury until the seizure ends","To attempt to restrain the patient to prevent movement","To leave the patient alone until the seizure passes","b"
"OIC-342-16-A","{""question"": ""What is the recommended first aid position for an unconscious adult?"", ""option_a"": ""Sitting position with legs elevated"", ""option_b"": ""Lateral safety position with legs elevated if blood pressure is low"", ""option_c"": ""Prone position with head tilted back"", ""option_d"": ""Supine position with arms crossed"", ""correct_option"": ""B""}",,"What is the recommended first aid position for an unconscious adult?","Sitting position with legs elevated","Lateral safety position with legs elevated if blood pressure is low","Prone position with head tilted back","Supine position with arms crossed","b"
"OIC-342-17-B","{""question"": ""What is the primary goal of follow-up care for a patient who has experienced malaise, syncope, or lipothymia of rhythmic cause?"", ""option_a"": ""To reduce the risk of recurrent symptoms"", ""option_b"": ""To prevent the risk of sudden death"", ""option_c"": ""To improve overall quality of life"", ""option_d"": ""To diagnose underlying cardiac conditions"", ""correct_option"": ""B""}",,"What is the primary goal of follow-up care for a patient who has experienced malaise, syncope, or lipothymia of rhythmic cause?","To reduce the risk of recurrent symptoms","To prevent the risk of sudden death","To improve overall quality of life","To diagnose underlying cardiac conditions","b"
"OIC-342-18-B","{""question"": ""What is the primary approach in managing a patient seen for malaise, syncope, or reflex lipothymia?"", ""option_a"": ""Immediate hospitalization for thorough examination"", ""option_b"": ""Patient reassurance and education on the benign nature of the condition"", ""option_c"": ""Prescription of medication to prevent future episodes"", ""option_d"": ""Referral to a specialist for further evaluation"", ""correct_option"": ""B""}","Management","What is the primary approach in managing a patient seen for malaise, syncope, or reflex lipothymia?","Immediate hospitalization for thorough examination","Patient reassurance and education on the benign nature of the condition","Prescription of medication to prevent future episodes","Referral to a specialist for further evaluation","b"
"OIC-342-19-B","{""question"": ""What is a crucial aspect of managing a patient, especially an elderly one, who has been seen for malaise and orthostatic arterial hypotension?"", ""option_a"": ""Immediate discharge without follow-up"", ""option_b"": ""Regular review of medication to prevent adverse interactions"", ""option_c"": ""Isolation from other patients to prevent infection spread"", ""option_d"": ""Discontinuation of all medications to avoid complications"", ""correct_option"": ""B""}",,"What is a crucial aspect of managing a patient, especially an elderly one, who has been seen for malaise and orthostatic arterial hypotension?","Immediate discharge without follow-up","Regular review of medication to prevent adverse interactions","Isolation from other patients to prevent infection spread","Discontinuation of all medications to avoid complications","b"
"OIC-342-20-A","{""question"": ""What type of medication is typically used for short-acting antiepileptic treatment?"", ""option_a"": ""Barbiturates"", ""option_b"": ""Benzodiazepines"", ""option_c"": ""Antipsychotics"", ""option_d"": ""Antidepressants"", ""correct_option"": ""B""}","Management","What type of medication is typically used for short-acting antiepileptic treatment?","Barbiturates","Benzodiazepines","Antipsychotics","Antidepressants","b"
"OIC-342-21-A","{""question"": ""What is the primary approach to managing a comital seizure in adults?"", ""option_a"": ""Using only short-acting treatments to immediately resolve the seizure"", ""option_b"": ""Combining long-acting treatments with short-acting treatments for comprehensive management"", ""option_c"": ""Focusing solely on long-acting treatments to prevent future seizures"", ""option_d"": ""Avoiding medication and opting for alternative therapies"", ""correct_option"": ""B""}","Management","What is the primary approach to managing a comital seizure in adults?","Using only short-acting treatments to immediately resolve the seizure","Combining long-acting treatments with short-acting treatments for comprehensive management","Focusing solely on long-acting treatments to prevent future seizures","Avoiding medication and opting for alternative therapies","b"
"OIC-347-01-A","{""question"": ""What is the definition of acute urinary retention?"", ""option_a"": ""A gradual and partial inability to urinate despite a mild need to do so"", ""option_b"": ""A complete and sudden inability to urinate despite an urgent or painful need to do so"", ""option_c"": ""A recurring and intermittent inability to urinate without any urgent need to do so"", ""option_d"": ""A chronic and persistent inability to urinate due to a lack of fluid intake"", ""correct_option"": ""B""}","Definition","What is the definition of acute urinary retention?","A gradual and partial inability to urinate despite a mild need to do so","A complete and sudden inability to urinate despite an urgent or painful need to do so","A recurring and intermittent inability to urinate without any urgent need to do so","A chronic and persistent inability to urinate due to a lack of fluid intake","b"
"OIC-347-02-B","{""question"": ""What is a crucial factor for normal micturition to occur?"", ""option_a"": ""A voluntarily closing bladder neck"", ""option_b"": ""A nervous system that allows simultaneous detrusor contraction and sphincter relaxation"", ""option_c"": ""A narrowed urethra"", ""option_d"": ""A bladder that expands thanks to the detrusor muscle"", ""correct_option"": ""B""}","Physiopathology","What is a crucial factor for normal micturition to occur?","A voluntarily closing bladder neck","A nervous system that allows simultaneous detrusor contraction and sphincter relaxation","A narrowed urethra","A bladder that expands thanks to the detrusor muscle","b"
"OIC-347-03-A","{""question"": ""What is a common cause of acute urinary retention in men due to mechanical obstruction?"", ""option_a"": ""Diabetic polyneuropathy"", ""option_b"": ""Benign prostatic hyperplasia (BPH)"", ""option_c"": ""Multiple sclerosis"", ""option_d"": ""Constipation"", ""correct_option"": ""B""}","Etiologies","What is a common cause of acute urinary retention in men due to mechanical obstruction?","Diabetic polyneuropathy","Benign prostatic hyperplasia (BPH)","Multiple sclerosis","Constipation","b"
"OIC-347-04-A","{""question"": ""A patient presents to the emergency department with suprapubic pain and an inability to urinate despite a full bladder. What is the most likely cause of their symptoms?"", ""option_a"": ""Urinary incontinence"", ""option_b"": ""Faecal impaction"", ""option_c"": ""Acute urinary retention"", ""option_d"": ""Prostate cancer"", ""correct_option"": ""C""}","Positive diagnosis","A patient presents to the emergency department with suprapubic pain and an inability to urinate despite a full bladder. What is the most likely cause of their symptoms?","Urinary incontinence","Faecal impaction","Acute urinary retention","Prostate cancer","c"
"OIC-347-05-B","{""question"": ""In which of the following patients may acute urine retention be painless due to a specific underlying condition?"", ""option_a"": ""Young patients with no prior medical history"", ""option_b"": ""Patients with diabetes due to bladder hyposensitivity secondary to vegetative neuropathy"", ""option_c"": ""Patients with spinal cord injury but only if the lesion is below T6"", ""option_d"": ""Patients with a history of urinary tract infections"", ""correct_option"": ""B""}",,"In which of the following patients may acute urine retention be painless due to a specific underlying condition?","Young patients with no prior medical history","Patients with diabetes due to bladder hyposensitivity secondary to vegetative neuropathy","Patients with spinal cord injury but only if the lesion is below T6","Patients with a history of urinary tract infections","b"
"OIC-347-06-A","{""question"": ""What is the primary distinction between acute urine retention and anuria?"", ""option_a"": ""The presence of severe abdominal pain"", ""option_b"": ""The presence of a palpable bladder and the desire to urinate"", ""option_c"": ""The complete absence of any urinary tract symptoms"", ""option_d"": ""The presence of a mild fever"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary distinction between acute urine retention and anuria?","The presence of severe abdominal pain","The presence of a palpable bladder and the desire to urinate","The complete absence of any urinary tract symptoms","The presence of a mild fever","b"
"OIC-347-07-A","{""question"": ""What is the appropriate next step in the initial assessment of a patient with suspected acute urine retention if there is any doubt about the diagnosis?"", ""option_a"": ""Perform a CT scan to rule out other abdominal issues"", ""option_b"": ""Conduct a suprapubic ultrasound to assess bladder fullness"", ""option_c"": ""Order a urine culture to check for infection"", ""option_d"": ""Prescribe antibiotics immediately to prevent infection"", ""correct_option"": ""B""}","Additional tests","What is the appropriate next step in the initial assessment of a patient with suspected acute urine retention if there is any doubt about the diagnosis?","Perform a CT scan to rule out other abdominal issues","Conduct a suprapubic ultrasound to assess bladder fullness","Order a urine culture to check for infection","Prescribe antibiotics immediately to prevent infection","b"
"OIC-347-08-A","{""question"": ""What is the primary purpose of performing an upper urinary tract ultrasound in a patient with acute urine retention?"", ""option_a"": ""To assess the bladder for tumours or lithiasis"", ""option_b"": ""To evaluate the prostate volume"", ""option_c"": ""To look for dilatation of the upper urinary tract"", ""option_d"": ""To check for hyperkalaemia or hyponatraemia"", ""correct_option"": ""C""}","Additional examinations","What is the primary purpose of performing an upper urinary tract ultrasound in a patient with acute urine retention?","To assess the bladder for tumours or lithiasis","To evaluate the prostate volume","To look for dilatation of the upper urinary tract","To check for hyperkalaemia or hyponatraemia","c"
"OIC-347-09-A","{""question"": ""What is a potential complication of acute urinary retention if the bladder is emptied too quickly?"", ""option_a"": ""Obstruction lifting syndrome"", ""option_b"": ""Vacuo haematuria"", ""option_c"": ""Acute renal failure"", ""option_d"": ""Bladder rupture"", ""correct_option"": ""B""}","Identification of the emergency","What is a potential complication of acute urinary retention if the bladder is emptied too quickly?","Obstruction lifting syndrome","Vacuo haematuria","Acute renal failure","Bladder rupture","b"
"OIC-347-10-B","{""question"": ""A patient is diagnosed with acute urine retention and has a history of urethral trauma. Which type of catheterization is most appropriate for this patient?"", ""option_a"": ""Bladder catheterisation"", ""option_b"": ""Suprapubic catheterisation"", ""option_c"": ""Intermittent self-catheterisation"", ""option_d"": ""Condom catheterisation"", ""correct_option"": ""B""}",,"A patient is diagnosed with acute urine retention and has a history of urethral trauma. Which type of catheterization is most appropriate for this patient?","Bladder catheterisation","Suprapubic catheterisation","Intermittent self-catheterisation","Condom catheterisation","b"
"OIC-347-11-A","{""question"": ""What is the primary goal of emergency management in acute urinary retention?"", ""option_a"": ""To immediately treat any underlying infection"", ""option_b"": ""To relieve the obstruction and prevent further complications"", ""option_c"": ""To solely monitor diuresis without intervention"", ""option_d"": ""To postpone treatment until outpatient care is feasible"", ""correct_option"": ""B""}","Management","What is the primary goal of emergency management in acute urinary retention?","To immediately treat any underlying infection","To relieve the obstruction and prevent further complications","To solely monitor diuresis without intervention","To postpone treatment until outpatient care is feasible","b"
"OIC-351-01-A","{""question"": ""What is the definition of agitation?"", ""option_a"": ""A state of emotional calmness and productive physical and mental activity"", ""option_b"": ""A state of emotional tension and unproductive physical and mental hyperactivity"", ""option_c"": ""A state of emotional numbness and lack of physical and mental activity"", ""option_d"": ""A state of emotional stability and purposeful physical and mental activity"", ""correct_option"": ""B""}","Definition","What is the definition of agitation?","A state of emotional calmness and productive physical and mental activity","A state of emotional tension and unproductive physical and mental hyperactivity","A state of emotional numbness and lack of physical and mental activity","A state of emotional stability and purposeful physical and mental activity","b"
"OIC-351-02-A","{""question"": ""What is the definition of hallucinations in the context of psychiatric symptoms?"", ""option_a"": ""Alterations in the content of thought leading to a loss of contact with reality, shared by the socio-cultural group"", ""option_b"": ""Sensory perception without the presence of a detectable object"", ""option_c"": ""A normal response to stress or anxiety"", ""option_d"": ""A type of delusional idea that is shared by others"", ""correct_option"": ""B""}","Definition","What is the definition of hallucinations in the context of psychiatric symptoms?","Alterations in the content of thought leading to a loss of contact with reality, shared by the socio-cultural group","Sensory perception without the presence of a detectable object","A normal response to stress or anxiety","A type of delusional idea that is shared by others","b"
"OIC-351-03-A","{""question"": ""What are the primary symptoms that characterize acute delirium?"", ""option_a"": ""Only depressive or manic symptoms"", ""option_b"": ""Delusional ideas and hallucinations, which are positive psychotic symptoms"", ""option_c"": ""Negative psychotic symptoms alone, such as social withdrawal"", ""option_d"": ""Symptoms of psychotic disorganisation without any positive psychotic symptoms"", ""correct_option"": ""B""}","Definition","What are the primary symptoms that characterize acute delirium?","Only depressive or manic symptoms","Delusional ideas and hallucinations, which are positive psychotic symptoms","Negative psychotic symptoms alone, such as social withdrawal","Symptoms of psychotic disorganisation without any positive psychotic symptoms","b"
"OIC-351-04-A","{""question"": ""In seniors, what is a common iatrogenic cause of agitation, often associated with confusion?"", ""option_a"": ""Antipsychotics without anticholinergic properties"", ""option_b"": ""Anticholinergic drugs, such as tricyclic antidepressants or correctors of adverse effects of antipsychotics"", ""option_c"": ""Non-steroidal anti-inflammatory drugs (NSAIDs)"", ""option_d"": ""Beta blockers"", ""correct_option"": ""B""}",,"In seniors, what is a common iatrogenic cause of agitation, often associated with confusion?","Antipsychotics without anticholinergic properties","Anticholinergic drugs, such as tricyclic antidepressants or correctors of adverse effects of antipsychotics","Non-steroidal anti-inflammatory drugs (NSAIDs)","Beta blockers","b"
"OIC-351-05-A","{""question"": ""When assessing the aetiology of acute delirious syndromes, what is the first step to take before suggesting a psychiatric aetiology?"", ""option_a"": ""Consider the patient's psychiatric history"", ""option_b"": ""Rule out non-psychiatric causes"", ""option_c"": ""Identify manic or depressive symptoms"", ""option_d"": ""Determine the patient's age group"", ""correct_option"": ""B""}",,"When assessing the aetiology of acute delirious syndromes, what is the first step to take before suggesting a psychiatric aetiology?","Consider the patient's psychiatric history","Rule out non-psychiatric causes","Identify manic or depressive symptoms","Determine the patient's age group","b"
"OIC-351-06-A","{""question"": ""What is the primary purpose of assessing vital signs, such as temperature, blood pressure, and heart rate, during the clinical examination of a patient with agitation?"", ""option_a"": ""To evaluate the patient's psychiatric history"", ""option_b"": ""To identify potential non-psychiatric causes of agitation, such as infection or severe dehydration"", ""option_c"": ""To assess the patient's depressive and manic symptoms"", ""option_d"": ""To determine the patient's anxiety level"", ""correct_option"": ""B""}","Positive diagnosis","What is the primary purpose of assessing vital signs, such as temperature, blood pressure, and heart rate, during the clinical examination of a patient with agitation?","To evaluate the patient's psychiatric history","To identify potential non-psychiatric causes of agitation, such as infection or severe dehydration","To assess the patient's depressive and manic symptoms","To determine the patient's anxiety level","b"
"OIC-351-07-A","{""question"": ""What characterizes the delusions in schizophrenia in terms of systematisation?"", ""option_a"": ""They are highly systematised with a clear logic and narrative thread"", ""option_b"": ""They are partially systematised, allowing for some criticism of delusional ideas"", ""option_c"": ""They are unsystematised, vague, and lack logic or a narrative thread"", ""option_d"": ""They fluctuate between being systematised and unsystematised depending on the patient's adherence"", ""correct_option"": ""C""}","Positive diagnosis","What characterizes the delusions in schizophrenia in terms of systematisation?","They are highly systematised with a clear logic and narrative thread","They are partially systematised, allowing for some criticism of delusional ideas","They are unsystematised, vague, and lack logic or a narrative thread","They fluctuate between being systematised and unsystematised depending on the patient's adherence","c"
"OIC-351-08-A","{""question"": ""A patient is experiencing voices commenting on their actions, which is an example of what type of hallucination?"", ""option_a"": ""Visual hallucination"", ""option_b"": ""Auditory hallucination"", ""option_c"": ""Tactile hallucination"", ""option_d"": ""Cenesthetic hallucination"", ""correct_option"": ""B""}","Positive diagnosis","A patient is experiencing voices commenting on their actions, which is an example of what type of hallucination?","Visual hallucination","Auditory hallucination","Tactile hallucination","Cenesthetic hallucination","b"
"OIC-351-09-B","{""question"": ""What should be considered first when evaluating a patient with acute agitation or delirium to determine if the cause is non-psychiatric?"", ""option_a"": ""Presence of hallucinations or delusions"", ""option_b"": ""Signs of cardiovascular or respiratory failure, or other physical signs such as dehydration or infection"", ""option_c"": ""History of psychiatric illness"", ""option_d"": ""Patient's age and medical history"", ""correct_option"": ""B""}","Positive diagnosis","What should be considered first when evaluating a patient with acute agitation or delirium to determine if the cause is non-psychiatric?","Presence of hallucinations or delusions","Signs of cardiovascular or respiratory failure, or other physical signs such as dehydration or infection","History of psychiatric illness","Patient's age and medical history","b"
"OIC-351-10-A","{""question"": ""In the context of agitation, what is the primary purpose of performing an ECG as part of the systematic examinations?"", ""option_a"": ""To assess liver function"", ""option_b"": ""To evaluate the risk of long QT interval, particularly before initiating antipsychotic treatment"", ""option_c"": ""To diagnose cerebral infections"", ""option_d"": ""To measure blood glucose levels"", ""correct_option"": ""B""}","Management","In the context of agitation, what is the primary purpose of performing an ECG as part of the systematic examinations?","To assess liver function","To evaluate the risk of long QT interval, particularly before initiating antipsychotic treatment","To diagnose cerebral infections","To measure blood glucose levels","b"
"OIC-351-11-A","{""question"": ""What is the primary approach to treating agitation in patients, according to the principles of management of acute delirium and agitation?"", ""option_a"": ""Physical or mechanical restraint as the first line of treatment"", ""option_b"": ""Pharmacological treatment with benzodiazepines or antipsychotics, ideally with patient involvement in the choice of product and route of administration"", ""option_c"": ""Immediate psychiatric hospitalization without initial treatment in the emergency department"", ""option_d"": ""Non-pharmacological treatments such as systematic relationship management and de-escalation techniques, but only after pharmacological treatment has been tried"", ""correct_option"": ""B""}","Management","What is the primary approach to treating agitation in patients, according to the principles of management of acute delirium and agitation?","Physical or mechanical restraint as the first line of treatment","Pharmacological treatment with benzodiazepines or antipsychotics, ideally with patient involvement in the choice of product and route of administration","Immediate psychiatric hospitalization without initial treatment in the emergency department","Non-pharmacological treatments such as systematic relationship management and de-escalation techniques, but only after pharmacological treatment has been tried","b"
"OIC-351-12-A","{""question"": ""According to the regulations, what is the primary consideration for determining the indications and conditions of free hospitalization and hospitalization without consent?"", ""option_a"": ""The patient's financial status"", ""option_b"": ""The patient's age and medical condition"", ""option_c"": ""The hospital's availability of resources"", ""option_d"": ""The patient's insurance coverage"", ""correct_option"": ""B""}","Management","According to the regulations, what is the primary consideration for determining the indications and conditions of free hospitalization and hospitalization without consent?","The patient's financial status","The patient's age and medical condition","The hospital's availability of resources","The patient's insurance coverage","b"
"OIC-353-01-A","{""question"": ""What is the definition of a suicidal person?"", ""option_a"": ""An individual who has voluntarily taken their own life"", ""option_b"": ""An individual who survives a suicide attempt or has suicidal thoughts"", ""option_c"": ""An individual who has never experienced suicidal ideation"", ""option_d"": ""An individual who has attempted suicide but has no history of suicidal thoughts"", ""correct_option"": ""B""}","Definition","What is the definition of a suicidal person?","An individual who has voluntarily taken their own life","An individual who survives a suicide attempt or has suicidal thoughts","An individual who has never experienced suicidal ideation","An individual who has attempted suicide but has no history of suicidal thoughts","b"
"OIC-353-02-A","{""question"": ""What is the estimated lifetime suicide mortality rate for a person who has attempted suicide?"", ""option_a"": ""5%"", ""option_b"": ""10%"", ""option_c"": ""20%"", ""option_d"": ""30%"", ""correct_option"": ""B""}","Epidemiology","What is the estimated lifetime suicide mortality rate for a person who has attempted suicide?","5%","10%","20%","30%","b"
"OIC-353-03-A","{""question"": ""What is a key characteristic of a suicidal crisis?"", ""option_a"": ""It is a permanent state with no reversible outcome"", ""option_b"": ""It is a temporary and reversible psychological crisis linked to prior vulnerability and suicidal ideation"", ""option_c"": ""It only occurs in individuals with no history of mental health issues"", ""option_d"": ""It is always preceded by a long period of visible emotional distress"", ""correct_option"": ""B""}","Positive diagnosis","What is a key characteristic of a suicidal crisis?","It is a permanent state with no reversible outcome","It is a temporary and reversible psychological crisis linked to prior vulnerability and suicidal ideation","It only occurs in individuals with no history of mental health issues","It is always preceded by a long period of visible emotional distress","b"
"OIC-353-04-A","{""question"": ""At what age are suicidal ideas and intentions possible in children?"", ""option_a"": ""From the age of 10-12"", ""option_b"": ""From the age of 5-6"", ""option_c"": ""From the age of 15-16"", ""option_d"": ""From the age of 20-21"", ""correct_option"": ""B""}","Positive diagnosis","At what age are suicidal ideas and intentions possible in children?","From the age of 10-12","From the age of 5-6","From the age of 15-16","From the age of 20-21","b"
"OIC-353-05-A","{""question"": ""What are the three components of assessing suicidal potential in psychiatry?"", ""option_a"": ""Risk, resilience, and protective factors"", ""option_b"": ""Urgency, dangerousness, and psychiatric pathology"", ""option_c"": ""Risk, urgency, and dangerousness"", ""option_d"": ""Individual factors, family factors, and psychosocial factors"", ""correct_option"": ""C""}","Positive diagnosis","What are the three components of assessing suicidal potential in psychiatry?","Risk, resilience, and protective factors","Urgency, dangerousness, and psychiatric pathology","Risk, urgency, and dangerousness","Individual factors, family factors, and psychosocial factors","c"
"OIC-353-06-B","{""question"": ""What is the primary focus of primary prevention measures in the context of suicidal risk and behavior?"", ""option_a"": ""Early detection of suicidal crises"", ""option_b"": ""Care for individuals who have attempted suicide"", ""option_c"": ""Identifying people with risk factors and providing treatment, such as for depression"", ""option_d"": ""Restricting access to resources that could be used for suicide"", ""correct_option"": ""C""}",,"What is the primary focus of primary prevention measures in the context of suicidal risk and behavior?","Early detection of suicidal crises","Care for individuals who have attempted suicide","Identifying people with risk factors and providing treatment, such as for depression","Restricting access to resources that could be used for suicide","c"
"OIC-353-07-B","{""question"": ""What is the appropriate approach when addressing a patient with suicidal thoughts?"", ""option_a"": ""Avoid discussing suicidal thoughts directly and focus on other mental health issues"", ""option_b"": ""Address suicidal thoughts directly and guarantee confidentiality in a quiet, face-to-face setting"", ""option_c"": ""Trivialize suicidal behavior as a normal response to stress"", ""option_d"": ""Only assess suicidal risk after other mental health issues have been addressed"", ""correct_option"": ""B""}","Management","What is the appropriate approach when addressing a patient with suicidal thoughts?","Avoid discussing suicidal thoughts directly and focus on other mental health issues","Address suicidal thoughts directly and guarantee confidentiality in a quiet, face-to-face setting","Trivialize suicidal behavior as a normal response to stress","Only assess suicidal risk after other mental health issues have been addressed","b"
"OIC-353-08-A","{""question"": ""What is the primary purpose of a psychiatric interview in the context of a suicidal crisis?"", ""option_a"": ""To decide on the indication for medicinal treatment, such as sedatives or anxiolytics"", ""option_b"": ""To assess the potential for suicidal crisis, evaluate associated psychiatric disorders, and guide treatment"", ""option_c"": ""To determine the need for hospital admission and develop a treatment plan"", ""option_d"": ""To provide a quiet welcome and keep the patient safe"", ""correct_option"": ""B""}","Management","What is the primary purpose of a psychiatric interview in the context of a suicidal crisis?","To decide on the indication for medicinal treatment, such as sedatives or anxiolytics","To assess the potential for suicidal crisis, evaluate associated psychiatric disorders, and guide treatment","To determine the need for hospital admission and develop a treatment plan","To provide a quiet welcome and keep the patient safe","b"
"OIC-353-09-B","{""question"": ""What is one of the indications for hospitalising a patient with suicidal risk?"", ""option_a"": ""Only when the patient has a low degree of urgency and no psychiatric disorders"", ""option_b"": ""In the event of a suicidal risk with a high degree of urgency"", ""option_c"": ""When the patient refuses to participate in outpatient follow-up"", ""option_d"": ""When the patient's family members are not available for support"", ""correct_option"": ""B""}","Management","What is one of the indications for hospitalising a patient with suicidal risk?","Only when the patient has a low degree of urgency and no psychiatric disorders","In the event of a suicidal risk with a high degree of urgency","When the patient refuses to participate in outpatient follow-up","When the patient's family members are not available for support","b"
"OIC-353-10-B","{""question"": ""What is a crucial component of managing suicidal risk in children and adolescents?"", ""option_a"": ""Only involving the patient in the care process"", ""option_b"": ""Drawing up a personalised safety plan with the patient and their parents"", ""option_c"": ""Conducting a medical assessment without a psychosocial assessment"", ""option_d"": ""Limiting access to lethal means without informing the parents"", ""correct_option"": ""B""}","Management","What is a crucial component of managing suicidal risk in children and adolescents?","Only involving the patient in the care process","Drawing up a personalised safety plan with the patient and their parents","Conducting a medical assessment without a psychosocial assessment","Limiting access to lethal means without informing the parents","b"
"OIC-353-11-B","{""question"": ""In managing suicidal risk in older adults, what is a crucial step that should be taken in the event of a proven suicidal crisis?"", ""option_a"": ""Increase social isolation to reduce stress"", ""option_b"": ""Remove access to the means of suicide"", ""option_c"": ""Ignore physical pain as it's a normal part of aging"", ""option_d"": ""Delay psychosocial assessment until the crisis passes"", ""correct_option"": ""B""}","Management","In managing suicidal risk in older adults, what is a crucial step that should be taken in the event of a proven suicidal crisis?","Increase social isolation to reduce stress","Remove access to the means of suicide","Ignore physical pain as it's a normal part of aging","Delay psychosocial assessment until the crisis passes","b"
"OIC-364-01-A","{""question"": ""What is the name of the classification system used to describe epiphyseal fracture-decollement in children?"", ""option_a"": ""Salter and Harris classification"", ""option_b"": ""Gartland classification"", ""option_c"": ""AO classification"", ""option_d"": ""Jenny classification"", ""correct_option"": ""A""}","Definition","What is the name of the classification system used to describe epiphyseal fracture-decollement in children?","Salter and Harris classification","Gartland classification","AO classification","Jenny classification","a"
"OIC-364-02-B","{""question"": ""What type of fractures are most commonly encountered in children?"", ""option_a"": ""Type III or IV epiphyseal dislocations and complete fractures"", ""option_b"": ""Epiphyseal dislocations, green wood fractures, and metaphyseal fractures"", ""option_c"": ""Butter clod fractures, epiphyseal fracture-decollement, and plastic deformation of the bones"", ""option_d"": ""Apophyseal fracture-avulsions and incomplete fractures"", ""correct_option"": ""B""}","Definition","What type of fractures are most commonly encountered in children?","Type III or IV epiphyseal dislocations and complete fractures","Epiphyseal dislocations, green wood fractures, and metaphyseal fractures","Butter clod fractures, epiphyseal fracture-decollement, and plastic deformation of the bones","Apophyseal fracture-avulsions and incomplete fractures","b"
"OIC-364-03-B","{""question"": ""What is the primary role of the periosteum in the context of bone fractures in children?"", ""option_a"": ""To reduce the risk of infection by encapsulating the fracture site"", ""option_b"": ""To facilitate the rapid formation of a 'periosteal' callus, ensuring early fracture stability"", ""option_c"": ""To increase the severity of the fracture by putting additional stress on the bone"", ""option_d"": ""To prevent any callus formation, allowing for a more natural healing process"", ""correct_option"": ""B""}",,"What is the primary role of the periosteum in the context of bone fractures in children?","To reduce the risk of infection by encapsulating the fracture site","To facilitate the rapid formation of a 'periosteal' callus, ensuring early fracture stability","To increase the severity of the fracture by putting additional stress on the bone","To prevent any callus formation, allowing for a more natural healing process","b"
"OIC-364-04-B","{""question"": ""What is the dominant aetiology of fractures in children from pre-adolescence onwards?"", ""option_a"": ""Accidents involving wheeled or rolling devices"", ""option_b"": ""Sports activities"", ""option_c"": ""Falls from heights"", ""option_d"": ""Playground accidents"", ""correct_option"": ""B""}","Epidemiology","What is the dominant aetiology of fractures in children from pre-adolescence onwards?","Accidents involving wheeled or rolling devices","Sports activities","Falls from heights","Playground accidents","b"
"OIC-364-05-A","{""question"": ""What is a suggestive sign of maltreatment in a child with a fracture?"", ""option_a"": ""A fracture occurring after the age of walking with a clear explanation"", ""option_b"": ""A fracture before the age of walking with an unexplained context"", ""option_c"": ""A single type of trauma with a consistent age"", ""option_d"": ""A fracture with no signs of ecchymosis, petechiae, or haematomas"", ""correct_option"": ""B""}","Identification of the emergency","What is a suggestive sign of maltreatment in a child with a fracture?","A fracture occurring after the age of walking with a clear explanation","A fracture before the age of walking with an unexplained context","A single type of trauma with a consistent age","A fracture with no signs of ecchymosis, petechiae, or haematomas","b"
"OIC-364-06-A","{""question"": ""What is the primary goal when initially managing a childhood trauma suspected to be a fracture?"", ""option_a"": ""To immediately start physical therapy to regain mobility"", ""option_b"": ""To treat pain, immobilize the affected limb, and prescribe targeted imaging"", ""option_c"": ""To administer a high dose of antibiotics to prevent infection"", ""option_d"": ""To encourage the child to move the affected limb to assess the range of motion"", ""correct_option"": ""B""}",,"What is the primary goal when initially managing a childhood trauma suspected to be a fracture?","To immediately start physical therapy to regain mobility","To treat pain, immobilize the affected limb, and prescribe targeted imaging","To administer a high dose of antibiotics to prevent infection","To encourage the child to move the affected limb to assess the range of motion","b"
"OIC-364-07-A","{""question"": ""What is the primary indication for requesting comparative radiography in children with suspected fractures?"", ""option_a"": ""All cases of suspected fractures to confirm the diagnosis"", ""option_b"": ""Exceptional cases of persistent doubt after initial radiography and specialist advice"", ""option_c"": ""When the fracture is located in a region with a high risk of complications"", ""option_d"": ""For cases where ultrasound or MRI are not available"", ""correct_option"": ""B""}","Additional examinations","What is the primary indication for requesting comparative radiography in children with suspected fractures?","All cases of suspected fractures to confirm the diagnosis","Exceptional cases of persistent doubt after initial radiography and specialist advice","When the fracture is located in a region with a high risk of complications","For cases where ultrasound or MRI are not available","b"
"OIC-364-08-B","{""question"": ""What is a key consideration when performing osteosynthesis in children?"", ""option_a"": ""The growth plate can be sacrificed if it means achieving better fracture alignment"", ""option_b"": ""The growth plate must be rigorously preserved during the procedure"", ""option_c"": ""Osteosynthesis in children is identical to that in adults, with no special considerations"", ""option_d"": ""Physiotherapy is always required after osteosynthesis in children to promote healing"", ""correct_option"": ""B""}","Management","What is a key consideration when performing osteosynthesis in children?","The growth plate can be sacrificed if it means achieving better fracture alignment","The growth plate must be rigorously preserved during the procedure","Osteosynthesis in children is identical to that in adults, with no special considerations","Physiotherapy is always required after osteosynthesis in children to promote healing","b"
"OIC-364-09-A","{""question"": ""What is the first sign of compartment syndrome in a child with a supracondylar fracture of the humerus?"", ""option_a"": ""Numbness in the forearm"", ""option_b"": ""Pain"", ""option_c"": ""Paralysis of the upper limb"", ""option_d"": ""Coolness of the extremities"", ""correct_option"": ""B""}",,"What is the first sign of compartment syndrome in a child with a supracondylar fracture of the humerus?","Numbness in the forearm","Pain","Paralysis of the upper limb","Coolness of the extremities","b"
"OIC-364-10-B","{""question"": ""What is a characteristic of a fracture of the lateral condyle of the elbow?"", ""option_a"": ""It is a non-articular fracture that can be treated conservatively."", ""option_b"": ""It is a type I or II epiphyseal detachment with minimal risk of displacement."", ""option_c"": ""It is a type III or IV epiphyseal detachment with a high risk of initial or secondary displacement due to muscle insertions."", ""option_d"": ""It is an extra-articular fracture that does not require surgical intervention."", ""correct_option"": ""C""}","Positive diagnosis","What is a characteristic of a fracture of the lateral condyle of the elbow?","It is a non-articular fracture that can be treated conservatively.","It is a type I or II epiphyseal detachment with minimal risk of displacement.","It is a type III or IV epiphyseal detachment with a high risk of initial or secondary displacement due to muscle insertions.","It is an extra-articular fracture that does not require surgical intervention.","c"
"OIC-364-11-A","{""question"": ""What is the typical treatment approach for type I or II epiphyseal dislocations in children?"", ""option_a"": ""Surgical treatment"", ""option_b"": ""Orthopaedic treatment"", ""option_c"": ""Immobilization only"", ""option_d"": ""Pain management only"", ""correct_option"": ""B""}","Positive diagnosis","What is the typical treatment approach for type I or II epiphyseal dislocations in children?","Surgical treatment","Orthopaedic treatment","Immobilization only","Pain management only","b"
"OIC-364-12-B","{""question"": ""What is a potential complication of ankle epiphyseal detachment fractures in adolescents?"", ""option_a"": ""Premature closure of the growth plate, leading to growth problems"", ""option_b"": ""Increased risk of osteoarthritis in adulthood"", ""option_c"": ""Temporary loss of ankle mobility"", ""option_d"": ""Fracture non-union"", ""correct_option"": ""A""}",,"What is a potential complication of ankle epiphyseal detachment fractures in adolescents?","Premature closure of the growth plate, leading to growth problems","Increased risk of osteoarthritis in adulthood","Temporary loss of ankle mobility","Fracture non-union","a"
